diff --git "a/test.jsonl" "b/test.jsonl" --- "a/test.jsonl" +++ "b/test.jsonl" @@ -1,2015 +1,2134 @@ -{"id": 13530, "instruction": "ジアフェンチウロンの別名は?", "response": "ジアフェンチウロンの別名はDiafenthiuronです。", "task": "replace", "name_q": "ジアフェンチウロン", "name_a": "Diafenthiuron"} -{"id": 2695, "instruction": "SYMDEKO(VertexPharmaceuticalsIncorporated)を主とした薬品は?", "response": "SYMDEKO(VertexPharmaceuticalsIncorporated)を主とした薬品はSYMDEKO(VertexPharmaceuticalsIncorporated)です。", "task": "product", "name_q": "SYMDEKO(VertexPharmaceuticalsIncorporated)", "name_a": "SYMDEKO(VertexPharmaceuticalsIncorporated)"} -{"id": 12079, "instruction": "エミテフルをを化学構造で記述すると?", "response": "エミテフルをを化学構造で記述するとC28H19FN4O8です。", "task": "formula", "name_q": "エミテフル", "name_a": "C28H19FN4O8"} -{"id": 9606, "instruction": "バスイムグルラントの英訳は?", "response": "バスイムグルラントの英訳はBasimglurant (USAN/INN)です。", "task": "replace ja to en", "name_q": "バスイムグルラント", "name_a": "Basimglurant (USAN/INN)"} -{"id": 26168, "instruction": "C22H27NO2をを分子式で記述すると?", "response": "C22H27NO2をを分子式で記述するとC22H27NO2です。", "task": "formula", "name_q": "C22H27NO2", "name_a": "C22H27NO2"} -{"id": 24205, "instruction": "OSMEDを言い換えると?", "response": "OSMEDを言い換えると耳・脊椎・巨大骨端異形成症です。", "task": "replace", "name_q": "OSMED", "name_a": "耳・脊椎・巨大骨端異形成症"} -{"id": 10253, "instruction": "Jacobs syndromeの日本語表記は?", "response": "Jacobs syndromeの日本語表記はJacobs 症候群です。", "task": "replace en to ja", "name_q": "Jacobs syndrome", "name_a": "Jacobs 症候群"} -{"id": 7992, "instruction": "Unsaturated alcoholをを分子式で記述すると?", "response": "Unsaturated alcoholをを分子式で記述するとC6H12Oです。", "task": "formula", "name_q": "Unsaturated alcohol", "name_a": "C6H12O"} -{"id": 8561, "instruction": "Nafcillin sodium (USP)を用いた医薬品名は?", "response": "Nafcillin sodium (USP)を用いた医薬品名はNAFCILLIN(BaxterHealthcareCorporation)です。", "task": "product", "name_q": "Nafcillin sodium (USP)", "name_a": "NAFCILLIN(BaxterHealthcareCorporation)"} -{"id": 22201, "instruction": "(14Z)-Hexadec-14-enoyl-CoAをを組成式で書くと?", "response": "(14Z)-Hexadec-14-enoyl-CoAをを組成式で書くとC37H64N7O17P3Sです。", "task": "formula", "name_q": "(14Z)-Hexadec-14-enoyl-CoA", "name_a": "C37H64N7O17P3S"} -{"id": 5901, "instruction": "ARGATROBAN(SagentPharmaceuticals)を使用した薬品は?", "response": "ARGATROBAN(SagentPharmaceuticals)を使用した薬品はGENERICARGATROBAN(AmnealPharmaceuticalsLLC)です。", "task": "product", "name_q": "ARGATROBAN(SagentPharmaceuticals)", "name_a": "GENERICARGATROBAN(AmnealPharmaceuticalsLLC)"} -{"id": 3991, "instruction": "Lonicera flower budの別の言い方は?", "response": "Lonicera flower budの別の言い方はLonicerae flosです。", "task": "replace", "name_q": "Lonicera flower bud", "name_a": "Lonicerae flos"} -{"id": 27779, "instruction": "ポルガビキシマブの別名称は?", "response": "ポルガビキシマブの別名称はPorgaviximab (USAN/INN)です。", "task": "replace", "name_q": "ポルガビキシマブ", "name_a": "Porgaviximab (USAN/INN)"} -{"id": 28939, "instruction": "3,22-Dimethyl-1,2,23,24-tetradehydro-2,3,22,23-tetrahydrosqualeneをを化学構造で書くと?", "response": "3,22-Dimethyl-1,2,23,24-tetradehydro-2,3,22,23-tetrahydrosqualeneをを化学構造で書くとC32H54です。", "task": "formula", "name_q": "3,22-Dimethyl-1,2,23,24-tetradehydro-2,3,22,23-tetrahydrosqualene", "name_a": "C32H54"} -{"id": 7565, "instruction": "Gambiriin A2をは化学構造で表すと?", "response": "Gambiriin A2をは化学構造で表すとC30H28O12です。", "task": "formula", "name_q": "Gambiriin A2", "name_a": "C30H28O12"} -{"id": 16346, "instruction": "Bird fluの別の呼び方は?", "response": "Bird fluの別の呼び方はAvian influenzaです。", "task": "replace", "name_q": "Bird flu", "name_a": "Avian influenza"} -{"id": 23398, "instruction": "ロルバマートを英語に訳すと?", "response": "ロルバマートを英語に訳すとLorbamate (USAN/INN)です。", "task": "replace ja to en", "name_q": "ロルバマート", "name_a": "Lorbamate (USAN/INN)"} -{"id": 12267, "instruction": "alpha-Hydroxy-p-xyleneの別記述は?", "response": "alpha-Hydroxy-p-xyleneの別記述は4-Methylbenzyl alcoholです。", "task": "replace", "name_q": "alpha-Hydroxy-p-xylene", "name_a": "4-Methylbenzyl alcohol"} -{"id": 4450, "instruction": "Tilmicosin (USP/INN)を日本語で記述すると?", "response": "Tilmicosin (USP/INN)を日本語で記述するとTMSです。", "task": "replace en to ja", "name_q": "Tilmicosin (USP/INN)", "name_a": "TMS"} -{"id": 9699, "instruction": "2,4-Dichlorobenzoateの別名称は?", "response": "2,4-Dichlorobenzoateの別名称���2,4-Dichlorobenzoic acidです。", "task": "replace", "name_q": "2,4-Dichlorobenzoate", "name_a": "2,4-Dichlorobenzoic acid"} -{"id": 7373, "instruction": "Levopront (TN)を日本語で記述すると?", "response": "Levopront (TN)を日本語で記述するとLevodropropizine (INN)です。", "task": "replace en to ja", "name_q": "Levopront (TN)", "name_a": "Levodropropizine (INN)"} -{"id": 13785, "instruction": "Sveinsson 網脈絡膜萎縮を英語で記述すると?", "response": "Sveinsson 網脈絡膜萎縮を英語で記述するとSveinsson chorioretinal atrophy (SCRA)です。", "task": "replace ja to en", "name_q": "Sveinsson 網脈絡膜萎縮", "name_a": "Sveinsson chorioretinal atrophy (SCRA)"} -{"id": 10596, "instruction": "Necuparanib sodium (USAN)の日本語訳は?", "response": "Necuparanib sodium (USAN)の日本語訳はネクパラニブナトリウムです。", "task": "replace en to ja", "name_q": "Necuparanib sodium (USAN)", "name_a": "ネクパラニブナトリウム"} -{"id": 30886, "instruction": "DEXTROSEMONOHYDRATE(MedicalPurchasingSolutions)を利用した医薬品は?", "response": "DEXTROSEMONOHYDRATE(MedicalPurchasingSolutions)を利用した医薬品は25%DEXTROSEINFANT(HFAcquisitionCo.LLC)です。", "task": "product", "name_q": "DEXTROSEMONOHYDRATE(MedicalPurchasingSolutions)", "name_a": "25%DEXTROSEINFANT(HFAcquisitionCo.LLC)"} -{"id": 13696, "instruction": "O-Phospho-D-serineは別の呼び方では?", "response": "O-Phospho-D-serineは別の呼び方ではD-O-Phosphoserineです。", "task": "replace", "name_q": "O-Phospho-D-serine", "name_a": "D-O-Phosphoserine"} -{"id": 16271, "instruction": "UDP-N-acetyl-6-(alpha-D-galactose-1-phospho)-alpha-D-glucosamineは別の呼び方では?", "response": "UDP-N-acetyl-6-(alpha-D-galactose-1-phospho)-alpha-D-glucosamineは別の呼び方ではUDP-N-acetyl-6-(D-galactose-1-phospho)-D-glucosamineです。", "task": "replace", "name_q": "UDP-N-acetyl-6-(alpha-D-galactose-1-phospho)-alpha-D-glucosamine", "name_a": "UDP-N-acetyl-6-(D-galactose-1-phospho)-D-glucosamine"} -{"id": 8938, "instruction": "C43H90N2O2をの組成式は?", "response": "C43H90N2O2をの組成式はC43H90N2O2です。", "task": "formula", "name_q": "C43H90N2O2", "name_a": "C43H90N2O2"} -{"id": 8065, "instruction": "Blepharitisの日本語表記は?", "response": "Blepharitisの日本語表記は眼瞼炎です。", "task": "replace en to ja", "name_q": "Blepharitis", "name_a": "眼瞼炎"} -{"id": 11138, "instruction": "3alpha-Hydroxy-3-aminoacylmonobactamic acidをは化学式で表すと?", "response": "3alpha-Hydroxy-3-aminoacylmonobactamic acidをは化学式で表すとC3H4N2O5S(R1)(R2)です。", "task": "formula", "name_q": "3alpha-Hydroxy-3-aminoacylmonobactamic acid", "name_a": "C3H4N2O5S(R1)(R2)"} -{"id": 12623, "instruction": "ジヒドロエルゴクリスチンを英語に訳すと?", "response": "ジヒドロエルゴクリスチンを英語に訳すとDihydroergocristine (BAN)です。", "task": "replace ja to en", "name_q": "ジヒドロエルゴクリスチン", "name_a": "Dihydroergocristine (BAN)"} -{"id": 3558, "instruction": "Synephrineの別の言い方は?", "response": "Synephrineの別の言い方は1-(4-Hydroxyphenyl)-2-(methylamino)ethanolです。", "task": "replace", "name_q": "Synephrine", "name_a": "1-(4-Hydroxyphenyl)-2-(methylamino)ethanol"} -{"id": 6822, "instruction": "MC-207,110をは化学構造で表すと?", "response": "MC-207,110をは化学構造で表すとC25H30N6O2です。", "task": "formula", "name_q": "MC-207,110", "name_a": "C25H30N6O2"} -{"id": 2184, "instruction": "D-Proline betaineをを化学式で表すと?", "response": "D-Proline betaineをを化学式で表すとC7H13NO2です。", "task": "formula", "name_q": "D-Proline betaine", "name_a": "C7H13NO2"} -{"id": 33877, "instruction": "Eupatundinをは化学構造で表すと?", "response": "Eupatundinをは化学構造で表すとC20H24O7です。", "task": "formula", "name_q": "Eupatundin", "name_a": "C20H24O7"} -{"id": 19415, "instruction": "イルモホシンをは組成式で表すと?", "response": "イルモホシンをは組成式で表すとC26H56NO5PSです。", "task": "formula", "name_q": "イルモホシン", "name_a": "C26H56NO5PS"} -{"id": 8279, "instruction": "アディポネクチンの別の呼び方は?", "response": "アディポネクチンの別の呼び方はAdiponectinです。", "task": "replace", "name_q": "アディポネクチン", "name_a": "Adiponectin"} -{"id": 28254, "instruction": "RNA (poly(A))の別名称は?", "response": "RNA (poly(A))の別名称はPoly(A)です。", "task": "replace", "name_q": "RNA (poly(A))", "name_a": "Poly(A)"} -{"id": 3287, "instruction": "酸化亜鉛・チョウジ油の英訳は?", "response": "酸化亜鉛・チョウジ油の英訳はSurgicalpack (TN)です。", "task": "replace ja to en", "name_q": "酸化亜鉛・チョウジ油", "name_a": "Surgicalpack (TN)"} -{"id": 12841, "instruction": "Gedaishimotsutokamiの日本語訳は?", "response": "Gedaishimotsutokamiの日本語訳はGedaishimotsutokamiで���。", "task": "replace en to ja", "name_q": "Gedaishimotsutokami", "name_a": "Gedaishimotsutokami"} -{"id": 31898, "instruction": "L-アスパラギナーゼ (JAN)は別の呼び方では?", "response": "L-アスパラギナーゼ (JAN)は別の呼び方ではAsparaginase (USAN)です。", "task": "replace", "name_q": "L-アスパラギナーゼ (JAN)", "name_a": "Asparaginase (USAN)"} -{"id": 26035, "instruction": "塩化ラジウム (223Ra)の別呼称は?", "response": "塩化ラジウム (223Ra)の別呼称はラジウム223二塩化物です。", "task": "replace", "name_q": "塩化ラジウム (223Ra)", "name_a": "ラジウム223二塩化物"} -{"id": 24607, "instruction": "ケルセチン 3,4'-ビススルファートをの分子式は?", "response": "ケルセチン 3,4'-ビススルファートをの分子式はC15H10O13S2です。", "task": "formula", "name_q": "ケルセチン 3,4'-ビススルファート", "name_a": "C15H10O13S2"} -{"id": 24915, "instruction": "Quizartinib (USAN/INN)をを化学構造で表すと?", "response": "Quizartinib (USAN/INN)をを化学構造で表すとC29H32N6O4Sです。", "task": "formula", "name_q": "Quizartinib (USAN/INN)", "name_a": "C29H32N6O4S"} -{"id": 1958, "instruction": "1-Arsono-3-phospho-D-glycerateをは化学式で表すと?", "response": "1-Arsono-3-phospho-D-glycerateをは化学式で表すとC3H6AsO10Pです。", "task": "formula", "name_q": "1-Arsono-3-phospho-D-glycerate", "name_a": "C3H6AsO10P"} -{"id": 14380, "instruction": "Dersimelagon (USAN/INN)をを化学構造で書くと?", "response": "Dersimelagon (USAN/INN)をを化学構造で書くとC36H45F4N3O5です。", "task": "formula", "name_q": "Dersimelagon (USAN/INN)", "name_a": "C36H45F4N3O5"} -{"id": 21719, "instruction": "3-Hydroxy-4-nitroestra-1,3,5(10)-trien-17-oneの異なる表現は?", "response": "3-Hydroxy-4-nitroestra-1,3,5(10)-trien-17-oneの異なる表現は4-Nitroestroneです。", "task": "replace", "name_q": "3-Hydroxy-4-nitroestra-1,3,5(10)-trien-17-one", "name_a": "4-Nitroestrone"} -{"id": 22571, "instruction": "VENTAVIS(ActelionPharmaceuticalsUS)を材料とする薬品名は?", "response": "VENTAVIS(ActelionPharmaceuticalsUS)を材料とする薬品名はVENTAVIS(ActelionPharmaceuticalsUS)です。", "task": "product", "name_q": "VENTAVIS(ActelionPharmaceuticalsUS)", "name_a": "VENTAVIS(ActelionPharmaceuticalsUS)"} -{"id": 5842, "instruction": "Deracoxib (USAN)を言い換えると?", "response": "Deracoxib (USAN)を言い換えるとデラコキシブです。", "task": "replace", "name_q": "Deracoxib (USAN)", "name_a": "デラコキシブ"} -{"id": 5091, "instruction": "Ruzasvir (USAN/INN)をを分子式で表すと?", "response": "Ruzasvir (USAN/INN)をを分子式で表すとC49H55FN10O7Sです。", "task": "formula", "name_q": "Ruzasvir (USAN/INN)", "name_a": "C49H55FN10O7S"} -{"id": 6687, "instruction": "Lumirhodopsinをを分子式で記述すると?", "response": "Lumirhodopsinをを分子式で記述するとC20H28Rです。", "task": "formula", "name_q": "Lumirhodopsin", "name_a": "C20H28R"} -{"id": 4923, "instruction": "Pneumococcal 10-valent conjugate vaccineを英語で書くと?", "response": "Pneumococcal 10-valent conjugate vaccineを英語で書くとPneumococcal 10-valent conjugate vaccineです。", "task": "replace ja to en", "name_q": "Pneumococcal 10-valent conjugate vaccine", "name_a": "Pneumococcal 10-valent conjugate vaccine"} -{"id": 16370, "instruction": "Somanをを分子式で記述すると?", "response": "Somanをを分子式で記述するとC7H16FO2Pです。", "task": "formula", "name_q": "Soman", "name_a": "C7H16FO2P"} -{"id": 8453, "instruction": "2-Nitrotolueneをを化学式で表すと?", "response": "2-Nitrotolueneをを化学式で表すとC7H7NO2です。", "task": "formula", "name_q": "2-Nitrotoluene", "name_a": "C7H7NO2"} -{"id": 17602, "instruction": "(1E,4E,7R)-Germacra-1(10),4-dien-11-olの異なる表現は?", "response": "(1E,4E,7R)-Germacra-1(10),4-dien-11-olの異なる表現は(2E,6E)-Hedycaryolです。", "task": "replace", "name_q": "(1E,4E,7R)-Germacra-1(10),4-dien-11-ol", "name_a": "(2E,6E)-Hedycaryol"} -{"id": 27999, "instruction": "Nororientalineをを分子式で記述すると?", "response": "Nororientalineをを分子式で記述するとC18H21NO4です。", "task": "formula", "name_q": "Nororientaline", "name_a": "C18H21NO4"} -{"id": 1460, "instruction": "Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndromeの日本語表記は?", "response": "Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndromeの日本語表記は血管炎・自己炎症・免疫不全・血液学的異常症候群です。", "task": "replace en to ja", "name_q": "Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome", "name_a": "血管炎・自己炎症・免疫不全・血液学的異常症候群"} -{"id": 3951, "instruction": "Sorbitol (NF)を使用した医薬品名は?", "response": "Sorbitol (NF)を使用した医薬品名はウロマチック(バクスター・ジ��パン)です。", "task": "product", "name_q": "Sorbitol (NF)", "name_a": "ウロマチック(バクスター・ジャパン)"} -{"id": 562, "instruction": "Asparagineをは組成式で表すと?", "response": "Asparagineをは組成式で表すとC4H8N2O3です。", "task": "formula", "name_q": "Asparagine", "name_a": "C4H8N2O3"} -{"id": 17211, "instruction": "Xenon Xe 129 hyperpolarizedをの組成式は?", "response": "Xenon Xe 129 hyperpolarizedをの組成式はXeです。", "task": "formula", "name_q": "Xenon Xe 129 hyperpolarized", "name_a": "Xe"} -{"id": 7805, "instruction": "Trostin (JAN)を日本語で記述すると?", "response": "Trostin (JAN)を日本語で記述するとTrostin (JAN)です。", "task": "replace en to ja", "name_q": "Trostin (JAN)", "name_a": "Trostin (JAN)"} -{"id": 2128, "instruction": "Tokishakuyakusankabushiの異なる名称は?", "response": "Tokishakuyakusankabushiの異なる名称はTokishakuyakukabushiです。", "task": "replace", "name_q": "Tokishakuyakusankabushi", "name_a": "Tokishakuyakukabushi"} -{"id": 2119, "instruction": "(2S,2'S)-Oscillol 2,2'-di(alpha-L-fucoside)をを化学構造で表すと?", "response": "(2S,2'S)-Oscillol 2,2'-di(alpha-L-fucoside)をを化学構造で表すとC52H76O12です。", "task": "formula", "name_q": "(2S,2'S)-Oscillol 2,2'-di(alpha-L-fucoside)", "name_a": "C52H76O12"} -{"id": 21831, "instruction": "N-Acetyl-O-demethylpuromycin-5'-phosphateをの化学式は?", "response": "N-Acetyl-O-demethylpuromycin-5'-phosphateをの化学式はC23H30N7O9Pです。", "task": "formula", "name_q": "N-Acetyl-O-demethylpuromycin-5'-phosphate", "name_a": "C23H30N7O9P"} -{"id": 20631, "instruction": "Bersiporocin hydrochloride (USAN)をを化学構造で書くと?", "response": "Bersiporocin hydrochloride (USAN)をを化学構造で書くとC15H19Cl2N3O. HClです。", "task": "formula", "name_q": "Bersiporocin hydrochloride (USAN)", "name_a": "C15H19Cl2N3O. HCl"} -{"id": 1970, "instruction": "Clamoxyl (TN)をの分子式は?", "response": "Clamoxyl (TN)をの分子式はC17H24ClN3O. 2HClです。", "task": "formula", "name_q": "Clamoxyl (TN)", "name_a": "C17H24ClN3O. 2HCl"} -{"id": 16261, "instruction": "Surfomer (USAN/INN)をを組成式で表すと?", "response": "Surfomer (USAN/INN)をを組成式で表すと(C22H40O4)nです。", "task": "formula", "name_q": "Surfomer (USAN/INN)", "name_a": "(C22H40O4)n"} -{"id": 16, "instruction": "Congenital pulmonary venous stenosisを日本語で書くと?", "response": "Congenital pulmonary venous stenosisを日本語で書くと先天性肺静脈狭窄症です。", "task": "replace en to ja", "name_q": "Congenital pulmonary venous stenosis", "name_a": "先天性肺静脈狭窄症"} -{"id": 15734, "instruction": "Opilon (TN)を日本語で書くと?", "response": "Opilon (TN)を日本語で書くとMoxisylyte hydrochloride (JAN)です。", "task": "replace en to ja", "name_q": "Opilon (TN)", "name_a": "Moxisylyte hydrochloride (JAN)"} -{"id": 608, "instruction": "(L-Tryptophyl)adenylateをを分子式で書くと?", "response": "(L-Tryptophyl)adenylateをを分子式で書くとC21H24N7O8Pです。", "task": "formula", "name_q": "(L-Tryptophyl)adenylate", "name_a": "C21H24N7O8P"} -{"id": 6756, "instruction": "12-Hydroxyjasmonate sulfateは別の呼び方では?", "response": "12-Hydroxyjasmonate sulfateは別の呼び方では12-Sulfooxyjasmonateです。", "task": "replace", "name_q": "12-Hydroxyjasmonate sulfate", "name_a": "12-Sulfooxyjasmonate"} -{"id": 1076, "instruction": "Bart-Pumphrey 症候群を英語に訳すと?", "response": "Bart-Pumphrey 症候群を英語に訳すとBart-Pumphrey syndromeです。", "task": "replace ja to en", "name_q": "Bart-Pumphrey 症候群", "name_a": "Bart-Pumphrey syndrome"} -{"id": 16733, "instruction": "Boucher-Neuhauser syndrome SUPERGRP PNPLA6-related disorders の日本語表記は?", "response": "Boucher-Neuhauser syndrome SUPERGRP PNPLA6-related disorders の日本語表記はBoucher-Neuhauser 症候群 上位グループ PNPLA6 関連疾患 です。", "task": "replace en to ja", "name_q": "Boucher-Neuhauser syndrome SUPERGRP PNPLA6-related disorders ", "name_a": "Boucher-Neuhauser 症候群 上位グループ PNPLA6 関連疾患 "} -{"id": 23667, "instruction": "脱毛・精神遅滞症候群を英語に訳すと?", "response": "脱毛・精神遅滞症候群を英語に訳すとAlopecia-mental retardation syndromeです。", "task": "replace ja to en", "name_q": "脱毛・精神遅滞症候群", "name_a": "Alopecia-mental retardation syndrome"} -{"id": 5158, "instruction": "Sorsby fundus dystrophyを日本語に訳すと?", "response": "Sorsby fundus dystrophyを日本語に訳すとソースビー眼底変性症です。", "task": "replace en to ja", "name_q": "Sorsby fundus dystrophy", "name_a": "ソースビー眼底変性症"} -{"id": 9944, "instruction": "ヒドノカルピン酸は別の呼び方では?", "response": "ヒドノカルピン酸は別の呼び方ではHydnocarpic acidです。", "task": "replace", "name_q": "ヒドノカルピン酸", "name_a": "Hydnocarpic acid"} -{"id": 20117, "instruction": "Atracurium besylate (USP)をを化学式で書くと?", "response": "Atracurium besylate (USP)をを化学式で書くとC53H72N2O12. (C6H5O3S)2です。", "task": "formula", "name_q": "Atracurium besylate (USP)", "name_a": "C53H72N2O12. (C6H5O3S)2"} -{"id": 27256, "instruction": "Tos-Lys-CH2Clをの化学式は?", "response": "Tos-Lys-CH2Clをの化学式はC14H21ClN2O3Sです。", "task": "formula", "name_q": "Tos-Lys-CH2Cl", "name_a": "C14H21ClN2O3S"} -{"id": 8689, "instruction": "停留精巣を英語で書くと?", "response": "停留精巣を英語で書くとCryptorchidismです。", "task": "replace ja to en", "name_q": "停留精巣", "name_a": "Cryptorchidism"} -{"id": 10601, "instruction": "Oral-facial-digital syndromeの別の呼び方は?", "response": "Oral-facial-digital syndromeの別の呼び方はOrofaciodigital syndromeです。", "task": "replace", "name_q": "Oral-facial-digital syndrome", "name_a": "Orofaciodigital syndrome"} -{"id": 13369, "instruction": "Neramexane mesylate (USAN)を日本語表記で表すと?", "response": "Neramexane mesylate (USAN)を日本語表記で表すとメシル酸ネラメキサンです。", "task": "replace en to ja", "name_q": "Neramexane mesylate (USAN)", "name_a": "メシル酸ネラメキサン"} -{"id": 13803, "instruction": "Adouetine Xをを分子式で表すと?", "response": "Adouetine Xをを分子式で表すとC28H44N4O4です。", "task": "formula", "name_q": "Adouetine X", "name_a": "C28H44N4O4"} -{"id": 29441, "instruction": "Alginic acidは別の呼び方では?", "response": "Alginic acidは別の呼び方ではAlginateです。", "task": "replace", "name_q": "Alginic acid", "name_a": "Alginate"} -{"id": 5660, "instruction": "Ursocholanic acidをを分子式で表すと?", "response": "Ursocholanic acidをを分子式で表すとC24H40O2です。", "task": "formula", "name_q": "Ursocholanic acid", "name_a": "C24H40O2"} -{"id": 34474, "instruction": "Edronax (TN)をを組成式で書くと?", "response": "Edronax (TN)をを組成式で書くとC19H23NO3です。", "task": "formula", "name_q": "Edronax (TN)", "name_a": "C19H23NO3"} -{"id": 2107, "instruction": "ベレキツグを英語に訳すと?", "response": "ベレキツグを英語に訳すとVerekitug (USAN/INN)です。", "task": "replace ja to en", "name_q": "ベレキツグ", "name_a": "Verekitug (USAN/INN)"} -{"id": 7510, "instruction": "ジネミシンAの別表現は?", "response": "ジネミシンAの別表現はDynemicin Aです。", "task": "replace", "name_q": "ジネミシンA", "name_a": "Dynemicin A"} -{"id": 19332, "instruction": "エリオジャポシド Bの別記述は?", "response": "エリオジャポシド Bの別記述はEriojaposide Bです。", "task": "replace", "name_q": "エリオジャポシド B", "name_a": "Eriojaposide B"} -{"id": 686, "instruction": "McKusick-Kaufman syndromeを日本語で記述すると?", "response": "McKusick-Kaufman syndromeを日本語で記述するとMcKusick-Kaufman 症候群です。", "task": "replace en to ja", "name_q": "McKusick-Kaufman syndrome", "name_a": "McKusick-Kaufman 症候群"} -{"id": 17979, "instruction": "Quercus cortexの異なる名称は?", "response": "Quercus cortexの異なる名称はボクソク (JP18)です。", "task": "replace", "name_q": "Quercus cortex", "name_a": "ボクソク (JP18)"} -{"id": 25978, "instruction": "Ferriprox (TN)を日本語で書くと?", "response": "Ferriprox (TN)を日本語で書くとDeferiprone (USAN/INN)です。", "task": "replace en to ja", "name_q": "Ferriprox (TN)", "name_a": "Deferiprone (USAN/INN)"} -{"id": 21232, "instruction": "Allophanic acid methyl esterの別名称は?", "response": "Allophanic acid methyl esterの別名称はアロファン酸メチルです。", "task": "replace", "name_q": "Allophanic acid methyl ester", "name_a": "アロファン酸メチル"} -{"id": 22103, "instruction": "乳酸アルミニウム (JAN)をを分子式で表すと?", "response": "乳酸アルミニウム (JAN)をを分子式で表すとC9H15AlO9です。", "task": "formula", "name_q": "乳酸アルミニウム (JAN)", "name_a": "C9H15AlO9"} -{"id": 14894, "instruction": "Midazolam (JAN/USP/INN)の英語表記は?", "response": "Midazolam (JAN/USP/INN)の英語表記はNayzilam (TN)です。", "task": "replace ja to en", "name_q": "Midazolam (JAN/USP/INN)", "name_a": "Nayzilam (TN)"} -{"id": 9718, "instruction": "C43H47N2O6S2. Naを主とした医薬品名は?", "response": "C43H47N2O6S2. Naを主とした医薬品名はINDOCYANINEGREEN(RenewPharmaceuticalsLimited)です。", "task": "product", "name_q": "C43H47N2O6S2. Na", "name_a": "INDOCYANINEGREEN(RenewPharmaceuticalsLimited)"} -{"id": 14828, "instruction": "Atoltivimab (USAN)をを化学構造で書くと?", "response": "Atoltivimab (USAN)をを化学構造で書くとC6448H9954N1726O2002S44です。", "task": "formula", "name_q": "Atoltivimab (USAN)", "name_a": "C6448H9954N1726O2002S44"} -{"id": 4242, "instruction": "デルシメラゴンリン酸塩をを組成式で書くと?", "response": "デルシメラゴンリン酸塩をを組成式で書くとC36H45F4N3O5. H3PO4です。", "task": "formula", "name_q": "デルシメラゴンリン酸塩", "name_a": "C36H45F4N3O5. H3PO4"} -{"id": 23691, "instruction": "Tiragolumab (USAN/INN)の異なる表現は?", "response": "Tiragolumab (USAN/INN)の異なる表現はTiragolumab (genetical recombination) (JAN)です。", "task": "replace", "name_q": "Tiragolumab (USAN/INN)", "name_a": "Tiragolumab (genetical recombination) (JAN)"} -{"id": 24222, "instruction": "L-Glutamic acid, L-alanine and glycineをの組成式は?", "response": "L-Glutamic acid, L-alanine and glycineをの組成式はC5H9NO4. C3H7NO2. C2H5NO2です。", "task": "formula", "name_q": "L-Glutamic acid, L-alanine and glycine", "name_a": "C5H9NO4. C3H7NO2. C2H5NO2"} -{"id": 8562, "instruction": "Pymetrozineをを組成式で記述すると?", "response": "Pymetrozineをを組成式で記述するとC10H11N5Oです。", "task": "formula", "name_q": "Pymetrozine", "name_a": "C10H11N5O"} -{"id": 17681, "instruction": "Dicirenone (USAN)をを組成式で記述すると?", "response": "Dicirenone (USAN)をを組成式で記述するとC26H36O5です。", "task": "formula", "name_q": "Dicirenone (USAN)", "name_a": "C26H36O5"} -{"id": 10563, "instruction": "Daxibotulinumtoxin A (USAN)を英語表記で表すと?", "response": "Daxibotulinumtoxin A (USAN)を英語表記で表すとDaxibotulinumtoxin A-lanmです。", "task": "replace ja to en", "name_q": "Daxibotulinumtoxin A (USAN)", "name_a": "Daxibotulinumtoxin A-lanm"} -{"id": 23771, "instruction": "プレグランディン(小野薬品工業)をは化学構造で表すと?", "response": "プレグランディン(小野薬品工業)をは化学構造で表すとC23H38O5です。", "task": "formula", "name_q": "プレグランディン(小野薬品工業)", "name_a": "C23H38O5"} -{"id": 15676, "instruction": "Takenouchi-Kosaki syndromeを日本語表記で表すと?", "response": "Takenouchi-Kosaki syndromeを日本語表記で表すと武内・小崎症候群です。", "task": "replace en to ja", "name_q": "Takenouchi-Kosaki syndrome", "name_a": "武内・小崎症候群"} -{"id": 8863, "instruction": "Mabuterol hydrochloride (JAN)を日本語表記で表すと?", "response": "Mabuterol hydrochloride (JAN)を日本語表記で表すとマブテロール塩酸塩 (JAN)です。", "task": "replace en to ja", "name_q": "Mabuterol hydrochloride (JAN)", "name_a": "マブテロール塩酸塩 (JAN)"} -{"id": 16982, "instruction": "Crexavibart (USAN/INN)を日本語で記述すると?", "response": "Crexavibart (USAN/INN)を日本語で記述するとCrexavibart (USAN/INN)です。", "task": "replace en to ja", "name_q": "Crexavibart (USAN/INN)", "name_a": "Crexavibart (USAN/INN)"} -{"id": 9637, "instruction": "Calcium iodideをを化学構造で書くと?", "response": "Calcium iodideをを化学構造で書くとCaI2です。", "task": "formula", "name_q": "Calcium iodide", "name_a": "CaI2"} -{"id": 10419, "instruction": "Isoathyriolをを化学式で記述すると?", "response": "Isoathyriolをを化学式で記述するとC14H10O6です。", "task": "formula", "name_q": "Isoathyriol", "name_a": "C14H10O6"} -{"id": 30054, "instruction": "Cetrimide (JAN)の日本語訳は?", "response": "Cetrimide (JAN)の日本語訳はセトリミド (JAN)です。", "task": "replace en to ja", "name_q": "Cetrimide (JAN)", "name_a": "セトリミド (JAN)"} -{"id": 6736, "instruction": "Senkyunolideをを分子式で書くと?", "response": "Senkyunolideをを分子式で書くとC12H16O2です。", "task": "formula", "name_q": "Senkyunolide", "name_a": "C12H16O2"} -{"id": 5889, "instruction": "Lysosomal-enzyme D-mannoseをを化学式で表すと?", "response": "Lysosomal-enzyme D-mannoseをを化学式で表すとC6H11O6Rです。", "task": "formula", "name_q": "Lysosomal-enzyme D-mannose", "name_a": "C6H11O6R"} -{"id": 28720, "instruction": "Infantile-onset multisystem neurologic, endocrine, and pancreatic diseaseを日本語表記で表すと?", "response": "Infantile-onset multisystem neurologic, endocrine, and pancreatic diseaseを日本語表記で表すと乳児期発症多系統神経・内分泌・膵臓疾患です。", "task": "replace en to ja", "name_q": "Infantile-onset multisystem neurologic, endocrine, and pancreatic disease", "name_a": "乳児期発症多系統神経・内分泌・膵臓疾患"} -{"id": 20723, "instruction": "Setileuton (USAN/INN)をを化学式で表すと?", "response": "Setileuton (USAN/INN)をを化学式で表すとC22H17F4N3O4です。", "task": "formula", "name_q": "Setileuton (USAN/INN)", "name_a": "C22H17F4N3O4"} -{"id": 6845, "instruction": "beta-Santoninをは化学式で表すと?", "response": "beta-Santoninをは化学式で表すとC15H18O3です。", "task": "formula", "name_q": "beta-Santonin", "name_a": "C15H18O3"} -{"id": 16065, "instruction": "Iminoarginineの別名は?", "response": "Iminoarginineの別名は5-Carbamimidamido-2-iminopentanoateです。", "task": "replace", "name_q": "Iminoarginine", "name_a": "5-Carbamimidamido-2-iminopentanoate"} -{"id": 23064, "instruction": "アンモニアをは化学式で表すと?", "response": "アンモニアをは化学式で表すとNH3です。", "task": "formula", "name_q": "アンモニア", "name_a": "NH3"} -{"id": 7849, "instruction": "Attapulgite, activated (USP)の異なる表記は?", "response": "Attapulgite, activated (USP)の異なる表記は活性アタパルガイトです。", "task": "replace", "name_q": "Attapulgite, activated (USP)", "name_a": "活性アタパルガイト"} -{"id": 28365, "instruction": "Fenugreek seedの日本語訳は?", "response": "Fenugreek seedの日本語訳はhú lú bāです。", "task": "replace en to ja", "name_q": "Fenugreek seed", "name_a": "hú lú bā"} -{"id": 17857, "instruction": "クロモブラストミコーシスを英語に訳すと?", "response": "クロモブラストミコーシスを英語に訳すとChromomycosisです。", "task": "replace ja to en", "name_q": "クロモブラストミコーシス", "name_a": "Chromomycosis"} -{"id": 16056, "instruction": "Benzilone bomideは別の呼び方では?", "response": "Benzilone bomideは別の呼び方では臭化ベンジロニウムです。", "task": "replace", "name_q": "Benzilone bomide", "name_a": "臭化ベンジロニウム"} -{"id": 13529, "instruction": "Colfosceril palmitate (USAN/INN)をは分子式で表すと?", "response": "Colfosceril palmitate (USAN/INN)をは分子式で表すとC40H80NO8Pです。", "task": "formula", "name_q": "Colfosceril palmitate (USAN/INN)", "name_a": "C40H80NO8P"} -{"id": 25818, "instruction": "デルカセルチブ酢酸塩の異なる表記は?", "response": "デルカセルチブ酢酸塩の異なる表記はDelcasertib acetate (USAN)です。", "task": "replace", "name_q": "デルカセルチブ酢酸塩", "name_a": "Delcasertib acetate (USAN)"} -{"id": 26501, "instruction": "Rosmarinineをを分子式で記述すると?", "response": "Rosmarinineをを分子式で記述するとC18H27NO6です。", "task": "formula", "name_q": "Rosmarinine", "name_a": "C18H27NO6"} -{"id": 5524, "instruction": "Elderの別名称は?", "response": "Elderの別名称はニワトコです。", "task": "replace", "name_q": "Elder", "name_a": "ニワトコ"} -{"id": 3643, "instruction": "甲状腺中毒症を英語で書くと?", "response": "甲状腺中毒症を英語で書くとThyrotoxicosisです。", "task": "replace ja to en", "name_q": "甲状腺中毒症", "name_a": "Thyrotoxicosis"} -{"id": 1015, "instruction": "(S)-2-Hydroxymyristate-modified lipid Aをを組成式で表すと?", "response": "(S)-2-Hydroxymyristate-modified lipid Aをを組成式で表すとC110H202N2O40P2です。", "task": "formula", "name_q": "(S)-2-Hydroxymyristate-modified lipid A", "name_a": "C110H202N2O40P2"} -{"id": 10178, "instruction": "2-Methyl-5alpha-androst-2-en-17beta-ol acetateをを分子式で表すと?", "response": "2-Methyl-5alpha-androst-2-en-17beta-ol acetateをを分子式で表すとC22H34O2です。", "task": "formula", "name_q": "2-Methyl-5alpha-androst-2-en-17beta-ol acetate", "name_a": "C22H34O2"} -{"id": 12264, "instruction": "beta-Pinaceneをは組成式で表すと?", "response": "beta-Pinaceneをは組成式で表すとC20H34です。", "task": "formula", "name_q": "beta-Pinacene", "name_a": "C20H34"} -{"id": 33525, "instruction": "Enterotoxigenic Escherichia coli (ETEC) infectionを日本語で記述すると?", "response": "Enterotoxigenic Escherichia coli (ETEC) infectionを日本語で記述すると腸管毒素原性大腸菌感染症です。", "task": "replace en to ja", "name_q": "Enterotoxigenic Escherichia coli (ETEC) infection", "name_a": "腸管毒素原性大腸菌感染症"} -{"id": 31949, "instruction": "Daclizumab (USAN/INN)の日本語訳は?", "response": "Daclizumab (USAN/INN)の日本語訳はダクリズマブです。", "task": "replace en to ja", "name_q": "Daclizumab (USAN/INN)", "name_a": "ダクリズマブ"} -{"id": 7485, "instruction": "Hainosanを日本語で書くと?", "response": "Hainosanを日本語で書くとHainosanです。", "task": "replace en to ja", "name_q": "Hainosan", "name_a": "Hainosan"} -{"id": 31407, "instruction": "N-カルバモイルサルコシンをの組成式は?", "response": "N-カルバモイルサルコシンをの組成式はC4H8N2O3です。", "task": "formula", "name_q": "N-カルバモイルサルコシン", "name_a": "C4H8N2O3"} -{"id": 34375, "instruction": "Visceral myopathyを日本語表記で表すと?", "response": "Visceral myopathyを日本語表記で表すと腹部ミオパチーです。", "task": "replace en to ja", "name_q": "Visceral myopathy", "name_a": "腹部ミオパチー"} -{"id": 1520, "instruction": "beta-D-Ribofuranoseをを組成式で表すと?", "response": "beta-D-Ribofuranoseをを組成式で表すとC5H10O5です。", "task": "formula", "name_q": "beta-D-Ribofuranose", "name_a": "C5H10O5"} -{"id": 6005, "instruction": "Oxalyl-CoAをを化学構造で表すと?", "response": "Oxalyl-CoAをを化学構造で表すとC23H36N7O19P3Sです。", "task": "formula", "name_q": "Oxalyl-CoA", "name_a": "C23H36N7O19P3S"} -{"id": 30181, "instruction": "(3beta,5beta,22R)-3,14,22,25-Tetrahydroxycholest-7-en-6-oneをを化学式で記述すると?", "response": "(3beta,5beta,22R)-3,14,22,25-Tetrahydroxycholest-7-en-6-oneをを化学式で記述するとC27H44O5です。", "task": "formula", "name_q": "(3beta,5beta,22R)-3,14,22,25-Tetrahydroxycholest-7-en-6-one", "name_a": "C27H44O5"} -{"id": 6713, "instruction": "ザポメラン (JAN)の英語表記は?", "response": "ザポメラン (JAN)の英語表記はZapomeran (JAN/INN)です。", "task": "replace ja to en", "name_q": "ザポメラン (JAN)", "name_a": "Zapomeran (JAN/INN)"} -{"id": 854, "instruction": "C14H8F3NO2Sをを化学式で記述すると?", "response": "C14H8F3NO2Sをを化学式で記述するとC14H8F3NO2Sです。", "task": "formula", "name_q": "C14H8F3NO2S", "name_a": "C14H8F3NO2S"} -{"id": 9488, "instruction": "Hamycin (USAN)の日本語訳は?", "response": "Hamycin (USAN)の日本語訳はHamycin (USAN)です。", "task": "replace en to ja", "name_q": "Hamycin (USAN)", "name_a": "Hamycin (USAN)"} -{"id": 11455, "instruction": "1-フェニルプロピルアセタートの別名称は?", "response": "1-フェニルプロピルアセタートの別名称は1-Phenylpropyl acetateです。", "task": "replace", "name_q": "1-フェニルプロピルアセタート", "name_a": "1-Phenylpropyl acetate"} -{"id": 22096, "instruction": "Mitochondrial DNA depletion syndrome SUBGROUP Alpers syndrome MNGIE syndrome SUPERGRP Mitochondrial disease を日本語表記で表すと?", "response": "Mitochondrial DNA depletion syndrome SUBGROUP Alpers syndrome MNGIE syndrome SUPERGRP Mitochondrial disease を日本語表記で表すとミトコンドリア DNA 枯渇症候群 下位グループ アルパーズ症候群 MNGIE 症候群 上位グループ ミトコンドリア病 です。", "task": "replace en to ja", "name_q": "Mitochondrial DNA depletion syndrome SUBGROUP Alpers syndrome MNGIE syndrome SUPERGRP Mitochondrial disease ", "name_a": "ミトコンドリア DNA 枯渇症候群 下位グループ アルパーズ症候群 MNGIE 症候群 上位グループ ミトコンドリア病 "} -{"id": 19870, "instruction": "Guretolimod (USAN/INN)を日本語に訳すと?", "response": "Guretolimod (USAN/INN)を日本語に訳すとGuretolimod (USAN/INN)です。", "task": "replace en to ja", "name_q": "Guretolimod (USAN/INN)", "name_a": "Guretolimod (USAN/INN)"} -{"id": 34492, "instruction": "Dexpramipexole (USAN/INN)をを分子式で表すと?", "response": "Dexpramipexole (USAN/INN)をを分子式で表すとC10H17N3Sです。", "task": "formula", "name_q": "Dexpramipexole (USAN/INN)", "name_a": "C10H17N3S"} -{"id": 29888, "instruction": "Mentha oil (TN)の日本語訳は?", "response": "Mentha oil (TN)の日本語訳はbó hé yóuです。", "task": "replace en to ja", "name_q": "Mentha oil (TN)", "name_a": "bó hé yóu"} -{"id": 27074, "instruction": "Foscanを言い換えると?", "response": "Foscanを言い換えるとTemoporfinです。", "task": "replace", "name_q": "Foscan", "name_a": "Temoporfin"} -{"id": 4150, "instruction": "5-Dehydro-4-deoxy-D-glucarateの別の呼び方は?", "response": "5-Dehydro-4-deoxy-D-glucarateの別の呼び方は(2R,3S)-2,3-Dihydroxy-5-oxohexanedioateです。", "task": "replace", "name_q": "5-Dehydro-4-deoxy-D-glucarate", "name_a": "(2R,3S)-2,3-Dihydroxy-5-oxohexanedioate"} -{"id": 21253, "instruction": "Pepstatin (USAN/INN)を日本語に訳すと?", "response": "Pepstatin (USAN/INN)を日本語に訳すとペプスタチンです。", "task": "replace en to ja", "name_q": "Pepstatin (USAN/INN)", "name_a": "ペプスタチン"} -{"id": 4581, "instruction": "Ethacizineをは組成式で表すと?", "response": "Ethacizineをは組成式で表すとC22H27N3O3Sです。", "task": "formula", "name_q": "Ethacizine", "name_a": "C22H27N3O3S"} -{"id": 22322, "instruction": "Eupatoriopicrinの別の言い方は?", "response": "Eupatoriopicrinの別の言い方はオイパトリオピクリンです。", "task": "replace", "name_q": "Eupatoriopicrin", "name_a": "オイパトリオピクリン"} -{"id": 5279, "instruction": "カルプロフェンは別の呼び方では?", "response": "カルプロフェンは別の呼び方ではCarprofenです。", "task": "replace", "name_q": "カルプロフェン", "name_a": "Carprofen"} -{"id": 18855, "instruction": "Polyvinylpyrrolidoneをは分子式で表すと?", "response": "Polyvinylpyrrolidoneをは分子式で表すと(C6H9NO)nです。", "task": "formula", "name_q": "Polyvinylpyrrolidone", "name_a": "(C6H9NO)n"} -{"id": 28689, "instruction": "Phosphoglycolic acidをは組成式で表すと?", "response": "Phosphoglycolic acidをは組成式で表すとC2H5O6Pです。", "task": "formula", "name_q": "Phosphoglycolic acid", "name_a": "C2H5O6P"} -{"id": 3591, "instruction": "Ultra-long-chain di-unsaturated 3-oxo-fatty acyl-[acyl-carrier protein]の異なる表記は?", "response": "Ultra-long-chain di-unsaturated 3-oxo-fatty acyl-[acyl-carrier protein]の異なる表記はUltra-long-chain di-unsaturated 3-oxoacyl-[acp]です。", "task": "replace", "name_q": "Ultra-long-chain di-unsaturated 3-oxo-fatty acyl-[acyl-carrier protein]", "name_a": "Ultra-long-chain di-unsaturated 3-oxoacyl-[acp]"} -{"id": 31372, "instruction": "Monovisc (TN)をを分子式で表すと?", "response": "Monovisc (TN)をを分子式で表すと(C14H21NO12)nです。", "task": "formula", "name_q": "Monovisc (TN)", "name_a": "(C14H21NO12)n"} -{"id": 16943, "instruction": "Estrone sodium sulfateを英語で書くと?", "response": "Estrone sodium sulfateを英語で書くとEstrone sodium sulfateです。", "task": "replace ja to en", "name_q": "Estrone sodium sulfate", "name_a": "Estrone sodium sulfate"} -{"id": 28959, "instruction": "Xamoterol (USAN)を英語表記で表すと?", "response": "Xamoterol (USAN)を英語表記で表すとXamoterol (USAN)です。", "task": "replace ja to en", "name_q": "Xamoterol (USAN)", "name_a": "Xamoterol (USAN)"} -{"id": 30307, "instruction": "5,7,4'-Trihydroxyisoflavoneの別記述は?", "response": "5,7,4'-Trihydroxyisoflavoneの別記述はGenisteinです。", "task": "replace", "name_q": "5,7,4'-Trihydroxyisoflavone", "name_a": "Genistein"} -{"id": 3549, "instruction": "Pegvisomant (USAN/INN)を英語で書くと?", "response": "Pegvisomant (USAN/INN)を英語で書くとSomavert (TN)です。", "task": "replace ja to en", "name_q": "Pegvisomant (USAN/INN)", "name_a": "Somavert (TN)"} -{"id": 11428, "instruction": "DEXLANSOPRAZOLE(TWIPHARMACEUTICALS)をの化学式は?", "response": "DEXLANSOPRAZOLE(TWIPHARMACEUTICALS)をの化学式はC16H14F3N3O2Sです。", "task": "formula", "name_q": "DEXLANSOPRAZOLE(TWIPHARMACEUTICALS)", "name_a": "C16H14F3N3O2S"} -{"id": 14738, "instruction": "Letrozoleを言い換えると?", "response": "Letrozoleを言い換えるとレトロゾールです。", "task": "replace", "name_q": "Letrozole", "name_a": "レトロゾール"} -{"id": 3943, "instruction": "McLeod syndrome SUPERGRP Core neuroacanthocytosis syndromes を日本語で書くと?", "response": "McLeod syndrome SUPERGRP Core neuroacanthocytosis syndromes を日本語で書くとMcLeod 症候群 上位グループ 中核群神経有棘赤血球症 です。", "task": "replace en to ja", "name_q": "McLeod syndrome SUPERGRP Core neuroacanthocytosis syndromes ", "name_a": "McLeod 症候群 上位グループ 中核群神経有棘赤血球症 "} -{"id": 5107, "instruction": "GLYCINE(ICUMedical)を用いた医薬品名は?", "response": "GLYCINE(ICUMedical)を用いた医薬品名はGLYCINE(ICUMedical)です。", "task": "product", "name_q": "GLYCINE(ICUMedical)", "name_a": "GLYCINE(ICUMedical)"} -{"id": 13989, "instruction": "アトラクチロシド Aをの組成式は?", "response": "アトラクチロシド Aをの組成式はC21H36O10です。", "task": "formula", "name_q": "アトラクチロシド A", "name_a": "C21H36O10"} -{"id": 193, "instruction": "N3'-Acetylkanamycinをを化学構造で記述すると?", "response": "N3'-Acetylkanamycinをを化学構造で記述するとC20H35N3O11R2です。", "task": "formula", "name_q": "N3'-Acetylkanamycin", "name_a": "C20H35N3O11R2"} -{"id": 25967, "instruction": "Trichomegalyの日本語訳は?", "response": "Trichomegalyの日本語訳は長睫毛症です。", "task": "replace en to ja", "name_q": "Trichomegaly", "name_a": "長睫毛症"} -{"id": 6103, "instruction": "Diisopropyl fluorophosphateの異なる表記は?", "response": "Diisopropyl fluorophosphateの異なる表記はDFPです。", "task": "replace", "name_q": "Diisopropyl fluorophosphate", "name_a": "DFP"} -{"id": 28633, "instruction": "L-Norvalineをの分子式は?", "response": "L-Norvalineをの分子式はC5H11NO2です。", "task": "formula", "name_q": "L-Norvaline", "name_a": "C5H11NO2"} -{"id": 4908, "instruction": "Dialkylarylamineをを化学構造で記述すると?", "response": "Dialkylarylamineをを化学構造で記述するとC6H5NR2です。", "task": "formula", "name_q": "Dialkylarylamine", "name_a": "C6H5NR2"} -{"id": 89, "instruction": "C38H38N4O6をの分子式は?", "response": "C38H38N4O6をの分子式はC38H38N4O6です。", "task": "formula", "name_q": "C38H38N4O6", "name_a": "C38H38N4O6"} -{"id": 29271, "instruction": "Persimmon calyx (Non-JPS)を日本語で書くと?", "response": "Persimmon calyx (Non-JPS)を日本語で書くとshì dìです。", "task": "replace en to ja", "name_q": "Persimmon calyx (Non-JPS)", "name_a": "shì dì"} -{"id": 30320, "instruction": "N-メチルアントラニル酸の異なる表記は?", "response": "N-メチルアントラニル酸の異なる表記はN-Methylanthranilateです。", "task": "replace", "name_q": "N-メチルアントラニル酸", "name_a": "N-Methylanthranilate"} -{"id": 1965, "instruction": "Linsitinib (USAN/INN)の日本語表記は?", "response": "Linsitinib (USAN/INN)の日本語表記はリンシチニブです。", "task": "replace en to ja", "name_q": "Linsitinib (USAN/INN)", "name_a": "リンシチニブ"} -{"id": 20866, "instruction": "3NO3. 9H2O. Gaをは分子式で表すと?", "response": "3NO3. 9H2O. Gaをは分子式で表すと3NO3. 9H2O. Gaです。", "task": "formula", "name_q": "3NO3. 9H2O. Ga", "name_a": "3NO3. 9H2O. Ga"} -{"id": 23558, "instruction": "C23H26N4O3をを組成式で書くと?", "response": "C23H26N4O3をを組成式で書くとC23H26N4O3です。", "task": "formula", "name_q": "C23H26N4O3", "name_a": "C23H26N4O3"} -{"id": 25751, "instruction": "Plasmanateの日本語表記は?", "response": "Plasmanateの日本語表記はHuman plasma protein fractionです。", "task": "replace en to ja", "name_q": "Plasmanate", "name_a": "Human plasma protein fraction"} -{"id": 18802, "instruction": "Dopamine quinoneの異なる表記は?", "response": "Dopamine quinoneの異なる表記はドーパミンキノンです。", "task": "replace", "name_q": "Dopamine quinone", "name_a": "ドーパミンキノン"} -{"id": 30869, "instruction": "ビュルガー病の英語表記は?", "response": "ビュルガー病の英語表記はBuerger diseaseです。", "task": "replace ja to en", "name_q": "ビュルガー病", "name_a": "Buerger disease"} -{"id": 2714, "instruction": "毛髪の異常と先端角化症を伴う炎症性多形皮膚萎縮症を英語表記で表すと?", "response": "毛髪の異常と先端角化症を伴う炎症性多形皮膚萎縮症を英語表記で表すとInflammatory poikiloderma with hair abnormalities and acral keratosesです。", "task": "replace ja to en", "name_q": "毛髪の異常と先端角化症を伴う炎症性多形皮膚萎縮症", "name_a": "Inflammatory poikiloderma with hair abnormalities and acral keratoses"} -{"id": 21207, "instruction": "(9Z,12Z)-Hexadeca-9,12,15-trienoyl-CoAをを化学式で記述すると?", "response": "(9Z,12Z)-Hexadeca-9,12,15-trienoyl-CoAをを化学式で記述するとC37H60N7O17P3Sです。", "task": "formula", "name_q": "(9Z,12Z)-Hexadeca-9,12,15-trienoyl-CoA", "name_a": "C37H60N7O17P3S"} -{"id": 26608, "instruction": "Seproxetine hydrochloride (USAN)をの化学構造は?", "response": "Seproxetine hydrochloride (USAN)をの化学構造はC16H16F3NO. HClです。", "task": "formula", "name_q": "Seproxetine hydrochloride (USAN)", "name_a": "C16H16F3NO. HCl"} -{"id": 8729, "instruction": "家族性血球貪食症候群 上位グループ 獲得免疫の障害 原発性免疫不全症 を英語表記で表すと?", "response": "家族性血球貪食症候群 上位グループ 獲得免疫の障害 原発性免疫不全症 を英語表記で表すとFamilial hemophagocytic lymphohistiocytosis SUPERGRP Disorders of adaptive immunity Primary immunodeficiency disease です。", "task": "replace ja to en", "name_q": "家族性血球貪食症候群 上位グループ 獲得免疫の障害 原発性免疫不全症 ", "name_a": "Familial hemophagocytic lymphohistiocytosis SUPERGRP Disorders of adaptive immunity Primary immunodeficiency disease "} -{"id": 28471, "instruction": "Desulfoglucotropeolinをを分子式で表すと?", "response": "Desulfoglucotropeolinをを分子式で表すとC14H19NO6Sです。", "task": "formula", "name_q": "Desulfoglucotropeolin", "name_a": "C14H19NO6S"} -{"id": 7934, "instruction": "エストラムスチンを英語で書くと?", "response": "エストラムスチンを英語で書くとEstramustine (USAN/INN)です。", "task": "replace ja to en", "name_q": "エストラムスチン", "name_a": "Estramustine (USAN/INN)"} -{"id": 33594, "instruction": "Desvenlafaxine succinate anhydrousをを化学構造で書くと?", "response": "Desvenlafaxine succinate anhydrousをを化学構造で書くとC16H25NO2. C4H6O4です。", "task": "formula", "name_q": "Desvenlafaxine succinate anhydrous", "name_a": "C16H25NO2. C4H6O4"} -{"id": 23907, "instruction": "ホミカエキス散(司生堂製薬)を用いた薬品は?", "response": "ホミカエキス散(司生堂製薬)を用いた薬品はホミカエキス(司生堂製薬)です。", "task": "product", "name_q": "ホミカエキス散(司生堂製薬)", "name_a": "ホミカエキス(司生堂製薬)"} -{"id": 12811, "instruction": "Sethoxydimをを化学式で表すと?", "response": "Sethoxydimをを化学式で表すとC17H29NO3Sです。", "task": "formula", "name_q": "Sethoxydim", "name_a": "C17H29NO3S"} -{"id": 27834, "instruction": "AMANTADINEHYDROCHLORIDE(MarlexPharmaceuticals)を利用した医薬品名は?", "response": "AMANTADINEHYDROCHLORIDE(MarlexPharmaceuticals)を利用した医薬品名はAMANTADINEHYDROCHLORIDE(AmericanHealthPackaging)です。", "task": "product", "name_q": "AMANTADINEHYDROCHLORIDE(MarlexPharmaceuticals)", "name_a": "AMANTADINEHYDROCHLORIDE(AmericanHealthPackaging)"} -{"id": 21052, "instruction": "C27H28N2O4. C6H8O7をを化学構造で書くと?", "response": "C27H28N2O4. C6H8O7をを化学構造で書くとC27H28N2O4. C6H8O7です。", "task": "formula", "name_q": "C27H28N2O4. C6H8O7", "name_a": "C27H28N2O4. C6H8O7"} -{"id": 12696, "instruction": "C444H561N177O272P44をを分子式で表すと?", "response": "C444H561N177O272P44をを分子式で表すとC444H561N177O272P44です。", "task": "formula", "name_q": "C444H561N177O272P44", "name_a": "C444H561N177O272P44"} -{"id": 11052, "instruction": "VALSARTAN(CamberPharmaceuticals)を主とした薬品は?", "response": "VALSARTAN(CamberPharmaceuticals)を主とした薬品はVALSARTAN(VionaPharmaceuticals)です。", "task": "product", "name_q": "VALSARTAN(CamberPharmaceuticals)", "name_a": "VALSARTAN(VionaPharmaceuticals)"} -{"id": 6043, "instruction": "タルネタント塩酸塩をを組成式で記述すると?", "response": "タルネタント塩酸塩をを組成式で記述するとC25H22N2O2. HClです。", "task": "formula", "name_q": "タルネタント塩酸塩", "name_a": "C25H22N2O2. HCl"} -{"id": 9951, "instruction": "Atelis 症候群を英語で記述すると?", "response": "Atelis 症候群を英語で記述するとAtelis syndromeです。", "task": "replace ja to en", "name_q": "Atelis 症候群", "name_a": "Atelis syndrome"} -{"id": 19207, "instruction": "Cenicriviroc mesylate (USAN)をを化学構造で表すと?", "response": "Cenicriviroc mesylate (USAN)をを化学構造で表すとC41H52N4O4S. CH4SO3です。", "task": "formula", "name_q": "Cenicriviroc mesylate (USAN)", "name_a": "C41H52N4O4S. CH4SO3"} -{"id": 30335, "instruction": "PALONOSETRON(Dr.Reddy'sLaboratoriesLimited)を利用した商品は?", "response": "PALONOSETRON(Dr.Reddy'sLaboratoriesLimited)を利用した商品はPALONOSETRONHYDROCHLORIDE(MylanInstitutionalLLC)です。", "task": "product", "name_q": "PALONOSETRON(Dr.Reddy'sLaboratoriesLimited)", "name_a": "PALONOSETRONHYDROCHLORIDE(MylanInstitutionalLLC)"} -{"id": 23297, "instruction": "エンドリンをを分子式で表すと?", "response": "エンドリンをを分子式で表すとC12H8Cl6Oです。", "task": "formula", "name_q": "エンドリン", "name_a": "C12H8Cl6O"} -{"id": 16548, "instruction": "Arthrogryposis multiplex congenita SUBGROUP AMC1, neurogenic, with myelin defect AMC2, neurogenic type AMC3, myogenic type AMC4, neurogenic, with agenesis of the corpus callosum AMC5 AMC6を日本語表記で表すと?", "response": "Arthrogryposis multiplex congenita SUBGROUP AMC1, neurogenic, with myelin defect AMC2, neurogenic type AMC3, myogenic type AMC4, neurogenic, with agenesis of the corpus callosum AMC5 AMC6を日本語表記で表すと先天性多発性関節拘縮症 下位グループ AMC1 ミエリン欠損を伴う神経原性型 AMC2 神経原性型 AMC3 筋原性型 AMC4 脳梁欠損を伴う神経原性型 AMC5 AMC6です。", "task": "replace en to ja", "name_q": "Arthrogryposis multiplex congenita SUBGROUP AMC1, neurogenic, with myelin defect AMC2, neurogenic type AMC3, myogenic type AMC4, neurogenic, with agenesis of the corpus callosum AMC5 AMC6", "name_a": "先天性多発性関節拘縮症 下位グループ AMC1 ミエリン欠損を伴う神経原性型 AMC2 神経原性型 AMC3 筋原性型 AMC4 脳梁欠損を伴う神経原性型 AMC5 AMC6"} -{"id": 22692, "instruction": "デザペリシブを英語で記述すると?", "response": "デザペリシブを英語で記述するとDezapelisib (USAN/INN)です。", "task": "replace ja to en", "name_q": "デザペリシブ", "name_a": "Dezapelisib (USAN/INN)"} -{"id": 1034, "instruction": "ネオセンブレンの別名は?", "response": "ネオセンブレンの別名はセンブレンAです。", "task": "replace", "name_q": "ネオセンブレン", "name_a": "センブレンA"} -{"id": 1401, "instruction": "メチル分枝鎖アシルCoA デヒドロゲナーゼ欠損症を英語に訳すと?", "response": "メチル分枝鎖アシルCoA デヒドロゲナーゼ欠損症を英語に訳すとSBCAD deficiencyです。", "task": "replace ja to en", "name_q": "メチル分枝鎖アシルCoA デヒドロゲナーゼ欠損症", "name_a": "SBCAD deficiency"} -{"id": 24473, "instruction": "Matricinの異なる表記は?", "response": "Matricinの異なる表記はマトリシンです。", "task": "replace", "name_q": "Matricin", "name_a": "マトリシン"} -{"id": 32677, "instruction": "塩化ベンゾイルの別表現は?", "response": "塩化ベンゾイルの別表現はBenzoyl chlorideです。", "task": "replace", "name_q": "塩化ベンゾイル", "name_a": "Benzoyl chloride"} -{"id": 14461, "instruction": "Norflurane (USAN/INN)をは化学構造で表すと?", "response": "Norflurane (USAN/INN)をは化学構造で表すとC2H2F4です。", "task": "formula", "name_q": "Norflurane (USAN/INN)", "name_a": "C2H2F4"} -{"id": 12422, "instruction": "N-Benzoyl-D-arginine-4-nitroanilideをを化学構造で記述すると?", "response": "N-Benzoyl-D-arginine-4-nitroanilideをを化学構造で記述するとC19H22N6O4です。", "task": "formula", "name_q": "N-Benzoyl-D-arginine-4-nitroanilide", "name_a": "C19H22N6O4"} -{"id": 31599, "instruction": "ベフロキサトンの別記述は?", "response": "ベフロキサトンの別記述はBefloxatone (INN)です。", "task": "replace", "name_q": "ベフロキサトン", "name_a": "Befloxatone (INN)"} -{"id": 17943, "instruction": "Bladder pain syndromeを日本語で記述すると?", "response": "Bladder pain syndromeを日本語で記述すると間質性膀胱炎です。", "task": "replace en to ja", "name_q": "Bladder pain syndrome", "name_a": "間質性膀胱炎"} -{"id": 13207, "instruction": "Pelargonidin 3-glucoside 5-caffeoylglucosideをを組成式で記述すると?", "response": "Pelargonidin 3-glucoside 5-caffeoylglucosideをを組成式で記述するとC36H37O18です。", "task": "formula", "name_q": "Pelargonidin 3-glucoside 5-caffeoylglucoside", "name_a": "C36H37O18"} -{"id": 3892, "instruction": "Nasaruplase (cell culture) (JAN)を日本語で記述すると?", "response": "Nasaruplase (cell culture) (JAN)を日本語で記述するとProurokinase (plasminogen activator prolyse)です。", "task": "replace en to ja", "name_q": "Nasaruplase (cell culture) (JAN)", "name_a": "Prourokinase (plasminogen activator prolyse)"} -{"id": 34554, "instruction": "フラボキサートの別名は?", "response": "フラボキサートの別名はFlavoxateです。", "task": "replace", "name_q": "フラボキサート", "name_a": "Flavoxate"} -{"id": 12474, "instruction": "C4aを言い換えると?", "response": "C4aを言い換えるとComplement component 4aです。", "task": "replace", "name_q": "C4a", "name_a": "Complement component 4a"} -{"id": 472, "instruction": "Aplotaxeneをは組成式で表すと?", "response": "Aplotaxeneをは組成式で表すとC17H28です。", "task": "formula", "name_q": "Aplotaxene", "name_a": "C17H28"} -{"id": 32298, "instruction": "九味檳榔湯の別記述は?", "response": "九味檳榔湯の別記述はクミビンロウトウです。", "task": "replace", "name_q": "九味檳榔湯", "name_a": "クミビンロウトウ"} -{"id": 23513, "instruction": "ナプロキシノドを英語に訳すと?", "response": "ナプロキシノドを英語に訳すとNaproxcinod (USAN/INN)です。", "task": "replace ja to en", "name_q": "ナプロキシノド", "name_a": "Naproxcinod (USAN/INN)"} -{"id": 10255, "instruction": "Berberine ursodeoxycholate (USAN)をの組成式は?", "response": "Berberine ursodeoxycholate (USAN)をの組成式はC24H39O4. C20H18NO4です。", "task": "formula", "name_q": "Berberine ursodeoxycholate (USAN)", "name_a": "C24H39O4. C20H18NO4"} -{"id": 5499, "instruction": "Naloxegol oxalate (USAN)は別の呼び方では?", "response": "Naloxegol oxalate (USAN)は別の呼び方ではナロキセゴルシュウ酸塩です。", "task": "replace", "name_q": "Naloxegol oxalate (USAN)", "name_a": "ナロキセゴルシュウ酸塩"} -{"id": 243, "instruction": "Codeinoneは別の呼び方では?", "response": "Codeinoneは別の呼び方ではコデイノンです。", "task": "replace", "name_q": "Codeinone", "name_a": "コデイノン"} -{"id": 4068, "instruction": "2-Hydroxy-6-ketononatrienedioateをの化学式は?", "response": "2-Hydroxy-6-ketononatrienedioateをの化学式はC9H8O6です。", "task": "formula", "name_q": "2-Hydroxy-6-ketononatrienedioate", "name_a": "C9H8O6"} -{"id": 6299, "instruction": "Epacadostat (JAN/USAN/INN)を日本語に訳すと?", "response": "Epacadostat (JAN/USAN/INN)を日本語に訳すとエパカドスタット (JAN)です。", "task": "replace en to ja", "name_q": "Epacadostat (JAN/USAN/INN)", "name_a": "エパカドスタット (JAN)"} -{"id": 25785, "instruction": "3-Sulfinylpyruvateの異なる表記は?", "response": "3-Sulfinylpyruvateの異なる表記は3-スルフィニルピルビン酸です。", "task": "replace", "name_q": "3-Sulfinylpyruvate", "name_a": "3-スルフィニルピルビン酸"} -{"id": 11238, "instruction": "Zopolrestat (USAN/INN)をを化学構造で書くと?", "response": "Zopolrestat (USAN/INN)をを化学構造で書くとC19H12F3N3O3Sです。", "task": "formula", "name_q": "Zopolrestat (USAN/INN)", "name_a": "C19H12F3N3O3S"} -{"id": 21739, "instruction": "Krintafel (TN)の日本語訳は?", "response": "Krintafel (TN)の日本語訳はTafenoquine succinate (USAN)です。", "task": "replace en to ja", "name_q": "Krintafel (TN)", "name_a": "Tafenoquine succinate (USAN)"} -{"id": 5106, "instruction": "Ethinyl estradiol (USP)を英語に訳すと?", "response": "Ethinyl estradiol (USP)を英語に訳すとEthinyl estradiol (USP)です。", "task": "replace ja to en", "name_q": "Ethinyl estradiol (USP)", "name_a": "Ethinyl estradiol (USP)"} -{"id": 21260, "instruction": "Mipasetamab (USAN/INN)を日本語で記述すると?", "response": "Mipasetamab (USAN/INN)を日本語で記述するとミパセタマブです。", "task": "replace en to ja", "name_q": "Mipasetamab (USAN/INN)", "name_a": "ミパセタマブ"} -{"id": 14256, "instruction": "L-alpha-Amino-gamma-oxalylaminobutyric acidをを分子式で記述すると?", "response": "L-alpha-Amino-gamma-oxalylaminobutyric acidをを分子式で記述するとC6H10N2O5です。", "task": "formula", "name_q": "L-alpha-Amino-gamma-oxalylaminobutyric acid", "name_a": "C6H10N2O5"} -{"id": 30099, "instruction": "ブーメラン異形成を英語に訳すと?", "response": "ブー���ラン異形成を英語に訳すとBoomerang dysplasiaです。", "task": "replace ja to en", "name_q": "ブーメラン異形成", "name_a": "Boomerang dysplasia"} -{"id": 14117, "instruction": "PHENYLEPHRINEHYDROCHLORIDE(NovadozPharmaceuticalsLLC)を使用した商品名は?", "response": "PHENYLEPHRINEHYDROCHLORIDE(NovadozPharmaceuticalsLLC)を使用した商品名はPHENYLEPHRINEHYDROCHLORIDE(Akorn)です。", "task": "product", "name_q": "PHENYLEPHRINEHYDROCHLORIDE(NovadozPharmaceuticalsLLC)", "name_a": "PHENYLEPHRINEHYDROCHLORIDE(Akorn)"} -{"id": 20345, "instruction": "Confertiflorinを言い換えると?", "response": "Confertiflorinを言い換えると(+)-Confertiflorinです。", "task": "replace", "name_q": "Confertiflorin", "name_a": "(+)-Confertiflorin"} -{"id": 24857, "instruction": "Lofemizole hydrochloride (USAN)を日本語で書くと?", "response": "Lofemizole hydrochloride (USAN)を日本語で書くとロフェミゾール塩酸塩です。", "task": "replace en to ja", "name_q": "Lofemizole hydrochloride (USAN)", "name_a": "ロフェミゾール塩酸塩"} -{"id": 5199, "instruction": "SULCONAZOLENITRATE(JGPharma)を主材料とする製品は?", "response": "SULCONAZOLENITRATE(JGPharma)を主材料とする製品はSULCONAZOLENITRATE(JGPharma)です。", "task": "product", "name_q": "SULCONAZOLENITRATE(JGPharma)", "name_a": "SULCONAZOLENITRATE(JGPharma)"} -{"id": 27293, "instruction": "アシアチン酸は別の呼び方では?", "response": "アシアチン酸は別の呼び方ではアシアト酸です。", "task": "replace", "name_q": "アシアチン酸", "name_a": "アシアト酸"} -{"id": 24122, "instruction": "Quinoxalineの異なる名称は?", "response": "Quinoxalineの異なる名称はキノキサリンです。", "task": "replace", "name_q": "Quinoxaline", "name_a": "キノキサリン"} -{"id": 4953, "instruction": "Trolnitrate phosphate (JAN)の別の呼び方は?", "response": "Trolnitrate phosphate (JAN)の別の呼び方はNitretamin (TN)です。", "task": "replace", "name_q": "Trolnitrate phosphate (JAN)", "name_a": "Nitretamin (TN)"} -{"id": 1695, "instruction": "Elfazepam (USAN/INN)の別表現は?", "response": "Elfazepam (USAN/INN)の別表現はエルファゼパムです。", "task": "replace", "name_q": "Elfazepam (USAN/INN)", "name_a": "エルファゼパム"} -{"id": 29810, "instruction": "Biotin sulfoneをを組成式で記述すると?", "response": "Biotin sulfoneをを組成式で記述するとC10H16N2O5Sです。", "task": "formula", "name_q": "Biotin sulfone", "name_a": "C10H16N2O5S"} -{"id": 15873, "instruction": "Zilucoplan (USAN/INN)をを化学式で表すと?", "response": "Zilucoplan (USAN/INN)をを化学式で表すとC172H278N24O55です。", "task": "formula", "name_q": "Zilucoplan (USAN/INN)", "name_a": "C172H278N24O55"} -{"id": 3499, "instruction": "C4H4O4をの分子式は?", "response": "C4H4O4をの分子式はC4H4O4です。", "task": "formula", "name_q": "C4H4O4", "name_a": "C4H4O4"} -{"id": 19972, "instruction": "Alphitoninをを組成式で記述すると?", "response": "Alphitoninをを組成式で記述するとC15H12O7です。", "task": "formula", "name_q": "Alphitonin", "name_a": "C15H12O7"} -{"id": 25639, "instruction": "Theobromineの別の呼び方は?", "response": "Theobromineの別の呼び方は3,7-Dimethylxanthineです。", "task": "replace", "name_q": "Theobromine", "name_a": "3,7-Dimethylxanthine"} -{"id": 32137, "instruction": "3'-Keto-3'-deoxy-AMPをを分子式で記述すると?", "response": "3'-Keto-3'-deoxy-AMPをを分子式で記述するとC10H12N5O7Pです。", "task": "formula", "name_q": "3'-Keto-3'-deoxy-AMP", "name_a": "C10H12N5O7P"} -{"id": 14143, "instruction": "Methylprednisolone succinate (JP18)を日本語で記述すると?", "response": "Methylprednisolone succinate (JP18)を日本語で記述するとMethylprednisolone hemisuccinate (USP)です。", "task": "replace en to ja", "name_q": "Methylprednisolone succinate (JP18)", "name_a": "Methylprednisolone hemisuccinate (USP)"} -{"id": 9782, "instruction": "Prosaposin deficiency SUPERGRP Lysosomal storage disease を日本語表記で表すと?", "response": "Prosaposin deficiency SUPERGRP Lysosomal storage disease を日本語表記で表すとプロサポシン欠損症 上位グループ ライソゾーム病 (リソソーム蓄積症) です。", "task": "replace en to ja", "name_q": "Prosaposin deficiency SUPERGRP Lysosomal storage disease ", "name_a": "プロサポシン欠損症 上位グループ ライソゾーム病 (リソソーム蓄積症) "} -{"id": 5788, "instruction": "(S)-3'-Hydroxy-N-methylcoclaurineをの化学式は?", "response": "(S)-3'-Hydroxy-N-methylcoclaurineをの化学式はC18H21NO4です。", "task": "formula", "name_q": "(S)-3'-Hydroxy-N-methylcoclaurine", "name_a": "C18H21NO4"} -{"id": 18349, "instruction": "L-Valyl-tRNA(Val)をの化学式は?", "response": "L-Valyl-tRNA(Val)をの化学式はC20H30N6O11PR(C5H8O6PR)nです。", "task": "formula", "name_q": "L-Valyl-tRNA(Val)", "name_a": "C20H30N6O11PR(C5H8O6PR)n"} -{"id": 2642, "instruction": "Nyoshinsanを日本語で書くと?", "response": "Nyoshinsanを日本語で書くと安栄湯です。", "task": "replace en to ja", "name_q": "Nyoshinsan", "name_a": "安栄湯"} -{"id": 23750, "instruction": "L-2-hydroxyglutaric aciduriaの日本語表記は?", "response": "L-2-hydroxyglutaric aciduriaの日本語表記はL-2-ヒドロキシグルタル酸尿症です。", "task": "replace en to ja", "name_q": "L-2-hydroxyglutaric aciduria", "name_a": "L-2-ヒドロキシグルタル酸尿症"} -{"id": 30289, "instruction": "Diallyl disulfideをを組成式で記述すると?", "response": "Diallyl disulfideをを組成式で記述するとC6H10S2です。", "task": "formula", "name_q": "Diallyl disulfide", "name_a": "C6H10S2"} -{"id": 11679, "instruction": "デネニコキンを英語で記述すると?", "response": "デネニコキンを英語で記述するとDenenicokin (USAN/INN)です。", "task": "replace ja to en", "name_q": "デネニコキン", "name_a": "Denenicokin (USAN/INN)"} -{"id": 22207, "instruction": "Ticarcillin sodium (JAN)の英訳は?", "response": "Ticarcillin sodium (JAN)の英訳はTicar (TN)です。", "task": "replace ja to en", "name_q": "Ticarcillin sodium (JAN)", "name_a": "Ticar (TN)"} -{"id": 32860, "instruction": "7-Methylguanosine 5'-triphospho-5'-oligonucleotideをの化学構造は?", "response": "7-Methylguanosine 5'-triphospho-5'-oligonucleotideをの化学構造はC11H18N5O11P2(C5H8O6PR)nです。", "task": "formula", "name_q": "7-Methylguanosine 5'-triphospho-5'-oligonucleotide", "name_a": "C11H18N5O11P2(C5H8O6PR)n"} -{"id": 29972, "instruction": "Icopezil maleate (USAN)の英訳は?", "response": "Icopezil maleate (USAN)の英訳はIcopezil maleate (USAN)です。", "task": "replace ja to en", "name_q": "Icopezil maleate (USAN)", "name_a": "Icopezil maleate (USAN)"} -{"id": 1534, "instruction": "3-Dehydro-4-phospho-D-erythronateをを化学構造で表すと?", "response": "3-Dehydro-4-phospho-D-erythronateをを化学構造で表すとC4H7O8Pです。", "task": "formula", "name_q": "3-Dehydro-4-phospho-D-erythronate", "name_a": "C4H7O8P"} -{"id": 15198, "instruction": "Hydroquinine hydrobromideを英語で記述すると?", "response": "Hydroquinine hydrobromideを英語で記述するとinhibin (TN)です。", "task": "replace ja to en", "name_q": "Hydroquinine hydrobromide", "name_a": "inhibin (TN)"} -{"id": 3029, "instruction": "デキストロアンフェタミンサッカリン酸塩をを分子式で表すと?", "response": "デキストロアンフェタミンサッカリン酸塩をを分子式で表すと(C6H10O8)x. C9H13Nです。", "task": "formula", "name_q": "デキストロアンフェタミンサッカリン酸塩", "name_a": "(C6H10O8)x. C9H13N"} -{"id": 10158, "instruction": "酢酸フルロゲストンをの分子式は?", "response": "酢酸フルロゲストンをの分子式はC23H31FO5です。", "task": "formula", "name_q": "酢酸フルロゲストン", "name_a": "C23H31FO5"} -{"id": 25491, "instruction": "Iodocetylic acid I 123 (USAN)の別記述は?", "response": "Iodocetylic acid I 123 (USAN)の別記述はIodocetylic acid (123I) (INN)です。", "task": "replace", "name_q": "Iodocetylic acid I 123 (USAN)", "name_a": "Iodocetylic acid (123I) (INN)"} -{"id": 7917, "instruction": "Capastat sulfate (TN)の別名は?", "response": "Capastat sulfate (TN)の別名はCapreomycin sulfate (JAN/USP)です。", "task": "replace", "name_q": "Capastat sulfate (TN)", "name_a": "Capreomycin sulfate (JAN/USP)"} -{"id": 33703, "instruction": "グリコリピドの別の呼び方は?", "response": "グリコリピドの別の呼び方は糖脂質です。", "task": "replace", "name_q": "グリコリピド", "name_a": "糖脂質"} -{"id": 26538, "instruction": "BTD deficiencyを言い換えると?", "response": "BTD deficiencyを言い換えるとLate-onset multiple carboxylase deficiencyです。", "task": "replace", "name_q": "BTD deficiency", "name_a": "Late-onset multiple carboxylase deficiency"} -{"id": 11602, "instruction": "Aflatoxin-M1-8,9-epoxideをの化学式は?", "response": "Aflatoxin-M1-8,9-epoxideをの化学式はC17H12O8です。", "task": "formula", "name_q": "Aflatoxin-M1-8,9-epoxide", "name_a": "C17H12O8"} -{"id": 20625, "instruction": "cis-trans-Nepetalactolの別の言い方は?", "response": "cis-trans-Nepetalactolの別の言い方は(4aS,7S,7aR)-4,7-Dimethyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-olです。", "task": "replace", "name_q": "cis-trans-Nepetalactol", "name_a": "(4aS,7S,7aR)-4,7-Dimethyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-ol"} -{"id": 19312, "instruction": "顔面中部低形成・難聴・楕円赤血球症および腎石灰化症を英語で記述すると?", "response": "顔面中部低形成・難聴・楕円赤血球症および腎石灰化症を英語で記述するとMidface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosisです。", "task": "replace ja to en", "name_q": "顔面中部低形成・難聴・楕円赤血球症および腎石灰化症", "name_a": "Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis"} -{"id": 681, "instruction": "Oxiperomide (USAN/INN)を日本語で書くと?", "response": "Oxiperomide (USAN/INN)を日本語で書くとオキシペロミドです。", "task": "replace en to ja", "name_q": "Oxiperomide (USAN/INN)", "name_a": "オキシペロミド"} -{"id": 14786, "instruction": "骨硬化性骨幹端異形成症を英語に訳すと?", "response": "骨硬化性骨幹端異形成症を英語に訳すとOsteosclerotic metaphyseal dysplasiaです。", "task": "replace ja to en", "name_q": "骨硬化性骨幹端異形成症", "name_a": "Osteosclerotic metaphyseal dysplasia"} -{"id": 2550, "instruction": "Natamycinをを化学構造で表すと?", "response": "Natamycinをを化学構造で表すとC33H47NO13です。", "task": "formula", "name_q": "Natamycin", "name_a": "C33H47NO13"} -{"id": 33505, "instruction": "脊椎分離-大骨端-骨幹端異形成を英語表記で表すと?", "response": "脊椎分離-大骨端-骨幹端異形成を英語表記で表すとSpondylo-megaepiphyseal-metaphyseal dysplasiaです。", "task": "replace ja to en", "name_q": "脊椎分離-大骨端-骨幹端異形成", "name_a": "Spondylo-megaepiphyseal-metaphyseal dysplasia"} -{"id": 1501, "instruction": "臭化水素酸ピブロゼレシンをを組成式で表すと?", "response": "臭化水素酸ピブロゼレシンをを組成式で表すとC32H36BrN5O8. HBrです。", "task": "formula", "name_q": "臭化水素酸ピブロゼレシン", "name_a": "C32H36BrN5O8. HBr"} -{"id": 32100, "instruction": "Balofloxacin hydrate (JAN)をを化学式で書くと?", "response": "Balofloxacin hydrate (JAN)をを化学式で書くとC20H24FN3O4. 2H2Oです。", "task": "formula", "name_q": "Balofloxacin hydrate (JAN)", "name_a": "C20H24FN3O4. 2H2O"} -{"id": 5304, "instruction": "シレマドリンをを化学式で記述すると?", "response": "シレマドリンをを化学式で記述するとC26H24Cl2N6O4です。", "task": "formula", "name_q": "シレマドリン", "name_a": "C26H24Cl2N6O4"} -{"id": 20201, "instruction": "Fosamprenavir sodium (USAN)の日本語表記は?", "response": "Fosamprenavir sodium (USAN)の日本語表記はFosamprenavir sodium (USAN)です。", "task": "replace en to ja", "name_q": "Fosamprenavir sodium (USAN)", "name_a": "Fosamprenavir sodium (USAN)"} -{"id": 11909, "instruction": "Fluxid (TN)を利用した商品は?", "response": "Fluxid (TN)を利用した商品はファモチジン(辰巳化学)です。", "task": "product", "name_q": "Fluxid (TN)", "name_a": "ファモチジン(辰巳化学)"} -{"id": 6207, "instruction": "Cuscuta seedの日本語訳は?", "response": "Cuscuta seedの日本語訳はCuscuta seedです。", "task": "replace en to ja", "name_q": "Cuscuta seed", "name_a": "Cuscuta seed"} -{"id": 22473, "instruction": "1-Hydroxyalkyl-sn-glycerolの別表現は?", "response": "1-Hydroxyalkyl-sn-glycerolの別表現は1-O-(1-Hydroxyalkyl)-sn-glycerolです。", "task": "replace", "name_q": "1-Hydroxyalkyl-sn-glycerol", "name_a": "1-O-(1-Hydroxyalkyl)-sn-glycerol"} -{"id": 16057, "instruction": "ガドペンテト酸をを組成式で記述すると?", "response": "ガドペンテト酸をを組成式で記述するとC14H18N3O10. Gd. 2Hです。", "task": "formula", "name_q": "ガドペンテト酸", "name_a": "C14H18N3O10. Gd. 2H"} -{"id": 23061, "instruction": "Amsacrineをを化学式で記述すると?", "response": "Amsacrineをを化学式で記述するとC21H19N3O3Sです。", "task": "formula", "name_q": "Amsacrine", "name_a": "C21H19N3O3S"} -{"id": 11133, "instruction": "C18H35NOをは分子式で表すと?", "response": "C18H35NOをは分子式で表すとC18H35NOです。", "task": "formula", "name_q": "C18H35NO", "name_a": "C18H35NO"} -{"id": 2557, "instruction": "Remoxipride hydrochloride (USAN)をは化学式で表すと?", "response": "Remoxipride hydrochloride (USAN)をは化学式で表すとC16H23BrN2O3. HCl. H2Oです。", "task": "formula", "name_q": "Remoxipride hydrochloride (USAN)", "name_a": "C16H23BrN2O3. HCl. H2O"} -{"id": 19129, "instruction": "Obatoclax mesylate (USAN)の英語表記は?", "response": "Obatoclax mesylate (USAN)の英語表記はObatoclax mesylate (USAN)です。", "task": "replace ja to en", "name_q": "Obatoclax mesylate (USAN)", "name_a": "Obatoclax mesylate (USAN)"} -{"id": 11149, "instruction": "セフタジジム水和物 (JP18)を英語で記述すると?", "response": "セフタジジム水和物 (JP18)を英語で記述するとCeftazidime (USP)です。", "task": "replace ja to en", "name_q": "セフタジジム水和物 (JP18)", "name_a": "Ceftazidime (USP)"} -{"id": 34617, "instruction": "Mifepristoneの異なる表現は?", "response": "Mifepristoneの異なる表現はRU-486です。", "task": "replace", "name_q": "Mifepristone", "name_a": "RU-486"} -{"id": 23295, "instruction": "Singleton-Merten syndromeの日本語表記は?", "response": "Singleton-Merten syndromeの日本語表記はSingleton-Merten 症候群です。", "task": "replace en to ja", "name_q": "Singleton-Merten syndrome", "name_a": "Singleton-Merten 症候群"} -{"id": 13646, "instruction": "TRYVIO(IdorsiaPharmaceuticals)を用いた医薬品は?", "response": "TRYVIO(IdorsiaPharmaceuticals)を用いた医薬品はTRYVIO(IdorsiaPharmaceuticals)です。", "task": "product", "name_q": "TRYVIO(IdorsiaPharmaceuticals)", "name_a": "TRYVIO(IdorsiaPharmaceuticals)"} -{"id": 2248, "instruction": "Pyridine-2,3-dicarboxylateの異なる表記は?", "response": "Pyridine-2,3-dicarboxylateの異なる表記はQuinolinateです。", "task": "replace", "name_q": "Pyridine-2,3-dicarboxylate", "name_a": "Quinolinate"} -{"id": 20688, "instruction": "Octabenzone (USAN)をの化学式は?", "response": "Octabenzone (USAN)をの化学式はC21H26O3です。", "task": "formula", "name_q": "Octabenzone (USAN)", "name_a": "C21H26O3"} -{"id": 8972, "instruction": "Propionibacterium acnes infection SUPERGRP Anaerobic infection の日本語表記は?", "response": "Propionibacterium acnes infection SUPERGRP Anaerobic infection の日本語表記はPropionibacterium acnes 感染 上位グループ 嫌気性菌感染症 です。", "task": "replace en to ja", "name_q": "Propionibacterium acnes infection SUPERGRP Anaerobic infection ", "name_a": "Propionibacterium acnes 感染 上位グループ 嫌気性菌感染症 "} -{"id": 24099, "instruction": "1D-myo-Inositol 1,4,5,6-tetrakisphosphateをの化学構造は?", "response": "1D-myo-Inositol 1,4,5,6-tetrakisphosphateをの化学構造はC6H16O18P4です。", "task": "formula", "name_q": "1D-myo-Inositol 1,4,5,6-tetrakisphosphate", "name_a": "C6H16O18P4"} -{"id": 3388, "instruction": "珍珠の英語表記は?", "response": "珍珠の英語表記はPearlです。", "task": "replace ja to en", "name_q": "珍珠", "name_a": "Pearl"} -{"id": 4138, "instruction": "4-Hydroxytolueneをを組成式で記述すると?", "response": "4-Hydroxytolueneをを組成式で記述するとC7H8Oです。", "task": "formula", "name_q": "4-Hydroxytoluene", "name_a": "C7H8O"} -{"id": 34628, "instruction": "C22H32O3をは化学式で表すと?", "response": "C22H32O3をは化学式で表すとC22H32O3です。", "task": "formula", "name_q": "C22H32O3", "name_a": "C22H32O3"} -{"id": 1258, "instruction": "Torg 症候群の別呼称は?", "response": "Torg 症候群の別呼称はTorg-Winchester 症候群です。", "task": "replace", "name_q": "Torg 症候群", "name_a": "Torg-Winchester 症候群"} -{"id": 13258, "instruction": "前脛骨表皮水泡症と難聴を伴う腎症を英語表記で表すと?", "response": "前脛骨表皮水泡症と難聴を伴う腎症を英語表記で表すとNephropathy with pretibial epidermolysis bullosa and deafnessです。", "task": "replace ja to en", "name_q": "前脛骨表皮水泡症と難聴を伴う腎症", "name_a": "Nephropathy with pretibial epidermolysis bullosa and deafness"} -{"id": 11838, "instruction": "12-Ethyl-8-isobutyl-3-vinylbacteriochlorophyllide dをを化学構造で表すと?", "response": "12-Ethyl-8-isobutyl-3-vinylbacteriochlorophyllide dをを化学構造で表すとC36H38MgN4O3です。", "task": "formula", "name_q": "12-Ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d", "name_a": "C36H38MgN4O3"} -{"id": 18203, "instruction": "イソシナノロンをの化学構造は?", "response": "イソシナノロンをの化学構造はC11H12O3です。", "task": "formula", "name_q": "イソシナノロン", "name_a": "C11H12O3"} -{"id": 6760, "instruction": "Retinyl esterをを分子式で記述すると?", "response": "Retinyl esterをを分子式で記述するとC21H29O2Rです。", "task": "formula", "name_q": "Retinyl ester", "name_a": "C21H29O2R"} -{"id": 21553, "instruction": "ノルエチステロン・メストラノールを英語で記述すると?", "response": "ノルエチステロン・メストラノールを英語で記述するとNorethisterone and mestranolです。", "task": "replace ja to en", "name_q": "ノルエチステロン・メストラノール", "name_a": "Norethisterone and mestranol"} -{"id": 25310, "instruction": "MOPD IIを英語で記述すると?", "response": "MOPD IIを英語で記述するとMicrocephalic osteodysplastic primordial dwarfism, type II (MOPD II)です。", "task": "replace ja to en", "name_q": "MOPD II", "name_a": "Microcephalic osteodysplastic primordial dwarfism, type II (MOPD II)"} -{"id": 11118, "instruction": "FLUCYTOSINE(SigmapharmLaboratories)をを化学構造で表すと?", "response": "FLUCYTOSINE(SigmapharmLaboratories)をを化学構造で表すとC4H4FN3Oです。", "task": "formula", "name_q": "FLUCYTOSINE(SigmapharmLaboratories)", "name_a": "C4H4FN3O"} -{"id": 18074, "instruction": "6-Deoxy-5-ketofructose 1-phosphateをを分子式で表すと?", "response": "6-Deoxy-5-ketofructose 1-phosphateをを分子式で表すとC6H11O8Pです。", "task": "formula", "name_q": "6-Deoxy-5-ketofructose 1-phosphate", "name_a": "C6H11O8P"} -{"id": 30909, "instruction": "Pirmagrel (USAN/INN)を日本語表記で表すと?", "response": "Pirmagrel (USAN/INN)を日本語表記で表すとCGS 13080です。", "task": "replace en to ja", "name_q": "Pirmagrel (USAN/INN)", "name_a": "CGS 13080"} -{"id": 10281, "instruction": "フェノフィブラートをを分子式で記述すると?", "response": "フェノフィブラートをを分子式で記述するとC20H21ClO4です。", "task": "formula", "name_q": "フェノフィブラート", "name_a": "C20H21ClO4"} -{"id": 3162, "instruction": "ピクナミンをを分子式で記述すると?", "response": "ピクナミンをを分子式で記述するとC37H40N2O6です。", "task": "formula", "name_q": "ピクナミン", "name_a": "C37H40N2O6"} -{"id": 16600, "instruction": "エタノール(大成薬品工業)を主材料とする商品名は?", "response": "エタノール(大成薬品工業)を主材料とする商品名はエタノール(健栄製薬)です。", "task": "product", "name_q": "エタノール(大成薬品工業)", "name_a": "エタノール(健栄製薬)"} -{"id": 19216, "instruction": "9-オキソノナン酸の別名称は?", "response": "9-オキソノナン酸の別名称は9-Oxononanoic acidです。", "task": "replace", "name_q": "9-オキソノナン酸", "name_a": "9-Oxononanoic acid"} -{"id": 4607, "instruction": "Liovel (TN)は別の呼び方では?", "response": "Liovel (TN)は別の呼び方ではAlogliptin benzoate and pioglitazone hydrochlorideです。", "task": "replace", "name_q": "Liovel (TN)", "name_a": "Alogliptin benzoate and pioglitazone hydrochloride"} -{"id": 12004, "instruction": "3-Hydroxy-L-tyrosyl-AMPをの分子式は?", "response": "3-Hydroxy-L-tyrosyl-AMPをの分子式はC19H23N6O10Pです。", "task": "formula", "name_q": "3-Hydroxy-L-tyrosyl-AMP", "name_a": "C19H23N6O10P"} -{"id": 2476, "instruction": "4-(ジメチルアミノ)フェニルアゾキシベンゼンは別の呼び方では?", "response": "4-(ジメチルアミノ)フェニルアゾキシベンゼンは別の呼び方では4-(Dimethylamino)phenylazoxybenzeneです。", "task": "replace", "name_q": "4-(ジメチルアミノ)フェニルアゾキシベンゼン", "name_a": "4-(Dimethylamino)phenylazoxybenzene"} -{"id": 6147, "instruction": "Yohimbine (DCF)をを化学式で書くと?", "response": "Yohimbine (DCF)をを化学式で書くとC21H26N2O3です。", "task": "formula", "name_q": "Yohimbine (DCF)", "name_a": "C21H26N2O3"} -{"id": 4714, "instruction": "4-Fluorobenzoyl-CoAをは組成式で表すと?", "response": "4-Fluorobenzoyl-CoAをは組成式で表すとC28H39FN7O17P3Sです。", "task": "formula", "name_q": "4-Fluorobenzoyl-CoA", "name_a": "C28H39FN7O17P3S"} -{"id": 15459, "instruction": "Tricosal (TN)をは化学構造で表すと?", "response": "Tricosal (TN)をは化学構造で表すと(C7H5O3)3. C5H14NO. Mgです。", "task": "formula", "name_q": "Tricosal (TN)", "name_a": "(C7H5O3)3. C5H14NO. Mg"} -{"id": 23471, "instruction": "Ceftolozane (USAN)を日本語で記述すると?", "response": "Ceftolozane (USAN)を日本語で記述するとセフトロザンです。", "task": "replace en to ja", "name_q": "Ceftolozane (USAN)", "name_a": "セフトロザン"} -{"id": 2271, "instruction": "METRONIDAZOLE(ZydusLifesciencesLimited)を主とした製品名は?", "response": "METRONIDAZOLE(ZydusLifesciencesLimited)を主とした製品名はフラジール(富士製薬工業)です。", "task": "product", "name_q": "METRONIDAZOLE(ZydusLifesciencesLimited)", "name_a": "フラジール(富士製薬工業)"} -{"id": 4616, "instruction": "lóng yǎn ròuの異なる名称は?", "response": "lóng yǎn ròuの異なる名称はLongan arillusです。", "task": "replace", "name_q": "lóng yǎn ròu", "name_a": "Longan arillus"} -{"id": 4232, "instruction": "Laninamivir (INN)をを分子式で表すと?", "response": "Laninamivir (INN)をを分子式で表すとC13H22N4O7です。", "task": "formula", "name_q": "Laninamivir (INN)", "name_a": "C13H22N4O7"} -{"id": 16710, "instruction": "頭部円形精子症 上位グループ 精子形成異常 の英語表記は?", "response": "頭部円形精子症 上位グループ 精子形成異常 の英語表記はGlobozoospermiaです。", "task": "replace ja to en", "name_q": "頭部円形精子症 上位グループ 精子形成異常 ", "name_a": "Globozoospermia"} -{"id": 13438, "instruction": "2',4'-Dihydroxycinnamic acidをを分子式で書くと?", "response": "2',4'-Dihydroxycinnamic acidをを分子式で書くとC8H7O2Rです。", "task": "formula", "name_q": "2',4'-Dihydroxycinnamic acid", "name_a": "C8H7O2R"} -{"id": 20506, "instruction": "C19H22N2Oをを分子式で書くと?", "response": "C19H22N2Oをを分子式で書くとC19H22N2Oです。", "task": "formula", "name_q": "C19H22N2O", "name_a": "C19H22N2O"} -{"id": 5987, "instruction": "トコフェロール酢酸エステル(東和薬品)をを化学式で書くと?", "response": "トコフェロール酢酸エステル(東和薬品)をを化学式で書くとC31H52O3です。", "task": "formula", "name_q": "トコフェロール酢酸エステル(東和薬品)", "name_a": "C31H52O3"} -{"id": 13694, "instruction": "Hyposulfiteをを化学構造で表すと?", "response": "Hyposulfiteをを化学構造で表すとHS2O3です。", "task": "formula", "name_q": "Hyposulfite", "name_a": "HS2O3"} -{"id": 20473, "instruction": "10-Deoxymethynolideをの化学構造は?", "response": "10-Deoxymethynolideをの化学構造はC17H28O4です。", "task": "formula", "name_q": "10-Deoxymethynolide", "name_a": "C17H28O4"} -{"id": 20402, "instruction": "Ganciclovir sodium (USAN)をを分子式で表すと?", "response": "Ganciclovir sodium (USAN)をを分子式で表すとC9H12N5O4. Naです。", "task": "formula", "name_q": "Ganciclovir sodium (USAN)", "name_a": "C9H12N5O4. Na"} -{"id": 22941, "instruction": "フマル酸尿症 上位グループ TCA回路の異常 ミトコンドリア病 の英訳は?", "response": "フマル酸尿症 上位グループ TCA回路の異常 ミトコンドリア病 の英訳はFumaric aciduria SUPERGRP Diseases of the tricarboxylic acid cycle Mitochondrial disease です。", "task": "replace ja to en", "name_q": "フマル酸尿症 上位グループ TCA回路の異常 ミトコンドリア病 ", "name_a": "Fumaric aciduria SUPERGRP Diseases of the tricarboxylic acid cycle Mitochondrial disease "} -{"id": 25233, "instruction": "Warfarinをを化学式で表すと?", "response": "Warfarinをを化学式で表すとC19H16O4です。", "task": "formula", "name_q": "Warfarin", "name_a": "C19H16O4"} -{"id": 27491, "instruction": "DIVALPROEXSODIUM(Dr.Reddy'sLaboratoriesLimited)を材料とする医薬品名は?", "response": "DIVALPROEXSODIUM(Dr.Reddy'sLaboratoriesLimited)を材料とする医薬品名はDIVALPROEXSODIUM(SunPharmaceuticalIndustries)です。", "task": "product", "name_q": "DIVALPROEXSODIUM(Dr.Reddy'sLaboratoriesLimited)", "name_a": "DIVALPROEXSODIUM(SunPharmaceuticalIndustries)"} -{"id": 21261, "instruction": "all-trans-Retinalの別呼称は?", "response": "all-trans-Retinalの別呼称はVitamin A aldehydeです。", "task": "replace", "name_q": "all-trans-Retinal", "name_a": "Vitamin A aldehyde"} -{"id": 28437, "instruction": "Zilurgisertib (USAN/INN)をを分子式で記述すると?", "response": "Zilurgisertib (USAN/INN)をを分子式で記述するとC30H38N4O3です。", "task": "formula", "name_q": "Zilurgisertib (USAN/INN)", "name_a": "C30H38N4O3"} -{"id": 9741, "instruction": "Ethanalの別呼称は?", "response": "Ethanalの別呼称はAcetaldehydeです。", "task": "replace", "name_q": "Ethanal", "name_a": "Acetaldehyde"} -{"id": 33109, "instruction": "X連鎖性点状軟骨異形成症 下位グループ X連鎖劣性遺伝性点状軟骨異形成症 (CDPX1) X連鎖優性遺伝性点状軟骨異形成症 (CDPX2)の英訳は?", "response": "X連鎖性点状軟骨異形成症 下位グループ X連鎖劣性遺伝性点状軟骨異形成症 (CDPX1) X連鎖優性遺伝性点状軟骨異形成症 (CDPX2)の英訳はX-linked chondrodysplasia punctata SUBGROUP X-linked recessive chondrodysplasia punctata (CDPX1) X-linked dominant chondrodysplasia punctata (CDPX2)です。", "task": "replace ja to en", "name_q": "X連鎖性点状軟骨異形成症 下位グループ X連鎖劣性遺伝性点状軟骨異形成症 (CDPX1) X連鎖優性遺伝性点状軟骨異形成症 (CDPX2)", "name_a": "X-linked chondrodysplasia punctata SUBGROUP X-linked recessive chondrodysplasia punctata (CDPX1) X-linked dominant chondrodysplasia punctata (CDPX2)"} -{"id": 31622, "instruction": "DCIをを化学構造で書くと?", "response": "DCIをを化学構造で書くとC11H15Cl2NOです。", "task": "formula", "name_q": "DCI", "name_a": "C11H15Cl2NO"} -{"id": 15058, "instruction": "Elapegademase-lvlrを言い換えると?", "response": "Elapegademase-lvlrを言い換えるとElapegademase (USAN/INN)です。", "task": "replace", "name_q": "Elapegademase-lvlr", "name_a": "Elapegademase (USAN/INN)"} -{"id": 26303, "instruction": "Acetorphine (INN)をを分子式で書くと?", "response": "Acetorphine (INN)をを分子式で書くとC27H35NO5です。", "task": "formula", "name_q": "Acetorphine (INN)", "name_a": "C27H35NO5"} -{"id": 31133, "instruction": "Rutamycin (USAN/INN)を日本語で書くと?", "response": "Rutamycin (USAN/INN)を日本語で書くとルタマイシンです。", "task": "replace en to ja", "name_q": "Rutamycin (USAN/INN)", "name_a": "ルタマイシン"} -{"id": 27051, "instruction": "omega-Agatoxin IVBの別の呼び方は?", "response": "omega-Agatoxin IVBの別の呼び方は[Protein]-D-serineです。", "task": "replace", "name_q": "omega-Agatoxin IVB", "name_a": "[Protein]-D-serine"} -{"id": 26825, "instruction": "大型血管炎 下位グループ 巨細胞性動脈炎 (GCA) 高安動脈炎 (TAK)を英語で記述すると?", "response": "大型血管炎 下位グループ 巨細胞性動脈炎 (GCA) 高安動脈炎 (TAK)を英語で記述するとLarge-vessel vasculitis SUBGROUP Giant cell arteritis (GCA) Takayasu arteritis (TAK)です。", "task": "replace ja to en", "name_q": "大型血管炎 下位グループ 巨細胞性動脈炎 (GCA) 高安動脈��� (TAK)", "name_a": "Large-vessel vasculitis SUBGROUP Giant cell arteritis (GCA) Takayasu arteritis (TAK)"} -{"id": 26973, "instruction": "Trastuzumab and hyaluronidase-oyskを日本語で記述すると?", "response": "Trastuzumab and hyaluronidase-oyskを日本語で記述するとトラスツズマブ・ヒアルロニダーゼです。", "task": "replace en to ja", "name_q": "Trastuzumab and hyaluronidase-oysk", "name_a": "トラスツズマブ・ヒアルロニダーゼ"} -{"id": 19549, "instruction": "フェリステンの別名は?", "response": "フェリステンの別名はFerristene (USAN)です。", "task": "replace", "name_q": "フェリステン", "name_a": "Ferristene (USAN)"} -{"id": 24181, "instruction": "N,N-Diethylethanamineをは分子式で表すと?", "response": "N,N-Diethylethanamineをは分子式で表すとC6H15Nです。", "task": "formula", "name_q": "N,N-Diethylethanamine", "name_a": "C6H15N"} -{"id": 5086, "instruction": "Alkyl sulfateをを化学構造で記述すると?", "response": "Alkyl sulfateをを化学構造で記述するとHSO4Rです。", "task": "formula", "name_q": "Alkyl sulfate", "name_a": "HSO4R"} -{"id": 15899, "instruction": "Fomepizoleをを化学式で表すと?", "response": "Fomepizoleをを化学式で表すとC4H6N2です。", "task": "formula", "name_q": "Fomepizole", "name_a": "C4H6N2"} -{"id": 4173, "instruction": "Giant cell arteritisを日本語表記で表すと?", "response": "Giant cell arteritisを日本語表記で表すと巨細胞性動脈炎です。", "task": "replace en to ja", "name_q": "Giant cell arteritis", "name_a": "巨細胞性動脈炎"} -{"id": 18265, "instruction": "Pondocillin (TN)をを化学構造で記述すると?", "response": "Pondocillin (TN)をを化学構造で記述するとC22H29N3O6Sです。", "task": "formula", "name_q": "Pondocillin (TN)", "name_a": "C22H29N3O6S"} -{"id": 9379, "instruction": "Clorazepate dipotassium (JP18/USP)の別名称は?", "response": "Clorazepate dipotassium (JP18/USP)の別名称はTranxene (TN)です。", "task": "replace", "name_q": "Clorazepate dipotassium (JP18/USP)", "name_a": "Tranxene (TN)"} -{"id": 12646, "instruction": "関節拘縮・骨軟骨腫およびB細胞リンパ腫を英語で書くと?", "response": "関節拘縮・骨軟骨腫およびB細胞リンパ腫を英語で書くとJoint contracture, osteochondromas, and B-cell lymphomaです。", "task": "replace ja to en", "name_q": "関節拘縮・骨軟骨腫およびB細胞リンパ腫", "name_a": "Joint contracture, osteochondromas, and B-cell lymphoma"} -{"id": 6391, "instruction": "イレキソリドＡの異なる表記は?", "response": "イレキソリドＡの異なる表記はIlexolide Aです。", "task": "replace", "name_q": "イレキソリドＡ", "name_a": "Ilexolide A"} -{"id": 22656, "instruction": "Hyperprolactinemiaの日本語訳は?", "response": "Hyperprolactinemiaの日本語訳は高プロラクチン血症です。", "task": "replace en to ja", "name_q": "Hyperprolactinemia", "name_a": "高プロラクチン血症"} -{"id": 2846, "instruction": "Crotonylfentanylの別の言い方は?", "response": "Crotonylfentanylの別の言い方はクロトニルフェンタニルです。", "task": "replace", "name_q": "Crotonylfentanyl", "name_a": "クロトニルフェンタニル"} -{"id": 17476, "instruction": "Gemopatrilat (USAN/INN)の別表現は?", "response": "Gemopatrilat (USAN/INN)の別表現はゲモパトリラトです。", "task": "replace", "name_q": "Gemopatrilat (USAN/INN)", "name_a": "ゲモパトリラト"} -{"id": 32590, "instruction": "(2E,6Z)-Dodecadienoyl-CoAをを化学構造で記述すると?", "response": "(2E,6Z)-Dodecadienoyl-CoAをを化学構造で記述するとC33H54N7O17P3Sです。", "task": "formula", "name_q": "(2E,6Z)-Dodecadienoyl-CoA", "name_a": "C33H54N7O17P3S"} -{"id": 11652, "instruction": "C19H18ClN3O3をの組成式は?", "response": "C19H18ClN3O3をの組成式はC19H18ClN3O3です。", "task": "formula", "name_q": "C19H18ClN3O3", "name_a": "C19H18ClN3O3"} -{"id": 10534, "instruction": "Resacetophenoneをを組成式で記述すると?", "response": "Resacetophenoneをを組成式で記述するとC8H8O3です。", "task": "formula", "name_q": "Resacetophenone", "name_a": "C8H8O3"} -{"id": 17319, "instruction": "C16H17N3O4をの化学構造は?", "response": "C16H17N3O4をの化学構造はC16H17N3O4です。", "task": "formula", "name_q": "C16H17N3O4", "name_a": "C16H17N3O4"} -{"id": 11639, "instruction": "顔異形を伴う先天性神経筋疾患を英語で記述すると?", "response": "顔異形を伴う先天性神経筋疾患を英語で記述するとCongenital neuromuscular disorder with dysmorphic faciesです。", "task": "replace ja to en", "name_q": "顔異形を伴う先天性神経筋疾患", "name_a": "Congenital neuromuscular disorder with dysmorphic facies"} -{"id": 3321, "instruction": "Phenylacetyl-CoAをを分子式で書くと?", "response": "Phenylacetyl-CoAをを分子式で書くとC29H42N7O17P3Sです。", "task": "formula", "name_q": "Phenylacetyl-CoA", "name_a": "C29H42N7O17P3S"} -{"id": 5503, "instruction": "11,14,15-THETAの別の呼び方は?", "response": "11,14,15-THETAの別の呼び方は(5Z,8Z,12E)-11,14,15-Trihydroxyeicosa-5,8,12-trienoic acidです。", "task": "replace", "name_q": "11,14,15-THETA", "name_a": "(5Z,8Z,12E)-11,14,15-Trihydroxyeicosa-5,8,12-trienoic acid"} -{"id": 4865, "instruction": "Spiclomazine hydrochloride (JAN)の別の言い方は?", "response": "Spiclomazine hydrochloride (JAN)の別の言い方は塩酸スピクロマジン (JAN)です。", "task": "replace", "name_q": "Spiclomazine hydrochloride (JAN)", "name_a": "塩酸スピクロマジン (JAN)"} -{"id": 2548, "instruction": "遅発性内リンパ水腫の英語表記は?", "response": "遅発性内リンパ水腫の英語表記はDelayed endolymphatic hydropsです。", "task": "replace ja to en", "name_q": "遅発性内リンパ水腫", "name_a": "Delayed endolymphatic hydrops"} -{"id": 6974, "instruction": "Boldenone (INN)の別の言い方は?", "response": "Boldenone (INN)の別の言い方はボルデノンです。", "task": "replace", "name_q": "Boldenone (INN)", "name_a": "ボルデノン"} -{"id": 30283, "instruction": "Galloway-Mowat syndromeの日本語表記は?", "response": "Galloway-Mowat syndromeの日本語表記はギャロウェイ・モワト症候群です。", "task": "replace en to ja", "name_q": "Galloway-Mowat syndrome", "name_a": "ギャロウェイ・モワト症候群"} -{"id": 34370, "instruction": "プラスミノーゲン欠損症 下位グループ 木質結膜炎 プラスミノーゲン分子異常症を英語で記述すると?", "response": "プラスミノーゲン欠損症 下位グループ 木質結膜炎 プラスミノーゲン分子異常症を英語で記述するとPlasminogen deficiency SUBGROUP Ligneous conjunctivitis Dysplasminogenemiaです。", "task": "replace ja to en", "name_q": "プラスミノーゲン欠損症 下位グループ 木質結膜炎 プラスミノーゲン分子異常症", "name_a": "Plasminogen deficiency SUBGROUP Ligneous conjunctivitis Dysplasminogenemia"} -{"id": 7273, "instruction": "Chloroxuronの異なる名称は?", "response": "Chloroxuronの異なる名称はクロロクスロンです。", "task": "replace", "name_q": "Chloroxuron", "name_a": "クロロクスロン"} -{"id": 19981, "instruction": "ent-Kaur-16(17)-en-19-oic acidの別名称は?", "response": "ent-Kaur-16(17)-en-19-oic acidの別名称はKaur-16-en-18-oic acidです。", "task": "replace", "name_q": "ent-Kaur-16(17)-en-19-oic acid", "name_a": "Kaur-16-en-18-oic acid"} -{"id": 10885, "instruction": "(+)-cis,cis-Nepetalactolをを分子式で記述すると?", "response": "(+)-cis,cis-Nepetalactolをを分子式で記述するとC10H16O2です。", "task": "formula", "name_q": "(+)-cis,cis-Nepetalactol", "name_a": "C10H16O2"} -{"id": 33203, "instruction": "骨髄異形成症候群 下位グループ 5q- 症候群 を英語で記述すると?", "response": "骨髄異形成症候群 下位グループ 5q- 症候群 を英語で記述するとMyelodysplastic syndrome SUBGROUP 5q- syndrome です。", "task": "replace ja to en", "name_q": "骨髄異形成症候群 下位グループ 5q- 症候群 ", "name_a": "Myelodysplastic syndrome SUBGROUP 5q- syndrome "} -{"id": 29368, "instruction": "ステボロニン(ステラファーマ)をの分子式は?", "response": "ステボロニン(ステラファーマ)をの分子式はC9H12BNO4です。", "task": "formula", "name_q": "ステボロニン(ステラファーマ)", "name_a": "C9H12BNO4"} -{"id": 30650, "instruction": "Delayed sleep phase disorderを日本語表記で表すと?", "response": "Delayed sleep phase disorderを日本語表記で表すと睡眠相後退症候群です。", "task": "replace en to ja", "name_q": "Delayed sleep phase disorder", "name_a": "睡眠相後退症候群"} -{"id": 20994, "instruction": "CIPROFLOXACINANDDEXAMETHASONE(SunPharmaceuticalIndustries)を利用した医薬品は?", "response": "CIPROFLOXACINANDDEXAMETHASONE(SunPharmaceuticalIndustries)を利用した医薬品はCIPROFLOXACINANDDEXAMETHASONE(SunPharmaceuticalIndustries)です。", "task": "product", "name_q": "CIPROFLOXACINANDDEXAMETHASONE(SunPharmaceuticalIndustries)", "name_a": "CIPROFLOXACINANDDEXAMETHASONE(SunPharmaceuticalIndustries)"} -{"id": 27645, "instruction": "先天性両側精管欠損症を英語で書くと?", "response": "先天性両側精管欠損症を英語で書くとCongenital bilateral absence of vas deferensです。", "task": "replace ja to en", "name_q": "先天性両側精管欠損症", "name_a": "Congenital bilateral absence of vas deferens"} -{"id": 4013, "instruction": "N-Formyl-L-methionineをを化学式で記述すると?", "response": "N-Formyl-L-methionineをを化学式で記述するとC6H11NO3Sです。", "task": "formula", "name_q": "N-Formyl-L-methionine", "name_a": "C6H11NO3S"} -{"id": 5026, "instruction": "ピリプロストの異なる名称は?", "response": "ピリプロストの異なる名称はPiriprost (USAN/INN)です。", "task": "replace", "name_q": "ピリプロスト", "name_a": "Piriprost (USAN/INN)"} -{"id": 924, "instruction": "Cystine (USAN/INN)の別名は?", "response": "Cystine (USAN/INN)の別名はシスチンです。", "task": "replace", "name_q": "Cystine (USAN/INN)", "name_a": "シスチン"} -{"id": 34521, "instruction": "Glycolithocholateをを組成式で書くと?", "response": "Glycolithocholateをを組成式で書くとC26H43NO4です。", "task": "formula", "name_q": "Glycolithocholate", "name_a": "C26H43NO4"} -{"id": 26380, "instruction": "ヘタシリンカリウム (JAN)の英訳は?", "response": "ヘタシリンカリウム (JAN)の英訳はHetacillin potassium (JAN/USAN)です。", "task": "replace ja to en", "name_q": "ヘタシリンカリウム (JAN)", "name_a": "Hetacillin potassium (JAN/USAN)"} -{"id": 4124, "instruction": "Mitocarcin (USAN)の英訳は?", "response": "Mitocarcin (USAN)の英訳はMitocarcin (USAN)です。", "task": "replace ja to en", "name_q": "Mitocarcin (USAN)", "name_a": "Mitocarcin (USAN)"} -{"id": 24167, "instruction": "Foscarbidopa hydarate (JAN)を日本語で記述すると?", "response": "Foscarbidopa hydarate (JAN)を日本語で記述するとFoscarbidopa hydarate (JAN)です。", "task": "replace en to ja", "name_q": "Foscarbidopa hydarate (JAN)", "name_a": "Foscarbidopa hydarate (JAN)"} -{"id": 10295, "instruction": "3-フルオロアニリンの異なる名称は?", "response": "3-フルオロアニリンの異なる名称は3-Fluoroanilineです。", "task": "replace", "name_q": "3-フルオロアニリン", "name_a": "3-Fluoroaniline"} -{"id": 27547, "instruction": "Disenecionyl cis-khellactoneをを化学式で書くと?", "response": "Disenecionyl cis-khellactoneをを化学式で書くとC24H26O7です。", "task": "formula", "name_q": "Disenecionyl cis-khellactone", "name_a": "C24H26O7"} -{"id": 12753, "instruction": "クロルヘキシジンホスファニル酸塩をを組成式で記述すると?", "response": "クロルヘキシジンホスファニル酸塩をを組成式で記述するとC22H30Cl2N10. (C6H8NO3P)2です。", "task": "formula", "name_q": "クロルヘキシジンホスファニル酸塩", "name_a": "C22H30Cl2N10. (C6H8NO3P)2"} -{"id": 30720, "instruction": "Ellsyl (TN)をを分子式で記述すると?", "response": "Ellsyl (TN)をを分子式で記述するとC13H14N2S. HClです。", "task": "formula", "name_q": "Ellsyl (TN)", "name_a": "C13H14N2S. HCl"} -{"id": 29565, "instruction": "C20H24ClN3S. C2H6O6S2をを化学式で記述すると?", "response": "C20H24ClN3S. C2H6O6S2をを化学式で記述するとC20H24ClN3S. C2H6O6S2です。", "task": "formula", "name_q": "C20H24ClN3S. C2H6O6S2", "name_a": "C20H24ClN3S. C2H6O6S2"} -{"id": 14972, "instruction": "デンプングリコール酸ナトリウム (JP18)の別呼称は?", "response": "デンプングリコール酸ナトリウム (JP18)の別呼称はSodium carboxymethylstarchです。", "task": "replace", "name_q": "デンプングリコール酸ナトリウム (JP18)", "name_a": "Sodium carboxymethylstarch"} -{"id": 16574, "instruction": "Gratusminal (TN)をを分子式で記述すると?", "response": "Gratusminal (TN)をを分子式で記述するとC12H12N2O3. C4H11Nです。", "task": "formula", "name_q": "Gratusminal (TN)", "name_a": "C12H12N2O3. C4H11N"} -{"id": 3193, "instruction": "Kikkanol Aをを化学式で表すと?", "response": "Kikkanol Aをを化学式で表すとC15H26O3です。", "task": "formula", "name_q": "Kikkanol A", "name_a": "C15H26O3"} -{"id": 28743, "instruction": "スペブルチニブの別の言い方は?", "response": "スペブルチニブの別の言い方はSpebrutinib (USAN/INN)です。", "task": "replace", "name_q": "スペブルチニブ", "name_a": "Spebrutinib (USAN/INN)"} -{"id": 11279, "instruction": "3-(Methylthio)propanoateの別記述は?", "response": "3-(Methylthio)propanoateの別記述は3-(Methylthio)propionic acidです。", "task": "replace", "name_q": "3-(Methylthio)propanoate", "name_a": "3-(Methylthio)propionic acid"} -{"id": 26557, "instruction": "Anaplastic large-cell lymphoma SUPERGRP Non-Hodgkin lymphoma を日本語に訳すと?", "response": "Anaplastic large-cell lymphoma SUPERGRP Non-Hodgkin lymphoma を日本語に訳すと未分化大細胞リンパ腫 上位グループ 非ホジキンリンパ腫 です。", "task": "replace en to ja", "name_q": "Anaplastic large-cell lymphoma SUPERGRP Non-Hodgkin lymphoma ", "name_a": "未分化大細胞リンパ腫 上位グループ 非ホジキンリンパ腫 "} -{"id": 17818, "instruction": "Eldacimibe (USAN/INN)をを化学式で表すと?", "response": "Eldacimibe (USAN/INN)をを化学式で表すとC39H58N2O5です。", "task": "formula", "name_q": "Eldacimibe (USAN/INN)", "name_a": "C39H58N2O5"} -{"id": 14573, "instruction": "2-Hydroxyisophthalaldehydic acidをを化学式で書くと?", "response": "2-Hydroxyisophthalaldehydic acidをを化学式で書くとC8H6O4です。", "task": "formula", "name_q": "2-Hydroxyisophthalaldehydic acid", "name_a": "C8H6O4"} -{"id": 10916, "instruction": "dàn chāng gēnを英語表記で表すと?", "response": "dàn chāng gēnを英語表記で表すとAcori graminei rhizomaです。", "task": "replace ja to en", "name_q": "dàn chāng gēn", "name_a": "Acori graminei rhizoma"} -{"id": 22553, "instruction": "Atropine oxide hydrochloride (USAN)をを化学構造で表すと?", "response": "Atropine oxide hydrochloride (USAN)をを化学構造で表すとC17H23NO4. HClです。", "task": "formula", "name_q": "Atropine oxide hydrochloride (USAN)", "name_a": "C17H23NO4. HCl"} -{"id": 28176, "instruction": "PREDNISOLONEACETATE(RedPharmDrug)を使用した商品名は?", "response": "PREDNISOLONEACETATE(RedPharmDrug)を使用した商品名はプレドニン(シオノギファーマ)です。", "task": "product", "name_q": "PREDNISOLONEACETATE(RedPharmDrug)", "name_a": "プレドニン(シオノギファーマ)"} -{"id": 22033, "instruction": "副甲状腺機能亢進症を英語で記述すると?", "response": "副甲状腺機能亢進症を英語で記述するとFamilial hyperparathyroidismです。", "task": "replace ja to en", "name_q": "副甲状腺機能亢進症", "name_a": "Familial hyperparathyroidism"} -{"id": 9152, "instruction": "Imidocarb (INN)をを分子式で記述すると?", "response": "Imidocarb (INN)をを分子式で記述するとC19H20N6Oです。", "task": "formula", "name_q": "Imidocarb (INN)", "name_a": "C19H20N6O"} -{"id": 5379, "instruction": "レンペロンは別の呼び方では?", "response": "レンペロンは別の呼び方ではLenperone (USAN)です。", "task": "replace", "name_q": "レンペロン", "name_a": "Lenperone (USAN)"} -{"id": 23086, "instruction": "Atenen (TN)をを分子式で書くと?", "response": "Atenen (TN)をを分子式で書くとC10H14N5O13P3. 2Naです。", "task": "formula", "name_q": "Atenen (TN)", "name_a": "C10H14N5O13P3. 2Na"} -{"id": 32865, "instruction": "Diquafosol sodium (JAN)をは分子式で表すと?", "response": "Diquafosol sodium (JAN)をは分子式で表すとC18H22N4Na4O23P4です。", "task": "formula", "name_q": "Diquafosol sodium (JAN)", "name_a": "C18H22N4Na4O23P4"} -{"id": 1699, "instruction": "5-Deoxyleucopelargonidinをは組成式で表すと?", "response": "5-Deoxyleucopelargonidinをは組成式で表すとC15H14O5です。", "task": "formula", "name_q": "5-Deoxyleucopelargonidin", "name_a": "C15H14O5"} -{"id": 27254, "instruction": "Thalassemia SUBGROUP Alpha Thalassemia Beta Thalassemia Alpha Thalassemia, X-linked (ATRX) を日本語で記述すると?", "response": "Thalassemia SUBGROUP Alpha Thalassemia Beta Thalassemia Alpha Thalassemia, X-linked (ATRX) を日本語で記述するとサラセミア 下位グループ αサラセミア βサラセミア X連鎖αサラセミア です。", "task": "replace en to ja", "name_q": "Thalassemia SUBGROUP Alpha Thalassemia Beta Thalassemia Alpha Thalassemia, X-linked (ATRX) ", "name_a": "サラセミア 下位グループ αサラセミア βサラセミア X連鎖αサラセミア "} -{"id": 23913, "instruction": "Chinese gallotanninをを化学式で記述すると?", "response": "Chinese gallotanninをを化学式で記述するとC76H52O46です。", "task": "formula", "name_q": "Chinese gallotannin", "name_a": "C76H52O46"} -{"id": 28710, "instruction": "Limb-girdle muscular dystrophy, caveolin myopathy SUPERGRP Limb-girdle muscular dystrophy の別名称は?", "response": "Limb-girdle muscular dystrophy, caveolin myopathy SUPERGRP Limb-girdle muscular dystrophy の別名称はLimb-girdle muscular dystrophy 1Cです。", "task": "replace", "name_q": "Limb-girdle muscular dystrophy, caveolin myopathy SUPERGRP Limb-girdle muscular dystrophy ", "name_a": "Limb-girdle muscular dystrophy 1C"} -{"id": 3567, "instruction": "Lipid Iの異なる表現は?", "response": "Lipid Iの異なる表現はN-Acetyl-D-glucosaminyldiphospho-ditrans,octacis-undecaprenolです。", "task": "replace", "name_q": "Lipid I", "name_a": "N-Acetyl-D-glucosaminyldiphospho-ditrans,octacis-undecaprenol"} -{"id": 6052, "instruction": "(5Z,8Z,11Z,14Z)-(16R)-16-Hydroxyeicosa-5,8,11,14-tetraenoic acidを言い換えると?", "response": "(5Z,8Z,11Z,14Z)-(16R)-16-Hydroxyeicosa-5,8,11,14-tetraenoic acidを言い換えると(5Z,8Z,11Z,14Z)-(16R)-16-Hydroxyicosa-5,8,11,14-tetraenoic acidです。", "task": "replace", "name_q": "(5Z,8Z,11Z,14Z)-(16R)-16-Hydroxyeicosa-5,8,11,14-tetraenoic acid", "name_a": "(5Z,8Z,11Z,14Z)-(16R)-16-Hydroxyicosa-5,8,11,14-tetraenoic acid"} -{"id": 8583, "instruction": "Rilapladib (USAN)の日本語表記は?", "response": "Rilapladib (USAN)の日本語表記はRilapladib (USAN)です。", "task": "replace en to ja", "name_q": "Rilapladib (USAN)", "name_a": "Rilapladib (USAN)"} -{"id": 6735, "instruction": "アンベノニウムをを分子式で記述すると?", "response": "アンベノニウムをを分子式で記述するとC28H42Cl2N4O2です。", "task": "formula", "name_q": "アンベノニウム", "name_a": "C28H42Cl2N4O2"} -{"id": 28321, "instruction": "デュタステリド(第一三共エスファ)を利��した医薬品は?", "response": "デュタステリド(第一三共エスファ)を利用した医薬品は)です。", "task": "product", "name_q": "デュタステリド(第一三共エスファ)", "name_a": ")"} -{"id": 15872, "instruction": "Sodium glucuronateをの化学構造は?", "response": "Sodium glucuronateをの化学構造はC6H9O7. Naです。", "task": "formula", "name_q": "Sodium glucuronate", "name_a": "C6H9O7. Na"} -{"id": 3433, "instruction": "リマンタジンを言い換えると?", "response": "リマンタジンを言い換えるとRimantadine (INN)です。", "task": "replace", "name_q": "リマンタジン", "name_a": "Rimantadine (INN)"} -{"id": 5182, "instruction": "Ferric fructose (USAN/INN)の英訳は?", "response": "Ferric fructose (USAN/INN)の英訳はFerric fructose (USAN/INN)です。", "task": "replace ja to en", "name_q": "Ferric fructose (USAN/INN)", "name_a": "Ferric fructose (USAN/INN)"} -{"id": 6725, "instruction": "ドロスピレノン・エステトロールを英語表記で表すと?", "response": "ドロスピレノン・エステトロールを英語表記で表すとDrovelis (TN)です。", "task": "replace ja to en", "name_q": "ドロスピレノン・エステトロール", "name_a": "Drovelis (TN)"} -{"id": 21399, "instruction": "セフォニシドの異なる名称は?", "response": "セフォニシドの異なる名称はCefonicid (INN)です。", "task": "replace", "name_q": "セフォニシド", "name_a": "Cefonicid (INN)"} -{"id": 9010, "instruction": "N-(6-Oxo-6H-dibenzo[b,d]pyran-2-yl)methanesulfonamideをを化学構造で表すと?", "response": "N-(6-Oxo-6H-dibenzo[b,d]pyran-2-yl)methanesulfonamideをを化学構造で表すとC14H11NO4Sです。", "task": "formula", "name_q": "N-(6-Oxo-6H-dibenzo[b,d]pyran-2-yl)methanesulfonamide", "name_a": "C14H11NO4S"} -{"id": 27152, "instruction": "Blue cone monochromacyを日本語表記で表すと?", "response": "Blue cone monochromacyを日本語表記で表すと青錐体全色覚異常です。", "task": "replace en to ja", "name_q": "Blue cone monochromacy", "name_a": "青錐体全色覚異常"} -{"id": 23461, "instruction": "Condurango (JP18)の別の呼び方は?", "response": "Condurango (JP18)の別の呼び方はコンズランゴ (JP18)です。", "task": "replace", "name_q": "Condurango (JP18)", "name_a": "コンズランゴ (JP18)"} -{"id": 11690, "instruction": "Familial encephalopathy with neuroserpin inclusion bodiesの日本語訳は?", "response": "Familial encephalopathy with neuroserpin inclusion bodiesの日本語訳はニューロセルピン封入体を持つ家族性脳症です。", "task": "replace en to ja", "name_q": "Familial encephalopathy with neuroserpin inclusion bodies", "name_a": "ニューロセルピン封入体を持つ家族性脳症"} -{"id": 29540, "instruction": "2-O-メチルスウェルチアニンをは分子式で表すと?", "response": "2-O-メチルスウェルチアニンをは分子式で表すとC15H12O6です。", "task": "formula", "name_q": "2-O-メチルスウェルチアニン", "name_a": "C15H12O6"} -{"id": 3616, "instruction": "Ginsenoside Rg1をを分子式で書くと?", "response": "Ginsenoside Rg1をを分子式で書くとC42H72O14です。", "task": "formula", "name_q": "Ginsenoside Rg1", "name_a": "C42H72O14"} -{"id": 10049, "instruction": "Budesonide, glycopyrrolate and formoterol fumarateを英語で書くと?", "response": "Budesonide, glycopyrrolate and formoterol fumarateを英語で書くとBudesonide, glycopyrronium bromide and formoterol fumarateです。", "task": "replace ja to en", "name_q": "Budesonide, glycopyrrolate and formoterol fumarate", "name_a": "Budesonide, glycopyrronium bromide and formoterol fumarate"} -{"id": 32490, "instruction": "5'-(N7-Methyl 5'-triphosphoguanosine)-(2'-O-methyl-purine-ribonucleotide)-(2'-O-methyl-ribonucleotide)-[mRNA]をの分子式は?", "response": "5'-(N7-Methyl 5'-triphosphoguanosine)-(2'-O-methyl-purine-ribonucleotide)-(2'-O-methyl-ribonucleotide)-[mRNA]をの分子式はC28H46N5O29P5R2(R1)(C5H8O6PR)nです。", "task": "formula", "name_q": "5'-(N7-Methyl 5'-triphosphoguanosine)-(2'-O-methyl-purine-ribonucleotide)-(2'-O-methyl-ribonucleotide)-[mRNA]", "name_a": "C28H46N5O29P5R2(R1)(C5H8O6PR)n"} -{"id": 10869, "instruction": "Tn 症候群を英語で書くと?", "response": "Tn 症候群を英語で書くとTn syndromeです。", "task": "replace ja to en", "name_q": "Tn 症候群", "name_a": "Tn syndrome"} -{"id": 18641, "instruction": "Ancitabine hydrochloride (JAN)をの化学式は?", "response": "Ancitabine hydrochloride (JAN)をの化学式はC9H11N3O4. HClです。", "task": "formula", "name_q": "Ancitabine hydrochloride (JAN)", "name_a": "C9H11N3O4. HCl"} -{"id": 10377, "instruction": "Yuvanci (TN)を主とした商品は?", "response": "Yuvanci (TN)を主とした商品はユバンシ(ヤンセンファーマ)です。", "task": "product", "name_q": "Yuvanci (TN)", "name_a": "ユバンシ(ヤンセンファーマ)"} -{"id": 15660, "instruction": "Nebivolol and valsartanを英語表記で表す��?", "response": "Nebivolol and valsartanを英語表記で表すとNebivolol and valsartanです。", "task": "replace ja to en", "name_q": "Nebivolol and valsartan", "name_a": "Nebivolol and valsartan"} -{"id": 30518, "instruction": "1,2-Dihydroxyoctaneの別名称は?", "response": "1,2-Dihydroxyoctaneの別名称は1,2-Octanediolです。", "task": "replace", "name_q": "1,2-Dihydroxyoctane", "name_a": "1,2-Octanediol"} -{"id": 431, "instruction": "9beta-Pimara-7,15-diene-3beta-olをを化学構造で記述すると?", "response": "9beta-Pimara-7,15-diene-3beta-olをを化学構造で記述するとC20H32Oです。", "task": "formula", "name_q": "9beta-Pimara-7,15-diene-3beta-ol", "name_a": "C20H32O"} -{"id": 13665, "instruction": "ギルゲンソニンをは組成式で表すと?", "response": "ギルゲンソニンをは組成式で表すとC13H16N2Oです。", "task": "formula", "name_q": "ギルゲンソニン", "name_a": "C13H16N2O"} -{"id": 24123, "instruction": "Chlorprothixeneをは組成式で表すと?", "response": "Chlorprothixeneをは組成式で表すとC18H18ClNSです。", "task": "formula", "name_q": "Chlorprothixene", "name_a": "C18H18ClNS"} -{"id": 7399, "instruction": "4-Chloro-1,3-benzenediamineの別呼称は?", "response": "4-Chloro-1,3-benzenediamineの別呼称は4-Chloro-meta-phenylenediamineです。", "task": "replace", "name_q": "4-Chloro-1,3-benzenediamine", "name_a": "4-Chloro-meta-phenylenediamine"} -{"id": 32778, "instruction": "MCT1 欠損症 下位グループ Erythrocyte lactate transporter 欠損症を英語で書くと?", "response": "MCT1 欠損症 下位グループ Erythrocyte lactate transporter 欠損症を英語で書くとMonocarboxylate transporter 1 deficiency SUBGROUP Erythrocyte lactate transporter defectです。", "task": "replace ja to en", "name_q": "MCT1 欠損症 下位グループ Erythrocyte lactate transporter 欠損症", "name_a": "Monocarboxylate transporter 1 deficiency SUBGROUP Erythrocyte lactate transporter defect"} -{"id": 3877, "instruction": "DDMSをを化学式で表すと?", "response": "DDMSをを化学式で表すとC14H11Cl3です。", "task": "formula", "name_q": "DDMS", "name_a": "C14H11Cl3"} -{"id": 391, "instruction": "(4R,6R)-cis-カルベオールの別表現は?", "response": "(4R,6R)-cis-カルベオールの別表現は(4R,6R)-cis-Carveolです。", "task": "replace", "name_q": "(4R,6R)-cis-カルベオール", "name_a": "(4R,6R)-cis-Carveol"} -{"id": 27250, "instruction": "Lapirium chloride (INN)を日本語で書くと?", "response": "Lapirium chloride (INN)を日本語で書くとラピリウムクロリドです。", "task": "replace en to ja", "name_q": "Lapirium chloride (INN)", "name_a": "ラピリウムクロリド"} -{"id": 18220, "instruction": "C16H24N2Oをを化学構造で記述すると?", "response": "C16H24N2Oをを化学構造で記述するとC16H24N2Oです。", "task": "formula", "name_q": "C16H24N2O", "name_a": "C16H24N2O"} -{"id": 32340, "instruction": "Cyclio [veterinary] (TN)の日本語訳は?", "response": "Cyclio [veterinary] (TN)の日本語訳はピリプロキシフェンです。", "task": "replace en to ja", "name_q": "Cyclio [veterinary] (TN)", "name_a": "ピリプロキシフェン"} -{"id": 7221, "instruction": "[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropan-1-yl)methanoneを言い換えると?", "response": "[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropan-1-yl)methanoneを言い換えるとXLR-11です。", "task": "replace", "name_q": "[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropan-1-yl)methanone", "name_a": "XLR-11"} -{"id": 7052, "instruction": "BENAZEPRILHYDROCHLORIDEANDHYDROCHLOROTHIAZIDE(PadagisUSLLC)を材料とする薬品名は?", "response": "BENAZEPRILHYDROCHLORIDEANDHYDROCHLOROTHIAZIDE(PadagisUSLLC)を材料とする薬品名はBENAZEPRILHYDROCHLORIDEANDHYDROCHLOROTHIAZIDE(BryantRanchPrepack)です。", "task": "product", "name_q": "BENAZEPRILHYDROCHLORIDEANDHYDROCHLOROTHIAZIDE(PadagisUSLLC)", "name_a": "BENAZEPRILHYDROCHLORIDEANDHYDROCHLOROTHIAZIDE(BryantRanchPrepack)"} -{"id": 30202, "instruction": "セフォニシドニナトリウムをを分子式で記述すると?", "response": "セフォニシドニナトリウムをを分子式で記述するとC18H16N6O8S3. 2Naです。", "task": "formula", "name_q": "セフォニシドニナトリウム", "name_a": "C18H16N6O8S3. 2Na"} -{"id": 1231, "instruction": "Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoateをを化学構造で書くと?", "response": "Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoateをを化学構造で書くとC21H29FN2O3です。", "task": "formula", "name_q": "Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate", "name_a": "C21H29FN2O3"} -{"id": 17016, "instruction": "Riboflavin (JP18/USP/INN)をを化学式で表すと?", "response": "Riboflavin (JP18/USP/INN)をを化学式で表すとC17H20N4O6です。", "task": "formula", "name_q": "Riboflavin (JP18/USP/INN)", "name_a": "C17H20N4O6"} -{"id": 1330, "instruction": "Doyne 蜂巣状網膜ジストロフィーの英語表記は?", "response": "Doyne 蜂巣状網膜ジストロフィーの英語表記はDoyne honeycomb retinal dystrophyです。", "task": "replace ja to en", "name_q": "Doyne 蜂巣状網膜ジストロフィー", "name_a": "Doyne honeycomb retinal dystrophy"} -{"id": 15767, "instruction": "Fosfomycin (USAN/INN)を日本語表記で表すと?", "response": "Fosfomycin (USAN/INN)を日本語表記で表すとPhosphonomycinです。", "task": "replace en to ja", "name_q": "Fosfomycin (USAN/INN)", "name_a": "Phosphonomycin"} -{"id": 15158, "instruction": "アナフィラキシーの英訳は?", "response": "アナフィラキシーの英訳はAnaphylaxisです。", "task": "replace ja to en", "name_q": "アナフィラキシー", "name_a": "Anaphylaxis"} -{"id": 22585, "instruction": "Asperlicinの別記述は?", "response": "Asperlicinの別記述はアスペルリシンです。", "task": "replace", "name_q": "Asperlicin", "name_a": "アスペルリシン"} -{"id": 904, "instruction": "フルネキシアン塩酸塩の別の言い方は?", "response": "フルネキシアン塩酸塩の別の言い方はFrunexian hydrochloride (USAN)です。", "task": "replace", "name_q": "フルネキシアン塩酸塩", "name_a": "Frunexian hydrochloride (USAN)"} -{"id": 8053, "instruction": "Afamelanotide acetate (USAN)は別の呼び方では?", "response": "Afamelanotide acetate (USAN)は別の呼び方ではアファメラノチド酢酸塩です。", "task": "replace", "name_q": "Afamelanotide acetate (USAN)", "name_a": "アファメラノチド酢酸塩"} -{"id": 5927, "instruction": "Nefazodone (INN)を英語で書くと?", "response": "Nefazodone (INN)を英語で書くとNefazodone (INN)です。", "task": "replace ja to en", "name_q": "Nefazodone (INN)", "name_a": "Nefazodone (INN)"} -{"id": 11595, "instruction": "Coenzyme Mの別の言い方は?", "response": "Coenzyme Mの別の言い方は2-メルカプトエタンスルホン酸です。", "task": "replace", "name_q": "Coenzyme M", "name_a": "2-メルカプトエタンスルホン酸"} -{"id": 6304, "instruction": "アクチノルホジンは別の呼び方では?", "response": "アクチノルホジンは別の呼び方ではActinorhodinです。", "task": "replace", "name_q": "アクチノルホジン", "name_a": "Actinorhodin"} -{"id": 25917, "instruction": "テトラキセタンをを化学式で表すと?", "response": "テトラキセタンをを化学式で表すとC16H28N4O8です。", "task": "formula", "name_q": "テトラキセタン", "name_a": "C16H28N4O8"} -{"id": 18880, "instruction": "Simple ointment (JP18)を英語で書くと?", "response": "Simple ointment (JP18)を英語で書くとSimple ointment (TN)です。", "task": "replace ja to en", "name_q": "Simple ointment (JP18)", "name_a": "Simple ointment (TN)"} -{"id": 32282, "instruction": "グルコン酸カリウム (JAN)をを組成式で表すと?", "response": "グルコン酸カリウム (JAN)をを組成式で表すとC6H11O7. Kです。", "task": "formula", "name_q": "グルコン酸カリウム (JAN)", "name_a": "C6H11O7. K"} -{"id": 15352, "instruction": "Calteridol calcium (USAN)を日本語で記述すると?", "response": "Calteridol calcium (USAN)を日本語で記述するとカルテリドールカルシウムです。", "task": "replace en to ja", "name_q": "Calteridol calcium (USAN)", "name_a": "カルテリドールカルシウム"} -{"id": 16981, "instruction": "2-Hexaprenyl-6-hydroxyphenolをを分子式で記述すると?", "response": "2-Hexaprenyl-6-hydroxyphenolをを分子式で記述するとC36H54O2です。", "task": "formula", "name_q": "2-Hexaprenyl-6-hydroxyphenol", "name_a": "C36H54O2"} -{"id": 13354, "instruction": "Isorhamnetin 3-O-glucosideをを分子式で書くと?", "response": "Isorhamnetin 3-O-glucosideをを分子式で書くとC22H22O12です。", "task": "formula", "name_q": "Isorhamnetin 3-O-glucoside", "name_a": "C22H22O12"} -{"id": 9284, "instruction": "プロパモカルブをの化学式は?", "response": "プロパモカルブをの化学式はC9H20N2O2です。", "task": "formula", "name_q": "プロパモカルブ", "name_a": "C9H20N2O2"} -{"id": 3, "instruction": "Cetotiamine hydrochloride hydrate (JP18)の日本語表記は?", "response": "Cetotiamine hydrochloride hydrate (JP18)の日本語表記はセトチアミン塩酸塩水和物 (JP18)です。", "task": "replace en to ja", "name_q": "Cetotiamine hydrochloride hydrate (JP18)", "name_a": "セトチアミン塩酸塩水和物 (JP18)"} -{"id": 18478, "instruction": "(24S)-24,25-エポキシコレステロールの別名称は?", "response": "(24S)-24,25-エポキシコレステロールの別名称は24(S),25-Epoxycholesterolです。", "task": "replace", "name_q": "(24S)-24,25-エポキシコレステロール", "name_a": "24(S),25-Epoxycholesterol"} -{"id": 2499, "instruction": "TENOFOVIRDISOPROXILFUMARATE(NorthStarRxLLC)を利用した薬品名は?", "response": "TENOFOVIRDISOPROXILFUMARATE(NorthStarRxLLC)を利用した薬品名はVIREAD(GileadSciences)です。", "task": "product", "name_q": "TENOFOVIRDISOPROXILFUMARATE(NorthStarRxLLC)", "name_a": "VIREAD(GileadSciences)"} -{"id": 10996, "instruction": "Sulfadiazine sodium (TN)をを化学構造で表すと?", "response": "Sulfadiazine sodium (TN)をを化学構造で表すとC10H9N4O2S. Naです。", "task": "formula", "name_q": "Sulfadiazine sodium (TN)", "name_a": "C10H9N4O2S. Na"} -{"id": 11095, "instruction": "Gorgostaneをを分子式で書くと?", "response": "Gorgostaneをを分子式で書くとC30H52です。", "task": "formula", "name_q": "Gorgostane", "name_a": "C30H52"} -{"id": 7691, "instruction": "エチドロン酸テクネチウム (99mTc)の異なる表記は?", "response": "エチドロン酸テクネチウム (99mTc)の異なる表記はTechnetium Tc 99m etidronate (USP)です。", "task": "replace", "name_q": "エチドロン酸テクネチウム (99mTc)", "name_a": "Technetium Tc 99m etidronate (USP)"} -{"id": 2276, "instruction": "Ovatifolinをの化学式は?", "response": "Ovatifolinをの化学式はC17H22O5です。", "task": "formula", "name_q": "Ovatifolin", "name_a": "C17H22O5"} -{"id": 23846, "instruction": "Metkephamid acetate (USAN)を日本語で記述すると?", "response": "Metkephamid acetate (USAN)を日本語で記述すると酢酸メトケファミドです。", "task": "replace en to ja", "name_q": "Metkephamid acetate (USAN)", "name_a": "酢酸メトケファミド"} -{"id": 14794, "instruction": "Varlitinib tosylate (USAN)の別の言い方は?", "response": "Varlitinib tosylate (USAN)の別の言い方はバルリチニブトシル酸塩です。", "task": "replace", "name_q": "Varlitinib tosylate (USAN)", "name_a": "バルリチニブトシル酸塩"} -{"id": 10846, "instruction": "Stemar-13-eneをを化学構造で記述すると?", "response": "Stemar-13-eneをを化学構造で記述するとC20H32です。", "task": "formula", "name_q": "Stemar-13-ene", "name_a": "C20H32"} -{"id": 12115, "instruction": "H. pylori KDO2-lipid Aをの化学式は?", "response": "H. pylori KDO2-lipid Aをの化学式はC128H238N2O39P2です。", "task": "formula", "name_q": "H. pylori KDO2-lipid A", "name_a": "C128H238N2O39P2"} -{"id": 5554, "instruction": "6beta,17beta-Dihydroxyandrost-4-en-3-one diacetateをを化学構造で記述すると?", "response": "6beta,17beta-Dihydroxyandrost-4-en-3-one diacetateをを化学構造で記述するとC23H32O5です。", "task": "formula", "name_q": "6beta,17beta-Dihydroxyandrost-4-en-3-one diacetate", "name_a": "C23H32O5"} -{"id": 4748, "instruction": "Abivertinib (USAN)は別の呼び方では?", "response": "Abivertinib (USAN)は別の呼び方ではアビベルチニブです。", "task": "replace", "name_q": "Abivertinib (USAN)", "name_a": "アビベルチニブ"} -{"id": 8748, "instruction": "α-ファルネセンをは化学構造で表すと?", "response": "α-ファルネセンをは化学構造で表すとC15H24です。", "task": "formula", "name_q": "α-ファルネセン", "name_a": "C15H24"} -{"id": 30398, "instruction": "3-Oxo-5,6-dehydrosuberyl-CoAをを化学構造で記述すると?", "response": "3-Oxo-5,6-dehydrosuberyl-CoAをを化学構造で記述するとC29H44N7O20P3Sです。", "task": "formula", "name_q": "3-Oxo-5,6-dehydrosuberyl-CoA", "name_a": "C29H44N7O20P3S"} -{"id": 30850, "instruction": "Adrenoleukodystrophy SUBGROUP Schilder-Addison Complex Childhood cerebral adrenoleukodystrophy (CCALD) Adrenomyeloneuropathy (AMN)の日本語表記は?", "response": "Adrenoleukodystrophy SUBGROUP Schilder-Addison Complex Childhood cerebral adrenoleukodystrophy (CCALD) Adrenomyeloneuropathy (AMN)の日本語表記は副腎白質ジストロフィー 下位グループ アジソン・シルダー病 小児大脳型副腎白質ジストロフィー (CCALD) 副腎脊髄神経障害 (AMN)です。", "task": "replace en to ja", "name_q": "Adrenoleukodystrophy SUBGROUP Schilder-Addison Complex Childhood cerebral adrenoleukodystrophy (CCALD) Adrenomyeloneuropathy (AMN)", "name_a": "副腎白質ジストロフィー 下位グループ アジソン・シルダー病 小児大脳型副腎白質ジストロフィー (CCALD) 副腎脊髄神経障害 (AMN)"} -{"id": 13034, "instruction": "Thiobinupharidineをの化学構造は?", "response": "Thiobinupharidineをの化学構造はC30H42N2O2Sです。", "task": "formula", "name_q": "Thiobinupharidine", "name_a": "C30H42N2O2S"} -{"id": 9697, "instruction": "Olcorolimus (USAN)を英語に訳すと?", "response": "Olcorolimus (USAN)を英語に訳すとOlcorolimus (USAN)です。", "task": "replace ja to en", "name_q": "Olcorolimus (USAN)", "name_a": "Olcorolimus (USAN)"} -{"id": 12778, "instruction": "tiān zhú huángの英訳は?", "response": "tiān zhú huángの英訳はAgglomerative substance of Bambooです。", "task": "replace ja to en", "name_q": "tiān zhú huáng", "name_a": "Agglomerative substance of Bamboo"} -{"id": 32863, "instruction": "Nepafenac (JAN/USAN/INN)の別名称は?", "response": "Nepafenac (JAN/USAN/INN)の別名称はネパフェナク (JAN)です。", "task": "replace", "name_q": "Nepafenac (JAN/USAN/INN)", "name_a": "ネパフェナク (JAN)"} -{"id": 8510, "instruction": "Depreotide (USAN/INN)をを組成式で表すと?", "response": "Depreotide (USAN/INN)をを組成式で表すとC65H96N16O12S2です。", "task": "formula", "name_q": "Depreotide (USAN/INN)", "name_a": "C65H96N16O12S2"} -{"id": 32922, "instruction": "Folina (TN)を日本語で記述すると?", "response": "Folina (TN)を日本語で記述すると葉酸ナトリウムです。", "task": "replace en to ja", "name_q": "Folina (TN)", "name_a": "葉酸ナトリウム"} -{"id": 6265, "instruction": "Saligren (TN)の別記述は?", "response": "Saligren (TN)の別記述はEvoxac (TN)です。", "task": "replace", "name_q": "Saligren (TN)", "name_a": "Evoxac (TN)"} -{"id": 13046, "instruction": "イプロニアジドホスファートの英訳は?", "response": "イプロニアジドホスファートの英訳はMarsilid (TN)です。", "task": "replace ja to en", "name_q": "イプロニアジドホスファート", "name_a": "Marsilid (TN)"} -{"id": 17562, "instruction": "Benzoyl isothiocyanateの異なる表記は?", "response": "Benzoyl isothiocyanateの異なる表記はベンゾイルイソチオシアナートです。", "task": "replace", "name_q": "Benzoyl isothiocyanate", "name_a": "ベンゾイルイソチオシアナート"} -{"id": 13039, "instruction": "Palbociclib isethionate (USAN)をを化学構造で表すと?", "response": "Palbociclib isethionate (USAN)をを化学構造で表すとC24H29N7O2. C2H6O4Sです。", "task": "formula", "name_q": "Palbociclib isethionate (USAN)", "name_a": "C24H29N7O2. C2H6O4S"} -{"id": 29999, "instruction": "S-Sulfinatoglutathioneをを化学式で書くと?", "response": "S-Sulfinatoglutathioneをを化学式で書くとC10H17N3O8S2です。", "task": "formula", "name_q": "S-Sulfinatoglutathione", "name_a": "C10H17N3O8S2"} -{"id": 19111, "instruction": "Quercetin 3,4',7-trissulfateをを組成式で書くと?", "response": "Quercetin 3,4',7-trissulfateをを組成式で書くとC15H10O16S3です。", "task": "formula", "name_q": "Quercetin 3,4',7-trissulfate", "name_a": "C15H10O16S3"} -{"id": 9180, "instruction": "(S)-3-Hydroxybutanoic acidの別表現は?", "response": "(S)-3-Hydroxybutanoic acidの別表現は(S)-3-Hydroxybutanoateです。", "task": "replace", "name_q": "(S)-3-Hydroxybutanoic acid", "name_a": "(S)-3-Hydroxybutanoate"} -{"id": 2965, "instruction": "Vibrio parahaemolyticus infectionを日本語で記述すると?", "response": "Vibrio parahaemolyticus infectionを日本語で記述すると腸炎ビブリオ感染症です。", "task": "replace en to ja", "name_q": "Vibrio parahaemolyticus infection", "name_a": "腸炎ビブリオ感染症"} -{"id": 2872, "instruction": "リンコフィリンをを組成式で書くと?", "response": "リンコフィリンをを組成式で書くとC22H28N2O4です。", "task": "formula", "name_q": "リンコフィリン", "name_a": "C22H28N2O4"} -{"id": 19605, "instruction": "6,8-Dimethyl-6,7,8,9-tetradehydroergolineをを組成式で書くと?", "response": "6,8-Dimethyl-6,7,8,9-tetradehydroergolineをを組成式で書くとC16H17N2です。", "task": "formula", "name_q": "6,8-Dimethyl-6,7,8,9-tetradehydroergoline", "name_a": "C16H17N2"} -{"id": 4284, "instruction": "Glycodeoxycholateを言い換えると?", "response": "Glycodeoxycholateを言い換えるとグリコデオキシコール酸です。", "task": "replace", "name_q": "Glycodeoxycholate", "name_a": "グリコデオキシコール酸"} -{"id": 18537, "instruction": "安中散(東洋薬行)を使用した薬品名は?", "response": "安中散(東洋薬行)を使用した薬品名は安中散(ジェーピーエス製薬)です。", "task": "product", "name_q": "安中散(東洋薬行)", "name_a": "安中散(ジェーピーエス製薬)"} -{"id": 6250, "instruction": "アンギオテンシン(1-5)は別の呼び方では?", "response": "アンギオテンシン(1-5)は別の呼び方ではAngiotensin (1-5)です。", "task": "replace", "name_q": "アンギオテンシン(1-5)", "name_a": "Angiotensin (1-5)"} -{"id": 28666, "instruction": "Sifrim-Hitz-Weiss syndrome SUPERGRP Neurodevelopmental disorder with macrocephaly を日本語で記述すると?", "response": "Sifrim-Hitz-Weiss syndrome SUPERGRP Neurodevelopmental disorder with macrocephaly を日本語で記述するとSifrim-Hitz-Weiss 症候群 上位グループ 巨頭症を伴う神経発達障害 です。", "task": "replace en to ja", "name_q": "Sifrim-Hitz-Weiss syndrome SUPERGRP Neurodevelopmental disorder with macrocephaly ", "name_a": "Sifrim-Hitz-Weiss 症候群 上位グループ 巨頭症を伴う神経発達障害 "} -{"id": 30536, "instruction": "シマテロールをは化学構造で表すと?", "response": "シマテロールをは化学構造で表すとC12H17N3Oです。", "task": "formula", "name_q": "シマテロール", "name_a": "C12H17N3O"} -{"id": 5324, "instruction": "前方仙骨部髄膜瘤を英語��訳すと?", "response": "前方仙骨部髄膜瘤を英語に訳すとCaudal regression syndromeです。", "task": "replace ja to en", "name_q": "前方仙骨部髄膜瘤", "name_a": "Caudal regression syndrome"} -{"id": 32451, "instruction": "Methylsulfomycin Iをを化学構造で書くと?", "response": "Methylsulfomycin Iをを化学構造で書くとC55H54N16O16S2です。", "task": "formula", "name_q": "Methylsulfomycin I", "name_a": "C55H54N16O16S2"} -{"id": 30943, "instruction": "1-Dehydro-7alpha,17-dimethyltestosteroneをは分子式で表すと?", "response": "1-Dehydro-7alpha,17-dimethyltestosteroneをは分子式で表すとC21H30O2です。", "task": "formula", "name_q": "1-Dehydro-7alpha,17-dimethyltestosterone", "name_a": "C21H30O2"} -{"id": 2920, "instruction": "Elepsin (TN)を日本語表記で表すと?", "response": "Elepsin (TN)を日本語表記で表すとImipraminoxide hydrochlorideです。", "task": "replace en to ja", "name_q": "Elepsin (TN)", "name_a": "Imipraminoxide hydrochloride"} -{"id": 31720, "instruction": "Periodic fever, immunodeficiency, and thrombocytopenia syndromeを日本語表記で表すと?", "response": "Periodic fever, immunodeficiency, and thrombocytopenia syndromeを日本語表記で表すと周期性発熱-免疫不全-血小板減少症候群です。", "task": "replace en to ja", "name_q": "Periodic fever, immunodeficiency, and thrombocytopenia syndrome", "name_a": "周期性発熱-免疫不全-血小板減少症候群"} -{"id": 16552, "instruction": "Jijinmeimokutoの日本語表記は?", "response": "Jijinmeimokutoの日本語表記はジジンメイモクトウです。", "task": "replace en to ja", "name_q": "Jijinmeimokuto", "name_a": "ジジンメイモクトウ"} -{"id": 28239, "instruction": "Nimazone (USAN)を日本語で書くと?", "response": "Nimazone (USAN)を日本語で書くとニマゾンです。", "task": "replace en to ja", "name_q": "Nimazone (USAN)", "name_a": "ニマゾン"} -{"id": 24009, "instruction": "O-Methylandrocymbineをの化学式は?", "response": "O-Methylandrocymbineをの化学式はC22H27NO5です。", "task": "formula", "name_q": "O-Methylandrocymbine", "name_a": "C22H27NO5"} -{"id": 3655, "instruction": "MAM-2201をの化学式は?", "response": "MAM-2201をの化学式はC25H24FNOです。", "task": "formula", "name_q": "MAM-2201", "name_a": "C25H24FNO"} -{"id": 28719, "instruction": "ラトルンクリンBの別表現は?", "response": "ラトルンクリンBの別表現はLatrunculin Bです。", "task": "replace", "name_q": "ラトルンクリンB", "name_a": "Latrunculin B"} -{"id": 18330, "instruction": "(5Z,8Z,11Z,14Z)-(17R,18S)-17,18-Epoxyicosa-5,8,11,14-tetraenoic acidの別記述は?", "response": "(5Z,8Z,11Z,14Z)-(17R,18S)-17,18-Epoxyicosa-5,8,11,14-tetraenoic acidの別記述は17R,18S-Epoxy-5Z,8Z,11Z,14Z-icosatetraenoic acidです。", "task": "replace", "name_q": "(5Z,8Z,11Z,14Z)-(17R,18S)-17,18-Epoxyicosa-5,8,11,14-tetraenoic acid", "name_a": "17R,18S-Epoxy-5Z,8Z,11Z,14Z-icosatetraenoic acid"} -{"id": 23356, "instruction": "ミオクロニー欠神てんかんの英語表記は?", "response": "ミオクロニー欠神てんかんの英語表記はEpilepsy with myoclonic absenceです。", "task": "replace ja to en", "name_q": "ミオクロニー欠神てんかん", "name_a": "Epilepsy with myoclonic absence"} -{"id": 10692, "instruction": "Carnosifloside VIの異なる名称は?", "response": "Carnosifloside VIの異なる名称はカルノシフロシドVIです。", "task": "replace", "name_q": "Carnosifloside VI", "name_a": "カルノシフロシドVI"} -{"id": 28059, "instruction": "6-((1S)-1-(Acetyloxy)-4-methyl-3-pentenyl)-8-hydroxy-5-methoxy-1,4-naphthalenedioneをは分子式で表すと?", "response": "6-((1S)-1-(Acetyloxy)-4-methyl-3-pentenyl)-8-hydroxy-5-methoxy-1,4-naphthalenedioneをは分子式で表すとC19H20O6です。", "task": "formula", "name_q": "6-((1S)-1-(Acetyloxy)-4-methyl-3-pentenyl)-8-hydroxy-5-methoxy-1,4-naphthalenedione", "name_a": "C19H20O6"} -{"id": 5198, "instruction": "プラスミノーゲン活性化因子インヒビター1欠損症の英訳は?", "response": "プラスミノーゲン活性化因子インヒビター1欠損症の英訳はPlasminogen activator inhibitor type 1 deficiencyです。", "task": "replace ja to en", "name_q": "プラスミノーゲン活性化因子インヒビター1欠損症", "name_a": "Plasminogen activator inhibitor type 1 deficiency"} -{"id": 23572, "instruction": "Thelin (TN)をの化学式は?", "response": "Thelin (TN)をの化学式はC18H15ClN2O6S2. Naです。", "task": "formula", "name_q": "Thelin (TN)", "name_a": "C18H15ClN2O6S2. Na"} -{"id": 6958, "instruction": "Senna extractを日本語表記で表すと?", "response": "Senna extractを日本語表記で表すとセンナエキスです。", "task": "replace en to ja", "name_q": "Senna extract", "name_a": "センナエキス"} -{"id": 27539, "instruction": "Pregnenolone, androstenedione, testosterone, estrone and dried thyroideの別の言い方は?", "response": "Pregnenolone, androstenedione, testosterone, estrone and dried thyroideの別の言い方はMetharmon-F (TN)です。", "task": "replace", "name_q": "Pregnenolone, androstenedione, testosterone, estrone and dried thyroide", "name_a": "Metharmon-F (TN)"} -{"id": 16110, "instruction": "ドロシノニドの別の言い方は?", "response": "ドロシノニドの別の言い方はDrocinonide (USAN/INN)です。", "task": "replace", "name_q": "ドロシノニド", "name_a": "Drocinonide (USAN/INN)"} -{"id": 33747, "instruction": "後発品プレドニゾロン(ヴィアトリス・ヘルスケア)をを組成式で表すと?", "response": "後発品プレドニゾロン(ヴィアトリス・ヘルスケア)をを組成式で表すとC21H28O5です。", "task": "formula", "name_q": "後発品プレドニゾロン(ヴィアトリス・ヘルスケア)", "name_a": "C21H28O5"} -{"id": 12363, "instruction": "Nizatidine (JP18/USP/INN)を主とした薬品名は?", "response": "Nizatidine (JP18/USP/INN)を主とした薬品名はニザチジン(陽進堂)です。", "task": "product", "name_q": "Nizatidine (JP18/USP/INN)", "name_a": "ニザチジン(陽進堂)"} -{"id": 2084, "instruction": "Diisopropyl sulfateをを組成式で表すと?", "response": "Diisopropyl sulfateをを組成式で表すとC6H14O4Sです。", "task": "formula", "name_q": "Diisopropyl sulfate", "name_a": "C6H14O4S"} -{"id": 30494, "instruction": "Cinitapride (INN)をの化学構造は?", "response": "Cinitapride (INN)をの化学構造はC21H30N4O4です。", "task": "formula", "name_q": "Cinitapride (INN)", "name_a": "C21H30N4O4"} -{"id": 17534, "instruction": "Gramicidin (JAN/USP/INN)の日本語表記は?", "response": "Gramicidin (JAN/USP/INN)の日本語表記はGramicidin (JAN/USP/INN)です。", "task": "replace en to ja", "name_q": "Gramicidin (JAN/USP/INN)", "name_a": "Gramicidin (JAN/USP/INN)"} -{"id": 1734, "instruction": "Escitalopram (INN)の別記述は?", "response": "Escitalopram (INN)の別記述はEsertia (TN)です。", "task": "replace", "name_q": "Escitalopram (INN)", "name_a": "Esertia (TN)"} -{"id": 3960, "instruction": "上衣下巨細胞性星細胞腫を英語に訳すと?", "response": "上衣下巨細胞性星細胞腫を英語に訳すとSubependymal giant cell astrocytomaです。", "task": "replace ja to en", "name_q": "上衣下巨細胞性星細胞腫", "name_a": "Subependymal giant cell astrocytoma"} -{"id": 24626, "instruction": "C14H22N2Oをを化学構造で書くと?", "response": "C14H22N2Oをを化学構造で書くとC14H22N2Oです。", "task": "formula", "name_q": "C14H22N2O", "name_a": "C14H22N2O"} -{"id": 122, "instruction": "IFN-gamma/IL-12 axisを言い換えると?", "response": "IFN-gamma/IL-12 axisを言い換えるとMendelian susceptibility to mycobacterial disease (MSMD) SUPERGRP Disorders of innate immunity Primary immunodeficiency disease です。", "task": "replace", "name_q": "IFN-gamma/IL-12 axis", "name_a": "Mendelian susceptibility to mycobacterial disease (MSMD) SUPERGRP Disorders of innate immunity Primary immunodeficiency disease "} -{"id": 14856, "instruction": "Ethylnitronateをを組成式で表すと?", "response": "Ethylnitronateをを組成式で表すとC2H4NO2です。", "task": "formula", "name_q": "Ethylnitronate", "name_a": "C2H4NO2"} -{"id": 26059, "instruction": "Congenital interstitial lung disease with nephrotic syndrome and epidermolysis bullosa SUPERGRP Epidermolysis bullosa, junctional Epidermolysis bullosa を日本語で書くと?", "response": "Congenital interstitial lung disease with nephrotic syndrome and epidermolysis bullosa SUPERGRP Epidermolysis bullosa, junctional Epidermolysis bullosa を日本語で書くとネフローゼ症候群と表皮水疱症を伴う先天性間質性肺疾患 上位グループ 接合部型表皮水疱症 表皮水疱症 です。", "task": "replace en to ja", "name_q": "Congenital interstitial lung disease with nephrotic syndrome and epidermolysis bullosa SUPERGRP Epidermolysis bullosa, junctional Epidermolysis bullosa ", "name_a": "ネフローゼ症候群と表皮水疱症を伴う先天性間質性肺疾患 上位グループ 接合部型表皮水疱症 表皮水疱症 "} -{"id": 20259, "instruction": "17beta-Hydroxysteroidをは分子式で表すと?", "response": "17beta-Hydroxysteroidをは分子式で表すとC19H32O2です。", "task": "formula", "name_q": "17beta-Hydroxysteroid", "name_a": "C19H32O2"} -{"id": 28329, "instruction": "p-Glucosyloxymandelonitrileの別記述は?", "response": "p-Glucosyloxymandelonitrileの別記述はp-グルコシルマンデロニトリルです。", "task": "replace", "name_q": "p-Glucosyloxymandelonitrile", "name_a": "p-グルコシルマンデロニトリル"} -{"id": 6405, "instruction": "5-Ureido-4-imidazole carboxylateをを組成式で記述すると?", "response": "5-Ureido-4-imidazole carboxylateをを組成式で記述するとC5H6N4O3です。", "task": "formula", "name_q": "5-Ureido-4-imidazole carboxylate", "name_a": "C5H6N4O3"} -{"id": 461, "instruction": "Germacrene Cをを化学構造で���くと?", "response": "Germacrene Cをを化学構造で書くとC15H24です。", "task": "formula", "name_q": "Germacrene C", "name_a": "C15H24"} -{"id": 7891, "instruction": "Docebenone (USAN/INN)を日本語表記で表すと?", "response": "Docebenone (USAN/INN)を日本語表記で表すとドセベノンです。", "task": "replace en to ja", "name_q": "Docebenone (USAN/INN)", "name_a": "ドセベノン"} -{"id": 19916, "instruction": "Pontocerebellar hypoplasiaの日本語訳は?", "response": "Pontocerebellar hypoplasiaの日本語訳は橋小脳低形成です。", "task": "replace en to ja", "name_q": "Pontocerebellar hypoplasia", "name_a": "橋小脳低形成"} -{"id": 28391, "instruction": "quǎn shān jiāoを英語で書くと?", "response": "quǎn shān jiāoを英語で書くとZanthoxylum schinifolium fruitです。", "task": "replace ja to en", "name_q": "quǎn shān jiāo", "name_a": "Zanthoxylum schinifolium fruit"} -{"id": 24743, "instruction": "Poor metabolism of thiopurines SUBGROUP Thiopurine S-methyltransferase deficiencyを日本語で書くと?", "response": "Poor metabolism of thiopurines SUBGROUP Thiopurine S-methyltransferase deficiencyを日本語で書くとPoor metabolism of thiopurines 下位グループ チオプリンS-メチルトランスフェラーゼ欠損です。", "task": "replace en to ja", "name_q": "Poor metabolism of thiopurines SUBGROUP Thiopurine S-methyltransferase deficiency", "name_a": "Poor metabolism of thiopurines 下位グループ チオプリンS-メチルトランスフェラーゼ欠損"} -{"id": 25645, "instruction": "ナイスタチン・トリアムシノロンアセトニドの英訳は?", "response": "ナイスタチン・トリアムシノロンアセトニドの英訳はNystatin and triamcinolone acetonideです。", "task": "replace ja to en", "name_q": "ナイスタチン・トリアムシノロンアセトニド", "name_a": "Nystatin and triamcinolone acetonide"} -{"id": 5136, "instruction": "Monensin (INN)を英語に訳すと?", "response": "Monensin (INN)を英語に訳すとElancoban [veterinary] (TN)です。", "task": "replace ja to en", "name_q": "Monensin (INN)", "name_a": "Elancoban [veterinary] (TN)"} -{"id": 32077, "instruction": "[(C3H2FO2)182. (C10H10)8. (C8H14)10. Ca91]nをを化学構造で表すと?", "response": "[(C3H2FO2)182. (C10H10)8. (C8H14)10. Ca91]nをを化学構造で表すと[(C3H2FO2)182. (C10H10)8. (C8H14)10. Ca91]nです。", "task": "formula", "name_q": "[(C3H2FO2)182. (C10H10)8. (C8H14)10. Ca91]n", "name_a": "[(C3H2FO2)182. (C10H10)8. (C8H14)10. Ca91]n"} -{"id": 29510, "instruction": "Trifluoperazine (INN)を日本語で記述すると?", "response": "Trifluoperazine (INN)を日本語で記述するとトリフルオペラジンです。", "task": "replace en to ja", "name_q": "Trifluoperazine (INN)", "name_a": "トリフルオペラジン"} -{"id": 17995, "instruction": "1,2-Bis-O-sinapoyl-beta-D-glucosideをを化学構造で書くと?", "response": "1,2-Bis-O-sinapoyl-beta-D-glucosideをを化学構造で書くとC28H32O14です。", "task": "formula", "name_q": "1,2-Bis-O-sinapoyl-beta-D-glucoside", "name_a": "C28H32O14"} -{"id": 30745, "instruction": "1,4-Dihydroxy-2-naphthoic acidをを組成式で表すと?", "response": "1,4-Dihydroxy-2-naphthoic acidをを組成式で表すとC11H8O4です。", "task": "formula", "name_q": "1,4-Dihydroxy-2-naphthoic acid", "name_a": "C11H8O4"} -{"id": 424, "instruction": "サルモネラ感染症の英訳は?", "response": "サルモネラ感染症の英訳はSalmonellosisです。", "task": "replace ja to en", "name_q": "サルモネラ感染症", "name_a": "Salmonellosis"} -{"id": 18134, "instruction": "C4H6N2を材料とする薬品名は?", "response": "C4H6N2を材料とする薬品名はホメピゾール(武田薬品工業)です。", "task": "product", "name_q": "C4H6N2", "name_a": "ホメピゾール(武田薬品工業)"} -{"id": 11582, "instruction": "16alpha-Hydroxypregnenoloneをは分子式で表すと?", "response": "16alpha-Hydroxypregnenoloneをは分子式で表すとC21H32O3です。", "task": "formula", "name_q": "16alpha-Hydroxypregnenolone", "name_a": "C21H32O3"} -{"id": 34067, "instruction": "Cystic leukoencephalopathy without megalencephalyを英語に訳すと?", "response": "Cystic leukoencephalopathy without megalencephalyを英語に訳すとCystic leukoencephalopathy without megalencephalyです。", "task": "replace ja to en", "name_q": "Cystic leukoencephalopathy without megalencephaly", "name_a": "Cystic leukoencephalopathy without megalencephaly"} -{"id": 6221, "instruction": "Shukla-Vernon 症候群を英語で記述すると?", "response": "Shukla-Vernon 症候群を英語で記述するとShukla-Vernon syndromeです。", "task": "replace ja to en", "name_q": "Shukla-Vernon 症候群", "name_a": "Shukla-Vernon syndrome"} -{"id": 23605, "instruction": "ビサンミノールをを組成式で記述すると?", "response": "ビサンミノールをを組成式で記述するとC15H16O5です。", "task": "formula", "name_q": "ビサンミノール", "name_a": "C15H16O5"} -{"id": 11625, "instruction": "Cleft lip and/or cleft palateの日本語訳は?", "response": "Cleft lip and/or cleft palateの日本語訳は口唇口蓋裂です。", "task": "replace en to ja", "name_q": "Cleft lip and/or cleft palate", "name_a": "口唇口蓋裂"} -{"id": 27951, "instruction": "吸収性ガーゼを英語表記で表すと?", "response": "吸収性ガーゼを英語表記で表すとGauze, absorbentです。", "task": "replace ja to en", "name_q": "吸収性ガーゼ", "name_a": "Gauze, absorbent"} -{"id": 18262, "instruction": "C23H22N8Oをを組成式で書くと?", "response": "C23H22N8Oをを組成式で書くとC23H22N8Oです。", "task": "formula", "name_q": "C23H22N8O", "name_a": "C23H22N8O"} -{"id": 33664, "instruction": "5-Oxohexanoateをは化学式で表すと?", "response": "5-Oxohexanoateをは化学式で表すとC6H10O3です。", "task": "formula", "name_q": "5-Oxohexanoate", "name_a": "C6H10O3"} -{"id": 25916, "instruction": "ブピリメートをの化学構造は?", "response": "ブピリメートをの化学構造はC13H24N4O3Sです。", "task": "formula", "name_q": "ブピリメート", "name_a": "C13H24N4O3S"} -{"id": 32205, "instruction": "Morphine hydrochloride trihydrateを利用した商品は?", "response": "Morphine hydrochloride trihydrateを利用した商品はモルヒネ塩酸塩(第一三共プロファーマ)です。", "task": "product", "name_q": "Morphine hydrochloride trihydrate", "name_a": "モルヒネ塩酸塩(第一三共プロファーマ)"} -{"id": 24186, "instruction": "DAPAの別の呼び方は?", "response": "DAPAの別の呼び方はBis(3-azidopyridinium)-1,10-decane perchlorateです。", "task": "replace", "name_q": "DAPA", "name_a": "Bis(3-azidopyridinium)-1,10-decane perchlorate"} -{"id": 11040, "instruction": "Insulin zinc, prompt (USP)の日本語表記は?", "response": "Insulin zinc, prompt (USP)の日本語表記はInsulin zinc, prompt (USP)です。", "task": "replace en to ja", "name_q": "Insulin zinc, prompt (USP)", "name_a": "Insulin zinc, prompt (USP)"} -{"id": 16391, "instruction": "Vilamakitug (USAN)をの組成式は?", "response": "Vilamakitug (USAN)をの組成式はC6464H9970N1702O2050S44です。", "task": "formula", "name_q": "Vilamakitug (USAN)", "name_a": "C6464H9970N1702O2050S44"} -{"id": 18881, "instruction": "Afasevikumab (USAN/INN)を日本語に訳すと?", "response": "Afasevikumab (USAN/INN)を日本語に訳すとアファセビクマブです。", "task": "replace en to ja", "name_q": "Afasevikumab (USAN/INN)", "name_a": "アファセビクマブ"} -{"id": 23878, "instruction": "Pedunculaginの別名は?", "response": "Pedunculaginの別名はペズンクラギンです。", "task": "replace", "name_q": "Pedunculagin", "name_a": "ペズンクラギン"} -{"id": 17179, "instruction": "Nylestriol (USAN)をの化学構造は?", "response": "Nylestriol (USAN)をの化学構造はC25H32O3です。", "task": "formula", "name_q": "Nylestriol (USAN)", "name_a": "C25H32O3"} -{"id": 10336, "instruction": "4,4-Difluoropregn-5-ene-3,20-dioneをを化学式で記述すると?", "response": "4,4-Difluoropregn-5-ene-3,20-dioneをを化学式で記述するとC21H28F2O2です。", "task": "formula", "name_q": "4,4-Difluoropregn-5-ene-3,20-dione", "name_a": "C21H28F2O2"} -{"id": 25504, "instruction": "Pelargoninの別名は?", "response": "Pelargoninの別名はPelargonidin 3,5-di-beta-D-glucosideです。", "task": "replace", "name_q": "Pelargonin", "name_a": "Pelargonidin 3,5-di-beta-D-glucoside"} -{"id": 22622, "instruction": "Ribostamycin sulfate (JP18)を日本語で書くと?", "response": "Ribostamycin sulfate (JP18)を日本語で書くとRibostamycin sulfate (JP18)です。", "task": "replace en to ja", "name_q": "Ribostamycin sulfate (JP18)", "name_a": "Ribostamycin sulfate (JP18)"} -{"id": 5715, "instruction": "Disitamab vedotin (USAN/INN)を英語表記で表すと?", "response": "Disitamab vedotin (USAN/INN)を英語表記で表すとDisitamab vedotin (USAN/INN)です。", "task": "replace ja to en", "name_q": "Disitamab vedotin (USAN/INN)", "name_a": "Disitamab vedotin (USAN/INN)"} -{"id": 29025, "instruction": "Pyrilamine maleate (USP)を日本語表記で表すと?", "response": "Pyrilamine maleate (USP)を日本語表記で表すとマレイン酸ピリラミンです。", "task": "replace en to ja", "name_q": "Pyrilamine maleate (USP)", "name_a": "マレイン酸ピリラミン"} -{"id": 32822, "instruction": "N1,N8-Bis(glutathionyl)spermidineの別表現は?", "response": "N1,N8-Bis(glutathionyl)spermidineの別表現はReduced trypanothioneです。", "task": "replace", "name_q": "N1,N8-Bis(glutathionyl)spermidine", "name_a": "Reduced trypanothione"} -{"id": 19020, "instruction": "Carisbamate (USAN)をを化学構造で書くと?", "response": "Carisbamate (USAN)をを化学構造で書くとC9H10ClNO3です。", "task": "formula", "name_q": "Carisbamate (USAN)", "name_a": "C9H10ClNO3"} -{"id": 17719, "instruction": "(R)-2-Alkyl-3-oxoalkanoateをを分子式で書くと?", "response": "(R)-2-Alkyl-3-oxoalkanoateをを分子式で書くとC3H2O3R2です。", "task": "formula", "name_q": "(R)-2-Alkyl-3-oxoalkanoate", "name_a": "C3H2O3R2"} -{"id": 3697, "instruction": "ノストシクロペプチドA3をを分子式で書くと?", "response": "ノストシクロペプチドA3をを分子式で書くとC41H56N8O9です。", "task": "formula", "name_q": "ノストシクロペプチドA3", "name_a": "C41H56N8O9"} -{"id": 12026, "instruction": "C35H46FN5O9Sをを組成式で記述すると?", "response": "C35H46FN5O9Sをを組成式で記述するとC35H46FN5O9Sです。", "task": "formula", "name_q": "C35H46FN5O9S", "name_a": "C35H46FN5O9S"} -{"id": 21382, "instruction": "Premature ventricular contractionsを日本語で記述すると?", "response": "Premature ventricular contractionsを日本語で記述すると心室期外収縮です。", "task": "replace en to ja", "name_q": "Premature ventricular contractions", "name_a": "心室期外収縮"} -{"id": 9773, "instruction": "Patellamide Aをは化学式で表すと?", "response": "Patellamide Aをは化学式で表すとC35H50N8O6S2です。", "task": "formula", "name_q": "Patellamide A", "name_a": "C35H50N8O6S2"} -{"id": 2897, "instruction": "ピロブタミンをは化学式で表すと?", "response": "ピロブタミンをは化学式で表すとC20H22ClNです。", "task": "formula", "name_q": "ピロブタミン", "name_a": "C20H22ClN"} -{"id": 14929, "instruction": "Dorfman-Chanarin syndromeを日本語で書くと?", "response": "Dorfman-Chanarin syndromeを日本語で書くとドルフマン・シャナリン症候群です。", "task": "replace en to ja", "name_q": "Dorfman-Chanarin syndrome", "name_a": "ドルフマン・シャナリン症候群"} -{"id": 14227, "instruction": "オバクノンをの分子式は?", "response": "オバクノンをの分子式はC26H30O7です。", "task": "formula", "name_q": "オバクノン", "name_a": "C26H30O7"} -{"id": 28700, "instruction": "Tenovil (TN)を日本語表記で表すと?", "response": "Tenovil (TN)を日本語表記で表すとIlodecakin (USAN/INN)です。", "task": "replace en to ja", "name_q": "Tenovil (TN)", "name_a": "Ilodecakin (USAN/INN)"} -{"id": 20191, "instruction": "Mecbotamab vedotinを言い換えると?", "response": "Mecbotamab vedotinを言い換えるとメクボタマブベドチンです。", "task": "replace", "name_q": "Mecbotamab vedotin", "name_a": "メクボタマブベドチン"} -{"id": 17528, "instruction": "Keishinieppiittoを日本語に訳すと?", "response": "Keishinieppiittoを日本語に訳すとケイシニエッピイットウです。", "task": "replace en to ja", "name_q": "Keishinieppiitto", "name_a": "ケイシニエッピイットウ"} -{"id": 23179, "instruction": "Mesoxalic acidの別記述は?", "response": "Mesoxalic acidの別記述はKetomalonic acidです。", "task": "replace", "name_q": "Mesoxalic acid", "name_a": "Ketomalonic acid"} -{"id": 21751, "instruction": "Eprenetapopt (USAN)をを分子式で書くと?", "response": "Eprenetapopt (USAN)をを分子式で書くとC10H17NO3です。", "task": "formula", "name_q": "Eprenetapopt (USAN)", "name_a": "C10H17NO3"} -{"id": 9434, "instruction": "Congenital asplenia SUBGROUP Isolated congenital asplenia Asplenia syndrome Ivemark syndromeを日本語表記で表すと?", "response": "Congenital asplenia SUBGROUP Isolated congenital asplenia Asplenia syndrome Ivemark syndromeを日本語表記で表すと先天性無脾症 下位グループ 先天性単独無脾症 無脾症候群 アイブマーク症候群です。", "task": "replace en to ja", "name_q": "Congenital asplenia SUBGROUP Isolated congenital asplenia Asplenia syndrome Ivemark syndrome", "name_a": "先天性無脾症 下位グループ 先天性単独無脾症 無脾症候群 アイブマーク症候群"} -{"id": 18660, "instruction": "Patent ductus arteriosusを日本語で書くと?", "response": "Patent ductus arteriosusを日本語で書くと動脈管開存症です。", "task": "replace en to ja", "name_q": "Patent ductus arteriosus", "name_a": "動脈管開存症"} -{"id": 21072, "instruction": "Cefuroxime axetilの別表現は?", "response": "Cefuroxime axetilの別表現はCefuroxime 1-acetoxyethyl esterです。", "task": "replace", "name_q": "Cefuroxime axetil", "name_a": "Cefuroxime 1-acetoxyethyl ester"} -{"id": 23768, "instruction": "Porphyropsinをの化学構造は?", "response": "Porphyropsinをの化学構造はC20H26Rです。", "task": "formula", "name_q": "Porphyropsin", "name_a": "C20H26R"} -{"id": 3702, "instruction": "ヒドロコルチゾンブテプラートの異なる表現は?", "response": "ヒドロコルチゾンブテプラートの異なる表現はHydrocortisone probutate (USAN)です。", "task": "replace", "name_q": "ヒドロコルチゾンブテプラート", "name_a": "Hydrocortisone probutate (USAN)"} -{"id": 16792, "instruction": "Colistin (INN)の日本語訳は?", "response": "Colistin (INN)の日本語訳はColistin (INN)です。", "task": "replace en to ja", "name_q": "Colistin (INN)", "name_a": "Colistin (INN)"} -{"id": 1532, "instruction": "Pyrimethanilの別記述は?", "response": "Pyrimethanilの別記述はピリメタニルです。", "task": "replace", "name_q": "Pyrimethanil", "name_a": "ピリメタニル"} -{"id": 8394, "instruction": "Low-density lipoprotein L-serineをを組成式で記述すると?", "response": "Low-density lipoprotein L-serineをを組成式で記述するとC4H6N2O3R2です。", "task": "formula", "name_q": "Low-density lipoprotein L-serine", "name_a": "C4H6N2O3R2"} -{"id": 1137, "instruction": "C24H34N2O18S3. 2Naをを化学構造で表すと?", "response": "C24H34N2O18S3. 2Naをを化学構造で表すとC24H34N2O18S3. 2Naです。", "task": "formula", "name_q": "C24H34N2O18S3. 2Na", "name_a": "C24H34N2O18S3. 2Na"} -{"id": 32138, "instruction": "Thermocryptoxanthin-11をを化学構造で書くと?", "response": "Thermocryptoxanthin-11をを化学構造で書くとC57H86O7です。", "task": "formula", "name_q": "Thermocryptoxanthin-11", "name_a": "C57H86O7"} -{"id": 6672, "instruction": "Farnesylfarnesylgeraniolの異なる名称は?", "response": "Farnesylfarnesylgeraniolの異なる名称はall-trans-Octaprenyl diphosphateです。", "task": "replace", "name_q": "Farnesylfarnesylgeraniol", "name_a": "all-trans-Octaprenyl diphosphate"} -{"id": 22888, "instruction": "C60H92N8O11をを組成式で表すと?", "response": "C60H92N8O11をを組成式で表すとC60H92N8O11です。", "task": "formula", "name_q": "C60H92N8O11", "name_a": "C60H92N8O11"} -{"id": 24438, "instruction": "Fuzeon (TN) ABBR EFV, T-20をの化学構造は?", "response": "Fuzeon (TN) ABBR EFV, T-20をの化学構造はC204H301N51O64です。", "task": "formula", "name_q": "Fuzeon (TN) ABBR EFV, T-20", "name_a": "C204H301N51O64"} -{"id": 5790, "instruction": "Sulfathiazole, diethylaminoethyl p-butylaminobenzoate hydrochloride, iodoform and calcium hydroxideを日本語で書くと?", "response": "Sulfathiazole, diethylaminoethyl p-butylaminobenzoate hydrochloride, iodoform and calcium hydroxideを日本語で書くとスルファチアゾール・パラブチルアミノ安息香酸ジエチルアミノエチル塩酸塩・ヨードホルム・水酸化カルシウムです。", "task": "replace en to ja", "name_q": "Sulfathiazole, diethylaminoethyl p-butylaminobenzoate hydrochloride, iodoform and calcium hydroxide", "name_a": "スルファチアゾール・パラブチルアミノ安息香酸ジエチルアミノエチル塩酸塩・ヨードホルム・水酸化カルシウム"} -{"id": 20023, "instruction": "Dexelvucitabine (USAN/INN)の異なる名称は?", "response": "Dexelvucitabine (USAN/INN)の異なる名称はデキセルブシタビンです。", "task": "replace", "name_q": "Dexelvucitabine (USAN/INN)", "name_a": "デキセルブシタビン"} -{"id": 21046, "instruction": "C16H17NO5Sをを組成式で記述すると?", "response": "C16H17NO5Sをを組成式で記述するとC16H17NO5Sです。", "task": "formula", "name_q": "C16H17NO5S", "name_a": "C16H17NO5S"} -{"id": 10250, "instruction": "Renovue-65 (TN)を日本語で書くと?", "response": "Renovue-65 (TN)を日本語で書くとIodamide meglumine (USAN)です。", "task": "replace en to ja", "name_q": "Renovue-65 (TN)", "name_a": "Iodamide meglumine (USAN)"} -{"id": 28767, "instruction": "2-Hydroxy-5-methyl-1-naphthoateをを化学式で表すと?", "response": "2-Hydroxy-5-methyl-1-naphthoateをを化学式で表すとC12H10O3です。", "task": "formula", "name_q": "2-Hydroxy-5-methyl-1-naphthoate", "name_a": "C12H10O3"} -{"id": 9579, "instruction": "Flavin adenine dinucleotide sodium (JP18)の別記述は?", "response": "Flavin adenine dinucleotide sodium (JP18)の別記述はFAD sodiumです。", "task": "replace", "name_q": "Flavin adenine dinucleotide sodium (JP18)", "name_a": "FAD sodium"} -{"id": 13082, "instruction": "D-Erythroseをの化学式は?", "response": "D-Erythroseをの化学式はC4H8O4です。", "task": "formula", "name_q": "D-Erythrose", "name_a": "C4H8O4"} -{"id": 20447, "instruction": "ドロプレニラミンの別の呼び方は?", "response": "ドロプレニラミンの別の呼び方はDroprenilamine (USAN/INN)です。", "task": "replace", "name_q": "ドロプレニラミン", "name_a": "Droprenilamine (USAN/INN)"} -{"id": 3485, "instruction": "Cyclosporin Aをを組成式で表すと?", "response": "Cyclosporin Aをを組成式で表すとC62H111N11O12です。", "task": "formula", "name_q": "Cyclosporin A", "name_a": "C62H111N11O12"} -{"id": 33709, "instruction": "Salicylamide (JAN/USP/INN)をの化学構造は?", "response": "Salicylamide (JAN/USP/INN)をの化学構造はC7H7NO2です。", "task": "formula", "name_q": "Salicylamide (JAN/USP/INN)", "name_a": "C7H7NO2"} -{"id": 15992, "instruction": "1,2,3,7,8,9-Hexachlorodibenzofuranの異なる名称は?", "response": "1,2,3,7,8,9-Hexachlorodibenzofuranの異なる名称は1,2,3,7,8,9-HxCDFです。", "task": "replace", "name_q": "1,2,3,7,8,9-Hexachlorodibenzofuran", "name_a": "1,2,3,7,8,9-HxCDF"} -{"id": 12949, "instruction": "エムポックス (サル痘)を英語表記で表すと?", "response": "エムポックス (サル痘)を英語表記で表すとMpox (Monkeypox)です。", "task": "replace ja to en", "name_q": "エムポックス (サル痘)", "name_a": "Mpox (Monkeypox)"} -{"id": 10042, "instruction": "Laninamivir octanoateを言い換えると?", "response": "Laninamivir octanoateを言い換えるとラニナミビルオクタン酸エステルです。", "task": "replace", "name_q": "Laninamivir octanoate", "name_a": "ラニナミビルオクタン酸エステル"} -{"id": 1601, "instruction": "顎骨骨幹異形成症の英訳は?", "response": "顎骨骨幹異形成症の英訳はGnathodiaphyseal dysplasiaです。", "task": "replace ja to en", "name_q": "顎骨骨幹異形成症", "name_a": "Gnathodiaphyseal dysplasia"} -{"id": 19049, "instruction": "Remimazolam (USAN/INN)の異なる表記は?", "response": "Remimazolam (USAN/INN)の異なる表記はレミマゾラムです。", "task": "replace", "name_q": "Remimazolam (USAN/INN)", "name_a": "レミマゾラム"} -{"id": 8302, "instruction": "Evodenoson (USAN/INN)をを分子式で表すと?", "response": "Evodenoson (USAN/INN)をを分子式で表すとC23H29N7O6です。", "task": "formula", "name_q": "Evodenoson (USAN/INN)", "name_a": "C23H29N7O6"} -{"id": 13202, "instruction": "エノキサシン水和物 (JP18)をを組成式で記述すると?", "response": "エノキサシン水和物 (JP18)をを組成式で記述すると(C15H17FN4O3)3. 2H2Oです。", "task": "formula", "name_q": "エノキサシン水和物 (JP18)", "name_a": "(C15H17FN4O3)3. 2H2O"} -{"id": 33760, "instruction": "C3H2N4Sをは分子式で表すと?", "response": "C3H2N4Sをは分子式で表すとC3H2N4Sです。", "task": "formula", "name_q": "C3H2N4S", "name_a": "C3H2N4S"} -{"id": 21371, "instruction": "12-epi-ハパリンドールUをを化学式で表すと?", "response": "12-epi-ハパリンドールUをを化学式で表すとC21H24N2です。", "task": "formula", "name_q": "12-epi-ハパリンドールU", "name_a": "C21H24N2"} -{"id": 21678, "instruction": "カンチウミンを言い換えると?", "response": "カンチウミンを言い換えるとCanthiumineです。", "task": "replace", "name_q": "カンチウミン", "name_a": "Canthiumine"} -{"id": 438, "instruction": "Amenamevir (JAN/INN) 略語 AMNVをを化学構造で書くと?", "response": "Amenamevir (JAN/INN) 略語 AMNVをを化学構造で書くとC24H26N4O5Sです。", "task": "formula", "name_q": "Amenamevir (JAN/INN) 略語 AMNV", "name_a": "C24H26N4O5S"} -{"id": 10196, "instruction": "ノルバデックス(アストラゼネカ)を使用した医薬品名は?", "response": "ノルバデックス(アストラゼネカ)を使用した医薬品名はTAMOXIFENCITRATE(BryantRanchPrepack)です。", "task": "product", "name_q": "ノルバデックス(アストラゼネカ)", "name_a": "TAMOXIFENCITRATE(BryantRanchPrepack)"} -{"id": 25345, "instruction": "Umibecestat (USAN/INN)の英語表記は?", "response": "Umibecestat (USAN/INN)の英語表記はUmibecestat (USAN/INN)です。", "task": "replace ja to en", "name_q": "Umibecestat (USAN/INN)", "name_a": "Umibecestat (USAN/INN)"} -{"id": 11883, "instruction": "D-Galactosyl-N-acetyl-alpha-D-galactosaminideをの化学式は?", "response": "D-Galactosyl-N-acetyl-alpha-D-galactosaminideをの化学式はC14H24NO11Rです。", "task": "formula", "name_q": "D-Galactosyl-N-acetyl-alpha-D-galactosaminide", "name_a": "C14H24NO11R"} -{"id": 26791, "instruction": "N-Acetyl-4-O-acetylneuraminateをを化学構造で記述すると?", "response": "N-Acetyl-4-O-acetylneuraminateをを化学構造で記述するとC13H21NO10です。", "task": "formula", "name_q": "N-Acetyl-4-O-acetylneuraminate", "name_a": "C13H21NO10"} -{"id": 25135, "instruction": "マレタメルの異なる表記は?", "response": "マレタメルの異なる表記はMalethamer (USAN/INN)です。", "task": "replace", "name_q": "マレタメル", "name_a": "Malethamer (USAN/INN)"} -{"id": 34393, "instruction": "メクロフェナム酸ナトリウムをを分子式で記述すると?", "response": "メクロフェナム酸ナトリウムをを分子式で記述するとC14H10Cl2NO2. Naです。", "task": "formula", "name_q": "メクロフェナム酸ナトリウム", "name_a": "C14H10Cl2NO2. Na"} -{"id": 21301, "instruction": "Karmi AMAP (TN)を日本語に訳すと?", "response": "Karmi AMAP (TN)を日本語に訳すと血液保存液A液 (ACD-A液)・赤血球保存液( MAP液)です。", "task": "replace en to ja", "name_q": "Karmi AMAP (TN)", "name_a": "血液保存液A液 (ACD-A液)・赤血球保存液( MAP液)"} -{"id": 12860, "instruction": "クフウショクツウトウの異なる名称は?", "response": "クフウショクツウトウの異なる名称はSeijokentsutoです。", "task": "replace", "name_q": "クフウショクツウトウ", "name_a": "Seijokentsuto"} -{"id": 25130, "instruction": "Procollagen trans-3-hydroxy-L-prolineをの化学構造は?", "response": "Procollagen trans-3-hydroxy-L-prolineをの化学構造はC6H8N2O3R2です。", "task": "formula", "name_q": "Procollagen trans-3-hydroxy-L-proline", "name_a": "C6H8N2O3R2"} -{"id": 4394, "instruction": "DMJをは化学式で表すと?", "response": "DMJをは化学式で表すとC6H13NO4です。", "task": "formula", "name_q": "DMJ", "name_a": "C6H13NO4"} -{"id": 9532, "instruction": "gamma-L-Glutamyl-L-2-aminobutyrylglycineの別名称は?", "response": "gamma-L-Glutamyl-L-2-aminobutyrylglycineの別名称はOphthalmateです。", "task": "replace", "name_q": "gamma-L-Glutamyl-L-2-aminobutyrylglycine", "name_a": "Ophthalmate"} -{"id": 31810, "instruction": "コレキシトラン塩酸塩の英訳は?", "response": "コレキシトラン塩酸塩の英訳はDexide (TN)です。", "task": "replace ja to en", "name_q": "コレキシトラン塩酸塩", "name_a": "Dexide (TN)"} -{"id": 2475, "instruction": "PROGESTERONE(ActavisPharma)を用いた製品名は?", "response": "PROGESTERONE(ActavisPharma)を用いた製品名はPROGESTERONE(REMEDYREPACK)です。", "task": "product", "name_q": "PROGESTERONE(ActavisPharma)", "name_a": "PROGESTERONE(REMEDYREPACK)"} -{"id": 1499, "instruction": "舌小体短縮症を伴う口蓋裂を英語に訳すと?", "response": "舌小体短縮症を伴う口蓋裂を英語に訳すとCleft palate with ankyloglossiaです。", "task": "replace ja to en", "name_q": "舌小体短縮症を伴う口蓋裂", "name_a": "Cleft palate with ankyloglossia"} -{"id": 18010, "instruction": "パラオキソンを言い換えると?", "response": "パラオキソンを言い換えるとParaoxonです。", "task": "replace", "name_q": "パラオキソン", "name_a": "Paraoxon"} -{"id": 30382, "instruction": "Zokumeitoの日本語表記は?", "response": "Zokumeitoの日本語表記はゾクメイトウです。", "task": "replace en to ja", "name_q": "Zokumeito", "name_a": "ゾクメイトウ"} -{"id": 6337, "instruction": "L-Galactono-1,4-lactoneの別の言い方は?", "response": "L-Galactono-1,4-lactoneの別の言い方はL-ガラクトノ-1,4-ラクトンです。", "task": "replace", "name_q": "L-Galactono-1,4-lactone", "name_a": "L-ガラクトノ-1,4-ラクトン"} -{"id": 26782, "instruction": "口蓋心臓顔面症候群 下位グループ Shprintzen 症候群 上位グループ 22q11.2 欠失症候群 を英語表記で表すと?", "response": "口蓋心臓顔面症候群 下位グループ Shprintzen 症候群 上位グループ 22q11.2 欠失症候群 を英語表記で表すとVelocardiofacial syndrome SUBGROUP Shprintzen syndrome SUPERGRP 22q11.2 deletion syndrome です。", "task": "replace ja to en", "name_q": "口蓋心臓顔面症候群 下位グループ Shprintzen 症候群 上位グループ 22q11.2 欠失症候群 ", "name_a": "Velocardiofacial syndrome SUBGROUP Shprintzen syndrome SUPERGRP 22q11.2 deletion syndrome "} -{"id": 13036, "instruction": "ES plasta (TN)を日本語に訳すと?", "response": "ES plasta (TN)を日本語に訳すとl-メントール・サリチル酸グリコールです。", "task": "replace en to ja", "name_q": "ES plasta (TN)", "name_a": "l-メントール・サリチル酸グリコール"} -{"id": 31195, "instruction": "BUPIVACAINEHYDROCHLORIDE(NorthStarRxLLC)を使用した医薬品は?", "response": "BUPIVACAINEHYDROCHLORIDE(NorthStarRxLLC)を使用した医薬品はBUPIVACAINEHYDROCHLORIDE(A-SMedicationSolutions)です。", "task": "product", "name_q": "BUPIVACAINEHYDROCHLORIDE(NorthStarRxLLC)", "name_a": "BUPIVACAINEHYDROCHLORIDE(A-SMedicationSolutions)"} -{"id": 3862, "instruction": "Gentiobiosyl-caldarchaeolの別呼称は?", "response": "Gentiobiosyl-caldarchaeolの別呼称はGlcbeta1-6Glcbeta-caldarchaeolです。", "task": "replace", "name_q": "Gentiobiosyl-caldarchaeol", "name_a": "Glcbeta1-6Glcbeta-caldarchaeol"} -{"id": 28159, "instruction": "(2S)-2-Acetamido-4-aminobutanoateの別表現は?", "response": "(2S)-2-Acetamido-4-aminobutanoateの別表現はN-alpha-Acetyl-L-2,4-diaminobutyrateです。", "task": "replace", "name_q": "(2S)-2-Acetamido-4-aminobutanoate", "name_a": "N-alpha-Acetyl-L-2,4-diaminobutyrate"} -{"id": 13873, "instruction": "4-Bromophenylacetic acidの別の呼び方は?", "response": "4-Bromophenylacetic acidの別の呼び方は4-Bromophenylacetateです。", "task": "replace", "name_q": "4-Bromophenylacetic acid", "name_a": "4-Bromophenylacetate"} -{"id": 848, "instruction": "5,7-ジヒドロキシ4',6-ヂメトキシフラボンの別記述は?", "response": "5,7-ジヒドロキシ4',6-ヂメトキシフラボンの別記述はPectolinarigeninです。", "task": "replace", "name_q": "5,7-ジヒドロキシ4',6-ヂメトキシフラボン", "name_a": "Pectolinarigenin"} -{"id": 29426, "instruction": "Naltrexone hydrochloride (USP)をを組成式で書くと?", "response": "Naltrexone hydrochloride (USP)をを組成式で書くとC20H23NO4. HClです。", "task": "formula", "name_q": "Naltrexone hydrochloride (USP)", "name_a": "C20H23NO4. HCl"} -{"id": 2950, "instruction": "Pyridoxal 5'-phosphateの異なる表��は?", "response": "Pyridoxal 5'-phosphateの異なる表記はPyridoxal phosphateです。", "task": "replace", "name_q": "Pyridoxal 5'-phosphate", "name_a": "Pyridoxal phosphate"} -{"id": 18223, "instruction": "D-Quinovosamineの異なる表記は?", "response": "D-Quinovosamineの異なる表記はD-キノボサミンです。", "task": "replace", "name_q": "D-Quinovosamine", "name_a": "D-キノボサミン"} -{"id": 26306, "instruction": "Squalamineをを化学式で書くと?", "response": "Squalamineをを化学式で書くとC34H65N3O5Sです。", "task": "formula", "name_q": "Squalamine", "name_a": "C34H65N3O5S"} -{"id": 1440, "instruction": "11-Dehydro-thromboxane B2をの化学式は?", "response": "11-Dehydro-thromboxane B2をの化学式はC20H32O6です。", "task": "formula", "name_q": "11-Dehydro-thromboxane B2", "name_a": "C20H32O6"} -{"id": 31492, "instruction": "3C 症候群を英語表記で表すと?", "response": "3C 症候群を英語表記で表すと3C syndromeです。", "task": "replace ja to en", "name_q": "3C 症候群", "name_a": "3C syndrome"} -{"id": 33966, "instruction": "Zedoarolをは組成式で表すと?", "response": "Zedoarolをは組成式で表すとC15H18O3です。", "task": "formula", "name_q": "Zedoarol", "name_a": "C15H18O3"} -{"id": 27568, "instruction": "Haloperidol (JP18/USP/INN)の別呼称は?", "response": "Haloperidol (JP18/USP/INN)の別呼称はハロペリドール (JP18)です。", "task": "replace", "name_q": "Haloperidol (JP18/USP/INN)", "name_a": "ハロペリドール (JP18)"} -{"id": 801, "instruction": "Zione (TN)の異なる表現は?", "response": "Zione (TN)の異なる表現はAluminum potassium sulfate hydrate and tannic acidです。", "task": "replace", "name_q": "Zione (TN)", "name_a": "Aluminum potassium sulfate hydrate and tannic acid"} -{"id": 16286, "instruction": "Chalconaringeninの別の言い方は?", "response": "Chalconaringeninの別の言い方は2',4,4',6'-Tetrahydroxychalconeです。", "task": "replace", "name_q": "Chalconaringenin", "name_a": "2',4,4',6'-Tetrahydroxychalcone"} -{"id": 28596, "instruction": "Broflanilide (JAN)をを分子式で書くと?", "response": "Broflanilide (JAN)をを分子式で書くとC25H14BrF11N2O2です。", "task": "formula", "name_q": "Broflanilide (JAN)", "name_a": "C25H14BrF11N2O2"} -{"id": 26074, "instruction": "クリミア・コンゴ出血熱 上位グループ 節足動物媒介ウイルス熱 の英訳は?", "response": "クリミア・コンゴ出血熱 上位グループ 節足動物媒介ウイルス熱 の英訳はCrimean-Congo hemorrhagic fever SUPERGRP Arthropod-borne viral fever です。", "task": "replace ja to en", "name_q": "クリミア・コンゴ出血熱 上位グループ 節足動物媒介ウイルス熱 ", "name_a": "Crimean-Congo hemorrhagic fever SUPERGRP Arthropod-borne viral fever "} -{"id": 16162, "instruction": "Cytochrome c N6-methyl-L-lysineをは化学式で表すと?", "response": "Cytochrome c N6-methyl-L-lysineをは化学式で表すとC8H15N3O2R2です。", "task": "formula", "name_q": "Cytochrome c N6-methyl-L-lysine", "name_a": "C8H15N3O2R2"} -{"id": 34315, "instruction": "Aldoximeをの化学式は?", "response": "Aldoximeをの化学式はCH2NORです。", "task": "formula", "name_q": "Aldoxime", "name_a": "CH2NOR"} -{"id": 28759, "instruction": "Technescan MAG3 (TN)を日本語表記で表すと?", "response": "Technescan MAG3 (TN)を日本語表記で表すとテクネチウム (99mTc) メリチアジドです。", "task": "replace en to ja", "name_q": "Technescan MAG3 (TN)", "name_a": "テクネチウム (99mTc) メリチアジド"} -{"id": 25055, "instruction": "Jamaicamide Bをは化学構造で表すと?", "response": "Jamaicamide Bをは化学構造で表すとC27H37ClN2O4です。", "task": "formula", "name_q": "Jamaicamide B", "name_a": "C27H37ClN2O4"} -{"id": 15165, "instruction": "N-Acetyl-beta-D-mannosaminuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenolをを化学式で書くと?", "response": "N-Acetyl-beta-D-mannosaminuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenolをを化学式で書くとC71H116N2O18P2です。", "task": "formula", "name_q": "N-Acetyl-beta-D-mannosaminuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol", "name_a": "C71H116N2O18P2"} -{"id": 30308, "instruction": "メスプリン塩酸塩の英訳は?", "response": "メスプリン塩酸塩の英訳はMesuprine hydrochloride (USAN)です。", "task": "replace ja to en", "name_q": "メスプリン塩酸塩", "name_a": "Mesuprine hydrochloride (USAN)"} -{"id": 20505, "instruction": "後発品CARBOPROSTTROMETHAMINE(AlembicPharmaceuticalsLimited)をは組成式で表すと?", "response": "後発品CARBOPROSTTROMETHAMINE(AlembicPharmaceuticalsLimited)をは組成式で表すとC21H36O5. C4H11NO3です。", "task": "formula", "name_q": "後発品CARBOPROSTTROMETHAMINE(AlembicPharmaceuticalsLimited)", "name_a": "C21H36O5. C4H11NO3"} -{"id": 9226, "instruction": "O-Acetyl-ADP-riboseの異なる名称は?", "response": "O-Acetyl-ADP-riboseの異なる名称はAADPRです。", "task": "replace", "name_q": "O-Acetyl-ADP-ribose", "name_a": "AADPR"} -{"id": 20482, "instruction": "Frangulin Bの別呼称は?", "response": "Frangulin Bの別呼称はフラングリンBです。", "task": "replace", "name_q": "Frangulin B", "name_a": "フラングリンB"} -{"id": 1571, "instruction": "Micromelinをは化学式で表すと?", "response": "Micromelinをは化学式で表すとC15H12O6です。", "task": "formula", "name_q": "Micromelin", "name_a": "C15H12O6"} -{"id": 12934, "instruction": "Tefibazumab (USAN/INN)の異なる表記は?", "response": "Tefibazumab (USAN/INN)の異なる表記はAurexis (TN)です。", "task": "replace", "name_q": "Tefibazumab (USAN/INN)", "name_a": "Aurexis (TN)"} -{"id": 3809, "instruction": "Butylated hydroxyanisole (NF)を日本語表記で表すと?", "response": "Butylated hydroxyanisole (NF)を日本語表記で表すとButylated hydroxyanisole (NF)です。", "task": "replace en to ja", "name_q": "Butylated hydroxyanisole (NF)", "name_a": "Butylated hydroxyanisole (NF)"} -{"id": 6626, "instruction": "Dehydrocorydalineをを化学式で表すと?", "response": "Dehydrocorydalineをを化学式で表すとC22H24NO4です。", "task": "formula", "name_q": "Dehydrocorydaline", "name_a": "C22H24NO4"} -{"id": 20950, "instruction": "Cinoxacin (JP18/USP/INN)をを化学構造で書くと?", "response": "Cinoxacin (JP18/USP/INN)をを化学構造で書くとC12H10N2O5です。", "task": "formula", "name_q": "Cinoxacin (JP18/USP/INN)", "name_a": "C12H10N2O5"} -{"id": 32335, "instruction": "Dextrates (NF)の異なる名称は?", "response": "Dextrates (NF)の異なる名称はデキストレーツです。", "task": "replace", "name_q": "Dextrates (NF)", "name_a": "デキストレーツ"} -{"id": 26814, "instruction": "Ethylparaben (NF)を日本語で書くと?", "response": "Ethylparaben (NF)を日本語で書くとEthyl parahydroxybenzoate (JP18)です。", "task": "replace en to ja", "name_q": "Ethylparaben (NF)", "name_a": "Ethyl parahydroxybenzoate (JP18)"} -{"id": 28935, "instruction": "アルミニウムセスキクロロハイドレックスポリエチレングリコールの異なる名称は?", "response": "アルミニウムセスキクロロハイドレックスポリエチレングリコールの異なる名称はAluminum sesquichlorohydrex polyethylene glycol (USP)です。", "task": "replace", "name_q": "アルミニウムセスキクロロハイドレックスポリエチレングリコール", "name_a": "Aluminum sesquichlorohydrex polyethylene glycol (USP)"} -{"id": 3273, "instruction": "Melengestrol acetate (USP)を英語で記述すると?", "response": "Melengestrol acetate (USP)を英語で記述するとMelengestrol acetate (USP)です。", "task": "replace ja to en", "name_q": "Melengestrol acetate (USP)", "name_a": "Melengestrol acetate (USP)"} -{"id": 26710, "instruction": "メセンブリンをは化学構造で表すと?", "response": "メセンブリンをは化学構造で表すとC17H23NO3です。", "task": "formula", "name_q": "メセンブリン", "name_a": "C17H23NO3"} -{"id": 31276, "instruction": "Olacaftor (USAN/INN)をを組成式で書くと?", "response": "Olacaftor (USAN/INN)をを組成式で書くとC29H34FN3O4Sです。", "task": "formula", "name_q": "Olacaftor (USAN/INN)", "name_a": "C29H34FN3O4S"} -{"id": 12751, "instruction": "セキショウズの別名は?", "response": "セキショウズの別名は赤小豆です。", "task": "replace", "name_q": "セキショウズ", "name_a": "赤小豆"} -{"id": 24046, "instruction": "Double-stranded DNAをの分子式は?", "response": "Double-stranded DNAをの分子式はC10H17O8PR2(C5H8O5PR)n. C10H17O7PR2(C5H8O6PR)nです。", "task": "formula", "name_q": "Double-stranded DNA", "name_a": "C10H17O8PR2(C5H8O5PR)n. C10H17O7PR2(C5H8O6PR)n"} -{"id": 21760, "instruction": "唐独活を英語で記述すると?", "response": "唐独活を英語で記述するとAngelica pubescens root (Non-JPS)です。", "task": "replace ja to en", "name_q": "唐独活", "name_a": "Angelica pubescens root (Non-JPS)"} -{"id": 9534, "instruction": "Elbasvir and grazoprevirの別名は?", "response": "Elbasvir and grazoprevirの別名はZepatier (TN)です。", "task": "replace", "name_q": "Elbasvir and grazoprevir", "name_a": "Zepatier (TN)"} -{"id": 34649, "instruction": "Choloxin (TN)の日本語訳は?", "response": "Choloxin (TN)の日本語訳はDextrothyroxine sodium (USAN)です。", "task": "replace en to ja", "name_q": "Choloxin (TN)", "name_a": "Dextrothyroxine sodium (USAN)"} -{"id": 2099, "instruction": "C6420H9946N1726O2012S44をは組成式で表すと?", "response": "C6420H9946N1726O2012S44をは組成式で表すとC6420H9946N1726O2012S44です。", "task": "formula", "name_q": "C6420H9946N1726O2012S44", "name_a": "C6420H9946N1726O2012S44"} -{"id": 27498, "instruction": "Clobenzorex (INN)の日本語表記は?", "response": "Clobenzorex (INN)の日本語表記はクロベンゾレックスで���。", "task": "replace en to ja", "name_q": "Clobenzorex (INN)", "name_a": "クロベンゾレックス"} -{"id": 27680, "instruction": "Seishitsuketantoの別名は?", "response": "Seishitsuketantoの別名は清湿化痰湯です。", "task": "replace", "name_q": "Seishitsuketanto", "name_a": "清湿化痰湯"} -{"id": 30981, "instruction": "Glutarate semialdehydeの異なる表記は?", "response": "Glutarate semialdehydeの異なる表記は5-Oxopentanoateです。", "task": "replace", "name_q": "Glutarate semialdehyde", "name_a": "5-Oxopentanoate"} -{"id": 10581, "instruction": "Erythromycin Dをを化学式で表すと?", "response": "Erythromycin Dをを化学式で表すとC36H65NO12です。", "task": "formula", "name_q": "Erythromycin D", "name_a": "C36H65NO12"} -{"id": 14746, "instruction": "Ortho-cept (TN)を利用した製品名は?", "response": "Ortho-cept (TN)を利用した製品名はファボワール(富士製薬工業)です。", "task": "product", "name_q": "Ortho-cept (TN)", "name_a": "ファボワール(富士製薬工業)"} -{"id": 30195, "instruction": "Pyricarbateの別の言い方は?", "response": "Pyricarbateの別の言い方はAnginin (TN)です。", "task": "replace", "name_q": "Pyricarbate", "name_a": "Anginin (TN)"} -{"id": 23360, "instruction": "Fresh-frozen human plasmaの異なる名称は?", "response": "Fresh-frozen human plasmaの異なる名称はFresh frozen plasma -leukocytes reduced (FFP-LR)です。", "task": "replace", "name_q": "Fresh-frozen human plasma", "name_a": "Fresh frozen plasma -leukocytes reduced (FFP-LR)"} -{"id": 31346, "instruction": "Nialamide (INN)を英語で書くと?", "response": "Nialamide (INN)を英語で書くとNiamid (TN)です。", "task": "replace ja to en", "name_q": "Nialamide (INN)", "name_a": "Niamid (TN)"} -{"id": 32412, "instruction": "Spastic quadriplegic cerebral palsyを日本語で書くと?", "response": "Spastic quadriplegic cerebral palsyを日本語で書くと痙攣性四肢脳性麻痺です。", "task": "replace en to ja", "name_q": "Spastic quadriplegic cerebral palsy", "name_a": "痙攣性四肢脳性麻痺"} -{"id": 25418, "instruction": "Acetaminophen and ibuprofenを日本語に訳すと?", "response": "Acetaminophen and ibuprofenを日本語に訳すとアセトアミノフェン・イブプロフェンです。", "task": "replace en to ja", "name_q": "Acetaminophen and ibuprofen", "name_a": "アセトアミノフェン・イブプロフェン"} -{"id": 6165, "instruction": "Diethylaminoethyl diphenylhydroxypropionate hydrochloride (JAN)をを分子式で表すと?", "response": "Diethylaminoethyl diphenylhydroxypropionate hydrochloride (JAN)をを分子式で表すとC21H27NO3. HClです。", "task": "formula", "name_q": "Diethylaminoethyl diphenylhydroxypropionate hydrochloride (JAN)", "name_a": "C21H27NO3. HCl"} -{"id": 13864, "instruction": "高グリシン尿症の英語表記は?", "response": "高グリシン尿症の英語表記はHyperglycinuriaです。", "task": "replace ja to en", "name_q": "高グリシン尿症", "name_a": "Hyperglycinuria"} -{"id": 11561, "instruction": "Chloromycetin succinate (TN)の別表現は?", "response": "Chloromycetin succinate (TN)の別表現はChloramphenicol sodium succinate (JP18/USP)です。", "task": "replace", "name_q": "Chloromycetin succinate (TN)", "name_a": "Chloramphenicol sodium succinate (JP18/USP)"} -{"id": 32875, "instruction": "Camphor (USP)の日本語訳は?", "response": "Camphor (USP)の日本語訳はCamphor (USP)です。", "task": "replace en to ja", "name_q": "Camphor (USP)", "name_a": "Camphor (USP)"} -{"id": 1790, "instruction": "筋緊張低下・呼吸機能不全および脳画像の異常を伴う小児発症神経変性疾患を英語で記述すると?", "response": "筋緊張低下・呼吸機能不全および脳画像の異常を伴う小児発症神経変性疾患を英語で記述するとChildhood-onset neurodegeneration with hypotonia, respiratory insufficiency, and brain imaging abnormalitiesです。", "task": "replace ja to en", "name_q": "筋緊張低下・呼吸機能不全および脳画像の異常を伴う小児発症神経変性疾患", "name_a": "Childhood-onset neurodegeneration with hypotonia, respiratory insufficiency, and brain imaging abnormalities"} -{"id": 9504, "instruction": "Tetraphyllicineの別名は?", "response": "Tetraphyllicineの別名はNSC72114です。", "task": "replace", "name_q": "Tetraphyllicine", "name_a": "NSC72114"} -{"id": 23727, "instruction": "YC 170をの化学構造は?", "response": "YC 170をの化学構造はC28H26ClN3O3です。", "task": "formula", "name_q": "YC 170", "name_a": "C28H26ClN3O3"} -{"id": 32732, "instruction": "C6287H9806N1862O1917S100をの分子式は?", "response": "C6287H9806N1862O1917S100をの分子式はC6287H9806N1862O1917S100です。", "task": "formula", "name_q": "C6287H9806N1862O1917S100", "name_a": "C6287H9806N1862O1917S100"} -{"id": 495, "instruction": "Epithienamycin Eの異なる表記は?", "response": "Epithienamycin Eの異なる表記はMM13902です。", "task": "replace", "name_q": "Epithienamycin E", "name_a": "MM13902"} -{"id": 19441, "instruction": "オウショウサンの英語表記は?", "response": "オウショウサンの英語表記はOshosanです。", "task": "replace ja to en", "name_q": "オウショウサン", "name_a": "Oshosan"} -{"id": 31052, "instruction": "Isobromindione (INN)をを分子式で書くと?", "response": "Isobromindione (INN)をを分子式で書くとC15H9BrO2です。", "task": "formula", "name_q": "Isobromindione (INN)", "name_a": "C15H9BrO2"} -{"id": 23966, "instruction": "(C12H20NO2)2. SO4をを組成式で表すと?", "response": "(C12H20NO2)2. SO4をを組成式で表すと(C12H20NO2)2. SO4です。", "task": "formula", "name_q": "(C12H20NO2)2. SO4", "name_a": "(C12H20NO2)2. SO4"} -{"id": 15542, "instruction": "CALCIPOTRIENEANDBETAMETHASONEDIPROPIONATE(TOLMAR)を主材料とする医薬品は?", "response": "CALCIPOTRIENEANDBETAMETHASONEDIPROPIONATE(TOLMAR)を主材料とする医薬品はCALCIPOTRIENEANDBETAMETHASONEDIPROPIONATE(PadagisIsraelPharmaceuticals)です。", "task": "product", "name_q": "CALCIPOTRIENEANDBETAMETHASONEDIPROPIONATE(TOLMAR)", "name_a": "CALCIPOTRIENEANDBETAMETHASONEDIPROPIONATE(PadagisIsraelPharmaceuticals)"} -{"id": 11405, "instruction": "ミツムプロチムト-Tの英語表記は?", "response": "ミツムプロチムト-Tの英語表記はMitumprotimut-T (USAN)です。", "task": "replace ja to en", "name_q": "ミツムプロチムト-T", "name_a": "Mitumprotimut-T (USAN)"} -{"id": 26110, "instruction": "Chimyl alcoholの異なる表記は?", "response": "Chimyl alcoholの異なる表記はGlycerol hexadecyl etherです。", "task": "replace", "name_q": "Chimyl alcohol", "name_a": "Glycerol hexadecyl ether"} -{"id": 16668, "instruction": "[eIF5A-precursor]-deoxyhypusineをの化学式は?", "response": "[eIF5A-precursor]-deoxyhypusineをの化学式はC11H22N4O2R2です。", "task": "formula", "name_q": "[eIF5A-precursor]-deoxyhypusine", "name_a": "C11H22N4O2R2"} -{"id": 26625, "instruction": "Imipramine embonateの異なる表現は?", "response": "Imipramine embonateの異なる表現はイミプラミンパモ酸塩です。", "task": "replace", "name_q": "Imipramine embonate", "name_a": "イミプラミンパモ酸塩"} -{"id": 5335, "instruction": "N-(Sulfonatooxy)alkenimidothioic acidをを化学式で表すと?", "response": "N-(Sulfonatooxy)alkenimidothioic acidをを化学式で表すとC3H5NO4S2(CH2)nです。", "task": "formula", "name_q": "N-(Sulfonatooxy)alkenimidothioic acid", "name_a": "C3H5NO4S2(CH2)n"} -{"id": 23328, "instruction": "Anti-human thymocyte immunoglobulin, equine (JAN)を言い換えると?", "response": "Anti-human thymocyte immunoglobulin, equine (JAN)を言い換えると抗ヒト胸腺細胞ウマ免疫グロブリン (JAN)です。", "task": "replace", "name_q": "Anti-human thymocyte immunoglobulin, equine (JAN)", "name_a": "抗ヒト胸腺細胞ウマ免疫グロブリン (JAN)"} -{"id": 32444, "instruction": "葶藶子の異なる表現は?", "response": "葶藶子の異なる表現はLepidium seedです。", "task": "replace", "name_q": "葶藶子", "name_a": "Lepidium seed"} -{"id": 10243, "instruction": "エチホキシンを英語で書くと?", "response": "エチホキシンを英語で書くとEtifoxine (INN/BAN)です。", "task": "replace ja to en", "name_q": "エチホキシン", "name_a": "Etifoxine (INN/BAN)"} -{"id": 23740, "instruction": "Intellectual developmental disorder with autism and speech delay SUBGROUP IDD with autism and speech delay (IDDAS) IDD with autistic features, language delay, and seizures (IDDALDS) IDD with autism and dysmorphic facies (IDDADF) IDD with language impairment and with or without autistic features (IDDLA) White-Sutton syndrome (WHSUS) SUPERGRP Syndromic intellectual developmental disorder を日本語で記述すると?", "response": "Intellectual developmental disorder with autism and speech delay SUBGROUP IDD with autism and speech delay (IDDAS) IDD with autistic features, language delay, and seizures (IDDALDS) IDD with autism and dysmorphic facies (IDDADF) IDD with language impairment and with or without autistic features (IDDLA) White-Sutton syndrome (WHSUS) SUPERGRP Syndromic intellectual developmental disorder を日本語で記述すると自閉症と言葉の遅れを伴う知的発達障害 下位グループ 自閉症と言葉の遅れを伴う知的発達障害 (IDDAS) 自閉症状、言葉の遅れおよび痙攣を伴う知的発達障害 (IDDALDS) 自閉症と顔異形を伴う知的発達障害 (IDDADF) 自閉症状を伴う（伴わない）言語障害を伴う知的発達障害 (IDDLA) White-Sutton 症候群 (WHSUS) 上位グループ 症候群性知的発達障害 です。", "task": "replace en to ja", "name_q": "Intellectual developmental disorder with autism and speech delay SUBGROUP IDD with autism and speech delay (IDDAS) IDD with autistic features, language delay, and seizures (IDDALDS) IDD with autism and dysmorphic facies (IDDADF) IDD with language impairment and with or without autistic features (IDDLA) White-Sutton syndrome (WHSUS) SUPERGRP Syndromic intellectual developmental disorder ", "name_a": "自閉症と言葉の遅れを伴う知的発達障害 下位グループ 自閉症と言葉の遅れを伴う知的発達障害 (IDDAS) 自閉症状、言葉の遅れおよび痙攣を伴う知的発達障害 (IDDALDS) 自閉症と顔異形を伴う知的発達障害 (IDDADF) 自閉症状を伴う（伴わない）言語障害を伴う知的発達障害 (IDDLA) White-Sutton 症候群 (WHSUS) 上位グループ 症候群性知的発達障害 "} -{"id": 23092, "instruction": "バリノマイシンの異なる表記は?", "response": "バリノマイシンの異なる表記はValinomycinです。", "task": "replace", "name_q": "バリノマイシン", "name_a": "Valinomycin"} -{"id": 4670, "instruction": "デルタ-12-プロスタグランジンJ2の別表現は?", "response": "デルタ-12-プロスタグランジンJ2の別表現はDelta-12-Prostaglandin J2です。", "task": "replace", "name_q": "デルタ-12-プロスタグランジンJ2", "name_a": "Delta-12-Prostaglandin J2"} -{"id": 7665, "instruction": "Omidenepag isopropyl (JAN)の日本語表記は?", "response": "Omidenepag isopropyl (JAN)の日本語表記はオミデネパグイソプロピル (JAN)です。", "task": "replace en to ja", "name_q": "Omidenepag isopropyl (JAN)", "name_a": "オミデネパグイソプロピル (JAN)"} -{"id": 3583, "instruction": "Alpertine (USAN/INN)をは分子式で表すと?", "response": "Alpertine (USAN/INN)をは分子式で表すとC25H31N3O4です。", "task": "formula", "name_q": "Alpertine (USAN/INN)", "name_a": "C25H31N3O4"} -{"id": 23416, "instruction": "Tinlarebant (USAN)を日本語で書くと?", "response": "Tinlarebant (USAN)を日本語で書くとTinlarebant (USAN)です。", "task": "replace en to ja", "name_q": "Tinlarebant (USAN)", "name_a": "Tinlarebant (USAN)"} -{"id": 12743, "instruction": "Ricinineをを化学構造で記述すると?", "response": "Ricinineをを化学構造で記述するとC8H8N2O2です。", "task": "formula", "name_q": "Ricinine", "name_a": "C8H8N2O2"} -{"id": 6200, "instruction": "プロパミジンイセチオナートの英訳は?", "response": "プロパミジンイセチオナートの英訳はGolden eye drops (TN)です。", "task": "replace ja to en", "name_q": "プロパミジンイセチオナート", "name_a": "Golden eye drops (TN)"} -{"id": 10111, "instruction": "N-Acetylarylamineの別名は?", "response": "N-Acetylarylamineの別名はN-Phenylacetamideです。", "task": "replace", "name_q": "N-Acetylarylamine", "name_a": "N-Phenylacetamide"} -{"id": 15882, "instruction": "Carbenicillin potassium (USAN)の別名称は?", "response": "Carbenicillin potassium (USAN)の別名称はカルベニシリンカリウムです。", "task": "replace", "name_q": "Carbenicillin potassium (USAN)", "name_a": "カルベニシリンカリウム"} -{"id": 28327, "instruction": "Ryokeimikantoの別の呼び方は?", "response": "Ryokeimikantoの別の呼び方は苓桂味甘湯です。", "task": "replace", "name_q": "Ryokeimikanto", "name_a": "苓桂味甘湯"} -{"id": 33066, "instruction": "Valerian rhizomeの日本語表記は?", "response": "Valerian rhizomeの日本語表記はセイヨウカノコソウです。", "task": "replace en to ja", "name_q": "Valerian rhizome", "name_a": "セイヨウカノコソウ"} -{"id": 16411, "instruction": "AMINOCAPROICACID(PURACAPLABORATORIESLLCDBABLUPHARMACEUTICALS)を主とした薬品は?", "response": "AMINOCAPROICACID(PURACAPLABORATORIESLLCDBABLUPHARMACEUTICALS)を主とした薬品はAMINOCAPROICACID(TruPharmaLLC)です。", "task": "product", "name_q": "AMINOCAPROICACID(PURACAPLABORATORIESLLCDBABLUPHARMACEUTICALS)", "name_a": "AMINOCAPROICACID(TruPharmaLLC)"} -{"id": 19522, "instruction": "Aluminum carbonate, basic (USAN)をを化学式で表すと?", "response": "Aluminum carbonate, basic (USAN)をを化学式で表すと(CO3)3. 2Alです。", "task": "formula", "name_q": "Aluminum carbonate, basic (USAN)", "name_a": "(CO3)3. 2Al"} -{"id": 23796, "instruction": "アニロパム塩酸塩をの組成式は?", "response": "アニロパム塩酸塩をの組成式はC20H26N2O. 2HClです。", "task": "formula", "name_q": "アニロパム塩酸塩", "name_a": "C20H26N2O. 2HCl"} -{"id": 24513, "instruction": "(-)-Sabineneをを化学式で表すと?", "response": "(-)-Sabineneをを化学式で表すとC10H16です。", "task": "formula", "name_q": "(-)-Sabinene", "name_a": "C10H16"} -{"id": 34160, "instruction": "Coactin (TN)をを組成式で表すと?", "response": "Coactin (TN)をを組成式で表すとC15H23N3O3Sです。", "task": "formula", "name_q": "Coactin (TN)", "name_a": "C15H23N3O3S"} -{"id": 25666, "instruction": "Erwinase (TN)を日本語で書くと?", "response": "Erwinase (TN)を日本語で書くとクリサンタスパーゼ (JAN)です。", "task": "replace en to ja", "name_q": "Erwinase (TN)", "name_a": "クリサンタスパーゼ (JAN)"} -{"id": 13317, "instruction": "Eletriptan (INN)をを化学式で表すと?", "response": "Eletriptan (INN)をを化学式で表すとC22H26N2O2Sです。", "task": "formula", "name_q": "Eletriptan (INN)", "name_a": "C22H26N2O2S"} -{"id": 8161, "instruction": "Calcium saccharin hydrateをの化学式は?", "response": "Calcium saccharin hydrateをの化学式は(C7H4NO3S)2. 7H2O. Caです。", "task": "formula", "name_q": "Calcium saccharin hydrate", "name_a": "(C7H4NO3S)2. 7H2O. Ca"} -{"id": 28046, "instruction": "3alpha,7alpha,12alpha-Trihydroxycoprostaneをを化学構造で書くと?", "response": "3alpha,7alpha,12alpha-Trihydroxycoprostaneをを化学構造で書くとC27H48O3です。", "task": "formula", "name_q": "3alpha,7alpha,12alpha-Trihydroxycoprostane", "name_a": "C27H48O3"} -{"id": 23057, "instruction": "Codein phosphate and aspirinの日本語表記は?", "response": "Codein phosphate and aspirinの日本語表記はコデイン・アスピリンです。", "task": "replace en to ja", "name_q": "Codein phosphate and aspirin", "name_a": "コデイン・アスピリン"} -{"id": 18307, "instruction": "Petasitenineをを化学式で書くと?", "response": "Petasitenineをを化学式で書くとC19H27NO7です。", "task": "formula", "name_q": "Petasitenine", "name_a": "C19H27NO7"} -{"id": 8795, "instruction": "Primary peritoneal carcinomaを日本語で記述すると?", "response": "Primary peritoneal carcinomaを日本語で記述すると原発性腹膜癌です。", "task": "replace en to ja", "name_q": "Primary peritoneal carcinoma", "name_a": "原発性腹膜癌"} -{"id": 15806, "instruction": "Auditory neuropathy SUBGROUP Autosomal dominant auditory neuropathy (AUNA) Auditory neuropathy and optic atrophy (ANOA)の日本語表記は?", "response": "Auditory neuropathy SUBGROUP Autosomal dominant auditory neuropathy (AUNA) Auditory neuropathy and optic atrophy (ANOA)の日本語表記はオーディトリーニューロパチー 下位グループ 常染色体優性遺伝性オーディトリーニューロパチー (AUNA) オーディトリーニューロパチーおよび視神経萎縮 (ANOA)です。", "task": "replace en to ja", "name_q": "Auditory neuropathy SUBGROUP Autosomal dominant auditory neuropathy (AUNA) Auditory neuropathy and optic atrophy (ANOA)", "name_a": "オーディトリーニューロパチー 下位グループ 常染色体優性遺伝性オーディトリーニューロパチー (AUNA) オーディトリーニューロパチーおよび視神経萎縮 (ANOA)"} -{"id": 24381, "instruction": "Florisilの別の言い方は?", "response": "Florisilの別の言い方はケイ酸マグネシウム (JP18)です。", "task": "replace", "name_q": "Florisil", "name_a": "ケイ酸マグネシウム (JP18)"} -{"id": 32788, "instruction": "リンコシン(ファイザー)を使用した製品は?", "response": "リンコシン(ファイザー)を使用した製品はLINCOMYCIN(SagentPharmaceuticals)です。", "task": "product", "name_q": "リンコシン(ファイザー)", "name_a": "LINCOMYCIN(SagentPharmaceuticals)"} -{"id": 15933, "instruction": "Japanese cedar pollen extractを利用した製品は?", "response": "Japanese cedar pollen extractを利用した製品はシダキュア(鳥居薬品)です。", "task": "product", "name_q": "Japanese cedar pollen extract", "name_a": "シダキュア(鳥居薬品)"} -{"id": 16957, "instruction": "カルベニシリンをの化学構造は?", "response": "カルベニシリンをの化学構造はC17H18N2O6Sです。", "task": "formula", "name_q": "カルベニシリン", "name_a": "C17H18N2O6S"} -{"id": 2609, "instruction": "Brooke-Spiegler syndromeの日本語表記は?", "response": "Brooke-Spiegler syndromeの日本語表記はBrooke-Spiegler 症候群です。", "task": "replace en to ja", "name_q": "Brooke-Spiegler syndrome", "name_a": "Brooke-Spiegler 症候群"} -{"id": 17777, "instruction": "オルメサルタン(東和薬品)を使用した医薬品名は?", "response": "オルメサルタン(東和薬品)を使用した医薬品名はオルメサルタン(陽進堂)です。", "task": "product", "name_q": "オルメサルタン(東和薬品)", "name_a": "オルメサルタン(陽進堂)"} -{"id": 25292, "instruction": "Histone-L-lysineをは組成式で表すと?", "response": "Histone-L-lysineをは組成式で表すとC7H13N3O2R2です。", "task": "formula", "name_q": "Histone-L-lysine", "name_a": "C7H13N3O2R2"} -{"id": 24023, "instruction": "Gambiriin A1の別名は?", "response": "Gambiriin A1の別名はガンビリイン A1です。", "task": "replace", "name_q": "Gambiriin A1", "name_a": "ガンビリイン A1"} -{"id": 15475, "instruction": "ニガキヘミアセタールAの別呼称は?", "response": "ニガキヘミアセタールAの別呼称はNigakihemiacetal Aです。", "task": "replace", "name_q": "ニガキヘミアセタールA", "name_a": "Nigakihemiacetal A"} -{"id": 25578, "instruction": "(22S)-22-Hydroxy-campesterolの別呼称は?", "response": "(22S)-22-Hydroxy-campesterolの別呼称は22alpha-Hydroxy-campesterolです。", "task": "replace", "name_q": "(22S)-22-Hydroxy-campesterol", "name_a": "22alpha-Hydroxy-campesterol"} -{"id": 4522, "instruction": "Sarcoplasmic body myopathyの日本語表記は?", "response": "Sarcoplasmic body myopathyの日本語表記はSarcoplasmic body myopathyです。", "task": "replace en to ja", "name_q": "Sarcoplasmic body myopathy", "name_a": "Sarcoplasmic body myopathy"} -{"id": 14433, "instruction": "L-システイン・アスコルビン酸の英訳は?", "response": "L-システイン・アスコルビン酸の英訳はCrystfan (TN)です。", "task": "replace ja to en", "name_q": "L-システイン・アスコルビン酸", "name_a": "Crystfan (TN)"} -{"id": 27525, "instruction": "Icomucret (USAN)をを化学構造で表すと?", "response": "Icomucret (USAN)をを化学構造で表すとC20H32O3です。", "task": "formula", "name_q": "Icomucret (USAN)", "name_a": "C20H32O3"} -{"id": 17382, "instruction": "Lyfnua (TN)の異なる表現は?", "response": "Lyfnua (TN)の異なる表現はGefapixant citrate (JAN/USAN)です。", "task": "replace", "name_q": "Lyfnua (TN)", "name_a": "Gefapixant citrate (JAN/USAN)"} -{"id": 24361, "instruction": "C28H37N3O4をを組成式で記述すると?", "response": "C28H37N3O4をを組成式で記述するとC28H37N3O4です。", "task": "formula", "name_q": "C28H37N3O4", "name_a": "C28H37N3O4"} -{"id": 26121, "instruction": "Familial pseudohyperkalemiaの日本語訳は?", "response": "Familial pseudohyperkalemiaの日本語訳は家族性偽高カリウム血症です。", "task": "replace en to ja", "name_q": "Familial pseudohyperkalemia", "name_a": "家族性偽高カリウム血症"} -{"id": 21308, "instruction": "アゾルビンをを化学構造で記述すると?", "response": "アゾルビンをを化学構造で記述するとC20H12N2O7S2. 2Naです。", "task": "formula", "name_q": "アゾルビン", "name_a": "C20H12N2O7S2. 2Na"} -{"id": 12656, "instruction": "C9H11NO2を用いた薬品名は?", "response": "C9H11NO2を用いた薬品名はエテンザミド(吉田製薬)です。", "task": "product", "name_q": "C9H11NO2", "name_a": "エテンザミド(吉田製薬)"} -{"id": 5272, "instruction": "p-フェニレンジアミンをの組成式は?", "response": "p-フェニレンジアミンをの組成式はC6H8N2です。", "task": "formula", "name_q": "p-フェニレンジアミン", "name_a": "C6H8N2"} -{"id": 21571, "instruction": "3-Vinylbacteriochlorophyllide aをを分子式で書くと?", "response": "3-Vinylbacteriochlorophyllide aをを分子式で書くとC35H36MgN4O5です。", "task": "formula", "name_q": "3-Vinylbacteriochlorophyllide a", "name_a": "C35H36MgN4O5"} -{"id": 7664, "instruction": "Cystic fibrosisの日本語訳は?", "response": "Cystic fibrosisの日本語訳は嚢胞性線維症です。", "task": "replace en to ja", "name_q": "Cystic fibrosis", "name_a": "嚢胞性線維症"} -{"id": 8477, "instruction": "グレンバツムマブをは組成式で表すと?", "response": "グレンバツムマブをは組成式で表すとC6466H9900N1712O2012S46です。", "task": "formula", "name_q": "グレンバツムマブ", "name_a": "C6466H9900N1712O2012S46"} -{"id": 20518, "instruction": "Dried thyroid (JP18)の英訳は?", "response": "Dried thyroid (JP18)の英訳はDried thyroid (JP18)です。", "task": "replace ja to en", "name_q": "Dried thyroid (JP18)", "name_a": "Dried thyroid (JP18)"} -{"id": 15682, "instruction": "Wax, Yellow (NF)の別呼称は?", "response": "Wax, Yellow (NF)の別呼称はYellow wax (TN)です。", "task": "replace", "name_q": "Wax, Yellow (NF)", "name_a": "Yellow wax (TN)"} -{"id": 1272, "instruction": "ネドシランナトリウムの異なる名称は?", "response": "ネドシランナトリウムの異なる名称はNedosiran sodium (USAN)です。", "task": "replace", "name_q": "ネドシランナトリウム", "name_a": "Nedosiran sodium (USAN)"} -{"id": 18191, "instruction": "沈降20価肺炎球菌結合型ワクチン (無毒性変異ジフテリア毒素結合体)は別の呼び方では?", "response": "沈降20価肺炎球菌結合型ワクチン (無毒性変異ジフテリア毒素結合体)は別の呼び方ではPneumococcal 20-valent conjugate vaccineです。", "task": "replace", "name_q": "沈降20価肺炎球菌結合型ワクチン (無毒性変異ジフテリア毒素結合体)", "name_a": "Pneumococcal 20-valent conjugate vaccine"} -{"id": 21885, "instruction": "移植片対宿主病を英語表記で表すと?", "response": "移植片対宿主病を英語表記で表すとGraft-versus-host diseaseです。", "task": "replace ja to en", "name_q": "移植片対宿主病", "name_a": "Graft-versus-host disease"} -{"id": 27924, "instruction": "Pentoil (TN)を日本語で記述すると?", "response": "Pentoil (TN)を日本語で記述するとEmorfazone (JP18/INN)です。", "task": "replace en to ja", "name_q": "Pentoil (TN)", "name_a": "Emorfazone (JP18/INN)"} -{"id": 26148, "instruction": "C17H14N2O3をの化学式は?", "response": "C17H14N2O3をの化学式はC17H14N2O3です。", "task": "formula", "name_q": "C17H14N2O3", "name_a": "C17H14N2O3"} -{"id": 28604, "instruction": "4-O-(2-N-Acetyl-beta-D-glucosaminyl-D-ribitylphospho)n-di[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenolをを組成式で書くと?", "response": "4-O-(2-N-Acetyl-beta-D-glucosaminyl-D-ribitylphospho)n-di[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenolをを組成式で書くとC77H132N2O27P4(C13H24NO12P)nです。", "task": "formula", "name_q": "4-O-(2-N-Acetyl-beta-D-glucosaminyl-D-ribitylphospho)n-di[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol", "name_a": "C77H132N2O27P4(C13H24NO12P)n"} -{"id": 15799, "instruction": "3-Carbethoxypsoralenをを化学式で書くと?", "response": "3-Carbethoxypsoralenをを化学式で書くとC14H10O5です。", "task": "formula", "name_q": "3-Carbethoxypsoralen", "name_a": "C14H10O5"} -{"id": 12192, "instruction": "Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephalyの別の言い方は?", "response": "Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephalyの別の言い方はHydranencephaly with renal aplasia-dysplasiaです。", "task": "replace", "name_q": "Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly", "name_a": "Hydranencephaly with renal aplasia-dysplasia"} -{"id": 16936, "instruction": "(Stearoyl)adenylateをを分子式で書くと?", "response": "(Stearoyl)adenylateをを分子式で書くとC28H48N5O8Pです。", "task": "formula", "name_q": "(Stearoyl)adenylate", "name_a": "C28H48N5O8P"} -{"id": 24055, "instruction": "乳香の異なる表現は?", "response": "乳香の異なる表現はニュウコウです。", "task": "replace", "name_q": "乳香", "name_a": "ニュウコウ"} -{"id": 26982, "instruction": "Sodium iodide I 131 (JP18/USP)を使用した薬品名は?", "response": "Sodium iodide I 131 (JP18/USP)を使用した薬品名はHICON(JubilantDraxImage)です。", "task": "product", "name_q": "Sodium iodide I 131 (JP18/USP)", "name_a": "HICON(JubilantDraxImage)"} -{"id": 11170, "instruction": "HELIX syndromeを日本語で書くと?", "response": "HELIX syndromeを日本語で書くとHELIX 症候群です。", "task": "replace en to ja", "name_q": "HELIX syndrome", "name_a": "HELIX 症候群"} -{"id": 25330, "instruction": "アバメクチンを英語に訳すと?", "response": "アバメクチンを英語に訳すとAbamectin (USAN/INN)です。", "task": "replace ja to en", "name_q": "アバメクチン", "name_a": "Abamectin (USAN/INN)"} -{"id": 1762, "instruction": "DEXTROAMPHETAMINESULFATE(BryantRanchPrepack)を用いた薬品は?", "response": "DEXTROAMPHETAMINESULFATE(BryantRanchPrepack)を用いた薬品はDEXTROAMPHETAMINESULFATE(TrisPharma)です。", "task": "product", "name_q": "DEXTROAMPHETAMINESULFATE(BryantRanchPrepack)", "name_a": "DEXTROAMPHETAMINESULFATE(TrisPharma)"} -{"id": 2820, "instruction": "Tetrabenazineをを組成式で書くと?", "response": "Tetrabenazineをを組成式で書くとC19H27NO3です。", "task": "formula", "name_q": "Tetrabenazine", "name_a": "C19H27NO3"} -{"id": 22652, "instruction": "ギビノスタットをの化学構造は?", "response": "ギビノスタットをの化学構造はC24H27N3O4です。", "task": "formula", "name_q": "ギビノスタット", "name_a": "C24H27N3O4"} -{"id": 18484, "instruction": "Pentigetide (USAN/INN)の別名称は?", "response": "Pentigetide (USAN/INN)の別名称はペンチゲチドです。", "task": "replace", "name_q": "Pentigetide (USAN/INN)", "name_a": "ペンチゲチド"} -{"id": 469, "instruction": "Emavusertib hydrochloride (USAN)をを組成式で表すと?", "response": "Emavusertib hydrochloride (USAN)をを組成式で表すとC24H25N7O5. HClです。", "task": "formula", "name_q": "Emavusertib hydrochloride (USAN)", "name_a": "C24H25N7O5. HCl"} -{"id": 26472, "instruction": "(+/-)-8-Acetonyldihydrosanguinarineをの組成式は?", "response": "(+/-)-8-Acetonyldihydrosanguinarineをの組成式はC23H19NO5です。", "task": "formula", "name_q": "(+/-)-8-Acetonyldihydrosanguinarine", "name_a": "C23H19NO5"} -{"id": 33459, "instruction": "Clindamycinをの分子式は?", "response": "Clindamycinをの分子式はC18H33ClN2O5Sです。", "task": "formula", "name_q": "Clindamycin", "name_a": "C18H33ClN2O5S"} -{"id": 26344, "instruction": "Norethindrone enanthateの別名は?", "response": "Norethindrone enanthateの別名はNorethisterone enanthateです。", "task": "replace", "name_q": "Norethindrone enanthate", "name_a": "Norethisterone enanthate"} -{"id": 28174, "instruction": "Azumolene sodium (USAN)をを化学構造で表すと?", "response": "Azumolene sodium (USAN)をを化学構造で表すとC13H8BrN4O3. 2H2O. Naです。", "task": "formula", "name_q": "Azumolene sodium (USAN)", "name_a": "C13H8BrN4O3. 2H2O. Na"} -{"id": 20955, "instruction": "2-Methoxyestradiol-17betaの別名は?", "response": "2-Methoxyestradiol-17betaの別名は2-Methoxy-17beta-estradiolです。", "task": "replace", "name_q": "2-Methoxyestradiol-17beta", "name_a": "2-Methoxy-17beta-estradiol"} -{"id": 21348, "instruction": "ゼアラレノンの別記述は?", "response": "ゼアラレノンの別記述はゼラレノンです。", "task": "replace", "name_q": "ゼアラレノン", "name_a": "ゼラレノン"} -{"id": 8666, "instruction": "Benzetimide (INN)をは分子式で表すと?", "response": "Benzetimide (INN)をは分子式で表すとC23H26N2O2です。", "task": "formula", "name_q": "Benzetimide (INN)", "name_a": "C23H26N2O2"} -{"id": 9103, "instruction": "C6434H9942N1718O2016S44をの分子式は?", "response": "C6434H9942N1718O2016S44をの分子式はC6434H9942N1718O2016S44です。", "task": "formula", "name_q": "C6434H9942N1718O2016S44", "name_a": "C6434H9942N1718O2016S44"} -{"id": 6774, "instruction": "後天性全身性脂肪萎縮症を言い換えると?", "response": "後天性全身性脂肪萎縮症を言い換えるとLawrence 症候群 上位グループ 脂肪萎縮症 です。", "task": "replace", "name_q": "後天性全身性脂肪萎縮症", "name_a": "Lawrence 症候群 上位グループ 脂肪萎縮症 "} -{"id": 16503, "instruction": "ロリトレムKをを化学構造で記述すると?", "response": "ロリトレムKをを化学構造で記述するとC37H47NO6です。", "task": "formula", "name_q": "ロリトレムK", "name_a": "C37H47NO6"} -{"id": 7094, "instruction": "メチルプレドニゾロン (JP18)を利用した医薬品名は?", "response": "メチルプレドニゾロン (JP18)を利用した医薬品名はMETHYLPREDNISOLONE(AmericanHealthPackaging)です。", "task": "product", "name_q": "メチルプレドニゾロン (JP18)", "name_a": "METHYLPREDNISOLONE(AmericanHealthPackaging)"} -{"id": 29413, "instruction": "Laribacter hongkongensis 感染の英訳は?", "response": "Laribacter hongkongensis 感染の英訳はLaribacter hongkongensis infectionです。", "task": "replace ja to en", "name_q": "Laribacter hongkongensis 感染", "name_a": "Laribacter hongkongensis infection"} -{"id": 29944, "instruction": "Hinokitiolを日本語で記述すると?", "response": "Hinokitiolを日本語で記述するとヒノキチオールです。", "task": "replace en to ja", "name_q": "Hinokitiol", "name_a": "ヒノキチオール"} -{"id": 1663, "instruction": "アシミニブは別の呼び方では?", "response": "アシミニブは別の呼び方ではアスキミニブです。", "task": "replace", "name_q": "アシミニブ", "name_a": "アスキミニブ"} -{"id": 17492, "instruction": "5,11,17,23-Tetrasulfonato-25,26,27,28-tetramethoxy-calix(4)areneをを組成式で記述すると?", "response": "5,11,17,23-Tetrasulfonato-25,26,27,28-tetramethoxy-calix(4)areneをを組成式で記述するとC32H32O16S4です。", "task": "formula", "name_q": "5,11,17,23-Tetrasulfonato-25,26,27,28-tetramethoxy-calix(4)arene", "name_a": "C32H32O16S4"} -{"id": 18924, "instruction": "Isobutyl alcoholを言い換えると?", "response": "Isobutyl alcoholを言い換えると2-Methyl-1-propanolです。", "task": "replace", "name_q": "Isobutyl alcohol", "name_a": "2-Methyl-1-propanol"} -{"id": 21648, "instruction": "4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfateをを分子式で表すと?", "response": "4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfateをを分子式で表すとC14H21NO14Sです。", "task": "formula", "name_q": "4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate", "name_a": "C14H21NO14S"} -{"id": 34739, "instruction": "8-Methylmenaquinoneをを化学式で記述すると?", "response": "8-Methylmenaquinoneをを化学式で記述するとC17H18O2(C5H8)nです。", "task": "formula", "name_q": "8-Methylmenaquinone", "name_a": "C17H18O2(C5H8)n"} -{"id": 28938, "instruction": "dTDP-D-olivoseをを分子式で表すと?", "response": "dTDP-D-olivoseをを分子式で表すとC16H26N2O14P2です。", "task": "formula", "name_q": "dTDP-D-olivose", "name_a": "C16H26N2O14P2"} -{"id": 8933, "instruction": "Palatinoseの別呼称は?", "response": "Palatinoseの別呼称はパラチノースです。", "task": "replace", "name_q": "Palatinose", "name_a": "パラチノース"} -{"id": 26985, "instruction": "Peginterferon alfa-2a (USAN/INN)を使用した薬品は?", "response": "Peginterferon alfa-2a (USAN/INN)を使用した薬品はPEGASYS(pharmaandGmbH)です。", "task": "product", "name_q": "Peginterferon alfa-2a (USAN/INN)", "name_a": "PEGASYS(pharmaandGmbH)"} -{"id": 34619, "instruction": "Loiasis SUPERGRP Filariasis を日本語に訳すと?", "response": "Loiasis SUPERGRP Filariasis を日本語に訳すとロア糸状虫症 上位グループ フィラリア症 です。", "task": "replace en to ja", "name_q": "Loiasis SUPERGRP Filariasis ", "name_a": "ロア糸状虫症 上位グループ フィラリア症 "} -{"id": 33014, "instruction": "Gisadenafil besylate (USAN)をを分子式で表すと?", "response": "Gisadenafil besylate (USAN)をを分子式で表すとC23H33N7O5S. C6H6O3Sです。", "task": "formula", "name_q": "Gisadenafil besylate (USAN)", "name_a": "C23H33N7O5S. C6H6O3S"} -{"id": 5646, "instruction": "Rhizomelic chondrodysplasia punctata SUBGROUP Peroxisomal fatty acyl-CoA reductase 1 disorder SUPERGRP Peroxisome biogenesis disorder の日本語訳は?", "response": "Rhizomelic chondrodysplasia punctata SUBGROUP Peroxisomal fatty acyl-CoA reductase 1 disorder SUPERGRP Peroxisome biogenesis disorder の日本語訳は肢根型点状軟骨異形成症 下位グループ ペルオキシソーム脂肪酸アシルCoAレダクターゼ 1 欠損症 上位グループ ペルオキシソーム形成異常症 です。", "task": "replace en to ja", "name_q": "Rhizomelic chondrodysplasia punctata SUBGROUP Peroxisomal fatty acyl-CoA reductase 1 disorder SUPERGRP Peroxisome biogenesis disorder ", "name_a": "肢根型点状軟骨異形成症 下位グループ ペルオキシソーム脂肪酸アシルCoAレダクターゼ 1 欠損症 上位グループ ペルオキシソーム形成異常症 "} -{"id": 20126, "instruction": "組換え沈降4価ヒトパピローマウイルス様粒子ワクチン (酵母由来)を使用した製品は?", "response": "組換え沈降4価ヒトパピローマウイルス様粒子ワクチン (酵母由来)を使用した製品はGARDASIL(MerckSharp&DohmeLLC)です。", "task": "product", "name_q": "組換え沈降4価ヒトパピローマウイルス様粒子ワクチン (酵母由来)", "name_a": "GARDASIL(MerckSharp&DohmeLLC)"} -{"id": 7619, "instruction": "Bethanecholをを組成式で書くと?", "response": "Bethanecholをを組成式で書くとC7H17N2O2です。", "task": "formula", "name_q": "Bethanechol", "name_a": "C7H17N2O2"} -{"id": 19016, "instruction": "DHKredをを組成式で表すと?", "response": "DHKredをを組成式で表すとC16H16O6です。", "task": "formula", "name_q": "DHKred", "name_a": "C16H16O6"} -{"id": 22805, "instruction": "Gemcitabine hydrochloride (JAN/USP)を使用した医薬品は?", "response": "Gemcitabine hydrochloride (JAN/USP)を使用した医薬品はGEMCITABINE(Dr.Reddy'sLaboratoriesLimited)です。", "task": "product", "name_q": "Gemcitabine hydrochloride (JAN/USP)", "name_a": "GEMCITABINE(Dr.Reddy'sLaboratoriesLimited)"} -{"id": 19546, "instruction": "ロイコマイシンVは別の呼び方では?", "response": "ロイコマイシンVは別の呼び方ではLeucomycin Vです。", "task": "replace", "name_q": "ロイコマイシンV", "name_a": "Leucomycin V"} -{"id": 4279, "instruction": "タイシャセキを英語に訳すと?", "response": "タイシャセキを英語に訳すとHematiteです。", "task": "replace ja to en", "name_q": "タイシャセキ", "name_a": "Hematite"} -{"id": 23896, "instruction": "Simkania negevensis 感染の英語表記は?", "response": "Simkania negevensis 感染の英語表記はSimkania negevensis infectionです。", "task": "replace ja to en", "name_q": "Simkania negevensis 感染", "name_a": "Simkania negevensis infection"} -{"id": 23234, "instruction": "Thymoglobuline (TN)の日本語表記は?", "response": "Thymoglobuline (TN)の日本語表記はAnti-human thymocyte immunoglobulin, rabbit (JAN)です。", "task": "replace en to ja", "name_q": "Thymoglobuline (TN)", "name_a": "Anti-human thymocyte immunoglobulin, rabbit (JAN)"} -{"id": 28680, "instruction": "Acetylsulfaphenazole (JAN)の日本語表記は?", "response": "Acetylsulfaphenazole (JAN)の日本語表記はアセチルスルファフェナゾール (JAN)です。", "task": "replace en to ja", "name_q": "Acetylsulfaphenazole (JAN)", "name_a": "アセチルスルファフェナゾール (JAN)"} -{"id": 30684, "instruction": "Precorrin 6Yは別の呼び方では?", "response": "Precorrin 6Yは別の呼び方ではPrecorrin 6Bです。", "task": "replace", "name_q": "Precorrin 6Y", "name_a": "Precorrin 6B"} -{"id": 18303, "instruction": "リン酸エトポシドの英語表記は?", "response": "リン酸エトポシドの英語表記はEtopophos (TN)です。", "task": "replace ja to en", "name_q": "リン酸エトポシド", "name_a": "Etopophos (TN)"} -{"id": 15034, "instruction": "Ascorbic acid, thiamine chloride hydrochloride, pyridoxine hydrochloride, riboflavin sodium phosphate, nicotinamide and panthenolの別の呼び方は?", "response": "Ascorbic acid, thiamine chloride hydrochloride, pyridoxine hydrochloride, riboflavin sodium phosphate, nicotinamide and panthenolの別の呼び方はC para (TN)です。", "task": "replace", "name_q": "Ascorbic acid, thiamine chloride hydrochloride, pyridoxine hydrochloride, riboflavin sodium phosphate, nicotinamide and panthenol", "name_a": "C para (TN)"} -{"id": 27490, "instruction": "4-Fluorocyclohexadiene-cis,cis-1,2-diolをを化学構造で記述すると?", "response": "4-Fluorocyclohexadiene-cis,cis-1,2-diolをを化学構造で記述するとC6H7FO2です。", "task": "formula", "name_q": "4-Fluorocyclohexadiene-cis,cis-1,2-diol", "name_a": "C6H7FO2"} -{"id": 29771, "instruction": "3-[(2-Chlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-oneをの化学構造は?", "response": "3-[(2-Chlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-oneをの化学構造はC20H12ClNO2です。", "task": "formula", "name_q": "3-[(2-Chlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one", "name_a": "C20H12ClNO2"} -{"id": 29717, "instruction": "5-Hydroxy-N-formylkynurenineをの分子式は?", "response": "5-Hydroxy-N-formylkynurenineをの分子式はC11H12N2O5です。", "task": "formula", "name_q": "5-Hydroxy-N-formylkynurenine", "name_a": "C11H12N2O5"} -{"id": 17711, "instruction": "カルバゼランを英語で記述すると?", "response": "カルバゼランを英語で記述するとCarbazeran (USAN/INN)です。", "task": "replace ja to en", "name_q": "カルバゼラン", "name_a": "Carbazeran (USAN/INN)"} -{"id": 32190, "instruction": "(2R,4S)-2,4-Diaminopentanoateは別の呼び方では?", "response": "(2R,4S)-2,4-Diaminopentanoateは別の呼び方ではD-threo-2,4-Diaminopentanoateです。", "task": "replace", "name_q": "(2R,4S)-2,4-Diaminopentanoate", "name_a": "D-threo-2,4-Diaminopentanoate"} -{"id": 7049, "instruction": "alpha-D-Glucosamine 1-phosphateをを組成式で記述すると?", "response": "alpha-D-Glucosamine 1-phosphateをを組成式で記述するとC6H14NO8Pです。", "task": "formula", "name_q": "alpha-D-Glucosamine 1-phosphate", "name_a": "C6H14NO8P"} -{"id": 13239, "instruction": "Nitrateをを化学構造で表すと?", "response": "Nitrateをを化学構造で表すとHNO3です。", "task": "formula", "name_q": "Nitrate", "name_a": "HNO3"} -{"id": 23259, "instruction": "Quillaic acid 3-O-alpha-L-Rha-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Fucをを化学式で記述すると?", "response": "Quillaic acid 3-O-alpha-L-Rha-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Fucをを化学式で記述するとC54H84O24です。", "task": "formula", "name_q": "Quillaic acid 3-O-alpha-L-Rha-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Fuc", "name_a": "C54H84O24"} -{"id": 33701, "instruction": "Pterosteroneの別呼称は?", "response": "Pterosteroneの別呼称はプテロステロンです。", "task": "replace", "name_q": "Pterosterone", "name_a": "プテロステロン"} -{"id": 25900, "instruction": "Norpethidineの別呼称は?", "response": "Norpethidineの別呼称は4-Phenylpiperidine-4-carboxylic acid ethyl esterです。", "task": "replace", "name_q": "Norpethidine", "name_a": "4-Phenylpiperidine-4-carboxylic acid ethyl ester"} -{"id": 9128, "instruction": "セチエジルクエン酸塩を英語で書くと?", "response": "セチエジルクエン酸塩を英語で書くとCelsis (TN)です。", "task": "replace ja to en", "name_q": "セチエジルクエン酸塩", "name_a": "Celsis (TN)"} -{"id": 19078, "instruction": "Endokinin Cの異なる表記は?", "response": "Endokinin Cの異なる表記はエンドキニン Cです。", "task": "replace", "name_q": "Endokinin C", "name_a": "エンドキニン C"} -{"id": 33450, "instruction": "Galgenprostucel-L (USAN)の日本語訳は?", "response": "Galgenprostucel-L (USAN)の日本語訳はガルジェンプロスツセル-Lです。", "task": "replace en to ja", "name_q": "Galgenprostucel-L (USAN)", "name_a": "ガルジェンプロスツセル-L"} -{"id": 15151, "instruction": "カイロミクロン停滞病を英語で記述すると?", "response": "カイロミクロン停滞病を英語で記述するとChylomicron retention diseaseです。", "task": "replace ja to en", "name_q": "カイロミクロン停滞病", "name_a": "Chylomicron retention disease"} -{"id": 25670, "instruction": "PHENDIMETRAZINETARTRATE(PreferredPharmaceuticals)を使用した医薬品名は?", "response": "PHENDIMETRAZINETARTRATE(PreferredPharmaceuticals)を使用した医薬品名はPHENDIMETRAZINETARTRATE(A-SMedicationSolutions)です。", "task": "product", "name_q": "PHENDIMETRAZINETARTRATE(PreferredPharmaceuticals)", "name_a": "PHENDIMETRAZINETARTRATE(A-SMedicationSolutions)"} -{"id": 17823, "instruction": "ジベレリン A12の別の言い方は?", "response": "ジベレリン A12の別の言い方はGibberellin A12です。", "task": "replace", "name_q": "ジベレリン A12", "name_a": "Gibberellin A12"} -{"id": 33935, "instruction": "カンスイニンBの異なる表現は?", "response": "カンスイニンBの異なる表現はKansuinine Bです。", "task": "replace", "name_q": "カンスイニンB", "name_a": "Kansuinine B"} -{"id": 26875, "instruction": "Succinylsulfathiazole (INN)をを化学構造で記述すると?", "response": "Succinylsulfathiazole (INN)をを化学構造で記述するとC13H13N3O5S2です。", "task": "formula", "name_q": "Succinylsulfathiazole (INN)", "name_a": "C13H13N3O5S2"} -{"id": 10054, "instruction": "Hydroxamic acidをを組成式で書くと?", "response": "Hydroxamic acidをを組成式で書くとCH2NO2Rです。", "task": "formula", "name_q": "Hydroxamic acid", "name_a": "CH2NO2R"} -{"id": 7712, "instruction": "Cimduo (TN)は別の呼び方では?", "response": "Cimduo (TN)は別の呼び方ではTemixys (TN)です。", "task": "replace", "name_q": "Cimduo (TN)", "name_a": "Temixys (TN)"} -{"id": 17004, "instruction": "Alcoholをを化学式で記述すると?", "response": "Alcoholをを化学式で記述するとHORです。", "task": "formula", "name_q": "Alcohol", "name_a": "HOR"} -{"id": 8317, "instruction": "Unfungicid (TN)をを組成式で書くと?", "response": "Unfungicid (TN)をを組成式で書くとC15H13ClN2. HClです。", "task": "formula", "name_q": "Unfungicid (TN)", "name_a": "C15H13ClN2. HCl"} -{"id": 3145, "instruction": "Benzoyl peroxide (JAN/USP)の日本語表記は?", "response": "Benzoyl peroxide (JAN/USP)の日本語表記はBenzoyl peroxide (JAN/USP)です。", "task": "replace en to ja", "name_q": "Benzoyl peroxide (JAN/USP)", "name_a": "Benzoyl peroxide (JAN/USP)"} -{"id": 15386, "instruction": "3-Benzylmalic acidをの化学構造は?", "response": "3-Benzylmalic acidをの化学構造はC11H12O5です。", "task": "formula", "name_q": "3-Benzylmalic acid", "name_a": "C11H12O5"} -{"id": 19979, "instruction": "Phenanthrene-4,5-dicarboxylateをの化学式は?", "response": "Phenanthrene-4,5-dicarboxylateをの化学式はC16H10O4です。", "task": "formula", "name_q": "Phenanthrene-4,5-dicarboxylate", "name_a": "C16H10O4"} -{"id": 33278, "instruction": "Dibenzoyl thiamineをを化学構造で書くと?", "response": "Dibenzoyl thiamineをを化学構造で書くとC26H26N4O4Sです。", "task": "formula", "name_q": "Dibenzoyl thiamine", "name_a": "C26H26N4O4S"} -{"id": 31649, "instruction": "O-D-Mannosylproteinの別記述は?", "response": "O-D-Mannosylproteinの別記述は[Protein]-3-O-(alpha-D-mannosyl)-L-threonineです。", "task": "replace", "name_q": "O-D-Mannosylprotein", "name_a": "[Protein]-3-O-(alpha-D-mannosyl)-L-threonine"} -{"id": 26067, "instruction": "Cetyl esters wax (NF)の異なる表現は?", "response": "Cetyl esters wax (NF)の異なる表現はセチルエステルワックスです。", "task": "replace", "name_q": "Cetyl esters wax (NF)", "name_a": "セチルエステルワックス"} -{"id": 13682, "instruction": "Aflatoxin Q1をを組成式で表すと?", "response": "Aflatoxin Q1をを組成式で表すとC17H12O7です。", "task": "formula", "name_q": "Aflatoxin Q1", "name_a": "C17H12O7"} -{"id": 17960, "instruction": "ペンテトラゾールの別名は?", "response": "ペンテトラゾールの別名はペンチレンテトラゾールです。", "task": "replace", "name_q": "ペンテトラゾール", "name_a": "ペンチレンテトラゾール"} -{"id": 13055, "instruction": "3,4-Methylenedioxymethamphetamineをは化学式で表すと?", "response": "3,4-Methylenedioxymethamphetamineをは化学式で表すとC11H15NO2です。", "task": "formula", "name_q": "3,4-Methylenedioxymethamphetamine", "name_a": "C11H15NO2"} -{"id": 6680, "instruction": "Cryptophorineの別記述は?", "response": "Cryptophorineの別記述はクリプトホリンです。", "task": "replace", "name_q": "Cryptophorine", "name_a": "クリプトホリン"} -{"id": 25197, "instruction": "リコファウシンの異なる名称は?", "response": "リコファウシンの異なる名称はLycofawcineです。", "task": "replace", "name_q": "リコファウシン", "name_a": "Lycofawcine"} -{"id": 14792, "instruction": "9,9'-Di-cis-zeta-caroteneは別の呼び方では?", "response": "9,9'-Di-cis-zeta-caroteneは別の呼び方では9,9'-dicis-zeta-Caroteneです。", "task": "replace", "name_q": "9,9'-Di-cis-zeta-carotene", "name_a": "9,9'-dicis-zeta-Carotene"} -{"id": 26834, "instruction": "t-Anetholeの別記述は?", "response": "t-Anetholeの別記述はAnetholeです。", "task": "replace", "name_q": "t-Anethole", "name_a": "Anethole"} -{"id": 5196, "instruction": "C5H4Cl6O3をを化学式で表すと?", "response": "C5H4Cl6O3をを化学式で表すとC5H4Cl6O3です。", "task": "formula", "name_q": "C5H4Cl6O3", "name_a": "C5H4Cl6O3"} -{"id": 9376, "instruction": "Paramyotonia congenita SUPERGRP Non-dystrophic myotonia を日本語で書くと?", "response": "Paramyotonia congenita SUPERGRP Non-dystrophic myotonia を日本語で書くと先天性パラミオトニー 上位グループ 非ジストロフィー性ミオトニー症候群 です。", "task": "replace en to ja", "name_q": "Paramyotonia congenita SUPERGRP Non-dystrophic myotonia ", "name_a": "先天性パラミオトニー 上位グループ 非ジストロフィー性ミオトニー症候群 "} -{"id": 25039, "instruction": "Acotiamideを言い換えると?", "response": "Acotiamideを言い換えるとMZ-338です。", "task": "replace", "name_q": "Acotiamide", "name_a": "MZ-338"} -{"id": 28148, "instruction": "2-(2-Hydroxyacyl)sphingosineをは化学式で表すと?", "response": "2-(2-Hydroxyacyl)sphingosineをは化学式で表すとC20H38NO4Rです。", "task": "formula", "name_q": "2-(2-Hydroxyacyl)sphingosine", "name_a": "C20H38NO4R"} -{"id": 4258, "instruction": "顆粒状角膜ジストロフィーを英��で書くと?", "response": "顆粒状角膜ジストロフィーを英語で書くとGranular corneal dystrophiesです。", "task": "replace ja to en", "name_q": "顆粒状角膜ジストロフィー", "name_a": "Granular corneal dystrophies"} -{"id": 30709, "instruction": "ナキトリオールをは化学式で表すと?", "response": "ナキトリオールをは化学式で表すとC11H12O3です。", "task": "formula", "name_q": "ナキトリオール", "name_a": "C11H12O3"} -{"id": 705, "instruction": "SOLOSEC(LupinPharmaceuticals)をの組成式は?", "response": "SOLOSEC(LupinPharmaceuticals)をの組成式はC7H11N3O3です。", "task": "formula", "name_q": "SOLOSEC(LupinPharmaceuticals)", "name_a": "C7H11N3O3"} -{"id": 11834, "instruction": "3-(1H-Indol-3-yl)propanoateをは分子式で表すと?", "response": "3-(1H-Indol-3-yl)propanoateをは分子式で表すとC11H11NO2です。", "task": "formula", "name_q": "3-(1H-Indol-3-yl)propanoate", "name_a": "C11H11NO2"} -{"id": 23236, "instruction": "D-2,3-Diketo-4-deoxy-epi-inositolを言い換えると?", "response": "D-2,3-Diketo-4-deoxy-epi-inositolを言い換えると3D-3,5/4-Trihydroxycyclohexane-1,2-dioneです。", "task": "replace", "name_q": "D-2,3-Diketo-4-deoxy-epi-inositol", "name_a": "3D-3,5/4-Trihydroxycyclohexane-1,2-dione"} -{"id": 26295, "instruction": "gamma-Pentachlorocyclohexeneの別名称は?", "response": "gamma-Pentachlorocyclohexeneの別名称はγ-ペンタクロロシクロヘキセンです。", "task": "replace", "name_q": "gamma-Pentachlorocyclohexene", "name_a": "γ-ペンタクロロシクロヘキセン"} -{"id": 20610, "instruction": "5-バレロラクトンをを組成式で表すと?", "response": "5-バレロラクトンをを組成式で表すとC5H8O2です。", "task": "formula", "name_q": "5-バレロラクトン", "name_a": "C5H8O2"} -{"id": 25274, "instruction": "ポデクジソンBをを分子式で書くと?", "response": "ポデクジソンBをを分子式で書くとC27H42O6です。", "task": "formula", "name_q": "ポデクジソンB", "name_a": "C27H42O6"} -{"id": 28213, "instruction": "テカルセト塩酸塩の異なる名称は?", "response": "テカルセト塩酸塩の異なる名称はTecalcet hydrochloride (USAN)です。", "task": "replace", "name_q": "テカルセト塩酸塩", "name_a": "Tecalcet hydrochloride (USAN)"} -{"id": 13496, "instruction": "ジフェノキシン塩酸塩・アトロピン硫酸塩水和物の英訳は?", "response": "ジフェノキシン塩酸塩・アトロピン硫酸塩水和物の英訳はDifenoxin hydrochloride and atropine sulfateです。", "task": "replace ja to en", "name_q": "ジフェノキシン塩酸塩・アトロピン硫酸塩水和物", "name_a": "Difenoxin hydrochloride and atropine sulfate"} -{"id": 30261, "instruction": "1,2-ジブロモ-3-クロロプロパンの別の呼び方は?", "response": "1,2-ジブロモ-3-クロロプロパンの別の呼び方は1,2-Dibromo-3-chloropropaneです。", "task": "replace", "name_q": "1,2-ジブロモ-3-クロロプロパン", "name_a": "1,2-Dibromo-3-chloropropane"} -{"id": 281, "instruction": "グルクロノラクトン (JAN)の別名は?", "response": "グルクロノラクトン (JAN)の別名はGlucurolactone (INN)です。", "task": "replace", "name_q": "グルクロノラクトン (JAN)", "name_a": "Glucurolactone (INN)"} -{"id": 27963, "instruction": "Testololactoneをを組成式で表すと?", "response": "Testololactoneをを組成式で表すとC19H26O3です。", "task": "formula", "name_q": "Testololactone", "name_a": "C19H26O3"} -{"id": 6542, "instruction": "アリピプラゾール(共和薬品工業)を主とした製品は?", "response": "アリピプラゾール(共和薬品工業)を主とした製品はARIPIPRAZOLE(ApotexCorp.)です。", "task": "product", "name_q": "アリピプラゾール(共和薬品工業)", "name_a": "ARIPIPRAZOLE(ApotexCorp.)"} -{"id": 18705, "instruction": "ジュリプロソピンの異なる名称は?", "response": "ジュリプロソピンの異なる名称はJuliflorineです。", "task": "replace", "name_q": "ジュリプロソピン", "name_a": "Juliflorine"} -{"id": 24717, "instruction": "硫酸アルミニウムを英語表記で表すと?", "response": "硫酸アルミニウムを英語表記で表すとAluminium sulfateです。", "task": "replace ja to en", "name_q": "硫酸アルミニウム", "name_a": "Aluminium sulfate"} -{"id": 7979, "instruction": "Lithospermum root extract, ethyl aminobenzoate, dibucaine hydrochloride, diphenhydramine hydrochloride and cetrimideの別表現は?", "response": "Lithospermum root extract, ethyl aminobenzoate, dibucaine hydrochloride, diphenhydramine hydrochloride and cetrimideの別表現はシコンエキス・アミノ安息香酸エチル・ジブカイン塩酸塩・ジフェンヒドラミン塩酸塩・セトリミドです。", "task": "replace", "name_q": "Lithospermum root extract, ethyl aminobenzoate, dibucaine hydrochloride, diphenhydramine hydrochloride and cetrimide", "name_a": "シコンエキス・アミノ��息香酸エチル・ジブカイン塩酸塩・ジフェンヒドラミン塩酸塩・セトリミド"} -{"id": 11669, "instruction": "Pamatolol sulfate (USAN)の日本語訳は?", "response": "Pamatolol sulfate (USAN)の日本語訳はPamatolol sulfate (USAN)です。", "task": "replace en to ja", "name_q": "Pamatolol sulfate (USAN)", "name_a": "Pamatolol sulfate (USAN)"} -{"id": 23217, "instruction": "C32H39NO2を主材料とする薬品は?", "response": "C32H39NO2を主材料とする薬品はエバスチン(日本ケミファ)です。", "task": "product", "name_q": "C32H39NO2", "name_a": "エバスチン(日本ケミファ)"} -{"id": 22117, "instruction": "N5-Ethyl-L-glutamineをを化学構造で表すと?", "response": "N5-Ethyl-L-glutamineをを化学構造で表すとC7H14N2O3です。", "task": "formula", "name_q": "N5-Ethyl-L-glutamine", "name_a": "C7H14N2O3"} -{"id": 24970, "instruction": "Pseudoachondroplasia SUPERGRP Spondyloepiphyseal dysplasia の日本語訳は?", "response": "Pseudoachondroplasia SUPERGRP Spondyloepiphyseal dysplasia の日本語訳は偽軟骨異形成症 上位グループ 脊椎骨端異形成 です。", "task": "replace en to ja", "name_q": "Pseudoachondroplasia SUPERGRP Spondyloepiphyseal dysplasia ", "name_a": "偽軟骨異形成症 上位グループ 脊椎骨端異形成 "} -{"id": 33154, "instruction": "5-Hydroxy-2-polyprenylphenolをは分子式で表すと?", "response": "5-Hydroxy-2-polyprenylphenolをは分子式で表すとC11H14O2(C5H8)nです。", "task": "formula", "name_q": "5-Hydroxy-2-polyprenylphenol", "name_a": "C11H14O2(C5H8)n"} -{"id": 16994, "instruction": "2-(Glutathion-S-yl)-2-methylbut-3-en-1-olをを組成式で表すと?", "response": "2-(Glutathion-S-yl)-2-methylbut-3-en-1-olをを組成式で表すとC15H25N3O7Sです。", "task": "formula", "name_q": "2-(Glutathion-S-yl)-2-methylbut-3-en-1-ol", "name_a": "C15H25N3O7S"} -{"id": 17261, "instruction": "Xenysalate hydrochlorideをを組成式で記述すると?", "response": "Xenysalate hydrochlorideをを組成式で記述するとC19H23NO3. HClです。", "task": "formula", "name_q": "Xenysalate hydrochloride", "name_a": "C19H23NO3. HCl"} -{"id": 32651, "instruction": "C16H26N5O8. Gd. xH2Oを用いた製品は?", "response": "C16H26N5O8. Gd. xH2Oを用いた製品はOMNISCAN(GEHealthcare)です。", "task": "product", "name_q": "C16H26N5O8. Gd. xH2O", "name_a": "OMNISCAN(GEHealthcare)"} -{"id": 32770, "instruction": "Soticlestat (JAN/USAN/INN)の別の言い方は?", "response": "Soticlestat (JAN/USAN/INN)の別の言い方はソチクレスタット (JAN)です。", "task": "replace", "name_q": "Soticlestat (JAN/USAN/INN)", "name_a": "ソチクレスタット (JAN)"} -{"id": 1569, "instruction": "Angiotensin II (human type) (JAN)をの分子式は?", "response": "Angiotensin II (human type) (JAN)をの分子式はC50H71N13O12です。", "task": "formula", "name_q": "Angiotensin II (human type) (JAN)", "name_a": "C50H71N13O12"} -{"id": 20069, "instruction": "Superpyrin (TN)を日本語で書くと?", "response": "Superpyrin (TN)を日本語で書くとAloxiprin (INN)です。", "task": "replace en to ja", "name_q": "Superpyrin (TN)", "name_a": "Aloxiprin (INN)"} -{"id": 26597, "instruction": "Mapracorat (USAN)をを分子式で表すと?", "response": "Mapracorat (USAN)をを分子式で表すとC25H26F4N2O2です。", "task": "formula", "name_q": "Mapracorat (USAN)", "name_a": "C25H26F4N2O2"} -{"id": 11767, "instruction": "スクシンイミドの別呼称は?", "response": "スクシンイミドの別呼称はサクシニミドです。", "task": "replace", "name_q": "スクシンイミド", "name_a": "サクシニミド"} -{"id": 7395, "instruction": "GENERICOXACILLIN(ArmasPharmaceuticals)を主とした商品は?", "response": "GENERICOXACILLIN(ArmasPharmaceuticals)を主とした商品はOXACILLIN(WockhardtUSALLC.)です。", "task": "product", "name_q": "GENERICOXACILLIN(ArmasPharmaceuticals)", "name_a": "OXACILLIN(WockhardtUSALLC.)"} -{"id": 9310, "instruction": "C15H15ClN4OSをを分子式で書くと?", "response": "C15H15ClN4OSをを分子式で書くとC15H15ClN4OSです。", "task": "formula", "name_q": "C15H15ClN4OS", "name_a": "C15H15ClN4OS"} -{"id": 11503, "instruction": "ビパラネバルトをは組成式で表すと?", "response": "ビパラネバルトをは組成式で表すとC6430H9912N1712O2018S48です。", "task": "formula", "name_q": "ビパラネバルト", "name_a": "C6430H9912N1712O2018S48"} -{"id": 3854, "instruction": "Parmodia (TN)を日本語に訳すと?", "response": "Parmodia (TN)を日本語に訳すとPemafibrate (JAN)です。", "task": "replace en to ja", "name_q": "Parmodia (TN)", "name_a": "Pemafibrate (JAN)"} -{"id": 1740, "instruction": "(-)-Menthyl O-beta-D-glucosideをを化学式で表すと?", "response": "(-)-Menthyl O-beta-D-glucosideをを化学式で表すとC16H30O6です。", "task": "formula", "name_q": "(-)-Menthyl O-beta-D-glucoside", "name_a": "C16H30O6"} -{"id": 8259, "instruction": "Parathyroid hormone-related peptide (1-36)の異なる���現は?", "response": "Parathyroid hormone-related peptide (1-36)の異なる表現はPTHrP (1-36)です。", "task": "replace", "name_q": "Parathyroid hormone-related peptide (1-36)", "name_a": "PTHrP (1-36)"} -{"id": 13857, "instruction": "Taenia saginata infectionを日本語に訳すと?", "response": "Taenia saginata infectionを日本語に訳すと無鉤条虫症です。", "task": "replace en to ja", "name_q": "Taenia saginata infection", "name_a": "無鉤条虫症"} -{"id": 8814, "instruction": "イソオイゲノールをを化学式で記述すると?", "response": "イソオイゲノールをを化学式で記述するとC10H12O2です。", "task": "formula", "name_q": "イソオイゲノール", "name_a": "C10H12O2"} -{"id": 32551, "instruction": "メプタジノールは別の呼び方では?", "response": "メプタジノールは別の呼び方ではMeptazinol (INN)です。", "task": "replace", "name_q": "メプタジノール", "name_a": "Meptazinol (INN)"} -{"id": 22671, "instruction": "Kinopreneをは組成式で表すと?", "response": "Kinopreneをは組成式で表すとC18H28O2です。", "task": "formula", "name_q": "Kinoprene", "name_a": "C18H28O2"} -{"id": 944, "instruction": "3-Acylpyruvateをを化学式で表すと?", "response": "3-Acylpyruvateをを化学式で表すとC4H3O4Rです。", "task": "formula", "name_q": "3-Acylpyruvate", "name_a": "C4H3O4R"} -{"id": 19862, "instruction": "バルクラバムをを化学式で書くと?", "response": "バルクラバムをを化学式で書くとC14H23N3O6です。", "task": "formula", "name_q": "バルクラバム", "name_a": "C14H23N3O6"} -{"id": 32537, "instruction": "スルフィンピラゾン (JAN)を言い換えると?", "response": "スルフィンピラゾン (JAN)を言い換えるとSulfinpyrazone (JAN/USP/INN)です。", "task": "replace", "name_q": "スルフィンピラゾン (JAN)", "name_a": "Sulfinpyrazone (JAN/USP/INN)"} -{"id": 17862, "instruction": "Multiple sulfatase deficiency SUPERGRP Sphingolipidosis Lysosomal storage disease を日本語で書くと?", "response": "Multiple sulfatase deficiency SUPERGRP Sphingolipidosis Lysosomal storage disease を日本語で書くとマルチプルスルファターゼ欠損症です。", "task": "replace en to ja", "name_q": "Multiple sulfatase deficiency SUPERGRP Sphingolipidosis Lysosomal storage disease ", "name_a": "マルチプルスルファターゼ欠損症"} -{"id": 24308, "instruction": "Interferon alfa-n1 (USAN)の別記述は?", "response": "Interferon alfa-n1 (USAN)の別記述はインターフェロンアルファ-n1です。", "task": "replace", "name_q": "Interferon alfa-n1 (USAN)", "name_a": "インターフェロンアルファ-n1"} -{"id": 10995, "instruction": "(Z)-Phenylacetaldehyde oximeの別呼称は?", "response": "(Z)-Phenylacetaldehyde oximeの別呼称はZ-Phenylacetaldoximeです。", "task": "replace", "name_q": "(Z)-Phenylacetaldehyde oxime", "name_a": "Z-Phenylacetaldoxime"} -{"id": 9443, "instruction": "Halistanol sulfateをを組成式で記述すると?", "response": "Halistanol sulfateをを組成式で記述するとC29H52O12S3です。", "task": "formula", "name_q": "Halistanol sulfate", "name_a": "C29H52O12S3"} -{"id": 20458, "instruction": "ラタルシン3aの別表現は?", "response": "ラタルシン3aの別表現はLatarcin 3aです。", "task": "replace", "name_q": "ラタルシン3a", "name_a": "Latarcin 3a"} -{"id": 23245, "instruction": "ESTRADIOLVALERATE(HikmaPharmaceuticalsUSA)を主材料とする商品名は?", "response": "ESTRADIOLVALERATE(HikmaPharmaceuticalsUSA)を主材料とする商品名はGENERICESTRADIOLVALERATE(AmericanRegent)です。", "task": "product", "name_q": "ESTRADIOLVALERATE(HikmaPharmaceuticalsUSA)", "name_a": "GENERICESTRADIOLVALERATE(AmericanRegent)"} -{"id": 4230, "instruction": "Ferrous citrate, Fe-59 (TN)の別呼称は?", "response": "Ferrous citrate, Fe-59 (TN)の別呼称はFerrous citrate Fe 59 (USAN)です。", "task": "replace", "name_q": "Ferrous citrate, Fe-59 (TN)", "name_a": "Ferrous citrate Fe 59 (USAN)"} -{"id": 723, "instruction": "歯爪症候群 上位グループ 外胚葉形成異常 を英語に訳すと?", "response": "歯爪症候群 上位グループ 外胚葉形成異常 を英語に訳すとTooth and nail syndromeです。", "task": "replace ja to en", "name_q": "歯爪症候群 上位グループ 外胚葉形成異常 ", "name_a": "Tooth and nail syndrome"} -{"id": 13560, "instruction": "エスケタミンの別呼称は?", "response": "エスケタミンの別呼称はEsketamine (USAN/INN)です。", "task": "replace", "name_q": "エスケタミン", "name_a": "Esketamine (USAN/INN)"} -{"id": 19658, "instruction": "4-Sulfobenzaldehydeの異なる表現は?", "response": "4-Sulfobenzaldehydeの異なる表現は4-Formylbenzenesulfonateです。", "task": "replace", "name_q": "4-Sulfobenzaldehyde", "name_a": "4-Formylbenzenesulfonate"} -{"id": 5237, "instruction": "9,10-DHOMEの別の言い方は?", "response": "9,10-DHOMEの別の言い方は9,10-DHOAです。", "task": "replace", "name_q": "9,10-DHOME", "name_a": "9,10-DHOA"} -{"id": 14374, "instruction": "SILODOSIN(CamberPharmaceuticals)を利用した医薬品は?", "response": "SILODOSIN(CamberPharmaceuticals)を利用した医薬品はシロドシン(キョーリンリメディオ)です。", "task": "product", "name_q": "SILODOSIN(CamberPharmaceuticals)", "name_a": "シロドシン(キョーリンリメディオ)"} -{"id": 9102, "instruction": "Teslac (TN)の別呼称は?", "response": "Teslac (TN)の別呼称はTestolactone (USP/INN)です。", "task": "replace", "name_q": "Teslac (TN)", "name_a": "Testolactone (USP/INN)"} -{"id": 23992, "instruction": "葛根湯を材料とする商品は?", "response": "葛根湯を材料とする商品は葛根湯(太虎精堂製薬)です。", "task": "product", "name_q": "葛根湯", "name_a": "葛根湯(太虎精堂製薬)"} -{"id": 23924, "instruction": "Clofedanol hydrochloride (JP18)をの分子式は?", "response": "Clofedanol hydrochloride (JP18)をの分子式はC17H20ClNO. HClです。", "task": "formula", "name_q": "Clofedanol hydrochloride (JP18)", "name_a": "C17H20ClNO. HCl"} -{"id": 10021, "instruction": "ビンカミン塩酸塩をの化学構造は?", "response": "ビンカミン塩酸塩をの化学構造はC21H26N2O3. HClです。", "task": "formula", "name_q": "ビンカミン塩酸塩", "name_a": "C21H26N2O3. HCl"} -{"id": 33199, "instruction": "B型肝炎ウイルス不活性化ワクチンの異なる表記は?", "response": "B型肝炎ウイルス不活性化ワクチンの異なる表記はHepatitis B virus vaccine inactivatedです。", "task": "replace", "name_q": "B型肝炎ウイルス不活性化ワクチン", "name_a": "Hepatitis B virus vaccine inactivated"} -{"id": 22127, "instruction": "dTDP-alpha-D-desosamineを言い換えると?", "response": "dTDP-alpha-D-desosamineを言い換えるとdTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucopyranoseです。", "task": "replace", "name_q": "dTDP-alpha-D-desosamine", "name_a": "dTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucopyranose"} -{"id": 26353, "instruction": "C22H42N4O8S2を使用した製品名は?", "response": "C22H42N4O8S2を使用した製品名はパントシン(アルフレッサファーマ)です。", "task": "product", "name_q": "C22H42N4O8S2", "name_a": "パントシン(アルフレッサファーマ)"} -{"id": 18426, "instruction": "Cucurbitacin Aの別呼称は?", "response": "Cucurbitacin Aの別呼称はククルビタシンAです。", "task": "replace", "name_q": "Cucurbitacin A", "name_a": "ククルビタシンA"} -{"id": 6181, "instruction": "フェニルプロパノール (JAN)をを分子式で表すと?", "response": "フェニルプロパノール (JAN)をを分子式で表すとC9H12Oです。", "task": "formula", "name_q": "フェニルプロパノール (JAN)", "name_a": "C9H12O"} -{"id": 10856, "instruction": "アトリドをを分子式で表すと?", "response": "アトリドをを分子式で表すとC18H23N3Oです。", "task": "formula", "name_q": "アトリド", "name_a": "C18H23N3O"} -{"id": 4390, "instruction": "α-シネンサールをの組成式は?", "response": "α-シネンサールをの組成式はC15H22Oです。", "task": "formula", "name_q": "α-シネンサール", "name_a": "C15H22O"} -{"id": 34416, "instruction": "Lactateの異なる表現は?", "response": "Lactateの異なる表現は乳酸です。", "task": "replace", "name_q": "Lactate", "name_a": "乳酸"} -{"id": 30245, "instruction": "塩酸イソプレナリン・プロナーゼの英訳は?", "response": "塩酸イソプレナリン・プロナーゼの英訳はIsopal P (TN)です。", "task": "replace ja to en", "name_q": "塩酸イソプレナリン・プロナーゼ", "name_a": "Isopal P (TN)"} -{"id": 24712, "instruction": "Extrahepatic portal venous obstructionを日本語で記述すると?", "response": "Extrahepatic portal venous obstructionを日本語で記述すると肝外門脈閉塞症です。", "task": "replace en to ja", "name_q": "Extrahepatic portal venous obstruction", "name_a": "肝外門脈閉塞症"} -{"id": 24326, "instruction": "N-Methyl-L-tryptophaneの別の言い方は?", "response": "N-Methyl-L-tryptophaneの別の言い方はAbrineです。", "task": "replace", "name_q": "N-Methyl-L-tryptophane", "name_a": "Abrine"} -{"id": 13172, "instruction": "Epithienamycin Bをは化学構造で表すと?", "response": "Epithienamycin Bをは化学構造で表すとC13H16N2O5Sです。", "task": "formula", "name_q": "Epithienamycin B", "name_a": "C13H16N2O5S"} -{"id": 10006, "instruction": "Hypochondroplasia SUPERGRP FGFR3-related short limb skeletal dysplasia を日本語表記で表すと?", "response": "Hypochondroplasia SUPERGRP FGFR3-related short limb skeletal dysplasia を日本語表記で表すと軟骨低形成症 上位グループ FGFR3関連骨異形成症 です。", "task": "replace en to ja", "name_q": "Hypochondroplasia SUPERGRP FGFR3-related short limb skeletal dysplasia ", "name_a": "軟骨低形成症 上位グループ FGFR3関連骨異形成症 "} -{"id": 27233, "instruction": "Sanilvudine (JAN)を日本語で記述すると?", "response": "Sanilvudine (JAN)を日本語で記述するとStavudine (USAN/INN)です。", "task": "replace en to ja", "name_q": "Sanilvudine (JAN)", "name_a": "Stavudine (USAN/INN)"} -{"id": 15615, "instruction": "Vistatolon (INN)を英語で記述すると?", "response": "Vistatolon (INN)を英語で記述するとVistatolon (INN)です。", "task": "replace ja to en", "name_q": "Vistatolon (INN)", "name_a": "Vistatolon (INN)"} -{"id": 6530, "instruction": "下垂体性ゴナドトロピン分泌異常症 上位グループ 男子性腺機能不全症 を英語で書くと?", "response": "下垂体性ゴナドトロピン分泌異常症 上位グループ 男子性腺機能不全症 を英語で書くとAbnormal pituitary gonadotropin secretion SUPERGRP Male hypogonadism です。", "task": "replace ja to en", "name_q": "下垂体性ゴナドトロピン分泌異常症 上位グループ 男子性腺機能不全症 ", "name_a": "Abnormal pituitary gonadotropin secretion SUPERGRP Male hypogonadism "} -{"id": 14505, "instruction": "C20H36O2をを化学式で表すと?", "response": "C20H36O2をを化学式で表すとC20H36O2です。", "task": "formula", "name_q": "C20H36O2", "name_a": "C20H36O2"} -{"id": 21771, "instruction": "チリソロールをは化学式で表すと?", "response": "チリソロールをは化学式で表すとC17H24N2O3です。", "task": "formula", "name_q": "チリソロール", "name_a": "C17H24N2O3"} -{"id": 24184, "instruction": "エルゴタミン酒石酸塩・無水カフェインを英語に訳すと?", "response": "エルゴタミン酒石酸塩・無水カフェインを英語に訳すとErgotamine tartrate and anhydrous caffeineです。", "task": "replace ja to en", "name_q": "エルゴタミン酒石酸塩・無水カフェイン", "name_a": "Ergotamine tartrate and anhydrous caffeine"} -{"id": 27806, "instruction": "Vitamin B12の異なる名称は?", "response": "Vitamin B12の異なる名称はCob(III)alaminです。", "task": "replace", "name_q": "Vitamin B12", "name_a": "Cob(III)alamin"} -{"id": 79, "instruction": "乏毛症・リンパ浮腫・毛細血管拡張症症候群の英語表記は?", "response": "乏毛症・リンパ浮腫・毛細血管拡張症症候群の英語表記はHypotrichosis-lymphedema-telangiectasia syndromeです。", "task": "replace ja to en", "name_q": "乏毛症・リンパ浮腫・毛細血管拡張症症候群", "name_a": "Hypotrichosis-lymphedema-telangiectasia syndrome"} -{"id": 20549, "instruction": "オリロチモドを英語で書くと?", "response": "オリロチモドを英語で書くとOrilotimod (USAN/INN)です。", "task": "replace ja to en", "name_q": "オリロチモド", "name_a": "Orilotimod (USAN/INN)"} -{"id": 11241, "instruction": "Alpidem (USAN/INN)をを化学式で記述すると?", "response": "Alpidem (USAN/INN)をを化学式で記述するとC21H23Cl2N3Oです。", "task": "formula", "name_q": "Alpidem (USAN/INN)", "name_a": "C21H23Cl2N3O"} -{"id": 28555, "instruction": "Mavacamten (JAN/USAN/INN)を日本語で書くと?", "response": "Mavacamten (JAN/USAN/INN)を日本語で書くとMavacamten (JAN/USAN/INN)です。", "task": "replace en to ja", "name_q": "Mavacamten (JAN/USAN/INN)", "name_a": "Mavacamten (JAN/USAN/INN)"} -{"id": 9003, "instruction": "3beta-Hydroxysteroid-4alpha-carboxylateをの組成式は?", "response": "3beta-Hydroxysteroid-4alpha-carboxylateをの組成式はC20H32O3です。", "task": "formula", "name_q": "3beta-Hydroxysteroid-4alpha-carboxylate", "name_a": "C20H32O3"} -{"id": 7603, "instruction": "1,2,3,4-Tetrachlorobenzeneをの組成式は?", "response": "1,2,3,4-Tetrachlorobenzeneをの組成式はC6H2Cl4です。", "task": "formula", "name_q": "1,2,3,4-Tetrachlorobenzene", "name_a": "C6H2Cl4"} -{"id": 12561, "instruction": "Triamcinolone hexacetonide (USP/INN)を日本語表記で表すと?", "response": "Triamcinolone hexacetonide (USP/INN)を日本語表記で表すとTriamcinolone hexacetonide (USP/INN)です。", "task": "replace en to ja", "name_q": "Triamcinolone hexacetonide (USP/INN)", "name_a": "Triamcinolone hexacetonide (USP/INN)"} -{"id": 19472, "instruction": "Arnottin IIをは化学構造で表すと?", "response": "Arnottin IIをは化学構造で表すとC20H14O7です。", "task": "formula", "name_q": "Arnottin II", "name_a": "C20H14O7"} -{"id": 30678, "instruction": "Polixetonium chloride (USAN/INN)をの分子式は?", "response": "Polixetonium chloride (USAN/INN)をの分子式は(C10H24N2O. 2Cl)nです。", "task": "formula", "name_q": "Polixetonium chloride (USAN/INN)", "name_a": "(C10H24N2O. 2Cl)n"} -{"id": 3348, "instruction": "TATの別名は?", "response": "TATの別名は破傷風抗毒素です。", "task": "replace", "name_q": "TAT", "name_a": "破傷風抗毒素"} -{"id": 12005, "instruction": "Metoprolol fumarate (USP)をの組成式は?", "response": "Metoprolol fumarate (USP)をの組成式は(C15H25NO3)2. C4H4O4です。", "task": "formula", "name_q": "Metoprolol fumarate (USP)", "name_a": "(C15H25NO3)2. C4H4O4"} -{"id": 2199, "instruction": "Sannamycin Bをを化学式で表すと?", "response": "Sannamycin Bをを化学式で表すとC15H32N4O4です。", "task": "formula", "name_q": "Sannamycin B", "name_a": "C15H32N4O4"} -{"id": 17388, "instruction": "Blarcamesine hydrochloride (USAN)を英語で記述すると?", "response": "Blarcamesine hydrochloride (USAN)を英語で記述するとBlarcamesine hydrochloride (USAN)です。", "task": "replace ja to en", "name_q": "Blarcamesine hydrochloride (USAN)", "name_a": "Blarcamesine hydrochloride (USAN)"} -{"id": 1159, "instruction": "ジブナートエチルの別の呼び方は?", "response": "ジブナートエチルの別の呼び方はEthyl dibunate (USAN/INN)です。", "task": "replace", "name_q": "ジブナートエチル", "name_a": "Ethyl dibunate (USAN/INN)"} -{"id": 24911, "instruction": "トコフェロール (JP18)を英語に訳すと?", "response": "トコフェロール (JP18)を英語に訳すとdl-alpha-Tocopherolです。", "task": "replace ja to en", "name_q": "トコフェロール (JP18)", "name_a": "dl-alpha-Tocopherol"} -{"id": 8780, "instruction": "ジクロフェナクエタルヒアルロン酸ナトリウム (JAN)の異なる名称は?", "response": "ジクロフェナクエタルヒアルロン酸ナトリウム (JAN)の異なる名称はDiclofenac etalhyaluronate sodium (JAN)です。", "task": "replace", "name_q": "ジクロフェナクエタルヒアルロン酸ナトリウム (JAN)", "name_a": "Diclofenac etalhyaluronate sodium (JAN)"} -{"id": 30917, "instruction": "5-Hydroxymethyl-2-furoic acidの別表現は?", "response": "5-Hydroxymethyl-2-furoic acidの別表現は5-Hydroxymethyl-2-furoateです。", "task": "replace", "name_q": "5-Hydroxymethyl-2-furoic acid", "name_a": "5-Hydroxymethyl-2-furoate"} -{"id": 7881, "instruction": "Mafenideの別表現は?", "response": "Mafenideの別表現はマフェニドです。", "task": "replace", "name_q": "Mafenide", "name_a": "マフェニド"} -{"id": 13573, "instruction": "4-Hydroxy-3-methoxyphenyl-beta-hydroxypropionyl-CoAの別の言い方は?", "response": "4-Hydroxy-3-methoxyphenyl-beta-hydroxypropionyl-CoAの別の言い方は3-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)propionyl-CoAです。", "task": "replace", "name_q": "4-Hydroxy-3-methoxyphenyl-beta-hydroxypropionyl-CoA", "name_a": "3-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)propionyl-CoA"} -{"id": 16639, "instruction": "ジブロムプロパミジンをを分子式で表すと?", "response": "ジブロムプロパミジンをを分子式で表すとC17H18Br2N4O2です。", "task": "formula", "name_q": "ジブロムプロパミジン", "name_a": "C17H18Br2N4O2"} -{"id": 962, "instruction": "Deferoxamineをの組成式は?", "response": "Deferoxamineをの組成式はC25H48N6O8です。", "task": "formula", "name_q": "Deferoxamine", "name_a": "C25H48N6O8"} -{"id": 22357, "instruction": "D-Urobilinをは化学式で表すと?", "response": "D-Urobilinをは化学式で表すとC33H40N4O6です。", "task": "formula", "name_q": "D-Urobilin", "name_a": "C33H40N4O6"} -{"id": 17077, "instruction": "ジピリチオンの英訳は?", "response": "ジピリチオンの英訳はDipyrithione (USAN/INN)です。", "task": "replace ja to en", "name_q": "ジピリチオン", "name_a": "Dipyrithione (USAN/INN)"} -{"id": 28178, "instruction": "2'-ヒドロキシジヒドロダイゼインをは化学式で表すと?", "response": "2'-ヒドロキシジヒドロダイゼインをは化学式で表すとC15H12O5です。", "task": "formula", "name_q": "2'-ヒドロキシジヒドロダイゼイン", "name_a": "C15H12O5"} -{"id": 13426, "instruction": "4alpha-Kaur-16-en-18-alをの化学式は?", "response": "4alpha-Kaur-16-en-18-alをの化学式はC20H30Oです。", "task": "formula", "name_q": "4alpha-Kaur-16-en-18-al", "name_a": "C20H30O"} -{"id": 5399, "instruction": "Dyskeratosis congenita SUBGROUP X-linked dyskeratosis congenita (DKCX) Autosomal dominant dyskeratosis congenita (DKCA) Autosomal recessive dyskeratosis congenita (DKCB) Digenic dyskeratosis congenita (DKCD) Revesz syndrome の日本語表記は?", "response": "Dyskeratosis congenita SUBGROUP X-linked dyskeratosis congenita (DKCX) Autosomal dominant dyskeratosis congenita (DKCA) Autosomal recessive dyskeratosis congenita (DKCB) Digenic dyskeratosis congenita (DKCD) Revesz syndrome の日本語表記は先天性角化異常症 下位グループ X連鎖先天性角化異常症 (DKCX) 常染色体優性遺伝性先天性角化異常症 (DKCA) 常染色体劣性遺伝性先天性角化異常症 (DKCB) 二遺伝子性遺伝先天性角化異常症 (DKCD) Revesz 症候群 です。", "task": "replace en to ja", "name_q": "Dyskeratosis congenita SUBGROUP X-linked dyskeratosis congenita (DKCX) Autosomal dominant dyskeratosis congenita (DKCA) Autosomal recessive dyskeratosis congenita (DKCB) Digenic dyskeratosis congenita (DKCD) Revesz syndrome ", "name_a": "先天性角化異常症 下位グループ X連鎖先天性角化異常症 (DKCX) 常染色体優性遺伝性先天性角化異常症 (DKCA) 常染色体劣性遺伝性先天性角化異常症 (DKCB) 二遺伝子性遺伝先天性角化異常症 (DKCD) Revesz 症候群 "} -{"id": 33524, "instruction": "Corticorelin ovine triflutate (USAN)を英語に訳すと?", "response": "Corticorelin ovine triflutate (USAN)を英語に訳すとCorticorelin ovine triflutate (USAN)です。", "task": "replace ja to en", "name_q": "Corticorelin ovine triflutate (USAN)", "name_a": "Corticorelin ovine triflutate (USAN)"} -{"id": 27025, "instruction": "ポリオキシル20セトステアリルエーテルの英語表記は?", "response": "ポリオキシル20セトステアリルエーテルの英語表記はPolyoxyl 20 cetostearyl ether (NF)です。", "task": "replace ja to en", "name_q": "ポリオキシル20セトステアリルエーテル", "name_a": "Polyoxyl 20 cetostearyl ether (NF)"} -{"id": 3752, "instruction": "乾燥炭酸ナトリウム (JP18)の異なる表現は?", "response": "乾燥炭酸ナトリウム (JP18)の異なる表現は炭酸ナトリウムです。", "task": "replace", "name_q": "乾燥炭酸ナトリウム (JP18)", "name_a": "炭酸ナトリウム"} -{"id": 23988, "instruction": "エナラプリルをを組成式で書くと?", "response": "エナラプリルをを組成式で書くとC20H28N2O5です。", "task": "formula", "name_q": "エナラプリル", "name_a": "C20H28N2O5"} -{"id": 25273, "instruction": "Serdexmethylphenidate and dexmethylphenidateを英語表記で表すと?", "response": "Serdexmethylphenidate and dexmethylphenidateを英語表記で表すとSerdexmethylphenidate and dexmethylphenidateです。", "task": "replace ja to en", "name_q": "Serdexmethylphenidate and dexmethylphenidate", "name_a": "Serdexmethylphenidate and dexmethylphenidate"} -{"id": 27881, "instruction": "UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimelateをを組成式で記述すると?", "response": "UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimelateをを組成式で記述するとC35H55N7O26P2です。", "task": "formula", "name_q": "UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimelate", "name_a": "C35H55N7O26P2"} -{"id": 375, "instruction": "酢酸クロメゲストンを言い換えると?", "response": "酢酸クロメゲストンを言い換えるとClomegestone acetate (USAN)です。", "task": "replace", "name_q": "酢酸クロメゲストン", "name_a": "Clomegestone acetate (USAN)"} -{"id": 9332, "instruction": "7alpha,12alpha-Dihydroxy-3-oxochol-4-en-24-oyl-CoAをを化学式で書くと?", "response": "7alpha,12alpha-Dihydroxy-3-oxochol-4-en-24-oyl-CoAをを化学式で書くとC45H70N7O20P3Sです。", "task": "formula", "name_q": "7alpha,12alpha-Dihydroxy-3-oxochol-4-en-24-oyl-CoA", "name_a": "C45H70N7O20P3S"} -{"id": 8609, "instruction": "C17H23N7O5. 4H2Oを使用した商品は?", "response": "C17H23N7O5. 4H2Oを使用した商品はセレジスト(田辺三菱製薬)です。", "task": "product", "name_q": "C17H23N7O5. 4H2O", "name_a": "セレジスト(田辺三菱製薬)"} -{"id": 20643, "instruction": "香蘇散を材料とする薬品名は?", "response": "香蘇散を材料とする薬品名は香蘇散(小太郎漢方製薬)です。", "task": "product", "name_q": "香蘇散", "name_a": "香蘇散(小太郎漢方製薬)"} -{"id": 26488, "instruction": "Sebastian syndrome SUPERGRP MYH9-related disease Macrothrombocytopenia の日本語表記は?", "response": "Sebastian syndrome SUPERGRP MYH9-related disease Macrothrombocytopenia の日本語表記はセバスチャン症候群 上位グループ MYH9 異常症 巨大血小板性血小板減少症 です。", "task": "replace en to ja", "name_q": "Sebastian syndrome SUPERGRP MYH9-related disease Macrothrombocytopenia ", "name_a": "セバスチャン症候群 上位グループ MYH9 異常症 巨大血小板性血小板減少症 "} -{"id": 404, "instruction": "3-Iodo-L-tyrosineをを化学式で記述すると?", "response": "3-Iodo-L-tyrosineをを化学式で記述するとC9H10INO3です。", "task": "formula", "name_q": "3-Iodo-L-tyrosine", "name_a": "C9H10INO3"} -{"id": 26522, "instruction": "ロサラミシンブチラートの異なる名称は?", "response": "ロサラミシンブチラートの異なる名称はRosaramicin butyrate (USAN)です。", "task": "replace", "name_q": "ロサラミシンブチラート", "name_a": "Rosaramicin butyrate (USAN)"} -{"id": 10471, "instruction": "Hydroxyprogesterone (INN)の異なる名称は?", "response": "Hydroxyprogesterone (INN)の異なる名称はヒドロキシプロゲステロンです。", "task": "replace", "name_q": "Hydroxyprogesterone (INN)", "name_a": "ヒドロキシプロゲステロン"} -{"id": 28310, "instruction": "1-Nitrosonaphthaleneをの組成式は?", "response": "1-Nitrosonaphthaleneをの組成式はC10H7NOです。", "task": "formula", "name_q": "1-Nitrosonaphthalene", "name_a": "C10H7NO"} -{"id": 4578, "instruction": "Adenosine deaminase deficiency SUPERGRP T-B-Severe combined immunodeficiency Disorders of adaptive immunity Primary immunodeficiency disease を日本語表記で表すと?", "response": "Adenosine deaminase deficiency SUPERGRP T-B-Severe combined immunodeficiency Disorders of adaptive immunity Primary immunodeficiency disease を日本語表記で表すとアデノシンデアミナーゼ欠損症 上位グループ T-B- 重症複合免疫不全症 獲得免疫の障害 原発性免疫不全症 です。", "task": "replace en to ja", "name_q": "Adenosine deaminase deficiency SUPERGRP T-B-Severe combined immunodeficiency Disorders of adaptive immunity Primary immunodeficiency disease ", "name_a": "アデノシンデアミナーゼ欠損症 上位グループ T-B- 重症複合免疫不全症 獲得免疫の障害 原発性免疫不全症 "} -{"id": 2321, "instruction": "Castasteroneの異なる名称は?", "response": "Castasteroneの異なる名称はカスタステロンです。", "task": "replace", "name_q": "Castasterone", "name_a": "カスタステロン"} -{"id": 7210, "instruction": "DSLETの別呼称は?", "response": "DSLETの別呼称はEnkephalin, Ser(2), Leu(5), Thr(6)-です。", "task": "replace", "name_q": "DSLET", "name_a": "Enkephalin, Ser(2), Leu(5), Thr(6)-"} -{"id": 26848, "instruction": "(+)-Kolavenyl diphosphateをを分子式で記述すると?", "response": "(+)-Kolavenyl diphosphateをを分子式で記述するとC20H36O7P2です。", "task": "formula", "name_q": "(+)-Kolavenyl diphosphate", "name_a": "C20H36O7P2"} -{"id": 3559, "instruction": "Matrilin型脊椎骨端骨幹端異形成 上位グループ 脊椎骨端骨幹端異形成 を英語に訳すと?", "response": "Matrilin型脊椎骨端骨幹端異形成 上位グループ 脊椎骨端骨幹端異形成 を英語に訳すとSEMD, Matrilin type SUPERGRP Spondyloepimetaphyseal dysplasia です。", "task": "replace ja to en", "name_q": "Matrilin型脊椎骨端骨幹端異形成 上位グループ 脊椎骨端骨幹端異形成 ", "name_a": "SEMD, Matrilin type SUPERGRP Spondyloepimetaphyseal dysplasia "} -{"id": 28205, "instruction": "Persistent Mullerian duct syndromeを日本語表記で表すと?", "response": "Persistent Mullerian duct syndromeを日本語表記で表すとミュラー管遺残症候群です。", "task": "replace en to ja", "name_q": "Persistent Mullerian duct syndrome", "name_a": "ミュラー管遺残症候群"} -{"id": 12651, "instruction": "Palifosfamide tromethamine (USAN)を日本語表記で表すと?", "response": "Palifosfamide tromethamine (USAN)を日本語表記で表すとパリホスファミドトロメタミンです。", "task": "replace en to ja", "name_q": "Palifosfamide tromethamine (USAN)", "name_a": "パリホスファミドトロメタミン"} -{"id": 208, "instruction": "Vicianinをの化学構造は?", "response": "Vicianinをの化学構造はC19H25NO10です。", "task": "formula", "name_q": "Vicianin", "name_a": "C19H25NO10"} -{"id": 7168, "instruction": "家族性良性慢性天疱瘡は別の呼び方では?", "response": "家族性良性慢性天疱瘡は別の呼び方ではヘイリー・ヘイリー病です。", "task": "replace", "name_q": "家族性良性慢性天疱瘡", "name_a": "ヘイリー・ヘイリー病"} -{"id": 2786, "instruction": "Alphaprodine (INN)をは化学構造で表すと?", "response": "Alphaprodine (INN)をは化学構造で表すとC16H23NO2です。", "task": "formula", "name_q": "Alphaprodine (INN)", "name_a": "C16H23NO2"} -{"id": 22237, "instruction": "Nociceptinをは化学式で表すと?", "response": "Nociceptinをは化学式で表すとC79H129N27O22です。", "task": "formula", "name_q": "Nociceptin", "name_a": "C79H129N27O22"} -{"id": 20825, "instruction": "Lucinactant (USAN)を英語表記で表すと?", "response": "Lucinactant (USAN)を英語表記で表すとLucinactant (USAN)です。", "task": "replace ja to en", "name_q": "Lucinactant (USAN)", "name_a": "Lucinactant (USAN)"} -{"id": 34566, "instruction": "Nornitrogen mustardは別の呼び方では?", "response": "Nornitrogen mustardは別の呼び方ではナイトロジェンマスタードです。", "task": "replace", "name_q": "Nornitrogen mustard", "name_a": "ナイトロジェンマスタード"} -{"id": 31044, "instruction": "ヘプタデカンをを化学式で表すと?", "response": "ヘプタデカンをを化学式で表すとC17H36です。", "task": "formula", "name_q": "ヘプタデカン", "name_a": "C17H36"} -{"id": 13374, "instruction": "Dendrobineをは分子式で表すと?", "response": "Dendrobineをは分子式で表すとC16H25NO2です。", "task": "formula", "name_q": "Dendrobine", "name_a": "C16H25NO2"} -{"id": 34311, "instruction": "ピラジナミド (JP18)をを分子式で表すと?", "response": "ピラジナミド (JP18)をを分子式で表すとC5H5N3Oです。", "task": "formula", "name_q": "ピラジナミド (JP18)", "name_a": "C5H5N3O"} -{"id": 21423, "instruction": "(25S)-26-Hydroxycholest-4-en-3-oneをは化学式で表すと?", "response": "(25S)-26-Hydroxycholest-4-en-3-oneをは化学式で表すとC27H44O2です。", "task": "formula", "name_q": "(25S)-26-Hydroxycholest-4-en-3-one", "name_a": "C27H44O2"} -{"id": 23588, "instruction": "N-Carbamoyl-L-2-amino acidの異なる表現は?", "response": "N-Carbamoyl-L-2-amino acidの異なる表現はN-Carbamoyl-L-amino acidです。", "task": "replace", "name_q": "N-Carbamoyl-L-2-amino acid", "name_a": "N-Carbamoyl-L-amino acid"} -{"id": 20393, "instruction": "センノシド(東和薬品)をは分子式で表すと?", "response": "センノシド(東和薬品)をは分子式で表すとC42H38O20です。", "task": "formula", "name_q": "センノシド(東和薬品)", "name_a": "C42H38O20"} -{"id": 16206, "instruction": "C21H22Cl2N4O2をを分子式で記述すると?", "response": "C21H22Cl2N4O2をを分子式で記述するとC21H22Cl2N4O2です。", "task": "formula", "name_q": "C21H22Cl2N4O2", "name_a": "C21H22Cl2N4O2"} -{"id": 21483, "instruction": "Behcet syndromeの異なる名称は?", "response": "Behcet syndromeの異なる名称はBehcet diseaseです。", "task": "replace", "name_q": "Behcet syndrome", "name_a": "Behcet disease"} -{"id": 176, "instruction": "Insulin human zinc (USP)を日本語表記で表すと?", "response": "Insulin human zinc (USP)を日本語表記で表すとInsulin human zinc (USP)です。", "task": "replace en to ja", "name_q": "Insulin human zinc (USP)", "name_a": "Insulin human zinc (USP)"} -{"id": 27852, "instruction": "Vira-A (TN)の別の言い方は?", "response": "Vira-A (TN)の別の言い方はVidarabine monohydrateです。", "task": "replace", "name_q": "Vira-A (TN)", "name_a": "Vidarabine monohydrate"} -{"id": 26267, "instruction": "L-Isoleucineの別記述は?", "response": "L-Isoleucineの別記述はL-イソロイシンです。", "task": "replace", "name_q": "L-Isoleucine", "name_a": "L-イソロイシン"} -{"id": 26970, "instruction": "デスシノロンアセトニドの異なる表記は?", "response": "デスシノロンアセトニドの異なる表記はDescinolone acetonide (USAN)です。", "task": "replace", "name_q": "デスシノロンアセトニド", "name_a": "Descinolone acetonide (USAN)"} -{"id": 7218, "instruction": "Benzoxonium chloride (INN)をの化学構造は?", "response": "Benzoxonium chloride (INN)をの化学構造はC23H42NO2. Clです。", "task": "formula", "name_q": "Benzoxonium chloride (INN)", "name_a": "C23H42NO2. Cl"} -{"id": 4065, "instruction": "2-Aminoestradiolを言い換えると?", "response": "2-Aminoestradiolを言い換えると2-Aminoestra-1,3,5(10)-triene-3,17beta-diolです。", "task": "replace", "name_q": "2-Aminoestradiol", "name_a": "2-Aminoestra-1,3,5(10)-triene-3,17beta-diol"} -{"id": 21748, "instruction": "(5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoateは別の呼び方では?", "response": "(5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoateは別の呼び方では15-Dehydro-prostaglandin D2です。", "task": "replace", "name_q": "(5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoate", "name_a": "15-Dehydro-prostaglandin D2"} -{"id": 9675, "instruction": "D-Hamameloseをは化学式で表すと?", "response": "D-Hamameloseをは化学式で表すとC6H12O6です。", "task": "formula", "name_q": "D-Hamamelose", "name_a": "C6H12O6"} -{"id": 3937, "instruction": "Yttrium Y 90 labetuzumab (USAN)を英語表記で表すと?", "response": "Yttrium Y 90 labetuzumab (USAN)を英語表記で表すとYttrium Y 90 labetuzumab (USAN)です。", "task": "replace ja to en", "name_q": "Yttrium Y 90 labetuzumab (USAN)", "name_a": "Yttrium Y 90 labetuzumab (USAN)"} -{"id": 25236, "instruction": "Fremanezumab (genetical recombination) (JAN)を用いた製品は?", "response": "Fremanezumab (genetical recombination) (JAN)を用いた製品はAJOVY(TevaPharmaceuticalsUSA)です。", "task": "product", "name_q": "Fremanezumab (genetical recombination) (JAN)", "name_a": "AJOVY(TevaPharmaceuticalsUSA)"} -{"id": 31029, "instruction": "ピラゾキシフェンをを化学構造で表すと?", "response": "ピラゾキシフェンをを化学構造で表すとC20H16Cl2N2O3です。", "task": "formula", "name_q": "ピラゾキシフェン", "name_a": "C20H16Cl2N2O3"} -{"id": 10219, "instruction": "ペタシンの別記述は?", "response": "ペタシンの別記述はPetasinです。", "task": "replace", "name_q": "ペタシン", "name_a": "Petasin"} -{"id": 9091, "instruction": "[Protein]-(Z)-2-aminobutenoateをを化学構造で書くと?", "response": "[Protein]-(Z)-2-aminobutenoateをを化学構造で書くとC5H6N2O2R2です。", "task": "formula", "name_q": "[Protein]-(Z)-2-aminobutenoate", "name_a": "C5H6N2O2R2"} -{"id": 3457, "instruction": "Profluralinをの組成式は?", "response": "Profluralinをの組成式はC14H16F3N3O4です。", "task": "formula", "name_q": "Profluralin", "name_a": "C14H16F3N3O4"} -{"id": 29251, "instruction": "禿頭と変形性脊椎症を伴う常染色体劣性白質脳症を英語表記で表すと?", "response": "禿頭と変形性脊椎症を伴う常染色体劣性白質脳症を英語表記で表すとCerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathyです。", "task": "replace ja to en", "name_q": "禿頭と変形性脊椎症を伴う常染色体劣性白質脳症", "name_a": "Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy"} -{"id": 4891, "instruction": "Taletrectinib adipate (USAN)を日本語表記で表すと?", "response": "Taletrectinib adipate (USAN)を日本語表記で表すとTaletrectinib adipate (USAN)です。", "task": "replace en to ja", "name_q": "Taletrectinib adipate (USAN)", "name_a": "Taletrectinib adipate (USAN)"} -{"id": 22073, "instruction": "Calcitonin-related polypeptide alphaの別呼称は?", "response": "Calcitonin-related polypeptide alphaの別呼称はalpha-CGRPです。", "task": "replace", "name_q": "Calcitonin-related polypeptide alpha", "name_a": "alpha-CGRP"} -{"id": 19899, "instruction": "Onatasertib (USAN)の英語表記は?", "response": "Onatasertib (USAN)の英語表記はOnatasertib (USAN)です。", "task": "replace ja to en", "name_q": "Onatasertib (USAN)", "name_a": "Onatasertib (USAN)"} -{"id": 33751, "instruction": "Emprumapimod (USAN)をを化学構造で記述すると?", "response": "Emprumapimod (USAN)をを化学構造で記述するとC24H29F2N5O3です。", "task": "formula", "name_q": "Emprumapimod (USAN)", "name_a": "C24H29F2N5O3"} -{"id": 603, "instruction": "Seglitide acetate (USAN)の日本語訳は?", "response": "Seglitide acetate (USAN)の日本語訳は酢酸セグリチドです。", "task": "replace en to ja", "name_q": "Seglitide acetate (USAN)", "name_a": "酢酸セグリチド"} -{"id": 13759, "instruction": "テロトリスタットエチルを英語に訳すと?", "response": "テロトリスタットエチルを英語に訳すとTelotristat ethyl (USAN)です。", "task": "replace ja to en", "name_q": "テロトリスタットエチル", "name_a": "Telotristat ethyl (USAN)"} -{"id": 28610, "instruction": "Vaccinia immune globulin (USP)を主材料とする商品名は?", "response": "Vaccinia immune globulin (USP)を主材料とする商品名はCNJ-016(EmergentBioSolutionsCanada)です。", "task": "product", "name_q": "Vaccinia immune globulin (USP)", "name_a": "CNJ-016(EmergentBioSolutionsCanada)"} -{"id": 10390, "instruction": "Jogan'ippoの日本語訳は?", "response": "Jogan'ippoの日本語訳はJogan'ippoです。", "task": "replace en to ja", "name_q": "Jogan'ippo", "name_a": "Jogan'ippo"} -{"id": 16761, "instruction": "3-Phenylsuccinyl-CoAをは組成式で表すと?", "response": "3-Phenylsuccinyl-CoAをは組成式で表すとC31H44N7O19P3Sです。", "task": "formula", "name_q": "3-Phenylsuccinyl-CoA", "name_a": "C31H44N7O19P3S"} -{"id": 8719, "instruction": "ヒカイは別の呼び方では?", "response": "ヒカイは別の呼び方では粉萆薢です。", "task": "replace", "name_q": "ヒカイ", "name_a": "粉萆薢"} -{"id": 33221, "instruction": "Amitriptylinoxide (INN)を英語表記で表すと?", "response": "Amitriptylinoxide (INN)を英語表記で表すとAmitriptylinoxide (INN)です。", "task": "replace ja to en", "name_q": "Amitriptylinoxide (INN)", "name_a": "Amitriptylinoxide (INN)"} -{"id": 26858, "instruction": "S-Adenosylmethionine disulfate ditosylateをを組成式で記述すると?", "response": "S-Adenosylmethionine disulfate ditosylateをを組成式で記述するとC15H23N6O5S. (C7H8O3S)2. H2SO4. HSO4です。", "task": "formula", "name_q": "S-Adenosylmethionine disulfate ditosylate", "name_a": "C15H23N6O5S. (C7H8O3S)2. H2SO4. HSO4"} -{"id": 7368, "instruction": "Autophagic vacuolar myopathyを日本語表記で表すと?", "response": "Autophagic vacuolar myopathyを日本語表記で表すと自己貪食空胞性ミオパチーです。", "task": "replace en to ja", "name_q": "Autophagic vacuolar myopathy", "name_a": "自己貪食空胞性ミオパチー"} -{"id": 22416, "instruction": "Harel-Yoon syndromeを日本語で記述すると?", "response": "Harel-Yoon syndromeを日本語で記述するとHarel-Yoon 症候群です。", "task": "replace en to ja", "name_q": "Harel-Yoon syndrome", "name_a": "Harel-Yoon 症候群"} -{"id": 34316, "instruction": "丹毒 上位グループ レンサ球菌感染症 の英語表記は?", "response": "丹毒 上位グループ レンサ球菌感染症 の英語表記はErysipelas SUPERGRP Streptococcal infection です。", "task": "replace ja to en", "name_q": "丹毒 上位グループ レンサ球菌感染症 ", "name_a": "Erysipelas SUPERGRP Streptococcal infection "} -{"id": 20088, "instruction": "Acetaminophen, caffeine and dihydrocodeine bitartrateを英語で書くと?", "response": "Acetaminophen, caffeine and dihydrocodeine bitartrateを英語で書くとTrezix (TN)です。", "task": "replace ja to en", "name_q": "Acetaminophen, caffeine and dihydrocodeine bitartrate", "name_a": "Trezix (TN)"} -{"id": 29193, "instruction": "3-Hydroxybenzo[a]pyreneをを化学式で書くと?", "response": "3-Hydroxybenzo[a]pyreneをを化学式で書くとC20H12Oです。", "task": "formula", "name_q": "3-Hydroxybenzo[a]pyrene", "name_a": "C20H12O"} -{"id": 7063, "instruction": "Oxpoconazole fumarateをを分子式で書くと?", "response": "Oxpoconazole fumarateをを分子式で書くと(C19H24ClN3O2)2. C4H4O4です。", "task": "formula", "name_q": "Oxpoconazole fumarate", "name_a": "(C19H24ClN3O2)2. C4H4O4"} -{"id": 7362, "instruction": "5-Deoxy-D-ribulose 1-phosphateをを分子式で書くと?", "response": "5-Deoxy-D-ribulose 1-phosphateをを分子式で書くとC5H11O7Pです。", "task": "formula", "name_q": "5-Deoxy-D-ribulose 1-phosphate", "name_a": "C5H11O7P"} -{"id": 2152, "instruction": "Broperamole (USAN/INN)をは分子式で表すと?", "response": "Broperamole (USAN/INN)をは分子式で表すとC15H18BrN5Oです。", "task": "formula", "name_q": "Broperamole (USAN/INN)", "name_a": "C15H18BrN5O"} -{"id": 5343, "instruction": "カプトプリル (JP18)を主材料とする商品は?", "response": "カプトプリル (JP18)を主材料とする商品はカプトリル(アルフレッサファーマ)です。", "task": "product", "name_q": "カプトプリル (JP18)", "name_a": "カプトリル(アルフレッサファーマ)"} -{"id": 3864, "instruction": "o-Phthalaldehydeの別表現は?", "response": "o-Phthalaldehydeの別表現はPhtharal (JAN)です。", "task": "replace", "name_q": "o-Phthalaldehyde", "name_a": "Phtharal (JAN)"} -{"id": 31301, "instruction": "Keishiを材料とする医薬品は?", "response": "Keishiを材料とする医薬品はケイシ(栃本天海堂)です。", "task": "product", "name_q": "Keishi", "name_a": "ケイシ(栃本天海堂)"} -{"id": 25443, "instruction": "面皰母斑の英語表記は?", "response": "面皰母斑の英語表記はNevus comedonicusです。", "task": "replace ja to en", "name_q": "面皰母斑", "name_a": "Nevus comedonicus"} -{"id": 10805, "instruction": "Oxidized coenzyme F420-0の別名称は?", "response": "Oxidized coenzyme F420-0の別名称はFactor 420-0です。", "task": "replace", "name_q": "Oxidized coenzyme F420-0", "name_a": "Factor 420-0"} -{"id": 33964, "instruction": "LEVETIRACETAM(OWPPharmaceuticals)を使用した医薬品名は?", "response": "LEVETIRACETAM(OWPPharmaceuticals)を使用した医薬品名はGENERICLEVERTIRACETAM(Direct_Rx)です。", "task": "product", "name_q": "LEVETIRACETAM(OWPPharmaceuticals)", "name_a": "GENERICLEVERTIRACETAM(Direct_Rx)"} -{"id": 29854, "instruction": "Precocene Iの別記述は?", "response": "Precocene Iの別記述はPrecocene 1です。", "task": "replace", "name_q": "Precocene I", "name_a": "Precocene 1"} -{"id": 27406, "instruction": "Roxatidine (INN)を日本語に訳すと?", "response": "Roxatidine (INN)を日本語に訳すとロキサチジンです。", "task": "replace en to ja", "name_q": "Roxatidine (INN)", "name_a": "ロキサチジン"} -{"id": 34094, "instruction": "Adenosine-5'-phosphoselenateの異なる名称は?", "response": "Adenosine-5'-phosphoselenateの異なる名称はAdenylylselenateです。", "task": "replace", "name_q": "Adenosine-5'-phosphoselenate", "name_a": "Adenylylselenate"} -{"id": 4795, "instruction": "Mavodelpar sodium (USAN)の日本語訳は?", "response": "Mavodelpar sodium (USAN)の日本語訳はMavodelpar sodium (USAN)です。", "task": "replace en to ja", "name_q": "Mavodelpar sodium (USAN)", "name_a": "Mavodelpar sodium (USAN)"} -{"id": 28268, "instruction": "Almagate (USAN/INN)の日本語表記は?", "response": "Almagate (USAN/INN)の日本語表記はアルマガートです。", "task": "replace en to ja", "name_q": "Almagate (USAN/INN)", "name_a": "アルマガート"} -{"id": 12900, "instruction": "dl-Methylephedrine hydrochloride, dihydrocodeine phosphate, diprophylline, diphenhydramine salicylate, acetaminophen and bromovalerylureaを利用した医薬品名は?", "response": "dl-Methylephedrine hydrochloride, dihydrocodeine phosphate, diprophylline, diphenhydramine salicylate, acetaminophen and bromovalerylureaを利用した医薬品名はカフコデ(ヴィアトリス・ヘルスケア)です。", "task": "product", "name_q": "dl-Methylephedrine hydrochloride, dihydrocodeine phosphate, diprophylline, diphenhydramine salicylate, acetaminophen and bromovalerylurea", "name_a": "カフコデ(ヴィアトリス・ヘルスケア)"} -{"id": 19147, "instruction": "リジンをを分子式で書くと?", "response": "リジンをを分子式で書くとC6H14N2O2です。", "task": "formula", "name_q": "リジン", "name_a": "C6H14N2O2"} -{"id": 26316, "instruction": "Indole-3-carboxylateをを化学構造で書くと?", "response": "Indole-3-carboxylateをを化学構造で書くとC9H7NO2です。", "task": "formula", "name_q": "Indole-3-carboxylate", "name_a": "C9H7NO2"} -{"id": 34165, "instruction": "3-Hydroxytolueneの別の呼び方は?", "response": "3-Hydroxytolueneの別の呼び方は3-Cresolです。", "task": "replace", "name_q": "3-Hydroxytoluene", "name_a": "3-Cresol"} -{"id": 24130, "instruction": "Teicoplanin A2-4をは分子式で表すと?", "response": "Teicoplanin A2-4をは分子式で表すとC89H99Cl2N9O33です。", "task": "formula", "name_q": "Teicoplanin A2-4", "name_a": "C89H99Cl2N9O33"} -{"id": 29954, "instruction": "メチルチオウラシルをは組成式で表すと?", "response": "メチルチオウラシルをは組成式で表すとC5H6N2OSです。", "task": "formula", "name_q": "メチルチオウラシル", "name_a": "C5H6N2OS"} -{"id": 680, "instruction": "Becker nevus syndromeの日本語表記は?", "response": "Becker nevus syndromeの日本語表記はベッカー母斑症候群です。", "task": "replace en to ja", "name_q": "Becker nevus syndrome", "name_a": "ベッカー母斑症候群"} -{"id": 31383, "instruction": "ジヒドロミカノリドの別名称は?", "response": "ジヒドロミカノリドの別名称はDihydromikanolideです。", "task": "replace", "name_q": "ジヒドロミカノリド", "name_a": "Dihydromikanolide"} -{"id": 30292, "instruction": "アルテルナリオールの異なる表記は?", "response": "アルテルナリオールの異なる表記はAlternariolです。", "task": "replace", "name_q": "アルテルナリオール", "name_a": "Alternariol"} -{"id": 4657, "instruction": "Arimoclomol (USAN)をは化学式で表すと?", "response": "Arimoclomol (USAN)をは化学式で表すとC14H20ClN3O3です。", "task": "formula", "name_q": "Arimoclomol (USAN)", "name_a": "C14H20ClN3O3"} -{"id": 31971, "instruction": "LURASIDONEHYDROCHLORIDE(AurobindoPharmaLimited)を主材料とする医薬品名は?", "response": "LURASIDONEHYDROCHLORIDE(AurobindoPharmaLimited)を主材料とする医薬品名はLURASIDONEHYDROCHLORIDE(ZydusPharmaceuticalsUSA)です。", "task": "product", "name_q": "LURASIDONEHYDROCHLORIDE(AurobindoPharmaLimited)", "name_a": "LURASIDONEHYDROCHLORIDE(ZydusPharmaceuticalsUSA)"} -{"id": 15119, "instruction": "塩基性酢酸アルミニウムの英訳は?", "response": "塩基性酢酸アルミニウムの英訳はAluminum subacetate (USP)です。", "task": "replace ja to en", "name_q": "塩基性酢酸アルミニウム", "name_a": "Aluminum subacetate (USP)"} -{"id": 29889, "instruction": "メピフィリンの別呼称は?", "response": "メピフィリンの別呼称はメピラミンテオフィリンアセテートです。", "task": "replace", "name_q": "メピフィリン", "name_a": "メピラミンテオフィリンアセテート"} -{"id": 23082, "instruction": "スクラロースをを分子式で書くと?", "response": "スクラロースをを分子式で書くとC12H19Cl3O8です。", "task": "formula", "name_q": "スクラロース", "name_a": "C12H19Cl3O8"} -{"id": 9285, "instruction": "ナルシクラシンの別呼称は?", "response": "ナルシクラシンの別呼称はNarciclasineです。", "task": "replace", "name_q": "ナルシクラシン", "name_a": "Narciclasine"} -{"id": 10672, "instruction": "2-(Dihydropentaprenyloxy)-dihydrophenazineの別名は?", "response": "2-(Dihydropentaprenyloxy)-dihydrophenazineの別名はDihydromethanophenazineです。", "task": "replace", "name_q": "2-(Dihydropentaprenyloxy)-dihydrophenazine", "name_a": "Dihydromethanophenazine"} -{"id": 24919, "instruction": "エラントリンをの化学式は?", "response": "エラントリンをの化学式はC20H24N2です。", "task": "formula", "name_q": "エラントリン", "name_a": "C20H24N2"} -{"id": 4800, "instruction": "Palmitoyl-KDO2-lipid Aの異なる表記は?", "response": "Palmitoyl-KDO2-lipid Aの異なる表記はPalmitoylated KDO2-lipid Aです。", "task": "replace", "name_q": "Palmitoyl-KDO2-lipid A", "name_a": "Palmitoylated KDO2-lipid A"} -{"id": 16945, "instruction": "バーサーノンの別表現は?", "response": "バーサーノンの別表現はベルシルノンです。", "task": "replace", "name_q": "バーサーノン", "name_a": "ベルシルノン"} -{"id": 29567, "instruction": "alpha-D-Mannosylchitobiosyldiphosphodolicholをを化学構造で書くと?", "response": "alpha-D-Mannosylchitobiosyldiphosphodolicholをを化学構造で書くとC42H74N2O22P2(C5H8)nです。", "task": "formula", "name_q": "alpha-D-Mannosylchitobiosyldiphosphodolichol", "name_a": "C42H74N2O22P2(C5H8)n"} -{"id": 4114, "instruction": "Viral hepatitis SUBGROUP Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E SUPERGRP Fulminant hepatic failure を日本語で書くと?", "response": "Viral hepatitis SUBGROUP Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E SUPERGRP Fulminant hepatic failure を日本語で書くとウイルス性肝炎 下位グループ A型肝炎 B型肝炎 C型肝炎 D型肝炎 E型肝炎 上位グループ 劇症肝炎 です。", "task": "replace en to ja", "name_q": "Viral hepatitis SUBGROUP Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E SUPERGRP Fulminant hepatic failure ", "name_a": "ウイルス性肝炎 下位グループ A型肝炎 B型肝炎 C型肝炎 D型肝炎 E型肝炎 上位グループ 劇症肝炎 "} -{"id": 25863, "instruction": "Nizon-Isidor 症候群を英語で記述すると?", "response": "Nizon-Isidor 症候群を英語で記述するとNizon-Isidor syndromeです。", "task": "replace ja to en", "name_q": "Nizon-Isidor 症候群", "name_a": "Nizon-Isidor syndrome"} -{"id": 10149, "instruction": "GEMFIBROZIL(NuCarePharmaceuticals)を主材料とする製品は?", "response": "GEMFIBROZIL(NuCarePharmaceuticals)を主材料とする製品はGEMFIBROZIL(ZydusLifesciencesLimited)です。", "task": "product", "name_q": "GEMFIBROZIL(NuCarePharmaceuticals)", "name_a": "GEMFIBROZIL(ZydusLifesciencesLimited)"} -{"id": 24425, "instruction": "HANAC 症候群を英語表記で表すと?", "response": "HANAC 症候群を英語表記で表すとHereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC)です。", "task": "replace ja to en", "name_q": "HANAC 症候群", "name_a": "Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC)"} -{"id": 1210, "instruction": "Hypoparathyroidism SUBGROUP Familial isolated hypoparathyroidism (FIH)を日本語で書くと?", "response": "Hypoparathyroidism SUBGROUP Familial isolated hypoparathyroidism (FIH)を日本語で書くと副甲状腺機能低下症 下位グループ 家族性弧発性副甲状腺機能低下症 (FIH)です。", "task": "replace en to ja", "name_q": "Hypoparathyroidism SUBGROUP Familial isolated hypoparathyroidism (FIH)", "name_a": "副甲状腺機能低下症 下位グループ 家族性弧発性副甲状腺機能低下症 (FIH)"} -{"id": 13110, "instruction": "Drisapersen sodium (JAN/USAN)をを分子式で記述すると?", "response": "Drisapersen sodium (JAN/USAN)をを分子式で記述するとC211H256N76O119P19S19. 19Naです。", "task": "formula", "name_q": "Drisapersen sodium (JAN/USAN)", "name_a": "C211H256N76O119P19S19. 19Na"} -{"id": 14113, "instruction": "Eletriptan hydrobromide monohydrateの別呼称は?", "response": "Eletriptan hydrobromide monohydrateの別呼称はエレトリプタン臭化水素酸塩水和物です。", "task": "replace", "name_q": "Eletriptan hydrobromide monohydrate", "name_a": "エレトリプタン臭化水素酸塩水和物"} -{"id": 20691, "instruction": "Chromobacterium violaceum infectionを日本語で記述すると?", "response": "Chromobacterium violaceum infectionを日本語で記述するとChromobacterium violaceum 感染です。", "task": "replace en to ja", "name_q": "Chromobacterium violaceum infection", "name_a": "Chromobacterium violaceum 感染"} -{"id": 19744, "instruction": "Cancer of the anal canalを日本語表記で表すと?", "response": "Cancer of the anal canalを日本語表記で表すと肛門管癌です。", "task": "replace en to ja", "name_q": "Cancer of the anal canal", "name_a": "肛門管癌"} -{"id": 33639, "instruction": "エスメラルジンAの別名は?", "response": "エスメラルジンAの別名はEsmeraldin Aです。", "task": "replace", "name_q": "エスメラルジンA", "name_a": "Esmeraldin A"} -{"id": 26584, "instruction": "人工移植片の英語表記は?", "response": "人工移植片の英語表記はArtegraft (USAN)です。", "task": "replace ja to en", "name_q": "人工移植片", "name_a": "Artegraft (USAN)"} -{"id": 16456, "instruction": "Difemerine (INN)を英語で書くと?", "response": "Difemerine (INN)を英語で書くとDifemerine (INN)です。", "task": "replace ja to en", "name_q": "Difemerine (INN)", "name_a": "Difemerine (INN)"} -{"id": 4093, "instruction": "Pituitary gigantism SUPERGRP Excessive secretion of growth hormone を日本語で書くと?", "response": "Pituitary gigantism SUPERGRP Excessive secretion of growth hormone を日本語で書くと下垂体性巨人症 上位グループ 下垂体性成長ホルモン分泌亢進症 です。", "task": "replace en to ja", "name_q": "Pituitary gigantism SUPERGRP Excessive secretion of growth hormone ", "name_a": "下垂体性巨人症 上位グループ 下垂体性成長ホルモン分泌亢進症 "} -{"id": 9074, "instruction": "trans-3-アミノシクロペンタン-1-カルボン酸をを化学式で表すと?", "response": "trans-3-アミノシクロペンタン-1-カルボン酸をを化学式で表すとC6H11NO2です。", "task": "formula", "name_q": "trans-3-アミノシクロペンタン-1-カルボン酸", "name_a": "C6H11NO2"} -{"id": 25802, "instruction": "アンギオテンシンアミドは別の呼び方では?", "response": "アンギオテンシンアミドは別の呼び方ではAngiotensinamide (INN)です。", "task": "replace", "name_q": "アンギオテンシンアミド", "name_a": "Angiotensinamide (INN)"} -{"id": 8287, "instruction": "舞踏病アテトーシス様運動と小球性貧血を伴う早期発症神経変性疾患を英語で記述すると?", "response": "舞踏病アテトーシス様運動と小球性貧血を伴う早期発症神経変性疾患を英語で記述するとEarly-onset neurodegeneration with choreoathetoid movements and microcytic anemiaです。", "task": "replace ja to en", "name_q": "舞踏病アテトーシス様運動と小球性貧血を伴う早期発症神経変性疾患", "name_a": "Early-onset neurodegeneration with choreoathetoid movements and microcytic anemia"} -{"id": 23108, "instruction": "メトロニダゾールをの組成式は?", "response": "メトロニダゾールをの組成式はC6H9N3O3です。", "task": "formula", "name_q": "メトロニダゾール", "name_a": "C6H9N3O3"} -{"id": 9811, "instruction": "リボフラビンリン酸ナトリウム二水和物の別表現は?", "response": "リボフラビンリン酸ナトリウム二水和物の別表現はRiboflavin sodium phosphate dihydrateです。", "task": "replace", "name_q": "リボフラビンリン酸ナトリウム二水和物", "name_a": "Riboflavin sodium phosphate dihydrate"} -{"id": 34193, "instruction": "2,4-Dibromophenolをの化学式は?", "response": "2,4-Dibromophenolをの化学式はC6H4Br2Oです。", "task": "formula", "name_q": "2,4-Dibromophenol", "name_a": "C6H4Br2O"} -{"id": 4955, "instruction": "D-Mannose 1-phosphateをの分子式は?", "response": "D-Mannose 1-phosphateをの分子式はC6H13O9Pです。", "task": "formula", "name_q": "D-Mannose 1-phosphate", "name_a": "C6H13O9P"} -{"id": 13161, "instruction": "4-Fluoro-L-threonineをを組成式で書くと?", "response": "4-Fluoro-L-threonineをを組成式で書くとC4H8FNO3です。", "task": "formula", "name_q": "4-Fluoro-L-threonine", "name_a": "C4H8FNO3"} -{"id": 15264, "instruction": "Iodohippurate sodium I 131 (USP)を英語で書くと?", "response": "Iodohippurate sodium I 131 (USP)を英語で書くとHippuran I 131 (TN)です。", "task": "replace ja to en", "name_q": "Iodohippurate sodium I 131 (USP)", "name_a": "Hippuran I 131 (TN)"} -{"id": 23844, "instruction": "Laing 遠位型ミオパチーの別表現は?", "response": "Laing 遠位型ミオパチーの別表現は遠位型ミオパチー 1 上位グループ 遠位型ミオパチー です。", "task": "replace", "name_q": "Laing 遠位型ミオパチー", "name_a": "遠位型ミオパチー 1 上位グループ 遠位型ミオパチー "} -{"id": 20064, "instruction": "2-Bromophenolをを化学構造で表すと?", "response": "2-Bromophenolをを化学構造で表すとC6H5BrOです。", "task": "formula", "name_q": "2-Bromophenol", "name_a": "C6H5BrO"} -{"id": 28028, "instruction": "Allylestrenolをの組成式は?", "response": "Allylestrenolをの組成式はC21H32Oです。", "task": "formula", "name_q": "Allylestrenol", "name_a": "C21H32O"} -{"id": 9444, "instruction": "Fusarenone Xの別名称は?", "response": "Fusarenone Xの別名称はフザレノンXです。", "task": "replace", "name_q": "Fusarenone X", "name_a": "フザレノンX"} -{"id": 34579, "instruction": "FEBUXOSTAT(MacleodsPharmaceuticalsLimited)を主とした商品名は?", "response": "FEBUXOSTAT(MacleodsPharmaceuticalsLimited)を主とした商品名はFEBUXOSTAT(SolcoHealthcareUSLLC)です。", "task": "product", "name_q": "FEBUXOSTAT(MacleodsPharmaceuticalsLimited)", "name_a": "FEBUXOSTAT(SolcoHealthcareUSLLC)"} -{"id": 103, "instruction": "Dicyclohexyl phthalateをを組成式で書くと?", "response": "Dicyclohexyl phthalateをを組成式で書くとC20H26O4です。", "task": "formula", "name_q": "Dicyclohexyl phthalate", "name_a": "C20H26O4"} -{"id": 12291, "instruction": "3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoyl-CoAをを分子式で記述すると?", "response": "3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoyl-CoAをを分子式で記述するとC48H80N7O20P3Sです。", "task": "formula", "name_q": "3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoyl-CoA", "name_a": "C48H80N7O20P3S"} -{"id": 9512, "instruction": "釣藤鉤を使用した商品は?", "response": "釣藤鉤を使用した商品はチョウトウコウ(高砂薬業)です。", "task": "product", "name_q": "釣藤鉤", "name_a": "チョウトウコウ(高砂薬業)"} -{"id": 415, "instruction": "2,3-Bis(4-hydroxyphenyl)-1,2-propanediolをの化学式は?", "response": "2,3-Bis(4-hydroxyphenyl)-1,2-propanediolをの化学式はC15H16O4です。", "task": "formula", "name_q": "2,3-Bis(4-hydroxyphenyl)-1,2-propanediol", "name_a": "C15H16O4"} -{"id": 19443, "instruction": "Rhodium immune human globulinの別名称は?", "response": "Rhodium immune human globulinの別名称はRho(D) immune globulin (USP)です。", "task": "replace", "name_q": "Rhodium immune human globulin", "name_a": "Rho(D) immune globulin (USP)"} -{"id": 34766, "instruction": "アルギン酸プロピレングリコールエステルの別名称は?", "response": "アルギン酸プロピレングリコールエステルの別名称はPropylene glycol alginate (NF)です。", "task": "replace", "name_q": "アルギン酸プロピレングリコールエステル", "name_a": "Propylene glycol alginate (NF)"} -{"id": 26572, "instruction": "エドキサバントシル酸塩の英語表記は?", "response": "エドキサバントシル酸塩の英語表記はEdoxaban tosylate (USAN)です。", "task": "replace ja to en", "name_q": "エドキサバントシル酸塩", "name_a": "Edoxaban tosylate (USAN)"} -{"id": 31744, "instruction": "Hexachlorophene (USP/INN)をを化学構造で記述すると?", "response": "Hexachlorophene (USP/INN)をを化学構造で記述するとC13H6Cl6O2です。", "task": "formula", "name_q": "Hexachlorophene (USP/INN)", "name_a": "C13H6Cl6O2"} -{"id": 32602, "instruction": "C26H28N2をを化学構造で表すと?", "response": "C26H28N2をを化学構造で表すとC26H28N2です。", "task": "formula", "name_q": "C26H28N2", "name_a": "C26H28N2"} -{"id": 26302, "instruction": "1,6-ジニトロピレンをは組成式で表すと?", "response": "1,6-ジニトロピレンをは組成式で表すとC16H8N2O4です。", "task": "formula", "name_q": "1,6-ジニトロピレン", "name_a": "C16H8N2O4"} -{"id": 21243, "instruction": "Costello syndrome SUPERGRP Noonan syndrome and related disorders を日本語表記で表すと?", "response": "Costello syndrome SUPERGRP Noonan syndrome and related disorders を日本語表記で表すとコステロ症候群 上位グループ ヌーナン症候群類縁疾患 です。", "task": "replace en to ja", "name_q": "Costello syndrome SUPERGRP Noonan syndrome and related disorders ", "name_a": "コステロ症候群 上位グループ ヌーナン症候群類縁疾患 "} -{"id": 16784, "instruction": "Methylureaをを組成式で書くと?", "response": "Methylureaをを組成式で書くとC2H6N2Oです。", "task": "formula", "name_q": "Methylurea", "name_a": "C2H6N2O"} -{"id": 364, "instruction": "ブタルビタール・アセトアミノフェン・カフェインを英語で記述すると?", "response": "ブタルビタール・アセトアミノフェン・カフェインを英語で記述するとButalbital, acetaminophen and caffeineです。", "task": "replace ja to en", "name_q": "ブタルビタール・アセトアミノフェン・カフェイン", "name_a": "Butalbital, acetaminophen and caffeine"} -{"id": 23088, "instruction": "ペキサスチモジンデバシレプベクを英語表記で表すと?", "response": "ペキサスチモジンデバシレプベクを英語表記で表すとPexastimogene devacirepvec (USAN/INN)です。", "task": "replace ja to en", "name_q": "ペキサスチモジンデバシレプベク", "name_a": "Pexastimogene devacirepvec (USAN/INN)"} -{"id": 22126, "instruction": "Danocrine (TN)をの分子式は?", "response": "Danocrine (TN)をの分子式はC22H27NO2です。", "task": "formula", "name_q": "Danocrine (TN)", "name_a": "C22H27NO2"} -{"id": 25097, "instruction": "Cybutryneの別表現は?", "response": "Cybutryneの別表現はイルガロール1051です。", "task": "replace", "name_q": "Cybutryne", "name_a": "イルガロール1051"} -{"id": 11151, "instruction": "Brassicanal Aをを化学構造で表すと?", "response": "Brassicanal Aをを化学構造で表すとC10H9NOSです。", "task": "formula", "name_q": "Brassicanal A", "name_a": "C10H9NOS"} -{"id": 13268, "instruction": "N,alpha-Dimethyl-N-2-propynylphenethylamineを言い換えると?", "response": "N,alpha-Dimethyl-N-2-propynylphenethylamineを言い換えるとDeprenylです。", "task": "replace", "name_q": "N,alpha-Dimethyl-N-2-propynylphenethylamine", "name_a": "Deprenyl"} -{"id": 33765, "instruction": "Valacyclovirをを化学式で表すと?", "response": "Valacyclovirをを化学式で表すとC13H20N6O4です。", "task": "formula", "name_q": "Valacyclovir", "name_a": "C13H20N6O4"} -{"id": 19426, "instruction": "Methylaminoacrylateの異なる表記は?", "response": "Methylaminoacrylateの異なる表記は(Z)-2-Methyl-3-aminoacrylateです。", "task": "replace", "name_q": "Methylaminoacrylate", "name_a": "(Z)-2-Methyl-3-aminoacrylate"} -{"id": 28093, "instruction": "下顎末端異形成症 下位グループ 下顎末端異形成早老症候群 (MDPS) 上位グループ 脂肪萎縮症 プロジェロイド・ラミノパチー の英語表記は?", "response": "下顎末端異形成症 下位グループ 下顎末端異形成早老症候群 (MDPS) 上位グループ 脂肪萎縮症 プロジェロイド・ラミノパチー の英語表記はMandibuloacral dysplasia SUBGROUP Mandibuloacral dysplasia progeroid syndrome (MDPS) SUPERGRP Lipodystrophy Progeroid laminopathy です。", "task": "replace ja to en", "name_q": "下顎末端異形成症 下位グループ 下顎末端異形成早老症候群 (MDPS) 上位グループ 脂肪萎縮症 プロジェロイド・ラミノパチー ", "name_a": "Mandibuloacral dysplasia SUBGROUP Mandibuloacral dysplasia progeroid syndrome (MDPS) SUPERGRP Lipodystrophy Progeroid laminopathy "} -{"id": 25063, "instruction": "アリモクロモルクエン酸塩を主材料とする医薬品は?", "response": "アリモクロモルクエン酸塩を主材料とする医薬品はMIPLYFFA(AcerTherapeutics)です。", "task": "product", "name_q": "アリモクロモルクエン酸塩", "name_a": "MIPLYFFA(AcerTherapeutics)"} -{"id": 22219, "instruction": "Azomycinをは化学構造で表すと?", "response": "Azomycinをは化学構造で表すとC3H3N3O2です。", "task": "formula", "name_q": "Azomycin", "name_a": "C3H3N3O2"} -{"id": 11636, "instruction": "Stylisterol Aをは化学式で表すと?", "response": "Stylisterol Aをは化学式で表すとC28H46O3です。", "task": "formula", "name_q": "Stylisterol A", "name_a": "C28H46O3"} -{"id": 25462, "instruction": "2,2,4-Trimethyl-3-(4-fluorophenyl)-2H-1-benzopyran-7-ol acetateをの組成式は?", "response": "2,2,4-Trimethyl-3-(4-fluorophenyl)-2H-1-benzopyran-7-ol acetateをの組成式はC20H19FO3です。", "task": "formula", "name_q": "2,2,4-Trimethyl-3-(4-fluorophenyl)-2H-1-benzopyran-7-ol acetate", "name_a": "C20H19FO3"} -{"id": 416, "instruction": "C18H22O5S. C4H10N2をを化学構造で書くと?", "response": "C18H22O5S. C4H10N2をを化学構造で書くとC18H22O5S. C4H10N2です。", "task": "formula", "name_q": "C18H22O5S. C4H10N2", "name_a": "C18H22O5S. C4H10N2"} -{"id": 13120, "instruction": "インデカイニド塩酸塩をは化学式で表すと?", "response": "インデカイニド塩酸塩をは化学式で表すとC20H24N2O. HClです。", "task": "formula", "name_q": "インデカイニド塩酸塩", "name_a": "C20H24N2O. HCl"} -{"id": 12836, "instruction": "3-Methylbutan-1-olの異なる名称は?", "response": "3-Methylbutan-1-olの異なる名称はIsoamyl alcoholです。", "task": "replace", "name_q": "3-Methylbutan-1-ol", "name_a": "Isoamyl alcohol"} -{"id": 9368, "instruction": "Dorzolamideをは分子式で表すと?", "response": "Dorzolamideをは分子式で表すとC10H16N2O4S3です。", "task": "formula", "name_q": "Dorzolamide", "name_a": "C10H16N2O4S3"} -{"id": 27085, "instruction": "7-Oxolumazineの別名称は?", "response": "7-Oxolumazineの別名称は6-Methyl-7-oxo-8-ribityllumazineです。", "task": "replace", "name_q": "7-Oxolumazine", "name_a": "6-Methyl-7-oxo-8-ribityllumazine"} -{"id": 12492, "instruction": "Greig cephalopolysyndactyly syndromeの日本語表記は?", "response": "Greig cephalopolysyndactyly syndromeの日本語表記はグレイグ尖頭多合指症候群です。", "task": "replace en to ja", "name_q": "Greig cephalopolysyndactyly syndrome", "name_a": "グレイグ尖頭多合指症候群"} -{"id": 27824, "instruction": "Dracunculiasisの別名称は?", "response": "Dracunculiasisの別名称はGuinea worm diseaseです。", "task": "replace", "name_q": "Dracunculiasis", "name_a": "Guinea worm disease"} -{"id": 10462, "instruction": "Miconazole nitrateをを化学構造で書くと?", "response": "Miconazole nitrateをを化学構造で書くとC18H14Cl4N2O. HNO3です。", "task": "formula", "name_q": "Miconazole nitrate", "name_a": "C18H14Cl4N2O. HNO3"} -{"id": 32265, "instruction": "Atalanineの異なる表現は?", "response": "Atalanineの異なる表現はアタラニンです。", "task": "replace", "name_q": "Atalanine", "name_a": "アタラニン"} -{"id": 4378, "instruction": "Tangeretinの別記述は?", "response": "Tangeretinの別記述は5,6,7,8,4'-Pentamethoxyflavoneです。", "task": "replace", "name_q": "Tangeretin", "name_a": "5,6,7,8,4'-Pentamethoxyflavone"} -{"id": 12755, "instruction": "Syndromic multisystem autoimmune disease SUBGROUP Multisystem autoimmune disease with facial dysmorphism (ADMFD) Autoimmune interstitial lung, joint, and kidney disease (AILJK) Autoimmune disease, susceptibility to (AIS)の日本語訳は?", "response": "Syndromic multisystem autoimmune disease SUBGROUP Multisystem autoimmune disease with facial dysmorphism (ADMFD) Autoimmune interstitial lung, joint, and kidney disease (AILJK) Autoimmune disease, susceptibility to (AIS)の日本語訳は症候群性多臓器自己免疫疾患 下位グループ 顔異形を伴う多臓器自己免疫疾患 (ADMFD) 自己免疫性間質性肺疾患、関節疾患、および腎疾患 (AILJK) 自己免疫疾患感受性 (AIS)です。", "task": "replace en to ja", "name_q": "Syndromic multisystem autoimmune disease SUBGROUP Multisystem autoimmune disease with facial dysmorphism (ADMFD) Autoimmune interstitial lung, joint, and kidney disease (AILJK) Autoimmune disease, susceptibility to (AIS)", "name_a": "症候群性多臓器自己免疫疾患 下位グループ 顔異形を伴う多臓器自己免疫疾患 (ADMFD) 自己免疫性間質性肺疾患、関節疾患、および腎疾患 (AILJK) 自己免疫疾患感受性 (AIS)"} -{"id": 16642, "instruction": "tRNA containing N1-methylguanineをは化学式で表すと?", "response": "tRNA containing N1-methylguanineをは化学式で表すとC11H16N5O8P(C5H8O6PR)n(C5H8O6PR)nです。", "task": "formula", "name_q": "tRNA containing N1-methylguanine", "name_a": "C11H16N5O8P(C5H8O6PR)n(C5H8O6PR)n"} -{"id": 19344, "instruction": "Prednisolone farnesylate (JAN)をの化学構造は?", "response": "Prednisolone farnesylate (JAN)をの化学構造はC36H50O6です。", "task": "formula", "name_q": "Prednisolone farnesylate (JAN)", "name_a": "C36H50O6"} -{"id": 2414, "instruction": "C14H14ClNS. HClを使用した薬品名は?", "response": "C14H14ClNS. HClを使用した薬品名はチクロピジン塩酸塩(陽進堂)です。", "task": "product", "name_q": "C14H14ClNS. HCl", "name_a": "チクロピジ���塩酸塩(陽進堂)"} -{"id": 26527, "instruction": "イデュルスルファーゼ (遺伝子組換え) (JAN)を英語で記述すると?", "response": "イデュルスルファーゼ (遺伝子組換え) (JAN)を英語で記述するとIdursulfase (USAN/INN)です。", "task": "replace ja to en", "name_q": "イデュルスルファーゼ (遺伝子組換え) (JAN)", "name_a": "Idursulfase (USAN/INN)"} -{"id": 7036, "instruction": "多毛症を伴う歯肉増殖症の英語表記は?", "response": "多毛症を伴う歯肉増殖症の英語表記はGingival fibromatosis with hypertrichosisです。", "task": "replace ja to en", "name_q": "多毛症を伴う歯肉増殖症", "name_a": "Gingival fibromatosis with hypertrichosis"} -{"id": 34361, "instruction": "ラルチトレキセド (JAN)を英語で書くと?", "response": "ラルチトレキセド (JAN)を英語で書くとRaltitrexed (JAN/USAN/INN)です。", "task": "replace ja to en", "name_q": "ラルチトレキセド (JAN)", "name_a": "Raltitrexed (JAN/USAN/INN)"} -{"id": 9393, "instruction": "3,4,6-Trichloro-cis-1,2-dihydroxycyclohexa-3,5-dieneをは組成式で表すと?", "response": "3,4,6-Trichloro-cis-1,2-dihydroxycyclohexa-3,5-dieneをは組成式で表すとC6H5Cl3O2です。", "task": "formula", "name_q": "3,4,6-Trichloro-cis-1,2-dihydroxycyclohexa-3,5-diene", "name_a": "C6H5Cl3O2"} -{"id": 1050, "instruction": "Glydanileを日本語で記述すると?", "response": "Glydanileを日本語で記述するとGlydanileです。", "task": "replace en to ja", "name_q": "Glydanile", "name_a": "Glydanile"} -{"id": 2864, "instruction": "Avermectin A1a aglyconeをを分子式で表すと?", "response": "Avermectin A1a aglyconeをを分子式で表すとC35H50O8です。", "task": "formula", "name_q": "Avermectin A1a aglycone", "name_a": "C35H50O8"} -{"id": 23031, "instruction": "DNTPの別記述は?", "response": "DNTPの別記述はO,O-Diethyl O-p-nitrophenyl phosphorothioateです。", "task": "replace", "name_q": "DNTP", "name_a": "O,O-Diethyl O-p-nitrophenyl phosphorothioate"} -{"id": 8164, "instruction": "アンセリンの別名称は?", "response": "アンセリンの別名称はbeta-Alanyl-N(pi)-methyl-L-histidineです。", "task": "replace", "name_q": "アンセリン", "name_a": "beta-Alanyl-N(pi)-methyl-L-histidine"} -{"id": 26999, "instruction": "C30H38N4O4. C6H6O3Sをを分子式で表すと?", "response": "C30H38N4O4. C6H6O3Sをを分子式で表すとC30H38N4O4. C6H6O3Sです。", "task": "formula", "name_q": "C30H38N4O4. C6H6O3S", "name_a": "C30H38N4O4. C6H6O3S"} -{"id": 10187, "instruction": "Cyperoloneをを化学式で記述すると?", "response": "Cyperoloneをを化学式で記述するとC15H24O2です。", "task": "formula", "name_q": "Cyperolone", "name_a": "C15H24O2"} -{"id": 3669, "instruction": "Perazine fendizoate (JAN)をを組成式で表すと?", "response": "Perazine fendizoate (JAN)をを組成式で表すと(C20H14O4)2. C20H25N3Sです。", "task": "formula", "name_q": "Perazine fendizoate (JAN)", "name_a": "(C20H14O4)2. C20H25N3S"} -{"id": 26024, "instruction": "Hutchinson-Gilford progeria syndrome SUPERGRP Progeroid laminopathy を日本語に訳すと?", "response": "Hutchinson-Gilford progeria syndrome SUPERGRP Progeroid laminopathy を日本語に訳すとハッチンソン・ギルフォード症候群 上位グループ プロジェロイド・ラミノパチー です。", "task": "replace en to ja", "name_q": "Hutchinson-Gilford progeria syndrome SUPERGRP Progeroid laminopathy ", "name_a": "ハッチンソン・ギルフォード症候群 上位グループ プロジェロイド・ラミノパチー "} -{"id": 14915, "instruction": "パルナパリンNa(扶桑薬品工業)を主材料とする商品は?", "response": "パルナパリンNa(扶桑薬品工業)を主材料とする商品はローヘパ(エイワイファーマ)です。", "task": "product", "name_q": "パルナパリンNa(扶桑薬品工業)", "name_a": "ローヘパ(エイワイファーマ)"} -{"id": 34347, "instruction": "Eupatolideをの化学式は?", "response": "Eupatolideをの化学式はC15H20O3です。", "task": "formula", "name_q": "Eupatolide", "name_a": "C15H20O3"} -{"id": 1001, "instruction": "EMPAVELI(ApellisPharmaceuticals)を使用した製品名は?", "response": "EMPAVELI(ApellisPharmaceuticals)を使用した製品名はエムパベリ(SwedishOrphanBiovitrumJapan)です。", "task": "product", "name_q": "EMPAVELI(ApellisPharmaceuticals)", "name_a": "エムパベリ(SwedishOrphanBiovitrumJapan)"} -{"id": 8587, "instruction": "Inotersen (USAN/INN)の別名は?", "response": "Inotersen (USAN/INN)の別名はイノテルセンです。", "task": "replace", "name_q": "Inotersen (USAN/INN)", "name_a": "イノテルセン"} -{"id": 1172, "instruction": "Onchidalをを化学式で書くと?", "response": "Onchidalをを化学式で書くとC17H24O3です。", "task": "formula", "name_q": "Onchidal", "name_a": "C17H24O3"} -{"id": 27770, "instruction": "メトジラジンの別表現は?", "response": "メトジラジンの別表現はMethdilazine (INN)です。", "task": "replace", "name_q": "メトジラジン", "name_a": "Methdilazine (INN)"} -{"id": 29788, "instruction": "グリミジンナトリウム (JAN)の異なる名称は?", "response": "グリミジンナトリウム (JAN)の異なる名称はGlymidine sodium (JAN/USAN/INN)です。", "task": "replace", "name_q": "グリミジンナトリウム (JAN)", "name_a": "Glymidine sodium (JAN/USAN/INN)"} -{"id": 32040, "instruction": "Versetamide (USAN/INN)の日本語表記は?", "response": "Versetamide (USAN/INN)の日本語表記はベルセタミドです。", "task": "replace en to ja", "name_q": "Versetamide (USAN/INN)", "name_a": "ベルセタミド"} -{"id": 31606, "instruction": "毛孔性紅色粃糠疹の英語表記は?", "response": "毛孔性紅色粃糠疹の英語表記はPityriasis rubra pilarisです。", "task": "replace ja to en", "name_q": "毛孔性紅色粃糠疹", "name_a": "Pityriasis rubra pilaris"} -{"id": 5831, "instruction": "Makisterone Aの別の呼び方は?", "response": "Makisterone Aの別の呼び方はマキステロン Aです。", "task": "replace", "name_q": "Makisterone A", "name_a": "マキステロン A"} -{"id": 32505, "instruction": "血清グリシン濃度正常のグリシン脳症を英語で記述すると?", "response": "血清グリシン濃度正常のグリシン脳症を英語で記述するとGlycine encephalopathy with normal serum glycineです。", "task": "replace ja to en", "name_q": "血清グリシン濃度正常のグリシン脳症", "name_a": "Glycine encephalopathy with normal serum glycine"} -{"id": 33595, "instruction": "Aderamastat (USAN/INN)の別の言い方は?", "response": "Aderamastat (USAN/INN)の別の言い方はアデラマスタットです。", "task": "replace", "name_q": "Aderamastat (USAN/INN)", "name_a": "アデラマスタット"} -{"id": 14107, "instruction": "ペグチバチナーゼの英訳は?", "response": "ペグチバチナーゼの英訳はPegtibatinase (USAN)です。", "task": "replace ja to en", "name_q": "ペグチバチナーゼ", "name_a": "Pegtibatinase (USAN)"} -{"id": 17060, "instruction": "C31H47O6. Naを利用した製品は?", "response": "C31H47O6. Naを利用した製品はフシジンレオ(アルフレッサファーマ)です。", "task": "product", "name_q": "C31H47O6. Na", "name_a": "フシジンレオ(アルフレッサファーマ)"} -{"id": 16995, "instruction": "Butalamine (INN)を英語で記述すると?", "response": "Butalamine (INN)を英語で記述するとButalamine (INN)です。", "task": "replace ja to en", "name_q": "Butalamine (INN)", "name_a": "Butalamine (INN)"} -{"id": 26727, "instruction": "ジベンゾ[a,h]ピレンをを分子式で記述すると?", "response": "ジベンゾ[a,h]ピレンをを分子式で記述するとC24H14です。", "task": "formula", "name_q": "ジベンゾ[a,h]ピレン", "name_a": "C24H14"} -{"id": 30137, "instruction": "VENLAFAXINE(QualityCareProducts)を主とした商品は?", "response": "VENLAFAXINE(QualityCareProducts)を主とした商品はVENLAFAXINEHYDROCHLORIDE(NuCarePharmaceuticals)です。", "task": "product", "name_q": "VENLAFAXINE(QualityCareProducts)", "name_a": "VENLAFAXINEHYDROCHLORIDE(NuCarePharmaceuticals)"} -{"id": 1646, "instruction": "Pipecuroniumの異なる表記は?", "response": "Pipecuroniumの異なる表記はピペクロニウムです。", "task": "replace", "name_q": "Pipecuronium", "name_a": "ピペクロニウム"} -{"id": 8631, "instruction": "タビレルミドをを組成式で書くと?", "response": "タビレルミドをを組成式で書くとC24H32N6O11です。", "task": "formula", "name_q": "タビレルミド", "name_a": "C24H32N6O11"} -{"id": 18406, "instruction": "DuP 697をを化学構造で表すと?", "response": "DuP 697をを化学構造で表すとC17H12BrFO2S2です。", "task": "formula", "name_q": "DuP 697", "name_a": "C17H12BrFO2S2"} -{"id": 3266, "instruction": "C39H70O6をの分子式は?", "response": "C39H70O6をの分子式はC39H70O6です。", "task": "formula", "name_q": "C39H70O6", "name_a": "C39H70O6"} -{"id": 18691, "instruction": "メチルドパをを分子式で表すと?", "response": "メチルドパをを分子式で表すとC10H13NO4です。", "task": "formula", "name_q": "メチルドパ", "name_a": "C10H13NO4"} -{"id": 25653, "instruction": "Novaminの別名称は?", "response": "Novaminの別名称はProchlorperazine methanesulfonateです。", "task": "replace", "name_q": "Novamin", "name_a": "Prochlorperazine methanesulfonate"} -{"id": 4535, "instruction": "プシコトリンをは組成式で表すと?", "response": "プシコトリンをは組成式で表すとC28H36N2O4です。", "task": "formula", "name_q": "プシコトリン", "name_a": "C28H36N2O4"} -{"id": 13048, "instruction": "Dimethylcarbamoyl chlorideは別の呼び方では?", "response": "Dimethylcarbamoyl chlorideは別の呼び方ではジメチルカルバモイルクロリドです。", "task": "replace", "name_q": "Dimethylcarbamoyl chloride", "name_a": "ジメチルカルバモイルク���リド"} -{"id": 29173, "instruction": "2-Carboxy-D-arabinitolをを組成式で書くと?", "response": "2-Carboxy-D-arabinitolをを組成式で書くとC6H12O7です。", "task": "formula", "name_q": "2-Carboxy-D-arabinitol", "name_a": "C6H12O7"} -{"id": 18730, "instruction": "Creston (TN)の日本語表記は?", "response": "Creston (TN)の日本語表記はRosuvastatin (INN)です。", "task": "replace en to ja", "name_q": "Creston (TN)", "name_a": "Rosuvastatin (INN)"} -{"id": 28895, "instruction": "Solution of novocain (TN)の異なる名称は?", "response": "Solution of novocain (TN)の異なる名称はProcaine (INN)です。", "task": "replace", "name_q": "Solution of novocain (TN)", "name_a": "Procaine (INN)"} -{"id": 32564, "instruction": "PEHO-like syndromeの日本語表記は?", "response": "PEHO-like syndromeの日本語表記はPEHO 様症候群です。", "task": "replace en to ja", "name_q": "PEHO-like syndrome", "name_a": "PEHO 様症候群"} -{"id": 27709, "instruction": "シンカッシオール Bの別表現は?", "response": "シンカッシオール Bの別表現はCinncassiol Bです。", "task": "replace", "name_q": "シンカッシオール B", "name_a": "Cinncassiol B"} -{"id": 11348, "instruction": "マルトースをを化学式で書くと?", "response": "マルトースをを化学式で書くとC12H22O11です。", "task": "formula", "name_q": "マルトース", "name_a": "C12H22O11"} -{"id": 30487, "instruction": "Disitamab (USAN/INN)は別の呼び方では?", "response": "Disitamab (USAN/INN)は別の呼び方ではジシタマブです。", "task": "replace", "name_q": "Disitamab (USAN/INN)", "name_a": "ジシタマブ"} -{"id": 34098, "instruction": "Benzoyl peroxideをを化学式で表すと?", "response": "Benzoyl peroxideをを化学式で表すとC14H10O4です。", "task": "formula", "name_q": "Benzoyl peroxide", "name_a": "C14H10O4"} -{"id": 2488, "instruction": "Hidermart (TN)の別呼称は?", "response": "Hidermart (TN)の別呼称はEnoxolone (INN)です。", "task": "replace", "name_q": "Hidermart (TN)", "name_a": "Enoxolone (INN)"} -{"id": 21545, "instruction": "Clear cell sarcoma of soft tissue SUPERGRP Solid tumor Soft tissue sarcomas を日本語に訳すと?", "response": "Clear cell sarcoma of soft tissue SUPERGRP Solid tumor Soft tissue sarcomas を日本語に訳すと明細胞肉腫 上位グループ 固形腫瘍 軟部肉腫 です。", "task": "replace en to ja", "name_q": "Clear cell sarcoma of soft tissue SUPERGRP Solid tumor Soft tissue sarcomas ", "name_a": "明細胞肉腫 上位グループ 固形腫瘍 軟部肉腫 "} -{"id": 12364, "instruction": "3',5'-Dihydroxyflavanoneをを化学式で表すと?", "response": "3',5'-Dihydroxyflavanoneをを化学式で表すとC15H12O4です。", "task": "formula", "name_q": "3',5'-Dihydroxyflavanone", "name_a": "C15H12O4"} -{"id": 2653, "instruction": "5-Fluorodeoxyuridineをを化学式で書くと?", "response": "5-Fluorodeoxyuridineをを化学式で書くとC9H11FN2O5です。", "task": "formula", "name_q": "5-Fluorodeoxyuridine", "name_a": "C9H11FN2O5"} -{"id": 5364, "instruction": "シチコリンナトリウムをを化学構造で書くと?", "response": "シチコリンナトリウムをを化学構造で書くとC14H25N4O11P2. Naです。", "task": "formula", "name_q": "シチコリンナトリウム", "name_a": "C14H25N4O11P2. Na"} -{"id": 18170, "instruction": "オセルタミビルの別名は?", "response": "オセルタミビルの別名はOseltamivirです。", "task": "replace", "name_q": "オセルタミビル", "name_a": "Oseltamivir"} -{"id": 22793, "instruction": "Brachydactyly-syndactyly syndromeの日本語表記は?", "response": "Brachydactyly-syndactyly syndromeの日本語表記は短指‐合指症候群です。", "task": "replace en to ja", "name_q": "Brachydactyly-syndactyly syndrome", "name_a": "短指‐合指症候群"} -{"id": 31318, "instruction": "ZITUVIO(ZydusLifesciencesLimited)を材料とする商品名は?", "response": "ZITUVIO(ZydusLifesciencesLimited)を材料とする商品名はSITAGLIPTIN(ZydusPharmaceuticals(USA)です。", "task": "product", "name_q": "ZITUVIO(ZydusLifesciencesLimited)", "name_a": "SITAGLIPTIN(ZydusPharmaceuticals(USA)"} -{"id": 17657, "instruction": "VLCAD deficiencyの日本語表記は?", "response": "VLCAD deficiencyの日本語表記はVLCAD 欠損症です。", "task": "replace en to ja", "name_q": "VLCAD deficiency", "name_a": "VLCAD 欠損症"} -{"id": 28204, "instruction": "Glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannoseをを組成式で書くと?", "response": "Glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannoseをを組成式で書くとC14H25NO14PRです。", "task": "formula", "name_q": "Glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannose", "name_a": "C14H25NO14PR"} -{"id": 32986, "instruction": "Parecoxib (USAN/INN)の日本語訳は?", "response": "Parecoxib (USAN/INN)の日本語訳はParecoxib (USAN/INN)です。", "task": "replace en to ja", "name_q": "Parecoxib (USAN/INN)", "name_a": "Parecoxib (USAN/INN)"} -{"id": 5939, "instruction": "小頭症・発育不全および姉妹染色分体交換の増加 下位グループ ブルーム症候群 の英訳は?", "response": "小頭症・発育不全および姉妹染色分体交換の増加 下位グループ ブルーム症候群 の英訳はMicrocephaly, growth restriction, and increased sister chromatid exchange SUBGROUP Bloom syndrome です。", "task": "replace ja to en", "name_q": "小頭症・発育不全および姉妹染色分体交換の増加 下位グループ ブルーム症候群 ", "name_a": "Microcephaly, growth restriction, and increased sister chromatid exchange SUBGROUP Bloom syndrome "} -{"id": 29081, "instruction": "Lymphangiomaを日本語で記述すると?", "response": "Lymphangiomaを日本語で記述するとリンパ管腫です。", "task": "replace en to ja", "name_q": "Lymphangioma", "name_a": "リンパ管腫"} -{"id": 6211, "instruction": "Serlopitant (USAN)を英語で書くと?", "response": "Serlopitant (USAN)を英語で書くとSerlopitant (USAN)です。", "task": "replace ja to en", "name_q": "Serlopitant (USAN)", "name_a": "Serlopitant (USAN)"} -{"id": 16836, "instruction": "Prosolanapyrone IIIの別の言い方は?", "response": "Prosolanapyrone IIIの別の言い方は4-Methoxy-2-oxo-6-(1E,7E,9E)-undeca-1,7,9-trien-1-yl-2H-pyran-3-carboxaldehydeです。", "task": "replace", "name_q": "Prosolanapyrone III", "name_a": "4-Methoxy-2-oxo-6-(1E,7E,9E)-undeca-1,7,9-trien-1-yl-2H-pyran-3-carboxaldehyde"} -{"id": 16821, "instruction": "Cathasteroneをは化学構造で表すと?", "response": "Cathasteroneをは化学構造で表すとC28H48O3です。", "task": "formula", "name_q": "Cathasterone", "name_a": "C28H48O3"} -{"id": 20697, "instruction": "N-Methylphenylethanolamineをは分子式で表すと?", "response": "N-Methylphenylethanolamineをは分子式で表すとC9H13NOです。", "task": "formula", "name_q": "N-Methylphenylethanolamine", "name_a": "C9H13NO"} -{"id": 24275, "instruction": "Revumenib (USAN/INN)をは組成式で表すと?", "response": "Revumenib (USAN/INN)をは組成式で表すとC32H47FN6O4Sです。", "task": "formula", "name_q": "Revumenib (USAN/INN)", "name_a": "C32H47FN6O4S"} -{"id": 28194, "instruction": "Cytidine 5'-({hydroxy[(S)-2-hydroxypropyl]phosphonoyl}phosphate)をを組成式で記述すると?", "response": "Cytidine 5'-({hydroxy[(S)-2-hydroxypropyl]phosphonoyl}phosphate)をを組成式で記述するとC12H21N3O11P2です。", "task": "formula", "name_q": "Cytidine 5'-({hydroxy[(S)-2-hydroxypropyl]phosphonoyl}phosphate)", "name_a": "C12H21N3O11P2"} -{"id": 20408, "instruction": "Ethylmorphine (BAN)をを組成式で表すと?", "response": "Ethylmorphine (BAN)をを組成式で表すとC19H23NO3です。", "task": "formula", "name_q": "Ethylmorphine (BAN)", "name_a": "C19H23NO3"} -{"id": 16615, "instruction": "Dexamethasone and glyteerの別名称は?", "response": "Dexamethasone and glyteerの別名称はデキサメタゾン・グリテールです。", "task": "replace", "name_q": "Dexamethasone and glyteer", "name_a": "デキサメタゾン・グリテール"} -{"id": 19501, "instruction": "Lonoctocog alfa (INN)を日本語で記述すると?", "response": "Lonoctocog alfa (INN)を日本語で記述するとLonoctocog alfa (INN)です。", "task": "replace en to ja", "name_q": "Lonoctocog alfa (INN)", "name_a": "Lonoctocog alfa (INN)"} -{"id": 10691, "instruction": "ペオニフロリンの別表現は?", "response": "ペオニフロリンの別表現はPaeoniflorinです。", "task": "replace", "name_q": "ペオニフロリン", "name_a": "Paeoniflorin"} -{"id": 9706, "instruction": "p-tert-Butylbenzoic acidの異なる表記は?", "response": "p-tert-Butylbenzoic acidの異なる表記は4-t-Butylbenzoic acidです。", "task": "replace", "name_q": "p-tert-Butylbenzoic acid", "name_a": "4-t-Butylbenzoic acid"} -{"id": 6426, "instruction": "Sea-blue histiocyte diseaseを日本語に訳すと?", "response": "Sea-blue histiocyte diseaseを日本語に訳すと海青組織球病です。", "task": "replace en to ja", "name_q": "Sea-blue histiocyte disease", "name_a": "海青組織球病"} -{"id": 23119, "instruction": "Hexylene glycol (NF)をを化学構造で表すと?", "response": "Hexylene glycol (NF)をを化学構造で表すとC6H14O2です。", "task": "formula", "name_q": "Hexylene glycol (NF)", "name_a": "C6H14O2"} -{"id": 29544, "instruction": "Adozelesin (USAN/INN)を日本語で書くと?", "response": "Adozelesin (USAN/INN)を日本語で書くとアドゼレシンです。", "task": "replace en to ja", "name_q": "Adozelesin (USAN/INN)", "name_a": "アドゼレシン"} -{"id": 17402, "instruction": "Tetralogy of Fallotの日本語表記は?", "response": "Tetralogy of Fallotの日本語表記はファロー四徴症です。", "task": "replace en to ja", "name_q": "Tetralogy of Fallot", "name_a": "ファロー四徴症"} -{"id": 22795, "instruction": "網膜や黄斑の変性を伴う視神経乳頭異常の英訳は?", "response": "網膜や黄斑の変性を伴う視���経乳頭異常の英訳はOptic disc anomalies with retinal and/or macular dystrophyです。", "task": "replace ja to en", "name_q": "網膜や黄斑の変性を伴う視神経乳頭異常", "name_a": "Optic disc anomalies with retinal and/or macular dystrophy"} -{"id": 2236, "instruction": "Danirixin (USAN/INN)の別名称は?", "response": "Danirixin (USAN/INN)の別名称はダニリキシンです。", "task": "replace", "name_q": "Danirixin (USAN/INN)", "name_a": "ダニリキシン"} -{"id": 34140, "instruction": "Naftalofos (USAN/INN)を英語で記述すると?", "response": "Naftalofos (USAN/INN)を英語で記述するとNaftalofos (USAN/INN)です。", "task": "replace ja to en", "name_q": "Naftalofos (USAN/INN)", "name_a": "Naftalofos (USAN/INN)"} -{"id": 14423, "instruction": "Farnesyl phosphateをの化学構造は?", "response": "Farnesyl phosphateをの化学構造はC15H27O4Pです。", "task": "formula", "name_q": "Farnesyl phosphate", "name_a": "C15H27O4P"} -{"id": 8184, "instruction": "(3R)-3-Methyl-D-ornithineをを化学式で表すと?", "response": "(3R)-3-Methyl-D-ornithineをを化学式で表すとC6H14N2O2です。", "task": "formula", "name_q": "(3R)-3-Methyl-D-ornithine", "name_a": "C6H14N2O2"} -{"id": 25598, "instruction": "Figitumumab (USAN)を日本語で書くと?", "response": "Figitumumab (USAN)を日本語で書くとフィギツムマブです。", "task": "replace en to ja", "name_q": "Figitumumab (USAN)", "name_a": "フィギツムマブ"} -{"id": 32924, "instruction": "Schizencephaly SUPERGRP Neuronal migration disorder を日本語表記で表すと?", "response": "Schizencephaly SUPERGRP Neuronal migration disorder を日本語表記で表すと裂脳症 上位グループ 神経細胞移動異常症 です。", "task": "replace en to ja", "name_q": "Schizencephaly SUPERGRP Neuronal migration disorder ", "name_a": "裂脳症 上位グループ 神経細胞移動異常症 "} -{"id": 17452, "instruction": "Raloxifene hydrochloride hydrate (JAN)をは組成式で表すと?", "response": "Raloxifene hydrochloride hydrate (JAN)をは組成式で表すとC28H27NO4S. HCl. H2Oです。", "task": "formula", "name_q": "Raloxifene hydrochloride hydrate (JAN)", "name_a": "C28H27NO4S. HCl. H2O"} -{"id": 17550, "instruction": "1,2-Dichloropropaneの別名称は?", "response": "1,2-Dichloropropaneの別名称は1,2-ジクロロプロパンです。", "task": "replace", "name_q": "1,2-Dichloropropane", "name_a": "1,2-ジクロロプロパン"} -{"id": 27977, "instruction": "Procinonide (USAN/INN)をの分子式は?", "response": "Procinonide (USAN/INN)をの分子式はC27H34F2O7です。", "task": "formula", "name_q": "Procinonide (USAN/INN)", "name_a": "C27H34F2O7"} -{"id": 18733, "instruction": "Progressive leukoencephalopathy SUBGROUP Leukoencephalopathy with vanishing white matter Megaloencephalic leukoencephalopathy with subcortical cysts Leukoencephalopathy, progressive, with ovarian failure を日本語表記で表すと?", "response": "Progressive leukoencephalopathy SUBGROUP Leukoencephalopathy with vanishing white matter Megaloencephalic leukoencephalopathy with subcortical cysts Leukoencephalopathy, progressive, with ovarian failure を日本語表記で表すと進行性白質脳症 下位グループ 白質消失病 皮質下嚢胞をもつ大頭型白質脳症 卵巣機能障害を伴う進行性白質脳症 です。", "task": "replace en to ja", "name_q": "Progressive leukoencephalopathy SUBGROUP Leukoencephalopathy with vanishing white matter Megaloencephalic leukoencephalopathy with subcortical cysts Leukoencephalopathy, progressive, with ovarian failure ", "name_a": "進行性白質脳症 下位グループ 白質消失病 皮質下嚢胞をもつ大頭型白質脳症 卵巣機能障害を伴う進行性白質脳症 "} -{"id": 3460, "instruction": "Nonacog gamma (INN)の日本語訳は?", "response": "Nonacog gamma (INN)の日本語訳はNonacog gamma (genetical recombination) (JAN)です。", "task": "replace en to ja", "name_q": "Nonacog gamma (INN)", "name_a": "Nonacog gamma (genetical recombination) (JAN)"} -{"id": 8383, "instruction": "Moxazocine (USAN/INN)の別の呼び方は?", "response": "Moxazocine (USAN/INN)の別の呼び方はモキサゾシンです。", "task": "replace", "name_q": "Moxazocine (USAN/INN)", "name_a": "モキサゾシン"} -{"id": 31502, "instruction": "Lisofylline (USAN/INN)を日本語表記で表すと?", "response": "Lisofylline (USAN/INN)を日本語表記で表すとリソフィリンです。", "task": "replace en to ja", "name_q": "Lisofylline (USAN/INN)", "name_a": "リソフィリン"} -{"id": 20669, "instruction": "3-Isopropylbut-3-enoyl-CoAをを組成式で書くと?", "response": "3-Isopropylbut-3-enoyl-CoAをを組成式で書くとC28H46N7O17P3Sです。", "task": "formula", "name_q": "3-Isopropylbut-3-enoyl-CoA", "name_a": "C28H46N7O17P3S"} -{"id": 25777, "instruction": "Hoarding disorderを日本語で書くと?", "response": "Hoarding disorderを日本語で書くと溜め込み障害です。", "task": "replace en to ja", "name_q": "Hoarding disorder", "name_a": "溜め込み障害"} -{"id": 24028, "instruction": "Cerivastatin sodium (JAN/USAN)を英語に訳すと?", "response": "Cerivastatin sodium (JAN/USAN)を英語に訳すとBaycol (TN)です。", "task": "replace ja to en", "name_q": "Cerivastatin sodium (JAN/USAN)", "name_a": "Baycol (TN)"} -{"id": 31073, "instruction": "2-Deoxystreptamine phospahteをは組成式で表すと?", "response": "2-Deoxystreptamine phospahteをは組成式で表すとC6H15N2O6Pです。", "task": "formula", "name_q": "2-Deoxystreptamine phospahte", "name_a": "C6H15N2O6P"} -{"id": 21421, "instruction": "サイログロブリン トリヨードチロニンの別呼称は?", "response": "サイログロブリン トリヨードチロニンの別呼称はThyroglobulin triiodothyronineです。", "task": "replace", "name_q": "サイログロブリン トリヨードチロニン", "name_a": "Thyroglobulin triiodothyronine"} -{"id": 26435, "instruction": "Oxydolは別の呼び方では?", "response": "Oxydolは別の呼び方ではHydrogen peroxideです。", "task": "replace", "name_q": "Oxydol", "name_a": "Hydrogen peroxide"} -{"id": 2801, "instruction": "Phosphonic acidをの分子式は?", "response": "Phosphonic acidをの分子式はH3PO3です。", "task": "formula", "name_q": "Phosphonic acid", "name_a": "H3PO3"} -{"id": 18431, "instruction": "Antiadipositum X-112 (TN)を日本語表記で表すと?", "response": "Antiadipositum X-112 (TN)を日本語表記で表すとd-Norpseudoephedrine hydrochlorideです。", "task": "replace en to ja", "name_q": "Antiadipositum X-112 (TN)", "name_a": "d-Norpseudoephedrine hydrochloride"} -{"id": 5862, "instruction": "Simeprevir (JAN/USAN)をを化学式で記述すると?", "response": "Simeprevir (JAN/USAN)をを化学式で記述するとC38H47N5O7S2です。", "task": "formula", "name_q": "Simeprevir (JAN/USAN)", "name_a": "C38H47N5O7S2"} -{"id": 26377, "instruction": "クロルフェネシンをは化学構造で表すと?", "response": "クロルフェネシンをは化学構造で表すとC9H11ClO3です。", "task": "formula", "name_q": "クロルフェネシン", "name_a": "C9H11ClO3"} -{"id": 10127, "instruction": "Hand-foot-genital syndromeを日本語で記述すると?", "response": "Hand-foot-genital syndromeを日本語で記述するとHand-foot-genital 症候群です。", "task": "replace en to ja", "name_q": "Hand-foot-genital syndrome", "name_a": "Hand-foot-genital 症候群"} -{"id": 16496, "instruction": "ネフローゼ症候群を英語に訳すと?", "response": "ネフローゼ症候群を英語に訳すとNephrotic syndromeです。", "task": "replace ja to en", "name_q": "ネフローゼ症候群", "name_a": "Nephrotic syndrome"} -{"id": 30899, "instruction": "Palmoxirate sodium (USAN)をの分子式は?", "response": "Palmoxirate sodium (USAN)をの分子式はC17H31O3. 2H2O. Naです。", "task": "formula", "name_q": "Palmoxirate sodium (USAN)", "name_a": "C17H31O3. 2H2O. Na"} -{"id": 15553, "instruction": "Chlorphenesin carbamate (JP18/USAN)をは組成式で表すと?", "response": "Chlorphenesin carbamate (JP18/USAN)をは組成式で表すとC10H12ClNO4です。", "task": "formula", "name_q": "Chlorphenesin carbamate (JP18/USAN)", "name_a": "C10H12ClNO4"} -{"id": 33314, "instruction": "ラパキスタット酢酸エステル (JAN)をの分子式は?", "response": "ラパキスタット酢酸エステル (JAN)をの分子式はC33H41ClN2O9です。", "task": "formula", "name_q": "ラパキスタット酢酸エステル (JAN)", "name_a": "C33H41ClN2O9"} -{"id": 32779, "instruction": "Alpha-methylacyl-CoA racemase deficiencyを日本語で記述すると?", "response": "Alpha-methylacyl-CoA racemase deficiencyを日本語で記述すると2-メチルアシルCoAラセマーゼ欠損症です。", "task": "replace en to ja", "name_q": "Alpha-methylacyl-CoA racemase deficiency", "name_a": "2-メチルアシルCoAラセマーゼ欠損症"} -{"id": 5299, "instruction": "4-Chloroacetophenoneの別記述は?", "response": "4-Chloroacetophenoneの別記述はp-Chloroacetophenoneです。", "task": "replace", "name_q": "4-Chloroacetophenone", "name_a": "p-Chloroacetophenone"} -{"id": 32441, "instruction": "Stepronin (INN)をの分子式は?", "response": "Stepronin (INN)をの分子式はC10H11NO4S2です。", "task": "formula", "name_q": "Stepronin (INN)", "name_a": "C10H11NO4S2"} -{"id": 32502, "instruction": "B-cell acute lymphocytic leukemia SUBGROUP Philadelphia chromosome positive acute lymphoblastic leukemia B-cell lymphoblastic lymphoma SUPERGRP Non-Hodgkin lymphoma を日本語で記述すると?", "response": "B-cell acute lymphocytic leukemia SUBGROUP Philadelphia chromosome positive acute lymphoblastic leukemia B-cell lymphoblastic lymphoma SUPERGRP Non-Hodgkin lymphoma を日本語で記述するとB細胞急性リンパ性白血病です。", "task": "replace en to ja", "name_q": "B-cell acute lymphocytic leukemia SUBGROUP Philadelphia chromosome positive acute lymphoblastic leukemia B-cell lymphoblastic lymphoma SUPERGRP Non-Hodgkin lymphoma ", "name_a": "B細胞急性リンパ性白血病"} -{"id": 9138, "instruction": "桃核承気湯(本草製薬)を材料とする製品名は?", "response": "桃核承気湯(本草製薬)を材料とする製品名は桃核承気湯(ツムラ)です。", "task": "product", "name_q": "桃核承気湯(本草製薬)", "name_a": "桃核承気湯(ツムラ)"} -{"id": 23670, "instruction": "LANTHANUMCARBONATE(ExelanPharmaceuticals)を主とした製品名は?", "response": "LANTHANUMCARBONATE(ExelanPharmaceuticals)を主とした製品名はLANTHANUMCARBONATE(PrascoLaboratories)です。", "task": "product", "name_q": "LANTHANUMCARBONATE(ExelanPharmaceuticals)", "name_a": "LANTHANUMCARBONATE(PrascoLaboratories)"} -{"id": 27208, "instruction": "5-Methyltetrahydromethanopterinの別の呼び方は?", "response": "5-Methyltetrahydromethanopterinの別の呼び方は5-Methyl-THMPTです。", "task": "replace", "name_q": "5-Methyltetrahydromethanopterin", "name_a": "5-Methyl-THMPT"} -{"id": 12053, "instruction": "Inclusion body myopathy 3 SUPERGRP Congenital myopathy の日本語訳は?", "response": "Inclusion body myopathy 3 SUPERGRP Congenital myopathy の日本語訳はInclusion body myopathy 3 上位グループ 先天性ミオパチー です。", "task": "replace en to ja", "name_q": "Inclusion body myopathy 3 SUPERGRP Congenital myopathy ", "name_a": "Inclusion body myopathy 3 上位グループ 先天性ミオパチー "} -{"id": 8705, "instruction": "柏子仁を英語で書くと?", "response": "柏子仁を英語で書くとOriental arborvitae kernelです。", "task": "replace ja to en", "name_q": "柏子仁", "name_a": "Oriental arborvitae kernel"} -{"id": 25191, "instruction": "Tacrineの別名称は?", "response": "Tacrineの別名称はタクリンです。", "task": "replace", "name_q": "Tacrine", "name_a": "タクリン"} -{"id": 22996, "instruction": "CEDNIK 症候群を英語で書くと?", "response": "CEDNIK 症候群を英語で書くとCerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndromeです。", "task": "replace ja to en", "name_q": "CEDNIK 症候群", "name_a": "Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome"} -{"id": 1228, "instruction": "2''-Adenylylgentamicin Aをを分子式で書くと?", "response": "2''-Adenylylgentamicin Aをを分子式で書くとC28H48N9O16Pです。", "task": "formula", "name_q": "2''-Adenylylgentamicin A", "name_a": "C28H48N9O16P"} -{"id": 31653, "instruction": "Lactobacillus caseiの日本語表記は?", "response": "Lactobacillus caseiの日本語表記はLactobacillus caseiです。", "task": "replace en to ja", "name_q": "Lactobacillus casei", "name_a": "Lactobacillus casei"} -{"id": 10326, "instruction": "Diphenhydramine tannate (JP18)の別名は?", "response": "Diphenhydramine tannate (JP18)の別名はRestamin A (TN)です。", "task": "replace", "name_q": "Diphenhydramine tannate (JP18)", "name_a": "Restamin A (TN)"} -{"id": 18859, "instruction": "Imeglimin hydrochloride (JAN)をを化学構造で書くと?", "response": "Imeglimin hydrochloride (JAN)をを化学構造で書くとC6H13N5. HClです。", "task": "formula", "name_q": "Imeglimin hydrochloride (JAN)", "name_a": "C6H13N5. HCl"} -{"id": 14262, "instruction": "ベータメプロジンをは組成式で表すと?", "response": "ベータメプロジンをは組成式で表すとC17H25NO2です。", "task": "formula", "name_q": "ベータメプロジン", "name_a": "C17H25NO2"} -{"id": 26633, "instruction": "C35H38Cl2N8O4を利用した医薬品名は?", "response": "C35H38Cl2N8O4を利用した医薬品名はITRACONAZOLE(AmericanHealthPackaging)です。", "task": "product", "name_q": "C35H38Cl2N8O4", "name_a": "ITRACONAZOLE(AmericanHealthPackaging)"} -{"id": 28613, "instruction": "メッケル症候群を英語で記述すると?", "response": "メッケル症候群を英語で記述するとMeckel syndromeです。", "task": "replace ja to en", "name_q": "メッケル症候群", "name_a": "Meckel syndrome"} -{"id": 30096, "instruction": "Peripheral neuropathy, myopathy, hoarseness, and hearing lossを英語表記で表すと?", "response": "Peripheral neuropathy, myopathy, hoarseness, and hearing lossを英語表記で表すとPeripheral neuropathy, myopathy, hoarseness, and hearing lossです。", "task": "replace ja to en", "name_q": "Peripheral neuropathy, myopathy, hoarseness, and hearing loss", "name_a": "Peripheral neuropathy, myopathy, hoarseness, and hearing loss"} -{"id": 18094, "instruction": "Indole-3-acetaldehydeを言い換えると?", "response": "Indole-3-acetaldehydeを言い換えるとIndoleacetaldehydeです。", "task": "replace", "name_q": "Indole-3-acetaldehyde", "name_a": "Indoleacetaldehyde"} -{"id": 27560, "instruction": "Divostrosideの別呼称は?", "response": "Divostrosideの別呼称はSarmentogenin 3-O-alpha-L-diginosideです。", "task": "replace", "name_q": "Divostroside", "name_a": "Sarmentogenin 3-O-alpha-L-diginoside"} -{"id": 9051, "instruction": "Androstanolone (INN)をの分子式は?", "response": "Androstanolone (INN)をの分子式はC19H30O2です。", "task": "formula", "name_q": "Androstanolone (INN)", "name_a": "C19H30O2"} -{"id": 4741, "instruction": "ゼニプラチンをを組成式で記述すると?", "response": "ゼニプラチンをを組成式で記述するとPt. C6H6O4. C5H14N2O2です。", "task": "formula", "name_q": "ゼニプラチン", "name_a": "Pt. C6H6O4. C5H14N2O2"} -{"id": 11362, "instruction": "DDAを言い換えると?", "response": "DDAを言い換えるとBis(4'-chlorophenyl)acetateです。", "task": "replace", "name_q": "DDA", "name_a": "Bis(4'-chlorophenyl)acetate"} -{"id": 1539, "instruction": "Zidovudine (JP18/USP/INN)を主材料とする商品は?", "response": "Zidovudine (JP18/USP/INN)を主材料とする商品はRETROVIR(ViiVHealthcareCompany)です。", "task": "product", "name_q": "Zidovudine (JP18/USP/INN)", "name_a": "RETROVIR(ViiVHealthcareCompany)"} -{"id": 9371, "instruction": "Tokishakuyakusan extract (JP18)を主材料とする商品名は?", "response": "Tokishakuyakusan extract (JP18)を主材料とする商品名は当帰芍薬散(三和生薬)です。", "task": "product", "name_q": "Tokishakuyakusan extract (JP18)", "name_a": "当帰芍薬散(三和生薬)"} -{"id": 23574, "instruction": "Very-long-chain mannosylinositol phospho-alpha-hydroxyphytoceramideをの分子式は?", "response": "Very-long-chain mannosylinositol phospho-alpha-hydroxyphytoceramideをの分子式はC32H61NO18PRです。", "task": "formula", "name_q": "Very-long-chain mannosylinositol phospho-alpha-hydroxyphytoceramide", "name_a": "C32H61NO18PR"} -{"id": 19454, "instruction": "Irtemazole (USAN/INN)をを化学構造で記述すると?", "response": "Irtemazole (USAN/INN)をを化学構造で記述するとC18H16N4です。", "task": "formula", "name_q": "Irtemazole (USAN/INN)", "name_a": "C18H16N4"} -{"id": 2927, "instruction": "Spore forming lactic acid bacteriaの異なる名称は?", "response": "Spore forming lactic acid bacteriaの異なる名称はLacbon (TN)です。", "task": "replace", "name_q": "Spore forming lactic acid bacteria", "name_a": "Lacbon (TN)"} -{"id": 10048, "instruction": "Oligonucleotide 5'-diphosphateをを組成式で書くと?", "response": "Oligonucleotide 5'-diphosphateをを組成式で書くとC5H11O10P2R(C5H8O6PR)n-1です。", "task": "formula", "name_q": "Oligonucleotide 5'-diphosphate", "name_a": "C5H11O10P2R(C5H8O6PR)n-1"} -{"id": 27196, "instruction": "Adenylosuccinateは別の呼び方では?", "response": "Adenylosuccinateは別の呼び方ではAdenylosuccinic acidです。", "task": "replace", "name_q": "Adenylosuccinate", "name_a": "Adenylosuccinic acid"} -{"id": 20719, "instruction": "Tolimidone (USAN)を日本語で書くと?", "response": "Tolimidone (USAN)を日本語で書くとTolimidone (USAN)です。", "task": "replace en to ja", "name_q": "Tolimidone (USAN)", "name_a": "Tolimidone (USAN)"} -{"id": 22868, "instruction": "Gentianadineをを組成式で記述すると?", "response": "Gentianadineをを組成式で記述するとC8H7NO2です。", "task": "formula", "name_q": "Gentianadine", "name_a": "C8H7NO2"} -{"id": 1058, "instruction": "Lasmiditan (USAN/INN)をを化学構造で記述すると?", "response": "Lasmiditan (USAN/INN)をを化学構造で記述するとC19H18F3N3O2です。", "task": "formula", "name_q": "Lasmiditan (USAN/INN)", "name_a": "C19H18F3N3O2"} -{"id": 30456, "instruction": "アチダチオンの異なる名称は?", "response": "アチダチオンの異なる名称はAthidathionです。", "task": "replace", "name_q": "アチダチオン", "name_a": "Athidathion"} -{"id": 10723, "instruction": "Carbaspirin calcium (USAN)を日本語で書くと?", "response": "Carbaspirin calcium (USAN)を日本語で書くとカルバサラートカルシウムです。", "task": "replace en to ja", "name_q": "Carbaspirin calcium (USAN)", "name_a": "カルバサラートカルシウム"} -{"id": 2892, "instruction": "Astegolimab (USAN/INN)をの化学式は?", "response": "Astegolimab (USAN/INN)をの化学式はC6424H9878N1694O2030S52です。", "task": "formula", "name_q": "Astegolimab (USAN/INN)", "name_a": "C6424H9878N1694O2030S52"} -{"id": 8332, "instruction": "UR-12947をは化学式で表すと?", "response": "UR-12947をは化学式で表すとC26H37N5O5S2です。", "task": "formula", "name_q": "UR-12947", "name_a": "C26H37N5O5S2"} -{"id": 7563, "instruction": "Hexadecanoyl-CoAをの分子式は?", "response": "Hexadecanoyl-CoAをの分子式はC37H66N7O17P3Sです。", "task": "formula", "name_q": "Hexadecanoyl-CoA", "name_a": "C37H66N7O17P3S"} -{"id": 19535, "instruction": "Homomethionineは別の呼び方では?", "response": "Homomethionineは別の呼び方ではホモメチオニンです。", "task": "replace", "name_q": "Homomethionine", "name_a": "ホモメチオニン"} -{"id": 26902, "instruction": "Lumasiran (USAN/INN)をは化学式で表すと?", "response": "Lumasiran (USAN/INN)をは化学式で表すとC530H712F10N173O320P43S6です。", "task": "formula", "name_q": "Lumasiran (USAN/INN)", "name_a": "C530H712F10N173O320P43S6"} -{"id": 24078, "instruction": "Carnitine palmitoyltransferase II deficiency SUPERGRP Disorders of mitochondrial fatty-acid oxidation Secondary hyperammonemia Mitochondrial disease Disorders of carnitine transport and the carnitine cycle の日本語表記は?", "response": "Carnitine palmitoyltransferase II deficiency SUPERGRP Disorders of mitochondrial fatty-acid oxidation Secondary hyperammonemia Mitochondrial disease Disorders of carnitine transport and the carnitine cycle の日本語表記はカルニチンパルミトイルトランスフェラーゼ II 欠損症 上位グループ ミトコンドリアの脂肪酸酸化異常症 二次性高アンモニア血症 ミトコンドリア病 カルニチン回路異常症 です。", "task": "replace en to ja", "name_q": "Carnitine palmitoyltransferase II deficiency SUPERGRP Disorders of mitochondrial fatty-acid oxidation Secondary hyperammonemia Mitochondrial disease Disorders of carnitine transport and the carnitine cycle ", "name_a": "カルニチンパルミトイルトランスフェラーゼ II 欠損症 上位グループ ミトコンドリアの脂肪酸酸化異常症 二次性高アンモニア血症 ミトコンドリア病 カルニチン回路異常症 "} -{"id": 33465, "instruction": "Ralimetinib (USAN/INN)をの組成式は?", "response": "Ralimetinib (USAN/INN)をの組成式はC24H29FN6です。", "task": "formula", "name_q": "Ralimetinib (USAN/INN)", "name_a": "C24H29FN6"} -{"id": 28235, "instruction": "(R)-3-(Phenyl)lactoyl-CoAをを化学式で表すと?", "response": "(R)-3-(Phenyl)lactoyl-CoAをを化学式で表すとC30H44N7O18P3Sです。", "task": "formula", "name_q": "(R)-3-(Phenyl)lactoyl-CoA", "name_a": "C30H44N7O18P3S"} -{"id": 20305, "instruction": "Bucetin (JAN/INN)をは組成式で表すと?", "response": "Bucetin (JAN/INN)をは組成式で表すとC12H17NO3です。", "task": "formula", "name_q": "Bucetin (JAN/INN)", "name_a": "C12H17NO3"} -{"id": 27725, "instruction": "Shiromodiol diacetateをを分子式で表すと?", "response": "Shiromodiol diacetateをを分子式で表すとC19H30O5です。", "task": "formula", "name_q": "Shiromodiol diacetate", "name_a": "C19H30O5"} -{"id": 14925, "instruction": "C12H12FN5O3をを分子式で記述すると?", "response": "C12H12FN5O3をを分子式で記述するとC12H12FN5O3です。", "task": "formula", "name_q": "C12H12FN5O3", "name_a": "C12H12FN5O3"} -{"id": 23626, "instruction": "Prepared glycyrrhiza (JP18)を主材料とする医薬品名は?", "response": "Prepared glycyrrhiza (JP18)を主材料とする医薬品名はカンゾウ(鈴粉末薬品)です。", "task": "product", "name_q": "Prepared glycyrrhiza (JP18)", "name_a": "カンゾウ(鈴粉末薬品)"} -{"id": 28193, "instruction": "Glycerophosphoglycerolをを組成式で表すと?", "response": "Glycerophosphoglycerolをを組成式で表すとC6H15O8Pです。", "task": "formula", "name_q": "Glycerophosphoglycerol", "name_a": "C6H15O8P"} -{"id": 338, "instruction": "Mannosylfructose 6-phosphateをを組成式で書くと?", "response": "Mannosylfructose 6-phosphateをを組成式で書くとC12H23O14Pです。", "task": "formula", "name_q": "Mannosylfructose 6-phosphate", "name_a": "C12H23O14P"} -{"id": 32574, "instruction": "Abnormal thyroid hormone metabolismの日本語表記は?", "response": "Abnormal thyroid hormone metabolismの日本語表記は甲状腺ホルモン代謝異常症です。", "task": "replace en to ja", "name_q": "Abnormal thyroid hormone metabolism", "name_a": "甲状腺ホルモン代謝異常症"} -{"id": 7752, "instruction": "中枢性思春期早発症 上位グループ 思春期早発症 を英語表記で表すと?", "response": "中枢性思春期早発症 上位グループ 思春期早発症 を英語表記で表すとCentral precocious puberty SUPERGRP Precocious puberty です。", "task": "replace ja to en", "name_q": "中枢性思春期早発症 上位グループ 思春期早発症 ", "name_a": "Central precocious puberty SUPERGRP Precocious puberty "} -{"id": 15941, "instruction": "バクテリオクロロフィリドdをは分子式で表すと?", "response": "バクテリオクロロフィリドdをは分子式で表すとC30H26MgN4O4(R1)(R2)です。", "task": "formula", "name_q": "バクテリオクロロフィリドd", "name_a": "C30H26MgN4O4(R1)(R2)"} -{"id": 2408, "instruction": "3,6-Dihydronicotinic acidをを化学構造で記述すると?", "response": "3,6-Dihydronicotinic acidをを化学構造で記述するとC6H7NO2です。", "task": "formula", "name_q": "3,6-Dihydronicotinic acid", "name_a": "C6H7NO2"} -{"id": 8942, "instruction": "Tasipimidine (USAN/INN)をを化学式で記述すると?", "response": "Tasipimidine (USAN/INN)をを化学式で記述するとC13H16N2O2です。", "task": "formula", "name_q": "Tasipimidine (USAN/INN)", "name_a": "C13H16N2O2"} -{"id": 8146, "instruction": "Megestrol (INN)の別記述は?", "response": "Megestrol (INN)の別記述は���ゲストロールです。", "task": "replace", "name_q": "Megestrol (INN)", "name_a": "メゲストロール"} -{"id": 32410, "instruction": "Guanadrel (INN)の別表現は?", "response": "Guanadrel (INN)の別表現はグアナドレルです。", "task": "replace", "name_q": "Guanadrel (INN)", "name_a": "グアナドレル"} -{"id": 31542, "instruction": "Fadrozole hydrochloride hydrate (JAN)をは化学構造で表すと?", "response": "Fadrozole hydrochloride hydrate (JAN)をは化学構造で表すと(C14H13N3. HCl)2. H2Oです。", "task": "formula", "name_q": "Fadrozole hydrochloride hydrate (JAN)", "name_a": "(C14H13N3. HCl)2. H2O"} -{"id": 19133, "instruction": "シデナム舞踏病の英語表記は?", "response": "シデナム舞踏病の英語表記はChorea minorです。", "task": "replace ja to en", "name_q": "シデナム舞踏病", "name_a": "Chorea minor"} -{"id": 5953, "instruction": "サリチル酸ナトリウムをは分子式で表すと?", "response": "サリチル酸ナトリウムをは分子式で表すとC7H5O3. Naです。", "task": "formula", "name_q": "サリチル酸ナトリウム", "name_a": "C7H5O3. Na"} -{"id": 2730, "instruction": "Antiogenin 3-O-alpha-L-rhamnosideの異なる名称は?", "response": "Antiogenin 3-O-alpha-L-rhamnosideの異なる名称はAntiosideです。", "task": "replace", "name_q": "Antiogenin 3-O-alpha-L-rhamnoside", "name_a": "Antioside"} -{"id": 33299, "instruction": "UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronateをを分子式で書くと?", "response": "UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronateをを分子式で書くとC17H26N4O17P2です。", "task": "formula", "name_q": "UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate", "name_a": "C17H26N4O17P2"} -{"id": 17651, "instruction": "Microleninをを分子式で書くと?", "response": "Microleninをを分子式で書くとC29H34O7です。", "task": "formula", "name_q": "Microlenin", "name_a": "C29H34O7"} -{"id": 3880, "instruction": "Cefepimeをの組成式は?", "response": "Cefepimeをの組成式はC19H24N6O5S2です。", "task": "formula", "name_q": "Cefepime", "name_a": "C19H24N6O5S2"} -{"id": 16729, "instruction": "メトヘモグロビン血症を英語で書くと?", "response": "メトヘモグロビン血症を英語で書くとMethemoglobinemiaです。", "task": "replace ja to en", "name_q": "メトヘモグロビン血症", "name_a": "Methemoglobinemia"} -{"id": 24688, "instruction": "Bornyl isovalerateの別名は?", "response": "Bornyl isovalerateの別名はHysterolです。", "task": "replace", "name_q": "Bornyl isovalerate", "name_a": "Hysterol"} -{"id": 9289, "instruction": "Terpendole Eの異なる表記は?", "response": "Terpendole Eの異なる表記はテルペンドールEです。", "task": "replace", "name_q": "Terpendole E", "name_a": "テルペンドールE"} -{"id": 27867, "instruction": "Rhodococcus equi infectionの日本語表記は?", "response": "Rhodococcus equi infectionの日本語表記はRhodococcus equi 感染です。", "task": "replace en to ja", "name_q": "Rhodococcus equi infection", "name_a": "Rhodococcus equi 感染"} -{"id": 15727, "instruction": "Neurodevelopmental disorder with structural brain abnormalities SUBGROUP RERE-related neurodevelopmental syndrome NED with ataxic gait, absent speech, and decreased cortical white matter (NDAGSCW) NED with brain anomalies and vertebral or cardiac anomalies (NEDBAVC) NED with cerebellar hypoplasia and spasticity (NEDCHS) NED with cerebellar atrophy and with seizures (NEDCAS) NED with epilepsy and hypoplasia of the corpus callosum (NEDEHCC) NED with nonspecific brain abnormalities and with seizures (NEDBAS) NED with spastic quadriplegia and brain abnormalities with seizures (NEDSBAS) NED with progressive spasticity and brain white matter abnormalities (NEDSWMA) NED with visual defects and brain anomalies (NEDVIBA) NED with variable brain abnormalities (NEDBA) NED with epilepsy, cataracts, feeding difficulties, and delayed brain myelination (NECFM) NED with midbrain and hindbrain malformations (NEDMHM) NED and structural brain anomalies with seizures and spasticity (NEDBASS) NED with alopecia and brain abnormalities (NEDABA) NED with epilepsy, spasticity, and brain atrophy (NEDESBA) NED with autistic features and structural brain abnormalities (NEDASB) NED with cerebellar atrophy and motor dysfunction (NEDCAM) NED with spasticity, cataracts, and cerebellar hypoplasia (NEDSCAC) NED with cardiomyopathy, spasticity, and brain abnormalities (NEDCASB) NED with hearing loss, seizures, and brain abnormalities (NEDCASB) NED with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy (NEDMLHB) NED with spasticity, seizures, and brain abnormalities (NEDSSBA) NED with motor and language delay, ocular defects, and brain abnormalities (NEDMLOB) NED with hyperkinetic movements, seizures, and structural brain abnormalities (NEDMSB) SUPERGRP Syndromic neurodevelopmental disorder の日本語表記は?", "response": "Neurodevelopmental disorder with structural brain abnormalities SUBGROUP RERE-related neurodevelopmental syndrome NED with ataxic gait, absent speech, and decreased cortical white matter (NDAGSCW) NED with brain anomalies and vertebral or cardiac anomalies (NEDBAVC) NED with cerebellar hypoplasia and spasticity (NEDCHS) NED with cerebellar atrophy and with seizures (NEDCAS) NED with epilepsy and hypoplasia of the corpus callosum (NEDEHCC) NED with nonspecific brain abnormalities and with seizures (NEDBAS) NED with spastic quadriplegia and brain abnormalities with seizures (NEDSBAS) NED with progressive spasticity and brain white matter abnormalities (NEDSWMA) NED with visual defects and brain anomalies (NEDVIBA) NED with variable brain abnormalities (NEDBA) NED with epilepsy, cataracts, feeding difficulties, and delayed brain myelination (NECFM) NED with midbrain and hindbrain malformations (NEDMHM) NED and structural brain anomalies with seizures and spasticity (NEDBASS) NED with alopecia and brain abnormalities (NEDABA) NED with epilepsy, spasticity, and brain atrophy (NEDESBA) NED with autistic features and structural brain abnormalities (NEDASB) NED with cerebellar atrophy and motor dysfunction (NEDCAM) NED with spasticity, cataracts, and cerebellar hypoplasia (NEDSCAC) NED with cardiomyopathy, spasticity, and brain abnormalities (NEDCASB) NED with hearing loss, seizures, and brain abnormalities (NEDCASB) NED with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy (NEDMLHB) NED with spasticity, seizures, and brain abnormalities (NEDSSBA) NED with motor and language delay, ocular defects, and brain abnormalities (NEDMLOB) NED with hyperkinetic movements, seizures, and structural brain abnormalities (NEDMSB) SUPERGRP Syndromic neurodevelopmental disorder の日本語表記は脳の構造異常を伴う神経発達障害 下位グループ RERE 関連神経発達症候群 失調性歩行、失語症および大脳白質減少を伴う神経発達障害 (NDAGSCW) 脳形態異常、脊椎や心臓の形態異常を伴う神経発達障害 (NEDBAVC) 小脳低形成および拘縮を伴う神経発達障害 (NEDCHS) 小脳萎縮および痙攣発作を伴う神経発達障害 (NEDCAS) てんかんおよび脳梁低形成を伴う神経発達障害 (NEDEHCC) 非特異性脳異常および痙攣発作を伴う神経発達障害 (NEDBAS) 痙性四肢麻痺および脳奇形と痙攣発作を伴う神経発達障害 (NEDSBAS) 進行性拘縮および大脳白質異常を伴う神経発達障害 (NEDSWMA) 視覚障害および脳の構造異常を伴う神経発達障害 (NEDVIBA) 様々な脳の構造異常を伴う神経発達障害 (NEDBA) てんかん、白内障、摂食困難および脳の髄鞘化遅延を伴う神経発達障害 (NECFM) 中脳と菱脳の奇形を伴う神経発達障害 (NEDMHM) 痙攣と拘縮を伴う神経発達障害および脳の構造異常 (NEDBASS) 脱毛と脳の異常を伴う神経発達障害 (NEDABA) 自閉症の症状と脳の構造異常を伴う神経発達障害 (NEDASB) 小脳萎縮および運動機能障害を伴う神経発達障害 (NEDCAM) 拘縮、白内障および小脳低形成を伴う神経発達障害(NEDSCAC) 心筋症、拘縮および脳の異常を伴う神経発達障害 (NEDCASB) 難聴、痙攣発作および脳の異常を伴う神経発達障害 (NEDCASB) 重度の運動障害、失語症、脳髄鞘形成不全および脳萎縮を伴う神経発達障害 (NEDMLHB) 痙縮、痙攣および脳の異常を伴う神経発達障害 (NEDSSBA) 運動と言葉の遅れ、目の欠陥および脳の異常を伴う神経発達障害 (NEDMLOB) 運動過剰、痙攣発作および脳の構造異常を伴う神経発達障害 (NEDMSB) 上位グループ 症候群性神経発達障害 です。", "task": "replace en to ja", "name_q": "Neurodevelopmental disorder with structural brain abnormalities SUBGROUP RERE-related neurodevelopmental syndrome NED with ataxic gait, absent speech, and decreased cortical white matter (NDAGSCW) NED with brain anomalies and vertebral or cardiac anomalies (NEDBAVC) NED with cerebellar hypoplasia and spasticity (NEDCHS) NED with cerebellar atrophy and with seizures (NEDCAS) NED with epilepsy and hypoplasia of the corpus callosum (NEDEHCC) NED with nonspecific brain abnormalities and with seizures (NEDBAS) NED with spastic quadriplegia and brain abnormalities with seizures (NEDSBAS) NED with progressive spasticity and brain white matter abnormalities (NEDSWMA) NED with visual defects and brain anomalies (NEDVIBA) NED with variable brain abnormalities (NEDBA) NED with epilepsy, cataracts, feeding difficulties, and delayed brain myelination (NECFM) NED with midbrain and hindbrain malformations (NEDMHM) NED and structural brain anomalies with seizures and spasticity (NEDBASS) NED with alopecia and brain abnormalities (NEDABA) NED with epilepsy, spasticity, and brain atrophy (NEDESBA) NED with autistic features and structural brain abnormalities (NEDASB) NED with cerebellar atrophy and motor dysfunction (NEDCAM) NED with spasticity, cataracts, and cerebellar hypoplasia (NEDSCAC) NED with cardiomyopathy, spasticity, and brain abnormalities (NEDCASB) NED with hearing loss, seizures, and brain abnormalities (NEDCASB) NED with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy (NEDMLHB) NED with spasticity, seizures, and brain abnormalities (NEDSSBA) NED with motor and language delay, ocular defects, and brain abnormalities (NEDMLOB) NED with hyperkinetic movements, seizures, and structural brain abnormalities (NEDMSB) SUPERGRP Syndromic neurodevelopmental disorder ", "name_a": "脳の構造異常を伴う神経発達障害 下位グループ RERE 関連神経発達症候群 失調性歩行、失語症および大脳白質減少を伴う神経発達障害 (NDAGSCW) 脳形態異常、脊椎や心臓の形態異常を伴う神経発達障害 (NEDBAVC) 小脳低形成および拘縮を伴う神経発達障害 (NEDCHS) 小脳萎縮および痙攣発作を伴う神経発達障害 (NEDCAS) てんかんおよび脳梁低形成を伴う神経発達障害 (NEDEHCC) 非特異性脳異常および痙攣発作を伴う神経発達障害 (NEDBAS) 痙性四肢麻痺および脳奇形と痙攣発作を伴う神経発達障害 (NEDSBAS) 進行性拘縮および大脳白質異常を伴う神経発達障害 (NEDSWMA) 視覚障害および脳の構造異常を伴う神経発達障害 (NEDVIBA) 様々な脳の構造異常を伴う神経発達障害 (NEDBA) てんかん、白内障、摂食困難および脳の髄鞘化遅延を伴う神経発達障害 (NECFM) 中脳と菱脳の奇形を伴う神経発達障害 (NEDMHM) 痙攣と拘縮を伴う神経発達障害および脳の構造異常 (NEDBASS) 脱毛と脳の異常を伴う神経発達障害 (NEDABA) 自閉症の症状と脳の構造異常を伴う神経発達障害 (NEDASB) 小脳萎縮および運動機能障害を伴う神経発達障害 (NEDCAM) 拘縮、白内障および小脳低形成を伴う神経発達障害(NEDSCAC) 心筋症、拘縮および脳の異常を伴う神経発達障害 (NEDCASB) 難聴、痙攣発作および脳の異常を伴う神経発達障害 (NEDCASB) 重度の運動障害、失語症、脳髄鞘形成不全および脳萎縮を伴う神経発達障害 (NEDMLHB) 痙縮、痙攣および脳の異常を伴う神経発達障害 (NEDSSBA) 運動と言葉の遅れ、目の欠陥および脳の異常を伴う神経発達障害 (NEDMLOB) 運動過剰、痙攣発作および脳の構造異常を伴う神経発達障害 (NEDMSB) 上位グループ 症候群性神経発達障害 "} -{"id": 18163, "instruction": "3,6,7,8-Tetrahydroxy-2-naphthoateをは化学構造で表すと?", "response": "3,6,7,8-Tetrahydroxy-2-naphthoateをは化学構造で表すとC11H8O6です。", "task": "formula", "name_q": "3,6,7,8-Tetrahydroxy-2-naphthoate", "name_a": "C11H8O6"} -{"id": 1079, "instruction": "Ribuloseをを組成式で書くと?", "response": "Ribuloseをを組成式で書くとC5H10O5です。", "task": "formula", "name_q": "Ribulose", "name_a": "C5H10O5"} -{"id": 21872, "instruction": "C48H78O19をを化学式で記述すると?", "response": "C48H78O19をを化学式で記述するとC48H78O19です。", "task": "formula", "name_q": "C48H78O19", "name_a": "C48H78O19"} -{"id": 22681, "instruction": "Dithranol (INN)の別の言い方は?", "response": "Dithranol (INN)の別の言い方はアントラリンです。", "task": "replace", "name_q": "Dithranol (INN)", "name_a": "アントラリン"} -{"id": 16184, "instruction": "Killed escherichia coli suspensionを日本語に訳すと?", "response": "Killed escherichia coli suspensionを日本語に訳すと大腸菌死菌浮遊液です。", "task": "replace en to ja", "name_q": "Killed escherichia coli suspension", "name_a": "大腸菌死菌浮遊液"} -{"id": 19764, "instruction": "ラミフィバン塩酸塩をを組成式で記述すると?", "response": "ラミフィバン塩酸塩をを組成式で記述するとC24H28N4O6. HClです。", "task": "formula", "name_q": "ラミフィバン塩酸塩", "name_a": "C24H28N4O6. HCl"} -{"id": 28945, "instruction": "レバミゾール塩酸塩をを分子式で記述すると?", "response": "レバミゾール塩酸塩をを分子式で記述するとC11H12N2S. HClです。", "task": "formula", "name_q": "レバミゾール塩酸塩", "name_a": "C11H12N2S. HCl"} -{"id": 22175, "instruction": "Brigimadlin (JAN/USAN/INN)をは化学式で表すと?", "response": "Brigimadlin (JAN/USAN/INN)をは化学式で表すとC31H25Cl2FN4O3です。", "task": "formula", "name_q": "Brigimadlin (JAN/USAN/INN)", "name_a": "C31H25Cl2FN4O3"} -{"id": 9348, "instruction": "Ocadusertib (USAN)をを分子式で書くと?", "response": "Ocadusertib (USAN)をを分子式で書くとC25H25N5O4です。", "task": "formula", "name_q": "Ocadusertib (USAN)", "name_a": "C25H25N5O4"} -{"id": 25894, "instruction": "UDP-3-O-[(3R)-3-hydroxyacyl]-alpha-D-glucosamineをを組成式で記述すると?", "response": "UDP-3-O-[(3R)-3-hydroxyacyl]-alpha-D-glucosamineをを組成式で記述するとC18H28N3O18P2Rです。", "task": "formula", "name_q": "UDP-3-O-[(3R)-3-hydroxyacyl]-alpha-D-glucosamine", "name_a": "C18H28N3O18P2R"} -{"id": 10535, "instruction": "Templetineをを組成式で記述すると?", "response": "Templetineをを組成式で記述するとC20H35N3です。", "task": "formula", "name_q": "Templetine", "name_a": "C20H35N3"} -{"id": 488, "instruction": "筋原線維性ミオパチー 3の英訳は?", "response": "筋原線維性ミオパチー 3の英訳はSpheroid body myopathyです。", "task": "replace ja to en", "name_q": "筋原線維性ミオパチー 3", "name_a": "Spheroid body myopathy"} -{"id": 29387, "instruction": "Selpercatinib (JAN/USAN/INN)を日本語に訳すと?", "response": "Selpercatinib (JAN/USAN/INN)を日本語に訳すとセルペルカチニブ (JAN)です。", "task": "replace en to ja", "name_q": "Selpercatinib (JAN/USAN/INN)", "name_a": "セルペルカチニブ (JAN)"} -{"id": 17803, "instruction": "フロニカミドをを化学構造で表すと?", "response": "フロニカミドをを化学構造で表すとC9H6F3N3Oです。", "task": "formula", "name_q": "フロニカミド", "name_a": "C9H6F3N3O"} -{"id": 30558, "instruction": "Utreloxastat (JAN/USAN/INN)をを化学式で記述すると?", "response": "Utreloxastat (JAN/USAN/INN)をを化学式で記述するとC18H28O2です。", "task": "formula", "name_q": "Utreloxastat (JAN/USAN/INN)", "name_a": "C18H28O2"} -{"id": 29062, "instruction": "フルプレドニデンをを化学式で表すと?", "response": "フルプレドニデンをを化学式で表すとC22H27FO5です。", "task": "formula", "name_q": "フルプレドニデン", "name_a": "C22H27FO5"} -{"id": 11039, "instruction": "Carteolol and latanoprostを日本語に訳すと?", "response": "Carteolol and latanoprostを日本語に訳すとCarteolol and latanoprostです。", "task": "replace en to ja", "name_q": "Carteolol and latanoprost", "name_a": "Carteolol and latanoprost"} -{"id": 9431, "instruction": "Mecamylamine hydrochloride (USP)を日本語に訳すと?", "response": "Mecamylamine hydrochloride (USP)を日本語に訳すとMecamylamine hydrochloride (USP)です。", "task": "replace en to ja", "name_q": "Mecamylamine hydrochloride (USP)", "name_a": "Mecamylamine hydrochloride (USP)"} -{"id": 29832, "instruction": "カウデン症候群 上位グループ PTEN過誤腫症候群 の英語表記は?", "response": "カウデン症候群 上位グループ PTEN過誤腫症候群 の英語表記はCowden syndrome SUPERGRP PTEN hamartoma tumor syndrome です。", "task": "replace ja to en", "name_q": "カウデン症候群 上位グループ PTEN過誤腫症候群 ", "name_a": "Cowden syndrome SUPERGRP PTEN hamartoma tumor syndrome "} -{"id": 30597, "instruction": "Pazufloxacin methanesulfonateの別表現は?", "response": "Pazufloxacin methanesulfonateの別表現はPasil (TN)です。", "task": "replace", "name_q": "Pazufloxacin methanesulfonate", "name_a": "Pasil (TN)"} -{"id": 27975, "instruction": "Methamphetamineをの化学式は?", "response": "Methamphetamineをの化学式はC10H15Nです。", "task": "formula", "name_q": "Methamphetamine", "name_a": "C10H15N"} -{"id": 5451, "instruction": "Carotenoid chi-end groupをの組成式は?", "response": "Carotenoid chi-end groupをの組成式はC19H23Rです。", "task": "formula", "name_q": "Carotenoid chi-end group", "name_a": "C19H23R"} -{"id": 1817, "instruction": "Nonacog alfa (genetical recombination) (JAN)の日本語表記は?", "response": "Nonacog alfa (genetical recombination) (JAN)の日本語表記はノナコグアルファ (遺伝子組換え) (JAN)です。", "task": "replace en to ja", "name_q": "Nonacog alfa (genetical recombination) (JAN)", "name_a": "ノナコグアルファ (遺伝子組換え) (JAN)"} -{"id": 7919, "instruction": "Cristacarpinをを分子式で記述すると?", "response": "Cristacarpinをを分子式で記述するとC21H22O5です。", "task": "formula", "name_q": "Cristacarpin", "name_a": "C21H22O5"} -{"id": 13753, "instruction": "Dihydrocodeine (INN)をの分子式は?", "response": "Dihydrocodeine (INN)をの分子式はC18H23NO3です。", "task": "formula", "name_q": "Dihydrocodeine (INN)", "name_a": "C18H23NO3"} -{"id": 24274, "instruction": "難聴、ジストニアおよび脳ミエリン形成不全症 下位グループ ABCD1/DXS1375E 連続欠失症候群 CADDSを英語で書くと?", "response": "難聴、ジストニアおよび脳ミエリン形成不全症 下位グループ ABCD1/DXS1375E 連続欠失症候群 CADDSを英語で書くとDeafness, dystonia, and cerebral hypomyelination SUBGROUP Contiguous ABCD1/DXS1375E deletion syndrome CADDSです。", "task": "replace ja to en", "name_q": "難聴、ジストニアおよび脳ミエリン形成不全症 下位グループ ABCD1/DXS1375E 連続欠失症候群 CADDS", "name_a": "Deafness, dystonia, and cerebral hypomyelination SUBGROUP Contiguous ABCD1/DXS1375E deletion syndrome CADDS"} -{"id": 29099, "instruction": "Reduced FMNの別記述は?", "response": "Reduced FMNの別記述はFMNH2です。", "task": "replace", "name_q": "Reduced FMN", "name_a": "FMNH2"} -{"id": 4580, "instruction": "Alicaforsen sodium (USAN)をを化学式で表すと?", "response": "Alicaforsen sodium (USAN)をを化学式で表すとC192H225N75O98P19S19. 19Naです。", "task": "formula", "name_q": "Alicaforsen sodium (USAN)", "name_a": "C192H225N75O98P19S19. 19Na"} -{"id": 10754, "instruction": "フォントリズマブの別呼称は?", "response": "フォントリズマブの別呼称はFontolizumab (USAN/INN)です。", "task": "replace", "name_q": "フォントリズマブ", "name_a": "Fontolizumab (USAN/INN)"} -{"id": 22825, "instruction": "Durekyl (TN)の異なる表記は?", "response": "Durekyl (TN)の異なる表記はResmethrinです。", "task": "replace", "name_q": "Durekyl (TN)", "name_a": "Resmethrin"} -{"id": 30995, "instruction": "REGONOL(Sandoz)を用いた商品名は?", "response": "REGONOL(Sandoz)を用いた商品名はPYRIDOSTIGMINEBROMIDE(SurgeonGeneral-DepartmentoftheArmy(TSG-DA)です。", "task": "product", "name_q": "REGONOL(Sandoz)", "name_a": "PYRIDOSTIGMINEBROMIDE(SurgeonGeneral-DepartmentoftheArmy(TSG-DA)"} -{"id": 9731, "instruction": "DOXAZOSINMESYLATE(ChartwellRX)を主材料とする医薬品名は?", "response": "DOXAZOSINMESYLATE(ChartwellRX)を主材料とする医薬品名は)です。", "task": "product", "name_q": "DOXAZOSINMESYLATE(ChartwellRX)", "name_a": ")"} -{"id": 9191, "instruction": "Uncaric acid Aをを化学式で表すと?", "response": "Uncaric acid Aをを化学式で表すとC20H22N2O4です。", "task": "formula", "name_q": "Uncaric acid A", "name_a": "C20H22N2O4"} -{"id": 31493, "instruction": "Allyl cyclohexylpropionateの別の呼び方は?", "response": "Allyl cyclohexylpropionateの別の呼び方は2-Propenyl 3-cyclohexylpropanoateです。", "task": "replace", "name_q": "Allyl cyclohexylpropionate", "name_a": "2-Propenyl 3-cyclohexylpropanoate"} -{"id": 2773, "instruction": "Cintazone (USAN)をは化学式で表すと?", "response": "Cintazone (USAN)をは化学式で表すとC22H22N2O2です。", "task": "formula", "name_q": "Cintazone (USAN)", "name_a": "C22H22N2O2"} -{"id": 31465, "instruction": "Ampicillin (USP/INN)をを分子式で表すと?", "response": "Ampicillin (USP/INN)をを分子式で表すとC16H19N3O4Sです。", "task": "formula", "name_q": "Ampicillin (USP/INN)", "name_a": "C16H19N3O4S"} -{"id": 7424, "instruction": "Quillaic acid 3-O-alpha-L-rhamnosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-apiosyl-1,3-beta-D-xylosyl-1,4-alpha-L-rhamnosyl-1,2-beta-D-fucosideをは組成式で表すと?", "response": "Quillaic acid 3-O-alpha-L-rhamnosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-apiosyl-1,3-beta-D-xylosyl-1,4-alpha-L-rhamnosyl-1,2-beta-D-fucosideをは組成式で表すとC70H110O36です。", "task": "formula", "name_q": "Quillaic acid 3-O-alpha-L-rhamnosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-apiosyl-1,3-beta-D-xylosyl-1,4-alpha-L-rhamnosyl-1,2-beta-D-fucoside", "name_a": "C70H110O36"} -{"id": 929, "instruction": "Nicotinate D-ribonucleosideは別の呼び方では?", "response": "Nicotinate D-ribonucleosideは別の呼び方ではニコチン酸D-リボヌクレオシドです。", "task": "replace", "name_q": "Nicotinate D-ribonucleoside", "name_a": "ニコチン酸D-リボヌクレオシド"} -{"id": 8226, "instruction": "Nandrolone laurateをは分子式で表すと?", "response": "Nandrolone laurateをは分子式で表すとC30H48O3です。", "task": "formula", "name_q": "Nandrolone laurate", "name_a": "C30H48O3"} -{"id": 23368, "instruction": "Sulfatideの異なる表記は?", "response": "Sulfatideの異なる表記はスルファチドです。", "task": "replace", "name_q": "Sulfatide", "name_a": "スルファチド"} -{"id": 29465, "instruction": "Dextranomer (INN)を日本語で書くと?", "response": "Dextranomer (INN)を日本語で書くとデキストラノマーです。", "task": "replace en to ja", "name_q": "Dextranomer (INN)", "name_a": "デキストラノマー"} -{"id": 25618, "instruction": "完全大血管転位症の英訳は?", "response": "完全大血管転位症の英訳はComplete transposition of the great arteriesです。", "task": "replace ja to en", "name_q": "完全大血管転位症", "name_a": "Complete transposition of the great arteries"} -{"id": 28068, "instruction": "Halofenate (USAN/INN)の異なる名称は?", "response": "Halofenate (USAN/INN)の異なる名称はハロフェナートです。", "task": "replace", "name_q": "Halofenate (USAN/INN)", "name_a": "ハロフェナート"} -{"id": 14459, "instruction": "NICARDIPINEHYDROCHLORIDE(AuroMedicsPharmaLLC)を用いた医薬品は?", "response": "NICARDIPINEHYDROCHLORIDE(AuroMedicsPharmaLLC)を用いた医薬品はNICARDIPINEHYDROCHLORIDE(SQUAREPHARMACEUTICALSLIMITED)です。", "task": "product", "name_q": "NICARDIPINEHYDROCHLORIDE(AuroMedicsPharmaLLC)", "name_a": "NICARDIPINEHYDROCHLORIDE(SQUAREPHARMACEUTICALSLIMITED)"} -{"id": 16963, "instruction": "Stresnil (TN)を日本語に訳すと?", "response": "Stresnil (TN)を日本語に訳すとAzaperone (USP/INN)です。", "task": "replace en to ja", "name_q": "Stresnil (TN)", "name_a": "Azaperone (USP/INN)"} -{"id": 33178, "instruction": "フェンホルミンをは分子式で表すと?", "response": "フェンホルミンをは分子式で表すとC10H15N5です。", "task": "formula", "name_q": "フェンホルミン", "name_a": "C10H15N5"} -{"id": 8951, "instruction": "C11H14FNO3をを化学構造で表すと?", "response": "C11H14FNO3をを化学構造で表すとC11H14FNO3です。", "task": "formula", "name_q": "C11H14FNO3", "name_a": "C11H14FNO3"} -{"id": 13808, "instruction": "Myrtenalをの化学式は?", "response": "Myrtenalをの化学式はC10H14Oです。", "task": "formula", "name_q": "Myrtenal", "name_a": "C10H14O"} -{"id": 13744, "instruction": "XE991をを化学式で書くと?", "response": "XE991をを化学式で書くとC26H20N2Oです。", "task": "formula", "name_q": "XE991", "name_a": "C26H20N2O"} -{"id": 12049, "instruction": "dTMPの別表現は?", "response": "dTMPの別表現はThymidylic acidです。", "task": "replace", "name_q": "dTMP", "name_a": "Thymidylic acid"} -{"id": 28645, "instruction": "Benzydamine (INN)は別の呼び方では?", "response": "Benzydamine (INN)は別の呼び方ではApo-Benzydamine (TN)です。", "task": "replace", "name_q": "Benzydamine (INN)", "name_a": "Apo-Benzydamine (TN)"} -{"id": 3573, "instruction": "O-アセチル-L-セリンをの分子式は?", "response": "O-アセチル-L-セリンをの分子式はC5H9NO4です。", "task": "formula", "name_q": "O-アセチル-L-セリン", "name_a": "C5H9NO4"} -{"id": 8378, "instruction": "C10H15Nをを組成式で記述すると?", "response": "C10H15Nをを組成式で記述するとC10H15Nです。", "task": "formula", "name_q": "C10H15N", "name_a": "C10H15N"} -{"id": 27307, "instruction": "Tilmicosin phosphate (USAN)の日本語表記は?", "response": "Tilmicosin phosphate (USAN)の日本語表記はTilmicosin phosphate (USAN)です。", "task": "replace en to ja", "name_q": "Tilmicosin phosphate (USAN)", "name_a": "Tilmicosin phosphate (USAN)"} -{"id": 24120, "instruction": "アムリンチドを英語表記で表すと?", "response": "アムリンチドを英語表記で表すとAmlintide (USAN/INN)です。", "task": "replace ja to en", "name_q": "アムリンチド", "name_a": "Amlintide (USAN/INN)"} -{"id": 17518, "instruction": "Glycogen storage disease type 0aの別表現は?", "response": "Glycogen storage disease type 0aの別表現はLiver glycogen synthase deficiency SUPERGRP Glycogen storage disease Hepatic glycogen storage disease です。", "task": "replace", "name_q": "Glycogen storage disease type 0a", "name_a": "Liver glycogen synthase deficiency SUPERGRP Glycogen storage disease Hepatic glycogen storage disease "} -{"id": 828, "instruction": "Difenoxin (USAN/INN)をを化学構造で書くと?", "response": "Difenoxin (USAN/INN)をを化学構造で書くとC28H28N2O2です。", "task": "formula", "name_q": "Difenoxin (USAN/INN)", "name_a": "C28H28N2O2"} -{"id": 898, "instruction": "Tetracenomycin Xをは分子式で表すと?", "response": "Tetracenomycin Xをは分子式で表すとC24H22O11です。", "task": "formula", "name_q": "Tetracenomycin X", "name_a": "C24H22O11"} -{"id": 11230, "instruction": "Oxaprozinの異なる名称は?", "response": "Oxaprozinの異なる名称はオキサプロジンです。", "task": "replace", "name_q": "Oxaprozin", "name_a": "オキサプロジン"} -{"id": 11711, "instruction": "アレタミン塩酸塩を英語表記で表すと?", "response": "アレタミン塩酸塩を英語表記で表すとAletamine hydrochloride (USAN)です。", "task": "replace ja to en", "name_q": "アレタミン塩酸塩", "name_a": "Aletamine hydrochloride (USAN)"} -{"id": 8542, "instruction": "酒石酸水素メタラミノール (JAN)の別記述は?", "response": "酒石酸水素メタラミノール (JAN)の別記述はMetaraminol bitartrate (JAN/USP)です。", "task": "replace", "name_q": "酒石酸水素メタラミノール (JAN)", "name_a": "Metaraminol bitartrate (JAN/USP)"} -{"id": 18202, "instruction": "ホスホエノールピルビン酸カルボキシキナーゼ欠損症を英語で記述すると?", "response": "ホスホエノールピルビン酸カルボキシキナーゼ欠損症を英語で記述するとPhosphoenolpyruvate carboxykinase deficiencyです。", "task": "replace ja to en", "name_q": "ホスホエノールピルビン酸カルボキシキナーゼ欠損症", "name_a": "Phosphoenolpyruvate carboxykinase deficiency"} -{"id": 14797, "instruction": "Clotrimazoleをは分子式で表すと?", "response": "Clotrimazoleをは分子式で表すとC22H17ClN2です。", "task": "formula", "name_q": "Clotrimazole", "name_a": "C22H17ClN2"} -{"id": 28857, "instruction": "Encukalnerの別記述は?", "response": "Encukalnerの別記述はAzetukalner (USAN/INN)です。", "task": "replace", "name_q": "Encukalner", "name_a": "Azetukalner (USAN/INN)"} -{"id": 31934, "instruction": "オペルコナゾールの別名は?", "response": "オペルコナゾールの別名はOpelconazole (USAN/INN)です。", "task": "replace", "name_q": "オペルコナゾール", "name_a": "Opelconazole (USAN/INN)"} -{"id": 8508, "instruction": "Ammonia water (JP18)を使用した薬品は?", "response": "Ammonia water (JP18)を使用した薬品はアンモニア水(恵美須薬品化工)です。", "task": "product", "name_q": "Ammonia water (JP18)", "name_a": "アンモニア水(恵美須薬品化工)"} -{"id": 34431, "instruction": "Epomediolの別記述は?", "response": "Epomediolの別記述はエポメジオールです。", "task": "replace", "name_q": "Epomediol", "name_a": "エポメジオール"} -{"id": 5879, "instruction": "Bilastine (JAN/INN)を主材料とする製品は?", "response": "Bilastine (JAN/INN)を主材料とする製品はビラノア(大鵬薬品工業)です。", "task": "product", "name_q": "Bilastine (JAN/INN)", "name_a": "ビラノア(大鵬薬品工業)"} -{"id": 11458, "instruction": "Prolyse (TN)を日本語表記で表すと?", "response": "Prolyse (TN)を日本語表記で表すとナサルプラーゼベータです。", "task": "replace en to ja", "name_q": "Prolyse (TN)", "name_a": "ナサルプラーゼベータ"} -{"id": 4518, "instruction": "D1927をを化学式で記述すると?", "response": "D1927をを化学式で記述するとC21H36N4O5Sです。", "task": "formula", "name_q": "D1927", "name_a": "C21H36N4O5S"} -{"id": 532, "instruction": "beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphospho-ditrans,octacis-undecaprenolをは化学式で表すと?", "response": "beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphospho-ditrans,octacis-undecaprenolをは化学式で表すとC94H156N8O26P2です。", "task": "formula", "name_q": "beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphospho-ditrans,octacis-undecaprenol", "name_a": "C94H156N8O26P2"} -{"id": 33330, "instruction": "クレマチキネノシド Bをの化学構造は?", "response": "クレマチキネノシド Bをの化学構造はC70H114O35です。", "task": "formula", "name_q": "クレマチキネノシド B", "name_a": "C70H114O35"} -{"id": 28546, "instruction": "クラミジア性尿道炎の別の言い方は?", "response": "クラミジア性尿道炎の別の言い方は性器クラミジア感染症です。", "task": "replace", "name_q": "クラミジア性尿道炎", "name_a": "性器クラミジア感染症"} -{"id": 32280, "instruction": "Hopantenic acid (INN)をは組成式で表すと?", "response": "Hopantenic acid (INN)をは組成式で表すとC10H19NO5です。", "task": "formula", "name_q": "Hopantenic acid (INN)", "name_a": "C10H19NO5"} -{"id": 33130, "instruction": "3-Enolpyruvoylanthranilateをの組成式は?", "response": "3-Enolpyruvoylanthranilateをの組成式はC10H9NO5です。", "task": "formula", "name_q": "3-Enolpyruvoylanthranilate", "name_a": "C10H9NO5"} -{"id": 25568, "instruction": "Apo-[acetyl-CoA:carbon-dioxide ligase (ADP-forming)]をを分子式で記述すると?", "response": "Apo-[acetyl-CoA:carbon-dioxide ligase (ADP-forming)]をを分子式で記述するとC7H13N3O2R2です。", "task": "formula", "name_q": "Apo-[acetyl-CoA:carbon-dioxide ligase (ADP-forming)]", "name_a": "C7H13N3O2R2"} -{"id": 26449, "instruction": "6-Ketoxycyclohex-1-ene-1-carboxyl-CoAをを化学式で表すと?", "response": "6-Ketoxycyclohex-1-ene-1-carboxyl-CoAをを化学式で表すとC28H42N7O18P3Sです。", "task": "formula", "name_q": "6-Ketoxycyclohex-1-ene-1-carboxyl-CoA", "name_a": "C28H42N7O18P3S"} -{"id": 29815, "instruction": "Wiedemann-Steiner syndromeを日本語で書くと?", "response": "Wiedemann-Steiner syndromeを日本語で書くとウィデマンスタイナー症候群です。", "task": "replace en to ja", "name_q": "Wiedemann-Steiner syndrome", "name_a": "ウィデマンスタイナー症候群"} -{"id": 10044, "instruction": "Glucaric acidを言い換えると?", "response": "Glucaric acidを言い換えるとL-Gularic acidです。", "task": "replace", "name_q": "Glucaric acid", "name_a": "L-Gularic acid"} -{"id": 28131, "instruction": "Peroxisomal acyl-CoA oxidase deficiency SUPERGRP Peroxisomal beta-oxidation enzyme deficiency を日本語に訳すと?", "response": "Peroxisomal acyl-CoA oxidase deficiency SUPERGRP Peroxisomal beta-oxidation enzyme deficiency を日本語に訳すとペルオキシソームアシルCoAオキシダーゼ欠損症 上位グループ ペルオキシソームβ酸化系酵素欠損症 です。", "task": "replace en to ja", "name_q": "Peroxisomal acyl-CoA oxidase deficiency SUPERGRP Peroxisomal beta-oxidation enzyme deficiency ", "name_a": "ペルオキシソームアシルCoAオキシダーゼ欠損症 上位グループ ペルオキシソームβ酸化系酵素欠損症 "} -{"id": 30609, "instruction": "Tabelecleucel (USAN)を日本語に訳すと?", "response": "Tabelecleucel (USAN)を日本語に訳すとタベレクルユーセルです。", "task": "replace en to ja", "name_q": "Tabelecleucel (USAN)", "name_a": "タベレクルユーセル"} -{"id": 31178, "instruction": "Stilbamidine dihydrochlorideをは化学構造で表すと?", "response": "Stilbamidine dihydrochlorideをは化学構造で表すとC16H16N4. 2HClです。", "task": "formula", "name_q": "Stilbamidine dihydrochloride", "name_a": "C16H16N4. 2HCl"} -{"id": 7823, "instruction": "ペゴテラートをは化学構造で表すと?", "response": "ペゴテラートをは化学構造で表すと(C10H8O4)nです。", "task": "formula", "name_q": "ペゴテラート", "name_a": "(C10H8O4)n"} -{"id": 14902, "instruction": "Lantrisul (TN)の別表現は?", "response": "Lantrisul (TN)の別表現はTrisulfapyrimidines (USP)です。", "task": "replace", "name_q": "Lantrisul (TN)", "name_a": "Trisulfapyrimidines (USP)"} -{"id": 26350, "instruction": "ベトラブチンを英語表記で表すと?", "response": "ベトラブチンを英語表記で表すとMonzal (TN)です。", "task": "replace ja to en", "name_q": "ベトラブチン", "name_a": "Monzal (TN)"} -{"id": 16915, "instruction": "Cabagin-U (TN)を主材料とする商品は?", "response": "Cabagin-U (TN)を主材料とする商品はキャベジン(興和)です。", "task": "product", "name_q": "Cabagin-U (TN)", "name_a": "キャベジン(興和)"} -{"id": 16239, "instruction": "Astragaloside IVをは分子式で表すと?", "response": "Astragaloside IVをは分子式で表すとC41H68O14です。", "task": "formula", "name_q": "Astragaloside IV", "name_a": "C41H68O14"} -{"id": 807, "instruction": "Befunolol hydrochloride (JAN)をは分子式で表すと?", "response": "Befunolol hydrochloride (JAN)をは分子式で表すとC16H22NO4. Clです。", "task": "formula", "name_q": "Befunolol hydrochloride (JAN)", "name_a": "C16H22NO4. Cl"} -{"id": 4842, "instruction": "プロバマー酢酸塩を英語で記述すると?", "response": "プロバマー酢酸塩を英語で記述するとPlovamer acetate (USAN)です。", "task": "replace ja to en", "name_q": "プロバマー酢酸塩", "name_a": "Plovamer acetate (USAN)"} -{"id": 4856, "instruction": "C14H22N2O3をを化学構造で記述すると?", "response": "C14H22N2O3をを化学構造で記述するとC14H22N2O3です。", "task": "formula", "name_q": "C14H22N2O3", "name_a": "C14H22N2O3"} -{"id": 19044, "instruction": "多剤耐性緑膿菌感染症の英語表記は?", "response": "多剤耐性緑膿菌感染症の英語表記はMultidrug-resistant Pseudomonas aeruginosa infectionです。", "task": "replace ja to en", "name_q": "多剤耐性緑膿菌感染症", "name_a": "Multidrug-resistant Pseudomonas aeruginosa infection"} -{"id": 15253, "instruction": "Tamoplex (TN)の異なる表現は?", "response": "Tamoplex (TN)の異なる表現はTamoxifen (TN)です。", "task": "replace", "name_q": "Tamoplex (TN)", "name_a": "Tamoxifen (TN)"} -{"id": 2075, "instruction": "12-Oxo-10,15(Z)-phytodienoic acidの異なる名称は?", "response": "12-Oxo-10,15(Z)-phytodienoic acidの異なる名称は(15Z)-12-Oxophyto-10,15-dienoic acidです。", "task": "replace", "name_q": "12-Oxo-10,15(Z)-phytodienoic acid", "name_a": "(15Z)-12-Oxophyto-10,15-dienoic acid"} -{"id": 3008, "instruction": "フラビンアデニンジヌクレオチドナトリウム・リン酸ピリドキサールを英語に訳すと?", "response": "フラビンアデニンジヌクレオチドナトリウム・リン酸ピリドキサールを英語に訳すとFlavin adenine dinucleotide sodium and pyridoxal phosphateです。", "task": "replace ja to en", "name_q": "フラビンアデニンジヌクレオチドナトリウム・リン酸ピリドキサール", "name_a": "Flavin adenine dinucleotide sodium and pyridoxal phosphate"} -{"id": 17085, "instruction": "オレイン酸ナトリウムの異なる表記は?", "response": "オレイン酸ナトリウムの異なる表記はSodium oleateです。", "task": "replace", "name_q": "オレイン酸ナトリウム", "name_a": "Sodium oleate"} -{"id": 28652, "instruction": "Isomaltoseの異なる名称は?", "response": "Isomaltoseの異なる名称はBrachioseです。", "task": "replace", "name_q": "Isomaltose", "name_a": "Brachiose"} -{"id": 1142, "instruction": "チベメシルノンをを分子式で書くと?", "response": "チベメシルノンをを分子式で書くとC24H27Cl2F3N6Oです。", "task": "formula", "name_q": "チベメシルノン", "name_a": "C24H27Cl2F3N6O"} -{"id": 4327, "instruction": "(1S,2E,6E,10R)-3,7-Dimethyl-10-(propan-2-yl)cyclodeca-2,6-dien-1-olをの化学式は?", "response": "(1S,2E,6E,10R)-3,7-Dimethyl-10-(propan-2-yl)cyclodeca-2,6-dien-1-olをの化学式はC15H26Oです。", "task": "formula", "name_q": "(1S,2E,6E,10R)-3,7-Dimethyl-10-(propan-2-yl)cyclodeca-2,6-dien-1-ol", "name_a": "C15H26O"} -{"id": 18062, "instruction": "アベキシチド酢酸塩の英訳は?", "response": "アベキシチド酢酸塩の英訳はAvexitide acetate (USAN)です。", "task": "replace ja to en", "name_q": "アベキシチド酢酸塩", "name_a": "Avexitide acetate (USAN)"} -{"id": 31359, "instruction": "Mosegor (TN)を日本語に訳すと?", "response": "Mosegor (TN)を日本語に訳すとPizotifen malateです。", "task": "replace en to ja", "name_q": "Mosegor (TN)", "name_a": "Pizotifen malate"} -{"id": 18879, "instruction": "Fosdagrocorat (USAN/INN)の英語表記は?", "response": "Fosdagrocorat (USAN/INN)の英語表記はFosdagrocorat (USAN/INN)です。", "task": "replace ja to en", "name_q": "Fosdagrocorat (USAN/INN)", "name_a": "Fosdagrocorat (USAN/INN)"} -{"id": 21331, "instruction": "6alpha,11beta,17,21-Tetrahydroxypregn-4-ene-3,20-dioneをは化学構造で表すと?", "response": "6alpha,11beta,17,21-Tetrahydroxypregn-4-ene-3,20-dioneをは化学構造で表すとC21H30O6です。", "task": "formula", "name_q": "6alpha,11beta,17,21-Tetrahydroxypregn-4-ene-3,20-dione", "name_a": "C21H30O6"} -{"id": 17725, "instruction": "Rapeseed oil, fully hydrogenated (NF)の英訳は?", "response": "Rapeseed oil, fully hydrogenated (NF)の英訳はRapeseed oil, fully hydrogenated (NF)です。", "task": "replace ja to en", "name_q": "Rapeseed oil, fully hydrogenated (NF)", "name_a": "Rapeseed oil, fully hydrogenated (NF)"} -{"id": 17266, "instruction": "3'-Amino-3'-deoxy-AMPをの化学構造は?", "response": "3'-Amino-3'-deoxy-AMPをの化学構造はC10H15N6O6Pです。", "task": "formula", "name_q": "3'-Amino-3'-deoxy-AMP", "name_a": "C10H15N6O6P"} -{"id": 13654, "instruction": "ナラトリプタンの別表現は?", "response": "ナラトリプタンの別表現はNaratriptan (INN)です。", "task": "replace", "name_q": "ナラトリプタン", "name_a": "Naratriptan (INN)"} -{"id": 23164, "instruction": "Glycogen storage disease type X SUPERGRP Glycogen storage disease Muscle glycogen storage disease を日本語で記述すると?", "response": "Glycogen storage disease type X SUPERGRP Glycogen storage disease Muscle glycogen storage disease を日本語で記述すると糖原病 X 型 上位グループ 糖原病 筋型糖原病 です。", "task": "replace en to ja", "name_q": "Glycogen storage disease type X SUPERGRP Glycogen storage disease Muscle glycogen storage disease ", "name_a": "糖原病 X 型 上位グループ 糖原病 筋型糖原病 "} -{"id": 8043, "instruction": "Desogestrelの別名称は?", "response": "Desogestrelの別名称はデソゲストレルです。", "task": "replace", "name_q": "Desogestrel", "name_a": "デソゲストレル"} -{"id": 6082, "instruction": "Poldine metilsulfateを日本語に訳すと?", "response": "Poldine metilsulfateを日本語に訳すとPoldine methylsulfate (USAN)です。", "task": "replace en to ja", "name_q": "Poldine metilsulfate", "name_a": "Poldine methylsulfate (USAN)"} -{"id": 15736, "instruction": "Sonrotoclax (USAN/INN)をを化学式で表すと?", "response": "Sonrotoclax (USAN/INN)をを化学式で表すとC49H59N7O7Sです。", "task": "formula", "name_q": "Sonrotoclax (USAN/INN)", "name_a": "C49H59N7O7S"} -{"id": 11387, "instruction": "Chondroitin sulfate Cの異なる表記は?", "response": "Chondroitin sulfate Cの異なる表記はChondroitin 6-sulfateです。", "task": "replace", "name_q": "Chondroitin sulfate C", "name_a": "Chondroitin 6-sulfate"} -{"id": 14823, "instruction": "Glycoprotein phospho-D-mannoseをは化学構造で表すと?", "response": "Glycoprotein phospho-D-mannoseをは化学構造で表すとC6H12O9PRです。", "task": "formula", "name_q": "Glycoprotein phospho-D-mannose", "name_a": "C6H12O9PR"} -{"id": 9454, "instruction": "N-Nitrosomethanamineをを化学構造で記述すると?", "response": "N-Nitrosomethanamineをを化学構造で記述するとCH4N2Oです。", "task": "formula", "name_q": "N-Nitrosomethanamine", "name_a": "CH4N2O"} -{"id": 12208, "instruction": "Flubron (TN)をを組成式で書くと?", "response": "Flubron (TN)をを組成式で書くとC24H29FNO3. Br. H2Oです。", "task": "formula", "name_q": "Flubron (TN)", "name_a": "C24H29FNO3. Br. H2O"} -{"id": 27700, "instruction": "Congenital central hypoventilation syndromeを日本語で書くと?", "response": "Congenital central hypoventilation syndromeを日本語で書くと先天性中枢性低換気症候群です。", "task": "replace en to ja", "name_q": "Congenital central hypoventilation syndrome", "name_a": "先天性中枢性低換気症候群"} -{"id": 12379, "instruction": "1-Chloro-2-(chlorophenylmethyl)benzeneをの化学式は?", "response": "1-Chloro-2-(chlorophenylmethyl)benzeneをの化学式はC13H10Cl2です。", "task": "formula", "name_q": "1-Chloro-2-(chlorophenylmethyl)benzene", "name_a": "C13H10Cl2"} -{"id": 34331, "instruction": "2-Hydroxy-4-(1-oxo-1,3-dihydro-2H-inden-2-ylidene)-but-2-enoic acidをを組成式で書くと?", "response": "2-Hydroxy-4-(1-oxo-1,3-dihydro-2H-inden-2-ylidene)-but-2-enoic acidをを組成式で書くとC13H10O4です。", "task": "formula", "name_q": "2-Hydroxy-4-(1-oxo-1,3-dihydro-2H-inden-2-ylidene)-but-2-enoic acid", "name_a": "C13H10O4"} -{"id": 2832, "instruction": "Filaminast (USAN/INN)を日本語に訳すと?", "response": "Filaminast (USAN/INN)��日本語に訳すとフィラミナストです。", "task": "replace en to ja", "name_q": "Filaminast (USAN/INN)", "name_a": "フィラミナスト"} -{"id": 22231, "instruction": "1,2,3-トリクロロベンゼンをを化学式で記述すると?", "response": "1,2,3-トリクロロベンゼンをを化学式で記述するとC6H3Cl3です。", "task": "formula", "name_q": "1,2,3-トリクロロベンゼン", "name_a": "C6H3Cl3"} -{"id": 22398, "instruction": "Pamaqueside (USAN/INN)をを組成式で表すと?", "response": "Pamaqueside (USAN/INN)をを組成式で表すとC39H62O14です。", "task": "formula", "name_q": "Pamaqueside (USAN/INN)", "name_a": "C39H62O14"} -{"id": 13030, "instruction": "ピロバレロン塩酸塩をを化学構造で記述すると?", "response": "ピロバレロン塩酸塩をを化学構造で記述するとC16H23NO. HClです。", "task": "formula", "name_q": "ピロバレロン塩酸塩", "name_a": "C16H23NO. HCl"} -{"id": 8466, "instruction": "放線菌腫の英訳は?", "response": "放線菌腫の英訳はActinomycetomaです。", "task": "replace ja to en", "name_q": "放線菌腫", "name_a": "Actinomycetoma"} -{"id": 27853, "instruction": "(S)-1,2-エポキシプロパンをを化学構造で表すと?", "response": "(S)-1,2-エポキシプロパンをを化学構造で表すとC3H6Oです。", "task": "formula", "name_q": "(S)-1,2-エポキシプロパン", "name_a": "C3H6O"} -{"id": 27832, "instruction": "Chivosazole Eをを分子式で記述すると?", "response": "Chivosazole Eをを分子式で記述するとC46H65NO12です。", "task": "formula", "name_q": "Chivosazole E", "name_a": "C46H65NO12"} -{"id": 9582, "instruction": "CDP-glucoseをを化学式で記述すると?", "response": "CDP-glucoseをを化学式で記述するとC15H25N3O16P2です。", "task": "formula", "name_q": "CDP-glucose", "name_a": "C15H25N3O16P2"} -{"id": 13765, "instruction": "C6360H9848N1692O2030S44をは分子式で表すと?", "response": "C6360H9848N1692O2030S44をは分子式で表すとC6360H9848N1692O2030S44です。", "task": "formula", "name_q": "C6360H9848N1692O2030S44", "name_a": "C6360H9848N1692O2030S44"} -{"id": 24166, "instruction": "Occipital horn syndrome SUPERGRP Menkes syndrome を日本語で記述すると?", "response": "Occipital horn syndrome SUPERGRP Menkes syndrome を日本語で記述するとオクシピタル・ホーン症候群 上位グループ メンケス症候群 です。", "task": "replace en to ja", "name_q": "Occipital horn syndrome SUPERGRP Menkes syndrome ", "name_a": "オクシピタル・ホーン症候群 上位グループ メンケス症候群 "} -{"id": 17997, "instruction": "Olmutinib (USAN/INN)を日本語で記述すると?", "response": "Olmutinib (USAN/INN)を日本語で記述するとOlmutinib (USAN/INN)です。", "task": "replace en to ja", "name_q": "Olmutinib (USAN/INN)", "name_a": "Olmutinib (USAN/INN)"} -{"id": 13367, "instruction": "(-)-Bisdechlorogeodinをを化学式で書くと?", "response": "(-)-Bisdechlorogeodinをを化学式で書くとC17H14O7です。", "task": "formula", "name_q": "(-)-Bisdechlorogeodin", "name_a": "C17H14O7"} -{"id": 31640, "instruction": "アラプロクラートの別呼称は?", "response": "アラプロクラートの別呼称はAlaproclate (USAN/INN)です。", "task": "replace", "name_q": "アラプロクラート", "name_a": "Alaproclate (USAN/INN)"} -{"id": 7885, "instruction": "3-Hydroxykynurenamineをを分子式で表すと?", "response": "3-Hydroxykynurenamineをを分子式で表すとC9H12N2O2です。", "task": "formula", "name_q": "3-Hydroxykynurenamine", "name_a": "C9H12N2O2"} -{"id": 633, "instruction": "ククルビタシンの別の呼び方は?", "response": "ククルビタシンの別の呼び方はCucurbitacinです。", "task": "replace", "name_q": "ククルビタシン", "name_a": "Cucurbitacin"} -{"id": 10114, "instruction": "DIMETHYLFUMARATE(AmnealPharmaceuticalsNYLLC)を主とした製品名は?", "response": "DIMETHYLFUMARATE(AmnealPharmaceuticalsNYLLC)を主とした製品名はDIMETHYLFUMARATE(GoldenStateMedicalSupply)です。", "task": "product", "name_q": "DIMETHYLFUMARATE(AmnealPharmaceuticalsNYLLC)", "name_a": "DIMETHYLFUMARATE(GoldenStateMedicalSupply)"} -{"id": 10653, "instruction": "Iopamiron (TN)は別の呼び方では?", "response": "Iopamiron (TN)は別の呼び方ではIsovue (TN)です。", "task": "replace", "name_q": "Iopamiron (TN)", "name_a": "Isovue (TN)"} -{"id": 5851, "instruction": "Idiopathic generalized epilepsies SUBGROUP Childhood absence epilepsy Juvenile absence epilepsy Juvenile myoclonic epilepsy Epilepsy with generalized tonic-clonic seizures aloneの日本語表記は?", "response": "Idiopathic generalized epilepsies SUBGROUP Childhood absence epilepsy Juvenile absence epilepsy Juvenile myoclonic epilepsy Epilepsy with generalized tonic-clonic seizures aloneの日本語表記は特発性全般てんかん 下位グループ 小児欠神てんかん 若年性欠神てんかん 若年性ミオクローヌスてんかん ���般性強直間代発作のみを伴うてんかんです。", "task": "replace en to ja", "name_q": "Idiopathic generalized epilepsies SUBGROUP Childhood absence epilepsy Juvenile absence epilepsy Juvenile myoclonic epilepsy Epilepsy with generalized tonic-clonic seizures alone", "name_a": "特発性全般てんかん 下位グループ 小児欠神てんかん 若年性欠神てんかん 若年性ミオクローヌスてんかん 全般性強直間代発作のみを伴うてんかん"} -{"id": 13708, "instruction": "Freeze-dried human blood-coagulation factor VIIIの別記述は?", "response": "Freeze-dried human blood-coagulation factor VIIIの別記述は乾燥濃縮人血液凝固第VIII因子です。", "task": "replace", "name_q": "Freeze-dried human blood-coagulation factor VIII", "name_a": "乾燥濃縮人血液凝固第VIII因子"} -{"id": 18207, "instruction": "4-(3-Methylbut-2-enyl)-L-abrineは別の呼び方では?", "response": "4-(3-Methylbut-2-enyl)-L-abrineは別の呼び方では4-Dimethylallyl-L-abrineです。", "task": "replace", "name_q": "4-(3-Methylbut-2-enyl)-L-abrine", "name_a": "4-Dimethylallyl-L-abrine"} -{"id": 27140, "instruction": "Diets-Jongmans syndromeを日本語で書くと?", "response": "Diets-Jongmans syndromeを日本語で書くとDiets-Jongmans 症候群です。", "task": "replace en to ja", "name_q": "Diets-Jongmans syndrome", "name_a": "Diets-Jongmans 症候群"} -{"id": 5025, "instruction": "Iturin Aの別の言い方は?", "response": "Iturin Aの別の言い方はイツリンAです。", "task": "replace", "name_q": "Iturin A", "name_a": "イツリンA"} -{"id": 20908, "instruction": "Dihydroquinidineを日本語に訳すと?", "response": "Dihydroquinidineを日本語に訳すとDihydroquinidineです。", "task": "replace en to ja", "name_q": "Dihydroquinidine", "name_a": "Dihydroquinidine"} -{"id": 2772, "instruction": "METHYLPHENIDATEHYDROCHLORIDE(BryantRanchPrepack)を用いた薬品は?", "response": "METHYLPHENIDATEHYDROCHLORIDE(BryantRanchPrepack)を用いた薬品はJORNAYPM(IronshorePharmaceuticals)です。", "task": "product", "name_q": "METHYLPHENIDATEHYDROCHLORIDE(BryantRanchPrepack)", "name_a": "JORNAYPM(IronshorePharmaceuticals)"} -{"id": 12856, "instruction": "Aceneuramateの異なる名称は?", "response": "Aceneuramateの異なる名称はアセノイラミン酸です。", "task": "replace", "name_q": "Aceneuramate", "name_a": "アセノイラミン酸"} -{"id": 16229, "instruction": "トリスフェリジンの別の言い方は?", "response": "トリスフェリジンの別の言い方はTrisphaeridineです。", "task": "replace", "name_q": "トリスフェリジン", "name_a": "Trisphaeridine"} -{"id": 33000, "instruction": "Vitamin Aの別名は?", "response": "Vitamin Aの別名はall-trans-Retinolです。", "task": "replace", "name_q": "Vitamin A", "name_a": "all-trans-Retinol"} -{"id": 12268, "instruction": "Sulphuretinの別の言い方は?", "response": "Sulphuretinの別の言い方はスルフレチンです。", "task": "replace", "name_q": "Sulphuretin", "name_a": "スルフレチン"} -{"id": 8805, "instruction": "原発性萌出不全を英語で記述すると?", "response": "原発性萌出不全を英語で記述するとPrimary failure of tooth eruptionです。", "task": "replace ja to en", "name_q": "原発性萌出不全", "name_a": "Primary failure of tooth eruption"} -{"id": 26133, "instruction": "C1541H2406N396O465S9をを化学式で表すと?", "response": "C1541H2406N396O465S9をを化学式で表すとC1541H2406N396O465S9です。", "task": "formula", "name_q": "C1541H2406N396O465S9", "name_a": "C1541H2406N396O465S9"} -{"id": 16837, "instruction": "Fenleuton (USAN/INN)をを化学構造で表すと?", "response": "Fenleuton (USAN/INN)をを化学構造で表すとC17H15FN2O3です。", "task": "formula", "name_q": "Fenleuton (USAN/INN)", "name_a": "C17H15FN2O3"} -{"id": 11418, "instruction": "テプラロキシジムをを分子式で表すと?", "response": "テプラロキシジムをを分子式で表すとC17H24ClNO4です。", "task": "formula", "name_q": "テプラロキシジム", "name_a": "C17H24ClNO4"} -{"id": 4484, "instruction": "Cytochalasin Bを言い換えると?", "response": "Cytochalasin Bを言い換えるとサイトカラシンBです。", "task": "replace", "name_q": "Cytochalasin B", "name_a": "サイトカラシンB"} -{"id": 25267, "instruction": "Waardenburg syndromeを日本語で書くと?", "response": "Waardenburg syndromeを日本語で書くとワールデンブルグ症候群です。", "task": "replace en to ja", "name_q": "Waardenburg syndrome", "name_a": "ワールデンブルグ症候群"} -{"id": 29273, "instruction": "Hemlibra (TN)の異なる表現は?", "response": "Hemlibra (TN)の異なる表現はEmicizumab (genetical recombination) (JAN)です。", "task": "replace", "name_q": "Hemlibra (TN)", "name_a": "Emicizumab (genetical recombination) (JAN)"} -{"id": 24148, "instruction": "Fluciclatide F 18 (USAN/INN)をを分子式で表すと?", "response": "Fluciclatide F 18 (USAN/INN)をを分子式で表すとC75H115FN18O27S3です。", "task": "formula", "name_q": "Fluciclatide F 18 (USAN/INN)", "name_a": "C75H115FN18O27S3"} -{"id": 16081, "instruction": "Aficamten (USAN/INN)をを化学式で記述すると?", "response": "Aficamten (USAN/INN)をを化学式で記述するとC18H19N5O2です。", "task": "formula", "name_q": "Aficamten (USAN/INN)", "name_a": "C18H19N5O2"} -{"id": 13342, "instruction": "trans-2-Enoyl-OPC4-CoAをを化学構造で書くと?", "response": "trans-2-Enoyl-OPC4-CoAをを化学構造で書くとC35H54N7O18P3Sです。", "task": "formula", "name_q": "trans-2-Enoyl-OPC4-CoA", "name_a": "C35H54N7O18P3S"} -{"id": 3132, "instruction": "Banti syndromeの日本語訳は?", "response": "Banti syndromeの日本語訳はバンチ症候群です。", "task": "replace en to ja", "name_q": "Banti syndrome", "name_a": "バンチ症候群"} -{"id": 15861, "instruction": "Duncan disease SUPERGRP Lymphoproliferative syndrome Other well-defined immunodeficiency syndromes Primary immunodeficiency disease の日本語表記は?", "response": "Duncan disease SUPERGRP Lymphoproliferative syndrome Other well-defined immunodeficiency syndromes Primary immunodeficiency disease の日本語表記はDuncan 病 上位グループ リンパ球増殖症候群 他のよく定義された免疫不全症候群 原発性免疫不全症 です。", "task": "replace en to ja", "name_q": "Duncan disease SUPERGRP Lymphoproliferative syndrome Other well-defined immunodeficiency syndromes Primary immunodeficiency disease ", "name_a": "Duncan 病 上位グループ リンパ球増殖症候群 他のよく定義された免疫不全症候群 原発性免疫不全症 "} -{"id": 20157, "instruction": "Ziracin (TN)をは化学式で表すと?", "response": "Ziracin (TN)をは化学式で表すとC70H97CI2NO38です。", "task": "formula", "name_q": "Ziracin (TN)", "name_a": "C70H97CI2NO38"} -{"id": 22864, "instruction": "Reactive blue 2の別呼称は?", "response": "Reactive blue 2の別呼称はリアクティブブルー2です。", "task": "replace", "name_q": "Reactive blue 2", "name_a": "リアクティブブルー2"} -{"id": 6132, "instruction": "ダウノマイシンの別の言い方は?", "response": "ダウノマイシンの別の言い方はDaunorubicinです。", "task": "replace", "name_q": "ダウノマイシン", "name_a": "Daunorubicin"} -{"id": 8240, "instruction": "アベルメクチンA2bの別名称は?", "response": "アベルメクチンA2bの別名称はAvermectin A2bです。", "task": "replace", "name_q": "アベルメクチンA2b", "name_a": "Avermectin A2b"} -{"id": 33854, "instruction": "シクラミン酸をを組成式で表すと?", "response": "シクラミン酸をを組成式で表すとC6H13NO3Sです。", "task": "formula", "name_q": "シクラミン酸", "name_a": "C6H13NO3S"} -{"id": 29424, "instruction": "Larcaviximab (USAN/INN)を日本語表記で表すと?", "response": "Larcaviximab (USAN/INN)を日本語表記で表すとラルカビキシマブです。", "task": "replace en to ja", "name_q": "Larcaviximab (USAN/INN)", "name_a": "ラルカビキシマブ"} -{"id": 11326, "instruction": "フィルゴチニブ塩酸塩をを化学構造で記述すると?", "response": "フィルゴチニブ塩酸塩をを化学構造で記述するとC21H23N5O3S. 3H2O. HClです。", "task": "formula", "name_q": "フィルゴチニブ塩酸塩", "name_a": "C21H23N5O3S. 3H2O. HCl"} -{"id": 21560, "instruction": "Lutetium (177Lu) chlorideの別名称は?", "response": "Lutetium (177Lu) chlorideの別名称はIlluzyce (TN)です。", "task": "replace", "name_q": "Lutetium (177Lu) chloride", "name_a": "Illuzyce (TN)"} -{"id": 24315, "instruction": "Estrogen resistance syndromeの日本語訳は?", "response": "Estrogen resistance syndromeの日本語訳はエストロゲン不応症候群です。", "task": "replace en to ja", "name_q": "Estrogen resistance syndrome", "name_a": "エストロゲン不応症候群"} -{"id": 7704, "instruction": "Bialamicol hydrochloride (USAN)を英語表記で表すと?", "response": "Bialamicol hydrochloride (USAN)を英語表記で表すとCamoform hydrochloride (TN)です。", "task": "replace ja to en", "name_q": "Bialamicol hydrochloride (USAN)", "name_a": "Camoform hydrochloride (TN)"} -{"id": 9946, "instruction": "エフィエント(第一三共)を利用した製品は?", "response": "エフィエント(第一三共)を利用した製品はPRASUGREL(PanaceaBiotecLimited)です。", "task": "product", "name_q": "エフィエント(第一三共)", "name_a": "PRASUGREL(PanaceaBiotecLimited)"} -{"id": 9140, "instruction": "Imidecyl iodine (USAN)の異なる名称は?", "response": "Imidecyl iodine (USAN)の異なる名称はイミデシルヨウ素です。", "task": "replace", "name_q": "Imidecyl iodine (USAN)", "name_a": "イミデシルヨウ素"} -{"id": 14254, "instruction": "5,10-Methenyl-5,6,7,8-tetrahydromethanopterinの別の言い方は?", "response": "5,10-Methenyl-5,6,7,8-tetrahydromethanopterinの別の言い方は5,10-Methenyltetrahydromethanopterinです。", "task": "replace", "name_q": "5,10-Methenyl-5,6,7,8-tetrahydromethanopterin", "name_a": "5,10-Methenyltetrahydromethanopterin"} -{"id": 23806, "instruction": "ダピプラゾール塩酸塩をの化学式は?", "response": "ダピプラゾール塩酸塩をの化学式はC19H27N5. HClです。", "task": "formula", "name_q": "ダピプラゾール塩酸塩", "name_a": "C19H27N5. HCl"} -{"id": 3843, "instruction": "フェントエートの別表現は?", "response": "フェントエートの別表現はPhenthoateです。", "task": "replace", "name_q": "フェントエート", "name_a": "Phenthoate"} -{"id": 28897, "instruction": "C18H29NO4. HClをを組成式で表すと?", "response": "C18H29NO4. HClをを組成式で表すとC18H29NO4. HClです。", "task": "formula", "name_q": "C18H29NO4. HCl", "name_a": "C18H29NO4. HCl"} -{"id": 31304, "instruction": "塩酸アモジアキンを英語で書くと?", "response": "塩酸アモジアキンを英語で書くとCamoquin hydrochloride (TN)です。", "task": "replace ja to en", "name_q": "塩酸アモジアキン", "name_a": "Camoquin hydrochloride (TN)"} -{"id": 33680, "instruction": "4-Chloro-17alpha-methyltestosteroneの別の呼び方は?", "response": "4-Chloro-17alpha-methyltestosteroneの別の呼び方は4-Chloro-17alpha-methyl-17beta-hydroxy-4-androsten-3-oneです。", "task": "replace", "name_q": "4-Chloro-17alpha-methyltestosterone", "name_a": "4-Chloro-17alpha-methyl-17beta-hydroxy-4-androsten-3-one"} -{"id": 2888, "instruction": "dl-Camphor and ethanolを材料とする薬品名は?", "response": "dl-Camphor and ethanolを材料とする薬品名はカンフルセー(昭和製薬)です。", "task": "product", "name_q": "dl-Camphor and ethanol", "name_a": "カンフルセー(昭和製薬)"} -{"id": 13723, "instruction": "(2S,3S)-Butane-2,3-diolをを化学構造で表すと?", "response": "(2S,3S)-Butane-2,3-diolをを化学構造で表すとC4H10O2です。", "task": "formula", "name_q": "(2S,3S)-Butane-2,3-diol", "name_a": "C4H10O2"} -{"id": 3024, "instruction": "4,5-Dihydroxypyreneをを組成式で書くと?", "response": "4,5-Dihydroxypyreneをを組成式で書くとC16H10O2です。", "task": "formula", "name_q": "4,5-Dihydroxypyrene", "name_a": "C16H10O2"} -{"id": 12389, "instruction": "Ligustici rhizomaの別名称は?", "response": "Ligustici rhizomaの別名称はLigusticum root and rhizomeです。", "task": "replace", "name_q": "Ligustici rhizoma", "name_a": "Ligusticum root and rhizome"} -{"id": 17728, "instruction": "Isobergaptolをの化学構造は?", "response": "Isobergaptolをの化学構造はC11H6O4です。", "task": "formula", "name_q": "Isobergaptol", "name_a": "C11H6O4"} -{"id": 4792, "instruction": "Chrysanthemum cinerariaefolium extractの異なる名称は?", "response": "Chrysanthemum cinerariaefolium extractの異なる名称はPyrethrum extract (USP)です。", "task": "replace", "name_q": "Chrysanthemum cinerariaefolium extract", "name_a": "Pyrethrum extract (USP)"} -{"id": 19295, "instruction": "Entolimod (USAN/INN)を日本語表記で表すと?", "response": "Entolimod (USAN/INN)を日本語表記で表すとEntolimod (USAN/INN)です。", "task": "replace en to ja", "name_q": "Entolimod (USAN/INN)", "name_a": "Entolimod (USAN/INN)"} -{"id": 9459, "instruction": "Monacolin L acidをを化学構造で書くと?", "response": "Monacolin L acidをを化学構造で書くとC19H30O4です。", "task": "formula", "name_q": "Monacolin L acid", "name_a": "C19H30O4"} -{"id": 27313, "instruction": "Hydrophilic petrolatum (JP18)の別記述は?", "response": "Hydrophilic petrolatum (JP18)の別記述はPetrolatum, hydrophilicです。", "task": "replace", "name_q": "Hydrophilic petrolatum (JP18)", "name_a": "Petrolatum, hydrophilic"} -{"id": 8663, "instruction": "Methyl [5-(4-hydroxyphenylsulfanyl)-1H-benzimidazol-2-yl]carbamateをを分子式で書くと?", "response": "Methyl [5-(4-hydroxyphenylsulfanyl)-1H-benzimidazol-2-yl]carbamateをを分子式で書くとC15H13N3O3Sです。", "task": "formula", "name_q": "Methyl [5-(4-hydroxyphenylsulfanyl)-1H-benzimidazol-2-yl]carbamate", "name_a": "C15H13N3O3S"} -{"id": 9120, "instruction": "Glycerol kinase deficiency SUPERGRP Chromosome Xp21 deletion syndrome の日本語表記は?", "response": "Glycerol kinase deficiency SUPERGRP Chromosome Xp21 deletion syndrome の日本語表記はグリセロールキナーゼ欠損症 上位グループ Xp21欠失症候群 です。", "task": "replace en to ja", "name_q": "Glycerol kinase deficiency SUPERGRP Chromosome Xp21 deletion syndrome ", "name_a": "グリセロールキナーゼ欠損症 上位グループ Xp21欠失症候群 "} -{"id": 13764, "instruction": "ファシグリファム水和物 (JAN)の別の言い方は?", "response": "ファシグリファム水和物 (JAN)の別の言い方はFasiglifam hemihydrateです。", "task": "replace", "name_q": "ファシグリファム水和物 (JAN)", "name_a": "Fasiglifam hemihydrate"} -{"id": 2461, "instruction": "Tartaric acid (JP18/NF)の日本���表記は?", "response": "Tartaric acid (JP18/NF)の日本語表記はTartaric acid (JP18/NF)です。", "task": "replace en to ja", "name_q": "Tartaric acid (JP18/NF)", "name_a": "Tartaric acid (JP18/NF)"} -{"id": 13109, "instruction": "(4S,5S)-(+)-ゲルマクロン 4,5-エポキシドの別の呼び方は?", "response": "(4S,5S)-(+)-ゲルマクロン 4,5-エポキシドの別の呼び方は(4S,5S)-(+)-Germacrone 4,5-epoxideです。", "task": "replace", "name_q": "(4S,5S)-(+)-ゲルマクロン 4,5-エポキシド", "name_a": "(4S,5S)-(+)-Germacrone 4,5-epoxide"} -{"id": 13180, "instruction": "Ethcathinoneの異なる名称は?", "response": "Ethcathinoneの異なる名称は2-Ethylamino-1-phenylpropan-1-oneです。", "task": "replace", "name_q": "Ethcathinone", "name_a": "2-Ethylamino-1-phenylpropan-1-one"} -{"id": 289, "instruction": "Amilorideの別名称は?", "response": "Amilorideの別名称はアミロライドです。", "task": "replace", "name_q": "Amiloride", "name_a": "アミロライド"} -{"id": 17911, "instruction": "Adaprolol maleate (USAN)の日本語表記は?", "response": "Adaprolol maleate (USAN)の日本語表記はマレイン酸アダプロロールです。", "task": "replace en to ja", "name_q": "Adaprolol maleate (USAN)", "name_a": "マレイン酸アダプロロール"} -{"id": 34495, "instruction": "Copanlisib hydrochloride (USAN)をは分子式で表すと?", "response": "Copanlisib hydrochloride (USAN)をは分子式で表すとC23H28N8O4. 2HClです。", "task": "formula", "name_q": "Copanlisib hydrochloride (USAN)", "name_a": "C23H28N8O4. 2HCl"} -{"id": 3059, "instruction": "Osteopetrosis SUBGROUP Osteopetrosis, autosomal dominant (OPTA) Osteopetrosis, autosomal recessive (OPTB)を日本語で記述すると?", "response": "Osteopetrosis SUBGROUP Osteopetrosis, autosomal dominant (OPTA) Osteopetrosis, autosomal recessive (OPTB)を日本語で記述すると大理石骨病 下位グループ 常染色体優性大理石骨病 (OPTA) 常染色体劣性大理石骨病 (OPTB)です。", "task": "replace en to ja", "name_q": "Osteopetrosis SUBGROUP Osteopetrosis, autosomal dominant (OPTA) Osteopetrosis, autosomal recessive (OPTB)", "name_a": "大理石骨病 下位グループ 常染色体優性大理石骨病 (OPTA) 常染色体劣性大理石骨病 (OPTB)"} -{"id": 17294, "instruction": "Purine nucleosideをを化学構造で表すと?", "response": "Purine nucleosideをを化学構造で表すとC10H12N4O4です。", "task": "formula", "name_q": "Purine nucleoside", "name_a": "C10H12N4O4"} -{"id": 26675, "instruction": "血管炎を伴う全身性自己炎症性疾患を英語で記述すると?", "response": "血管炎を伴う全身性自己炎症性疾患を英語で記述するとSystemic autoinflammatory disease with vasculitisです。", "task": "replace ja to en", "name_q": "血管炎を伴う全身性自己炎症性疾患", "name_a": "Systemic autoinflammatory disease with vasculitis"} -{"id": 29470, "instruction": "6-Oxocampestanolをを組成式で書くと?", "response": "6-Oxocampestanolをを組成式で書くとC28H48O2です。", "task": "formula", "name_q": "6-Oxocampestanol", "name_a": "C28H48O2"} -{"id": 23182, "instruction": "C20H17N9をは組成式で表すと?", "response": "C20H17N9をは組成式で表すとC20H17N9です。", "task": "formula", "name_q": "C20H17N9", "name_a": "C20H17N9"} -{"id": 4691, "instruction": "Major depressive disorderの日本語訳は?", "response": "Major depressive disorderの日本語訳はうつ病です。", "task": "replace en to ja", "name_q": "Major depressive disorder", "name_a": "うつ病"} -{"id": 15425, "instruction": "(6S)-H4PteGlu3の別記述は?", "response": "(6S)-H4PteGlu3の別記述はTetrahydropteroyltri-L-glutamateです。", "task": "replace", "name_q": "(6S)-H4PteGlu3", "name_a": "Tetrahydropteroyltri-L-glutamate"} -{"id": 28738, "instruction": "Rofecoxib (JAN/USAN/INN)をを化学構造で記述すると?", "response": "Rofecoxib (JAN/USAN/INN)をを化学構造で記述するとC17H14O4Sです。", "task": "formula", "name_q": "Rofecoxib (JAN/USAN/INN)", "name_a": "C17H14O4S"} -{"id": 4370, "instruction": "2-(Acetamidomethylene)succinateをを化学構造で記述すると?", "response": "2-(Acetamidomethylene)succinateをを化学構造で記述するとC7H9NO5です。", "task": "formula", "name_q": "2-(Acetamidomethylene)succinate", "name_a": "C7H9NO5"} -{"id": 1382, "instruction": "クロリムロンエチルをの化学式は?", "response": "クロリムロンエチルをの化学式はC15H15ClN4O6Sです。", "task": "formula", "name_q": "クロリムロンエチル", "name_a": "C15H15ClN4O6S"} -{"id": 5641, "instruction": "Stimuvax (TN)を日本語で記述すると?", "response": "Stimuvax (TN)を日本語で記述するとEmepepimut-S (USAN)です。", "task": "replace en to ja", "name_q": "Stimuvax (TN)", "name_a": "Emepepimut-S (USAN)"} -{"id": 15083, "instruction": "オロプーシェ熱 上位グループ 蚊媒介ウイルス熱 節足動物媒介ウイルス熱 を英語で書くと?", "response": "オロプーシェ熱 上位グループ 蚊媒介ウイルス熱 節足動物媒介ウイルス熱 を英語で書くとOropouche fever SUPERGRP Mosquito-borne viral fever Arthropod-borne viral fever です。", "task": "replace ja to en", "name_q": "オロプーシェ熱 上位グループ 蚊媒介ウイルス熱 節足動物媒介ウイルス熱 ", "name_a": "Oropouche fever SUPERGRP Mosquito-borne viral fever Arthropod-borne viral fever "} -{"id": 401, "instruction": "ルシデュリンの別表現は?", "response": "ルシデュリンの別表現はLucidulineです。", "task": "replace", "name_q": "ルシデュリン", "name_a": "Luciduline"} -{"id": 30515, "instruction": "三物黄芩湯の英訳は?", "response": "三物黄芩湯の英訳はSammotsuogontoです。", "task": "replace ja to en", "name_q": "三物黄芩湯", "name_a": "Sammotsuogonto"} -{"id": 27996, "instruction": "Imazodan hydrochloride (USAN)をの化学式は?", "response": "Imazodan hydrochloride (USAN)をの化学式はC13H12N4O. HClです。", "task": "formula", "name_q": "Imazodan hydrochloride (USAN)", "name_a": "C13H12N4O. HCl"} -{"id": 12693, "instruction": "多発性翼状片症候群 下位グループ 致死型多発性翼状片症候群 エスコバル型多発性翼状片症候群を英語表記で表すと?", "response": "多発性翼状片症候群 下位グループ 致死型多発性翼状片症候群 エスコバル型多発性翼状片症候群を英語表記で表すとMultiple pterygium syndrome SUBGROUP Multiple pterygium syndrome, lethal type (LMPS) Multiple pterygium syndrome, Escobar variant (EVMPS)です。", "task": "replace ja to en", "name_q": "多発性翼状片症候群 下位グループ 致死型多発性翼状片症候群 エスコバル型多発性翼状片症候群", "name_a": "Multiple pterygium syndrome SUBGROUP Multiple pterygium syndrome, lethal type (LMPS) Multiple pterygium syndrome, Escobar variant (EVMPS)"} -{"id": 772, "instruction": "Allenolic acidをを分子式で記述すると?", "response": "Allenolic acidをを分子式で記述するとC13H12O3です。", "task": "formula", "name_q": "Allenolic acid", "name_a": "C13H12O3"} -{"id": 13487, "instruction": "Securinineの別名称は?", "response": "Securinineの別名称はセクリニンです。", "task": "replace", "name_q": "Securinine", "name_a": "セクリニン"} -{"id": 15946, "instruction": "硝酸鉛(II)の異なる表記は?", "response": "硝酸鉛(II)の異なる表記はLead nitrateです。", "task": "replace", "name_q": "硝酸鉛(II)", "name_a": "Lead nitrate"} -{"id": 5186, "instruction": "BAL (TN)をは化学式で表すと?", "response": "BAL (TN)をは化学式で表すとC3H8OS2です。", "task": "formula", "name_q": "BAL (TN)", "name_a": "C3H8OS2"} -{"id": 28930, "instruction": "ジフルニサル (JAN)の別の呼び方は?", "response": "ジフルニサル (JAN)の別の呼び方はDiflunisal (JAN/USP/INN)です。", "task": "replace", "name_q": "ジフルニサル (JAN)", "name_a": "Diflunisal (JAN/USP/INN)"} -{"id": 22444, "instruction": "5-Fluorodeoxyuridine diphosphateをを化学式で記述すると?", "response": "5-Fluorodeoxyuridine diphosphateをを化学式で記述するとC9H13FN2O11P2です。", "task": "formula", "name_q": "5-Fluorodeoxyuridine diphosphate", "name_a": "C9H13FN2O11P2"} -{"id": 17838, "instruction": "サイコケイシトウを利用した医薬品名は?", "response": "サイコケイシトウを利用した医薬品名は柴胡桂枝湯(太虎精堂製薬)です。", "task": "product", "name_q": "サイコケイシトウ", "name_a": "柴胡桂枝湯(太虎精堂製薬)"} -{"id": 15516, "instruction": "Myasthenia gravisを日本語表記で表すと?", "response": "Myasthenia gravisを日本語表記で表すと重症筋無力症です。", "task": "replace en to ja", "name_q": "Myasthenia gravis", "name_a": "重症筋無力症"} -{"id": 14757, "instruction": "CMP-Leg5Ac7Acをを化学式で表すと?", "response": "CMP-Leg5Ac7Acをを化学式で表すとC22H34N5O15Pです。", "task": "formula", "name_q": "CMP-Leg5Ac7Ac", "name_a": "C22H34N5O15P"} -{"id": 10874, "instruction": "Cyanohydrinをの化学構造は?", "response": "Cyanohydrinをの化学構造はC2HNOR2です。", "task": "formula", "name_q": "Cyanohydrin", "name_a": "C2HNOR2"} -{"id": 16247, "instruction": "(+)-Demethylcoclaurineをを化学構造で記述すると?", "response": "(+)-Demethylcoclaurineをを化学構造で記述するとC16H17NO3です。", "task": "formula", "name_q": "(+)-Demethylcoclaurine", "name_a": "C16H17NO3"} -{"id": 19941, "instruction": "5-L-Glutamyl-Se-methylselenocysteineをを化学式で書くと?", "response": "5-L-Glutamyl-Se-methylselenocysteineをを化学式で書くとC9H16N2O5Seです。", "task": "formula", "name_q": "5-L-Glutamyl-Se-methylselenocysteine", "name_a": "C9H16N2O5Se"} -{"id": 26692, "instruction": "スチグマスタノールをを組成式で記述すると?", "response": "スチグマスタノールをを組成式で記述するとC29H52O���す。", "task": "formula", "name_q": "スチグマスタノール", "name_a": "C29H52O"} -{"id": 28120, "instruction": "25I-NBOMeをは組成式で表すと?", "response": "25I-NBOMeをは組成式で表すとC18H22INO3です。", "task": "formula", "name_q": "25I-NBOMe", "name_a": "C18H22INO3"} -{"id": 5169, "instruction": "X-linked dominant hypophosphatemic rickets SUPERGRP Hypophosphatemic rickets を日本語で記述すると?", "response": "X-linked dominant hypophosphatemic rickets SUPERGRP Hypophosphatemic rickets を日本語で記述するとX 連鎖優性低リン血症性くる病 上位グループ 低リン血症性くる病 です。", "task": "replace en to ja", "name_q": "X-linked dominant hypophosphatemic rickets SUPERGRP Hypophosphatemic rickets ", "name_a": "X 連鎖優性低リン血症性くる病 上位グループ 低リン血症性くる病 "} -{"id": 32261, "instruction": "Yokukansankashakuyakuorenの別呼称は?", "response": "Yokukansankashakuyakuorenの別呼称は抑肝散加芍薬黄連です。", "task": "replace", "name_q": "Yokukansankashakuyakuoren", "name_a": "抑肝散加芍薬黄連"} -{"id": 8842, "instruction": "レタトルチドをの化学構造は?", "response": "レタトルチドをの化学構造はC221H342N46O68です。", "task": "formula", "name_q": "レタトルチド", "name_a": "C221H342N46O68"} -{"id": 5338, "instruction": "アルミニウムジルコニウムオクタクロロハイドレックスグリシンの英訳は?", "response": "アルミニウムジルコニウムオクタクロロハイドレックスグリシンの英訳はAluminum zirconium octachlorohydrex Gly (USP)です。", "task": "replace ja to en", "name_q": "アルミニウムジルコニウムオクタクロロハイドレックスグリシン", "name_a": "Aluminum zirconium octachlorohydrex Gly (USP)"} -{"id": 10880, "instruction": "オクトチアミン・リボフラビン・ピリドキシン塩酸塩・シアノコバラミンを用いた製品名は?", "response": "オクトチアミン・リボフラビン・ピリドキシン塩酸塩・シアノコバラミンを用いた製品名はノイロビタン(LTLファーマ)です。", "task": "product", "name_q": "オクトチアミン・リボフラビン・ピリドキシン塩酸塩・シアノコバラミン", "name_a": "ノイロビタン(LTLファーマ)"} -{"id": 34071, "instruction": "Thiostreptonをを化学式で表すと?", "response": "Thiostreptonをを化学式で表すとC72H85N19O18S5です。", "task": "formula", "name_q": "Thiostrepton", "name_a": "C72H85N19O18S5"} -{"id": 20572, "instruction": "Sanguisorbae radixの別の言い方は?", "response": "Sanguisorbae radixの別の言い方はBurnet rootです。", "task": "replace", "name_q": "Sanguisorbae radix", "name_a": "Burnet root"} -{"id": 20755, "instruction": "Glutamic acid (USP)の異なる表記は?", "response": "Glutamic acid (USP)の異なる表記はL-Glutamic acid (JP18)です。", "task": "replace", "name_q": "Glutamic acid (USP)", "name_a": "L-Glutamic acid (JP18)"} -{"id": 11596, "instruction": "D-アラビノースは別の呼び方では?", "response": "D-アラビノースは別の呼び方ではD-Arabinoseです。", "task": "replace", "name_q": "D-アラビノース", "name_a": "D-Arabinose"} -{"id": 21746, "instruction": "Cefa-Dri (TN)をを組成式で表すと?", "response": "Cefa-Dri (TN)をを組成式で表すと(C17H17N3O6S2)2. C16H20N2です。", "task": "formula", "name_q": "Cefa-Dri (TN)", "name_a": "(C17H17N3O6S2)2. C16H20N2"} -{"id": 19354, "instruction": "クロロホルムを言い換えると?", "response": "クロロホルムを言い換えるとChloroformです。", "task": "replace", "name_q": "クロロホルム", "name_a": "Chloroform"} -{"id": 28791, "instruction": "Meromycoloyl-[acp Pks13]をを化学式で記述すると?", "response": "Meromycoloyl-[acp Pks13]をを化学式で記述するとC5H8OSR(R1)です。", "task": "formula", "name_q": "Meromycoloyl-[acp Pks13]", "name_a": "C5H8OSR(R1)"} -{"id": 10395, "instruction": "経口生ポリオワクチン (JAN)を英語で書くと?", "response": "経口生ポリオワクチン (JAN)を英語で書くとOrimune (TN)です。", "task": "replace ja to en", "name_q": "経口生ポリオワクチン (JAN)", "name_a": "Orimune (TN)"} -{"id": 363, "instruction": "2,2-Bis(4-hydroxyphenyl)-propanoic acidをを組成式で記述すると?", "response": "2,2-Bis(4-hydroxyphenyl)-propanoic acidをを組成式で記述するとC15H14O4です。", "task": "formula", "name_q": "2,2-Bis(4-hydroxyphenyl)-propanoic acid", "name_a": "C15H14O4"} -{"id": 19353, "instruction": "低マグネシウム血症 下位グループ 低マグネシウム血症、てんかんおよび精神遅滞 (HOMGSMR)を英語で書くと?", "response": "低マグネシウム血症 下位グループ 低マグネシウム血症、てんかんおよび精神遅滞 (HOMGSMR)を英語で書くとHypomagnesemia SUBGROUP Hypomagnesemia, seizures, and mental retardation (HOMGSMR)です。", "task": "replace ja to en", "name_q": "低マグネシウム血症 下位グループ 低マグネシウム血症、てんかんおよび精神遅滞 (HOMGSMR)", "name_a": "Hypomagnesemia SUBGROUP Hypomagnesemia, seizures, and mental retardation (HOMGSMR)"} -{"id": 5520, "instruction": "HSV 感染症は別の呼び方では?", "response": "HSV 感染症は別の呼び方では単純ヘルペスウイルス感染症です。", "task": "replace", "name_q": "HSV 感染症", "name_a": "単純ヘルペスウイルス感染症"} -{"id": 33031, "instruction": "C59H84N16O12をを分子式で表すと?", "response": "C59H84N16O12をを分子式で表すとC59H84N16O12です。", "task": "formula", "name_q": "C59H84N16O12", "name_a": "C59H84N16O12"} -{"id": 18734, "instruction": "Bothnian 型掌蹠角化症 上位グループ 非表皮剥離性掌蹠角化症 掌蹠角化症 の英語表記は?", "response": "Bothnian 型掌蹠角化症 上位グループ 非表皮剥離性掌蹠角化症 掌蹠角化症 の英語表記はPalmoplantar keratoderma, Bothnian type SUPERGRP Non-epidermolytic palmoplantar keratoderma Palmoplantar keratoderma です。", "task": "replace ja to en", "name_q": "Bothnian 型掌蹠角化症 上位グループ 非表皮剥離性掌蹠角化症 掌蹠角化症 ", "name_a": "Palmoplantar keratoderma, Bothnian type SUPERGRP Non-epidermolytic palmoplantar keratoderma Palmoplantar keratoderma "} -{"id": 19355, "instruction": "Annotineをは分子式で表すと?", "response": "Annotineをは分子式で表すとC16H21NO3です。", "task": "formula", "name_q": "Annotine", "name_a": "C16H21NO3"} -{"id": 7754, "instruction": "Hydrazineをを化学構造で表すと?", "response": "Hydrazineをを化学構造で表すとN2H4です。", "task": "formula", "name_q": "Hydrazine", "name_a": "N2H4"} -{"id": 7455, "instruction": "アトロピンをを分子式で書くと?", "response": "アトロピンをを分子式で書くとC17H23NO3です。", "task": "formula", "name_q": "アトロピン", "name_a": "C17H23NO3"} -{"id": 10459, "instruction": "2-Formylglutarateをを組成式で記述すると?", "response": "2-Formylglutarateをを組成式で記述するとC6H8O5です。", "task": "formula", "name_q": "2-Formylglutarate", "name_a": "C6H8O5"} -{"id": 11519, "instruction": "Nordihydrocapsaicinをを化学式で表すと?", "response": "Nordihydrocapsaicinをを化学式で表すとC17H27NO3です。", "task": "formula", "name_q": "Nordihydrocapsaicin", "name_a": "C17H27NO3"} -{"id": 5067, "instruction": "S-(2-Hydroxyethyl)glutathioneをを組成式で記述すると?", "response": "S-(2-Hydroxyethyl)glutathioneをを組成式で記述するとC12H21N3O7Sです。", "task": "formula", "name_q": "S-(2-Hydroxyethyl)glutathione", "name_a": "C12H21N3O7S"} -{"id": 17759, "instruction": "HALCINONIDE(SunPharmaceuticalIndustries)を使用した医薬品名は?", "response": "HALCINONIDE(SunPharmaceuticalIndustries)を使用した医薬品名はHALOG(SunPharmaceuticalIndustries)です。", "task": "product", "name_q": "HALCINONIDE(SunPharmaceuticalIndustries)", "name_a": "HALOG(SunPharmaceuticalIndustries)"} -{"id": 23117, "instruction": "1,2-Ditetradecanoyl-sn-glycerolの別名称は?", "response": "1,2-Ditetradecanoyl-sn-glycerolの別名称は1,2-Dimyristyl-sn-glycerolです。", "task": "replace", "name_q": "1,2-Ditetradecanoyl-sn-glycerol", "name_a": "1,2-Dimyristyl-sn-glycerol"} -{"id": 10804, "instruction": "ディルマピモドトシル酸塩をの化学構造は?", "response": "ディルマピモドトシル酸塩をの化学構造はC23H19F3N4O3. C7H8O3Sです。", "task": "formula", "name_q": "ディルマピモドトシル酸塩", "name_a": "C23H19F3N4O3. C7H8O3S"} -{"id": 22854, "instruction": "低身長、成長遅滞、先天性心疾患を英語表記で表すと?", "response": "低身長、成長遅滞、先天性心疾患を英語表記で表すとShort stature, developmental delay, congenital heart defectです。", "task": "replace ja to en", "name_q": "低身長、成長遅滞、先天性心疾患", "name_a": "Short stature, developmental delay, congenital heart defect"} -{"id": 29122, "instruction": "Urdamycin Aの別表現は?", "response": "Urdamycin Aの別表現はウルダマイシンAです。", "task": "replace", "name_q": "Urdamycin A", "name_a": "ウルダマイシンA"} -{"id": 30410, "instruction": "Aclacinomycin Aの別名称は?", "response": "Aclacinomycin Aの別名称はAclarubicin (USAN/INN)です。", "task": "replace", "name_q": "Aclacinomycin A", "name_a": "Aclarubicin (USAN/INN)"} -{"id": 2704, "instruction": "N,N-Dimethylmethanamideをの組成式は?", "response": "N,N-Dimethylmethanamideをの組成式はC3H7NOです。", "task": "formula", "name_q": "N,N-Dimethylmethanamide", "name_a": "C3H7NO"} -{"id": 15846, "instruction": "ククルビタシンDの別呼称は?", "response": "ククルビタシンDの別呼称はCucurbitacin Dです。", "task": "replace", "name_q": "ククルビタシンD", "name_a": "Cucurbitacin D"} -{"id": 14382, "instruction": "サインフランをは化学��造で表すと?", "response": "サインフランをは化学構造で表すとC16H14O5です。", "task": "formula", "name_q": "サインフラン", "name_a": "C16H14O5"} -{"id": 17798, "instruction": "Flufenoxuronの異なる表現は?", "response": "Flufenoxuronの異なる表現はフルフェノクスロンです。", "task": "replace", "name_q": "Flufenoxuron", "name_a": "フルフェノクスロン"} -{"id": 12186, "instruction": "Reticulate acropigmentation of Kitamuraを日本語表記で表すと?", "response": "Reticulate acropigmentation of Kitamuraを日本語表記で表すと網状肢端色素沈着症（北村）です。", "task": "replace en to ja", "name_q": "Reticulate acropigmentation of Kitamura", "name_a": "網状肢端色素沈着症（北村）"} -{"id": 16859, "instruction": "アミノプロピロンをを分子式で書くと?", "response": "アミノプロピロンをを分子式で書くとC16H22N4O2です。", "task": "formula", "name_q": "アミノプロピロン", "name_a": "C16H22N4O2"} -{"id": 25506, "instruction": "マレイン酸アチプリモドを英語に訳すと?", "response": "マレイン酸アチプリモドを英語に訳すとAtiprimod dimaleate (USAN)です。", "task": "replace ja to en", "name_q": "マレイン酸アチプリモド", "name_a": "Atiprimod dimaleate (USAN)"} -{"id": 32884, "instruction": "Cherry bark extract and codeine phosphate hydrateを日本語で記述すると?", "response": "Cherry bark extract and codeine phosphate hydrateを日本語で記述するとCherry bark extract and codeine phosphate hydrateです。", "task": "replace en to ja", "name_q": "Cherry bark extract and codeine phosphate hydrate", "name_a": "Cherry bark extract and codeine phosphate hydrate"} -{"id": 1150, "instruction": "ピバリン酸デスオキシコルチコステロンをを分子式で表すと?", "response": "ピバリン酸デスオキシコルチコステロンをを分子式で表すとC26H38O4です。", "task": "formula", "name_q": "ピバリン酸デスオキシコルチコステロン", "name_a": "C26H38O4"} -{"id": 19080, "instruction": "硬化ダイズ油の別表現は?", "response": "硬化ダイズ油の別表現はSoybean oil, hydrogenated (NF)です。", "task": "replace", "name_q": "硬化ダイズ油", "name_a": "Soybean oil, hydrogenated (NF)"} -{"id": 26935, "instruction": "ジボテルミンアルファを英語で書くと?", "response": "ジボテルミンアルファを英語で書くとDibotermin alfa (USAN/INN)です。", "task": "replace ja to en", "name_q": "ジボテルミンアルファ", "name_a": "Dibotermin alfa (USAN/INN)"} -{"id": 7335, "instruction": "Hellicosideをを組成式で表すと?", "response": "Hellicosideをを組成式で表すとC29H36O17です。", "task": "formula", "name_q": "Hellicoside", "name_a": "C29H36O17"} -{"id": 28458, "instruction": "オリブ油 (JP18)は別の呼び方では?", "response": "オリブ油 (JP18)は別の呼び方ではOlive oil (JP18/NF)です。", "task": "replace", "name_q": "オリブ油 (JP18)", "name_a": "Olive oil (JP18/NF)"} -{"id": 2862, "instruction": "Oxalaldehydeをは組成式で表すと?", "response": "Oxalaldehydeをは組成式で表すとC2H2O2です。", "task": "formula", "name_q": "Oxalaldehyde", "name_a": "C2H2O2"} -{"id": 21387, "instruction": "小角膜・錐体杆体ジストロフィー・白内障および後部ぶどう腫を英語で書くと?", "response": "小角膜・錐体杆体ジストロフィー・白内障および後部ぶどう腫を英語で書くとMicrocornea, rod-cone dystrophy, cataract, and posterior staphylomaです。", "task": "replace ja to en", "name_q": "小角膜・錐体杆体ジストロフィー・白内障および後部ぶどう腫", "name_a": "Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma"} -{"id": 14963, "instruction": "Carbamoyl phosphateの異なる名称は?", "response": "Carbamoyl phosphateの異なる名称はカルバモイルリン酸です。", "task": "replace", "name_q": "Carbamoyl phosphate", "name_a": "カルバモイルリン酸"} -{"id": 10122, "instruction": "常染色体劣性精神遅滞 -42 上位グループ 先天性グリコシルホスファチジルイノシトール (GPI) 欠損症 を英語で記述すると?", "response": "常染色体劣性精神遅滞 -42 上位グループ 先天性グリコシルホスファチジルイノシトール (GPI) 欠損症 を英語で記述するとAutosomal recessive mental retardation-42 SUPERGRP Inherited glycosylphosphatidylinositol deficiencies です。", "task": "replace ja to en", "name_q": "常染色体劣性精神遅滞 -42 上位グループ 先天性グリコシルホスファチジルイノシトール (GPI) 欠損症 ", "name_a": "Autosomal recessive mental retardation-42 SUPERGRP Inherited glycosylphosphatidylinositol deficiencies "} -{"id": 8924, "instruction": "Mazapertine succinate (USAN)をの分子式は?", "response": "Mazapertine succinate (USAN)をの分子式はC26H35N3O2. C4H6O4です。", "task": "formula", "name_q": "Mazapertine succinate (USAN)", "name_a": "C26H35N3O2. C4H6O4"} -{"id": 13880, "instruction": "C19H27NO7S3をの化学式は?", "response": "C19H27NO7S3をの化学式はC19H27NO7S3です。", "task": "formula", "name_q": "C19H27NO7S3", "name_a": "C19H27NO7S3"} -{"id": 9666, "instruction": "Selenohomocystineをは分子式で表すと?", "response": "Selenohomocystineをは分子式で表すとC8H16N2O4Se2です。", "task": "formula", "name_q": "Selenohomocystine", "name_a": "C8H16N2O4Se2"} -{"id": 24691, "instruction": "Etorphineをを化学式で記述すると?", "response": "Etorphineをを化学式で記述するとC25H33NO4です。", "task": "formula", "name_q": "Etorphine", "name_a": "C25H33NO4"} -{"id": 33315, "instruction": "Dimethoxanate (INN)をを分子式で書くと?", "response": "Dimethoxanate (INN)をを分子式で書くとC19H22N2O3Sです。", "task": "formula", "name_q": "Dimethoxanate (INN)", "name_a": "C19H22N2O3S"} -{"id": 18828, "instruction": "8-Allyl-2-phenyl-8H-1,3a,8-triaza-cyclopenta[a]indeneをを組成式で書くと?", "response": "8-Allyl-2-phenyl-8H-1,3a,8-triaza-cyclopenta[a]indeneをを組成式で書くとC18H15N3です。", "task": "formula", "name_q": "8-Allyl-2-phenyl-8H-1,3a,8-triaza-cyclopenta[a]indene", "name_a": "C18H15N3"} -{"id": 33737, "instruction": "オキソトレモリンをを分子式で書くと?", "response": "オキソトレモリンをを分子式で書くとC12H18N2Oです。", "task": "formula", "name_q": "オキソトレモリン", "name_a": "C12H18N2O"} -{"id": 11617, "instruction": "グランジシンをを分子式で書くと?", "response": "グランジシンをを分子式で書くとC24H32O7です。", "task": "formula", "name_q": "グランジシン", "name_a": "C24H32O7"} -{"id": 4354, "instruction": "细茶を用いた医薬品は?", "response": "细茶を用いた医薬品はサイチャ(栃本天海堂)です。", "task": "product", "name_q": "细茶", "name_a": "サイチャ(栃本天海堂)"} -{"id": 12745, "instruction": "DOFETILIDE(GoldenStateMedicalSupply)を主とした商品は?", "response": "DOFETILIDE(GoldenStateMedicalSupply)を主とした商品はDOFETILIDE(MajorPharmaceuticals)です。", "task": "product", "name_q": "DOFETILIDE(GoldenStateMedicalSupply)", "name_a": "DOFETILIDE(MajorPharmaceuticals)"} -{"id": 1182, "instruction": "C4H8Cl3O4Pをは組成式で表すと?", "response": "C4H8Cl3O4Pをは組成式で表すとC4H8Cl3O4Pです。", "task": "formula", "name_q": "C4H8Cl3O4P", "name_a": "C4H8Cl3O4P"} -{"id": 18417, "instruction": "Racepinephrine hydrochloride (USP)の別名は?", "response": "Racepinephrine hydrochloride (USP)の別名はラセピネフリン塩酸塩です。", "task": "replace", "name_q": "Racepinephrine hydrochloride (USP)", "name_a": "ラセピネフリン塩酸塩"} -{"id": 13436, "instruction": "3'-O-(4-Benzoyl)benzoyl ATPの別名は?", "response": "3'-O-(4-Benzoyl)benzoyl ATPの別名はBzATPです。", "task": "replace", "name_q": "3'-O-(4-Benzoyl)benzoyl ATP", "name_a": "BzATP"} -{"id": 33888, "instruction": "Emtricitabine (JAN/USAN/INN)を用いた薬品は?", "response": "Emtricitabine (JAN/USAN/INN)を用いた薬品は後発品EMTRICITABINE(AurobindoPharmaLimited)です。", "task": "product", "name_q": "Emtricitabine (JAN/USAN/INN)", "name_a": "後発品EMTRICITABINE(AurobindoPharmaLimited)"} -{"id": 25448, "instruction": "Fecosterolをの化学式は?", "response": "Fecosterolをの化学式はC28H46Oです。", "task": "formula", "name_q": "Fecosterol", "name_a": "C28H46O"} -{"id": 24021, "instruction": "Nisbuterol mesylate (USAN)をを組成式で記述すると?", "response": "Nisbuterol mesylate (USAN)をを組成式で記述するとC22H27NO6. CH4SO3です。", "task": "formula", "name_q": "Nisbuterol mesylate (USAN)", "name_a": "C22H27NO6. CH4SO3"} -{"id": 18517, "instruction": "Chronic thromboembolic pulmonary hypertensionを日本語に訳すと?", "response": "Chronic thromboembolic pulmonary hypertensionを日本語に訳すと慢性血栓塞栓性肺高血圧症です。", "task": "replace en to ja", "name_q": "Chronic thromboembolic pulmonary hypertension", "name_a": "慢性血栓塞栓性肺高血圧症"} -{"id": 11089, "instruction": "Lidofenin (USAN/INN)をは化学式で表すと?", "response": "Lidofenin (USAN/INN)をは化学式で表すとC14H18N2O5です。", "task": "formula", "name_q": "Lidofenin (USAN/INN)", "name_a": "C14H18N2O5"} -{"id": 16462, "instruction": "PREVYMIS(MerckSharp&DohmeLLC)をを分子式で書くと?", "response": "PREVYMIS(MerckSharp&DohmeLLC)をを分子式で書くとC29H28F4N4O4です。", "task": "formula", "name_q": "PREVYMIS(MerckSharp&DohmeLLC)", "name_a": "C29H28F4N4O4"} -{"id": 18706, "instruction": "ロイレアノンをは組成式で表すと?", "response": "ロイレアノンをは組成式で表すとC20H28O3です。", "task": "formula", "name_q": "ロイレアノン", "name_a": "C20H28O3"} -{"id": 24145, "instruction": "Novoeight (TN)の異なる表現は?", "response": "Novoeight (TN)の異なる表現はTuroctocog alfa (INN)です。", "task": "replace", "name_q": "Novoeight (TN)", "name_a": "Turoctocog alfa (INN)"} -{"id": 24249, "instruction": "Carboplatin (JP18/USP/INN)の別名は?", "response": "Carboplatin (JP18/USP/INN)の別名はカルボプラチン (JP18)です。", "task": "replace", "name_q": "Carboplatin (JP18/USP/INN)", "name_a": "カルボプラチン (JP18)"} -{"id": 31217, "instruction": "Ioflubenzamide I 131 (USAN/INN)を日本語で書くと?", "response": "Ioflubenzamide I 131 (USAN/INN)を日本語で書くとIoflubenzamide I 131 (USAN/INN)です。", "task": "replace en to ja", "name_q": "Ioflubenzamide I 131 (USAN/INN)", "name_a": "Ioflubenzamide I 131 (USAN/INN)"} -{"id": 12288, "instruction": "Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside)をの化学構造は?", "response": "Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside)をの化学構造はC24H23O14です。", "task": "formula", "name_q": "Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside)", "name_a": "C24H23O14"} -{"id": 5205, "instruction": "C6496H9952N1716O2014S44. (C16H23N4O7Y)nをを化学構造で書くと?", "response": "C6496H9952N1716O2014S44. (C16H23N4O7Y)nをを化学構造で書くとC6496H9952N1716O2014S44. (C16H23N4O7Y)nです。", "task": "formula", "name_q": "C6496H9952N1716O2014S44. (C16H23N4O7Y)n", "name_a": "C6496H9952N1716O2014S44. (C16H23N4O7Y)n"} -{"id": 16781, "instruction": "Lipoproteinは別の呼び方では?", "response": "Lipoproteinは別の呼び方ではリポタンパク質です。", "task": "replace", "name_q": "Lipoprotein", "name_a": "リポタンパク質"} -{"id": 26503, "instruction": "3-Bromo-3,5-cyclohexadiene-1,2-diolをを分子式で記述すると?", "response": "3-Bromo-3,5-cyclohexadiene-1,2-diolをを分子式で記述するとC6H7BrO2です。", "task": "formula", "name_q": "3-Bromo-3,5-cyclohexadiene-1,2-diol", "name_a": "C6H7BrO2"} -{"id": 26103, "instruction": "セフチオフルナトリウム (JAN)をを分子式で書くと?", "response": "セフチオフルナトリウム (JAN)をを分子式で書くとC19H16N5O7S3. Naです。", "task": "formula", "name_q": "セフチオフルナトリウム (JAN)", "name_a": "C19H16N5O7S3. Na"} -{"id": 16030, "instruction": "Carditonic (TN)をは化学構造で表すと?", "response": "Carditonic (TN)をは化学構造で表すとC10H14N2Oです。", "task": "formula", "name_q": "Carditonic (TN)", "name_a": "C10H14N2O"} -{"id": 6944, "instruction": "Levamlodipine maleate (USAN)の日本語訳は?", "response": "Levamlodipine maleate (USAN)の日本語訳はレバムロジピンマレイン酸塩です。", "task": "replace en to ja", "name_q": "Levamlodipine maleate (USAN)", "name_a": "レバムロジピンマレイン酸塩"} -{"id": 5806, "instruction": "Berefrine (USAN/INN)をを分子式で記述すると?", "response": "Berefrine (USAN/INN)をを分子式で記述するとC14H21NO2です。", "task": "formula", "name_q": "Berefrine (USAN/INN)", "name_a": "C14H21NO2"} -{"id": 23773, "instruction": "Aflatoxin B1exo-8,9-epoxide-GSHの別の呼び方は?", "response": "Aflatoxin B1exo-8,9-epoxide-GSHの別の呼び方は8,9-Dihydro-8-(S-glutathionyl)-9-hydroxyaflatoxin B1です。", "task": "replace", "name_q": "Aflatoxin B1exo-8,9-epoxide-GSH", "name_a": "8,9-Dihydro-8-(S-glutathionyl)-9-hydroxyaflatoxin B1"} -{"id": 32714, "instruction": "dTDP-D-fucoseの別名称は?", "response": "dTDP-D-fucoseの別名称はdTDP-alpha-D-fucopyranoseです。", "task": "replace", "name_q": "dTDP-D-fucose", "name_a": "dTDP-alpha-D-fucopyranose"} -{"id": 1162, "instruction": "Declomycin (TN)の日本語表記は?", "response": "Declomycin (TN)の日本語表記はデメクロサイクリン塩酸塩です。", "task": "replace en to ja", "name_q": "Declomycin (TN)", "name_a": "デメクロサイクリン塩酸塩"} -{"id": 34065, "instruction": "Dermaren (TN)を日本語で記述すると?", "response": "Dermaren (TN)を日本語で記述するとDichlorisone acetateです。", "task": "replace en to ja", "name_q": "Dermaren (TN)", "name_a": "Dichlorisone acetate"} -{"id": 34661, "instruction": "ドラセトロンメシル酸塩をを化学構造で表すと?", "response": "ドラセトロンメシル酸塩をを化学構造で表すとC19H20N2O3. CH4SO3です。", "task": "formula", "name_q": "ドラセトロンメシル酸塩", "name_a": "C19H20N2O3. CH4SO3"} -{"id": 8177, "instruction": "Ar4Cerをの分子式は?", "response": "Ar4Cerをの分子式はC47H82N3O23Rです。", "task": "formula", "name_q": "Ar4Cer", "name_a": "C47H82N3O23R"} -{"id": 2340, "instruction": "3-Hydroxyestra-1,3,5(10),6-tetraen-17-oneをを組成式で表すと?", "response": "3-Hydroxyestra-1,3,5(10),6-tetraen-17-oneをを組成式で表すとC18H20O2です。", "task": "formula", "name_q": "3-Hydroxyestra-1,3,5(10),6-tetraen-17-one", "name_a": "C18H20O2"} -{"id": 33913, "instruction": "C24H30ClN7O3Sをの化学構造は?", "response": "C24H30ClN7O3Sをの化学構造はC24H30ClN7O3Sです。", "task": "formula", "name_q": "C24H30ClN7O3S", "name_a": "C24H30ClN7O3S"} -{"id": 7072, "instruction": "Bispyribacの別の言い方は?", "response": "Bispyribacの別の言い方はビスピリバックです。", "task": "replace", "name_q": "Bispyribac", "name_a": "ビスピリバック"} -{"id": 29959, "instruction": "エルフコースを英語で書くと?", "response": "エルフコースを英語で書くとL-Fucoseです。", "task": "replace ja to en", "name_q": "エルフコース", "name_a": "L-Fucose"} -{"id": 14067, "instruction": "alpha-Ketovaleric acidをは化学式で表すと?", "response": "alpha-Ketovaleric acidをは化学式で表すとC5H8O3です。", "task": "formula", "name_q": "alpha-Ketovaleric acid", "name_a": "C5H8O3"} -{"id": 28198, "instruction": "Human prothrombin complex, freeze-dried concentratedの異なる表現は?", "response": "Human prothrombin complex, freeze-dried concentratedの異なる表現は乾燥濃縮人プロトロンビン複合体です。", "task": "replace", "name_q": "Human prothrombin complex, freeze-dried concentrated", "name_a": "乾燥濃縮人プロトロンビン複合体"} -{"id": 29145, "instruction": "エピナスチン塩酸塩(テイカ製薬)を主とした医薬品名は?", "response": "エピナスチン塩酸塩(テイカ製薬)を主とした医薬品名はアレジオン(日本ベーリンガーインゲルハイム)です。", "task": "product", "name_q": "エピナスチン塩酸塩(テイカ製薬)", "name_a": "アレジオン(日本ベーリンガーインゲルハイム)"} -{"id": 5376, "instruction": "trans-Zeatin-7-beta-D-glucosideをを分子式で表すと?", "response": "trans-Zeatin-7-beta-D-glucosideをを分子式で表すとC16H23N5O6です。", "task": "formula", "name_q": "trans-Zeatin-7-beta-D-glucoside", "name_a": "C16H23N5O6"} -{"id": 12286, "instruction": "Zofenopril calcium (USAN)の別表現は?", "response": "Zofenopril calcium (USAN)の別表現はZoprace (TN)です。", "task": "replace", "name_q": "Zofenopril calcium (USAN)", "name_a": "Zoprace (TN)"} -{"id": 6798, "instruction": "Adegramotide (INN)をを分子式で書くと?", "response": "Adegramotide (INN)をを分子式で書くとC87H123N19O24です。", "task": "formula", "name_q": "Adegramotide (INN)", "name_a": "C87H123N19O24"} -{"id": 32901, "instruction": "Chlorfluazuronをを分子式で書くと?", "response": "Chlorfluazuronをを分子式で書くとC20H9Cl3F5N3O3です。", "task": "formula", "name_q": "Chlorfluazuron", "name_a": "C20H9Cl3F5N3O3"} -{"id": 4207, "instruction": "Laudanineをは化学式で表すと?", "response": "Laudanineをは化学式で表すとC20H25NO4です。", "task": "formula", "name_q": "Laudanine", "name_a": "C20H25NO4"} -{"id": 28295, "instruction": "Fodosine (TN)の日本語訳は?", "response": "Fodosine (TN)の日本語訳はフォロデシンです。", "task": "replace en to ja", "name_q": "Fodosine (TN)", "name_a": "フォロデシン"} -{"id": 27481, "instruction": "プラリシグアトを英語に訳すと?", "response": "プラリシグアトを英語に訳すとPraliciguat (USAN/INN)です。", "task": "replace ja to en", "name_q": "プラリシグアト", "name_a": "Praliciguat (USAN/INN)"} -{"id": 33917, "instruction": "Megibal (TN)を日本語表記で表すと?", "response": "Megibal (TN)を日本語表記で表すとBemegride (JAN/INN)です。", "task": "replace en to ja", "name_q": "Megibal (TN)", "name_a": "Bemegride (JAN/INN)"} -{"id": 6529, "instruction": "Autosomal recessive neuromyotonia and axonal neuropathyを日本語で記述すると?", "response": "Autosomal recessive neuromyotonia and axonal neuropathyを日本語で記述すると常染色体劣性遺伝性神経性筋強直および軸索性ニューロパチーです。", "task": "replace en to ja", "name_q": "Autosomal recessive neuromyotonia and axonal neuropathy", "name_a": "常染色体劣性遺伝性神経性筋強直および軸索性ニューロパチー"} -{"id": 10520, "instruction": "FLUVASTATIN(BryantRanchPrepack)を使用した製品名は?", "response": "FLUVASTATIN(BryantRanchPrepack)を使用した製品名はLESCOL(Sandoz)です。", "task": "product", "name_q": "FLUVASTATIN(BryantRanchPrepack)", "name_a": "LESCOL(Sandoz)"} -{"id": 14237, "instruction": "C26H26F6N4O3をの化学構造は?", "response": "C26H26F6N4O3をの化学構造はC26H26F6N4O3です。", "task": "formula", "name_q": "C26H26F6N4O3", "name_a": "C26H26F6N4O3"} -{"id": 34126, "instruction": "γ-コニセインをを化学構造で表すと?", "response": "γ-コニセインをを化学構造で表すとC8H15Nです。", "task": "formula", "name_q": "γ-コニセイン", "name_a": "C8H15N"} -{"id": 30314, "instruction": "Risatarun (TN)をを化学構造で表すと?", "response": "Risatarun (TN)をを化学構造で表すとC7H11NO5. C4H11NOです。", "task": "formula", "name_q": "Risatarun (TN)", "name_a": "C7H11NO5. C4H11NO"} -{"id": 22660, "instruction": "Lunlekitug (USAN)をを化学式で表すと?", "response": "Lunlekitug (USAN)をを化学式で表すとC6484H10022N1714O2040S44です。", "task": "formula", "name_q": "Lunlekitug (USAN)", "name_a": "C6484H10022N1714O2040S44"} -{"id": 11780, "instruction": "Dehydrohistidyltryptophyldiketopiperazineをを組成式で書くと?", "response": "Dehydrohistidyltryptophyldiketopiperazineをを組成式で書くとC17H15N5O2です。", "task": "formula", "name_q": "Dehydrohistidyltryptophyldiketopiperazine", "name_a": "C17H15N5O2"} -{"id": 1553, "instruction": "Valturna (TN)を日本語表記で表すと?", "response": "Valturna (TN)を日本語表記で表すとアリスキレンフマル酸塩・バルサルタンです。", "task": "replace en to ja", "name_q": "Valturna (TN)", "name_a": "アリスキレンフマル酸塩・バルサルタン"} -{"id": 26256, "instruction": "Urethane dimethacrylateの別表現は?", "response": "Urethane dimethacrylateの別表現はUDMAです。", "task": "replace", "name_q": "Urethane dimethacrylate", "name_a": "UDMA"} -{"id": 11265, "instruction": "Dabigatran (USAN/INN)をを化学構造で記述すると?", "response": "Dabigatran (USAN/INN)をを化学構造で記述するとC25H25N7O3です。", "task": "formula", "name_q": "Dabigatran (USAN/INN)", "name_a": "C25H25N7O3"} -{"id": 217, "instruction": "Corrinoid protein Co+の別表現は?", "response": "Corrinoid protein Co+の別表現はCorrinoidです。", "task": "replace", "name_q": "Corrinoid protein Co+", "name_a": "Corrinoid"} -{"id": 26941, "instruction": "Chloropyramine (INN)の日本語表記は?", "response": "Chloropyramine (INN)の日本語表記はクロロピラミンです。", "task": "replace en to ja", "name_q": "Chloropyramine (INN)", "name_a": "クロロピラミン"} -{"id": 10460, "instruction": "12alpha-Hydroxy-3-oxocholan-24-oyl-CoAをを分子式で書くと?", "response": "12alpha-Hydroxy-3-oxocholan-24-oyl-CoAをを分子式で書くとC45H72N7O19P3Sです。", "task": "formula", "name_q": "12alpha-Hydroxy-3-oxocholan-24-oyl-CoA", "name_a": "C45H72N7O19P3S"} -{"id": 8802, "instruction": "甘草湯の英語表記は?", "response": "甘草湯の英語表記はKanzotoです。", "task": "replace ja to en", "name_q": "甘草湯", "name_a": "Kanzoto"} -{"id": 2497, "instruction": "LETROZOLE(BryantRanchPrepack)を使用した薬品名は?", "response": "LETROZOLE(BryantRanchPrepack)を使用した薬品名はレトロゾール(日医工)です。", "task": "product", "name_q": "LETROZOLE(BryantRanchPrepack)", "name_a": "レトロゾール(日医工)"} -{"id": 1377, "instruction": "ノコダゾールの別名称は?", "response": "ノコダゾールの別名称はNocodazole (USAN/INN)です。", "task": "replace", "name_q": "ノコダゾール", "name_a": "Nocodazole (USAN/INN)"} -{"id": 372, "instruction": "ギレデストラントの英語表記は?", "response": "ギレデストラントの英語表記はGiredestrant (USAN/INN)です。", "task": "replace ja to en", "name_q": "ギレデストラント", "name_a": "Giredestrant (USAN/INN)"} -{"id": 15242, "instruction": "m-Cresolを英語表記で表すと?", "response": "m-Cresolを英語表記で表すとMetacresol (USP)です。", "task": "replace ja to en", "name_q": "m-Cresol", "name_a": "Metacresol (USP)"} -{"id": 6056, "instruction": "12-Hydroperoxyeicosatetraenoateの異なる名称は?", "response": "12-Hydroperoxyeicosatetraenoateの異なる名称は12-Hydroperoxyicosatetraenoateです。", "task": "replace", "name_q": "12-Hydroperoxyeicosatetraenoate", "name_a": "12-Hydroperoxyicosatetraenoate"} -{"id": 10620, "instruction": "Mupirocinの別の呼び方は?", "response": "Mupirocinの別の呼び方はムピロシンです。", "task": "replace", "name_q": "Mupirocin", "name_a": "ムピロシン"} -{"id": 14989, "instruction": "9,10-フェナントレンキノンをの分子式は?", "response": "9,10-フェナントレンキノンをの分子式はC14H8O2です。", "task": "formula", "name_q": "9,10-フェナントレンキノン", "name_a": "C14H8O2"} -{"id": 33256, "instruction": "Propylene carbonate (NF)をを組成式で記述すると?", "response": "Propylene carbonate (NF)をを組成式で記述するとC4H6O3です。", "task": "formula", "name_q": "Propylene carbonate (NF)", "name_a": "C4H6O3"} -{"id": 32538, "instruction": "Rabies immune globulin (USP)を日本語で記述すると?", "response": "Rabies immune globulin (USP)を日本語で記述すると狂犬病免疫グロブリンです。", "task": "replace en to ja", "name_q": "Rabies immune globulin (USP)", "name_a": "狂犬病免疫グロブリン"} -{"id": 25886, "instruction": "Urocortin Iの別呼称は?", "response": "Urocortin Iの別呼称はウロコルチン Iです。", "task": "replace", "name_q": "Urocortin I", "name_a": "ウロコルチン I"} -{"id": 11847, "instruction": "NOPMをを化学構造で表すと?", "response": "NOPMをを化学構造で表すとC14H14O3です。", "task": "formula", "name_q": "NOPM", "name_a": "C14H14O3"} -{"id": 8657, "instruction": "BCKDK deficiencyの別記述は?", "response": "BCKDK deficiencyの別記述はBranched-chain ketoacid dehydrogenase kinase deficiencyです。", "task": "replace", "name_q": "BCKDK deficiency", "name_a": "Branched-chain ketoacid dehydrogenase kinase deficiency"} -{"id": 24897, "instruction": "(R)-5-Phosphomevalonateをを分子式で書くと?", "response": "(R)-5-Phosphomevalonateをを分子式で書くとC6H13O7Pです。", "task": "formula", "name_q": "(R)-5-Phosphomevalonate", "name_a": "C6H13O7P"} -{"id": 6143, "instruction": "C10H14N2O8. 2K. 2H2Oをの化学構造は?", "response": "C10H14N2O8. 2K. 2H2Oをの化学構造はC10H14N2O8. 2K. 2H2Oです。", "task": "formula", "name_q": "C10H14N2O8. 2K. 2H2O", "name_a": "C10H14N2O8. 2K. 2H2O"} -{"id": 22508, "instruction": "CHOPS 症候群を英語に訳すと?", "response": "CHOPS 症候群を英語に訳すとCHOPS syndromeです。", "task": "replace ja to en", "name_q": "CHOPS 症候群", "name_a": "CHOPS syndrome"} -{"id": 27615, "instruction": "アルファ-アミノアジピン酸をの化学式は?", "response": "アルファ-アミノアジピン酸をの化学式はC6H11NO4です。", "task": "formula", "name_q": "アルファ-アミノアジピン酸", "name_a": "C6H11NO4"} -{"id": 30471, "instruction": "モリブレシブべシル酸塩をは化学式で表すと?", "response": "モリブレシブべシル酸塩をは化学式で表すとC22H22ClN5O2. C6H6O3Sです。", "task": "formula", "name_q": "モリブレシブべシル酸塩", "name_a": "C22H22ClN5O2. C6H6O3S"} -{"id": 3788, "instruction": "スルピリド(日医工岐阜工場)を用いた薬品は?", "response": "スルピリド(日医工岐阜工場)を用いた薬品はスルピリド(沢井製薬)です。", "task": "product", "name_q": "スルピリド(日医工岐阜工場)", "name_a": "スルピリド(沢井製薬)"} -{"id": 2417, "instruction": "Kamikihito extract (JP18)の英語表記は?", "response": "Kamikihito extract (JP18)の英語表記はKamikihito extract (JP18)です。", "task": "replace ja to en", "name_q": "Kamikihito extract (JP18)", "name_a": "Kamikihito extract (JP18)"} -{"id": 25076, "instruction": "ウラジロガシ (Non-JPS)の異なる名称は?", "response": "ウラジロガシ (Non-JPS)の異なる名称はlǐ bái jiānです。", "task": "replace", "name_q": "ウラジロガシ (Non-JPS)", "name_a": "lǐ bái jiān"} -{"id": 4109, "instruction": "C6322H9722N1674O1988S46をを化学構造で書くと?", "response": "C6322H9722N1674O1988S46をを化学構造で書くとC6322H9722N1674O1988S46です。", "task": "formula", "name_q": "C6322H9722N1674O1988S46", "name_a": "C6322H9722N1674O1988S46"} -{"id": 5142, "instruction": "3-Phospho-D-glycerateの異なる表記は?", "response": "3-Phospho-D-glycerateの異なる表記は3-Phosphoglycerateです。", "task": "replace", "name_q": "3-Phospho-D-glycerate", "name_a": "3-Phosphoglycerate"} -{"id": 18340, "instruction": "2-セカンダリ-ブチルフェニル-N-メチルカーバメイトは別の呼び方では?", "response": "2-セカンダリ-ブチルフェニル-N-メチルカーバメイトは別の呼び方ではフェノブカルブです。", "task": "replace", "name_q": "2-セカンダリ-ブチルフェニル-N-メチルカーバメイト", "name_a": "フェノブカルブ"} -{"id": 11208, "instruction": "Bromelain (JAN)の英訳は?", "response": "Bromelain (JAN)の英訳はBromelain (JAN)です。", "task": "replace ja to en", "name_q": "Bromelain (JAN)", "name_a": "Bromelain (JAN)"} -{"id": 25798, "instruction": "Digitalis (USP)を英語で書くと?", "response": "Digitalis (USP)を英語で書くとDigitalis (USP)です。", "task": "replace ja to en", "name_q": "Digitalis (USP)", "name_a": "Digitalis (USP)"} -{"id": 34301, "instruction": "Binfloxacin (USAN/INN)の異なる表現は?", "response": "Binfloxacin (USAN/INN)の異なる表現はビンフロキサシンです。", "task": "replace", "name_q": "Binfloxacin (USAN/INN)", "name_a": "ビンフロキサシン"} -{"id": 3494, "instruction": "ZOLMITRIPTAN(AmnealPharmaceuticalsNYLLC)を材料とする薬品名は?", "response": "ZOLMITRIPTAN(AmnealPharmaceuticalsNYLLC)を材料とする薬品名はZOLMITRIPTAN(RisingPharmaHoldings)です。", "task": "product", "name_q": "ZOLMITRIPTAN(AmnealPharmaceuticalsNYLLC)", "name_a": "ZOLMITRIPTAN(RisingPharmaHoldings)"} -{"id": 12917, "instruction": "ソラベグロン塩酸塩をを化学構造で書くと?", "response": "ソラベグロン塩酸塩をを化学構造で書くとC23H23ClN2O3. HClです。", "task": "formula", "name_q": "ソラベグロン塩酸塩", "name_a": "C23H23ClN2O3. HCl"} -{"id": 16095, "instruction": "p-Methoxystilbeneをを組成式で記述すると?", "response": "p-Methoxystilbeneをを組成式で記述するとC15H14Oです。", "task": "formula", "name_q": "p-Methoxystilbene", "name_a": "C15H14O"} -{"id": 25511, "instruction": "Freeze-dried human anti-D (Rho) immunoglobulinを日本語に訳すと?", "response": "Freeze-dried human anti-D (Rho) immunoglobulinを日本語に訳すとFreeze-dried human anti-D (Rho) immunoglobulinです。", "task": "replace en to ja", "name_q": "Freeze-dried human anti-D (Rho) immunoglobulin", "name_a": "Freeze-dried human anti-D (Rho) immunoglobulin"} -{"id": 8170, "instruction": "Urofollitropin (USAN/INN)の日本語訳は?", "response": "Urofollitropin (USAN/INN)の日本語訳はウロフォリトロピンです。", "task": "replace en to ja", "name_q": "Urofollitropin (USAN/INN)", "name_a": "ウロフォリトロピン"} -{"id": 10271, "instruction": "AMMONIAN13(WashingtonUniversitySchoolofMedicine)を使用した製品は?", "response": "AMMONIAN13(WashingtonUniversitySchoolofMedicine)を使用した製品はAMMONIAN13(MassachusettsGeneralHospital)です。", "task": "product", "name_q": "AMMONIAN13(WashingtonUniversitySchoolofMedicine)", "name_a": "AMMONIAN13(MassachusettsGeneralHospital)"} -{"id": 21752, "instruction": "びまん性大細胞型B細胞リンパ腫、非特定 上位グループ 非ホジキンリンパ腫 の英語表記は?", "response": "びまん性大細胞型B細胞リンパ腫、非特定 上位グループ 非ホジキンリンパ腫 の英語表記はDiffuse large B-cell lymphoma, not otherwise specified SUPERGRP Non-Hodgkin lymphoma です。", "task": "replace ja to en", "name_q": "びまん性大細胞型B細胞リンパ腫、非特定 上位グループ 非ホジキンリンパ腫 ", "name_a": "Diffuse large B-cell lymphoma, not otherwise specified SUPERGRP Non-Hodgkin lymphoma "} -{"id": 16731, "instruction": "Blackberry lily rootの別の呼び方は?", "response": "Blackberry lily rootの別の呼び方は射干です。", "task": "replace", "name_q": "Blackberry lily root", "name_a": "射干"} -{"id": 8959, "instruction": "アルカプトン尿症の英語表記は?", "response": "アルカプトン尿症の英語表記はAlkaptonuriaです。", "task": "replace ja to en", "name_q": "アルカプトン尿症", "name_a": "Alkaptonuria"} -{"id": 8656, "instruction": "Bifidobacteriumを材料とする薬品名は?", "response": "Bifidobacteriumを材料とする薬品名はラックビー(興和)です。", "task": "product", "name_q": "Bifidobacterium", "name_a": "ラックビー(興和)"} -{"id": 4773, "instruction": "Zeteletinib adipate (USAN)をを化学式で記述すると?", "response": "Zeteletinib adipate (USAN)をを化学式で記述すると(C25H23F3N4O4)2. C6H10O4です。", "task": "formula", "name_q": "Zeteletinib adipate (USAN)", "name_a": "(C25H23F3N4O4)2. C6H10O4"} -{"id": 12536, "instruction": "C23H27Cl2N3O2. H2Oをを組成式で表すと?", "response": "C23H27Cl2N3O2. H2Oをを組成式で表すとC23H27Cl2N3O2. H2Oです。", "task": "formula", "name_q": "C23H27Cl2N3O2. H2O", "name_a": "C23H27Cl2N3O2. H2O"} -{"id": 12183, "instruction": "4-Dimethylaminobenzenediazonium fluoroborateの別呼称は?", "response": "4-Dimethylaminobenzenediazonium fluoroborateの別呼称はp-N,N-(Dimethylamino)phenyldiazonium fluoroborateです。", "task": "replace", "name_q": "4-Dimethylaminobenzenediazonium fluoroborate", "name_a": "p-N,N-(Dimethylamino)phenyldiazonium fluoroborate"} -{"id": 13358, "instruction": "ジクロロ酢酸ジイソプロピルアミン (JAN)を英語に訳すと?", "response": "ジクロロ酢酸ジイソプロピルアミン (JAN)を英語に訳すとLiverall (TN)です。", "task": "replace ja to en", "name_q": "ジクロロ酢酸ジイソプロピルアミン (JAN)", "name_a": "Liverall (TN)"} -{"id": 7816, "instruction": "N-Acetyl-alpha-D-galactosaminyl-polypeptideの異なる名称は?", "response": "N-Acetyl-alpha-D-galactosaminyl-polypeptideの異なる名称はTn antigenです。", "task": "replace", "name_q": "N-Acetyl-alpha-D-galactosaminyl-polypeptide", "name_a": "Tn antigen"} -{"id": 29515, "instruction": "Gold Au 198 (USAN)の英訳は?", "response": "Gold Au 198 (USAN)の英訳はGold Au 198 (USAN)です。", "task": "replace ja to en", "name_q": "Gold Au 198 (USAN)", "name_a": "Gold Au 198 (USAN)"} -{"id": 24383, "instruction": "Musenninの別呼称は?", "response": "Musenninの別呼称はムセニンです。", "task": "replace", "name_q": "Musennin", "name_a": "ムセニン"} -{"id": 27046, "instruction": "Thiamin phosphateの異なる名称は?", "response": "Thiamin phosphateの異なる名称はThiamine monophosphateです。", "task": "replace", "name_q": "Thiamin phosphate", "name_a": "Thiamine monophosphate"} -{"id": 4108, "instruction": "Cycasinをを化学式で表すと?", "response": "Cycasinをを化学式で表すとC8H16N2O7です。", "task": "formula", "name_q": "Cycasin", "name_a": "C8H16N2O7"} -{"id": 22764, "instruction": "C35H45Cl2NO6をを化学式で書くと?", "response": "C35H45Cl2NO6をを化学式で書くとC35H45Cl2NO6です。", "task": "formula", "name_q": "C35H45Cl2NO6", "name_a": "C35H45Cl2NO6"} -{"id": 19530, "instruction": "ALBUMINEX(BPL)を利用した製品は?", "response": "ALBUMINEX(BPL)を利用した製品はALBUMINEX(BPL)です。", "task": "product", "name_q": "ALBUMINEX(BPL)", "name_a": "ALBUMINEX(BPL)"} -{"id": 1098, "instruction": "子宮筋腫の英訳は?", "response": "子宮筋腫の英訳はFibroidです。", "task": "replace ja to en", "name_q": "子宮筋腫", "name_a": "Fibroid"} -{"id": 16641, "instruction": "Cerium oxalateを英語で書くと?", "response": "Cerium oxalateを英語で書くとCerium oxalateです。", "task": "replace ja to en", "name_q": "Cerium oxalate", "name_a": "Cerium oxalate"} -{"id": 28407, "instruction": "Sialidosisの日本語訳は?", "response": "Sialidosisの日本語訳はシアリドーシスです。", "task": "replace en to ja", "name_q": "Sialidosis", "name_a": "シアリドーシス"} -{"id": 4695, "instruction": "Rezpegaldesleukin (USAN)の日本語表記は?", "response": "Rezpegaldesleukin (USAN)の日本語表記はRezpegaldesleukin (USAN)です。", "task": "replace en to ja", "name_q": "Rezpegaldesleukin (USAN)", "name_a": "Rezpegaldesleukin (USAN)"} -{"id": 27010, "instruction": "Cryptogeninの別記述は?", "response": "Cryptogeninの別記述はクリプトゲニンです。", "task": "replace", "name_q": "Cryptogenin", "name_a": "クリプトゲニン"} -{"id": 16345, "instruction": "1,3-Propane sultoneの別名は?", "response": "1,3-Propane sultoneの別名は1,3-プロパンサルトンです。", "task": "replace", "name_q": "1,3-Propane sultone", "name_a": "1,3-プロパンサルトン"} -{"id": 2797, "instruction": "Repromicin (USAN/INN)をの組成式は?", "response": "Repromicin (USAN/INN)をの組成式はC31H51NO8です。", "task": "formula", "name_q": "Repromicin (USAN/INN)", "name_a": "C31H51NO8"} -{"id": 33910, "instruction": "ノルトリプチリン塩酸塩 (JP18)を用いた製品名は?", "response": "ノルトリプチリン塩酸塩 (JP18)を用いた製品名はNORTRIPTYLINEHYDROCHLORIDE(NuCarePharmaceuticals)です。", "task": "product", "name_q": "ノルトリプチリン塩酸塩 (JP18)", "name_a": "NORTRIPTYLINEHYDROCHLORIDE(NuCarePharmaceuticals)"} -{"id": 10685, "instruction": "Otsujitokyodaioを日本語で記述すると?", "response": "Otsujitokyodaioを日本語で記述すると乙字湯去大黄です。", "task": "replace en to ja", "name_q": "Otsujitokyodaio", "name_a": "乙字湯去大黄"} -{"id": 5497, "instruction": "Familial breast-ovarian cancer SUBGROUP Hereditary breast ovarian cancer syndrome (HBOC)を日本語で書くと?", "response": "Familial breast-ovarian cancer SUBGROUP Hereditary breast ovarian cancer syndrome (HBOC)を日本語で書くと家族性乳がん卵巣がん 下位グループ 遺伝性乳癌卵巣癌症候群 (HBOC)です。", "task": "replace en to ja", "name_q": "Familial breast-ovarian cancer SUBGROUP Hereditary breast ovarian cancer syndrome (HBOC)", "name_a": "家族性乳がん卵巣がん 下位グループ 遺伝性乳癌卵巣癌症候群 (HBOC)"} -{"id": 28156, "instruction": "Oxycodone (USAN/INN)を主とした医薬品は?", "response": "Oxycodone (USAN/INN)を主とした医薬品はXTAMPZA(CollegiumPharmaceutical)です。", "task": "product", "name_q": "Oxycodone (USAN/INN)", "name_a": "XTAMPZA(CollegiumPharmaceutical)"} -{"id": 19772, "instruction": "Phentolamine (INN)をを組成式で記述すると?", "response": "Phentolamine (INN)をを組成式で記述するとC17H19N3Oです。", "task": "formula", "name_q": "Phentolamine (INN)", "name_a": "C17H19N3O"} -{"id": 31084, "instruction": "Agnusideの別名称は?", "response": "Agnusideの別名称はアグヌシドです。", "task": "replace", "name_q": "Agnuside", "name_a": "アグヌシド"} -{"id": 18270, "instruction": "Trental (TN)をを化学式で書くと?", "response": "Trental (TN)をを化学式で書くとC13H18N4O3です。", "task": "formula", "name_q": "Trental (TN)", "name_a": "C13H18N4O3"} -{"id": 29663, "instruction": "7,8-Dihydroxykynurenateをは化学式で表すと?", "response": "7,8-Dihydroxykynurenateをは化学式で表すとC10H7NO5です。", "task": "formula", "name_q": "7,8-Dihydroxykynurenate", "name_a": "C10H7NO5"} -{"id": 26515, "instruction": "Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside)をは化学構造で表すと?", "response": "Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside)をは化学構造で表すとC30H27O15です。", "task": "formula", "name_q": "Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside)", "name_a": "C30H27O15"} -{"id": 25747, "instruction": "(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoAをの化学式は?", "response": "(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoAをの化学式はC45H72N7O17P3Sです。", "task": "formula", "name_q": "(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoA", "name_a": "C45H72N7O17P3S"} -{"id": 24253, "instruction": "テナリジンを英語で記述すると?", "response": "テナリジンを英語で記述するとThenalidine (INN)です。", "task": "replace ja to en", "name_q": "テナリジン", "name_a": "Thenalidine (INN)"} -{"id": 10549, "instruction": "Bayhep B (TN)の別名称は?", "response": "Bayhep B (TN)の別名称はHepatitis B immune globulin (USP)です。", "task": "replace", "name_q": "Bayhep B (TN)", "name_a": "Hepatitis B immune globulin (USP)"} -{"id": 29436, "instruction": "Landomycin Aをの分子式は?", "response": "Landomycin Aをの分子式はC55H74O22です。", "task": "formula", "name_q": "Landomycin A", "name_a": "C55H74O22"} -{"id": 31187, "instruction": "Pyrinoline (USAN/INN)を英語で書���と?", "response": "Pyrinoline (USAN/INN)を英語で書くとPyrinoline (USAN/INN)です。", "task": "replace ja to en", "name_q": "Pyrinoline (USAN/INN)", "name_a": "Pyrinoline (USAN/INN)"} -{"id": 6848, "instruction": "Ethanolの別名称は?", "response": "Ethanolの別名称はMethylcarbinolです。", "task": "replace", "name_q": "Ethanol", "name_a": "Methylcarbinol"} -{"id": 20103, "instruction": "Mumpsvax (TN)の異なる表現は?", "response": "Mumpsvax (TN)の異なる表現はMumps virus vaccine liveです。", "task": "replace", "name_q": "Mumpsvax (TN)", "name_a": "Mumps virus vaccine live"} -{"id": 29706, "instruction": "Familial dementiaを日本語表記で表すと?", "response": "Familial dementiaを日本語表記で表すと家族性認知症です。", "task": "replace en to ja", "name_q": "Familial dementia", "name_a": "家族性認知症"} -{"id": 25455, "instruction": "Lorbrena (TN)を主とした薬品名は?", "response": "Lorbrena (TN)を主とした薬品名はLORBRENA(PfizerLaboratoriesDivPfizer)です。", "task": "product", "name_q": "Lorbrena (TN)", "name_a": "LORBRENA(PfizerLaboratoriesDivPfizer)"} -{"id": 11827, "instruction": "ファビハルタ(ノバルティスファーマ)を主材料とする医薬品は?", "response": "ファビハルタ(ノバルティスファーマ)を主材料とする医薬品はFABHALTA(NovartisPharmaceuticalsCorporation)です。", "task": "product", "name_q": "ファビハルタ(ノバルティスファーマ)", "name_a": "FABHALTA(NovartisPharmaceuticalsCorporation)"} -{"id": 10793, "instruction": "Upadacitinib (USAN/INN)をは分子式で表すと?", "response": "Upadacitinib (USAN/INN)をは分子式で表すとC17H19F3N6Oです。", "task": "formula", "name_q": "Upadacitinib (USAN/INN)", "name_a": "C17H19F3N6O"} -{"id": 26820, "instruction": "Chlormadinone acetate and mestranolを日本語表記で表すと?", "response": "Chlormadinone acetate and mestranolを日本語表記で表すとChlormadinone acetate and mestranolです。", "task": "replace en to ja", "name_q": "Chlormadinone acetate and mestranol", "name_a": "Chlormadinone acetate and mestranol"} -{"id": 3795, "instruction": "Cyanophycinの別名は?", "response": "Cyanophycinの別名は[L-Asp(4-L-Arg)]nです。", "task": "replace", "name_q": "Cyanophycin", "name_a": "[L-Asp(4-L-Arg)]n"} -{"id": 21105, "instruction": "Binapacrylをを分子式で書くと?", "response": "Binapacrylをを分子式で書くとC15H18N2O6です。", "task": "formula", "name_q": "Binapacryl", "name_a": "C15H18N2O6"} -{"id": 20164, "instruction": "Lorcainide hydrochloride (USAN)の日本語訳は?", "response": "Lorcainide hydrochloride (USAN)の日本語訳はLorcainide hydrochloride (USAN)です。", "task": "replace en to ja", "name_q": "Lorcainide hydrochloride (USAN)", "name_a": "Lorcainide hydrochloride (USAN)"} -{"id": 27704, "instruction": "4-APをは化学式で表すと?", "response": "4-APをは化学式で表すとC5H6N2です。", "task": "formula", "name_q": "4-AP", "name_a": "C5H6N2"} -{"id": 32635, "instruction": "Vibratory angioedemaを日本語表記で表すと?", "response": "Vibratory angioedemaを日本語表記で表すと振動性蕁麻疹です。", "task": "replace en to ja", "name_q": "Vibratory angioedema", "name_a": "振動性蕁麻疹"} -{"id": 6629, "instruction": "Hydrotalcite (JAN/INN)は別の呼び方では?", "response": "Hydrotalcite (JAN/INN)は別の呼び方ではヒドロタルサイト (JAN)です。", "task": "replace", "name_q": "Hydrotalcite (JAN/INN)", "name_a": "ヒドロタルサイト (JAN)"} -{"id": 7869, "instruction": "デキストラン40・ブドウ糖を英語に訳すと?", "response": "デキストラン40・ブドウ糖を英語に訳すとDextran 40 and glucoseです。", "task": "replace ja to en", "name_q": "デキストラン40・ブドウ糖", "name_a": "Dextran 40 and glucose"} -{"id": 18762, "instruction": "Ginsenoside Reをは分子式で表すと?", "response": "Ginsenoside Reをは分子式で表すとC48H82O18です。", "task": "formula", "name_q": "Ginsenoside Re", "name_a": "C48H82O18"} -{"id": 12442, "instruction": "オニオニオン熱 上位グループ 蚊媒介ウイルス熱 節足動物媒介ウイルス熱 を英語に訳すと?", "response": "オニオニオン熱 上位グループ 蚊媒介ウイルス熱 節足動物媒介ウイルス熱 を英語に訳すとO'nyong-nyong fever SUPERGRP Mosquito-borne viral fever Arthropod-borne viral fever です。", "task": "replace ja to en", "name_q": "オニオニオン熱 上位グループ 蚊媒介ウイルス熱 節足動物媒介ウイルス熱 ", "name_a": "O'nyong-nyong fever SUPERGRP Mosquito-borne viral fever Arthropod-borne viral fever "} -{"id": 10979, "instruction": "Diclobutrazolの異なる表現は?", "response": "Diclobutrazolの異なる表現はジクロブトラゾールです。", "task": "replace", "name_q": "Diclobutrazol", "name_a": "ジクロブトラゾール"} -{"id": 19686, "instruction": "tRNA containing 5-carboxymethylaminomethyl-2-thiouridineをの化学構造は?", "response": "tRNA containing 5-carboxymethylaminomethyl-2-thiouridineをの化学構造はC12H18N3O10PS(C5H8O6PR)n(C5H8O6PR)nです。", "task": "formula", "name_q": "tRNA containing 5-carboxymethylaminomethyl-2-thiouridine", "name_a": "C12H18N3O10PS(C5H8O6PR)n(C5H8O6PR)n"} -{"id": 13734, "instruction": "Tromantadine (INN)をを組成式で記述すると?", "response": "Tromantadine (INN)をを組成式で記述するとC16H28N2O2です。", "task": "formula", "name_q": "Tromantadine (INN)", "name_a": "C16H28N2O2"} -{"id": 26536, "instruction": "Chlorpheniramineの別の呼び方は?", "response": "Chlorpheniramineの別の呼び方はChlorphenamineです。", "task": "replace", "name_q": "Chlorpheniramine", "name_a": "Chlorphenamine"} -{"id": 21966, "instruction": "1-(7-Methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)ethanoneの別呼称は?", "response": "1-(7-Methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)ethanoneの別呼称はEncecalinです。", "task": "replace", "name_q": "1-(7-Methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)ethanone", "name_a": "Encecalin"} -{"id": 7401, "instruction": "SUMATRIPTAN(ProficientRxLP)を主材料とする薬品は?", "response": "SUMATRIPTAN(ProficientRxLP)を主材料とする薬品はSUMATRIPTAN(NuCarePharmaceuticals)です。", "task": "product", "name_q": "SUMATRIPTAN(ProficientRxLP)", "name_a": "SUMATRIPTAN(NuCarePharmaceuticals)"} -{"id": 11567, "instruction": "COMBIVIR(ViiVHealthcareCompany)を材料とする薬品名は?", "response": "COMBIVIR(ViiVHealthcareCompany)を材料とする薬品名はLAMIVUDINEANDZIDOVUDINE(BryantRanchPrepack)です。", "task": "product", "name_q": "COMBIVIR(ViiVHealthcareCompany)", "name_a": "LAMIVUDINEANDZIDOVUDINE(BryantRanchPrepack)"} -{"id": 4975, "instruction": "C17H18N4O3Sをを分子式で記述すると?", "response": "C17H18N4O3Sをを分子式で記述するとC17H18N4O3Sです。", "task": "formula", "name_q": "C17H18N4O3S", "name_a": "C17H18N4O3S"} -{"id": 10239, "instruction": "Pagoclone (USAN/INN)をの化学構造は?", "response": "Pagoclone (USAN/INN)をの化学構造はC23H22ClN3O2です。", "task": "formula", "name_q": "Pagoclone (USAN/INN)", "name_a": "C23H22ClN3O2"} -{"id": 2985, "instruction": "Leukotriene C4をを組成式で記述すると?", "response": "Leukotriene C4をを組成式で記述するとC30H47N3O9Sです。", "task": "formula", "name_q": "Leukotriene C4", "name_a": "C30H47N3O9S"} -{"id": 9893, "instruction": "7-epi-ent-Eudesmane-5,11-diolをを分子式で記述すると?", "response": "7-epi-ent-Eudesmane-5,11-diolをを分子式で記述するとC15H28O2です。", "task": "formula", "name_q": "7-epi-ent-Eudesmane-5,11-diol", "name_a": "C15H28O2"} -{"id": 33887, "instruction": "α-サンタロールをを化学構造で書くと?", "response": "α-サンタロールをを化学構造で書くとC15H24Oです。", "task": "formula", "name_q": "α-サンタロール", "name_a": "C15H24O"} -{"id": 17667, "instruction": "Spondyloepiphyseal dysplasia tarda SUPERGRP Spondyloepiphyseal dysplasia を日本語に訳すと?", "response": "Spondyloepiphyseal dysplasia tarda SUPERGRP Spondyloepiphyseal dysplasia を日本語に訳すと遅発性脊椎骨端異形成 上位グループ 脊椎骨端異形成 です。", "task": "replace en to ja", "name_q": "Spondyloepiphyseal dysplasia tarda SUPERGRP Spondyloepiphyseal dysplasia ", "name_a": "遅発性脊椎骨端異形成 上位グループ 脊椎骨端異形成 "} -{"id": 1669, "instruction": "Suxibuzone (JAN/INN)を言い換えると?", "response": "Suxibuzone (JAN/INN)を言い換えるとスキシブゾン (JAN)です。", "task": "replace", "name_q": "Suxibuzone (JAN/INN)", "name_a": "スキシブゾン (JAN)"} -{"id": 19558, "instruction": "Gamolenic acid (INN)を英語表記で表すと?", "response": "Gamolenic acid (INN)を英語表記で表すとGamolenic acid (INN)です。", "task": "replace ja to en", "name_q": "Gamolenic acid (INN)", "name_a": "Gamolenic acid (INN)"} -{"id": 16481, "instruction": "Thiamazole (JP18/INN)を日本語で書くと?", "response": "Thiamazole (JP18/INN)を日本語で書くとMethimazole (USP)です。", "task": "replace en to ja", "name_q": "Thiamazole (JP18/INN)", "name_a": "Methimazole (USP)"} -{"id": 3232, "instruction": "Aplysinをを化学式で記述すると?", "response": "Aplysinをを化学式で記述するとC15H19BrOです。", "task": "formula", "name_q": "Aplysin", "name_a": "C15H19BrO"} -{"id": 29973, "instruction": "タクシャ (JP18)を材料とする薬品名は?", "response": "タクシャ (JP18)を材料とする薬品名はタクシャ(ウチダ和漢薬)です。", "task": "product", "name_q": "タクシャ (JP18)", "name_a": "タクシャ(ウチダ和漢薬)"} -{"id": 4921, "instruction": "Hereditary neuropathy with liability to pressure palsiesを日本語で記述すると?", "response": "Hereditary neuropathy with liability to pressure palsiesを日本語で記述すると圧迫麻痺性遺伝性ニューロパチー (HNPP)です。", "task": "replace en to ja", "name_q": "Hereditary neuropathy with liability to pressure palsies", "name_a": "圧迫麻痺性遺伝性ニューロパチー (HNPP)"} -{"id": 19894, "instruction": "Diatrizoate sodium I 125 (USAN)をを化学構造で表すと?", "response": "Diatrizoate sodium I 125 (USAN)をを化学構造で表すとC11H8I3N2O4. Naです。", "task": "formula", "name_q": "Diatrizoate sodium I 125 (USAN)", "name_a": "C11H8I3N2O4. Na"} -{"id": 9020, "instruction": "スタージ・ウェーバー症候群を英語表記で表すと?", "response": "スタージ・ウェーバー症候群を英語表記で表すとSturge-Weber syndromeです。", "task": "replace ja to en", "name_q": "スタージ・ウェーバー症候群", "name_a": "Sturge-Weber syndrome"} -{"id": 21636, "instruction": "Thimerosal (JAN/USP)の英訳は?", "response": "Thimerosal (JAN/USP)の英訳はThiomersal (INN)です。", "task": "replace ja to en", "name_q": "Thimerosal (JAN/USP)", "name_a": "Thiomersal (INN)"} -{"id": 14393, "instruction": "2-アミノ-9H-ピリド[2,3-b]インドールを言い換えると?", "response": "2-アミノ-9H-ピリド[2,3-b]インドールを言い換えると2-Amino-9H-pyrido[2,3-b]indoleです。", "task": "replace", "name_q": "2-アミノ-9H-ピリド[2,3-b]インドール", "name_a": "2-Amino-9H-pyrido[2,3-b]indole"} -{"id": 9087, "instruction": "D-Biotinの異なる名称は?", "response": "D-Biotinの異なる名称はCoenzyme Rです。", "task": "replace", "name_q": "D-Biotin", "name_a": "Coenzyme R"} -{"id": 943, "instruction": "C16H21N7O7S3をを組成式で記述すると?", "response": "C16H21N7O7S3をを組成式で記述するとC16H21N7O7S3です。", "task": "formula", "name_q": "C16H21N7O7S3", "name_a": "C16H21N7O7S3"} -{"id": 18279, "instruction": "(22S,24R)-22-Hydroxy-ergost-4 en-3-oneをを組成式で表すと?", "response": "(22S,24R)-22-Hydroxy-ergost-4 en-3-oneをを組成式で表すとC28H46O2です。", "task": "formula", "name_q": "(22S,24R)-22-Hydroxy-ergost-4 en-3-one", "name_a": "C28H46O2"} -{"id": 34413, "instruction": "Lotilaner (USAN/INN)をは組成式で表すと?", "response": "Lotilaner (USAN/INN)をは組成式で表すとC20H14Cl3F6N3O3Sです。", "task": "formula", "name_q": "Lotilaner (USAN/INN)", "name_a": "C20H14Cl3F6N3O3S"} -{"id": 12926, "instruction": "シプロフロキサシンをを組成式で記述すると?", "response": "シプロフロキサシンをを組成式で記述するとC17H18FN3O3です。", "task": "formula", "name_q": "シプロフロキサシン", "name_a": "C17H18FN3O3"} -{"id": 29941, "instruction": "Emphysemaを日本語で書くと?", "response": "Emphysemaを日本語で書くと慢性閉塞性肺疾患 (COPD)です。", "task": "replace en to ja", "name_q": "Emphysema", "name_a": "慢性閉塞性肺疾患 (COPD)"} -{"id": 20995, "instruction": "ナルゾタンは別の呼び方では?", "response": "ナルゾタンは別の呼び方ではNaluzotan (USAN/INN)です。", "task": "replace", "name_q": "ナルゾタン", "name_a": "Naluzotan (USAN/INN)"} -{"id": 25744, "instruction": "Neoproserineを日本語に訳すと?", "response": "Neoproserineを日本語に訳すとNeoproserineです。", "task": "replace en to ja", "name_q": "Neoproserine", "name_a": "Neoproserine"} -{"id": 9395, "instruction": "1'-Hydroxyversicoloroneの別の呼び方は?", "response": "1'-Hydroxyversicoloroneの別の呼び方はHydroxyversicoloroneです。", "task": "replace", "name_q": "1'-Hydroxyversicolorone", "name_a": "Hydroxyversicolorone"} -{"id": 2646, "instruction": "Chibakujioganの日本語訳は?", "response": "Chibakujioganの日本語訳は知柏地黄丸です。", "task": "replace en to ja", "name_q": "Chibakujiogan", "name_a": "知柏地黄丸"} -{"id": 6021, "instruction": "Carvotroline hydrochloride (USAN)の日本語訳は?", "response": "Carvotroline hydrochloride (USAN)の日本語訳はカルボトリン塩酸塩です。", "task": "replace en to ja", "name_q": "Carvotroline hydrochloride (USAN)", "name_a": "カルボトリン塩酸塩"} -{"id": 14626, "instruction": "(24R,25R)-3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoAをを組成式で表すと?", "response": "(24R,25R)-3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoAをを組成式で表すとC48H80N7O20P3Sです。", "task": "formula", "name_q": "(24R,25R)-3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA", "name_a": "C48H80N7O20P3S"} -{"id": 12649, "instruction": "TRUDHESA(ImpelPharmaceuticals)を主材料とする商品名は?", "response": "TRUDHESA(ImpelPharmaceuticals)を主材料とする商品名はDIHYDROERGOTAMINEMESYLATE(GlandPharmaLimited)です。", "task": "product", "name_q": "TRUDHESA(ImpelPharmaceuticals)", "name_a": "DIHYDROERGOTAMINEMESYLATE(GlandPharmaLimited)"} -{"id": 27741, "instruction": "Boschnialactoneの別呼称は?", "response": "Boschnialactoneの別呼称はボシュニアラクトンです。", "task": "replace", "name_q": "Boschnialactone", "name_a": "ボシュニアラクトン"} -{"id": 12780, "instruction": "Ethiproleをを組成式で記述すると?", "response": "Ethiproleをを組��式で記述するとC13H9Cl2F3N4OSです。", "task": "formula", "name_q": "Ethiprole", "name_a": "C13H9Cl2F3N4OS"} -{"id": 14215, "instruction": "dl-Methylephedrine hydrochloride, noscapine and chlorpheniramine maleateを日本語に訳すと?", "response": "dl-Methylephedrine hydrochloride, noscapine and chlorpheniramine maleateを日本語に訳すとdl-メチルエフェドリン塩酸塩・ノスカピン・クロルフェニラミンマレイン酸塩です。", "task": "replace en to ja", "name_q": "dl-Methylephedrine hydrochloride, noscapine and chlorpheniramine maleate", "name_a": "dl-メチルエフェドリン塩酸塩・ノスカピン・クロルフェニラミンマレイン酸塩"} -{"id": 31586, "instruction": "Rydapt (TN)の日本語表記は?", "response": "Rydapt (TN)の日本語表記はミドスタウリン (JAN)です。", "task": "replace en to ja", "name_q": "Rydapt (TN)", "name_a": "ミドスタウリン (JAN)"} -{"id": 14230, "instruction": "ビューベリシンをの化学式は?", "response": "ビューベリシンをの化学式はC45H57N3O9です。", "task": "formula", "name_q": "ビューベリシン", "name_a": "C45H57N3O9"} -{"id": 34490, "instruction": "cis-2-Carboxycyclohexyl-acetic acidをは化学式で表すと?", "response": "cis-2-Carboxycyclohexyl-acetic acidをは化学式で表すとC9H14O4です。", "task": "formula", "name_q": "cis-2-Carboxycyclohexyl-acetic acid", "name_a": "C9H14O4"} -{"id": 13100, "instruction": "Vitamin B12をを分子式で書くと?", "response": "Vitamin B12をを分子式で書くとC62H88CoN13O14PRです。", "task": "formula", "name_q": "Vitamin B12", "name_a": "C62H88CoN13O14PR"} -{"id": 33012, "instruction": "Congenital juvenile recurrent respiratory papillomatosisを日本語表記で表すと?", "response": "Congenital juvenile recurrent respiratory papillomatosisを日本語表記で表すと先天性若年発症型再発性呼吸器乳頭腫症です。", "task": "replace en to ja", "name_q": "Congenital juvenile recurrent respiratory papillomatosis", "name_a": "先天性若年発症型再発性呼吸器乳頭腫症"} -{"id": 33065, "instruction": "ナパブカシン (JAN)の別表現は?", "response": "ナパブカシン (JAN)の別表現はNapabucasin (JAN/USAN/INN)です。", "task": "replace", "name_q": "ナパブカシン (JAN)", "name_a": "Napabucasin (JAN/USAN/INN)"} -{"id": 15715, "instruction": "Jackson-Weiss syndrome SUPERGRP Syndromic craniosynostoses の日本語表記は?", "response": "Jackson-Weiss syndrome SUPERGRP Syndromic craniosynostoses の日本語表記はJackson-Weiss 症候群 上位グループ 症候性頭蓋縫合早期癒合症 です。", "task": "replace en to ja", "name_q": "Jackson-Weiss syndrome SUPERGRP Syndromic craniosynostoses ", "name_a": "Jackson-Weiss 症候群 上位グループ 症候性頭蓋縫合早期癒合症 "} -{"id": 18815, "instruction": "Bismuth magnesium aluminosilicate (JAN)を日本語で書くと?", "response": "Bismuth magnesium aluminosilicate (JAN)を日本語で書くとケイ酸アルミン酸マグネシウムビスマス (JAN)です。", "task": "replace en to ja", "name_q": "Bismuth magnesium aluminosilicate (JAN)", "name_a": "ケイ酸アルミン酸マグネシウムビスマス (JAN)"} -{"id": 34003, "instruction": "Mycinamicin VIIIをの組成式は?", "response": "Mycinamicin VIIIをの組成式はC29H47NO6です。", "task": "formula", "name_q": "Mycinamicin VIII", "name_a": "C29H47NO6"} -{"id": 4086, "instruction": "Cholesteryl oleateをは組成式で表すと?", "response": "Cholesteryl oleateをは組成式で表すとC45H78O2です。", "task": "formula", "name_q": "Cholesteryl oleate", "name_a": "C45H78O2"} -{"id": 29312, "instruction": "X連鎖先天性角化異常症 上位グループ 先天性角化異常症 の別記述は?", "response": "X連鎖先天性角化異常症 上位グループ 先天性角化異常症 の別記述はHoyeraal-Hreidarsson 症候群です。", "task": "replace", "name_q": "X連鎖先天性角化異常症 上位グループ 先天性角化異常症 ", "name_a": "Hoyeraal-Hreidarsson 症候群"} -{"id": 21155, "instruction": "Azetepa (USAN/INN)をを分子式で記述すると?", "response": "Azetepa (USAN/INN)をを分子式で記述するとC8H14N5OPSです。", "task": "formula", "name_q": "Azetepa (USAN/INN)", "name_a": "C8H14N5OPS"} -{"id": 16866, "instruction": "ストロバンを言い換えると?", "response": "ストロバンを言い換えるとStrobaneです。", "task": "replace", "name_q": "ストロバン", "name_a": "Strobane"} -{"id": 23377, "instruction": "ダイアモンド・ブラックファン貧血を英語表記で表すと?", "response": "ダイアモンド・ブラックファン貧血を英語表記で表すとDiamond-Blackfan anemiaです。", "task": "replace ja to en", "name_q": "ダイアモンド・ブラックファン貧血", "name_a": "Diamond-Blackfan anemia"} -{"id": 8054, "instruction": "沈降精製百日せきワクチン (JP18)の別呼称は?", "response": "沈降精製百日せ���ワクチン (JP18)の別呼称はAdsorbed purified pertussis vaccine (JP18)です。", "task": "replace", "name_q": "沈降精製百日せきワクチン (JP18)", "name_a": "Adsorbed purified pertussis vaccine (JP18)"} -{"id": 13186, "instruction": "Codoxime (USAN/INN)の別表現は?", "response": "Codoxime (USAN/INN)の別表現はコドキシムです。", "task": "replace", "name_q": "Codoxime (USAN/INN)", "name_a": "コドキシム"} -{"id": 24183, "instruction": "ビネトラキンの異なる表現は?", "response": "ビネトラキンの異なる表現はBinetrakin (USAN/INN)です。", "task": "replace", "name_q": "ビネトラキン", "name_a": "Binetrakin (USAN/INN)"} -{"id": 31619, "instruction": "Epidermolysis bullosa, hemidesmosomal SUBGROUP Epidermolysis bullosa simplex, Ogna type (EBS-Ogna) Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) Epidermolysis bullosa simplex with pyloric atresia (EBS-PA) SUPERGRP Epidermolysis bullosa simplex Epidermolysis bullosa を日本語で書くと?", "response": "Epidermolysis bullosa, hemidesmosomal SUBGROUP Epidermolysis bullosa simplex, Ogna type (EBS-Ogna) Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) Epidermolysis bullosa simplex with pyloric atresia (EBS-PA) SUPERGRP Epidermolysis bullosa simplex Epidermolysis bullosa を日本語で書くとヘミデスモソーム型表皮水疱症 下位グループ 単純型表皮水疱症 Ogna 型 単純型表皮水疱症 筋ジストロフィー合併型 単純型表皮水疱症 幽門閉鎖合併型 上位グループ 単純型表皮水疱症 表皮水疱症 です。", "task": "replace en to ja", "name_q": "Epidermolysis bullosa, hemidesmosomal SUBGROUP Epidermolysis bullosa simplex, Ogna type (EBS-Ogna) Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) Epidermolysis bullosa simplex with pyloric atresia (EBS-PA) SUPERGRP Epidermolysis bullosa simplex Epidermolysis bullosa ", "name_a": "ヘミデスモソーム型表皮水疱症 下位グループ 単純型表皮水疱症 Ogna 型 単純型表皮水疱症 筋ジストロフィー合併型 単純型表皮水疱症 幽門閉鎖合併型 上位グループ 単純型表皮水疱症 表皮水疱症 "} -{"id": 19269, "instruction": "Ketosis-prone diabetes mellitusを英語で書くと?", "response": "Ketosis-prone diabetes mellitusを英語で書くとKetosis-prone diabetes mellitusです。", "task": "replace ja to en", "name_q": "Ketosis-prone diabetes mellitus", "name_a": "Ketosis-prone diabetes mellitus"} -{"id": 28355, "instruction": "Kenchutoの日本語表記は?", "response": "Kenchutoの日本語表記はKenchutoです。", "task": "replace en to ja", "name_q": "Kenchuto", "name_a": "Kenchuto"} -{"id": 4621, "instruction": "酢酸メゲストロールは別の呼び方では?", "response": "酢酸メゲストロールは別の呼び方ではMegestrol acetateです。", "task": "replace", "name_q": "酢酸メゲストロール", "name_a": "Megestrol acetate"} -{"id": 25118, "instruction": "L 735821をを分子式で表すと?", "response": "L 735821をを分子式で表すとC25H19Cl2N3O2です。", "task": "formula", "name_q": "L 735821", "name_a": "C25H19Cl2N3O2"} -{"id": 24001, "instruction": "Scott syndromeを日本語に訳すと?", "response": "Scott syndromeを日本語に訳すとスコット症候群です。", "task": "replace en to ja", "name_q": "Scott syndrome", "name_a": "スコット症候群"} -{"id": 2938, "instruction": "Darifenacin hydrobromide (JAN/USAN)の別記述は?", "response": "Darifenacin hydrobromide (JAN/USAN)の別記述はEnablex (TN)です。", "task": "replace", "name_q": "Darifenacin hydrobromide (JAN/USAN)", "name_a": "Enablex (TN)"} -{"id": 32559, "instruction": "KDO2-lipid IVAの別名称は?", "response": "KDO2-lipid IVAの別名称はKDO2-lipid IV(A)です。", "task": "replace", "name_q": "KDO2-lipid IVA", "name_a": "KDO2-lipid IV(A)"} -{"id": 6521, "instruction": "Brofaromine (INN)をは化学構造で表すと?", "response": "Brofaromine (INN)をは化学構造で表すとC14H16BrNO2です。", "task": "formula", "name_q": "Brofaromine (INN)", "name_a": "C14H16BrNO2"} -{"id": 6782, "instruction": "Pentamorphone (USAN/INN)を日本語に訳すと?", "response": "Pentamorphone (USAN/INN)を日本語に訳すとペンタモルホンです。", "task": "replace en to ja", "name_q": "Pentamorphone (USAN/INN)", "name_a": "ペンタモルホン"} -{"id": 20169, "instruction": "Acolbifene hydrochloride (USAN)をを化学式で記述すると?", "response": "Acolbifene hydrochloride (USAN)をを化学式で記述するとC29H31NO4. HClです。", "task": "formula", "name_q": "Acolbifene hydrochloride (USAN)", "name_a": "C29H31NO4. HCl"} -{"id": 34627, "instruction": "BELEODAQ(AcrotechBiopharma)をの化学構造は?", "response": "BELEODAQ(AcrotechBiopharma)をの化学構造はC15H14N2O4Sです。", "task": "formula", "name_q": "BELEODAQ(AcrotechBiopharma)", "name_a": "C15H14N2O4S"} -{"id": 21354, "instruction": "ディセントリンをは化学式で表すと?", "response": "ディセントリンをは化学式で表すとC20H21NO4です。", "task": "formula", "name_q": "ディセントリン", "name_a": "C20H21NO4"} -{"id": 24241, "instruction": "Inosine 5'-tetraphosphateをを分子式で記述すると?", "response": "Inosine 5'-tetraphosphateをを分子式で記述するとC10H16N4O17P4です。", "task": "formula", "name_q": "Inosine 5'-tetraphosphate", "name_a": "C10H16N4O17P4"} -{"id": 23575, "instruction": "Tymlos (TN)を利用した薬品は?", "response": "Tymlos (TN)を利用した薬品はTYMLOS(RadiusHealth)です。", "task": "product", "name_q": "Tymlos (TN)", "name_a": "TYMLOS(RadiusHealth)"} -{"id": 29604, "instruction": "Pentanoateをの分子式は?", "response": "Pentanoateをの分子式はC5H10O2です。", "task": "formula", "name_q": "Pentanoate", "name_a": "C5H10O2"} -{"id": 13563, "instruction": "Cefamandole (USAN/INN)を英語に訳すと?", "response": "Cefamandole (USAN/INN)を英語に訳すとCefamandole (USAN/INN)です。", "task": "replace ja to en", "name_q": "Cefamandole (USAN/INN)", "name_a": "Cefamandole (USAN/INN)"} -{"id": 30203, "instruction": "alpha-D-Galactosyl-(1,1')-sn-glycerol 3-phosphateの別記述は?", "response": "alpha-D-Galactosyl-(1,1')-sn-glycerol 3-phosphateの別記述は1-O-alpha-D-Galactosyl-sn-glycerol 3-phosphateです。", "task": "replace", "name_q": "alpha-D-Galactosyl-(1,1')-sn-glycerol 3-phosphate", "name_a": "1-O-alpha-D-Galactosyl-sn-glycerol 3-phosphate"} -{"id": 14959, "instruction": "C3508H5440N922O1096S32を利用した製品は?", "response": "C3508H5440N922O1096S32を利用した製品はNULOJIX(E.R.Squibb&Sons)です。", "task": "product", "name_q": "C3508H5440N922O1096S32", "name_a": "NULOJIX(E.R.Squibb&Sons)"} -{"id": 11248, "instruction": "C8H6N4O4Sをを化学式で記述すると?", "response": "C8H6N4O4Sをを化学式で記述するとC8H6N4O4Sです。", "task": "formula", "name_q": "C8H6N4O4S", "name_a": "C8H6N4O4S"} -{"id": 28370, "instruction": "バトラコトキシンをを化学構造で記述すると?", "response": "バトラコトキシンをを化学構造で記述するとC31H42N2O6です。", "task": "formula", "name_q": "バトラコトキシン", "name_a": "C31H42N2O6"} -{"id": 7722, "instruction": "Paldimycin (USAN)をを化学式で記述すると?", "response": "Paldimycin (USAN)をを化学式で記述するとC43H61N4O23S3Rです。", "task": "formula", "name_q": "Paldimycin (USAN)", "name_a": "C43H61N4O23S3R"} -{"id": 22789, "instruction": "Ohiを日本語表記で表すと?", "response": "Ohiを日本語表記で表すとPruni jamasakura cortexです。", "task": "replace en to ja", "name_q": "Ohi", "name_a": "Pruni jamasakura cortex"} -{"id": 34025, "instruction": "テオフィリン水和物を英語で記述すると?", "response": "テオフィリン水和物を英語で記述するとTheophylline monohydrateです。", "task": "replace ja to en", "name_q": "テオフィリン水和物", "name_a": "Theophylline monohydrate"} -{"id": 31567, "instruction": "Adecut (TN)を日本語に訳すと?", "response": "Adecut (TN)を日本語に訳すとDelapril hydrochloride (JAN/USAN)です。", "task": "replace en to ja", "name_q": "Adecut (TN)", "name_a": "Delapril hydrochloride (JAN/USAN)"} -{"id": 7675, "instruction": "Ombitasvir heminonahydrateを英語で記述すると?", "response": "Ombitasvir heminonahydrateを英語で記述するとOmbitasvir hydrate (JAN)です。", "task": "replace ja to en", "name_q": "Ombitasvir heminonahydrate", "name_a": "Ombitasvir hydrate (JAN)"} -{"id": 12151, "instruction": "特発性ステロイド性骨壊死症を英語で書くと?", "response": "特発性ステロイド性骨壊死症を英語で書くとGlucocorticoid-induced osteonecrosisです。", "task": "replace ja to en", "name_q": "特発性ステロイド性骨壊死症", "name_a": "Glucocorticoid-induced osteonecrosis"} -{"id": 19670, "instruction": "トロポロンの異なる表現は?", "response": "トロポロンの異なる表現はTropoloneです。", "task": "replace", "name_q": "トロポロン", "name_a": "Tropolone"} -{"id": 15486, "instruction": "Namzaric (TN)を主材料とする薬品は?", "response": "Namzaric (TN)を主材料とする薬品は後発品MEMANTINEANDDONEPEZILHYDROCHLORIDESEXTENDED-RELEASE(AmnealPharmaceuticalsNYLLC)です。", "task": "product", "name_q": "Namzaric (TN)", "name_a": "後発品MEMANTINEANDDONEPEZILHYDROCHLORIDESEXTENDED-RELEASE(AmnealPharmaceuticalsNYLLC)"} -{"id": 19385, "instruction": "2,2-Dichloropropanoic acidの別名称は?", "response": "2,2-Dichloropropanoic acidの別名称は2,2-DPAです。", "task": "replace", "name_q": "2,2-Dichloropropanoic acid", "name_a": "2,2-DPA"} -{"id": 15678, "instruction": "早期発症ミオパチー・反射消失・呼吸困難および嚥下障害を英語表記で表すと?", "response": "早期発症ミオパチー・反射消失・呼吸困難および嚥下障害を英語表記で表すとEarly-onset myopathy, areflexia, respiratory distress, and dysphagia SUPERGRP Congenital myopathy です。", "task": "replace ja to en", "name_q": "早期発症ミオパチー・反射消失・呼吸困難および嚥下障害", "name_a": "Early-onset myopathy, areflexia, respiratory distress, and dysphagia SUPERGRP Congenital myopathy "} -{"id": 31565, "instruction": "Phosphoenolpyruvic acidの別名称は?", "response": "Phosphoenolpyruvic acidの別名称はPEPです。", "task": "replace", "name_q": "Phosphoenolpyruvic acid", "name_a": "PEP"} -{"id": 18229, "instruction": "N-3-Oxo-dodecanoyl-L-homoserine lactoneをの組成式は?", "response": "N-3-Oxo-dodecanoyl-L-homoserine lactoneをの組成式はC16H27NO4です。", "task": "formula", "name_q": "N-3-Oxo-dodecanoyl-L-homoserine lactone", "name_a": "C16H27NO4"} -{"id": 20112, "instruction": "シャクヤク(鈴粉末薬品)を利用した製品は?", "response": "シャクヤク(鈴粉末薬品)を利用した製品はセキシャク(高砂薬業)です。", "task": "product", "name_q": "シャクヤク(鈴粉末薬品)", "name_a": "セキシャク(高砂薬業)"} -{"id": 20273, "instruction": "モセチノスタットの異なる表現は?", "response": "モセチノスタットの異なる表現はMocetinostat (USAN/INN)です。", "task": "replace", "name_q": "モセチノスタット", "name_a": "Mocetinostat (USAN/INN)"} -{"id": 34191, "instruction": "メタラミノールの別名は?", "response": "メタラミノールの別名はMetaraminolです。", "task": "replace", "name_q": "メタラミノール", "name_a": "Metaraminol"} -{"id": 6784, "instruction": "Stenbolone acetate (USAN)をを組成式で表すと?", "response": "Stenbolone acetate (USAN)をを組成式で表すとC22H32O3です。", "task": "formula", "name_q": "Stenbolone acetate (USAN)", "name_a": "C22H32O3"} -{"id": 33495, "instruction": "Relacatib (USAN/INN)をは化学式で表すと?", "response": "Relacatib (USAN/INN)をは化学式で表すとC27H32N4O6Sです。", "task": "formula", "name_q": "Relacatib (USAN/INN)", "name_a": "C27H32N4O6S"} -{"id": 2310, "instruction": "Ketophenylbutazone (JAN)を日本語で記述すると?", "response": "Ketophenylbutazone (JAN)を日本語で記述するとKebuzone (INN)です。", "task": "replace en to ja", "name_q": "Ketophenylbutazone (JAN)", "name_a": "Kebuzone (INN)"} -{"id": 20962, "instruction": "Uproleselan (USAN/INN)は別の呼び方では?", "response": "Uproleselan (USAN/INN)は別の呼び方ではユプロレセランです。", "task": "replace", "name_q": "Uproleselan (USAN/INN)", "name_a": "ユプロレセラン"} -{"id": 9424, "instruction": "アドロゴリド塩酸塩をを分子式で表すと?", "response": "アドロゴリド塩酸塩をを分子式で表すとC22H25NO4S. HClです。", "task": "formula", "name_q": "アドロゴリド塩酸塩", "name_a": "C22H25NO4S. HCl"} -{"id": 20943, "instruction": "Efloxate (JAN/INN)をを分子式で記述すると?", "response": "Efloxate (JAN/INN)をを分子式で記述するとC19H16O5です。", "task": "formula", "name_q": "Efloxate (JAN/INN)", "name_a": "C19H16O5"} -{"id": 30348, "instruction": "アルミニウムジルコニウムペンタクロロハイドレックスグリシンを英語に訳すと?", "response": "アルミニウムジルコニウムペンタクロロハイドレックスグリシンを英語に訳すとAluminum zirconium pentachlorohydrex Gly (USP)です。", "task": "replace ja to en", "name_q": "アルミニウムジルコニウムペンタクロロハイドレックスグリシン", "name_a": "Aluminum zirconium pentachlorohydrex Gly (USP)"} -{"id": 17889, "instruction": "Diallyl sulfideをを化学構造で記述すると?", "response": "Diallyl sulfideをを化学構造で記述するとC6H10Sです。", "task": "formula", "name_q": "Diallyl sulfide", "name_a": "C6H10S"} -{"id": 22862, "instruction": "Tricaprilinをを化学構造で書くと?", "response": "Tricaprilinをを化学構造で書くとC27H50O6です。", "task": "formula", "name_q": "Tricaprilin", "name_a": "C27H50O6"} -{"id": 1880, "instruction": "ハエ幼虫症を英語表記で表すと?", "response": "ハエ幼虫症を英語表記で表すとMyiasisです。", "task": "replace ja to en", "name_q": "ハエ幼虫症", "name_a": "Myiasis"} -{"id": 13652, "instruction": "ペルゴリドの異なる名称は?", "response": "ペルゴリドの異なる名称はPergolideです。", "task": "replace", "name_q": "ペルゴリド", "name_a": "Pergolide"} -{"id": 896, "instruction": "9-Methylthiononanaldoximeをは組成式で表すと?", "response": "9-Methylthiononanaldoximeをは組成式で表すとC10H21NOSです。", "task": "formula", "name_q": "9-Methylthiononanaldoxime", "name_a": "C10H21NOS"} -{"id": 29039, "instruction": "Pararosaniline pamoate (USAN)の異なる名称は?", "response": "Pararosaniline pamoate (USAN)の異なる名称はPararosaniline pamoate dihydrateです。", "task": "replace", "name_q": "Pararosaniline pamoate (USAN)", "name_a": "Pararosaniline pamoate dihydrate"} -{"id": 792, "instruction": "Bunolol hydrochloride (USAN)をの分子式は?", "response": "Bunolol hydrochloride (USAN)をの分子式はC17H25NO3. HClです。", "task": "formula", "name_q": "Bunolol hydrochloride (USAN)", "name_a": "C17H25NO3. HCl"} -{"id": 26312, "instruction": "PN 202-791の別記述は?", "response": "PN 202-791の別記述は202-791です。", "task": "replace", "name_q": "PN 202-791", "name_a": "202-791"} -{"id": 25904, "instruction": "塩酸エタフェドリンを英語で記述すると?", "response": "塩酸エタフェドリンを英語で記述するとNethamine (TN)です。", "task": "replace ja to en", "name_q": "塩酸エタフェドリン", "name_a": "Nethamine (TN)"} -{"id": 16926, "instruction": "1-Benzyl-7,8-dimethoxy-3-phenyl-3H-pyrazolo[3,4-c]isoquinolineをを化学式で記述すると?", "response": "1-Benzyl-7,8-dimethoxy-3-phenyl-3H-pyrazolo[3,4-c]isoquinolineをを化学式で記述するとC25H21N3O2です。", "task": "formula", "name_q": "1-Benzyl-7,8-dimethoxy-3-phenyl-3H-pyrazolo[3,4-c]isoquinoline", "name_a": "C25H21N3O2"} -{"id": 8886, "instruction": "Bimatoprost and timololの別呼称は?", "response": "Bimatoprost and timololの別呼称はビマトプロスト・チモロールマレイン酸塩です。", "task": "replace", "name_q": "Bimatoprost and timolol", "name_a": "ビマトプロスト・チモロールマレイン酸塩"} -{"id": 19437, "instruction": "アザニダゾールを英語に訳すと?", "response": "アザニダゾールを英語に訳すとAzanidazole (USAN/INN)です。", "task": "replace ja to en", "name_q": "アザニダゾール", "name_a": "Azanidazole (USAN/INN)"} -{"id": 12881, "instruction": "Cryptopleurineの異なる名称は?", "response": "Cryptopleurineの異なる名称はクリプトプレウリンです。", "task": "replace", "name_q": "Cryptopleurine", "name_a": "クリプトプレウリン"} -{"id": 4278, "instruction": "Papaveroxineをは化学構造で表すと?", "response": "Papaveroxineをは化学構造で表すとC22H25NO7です。", "task": "formula", "name_q": "Papaveroxine", "name_a": "C22H25NO7"} -{"id": 27080, "instruction": "Validamine 7-phosphateをを分子式で表すと?", "response": "Validamine 7-phosphateをを分子式で表すとC7H16NO7Pです。", "task": "formula", "name_q": "Validamine 7-phosphate", "name_a": "C7H16NO7P"} -{"id": 25026, "instruction": "5-Keto-fumagillolをは組成式で表すと?", "response": "5-Keto-fumagillolをは組成式で表すとC16H24O4です。", "task": "formula", "name_q": "5-Keto-fumagillol", "name_a": "C16H24O4"} -{"id": 13544, "instruction": "Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosisの日本語表記は?", "response": "Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosisの日本語表記は肺静脈閉塞症／肺毛細血管腫症です。", "task": "replace en to ja", "name_q": "Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis", "name_a": "肺静脈閉塞症／肺毛細血管腫症"} -{"id": 6933, "instruction": "Anaphelineをを化学構造で表すと?", "response": "Anaphelineをを化学構造で表すとC13H24N2Oです。", "task": "formula", "name_q": "Anapheline", "name_a": "C13H24N2O"} -{"id": 16593, "instruction": "Bjornstad 症候群 上位グループ ミトコンドリア病 を英語で記述すると?", "response": "Bjornstad 症候群 上位グループ ミトコンドリア病 を英語で記述するとBjornstad syndrome SUPERGRP Mitochondrial disease です。", "task": "replace ja to en", "name_q": "Bjornstad 症候群 上位グループ ミトコンドリア病 ", "name_a": "Bjornstad syndrome SUPERGRP Mitochondrial disease "} -{"id": 32236, "instruction": "Weyers 四肢顔面骨形成不全症の英訳は?", "response": "Weyers 四肢顔面骨形成不全症の英訳はCurry-Hall syndrome SUPERGRP Acrofacial dysostosis です。", "task": "replace ja to en", "name_q": "Weyers 四肢顔面骨形成不全症", "name_a": "Curry-Hall syndrome SUPERGRP Acrofacial dysostosis "} -{"id": 29187, "instruction": "Cholesterol-5beta,6beta-epoxideをを化学構造で記述すると?", "response": "Cholesterol-5beta,6beta-epoxideをを化学構造で記述するとC27H46O2です。", "task": "formula", "name_q": "Cholesterol-5beta,6beta-epoxide", "name_a": "C27H46O2"} -{"id": 4110, "instruction": "Navidrex (TN)の日本語表記は?", "response": "Navidrex (TN)の日本語表記はシクロペンチアジド (JAN)です。", "task": "replace en to ja", "name_q": "Navidrex (TN)", "name_a": "シクロペンチアジド (JAN)"} -{"id": 28427, "instruction": "C28H33O8. Naをは分子式で表すと?", "response": "C28H33O8. Naをは分子式で表すとC28H33O8. Naです。", "task": "formula", "name_q": "C28H33O8. Na", "name_a": "C28H33O8. Na"} -{"id": 29838, "instruction": "ランセオトキシンAをを化学式で書くと?", "response": "ランセオトキシンAをを化学式で書くとC32H44O12です。", "task": "formula", "name_q": "ランセオトキシンA", "name_a": "C32H44O12"} -{"id": 24959, "instruction": "N-(1-Deoxy-D-fructos-1-yl)amineをは組成式で表すと?", "response": "N-(1-Deoxy-D-fructos-1-yl)amineをは組成式で表すとC7H14NO5Rです。", "task": "formula", "name_q": "N-(1-Deoxy-D-fructos-1-yl)amine", "name_a": "C7H14NO5R"} -{"id": 4730, "instruction": "C13H16N2をを化学式で表すと?", "response": "C13H16N2をを化学式で表すとC13H16N2です。", "task": "formula", "name_q": "C13H16N2", "name_a": "C13H16N2"} -{"id": 23492, "instruction": "4',5,6,7-Tetramethoxyflavoneを言い換えると?", "response": "4',5,6,7-Tetramethoxyflavoneを言い換えるとTetra-O-methylscutellareinです。", "task": "replace", "name_q": "4',5,6,7-Tetramethoxyflavone", "name_a": "Tetra-O-methylscutellarein"} -{"id": 29175, "instruction": "Aminophylline (USP/INN)をは化学構造で表すと?", "response": "Aminophylline (USP/INN)をは化学構造で表すと(C7H8N4O2)2. C2H8N2です。", "task": "formula", "name_q": "Aminophylline (USP/INN)", "name_a": "(C7H8N4O2)2. C2H8N2"} -{"id": 32577, "instruction": "Rivogenlecleucel (USAN)の別名称は?", "response": "Rivogenlecleucel (USAN)の別名称はリボジェンレクルユーセルです。", "task": "replace", "name_q": "Rivogenlecleucel (USAN)", "name_a": "リボジェンレクルユーセル"} -{"id": 23369, "instruction": "ポリエチレンスルホン酸ナトリウム (JAN)を英語で記述すると?", "response": "ポリエチレンスルホン酸ナトリウム (JAN)を英語で記述するとLyapolate sodium (USAN)です。", "task": "replace ja to en", "name_q": "ポリエチレンスルホン酸ナトリウム (JAN)", "name_a": "Lyapolate sodium (USAN)"} -{"id": 5729, "instruction": "Atherosclerosisの日本語表記は?", "response": "Atherosclerosisの日本語表記はアテローム性動脈硬化です。", "task": "replace en to ja", "name_q": "Atherosclerosis", "name_a": "アテローム性動脈硬化"} -{"id": 14324, "instruction": "IGF-I resistanceの日本語表記は?", "response": "IGF-I resistanceの日本語表記はIGF-I resistanceです。", "task": "replace en to ja", "name_q": "IGF-I resistance", "name_a": "IGF-I resistance"} -{"id": 2278, "instruction": "Oleandolideをは化学式で表すと?", "response": "Oleandolideをは化学式で表すとC20H34O7です。", "task": "formula", "name_q": "Oleandolide", "name_a": "C20H34O7"} -{"id": 2149, "instruction": "トラスツズマブパミルテカンの別の呼び方は?", "response": "トラスツズマブパミルテカンの別の呼び方はTrastuzumab pamirtecan (USAN)です。", "task": "replace", "name_q": "トラスツズマブパミルテカン", "name_a": "Trastuzumab pamirtecan (USAN)"} -{"id": 30764, "instruction": "腸管神経節細胞僅少症の英語表記は?", "response": "腸管神経節細胞僅少症の英語表記はIsolated hypoganglionosisです。", "task": "replace ja to en", "name_q": "腸管神経節細胞僅少症", "name_a": "Isolated hypoganglionosis"} -{"id": 951, "instruction": "Equipin (TN)を日本語で記述すると?", "response": "Equipin (TN)を日本語で記述するとHomatropine methylbromide (USP)です。", "task": "replace en to ja", "name_q": "Equipin (TN)", "name_a": "Homatropine methylbromide (USP)"} -{"id": 14094, "instruction": "Magnesium glucoheptonateは別の呼び方では?", "response": "Magnesium glucoheptonateは別の呼び方ではグルコヘプトン酸マグネシウムです。", "task": "replace", "name_q": "Magnesium glucoheptonate", "name_a": "グルコヘプトン酸マグネシウム"} -{"id": 11533, "instruction": "Phthalofyne (USAN)を日本語で記述すると?", "response": "Phthalofyne (USAN)を日本語で記述するとフタロフィンです。", "task": "replace en to ja", "name_q": "Phthalofyne (USAN)", "name_a": "フタロフィン"} -{"id": 17648, "instruction": "Sanggenon Dをを分子式で記述すると?", "response": "Sanggenon Dをを分子式で記述するとC40H36O12です。", "task": "formula", "name_q": "Sanggenon D", "name_a": "C40H36O12"} -{"id": 5069, "instruction": "Medulloblastomaの日本語訳は?", "response": "Medulloblastomaの日本語訳は髄芽腫です。", "task": "replace en to ja", "name_q": "Medulloblastoma", "name_a": "髄芽腫"} -{"id": 33906, "instruction": "Methamphetamine hydrochloride (JP18/USP)の別呼称は?", "response": "Methamphetamine hydrochloride (JP18/USP)の別呼称はメタンフェタミン塩酸塩 (JP18)です。", "task": "replace", "name_q": "Methamphetamine hydrochloride (JP18/USP)", "name_a": "メタンフェタミン塩酸塩 (JP18)"} -{"id": 9587, "instruction": "骨粗鬆症 下位グループ 小児または若年発症の発達遅滞を伴う骨粗鬆症 (OPDD)の英訳は?", "response": "骨粗鬆症 下位グループ 小児または若年発症の発達遅滞を伴う骨粗鬆症 (OPDD)の英訳はOsteoporosis SUBGROUP Osteoporosis, childhood- or juvenile-onset, with developmental delay (OPDD)です。", "task": "replace ja to en", "name_q": "骨粗鬆症 下位グループ 小児または若年発症の発達遅滞を伴う骨粗鬆症 (OPDD)", "name_a": "Osteoporosis SUBGROUP Osteoporosis, childhood- or juvenile-onset, with developmental delay (OPDD)"} -{"id": 28915, "instruction": "ヨードチンキ (JP18)の別の呼び方は?", "response": "ヨードチンキ (JP18)の別の呼び方はIodine tincture (JP18)です。", "task": "replace", "name_q": "ヨードチンキ (JP18)", "name_a": "Iodine tincture (JP18)"} -{"id": 14768, "instruction": "ヒアルロン酸ナトリウム架橋処理ポリマーを英語で記述すると?", "response": "ヒアルロン酸ナトリウム架橋処理ポリマーを英語で記述するとSodium hyaluronate crosslinked polymer (JAN)です。", "task": "replace ja to en", "name_q": "ヒアルロン酸ナトリウム架橋処理ポリマー", "name_a": "Sodium hyaluronate crosslinked polymer (JAN)"} -{"id": 8390, "instruction": "Zanamivirをは組成式で表すと?", "response": "Zanamivirをは組成式で表すとC12H20N4O7です。", "task": "formula", "name_q": "Zanamivir", "name_a": "C12H20N4O7"} -{"id": 10536, "instruction": "ロブカビルをを化学式で書くと?", "response": "ロブカビルをを化学式で書くとC11H15N5O3です。", "task": "formula", "name_q": "ロブカビル", "name_a": "C11H15N5O3"} -{"id": 17407, "instruction": "ACCES 症候群を英語に訳すと?", "response": "ACCES 症候群を英語に訳すとACCES syndromeです。", "task": "replace ja to en", "name_q": "ACCES 症候群", "name_a": "ACCES syndrome"} -{"id": 21626, "instruction": "Unsaturated fatty acidをを組成式で書くと?", "response": "Unsaturated fatty acidをを組成式で書くとCHO2Rです。", "task": "formula", "name_q": "Unsaturated fatty acid", "name_a": "CHO2R"} -{"id": 2277, "instruction": "フルメシクロックスの別の呼び方は?", "response": "フルメシクロックスの別の呼び方はFurmecycloxです。", "task": "replace", "name_q": "フルメシクロックス", "name_a": "Furmecyclox"} -{"id": 5190, "instruction": "胃苓湯の別名は?", "response": "胃苓湯の別名はIreitoです。", "task": "replace", "name_q": "胃苓湯", "name_a": "Ireito"} -{"id": 21208, "instruction": "Carperitide (USAN/INN)の別名称は?", "response": "Carperitide (USAN/INN)の別名称はHanp (TN)です。", "task": "replace", "name_q": "Carperitide (USAN/INN)", "name_a": "Hanp (TN)"} -{"id": 23660, "instruction": "Indium (111In) diethylenetriamine pentaacetate injection (JAN)を日本語で記述すると?", "response": "Indium (111In) diethylenetriamine pentaacetate injection (JAN)を日本語で記述するとジエチレントリアミン五酢酸インジウム (JAN)です。", "task": "replace en to ja", "name_q": "Indium (111In) diethylenetriamine pentaacetate injection (JAN)", "name_a": "ジエチレントリアミン五酢酸インジウム (JAN)"} -{"id": 477, "instruction": "1,2,6-Trigalloylglucoseをの化学構造は?", "response": "1,2,6-Trigalloylglucoseをの化学構造はC27H24O18です。", "task": "formula", "name_q": "1,2,6-Trigalloylglucose", "name_a": "C27H24O18"} -{"id": 29060, "instruction": "2-Dehydro-3-deoxy-L-arabinonic acidの別の言い方は?", "response": "2-Dehydro-3-deoxy-L-arabinonic acidの別の言い方は2-Dehydro-3-deoxy-L-arabinonateです。", "task": "replace", "name_q": "2-Dehydro-3-deoxy-L-arabinonic acid", "name_a": "2-Dehydro-3-deoxy-L-arabinonate"} -{"id": 16374, "instruction": "Corrinoid protein Co2+-CH3の異なる名称は?", "response": "Corrinoid protein Co2+-CH3の異なる名称はMethylcorrinoidです。", "task": "replace", "name_q": "Corrinoid protein Co2+-CH3", "name_a": "Methylcorrinoid"} -{"id": 9249, "instruction": "C26H24ClN2O6P. 2Naを利用した商品名は?", "response": "C26H24ClN2O6P. 2Naを利用した商品名はサムタス(大塚製薬)です。", "task": "product", "name_q": "C26H24ClN2O6P. 2Na", "name_a": "サムタス(大塚製薬)"} -{"id": 2670, "instruction": "G 511をの組成式は?", "response": "G 511をの組成式はC36H60O30. C20H34O5です。", "task": "formula", "name_q": "G 511", "name_a": "C36H60O30. C20H34O5"} -{"id": 7937, "instruction": "Fenoldopamをを分子式で書くと?", "response": "Fenoldopamをを分子式で書くとC16H16ClNO3です。", "task": "formula", "name_q": "Fenoldopam", "name_a": "C16H16ClNO3"} -{"id": 25205, "instruction": "L-Galactonic acidの異なる表現は?", "response": "L-Galactonic acidの異なる表現はL-Galactonateです。", "task": "replace", "name_q": "L-Galactonic acid", "name_a": "L-Galactonate"} -{"id": 27644, "instruction": "食塩をを組成式で表すと?", "response": "食塩をを組成式で表すとNaClです。", "task": "formula", "name_q": "食塩", "name_a": "NaCl"} -{"id": 21098, "instruction": "Premithramycinoneをを化学式で記述すると?", "response": "Premithramycinoneをを化学式で記述するとC21H18O9です。", "task": "formula", "name_q": "Premithramycinone", "name_a": "C21H18O9"} -{"id": 18557, "instruction": "ワルファリンカリウム (JP18)を使用した商品は?", "response": "ワルファリンカリウム (JP18)を使用した商品はワルファリ��K(日医工岐阜工場)です。", "task": "product", "name_q": "ワルファリンカリウム (JP18)", "name_a": "ワルファリンK(日医工岐阜工場)"} -{"id": 33081, "instruction": "Papain (USP)を日本語表記で表すと?", "response": "Papain (USP)を日本語表記で表すとPapain (USP)です。", "task": "replace en to ja", "name_q": "Papain (USP)", "name_a": "Papain (USP)"} -{"id": 21231, "instruction": "13-Dihydrodaunorubicinは別の呼び方では?", "response": "13-Dihydrodaunorubicinは別の呼び方では(13S)-13-Dihydrodaunorubicinです。", "task": "replace", "name_q": "13-Dihydrodaunorubicin", "name_a": "(13S)-13-Dihydrodaunorubicin"} -{"id": 8441, "instruction": "Enfortumab (USAN)をは化学構造で表すと?", "response": "Enfortumab (USAN)をは化学構造で表すとC6370H9860N1698O2003S46です。", "task": "formula", "name_q": "Enfortumab (USAN)", "name_a": "C6370H9860N1698O2003S46"} -{"id": 33846, "instruction": "骨髄異形成/骨髄増殖性腫瘍 下位グループ 慢性骨髄単球性白血病 (CMML) 若年性骨髄単球性白血病 (JMML) 血小板増多と環状鉄芽球を伴う骨髄異形性/骨髄増殖性腫瘍 (MDS/MPN-RS-T) 非定型慢性骨髄性白血病、BCR-ABL1陰性 (aCML) 骨髄異形成/骨髄増殖性腫瘍、分類不能 (MDS/MPN-u)を英語で書くと?", "response": "骨髄異形成/骨髄増殖性腫瘍 下位グループ 慢性骨髄単球性白血病 (CMML) 若年性骨髄単球性白血病 (JMML) 血小板増多と環状鉄芽球を伴う骨髄異形性/骨髄増殖性腫瘍 (MDS/MPN-RS-T) 非定型慢性骨髄性白血病、BCR-ABL1陰性 (aCML) 骨髄異形成/骨髄増殖性腫瘍、分類不能 (MDS/MPN-u)を英語で書くとMyelodysplastic/myeloproliferative neoplasms SUBGROUP Chronic myelomonocytic leukemia (CMML) Juvenile myelomonocytic leukemia (JMML) MDS/MPN with ringed sideroblasts and thrombocytosis (MDS/MPN-RS-T) Atypical BCR-ABL1 negative chronic myeloid leukemia (aCML) MDS/MPN-unclassifiable (MDS/MPN-u)です。", "task": "replace ja to en", "name_q": "骨髄異形成/骨髄増殖性腫瘍 下位グループ 慢性骨髄単球性白血病 (CMML) 若年性骨髄単球性白血病 (JMML) 血小板増多と環状鉄芽球を伴う骨髄異形性/骨髄増殖性腫瘍 (MDS/MPN-RS-T) 非定型慢性骨髄性白血病、BCR-ABL1陰性 (aCML) 骨髄異形成/骨髄増殖性腫瘍、分類不能 (MDS/MPN-u)", "name_a": "Myelodysplastic/myeloproliferative neoplasms SUBGROUP Chronic myelomonocytic leukemia (CMML) Juvenile myelomonocytic leukemia (JMML) MDS/MPN with ringed sideroblasts and thrombocytosis (MDS/MPN-RS-T) Atypical BCR-ABL1 negative chronic myeloid leukemia (aCML) MDS/MPN-unclassifiable (MDS/MPN-u)"} -{"id": 14685, "instruction": "Cetrorelix (INN)をを化学式で記述すると?", "response": "Cetrorelix (INN)をを化学式で記述するとC70H92ClN17O14です。", "task": "formula", "name_q": "Cetrorelix (INN)", "name_a": "C70H92ClN17O14"} -{"id": 8837, "instruction": "ホステアビンをを分子式で記述すると?", "response": "ホステアビンをを分子式で記述するとC27H50N3O8Pです。", "task": "formula", "name_q": "ホステアビン", "name_a": "C27H50N3O8P"} -{"id": 22215, "instruction": "Taclamine hydrochloride (USAN)をは化学式で表すと?", "response": "Taclamine hydrochloride (USAN)をは化学式で表すとC21H23N. HClです。", "task": "formula", "name_q": "Taclamine hydrochloride (USAN)", "name_a": "C21H23N. HCl"} -{"id": 24576, "instruction": "セタベンナトリウムをを組成式で記述すると?", "response": "セタベンナトリウムをを組成式で記述するとC23H38NO2. Naです。", "task": "formula", "name_q": "セタベンナトリウム", "name_a": "C23H38NO2. Na"} -{"id": 27149, "instruction": "Miraxanthin-Iをは化学式で表すと?", "response": "Miraxanthin-Iをは化学式で表すとC14H18N2O7Sです。", "task": "formula", "name_q": "Miraxanthin-I", "name_a": "C14H18N2O7S"} -{"id": 27845, "instruction": "Pentiapine maleate (USAN)を英語表記で表すと?", "response": "Pentiapine maleate (USAN)を英語表記で表すとPentiapine maleate (USAN)です。", "task": "replace ja to en", "name_q": "Pentiapine maleate (USAN)", "name_a": "Pentiapine maleate (USAN)"} -{"id": 30698, "instruction": "alpha-Pyrufuranの異なる表現は?", "response": "alpha-Pyrufuranの異なる表現はα-ピルフランです。", "task": "replace", "name_q": "alpha-Pyrufuran", "name_a": "α-ピルフラン"} -{"id": 4686, "instruction": "Cefzil (TN)をは化学構造で表すと?", "response": "Cefzil (TN)をは化学構造で表すとC18H19N3O5S. H2Oです。", "task": "formula", "name_q": "Cefzil (TN)", "name_a": "C18H19N3O5S. H2O"} -{"id": 27096, "instruction": "N-Amidinoglycineの別記述は?", "response": "N-Amidinoglycineの別記述はGuanidinoacetic acidです。", "task": "replace", "name_q": "N-Amidinoglycine", "name_a": "Guanidinoacetic acid"} -{"id": 983, "instruction": "Staderm (TN)の日本語訳は?", "response": "Staderm (TN)の日本語訳はIbuprofen piconol (JP18/USAN)です。", "task": "replace en to ja", "name_q": "Staderm (TN)", "name_a": "Ibuprofen piconol (JP18/USAN)"} -{"id": 8095, "instruction": "Muscular dystrophy-dystroglycanopathy SUBGROUP Muscular dystrophy-dystroglycanopathy type A Muscular dystrophy-dystroglycanopathy type B Muscular dystrophy-dystroglycanopathy type C の日本語表記は?", "response": "Muscular dystrophy-dystroglycanopathy SUBGROUP Muscular dystrophy-dystroglycanopathy type A Muscular dystrophy-dystroglycanopathy type B Muscular dystrophy-dystroglycanopathy type C の日本語表記は筋ジストロフィー・ジストログリカノパチー 下位グループ 筋ジストロフィー・ジストログリカノパチー A 型 筋ジストロフィー・ジストログリカノパチー B 型 筋ジストロフィー・ジストログリカノパチー C 型 です。", "task": "replace en to ja", "name_q": "Muscular dystrophy-dystroglycanopathy SUBGROUP Muscular dystrophy-dystroglycanopathy type A Muscular dystrophy-dystroglycanopathy type B Muscular dystrophy-dystroglycanopathy type C ", "name_a": "筋ジストロフィー・ジストログリカノパチー 下位グループ 筋ジストロフィー・ジストログリカノパチー A 型 筋ジストロフィー・ジストログリカノパチー B 型 筋ジストロフィー・ジストログリカノパチー C 型 "} -{"id": 18272, "instruction": "4-Hydroxymandelonitrileの別名は?", "response": "4-Hydroxymandelonitrileの別名は4-ヒドロキシマンデロニトリルです。", "task": "replace", "name_q": "4-Hydroxymandelonitrile", "name_a": "4-ヒドロキシマンデロニトリル"} -{"id": 27627, "instruction": "Thujopseneの異なる名称は?", "response": "Thujopseneの異なる名称はツヨプセンです。", "task": "replace", "name_q": "Thujopsene", "name_a": "ツヨプセン"} -{"id": 18424, "instruction": "Chromocarb diethylamineを英語表記で表すと?", "response": "Chromocarb diethylamineを英語表記で表すとChromocarb diethylazanです。", "task": "replace ja to en", "name_q": "Chromocarb diethylamine", "name_a": "Chromocarb diethylazan"} -{"id": 22345, "instruction": "好酸球性筋膜炎の異なる表記は?", "response": "好酸球性筋膜炎の異なる表記はびまん性筋膜炎です。", "task": "replace", "name_q": "好酸球性筋膜炎", "name_a": "びまん性筋膜炎"} -{"id": 19675, "instruction": "trans,octacis-Decaprenyl phosphateをを化学式で記述すると?", "response": "trans,octacis-Decaprenyl phosphateをを化学式で記述するとC50H83O4Pです。", "task": "formula", "name_q": "trans,octacis-Decaprenyl phosphate", "name_a": "C50H83O4P"} -{"id": 19253, "instruction": "脳幹および脊髄の障害と下肢痙縮を伴う髄鞘低形成の英訳は?", "response": "脳幹および脊髄の障害と下肢痙縮を伴う髄鞘低形成の英訳はHypomyelination with brainstem and spinal cord involvement and leg spasticityです。", "task": "replace ja to en", "name_q": "脳幹および脊髄の障害と下肢痙縮を伴う髄鞘低形成", "name_a": "Hypomyelination with brainstem and spinal cord involvement and leg spasticity"} -{"id": 12534, "instruction": "Catequentinib (USAN/INN)をの化学式は?", "response": "Catequentinib (USAN/INN)をの化学式はC23H22FN3O3です。", "task": "formula", "name_q": "Catequentinib (USAN/INN)", "name_a": "C23H22FN3O3"} -{"id": 5624, "instruction": "3-Butyn-1-olをを分子式で記述すると?", "response": "3-Butyn-1-olをを分子式で記述するとC4H6Oです。", "task": "formula", "name_q": "3-Butyn-1-ol", "name_a": "C4H6O"} -{"id": 25932, "instruction": "Pefcalcitol (JAN/USAN/INN)を英語に訳すと?", "response": "Pefcalcitol (JAN/USAN/INN)を英語に訳すとPefcalcitol (JAN/USAN/INN)です。", "task": "replace ja to en", "name_q": "Pefcalcitol (JAN/USAN/INN)", "name_a": "Pefcalcitol (JAN/USAN/INN)"} -{"id": 32279, "instruction": "α-メチル-m-チロシンの別の呼び方は?", "response": "α-メチル-m-チロシンの別の呼び方はalpha-Methyl-m-tyrosineです。", "task": "replace", "name_q": "α-メチル-m-チロシン", "name_a": "alpha-Methyl-m-tyrosine"} -{"id": 25782, "instruction": "Acequinocylをの組成式は?", "response": "Acequinocylをの組成式はC24H32O4です。", "task": "formula", "name_q": "Acequinocyl", "name_a": "C24H32O4"} -{"id": 23494, "instruction": "リンゴ酸ナホミンをは分子式で表すと?", "response": "リンゴ酸ナホミンをは分子式で表すとC12H13NO. C4H6O5です。", "task": "formula", "name_q": "リンゴ酸ナホミン", "name_a": "C12H13NO. C4H6O5"} -{"id": 4081, "instruction": "Sulfisoxazole diolamine (USAN)を英語に訳すと?", "response": "Sulfisoxazole diolamine (USAN)を英語に訳すとSulfafurazole diolamineです。", "task": "replace ja to en", "name_q": "Sulfisoxazole diolamine (USAN)", "name_a": "Sulfafurazole diolamine"} -{"id": 13637, "instruction": "2-Methyl-3-[(2E,10E,14E,18E,22E,26E,30E,33E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,10,14,18,22,26,30,33-octaen-1-yl]naphthalene-1,4-dioneを言い換えると?", "response": "2-Methyl-3-[(2E,10E,14E,18E,22E,26E,30E,33E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,10,14,18,22,26,30,33-octaen-1-yl]naphthalene-1,4-dioneを言い換えるとMK-9(II-H2)です。", "task": "replace", "name_q": "2-Methyl-3-[(2E,10E,14E,18E,22E,26E,30E,33E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,10,14,18,22,26,30,33-octaen-1-yl]naphthalene-1,4-dione", "name_a": "MK-9(II-H2)"} -{"id": 31677, "instruction": "SIROLIMUS(NovadozPharmaceuticalsLLC)を使用した製品は?", "response": "SIROLIMUS(NovadozPharmaceuticalsLLC)を使用した製品はSIROLIMUS(MajorPharmaceuticals)です。", "task": "product", "name_q": "SIROLIMUS(NovadozPharmaceuticalsLLC)", "name_a": "SIROLIMUS(MajorPharmaceuticals)"} -{"id": 19505, "instruction": "Zindoxifeneをを組成式で書くと?", "response": "Zindoxifeneをを組成式で書くとC21H21NO4です。", "task": "formula", "name_q": "Zindoxifene", "name_a": "C21H21NO4"} -{"id": 14742, "instruction": "赤色ぼろ線維・ミオクローヌスてんかん症候群の英語表記は?", "response": "赤色ぼろ線維・ミオクローヌスてんかん症候群の英語表記はFukuhara syndrome SUPERGRP Progressive myoclonic epilepsy Mitochondrial disease です。", "task": "replace ja to en", "name_q": "赤色ぼろ線維・ミオクローヌスてんかん症候群", "name_a": "Fukuhara syndrome SUPERGRP Progressive myoclonic epilepsy Mitochondrial disease "} -{"id": 2338, "instruction": "Cyclohepta(6)pyran-5,8-imin-4(5H)-one, 2,3,6,7,8,9-hexahydro-10-methyl-2-phenyl-,(2alpha,5beta,8beta)-(+)-の別表現は?", "response": "Cyclohepta(6)pyran-5,8-imin-4(5H)-one, 2,3,6,7,8,9-hexahydro-10-methyl-2-phenyl-,(2alpha,5beta,8beta)-(+)-の別表現はStrobamineです。", "task": "replace", "name_q": "Cyclohepta(6)pyran-5,8-imin-4(5H)-one, 2,3,6,7,8,9-hexahydro-10-methyl-2-phenyl-,(2alpha,5beta,8beta)-(+)-", "name_a": "Strobamine"} -{"id": 13826, "instruction": "Thiazosulfone (INN)を英語に訳すと?", "response": "Thiazosulfone (INN)を英語に訳すとPromizole (TN)です。", "task": "replace ja to en", "name_q": "Thiazosulfone (INN)", "name_a": "Promizole (TN)"} -{"id": 34540, "instruction": "Demecolcineの異なる名称は?", "response": "Demecolcineの異なる名称はデメコルシンです。", "task": "replace", "name_q": "Demecolcine", "name_a": "デメコルシン"} -{"id": 34190, "instruction": "Erythromycin thiocyanateの英語表記は?", "response": "Erythromycin thiocyanateの英語表記はErythromycin thiocyanateです。", "task": "replace ja to en", "name_q": "Erythromycin thiocyanate", "name_a": "Erythromycin thiocyanate"} -{"id": 10934, "instruction": "Extrinsic allergic alveolitisの別名は?", "response": "Extrinsic allergic alveolitisの別名はHypersensitivity pneumonitisです。", "task": "replace", "name_q": "Extrinsic allergic alveolitis", "name_a": "Hypersensitivity pneumonitis"} -{"id": 28515, "instruction": "風疹 下位グループ 先天性風疹症候群を英語で書くと?", "response": "風疹 下位グループ 先天性風疹症候群を英語で書くとRubella SUBGROUP Congenital rubella syndromeです。", "task": "replace ja to en", "name_q": "風疹 下位グループ 先天性風疹症候群", "name_a": "Rubella SUBGROUP Congenital rubella syndrome"} -{"id": 5249, "instruction": "結晶トリプシン (JAN)の別の呼び方は?", "response": "結晶トリプシン (JAN)の別の呼び方はTrypsin, crystallized (USP)です。", "task": "replace", "name_q": "結晶トリプシン (JAN)", "name_a": "Trypsin, crystallized (USP)"} -{"id": 21360, "instruction": "Isatuximab (genetical recombination) (JAN)を利用した医薬品名は?", "response": "Isatuximab (genetical recombination) (JAN)を利用した医薬品名はサークリサ(サノフィ)です。", "task": "product", "name_q": "Isatuximab (genetical recombination) (JAN)", "name_a": "サークリサ(サノフィ)"} -{"id": 17176, "instruction": "Allergic contact dermatitisを日本語で記述すると?", "response": "Allergic contact dermatitisを日本語で記述するとアレルギー性接触性皮膚炎です。", "task": "replace en to ja", "name_q": "Allergic contact dermatitis", "name_a": "アレルギー性接触性皮膚炎"} -{"id": 10540, "instruction": "Mibakujioganの日本語訳は?", "response": "Mibakujioganの日本語訳はミバクジオウガンです。", "task": "replace en to ja", "name_q": "Mibakujiogan", "name_a": "ミバクジオウガン"} -{"id": 26775, "instruction": "Furomine (USAN/INN)をを化学式で記述すると?", "response": "Furomine (USAN/INN)をを化学式で記述するとC20H32N2O4です。", "task": "formula", "name_q": "Furomine (USAN/INN)", "name_a": "C20H32N2O4"} -{"id": 33355, "instruction": "Istamycin Cをを化学構造で書くと?", "response": "Istamycin Cをを化学構造で書くとC18H37N5O5です。", "task": "formula", "name_q": "Istamycin C", "name_a": "C18H37N5O5"} -{"id": 18219, "instruction": "Cinnamodialをを分子式で書くと?", "response": "Cinnamodialをを分子式で書くとC17H24O5です。", "task": "formula", "name_q": "Cinnamodial", "name_a": "C17H24O5"} -{"id": 16334, "instruction": "Benzenediazoniumをの組成式は?", "response": "Benzenediazoniumをの組成式はC6H5N2です。", "task": "formula", "name_q": "Benzenediazonium", "name_a": "C6H5N2"} -{"id": 17905, "instruction": "Beclometason (TN)の日本語訳は?", "response": "Beclometason (TN)の日本語訳はベクロメタゾンです。", "task": "replace en to ja", "name_q": "Beclometason (TN)", "name_a": "ベクロメタゾン"} -{"id": 26748, "instruction": "リフィラフェニブマレイン酸塩を英語で書くと?", "response": "リフィラフェニブマレイン酸塩を英語で書くとLifirafenib maleate (USAN)です。", "task": "replace ja to en", "name_q": "リフィラフェニブマレイン酸塩", "name_a": "Lifirafenib maleate (USAN)"} -{"id": 18958, "instruction": "Tolpyrramide (USAN/INN)をの化学式は?", "response": "Tolpyrramide (USAN/INN)をの化学式はC12H16N2O3Sです。", "task": "formula", "name_q": "Tolpyrramide (USAN/INN)", "name_a": "C12H16N2O3S"} -{"id": 9584, "instruction": "NAPROXENANDESOMEPRAZOLEMAGNESIUM(Dr.Reddy'sLaboratoriesLimited)を主とした商品は?", "response": "NAPROXENANDESOMEPRAZOLEMAGNESIUM(Dr.Reddy'sLaboratoriesLimited)を主とした商品はNAPROXENANDESOMEPRAZOLEMAGNESIUM(ScieGenPharmaceuticals)です。", "task": "product", "name_q": "NAPROXENANDESOMEPRAZOLEMAGNESIUM(Dr.Reddy'sLaboratoriesLimited)", "name_a": "NAPROXENANDESOMEPRAZOLEMAGNESIUM(ScieGenPharmaceuticals)"} -{"id": 33548, "instruction": "Iodine addition products of the ethylesters of the fatty acids obtained from poppyseed oilを用いた薬品は?", "response": "Iodine addition products of the ethylesters of the fatty acids obtained from poppyseed oilを用いた薬品はミリプラ(住友ファーマ)です。", "task": "product", "name_q": "Iodine addition products of the ethylesters of the fatty acids obtained from poppyseed oil", "name_a": "ミリプラ(住友ファーマ)"} -{"id": 19626, "instruction": "Lochnerinineをは組成式で表すと?", "response": "Lochnerinineをは組成式で表すとC22H26N2O4です。", "task": "formula", "name_q": "Lochnerinine", "name_a": "C22H26N2O4"} -{"id": 7285, "instruction": "Acalyphinをを化学構造で記述すると?", "response": "Acalyphinをを化学構造で記述するとC14H20N2O9です。", "task": "formula", "name_q": "Acalyphin", "name_a": "C14H20N2O9"} -{"id": 12732, "instruction": "Perilla frutescens fruitの別の言い方は?", "response": "Perilla frutescens fruitの別の言い方はPerillae fructusです。", "task": "replace", "name_q": "Perilla frutescens fruit", "name_a": "Perillae fructus"} -{"id": 26231, "instruction": "塩酸ナフチフィンをを組成式で記述すると?", "response": "塩酸ナフチフィンをを組成式で記述するとC21H21N. HClです。", "task": "formula", "name_q": "塩酸ナフチフィン", "name_a": "C21H21N. HCl"} -{"id": 13467, "instruction": "ヘスペリジン (JAN)をを化学構造で記述すると?", "response": "ヘスペリジン (JAN)をを化学構造で記述するとC28H34O15です。", "task": "formula", "name_q": "ヘスペリジン (JAN)", "name_a": "C28H34O15"} -{"id": 15105, "instruction": "Congenital myopathy SUBGROUP Nemaline myopathy Central core disease Centronuclear myopathy Congenital fiber type disproportion Multi-minicore disease Early-onset myopathy, areflexia, respiratory distress, and dysphagia Native American myopathy Inclusion body myopathy 3 Scapuloperoneal myopathy, MYH7-related Myosin storage myopathy Congenital myopathy with neuropathy and deafness (CMND)を日本語表記で表すと?", "response": "Congenital myopathy SUBGROUP Nemaline myopathy Central core disease Centronuclear myopathy Congenital fiber type disproportion Multi-minicore disease Early-onset myopathy, areflexia, respiratory distress, and dysphagia Native American myopathy Inclusion body myopathy 3 Scapuloperoneal myopathy, MYH7-related Myosin storage myopathy Congenital myopathy with neuropathy and deafness (CMND)を日本語表記で表すと先天性ミオパチー 下位グループ ネマリンミオパチー セントラルコア病 中心核ミオパチー 先天性筋線維タイプ不均等症 マルチミニコア病 封入体ミオパチー 3 肩甲腓骨型筋ジストロフィー, MYH7-related ミオシンストレージミオパチー ニューロパチーと難聴を伴う先天性ミオパチー (CMND)です。", "task": "replace en to ja", "name_q": "Congenital myopathy SUBGROUP Nemaline myopathy Central core disease Centronuclear myopathy Congenital fiber type disproportion Multi-minicore disease Early-onset myopathy, areflexia, respiratory distress, and dysphagia Native American myopathy Inclusion body myopathy 3 Scapuloperoneal myopathy, MYH7-related Myosin storage myopathy Congenital myopathy with neuropathy and deafness (CMND)", "name_a": "先天性ミオパチー 下位グループ ネマリンミオパチー セントラルコア病 中心核ミオパチー 先天性筋線維タイプ不均等症 マルチミニコア病 封入体ミオパチー 3 肩甲腓骨型筋ジストロフィー, MYH7-related ミオシンストレージミオパチー ニューロパチーと難聴を伴う先天性ミオパチー (CMND)"} -{"id": 32319, "instruction": "N-Benzoylglycineの別表現は?", "response": "N-Benzoylglycineの別表現はHippurateです。", "task": "replace", "name_q": "N-Benzoylglycine", "name_a": "Hippurate"} -{"id": 2111, "instruction": "天然痘の英訳は?", "response": "天然痘の英訳はSmallpoxです。", "task": "replace ja to en", "name_q": "天然痘", "name_a": "Smallpox"} -{"id": 31539, "instruction": "C22H30N2Oをを組成式で表すと?", "response": "C22H30N2Oをを組成式で表すとC22H30N2Oです。", "task": "formula", "name_q": "C22H30N2O", "name_a": "C22H30N2O"} -{"id": 13612, "instruction": "Safflower oil (USP)の英語表記は?", "response": "Safflower oil (USP)の英語表記はLiposyn (TN)です。", "task": "replace ja to en", "name_q": "Safflower oil (USP)", "name_a": "Liposyn (TN)"} -{"id": 26480, "instruction": "ドロキサシンナトリウムを英語で記述すると?", "response": "ドロキサシンナトリウムを英語で記述するとDroxacin sodium (USAN)です。", "task": "replace ja to en", "name_q": "ドロキサシンナトリウム", "name_a": "Droxacin sodium (USAN)"} -{"id": 23699, "instruction": "4-Amino-2-nitrophenolをは分子式で表すと?", "response": "4-Amino-2-nitrophenolをは分子式で表すとC6H6N2O3です。", "task": "formula", "name_q": "4-Amino-2-nitrophenol", "name_a": "C6H6N2O3"} -{"id": 31920, "instruction": "Cravit (TN)をを化学構造で表すと?", "response": "Cravit (TN)をを化学構造で表すとC18H20FN3O4です。", "task": "formula", "name_q": "Cravit (TN)", "name_a": "C18H20FN3O4"} -{"id": 14682, "instruction": "プロクアゾンをを化学式で表すと?", "response": "プロクアゾンをを化学式で表すとC18H18N2Oです。", "task": "formula", "name_q": "プロクアゾン", "name_a": "C18H18N2O"} -{"id": 28113, "instruction": "水疱性口内炎熱を英語に訳すと?", "response": "水疱性口内炎熱を英語に訳すとVesicular stomatitis feverです。", "task": "replace ja to en", "name_q": "水疱性口内炎熱", "name_a": "Vesicular stomatitis fever"} -{"id": 7632, "instruction": "Vici 症候群を英語表記で表すと?", "response": "Vici 症候群を英語表記で表すとVici syndromeです。", "task": "replace ja to en", "name_q": "Vici 症候群", "name_a": "Vici syndrome"} -{"id": 5570, "instruction": "Vadastuximab talirine (USAN)を日本語表記で表すと?", "response": "Vadastuximab talirine (USAN)を日本語表記で表すとVadastuximab talirine (USAN)です。", "task": "replace en to ja", "name_q": "Vadastuximab talirine (USAN)", "name_a": "Vadastuximab talirine (USAN)"} -{"id": 26994, "instruction": "フェノールスルホンフタレイン (JP18)の別表現は?", "response": "フェノールスルホンフタレイン (JP18)の別表現はPhenol redです。", "task": "replace", "name_q": "フェノールスルホンフタレイン (JP18)", "name_a": "Phenol red"} -{"id": 11247, "instruction": "Bamocaftor (USAN)の日本語訳は?", "response": "Bamocaftor (USAN)の日本語訳はBamocaftor (USAN)です。", "task": "replace en to ja", "name_q": "Bamocaftor (USAN)", "name_a": "Bamocaftor (USAN)"} -{"id": 15152, "instruction": "4-Hydroxyphenylacetylglycineをを組成式で表すと?", "response": "4-Hydroxyphenylacetylglycineをを組成式で表すとC10H11NO4です。", "task": "formula", "name_q": "4-Hydroxyphenylacetylglycine", "name_a": "C10H11NO4"} -{"id": 15412, "instruction": "Limit dextrinの別の言い方は?", "response": "Limit dextrinの別の言い方はalpha- and beta-Limit dextrinです。", "task": "replace", "name_q": "Limit dextrin", "name_a": "alpha- and beta-Limit dextrin"} -{"id": 756, "instruction": "Developmental delay with variable intellectual disability and dysmorphic faciesを日本語表記で表すと?", "response": "Developmental delay with variable intellectual disability and dysmorphic faciesを日本語表記で表すと様々な知的障害と顔異形を伴う発達遅滞です。", "task": "replace en to ja", "name_q": "Developmental delay with variable intellectual disability and dysmorphic facies", "name_a": "様々な知的障害と顔異形を伴う発達遅滞"} -{"id": 7167, "instruction": "Enciprazine hydrochloride (USAN)の日本語表記は?", "response": "Enciprazine hydrochloride (USAN)の日本語表記はエンシプラジン塩酸塩です。", "task": "replace en to ja", "name_q": "Enciprazine hydrochloride (USAN)", "name_a": "エンシプラジン塩酸塩"} -{"id": 29157, "instruction": "Edoxaban (USAN/INN)の英訳は?", "response": "Edoxaban (USAN/INN)の英訳はEdoxaban (USAN/INN)です。", "task": "replace ja to en", "name_q": "Edoxaban (USAN/INN)", "name_a": "Edoxaban (USAN/INN)"} -{"id": 21079, "instruction": "Methazoleをを分子式で表すと?", "response": "Methazoleをを分子式で表すとC9H6Cl2N2O3です。", "task": "formula", "name_q": "Methazole", "name_a": "C9H6Cl2N2O3"} -{"id": 19621, "instruction": "Passionflowerの別記述は?", "response": "Passionflowerの別記述はパッシフローラエキスです。", "task": "replace", "name_q": "Passionflower", "name_a": "パッシフローラエキス"} -{"id": 31831, "instruction": "Infantile or early childhood epileptic encephalopathyを日本語で書くと?", "response": "Infantile or early childhood epileptic encephalopathyを日本語で書くと乳児または幼児てんかん性脳症です。", "task": "replace en to ja", "name_q": "Infantile or early childhood epileptic encephalopathy", "name_a": "乳児または幼児てんかん性脳症"} -{"id": 29309, "instruction": "Lonapalene (USAN)をを化学構造で表すと?", "response": "Lonapalene (USAN)をを化学構造で表すとC16H15ClO6です。", "task": "formula", "name_q": "Lonapalene (USAN)", "name_a": "C16H15ClO6"} -{"id": 17855, "instruction": "Tokiinshiを日本語で記述すると?", "response": "Tokiinshiを日本語で記述するとTokiinshiです。", "task": "replace en to ja", "name_q": "Tokiinshi", "name_a": "Tokiinshi"} -{"id": 1873, "instruction": "Arabinogalactoglycanを言い換えると?", "response": "Arabinogalactoglycanを言い換えるとArabinogalactanです。", "task": "replace", "name_q": "Arabinogalactoglycan", "name_a": "Arabinogalactan"} -{"id": 12800, "instruction": "OAを日本語で記述すると?", "response": "OAを日本語で記述するとOAです。", "task": "replace en to ja", "name_q": "OA", "name_a": "OA"} -{"id": 6309, "instruction": "フェノプロフェンをを化学式で表すと?", "response": "フェノプロフェンをを化学式で表すとC15H14O3です。", "task": "formula", "name_q": "フェノプロフェン", "name_a": "C15H14O3"} -{"id": 26496, "instruction": "C24H25Cl2FN4O2. C7H8O3Sをは組成式で表すと?", "response": "C24H25Cl2FN4O2. C7H8O3Sをは組成式で表すとC24H25Cl2FN4O2. C7H8O3Sです。", "task": "formula", "name_q": "C24H25Cl2FN4O2. C7H8O3S", "name_a": "C24H25Cl2FN4O2. C7H8O3S"} -{"id": 6356, "instruction": "Hydronitroxide radicalをは化学構造で表すと?", "response": "Hydronitroxide radicalをは化学構造で表すとC12H10NOです。", "task": "formula", "name_q": "Hydronitroxide radical", "name_a": "C12H10NO"} -{"id": 16953, "instruction": "7-O-Geranyl-2-O,3-dimethylflaviolinをは組成式で表すと?", "response": "7-O-Geranyl-2-O,3-dimethylflaviolinをは組成式で表すとC22H26O5です。", "task": "formula", "name_q": "7-O-Geranyl-2-O,3-dimethylflaviolin", "name_a": "C22H26O5"} -{"id": 21531, "instruction": "精神運動発達遅滞を伴う小児発症舞踏病の英語表記は?", "response": "精神運動発達遅滞を伴う小児発症舞踏病の英語表記はChorea, childhood-onset, with psychomotor retardationです。", "task": "replace ja to en", "name_q": "精神運動発達遅滞を伴う小児発症舞踏病", "name_a": "Chorea, childhood-onset, with psychomotor retardation"} -{"id": 21415, "instruction": "Dianexin (USAN/INN)の別の呼び方は?", "response": "Dianexin (USAN/INN)の別の呼び方はダイアネキシンです。", "task": "replace", "name_q": "Dianexin (USAN/INN)", "name_a": "ダイアネキシン"} -{"id": 21373, "instruction": "Clarithromycin lactobionateをの組成式は?", "response": "Clarithromycin lactobionateをの組成式はC38H69NO13. C12H22O12です。", "task": "formula", "name_q": "Clarithromycin lactobionate", "name_a": "C38H69NO13. C12H22O12"} -{"id": 1347, "instruction": "QUININESULFATE(SunPharmaceuticalIndustries)を材料とする商品名は?", "response": "QUININESULFATE(SunPharmaceuticalIndustries)を材料とする商品名はQUININESULFATE(IngenusPharmaceuticals)です。", "task": "product", "name_q": "QUININESULFATE(SunPharmaceuticalIndustries)", "name_a": "QUININESULFATE(IngenusPharmaceuticals)"} -{"id": 33729, "instruction": "C26H24N4O5をの分子式は?", "response": "C26H24N4O5をの分子式はC26H24N4O5です。", "task": "formula", "name_q": "C26H24N4O5", "name_a": "C26H24N4O5"} -{"id": 1036, "instruction": "3節母指・多合指症候群の英訳は?", "response": "3節母指・多合指症候群の英訳はTriphalangeal thumb-polysyndactyly syndromeです。", "task": "replace ja to en", "name_q": "3節母指・多合指症候群", "name_a": "Triphalangeal thumb-polysyndactyly syndrome"} -{"id": 28856, "instruction": "MYALEPT(AmrytPharmaceuticalsDAC)を主とした商品名は?", "response": "MYALEPT(AmrytPharmaceuticalsDAC)を主とした商品名はMYALEPT(ChiesiUSA)です。", "task": "product", "name_q": "MYALEPT(AmrytPharmaceuticalsDAC)", "name_a": "MYALEPT(ChiesiUSA)"} -{"id": 29685, "instruction": "エプタゾシン臭化水素酸塩 (JAN)をを化学構造で表すと?", "response": "エプタゾシン臭化水素酸塩 (JAN)をを化学構造で表すとC15H21NO. HBrです。", "task": "formula", "name_q": "エプタゾシン臭化水素酸塩 (JAN)", "name_a": "C15H21NO. HBr"} -{"id": 34253, "instruction": "3-(Hydroxymethyl)erythritolをを化学構造で書くと?", "response": "3-(Hydroxymethyl)erythritolをを化学構造で書くとC5H12O5です。", "task": "formula", "name_q": "3-(Hydroxymethyl)erythritol", "name_a": "C5H12O5"} -{"id": 15428, "instruction": "Veledimex (USAN/INN)をは化学構造で表すと?", "response": "Veledimex (USAN/INN)をは化学構造で表すとC27H38N2O3です。", "task": "formula", "name_q": "Veledimex (USAN/INN)", "name_a": "C27H38N2O3"} -{"id": 8872, "instruction": "N-Terminal amino acidをは化学式で表すと?", "response": "N-Terminal amino acidをは化学式で表すとC2H3NOR2です。", "task": "formula", "name_q": "N-Terminal amino acid", "name_a": "C2H3NOR2"} -{"id": 57, "instruction": "ラセピネフリンをは分子式で表すと?", "response": "ラセピネフリンをは分子式で表すとC9H13NO3です。", "task": "formula", "name_q": "ラセピネフリン", "name_a": "C9H13NO3"} -{"id": 22722, "instruction": "ワルファリンをを分子式で書くと?", "response": "ワルファリンをを分子式で書くとC19H16O4です。", "task": "formula", "name_q": "ワルファリン", "name_a": "C19H16O4"} -{"id": 2349, "instruction": "2-Hydroxy-6-oxonona-2,4-diene-1,9-dioateの異なる名称は?", "response": "2-Hydroxy-6-oxonona-2,4-diene-1,9-dioateの異なる名称は(2Z,4E)-2-Hydroxy-6-oxonona-2,4-diene-1,9-dioateです。", "task": "replace", "name_q": "2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate", "name_a": "(2Z,4E)-2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate"} -{"id": 22246, "instruction": "Chlorpromazine (USP/INN)を英語に訳すと?", "response": "Chlorpromazine (USP/INN)を英語に訳すとThorazine (TN)です。", "task": "replace ja to en", "name_q": "Chlorpromazine (USP/INN)", "name_a": "Thorazine (TN)"} -{"id": 16484, "instruction": "alpha-Cotonefuranをは化学式で表すと?", "response": "alpha-Cotonefuranをは化学式で表すとC15H14O6です。", "task": "formula", "name_q": "alpha-Cotonefuran", "name_a": "C15H14O6"} -{"id": 32027, "instruction": "Familial focal epilepsy with variable fociを日本語で書くと?", "response": "Familial focal epilepsy with variable fociを日本語で書くと多様な焦点を示す家族性焦点性てんかんです。", "task": "replace en to ja", "name_q": "Familial focal epilepsy with variable foci", "name_a": "多様な焦点を示す家族性焦点性てんかん"} -{"id": 25797, "instruction": "キャッシュバレーウイルス感染症を英語に訳すと?", "response": "キャッシュバレーウイルス感染症を英語に訳すとCache Valley virus infectionです。", "task": "replace ja to en", "name_q": "キャッシュバレーウイルス感染症", "name_a": "Cache Valley virus infection"} -{"id": 18042, "instruction": "プリチデプシンの別記述は?", "response": "プリチデプシンの別記述はPlitidepsin (INN)です。", "task": "replace", "name_q": "プリチデプシン", "name_a": "Plitidepsin (INN)"} -{"id": 20401, "instruction": "クロチキサミドマレイン酸塩をは組成式で表すと?", "response": "クロチキサミドマレイン酸塩をは組成式で表すとC24H28ClN3OS. (C4H4O4)2です。", "task": "formula", "name_q": "クロチキサミドマレイン酸塩", "name_a": "C24H28ClN3OS. (C4H4O4)2"} -{"id": 6940, "instruction": "Primary open angle glaucomaの別の言い方は?", "response": "Primary open angle glaucomaの別の言い方はGlaucoma 1です。", "task": "replace", "name_q": "Primary open angle glaucoma", "name_a": "Glaucoma 1"} -{"id": 14177, "instruction": "バレレン酸の異なる名称は?", "response": "バレレン酸の異なる名称はValerenic acidです。", "task": "replace", "name_q": "バレレン酸", "name_a": "Valerenic acid"} -{"id": 31805, "instruction": "Noscapine (JP18/USP/INN)を日本語に訳すと?", "response": "Noscapine (JP18/USP/INN)を日本語に訳すとノスカピン (JP18)です。", "task": "replace en to ja", "name_q": "Noscapine (JP18/USP/INN)", "name_a": "ノスカピン (JP18)"} -{"id": 6122, "instruction": "Vatiquinone (JAN/USAN/INN)をの化学構造は?", "response": "Vatiquinone (JAN/USAN/INN)をの化学構造はC29H44O3です。", "task": "formula", "name_q": "Vatiquinone (JAN/USAN/INN)", "name_a": "C29H44O3"} -{"id": 3119, "instruction": "Methyl alpha-acetylphenylacetateをを化学構造で書くと?", "response": "Methyl alpha-acetylphenylacetateをを化学構造で書くとC11H12O3です。", "task": "formula", "name_q": "Methyl alpha-acetylphenylacetate", "name_a": "C11H12O3"} -{"id": 31818, "instruction": "5-(Heptadec-12-enyl)resorcinolをを組成式で記述すると?", "response": "5-(Heptadec-12-enyl)resorcinolをを組成式で記述するとC23H38O2です。", "task": "formula", "name_q": "5-(Heptadec-12-enyl)resorcinol", "name_a": "C23H38O2"} -{"id": 6498, "instruction": "Arachidonyl-CoAは別の呼び方では?", "response": "Arachidonyl-CoAは別の呼び方ではArachidonoyl-CoAです。", "task": "replace", "name_q": "Arachidonyl-CoA", "name_a": "Arachidonoyl-CoA"} -{"id": 25362, "instruction": "N2-Acetyl-L-ornithineは別の呼び方では?", "response": "N2-Acetyl-L-ornithineは別の呼び方ではN-Acetylornithineです。", "task": "replace", "name_q": "N2-Acetyl-L-ornithine", "name_a": "N-Acetylornithine"} -{"id": 14890, "instruction": "Carzenide (INN)の英語表記は?", "response": "Carzenide (INN)の英語表記はCarzenide (INN)です。", "task": "replace ja to en", "name_q": "Carzenide (INN)", "name_a": "Carzenide (INN)"} -{"id": 5822, "instruction": "酢酸ピルブテロールの別名称は?", "response": "酢酸ピルブテロールの別名称はPirbuterol acetate (USAN)です。", "task": "replace", "name_q": "酢酸ピルブテロール", "name_a": "Pirbuterol acetate (USAN)"} -{"id": 21706, "instruction": "Beef tallow (JP18)を言い換えると?", "response": "Beef tallow (JP18)を言い換えるとTallowです。", "task": "replace", "name_q": "Beef tallow (JP18)", "name_a": "Tallow"} -{"id": 18561, "instruction": "鉤虫症 下位グループ 十二指腸虫症 アメリカ鉤虫症 皮膚幼虫移行症を英語で書くと?", "response": "鉤虫症 下位グループ 十二指腸虫症 アメリカ鉤虫症 皮膚幼虫移行症を英語で書くとHookworm disease SUBGROUP Ancylostomiasis Necatoriasis Cutaneous larva migransです。", "task": "replace ja to en", "name_q": "鉤虫症 下位グループ 十二指腸虫症 アメリカ鉤虫症 皮膚幼虫移行症", "name_a": "Hookworm disease SUBGROUP Ancylostomiasis Necatoriasis Cutaneous larva migrans"} -{"id": 1784, "instruction": "Amuvatinib hydrochloride (USAN)をの化学式は?", "response": "Amuvatinib hydrochloride (USAN)をの化学式はC23H21N5O3S. HClです。", "task": "formula", "name_q": "Amuvatinib hydrochloride (USAN)", "name_a": "C23H21N5O3S. HCl"} -{"id": 7193, "instruction": "Bucharaineをは化学式で表すと?", "response": "Bucharaineをは化学式で表すとC19H25NO4です。", "task": "formula", "name_q": "Bucharaine", "name_a": "C19H25NO4"} -{"id": 15082, "instruction": "ブレオマイシン硫酸塩 (JP18)の別呼称は?", "response": "ブレオマイシン硫酸塩 (JP18)の別呼称はBleomycin sulfate (JP18/USP)です。", "task": "replace", "name_q": "ブレオマイシン硫酸塩 (JP18)", "name_a": "Bleomycin sulfate (JP18/USP)"} -{"id": 18434, "instruction": "Polyethadene (USAN)の日本語訳は?", "response": "Polyethadene (USAN)の日本語訳はPolyethadene (USAN)です。", "task": "replace en to ja", "name_q": "Polyethadene (USAN)", "name_a": "Polyethadene (USAN)"} -{"id": 11950, "instruction": "フィンゴリモドを英語で書くと?", "response": "フィンゴリモドを英語で書くとGilenya (TN)です。", "task": "replace ja to en", "name_q": "フィンゴリモド", "name_a": "Gilenya (TN)"} -{"id": 30771, "instruction": "Vebicorvir (USAN/INN)をを化学式で表すと?", "response": "Vebicorvir (USAN/INN)をを化学式で表すとC19H12F3N3O4S2です。", "task": "formula", "name_q": "Vebicorvir (USAN/INN)", "name_a": "C19H12F3N3O4S2"} -{"id": 24134, "instruction": "Rhododendron leafを日本語表記で表すと?", "response": "Rhododendron leafを日本語表記で表すとシャクナゲヨウです。", "task": "replace en to ja", "name_q": "Rhododendron leaf", "name_a": "シャクナゲヨウ"} -{"id": 24783, "instruction": "Itasetron hydrochloride hydrate (JAN)をは化学式で表すと?", "response": "Itasetron hydrochloride hydrate (JAN)をは化学式で表すとC16H20N4O2. HCl. H2Oです。", "task": "formula", "name_q": "Itasetron hydrochloride hydrate (JAN)", "name_a": "C16H20N4O2. HCl. H2O"} -{"id": 20230, "instruction": "Tsukamurella 感染の英訳は?", "response": "Tsukamurella 感染の英訳はTsukamurella infectionです。", "task": "replace ja to en", "name_q": "Tsukamurella 感染", "name_a": "Tsukamurella infection"} -{"id": 3860, "instruction": "Brevetoxin Aをを分子式で表すと?", "response": "Brevetoxin Aをを分子式で表すとC49H70O13です。", "task": "formula", "name_q": "Brevetoxin A", "name_a": "C49H70O13"} -{"id": 26805, "instruction": "Albumin aggregated iodinated I 131の別の言い方は?", "response": "Albumin aggregated iodinated I 131の別の言い方はIodinated I 131 albumin aggregated (USP)です。", "task": "replace", "name_q": "Albumin aggregated iodinated I 131", "name_a": "Iodinated I 131 albumin aggregated (USP)"} -{"id": 28382, "instruction": "Limonene-1,2-epoxideの異なる表記は?", "response": "Limonene-1,2-epoxideの異なる表記はLimonene oxideです。", "task": "replace", "name_q": "Limonene-1,2-epoxide", "name_a": "Limonene oxide"} -{"id": 29174, "instruction": "Elaiophylinをを分子式で記述すると?", "response": "Elaiophylinをを分子式で記述するとC54H88O18です。", "task": "formula", "name_q": "Elaiophylin", "name_a": "C54H88O18"} -{"id": 4826, "instruction": "Tolu balsam (USP)の別記述は?", "response": "Tolu balsam (USP)の別記述はTolu balsam oilです。", "task": "replace", "name_q": "Tolu balsam (USP)", "name_a": "Tolu balsam oil"} -{"id": 30023, "instruction": "Congenital nongoitrous hypothyroidism (CHNG)を日本語で記述すると?", "response": "Congenital nongoitrous hypothyroidism (CHNG)を日本語で記述すると先天性甲状腺機能低下症 (甲状腺腫を伴わない)です。", "task": "replace en to ja", "name_q": "Congenital nongoitrous hypothyroidism (CHNG)", "name_a": "先天性甲状腺機能低下症 (甲状腺腫を伴わない)"} -{"id": 19800, "instruction": "DIBENZYLINE(ConcordiaPharmaceuticals)を主とした製品名は?", "response": "DIBENZYLINE(ConcordiaPharmaceuticals)を主とした製品名はPHENOXYBENZAMINEHYDROCHLORIDE(ParPharmaceutical)です。", "task": "product", "name_q": "DIBENZYLINE(ConcordiaPharmaceuticals)", "name_a": "PHENOXYBENZAMINEHYDROCHLORIDE(ParPharmaceutical)"} -{"id": 21227, "instruction": "Navoban (TN)の日本語表記は?", "response": "Navoban (TN)の日本語表記はTropisetron (INN)です。", "task": "replace en to ja", "name_q": "Navoban (TN)", "name_a": "Tropisetron (INN)"} -{"id": 29264, "instruction": "β-D-ガラクトースを言い換えると?", "response": "β-D-ガラクトースを言い換えるとbeta-D-Galactoseです。", "task": "replace", "name_q": "β-D-ガラクトース", "name_a": "beta-D-Galactose"} -{"id": 2669, "instruction": "Dexamethasone 21-tebutateの別記述は?", "response": "Dexamethasone 21-tebutateの別記述はDexamethasone tertiary butyl acetateです。", "task": "replace", "name_q": "Dexamethasone 21-tebutate", "name_a": "Dexamethasone tertiary butyl acetate"} -{"id": 29638, "instruction": "Heptaprenylglyceryl phosphateをを化学構造で表すと?", "response": "Heptaprenylglyceryl phosphateをを化学構造で表すとC38H65O6Pです。", "task": "formula", "name_q": "Heptaprenylglyceryl phosphate", "name_a": "C38H65O6P"} -{"id": 34344, "instruction": "2-(1,2-Epoxy-1,2-dihydrophenyl)acetyl-CoAをを化学構造で表すと?", "response": "2-(1,2-Epoxy-1,2-dihydrophenyl)acetyl-CoAをを化学構造で表すとC29H42N7O18P3Sです。", "task": "formula", "name_q": "2-(1,2-Epoxy-1,2-dihydrophenyl)acetyl-CoA", "name_a": "C29H42N7O18P3S"} -{"id": 1484, "instruction": "Dusquetide (USAN/INN)を日本語で記述すると?", "response": "Dusquetide (USAN/INN)を日本語で記述するとDusquetide (USAN/INN)です。", "task": "replace en to ja", "name_q": "Dusquetide (USAN/INN)", "name_a": "Dusquetide (USAN/INN)"} -{"id": 5758, "instruction": "(6S)-6-Hydroxy-3-oxo-alpha-iononeは別の呼び方では?", "response": "(6S)-6-Hydroxy-3-oxo-alpha-iononeは別の呼び方ではDehydrovomifoliolです。", "task": "replace", "name_q": "(6S)-6-Hydroxy-3-oxo-alpha-ionone", "name_a": "Dehydrovomifoliol"} -{"id": 25450, "instruction": "Prunella spike (TN)を主材料とする商品は?", "response": "Prunella spike (TN)を主材料とする商品はカゴソウ(大晃生薬)です。", "task": "product", "name_q": "Prunella spike (TN)", "name_a": "カゴソウ(大晃生薬)"} -{"id": 4118, "instruction": "ベビリマトジメグルミンをは化学式で表すと?", "response": "ベビリマトジメグルミンをは化学式で表すとC36H56O6. (C7H17NO5)2です。", "task": "formula", "name_q": "ベビリマトジメグルミン", "name_a": "C36H56O6. (C7H17NO5)2"} -{"id": 26912, "instruction": "(4R,7S)-4-Methyl-7-(1-methylethyl)-2-oxepanoneの異なる表現は?", "response": "(4R,7S)-4-Methyl-7-(1-methylethyl)-2-oxepanoneの異なる表現はMentholactoneです。", "task": "replace", "name_q": "(4R,7S)-4-Methyl-7-(1-methylethyl)-2-oxepanone", "name_a": "Mentholactone"} -{"id": 19013, "instruction": "Piperazine adipateの別の呼び方は?", "response": "Piperazine adipateの別の呼び方はピペラジンアジピン酸塩です。", "task": "replace", "name_q": "Piperazine adipate", "name_a": "ピペラジンアジピン酸塩"} -{"id": 11394, "instruction": "アセトヘキサミド (JP18)を英語で書くと?", "response": "アセトヘキサミド (JP18)を英語で書くとAcetohexamide (JP18/USP/INN)です。", "task": "replace ja to en", "name_q": "アセトヘキサミド (JP18)", "name_a": "Acetohexamide (JP18/USP/INN)"} -{"id": 3755, "instruction": "9-Chloro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-oneをを組成式で書くと?", "response": "9-Chloro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-oneをを組成式で書くとC20H29ClO3です。", "task": "formula", "name_q": "9-Chloro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one", "name_a": "C20H29ClO3"} -{"id": 7692, "instruction": "15alpha-Hydroxytestosteroneをを組成式で表すと?", "response": "15alpha-Hydroxytestosteroneをを組成式で表すとC19H28O3です。", "task": "formula", "name_q": "15alpha-Hydroxytestosterone", "name_a": "C19H28O3"} -{"id": 15536, "instruction": "Belladonna extract (JP18)を日本語で記述すると?", "response": "Belladonna extract (JP18)を日本語で記述するとBelladonna extract (JP18)です。", "task": "replace en to ja", "name_q": "Belladonna extract (JP18)", "name_a": "Belladonna extract (JP18)"} -{"id": 29116, "instruction": "Alpiniae katsumadai semenの日本語訳は?", "response": "Alpiniae katsumadai semenの日本語訳はAlpiniae katsumadai semenです。", "task": "replace en to ja", "name_q": "Alpiniae katsumadai semen", "name_a": "Alpiniae katsumadai semen"} -{"id": 28781, "instruction": "Midodrineの異なる名称は?", "response": "Midodrineの異なる名称はミドドリンです。", "task": "replace", "name_q": "Midodrine", "name_a": "ミドドリン"} -{"id": 7192, "instruction": "Ropivacaineをは化学構造で表すと?", "response": "Ropivacaineをは化学構造で表すとC17H26N2Oです。", "task": "formula", "name_q": "Ropivacaine", "name_a": "C17H26N2O"} -{"id": 3084, "instruction": "Jizusoippokyodaioの別の呼び方は?", "response": "Jizusoippokyodaioの別の呼び方は治頭瘡一方去大黄です。", "task": "replace", "name_q": "Jizusoippokyodaio", "name_a": "治頭瘡一方去大黄"} -{"id": 23027, "instruction": "2-Dehydro-D-galactonateをを化学式で記述すると?", "response": "2-Dehydro-D-galactonateをを化学式で記述するとC6H10O7です。", "task": "formula", "name_q": "2-Dehydro-D-galactonate", "name_a": "C6H10O7"} +{"id": 26903, "instruction": "2-Caffeoylisocitrateの別名称は?", "response": "2-Caffeoylisocitrateの別名称は(E)-Caffeoylisocitrateです。", "task": "replace", "name_q": "2-Caffeoylisocitrate", "name_a": "(E)-Caffeoylisocitrate"} +{"id": 27680, "instruction": "Autosomal recessive hypophosphatemic rickets SUPERGRP Hypophosphatemic rickets を日本語に訳すと?", "response": "Autosomal recessive hypophosphatemic rickets SUPERGRP Hypophosphatemic rickets を日本語に訳すと常染色体劣性低リン血症性くる病 上位グループ 低リン血症性くる病 です。", "task": "replace en to ja", "name_q": "Autosomal recessive hypophosphatemic rickets SUPERGRP Hypophosphatemic rickets ", "name_a": "常染色体劣性低リン血症性くる病 上位グループ 低リン血症性くる病 "} +{"id": 27189, "instruction": "Spasmoplex (TN)をの組成式は?", "response": "Spasmoplex (TN)をの組成式はC25H30NO3. Clです。", "task": "formula", "name_q": "Spasmoplex (TN)", "name_a": "C25H30NO3. Cl"} +{"id": 26045, "instruction": "瞳孔反射異常を伴う自律神経膀胱機能障害および先天性腎尿路奇形を英語に訳すと?", "response": "瞳孔反射異常を伴う自律神経膀胱機能障害および先天性腎尿路奇形を英語に訳すとAutonomic bladder dysfunction with impaired pupillary reflex and secondary CAKUTです。", "task": "replace ja to en", "name_q": "瞳孔反射異常を伴う自律神経膀胱機能障害および先天性腎尿路奇形", "name_a": "Autonomic bladder dysfunction with impaired pupillary reflex and secondary CAKUT"} +{"id": 26199, "instruction": "ニレストリオールの別名称は?", "response": "ニレストリオールの別名称はNylestriol (USAN)です。", "task": "replace", "name_q": "ニレストリオール", "name_a": "Nylestriol (USAN)"} +{"id": 18928, "instruction": "(Glutathione-S-yl)(1H-indol-3-yl)acetonitrileをを分子式で書くと?", "response": "(Glutathione-S-yl)(1H-indol-3-yl)acetonitrileをを分子式で書くとC20H23N5O6Sです。", "task": "formula", "name_q": "(Glutathione-S-yl)(1H-indol-3-yl)acetonitrile", "name_a": "C20H23N5O6S"} +{"id": 301, "instruction": "大腸菌性髄膜炎を英語に訳すと?", "response": "大腸菌性髄膜炎を英語に訳すとNeonatal meningitis-associated Escherichia coli (NMEC) infectionです。", "task": "replace ja to en", "name_q": "大腸菌性髄膜炎", "name_a": "Neonatal meningitis-associated Escherichia coli (NMEC) infection"} +{"id": 6252, "instruction": "Fenuron-TCAの別名は?", "response": "Fenuron-TCAの別名はフェニュロン-TCAです。", "task": "replace", "name_q": "Fenuron-TCA", "name_a": "フェニュロン-TCA"} +{"id": 28280, "instruction": "Nitrosobenzeneをの化学式は?", "response": "Nitrosobenzeneをの化学式はC6H5NOです。", "task": "formula", "name_q": "Nitrosobenzene", "name_a": "C6H5NO"} +{"id": 21984, "instruction": "Costatolをを化学式で書くと?", "response": "Costatolをを化学式で書くとC10H14BrCl3Oです。", "task": "formula", "name_q": "Costatol", "name_a": "C10H14BrCl3O"} +{"id": 8086, "instruction": "Aeruginopeptin 917S-Cをを組成式で書くと?", "response": "Aeruginopeptin 917S-Cをを組成式で書くとC51H74N8O14です。", "task": "formula", "name_q": "Aeruginopeptin 917S-C", "name_a": "C51H74N8O14"} +{"id": 16839, "instruction": "Medicarpinの別名は?", "response": "Medicarpinの別名はメディカルピンです。", "task": "replace", "name_q": "Medicarpin", "name_a": "メディカルピン"} +{"id": 31948, "instruction": "ペルツズマブ・トラスツズマブ・ヒアルロニダー��を英語で書くと?", "response": "ペルツズマブ・トラスツズマブ・ヒアルロニダーゼを英語で書くとPhesgo (TN)です。", "task": "replace ja to en", "name_q": "ペルツズマブ・トラスツズマブ・ヒアルロニダーゼ", "name_a": "Phesgo (TN)"} +{"id": 32498, "instruction": "5'-Butyrylphosphoinosineをを化学構造で記述すると?", "response": "5'-Butyrylphosphoinosineをを化学構造で記述するとC14H19N4O9Pです。", "task": "formula", "name_q": "5'-Butyrylphosphoinosine", "name_a": "C14H19N4O9P"} +{"id": 3806, "instruction": "9alpha-Fluoro-17beta-hydroxy-17alpha-methylandrost-4-ene-3,11-dioneの異なる表記は?", "response": "9alpha-Fluoro-17beta-hydroxy-17alpha-methylandrost-4-ene-3,11-dioneの異なる表記は9-Fluoro-17-methyl-11-oxotestosteroneです。", "task": "replace", "name_q": "9alpha-Fluoro-17beta-hydroxy-17alpha-methylandrost-4-ene-3,11-dione", "name_a": "9-Fluoro-17-methyl-11-oxotestosterone"} +{"id": 27184, "instruction": "Bearberry leaf (JP18)を主とした製品は?", "response": "Bearberry leaf (JP18)を主とした製品はウワウルシ(小西製薬)です。", "task": "product", "name_q": "Bearberry leaf (JP18)", "name_a": "ウワウルシ(小西製薬)"} +{"id": 227, "instruction": "Isofebrifugineをは分子式で表すと?", "response": "Isofebrifugineをは分子式で表すとC16H19N3O3です。", "task": "formula", "name_q": "Isofebrifugine", "name_a": "C16H19N3O3"} +{"id": 33438, "instruction": "ソフィツズマブベドチンの英訳は?", "response": "ソフィツズマブベドチンの英訳はSofituzumab vedotin (USAN/INN)です。", "task": "replace ja to en", "name_q": "ソフィツズマブベドチン", "name_a": "Sofituzumab vedotin (USAN/INN)"} +{"id": 20620, "instruction": "Congenital tricuspid valve stenosisを日本語で記述すると?", "response": "Congenital tricuspid valve stenosisを日本語で記述すると先天性三尖弁狭窄症です。", "task": "replace en to ja", "name_q": "Congenital tricuspid valve stenosis", "name_a": "先天性三尖弁狭窄症"} +{"id": 24706, "instruction": "Methyl group acceptorは別の呼び方では?", "response": "Methyl group acceptorは別の呼び方ではRです。", "task": "replace", "name_q": "Methyl group acceptor", "name_a": "R"} +{"id": 29256, "instruction": "X-linked dominant hypophosphatemic rickets SUPERGRP Hypophosphatemic rickets を日本語で記述すると?", "response": "X-linked dominant hypophosphatemic rickets SUPERGRP Hypophosphatemic rickets を日本語で記述するとX 連鎖優性低リン血症性くる病 上位グループ 低リン血症性くる病 です。", "task": "replace en to ja", "name_q": "X-linked dominant hypophosphatemic rickets SUPERGRP Hypophosphatemic rickets ", "name_a": "X 連鎖優性低リン血症性くる病 上位グループ 低リン血症性くる病 "} +{"id": 19361, "instruction": "滋腎通耳湯の英訳は?", "response": "滋腎通耳湯の英訳はJijintsujitoです。", "task": "replace ja to en", "name_q": "滋腎通耳湯", "name_a": "Jijintsujito"} +{"id": 4823, "instruction": "ソニデギブリン酸塩を主とした製品は?", "response": "ソニデギブリン酸塩を主とした製品はODOMZO(SunPharmaceuticalIndustries)です。", "task": "product", "name_q": "ソニデギブリン酸塩", "name_a": "ODOMZO(SunPharmaceuticalIndustries)"} +{"id": 31404, "instruction": "中核群神経有棘赤血球症 下位グループ 有棘赤血球を伴う舞踏病 (ChAc) マクラウド症候群 (MLS) ハンチントン病類縁疾患 2 型 (HDL2) パントテン酸キナーゼ関連神経変性症 (PKAN) を英語で記述すると?", "response": "中核群神経有棘赤血球症 下位グループ 有棘赤血球を伴う舞踏病 (ChAc) マクラウド症候群 (MLS) ハンチントン病類縁疾患 2 型 (HDL2) パントテン酸キナーゼ関連神経変性症 (PKAN) を英語で記述するとCore neuroacanthocytosis syndromes SUBGROUP Chorea-acanthocytosis (ChAc) McLeod syndrome (MLS) Huntington's disease-like 2 (HDL2) Pantothenate kinase associated neurodegeneration (PKAN) です。", "task": "replace ja to en", "name_q": "中核群神経有棘赤血球症 下位グループ 有棘赤血球を伴う舞踏病 (ChAc) マクラウド症候群 (MLS) ハンチントン病類縁疾患 2 型 (HDL2) パントテン酸キナーゼ関連神経変性症 (PKAN) ", "name_a": "Core neuroacanthocytosis syndromes SUBGROUP Chorea-acanthocytosis (ChAc) McLeod syndrome (MLS) Huntington's disease-like 2 (HDL2) Pantothenate kinase associated neurodegeneration (PKAN) "} +{"id": 6103, "instruction": "Inherited autoinflammatory disease SUBGROUP NLRC4 inflammasomopathy Aicardi-Goutieres syndrome ADA2 deficiency Familial Behcet-like autoinflammatory syndrome を日本語表記で表すと?", "response": "Inherited autoinflammatory disease SUBGROUP NLRC4 inflammasomopathy Aicardi-Goutieres syndrome ADA2 deficiency Familial Behcet-like autoinflammatory syndrome を日本語表記で表すと遺伝性自己炎症疾患 下位グループ NLRC4 異常症 エカルディ・グティエール症候群 ADA2 欠損症 家族性ベーチェット病様自己炎症性症候群 です。", "task": "replace en to ja", "name_q": "Inherited autoinflammatory disease SUBGROUP NLRC4 inflammasomopathy Aicardi-Goutieres syndrome ADA2 deficiency Familial Behcet-like autoinflammatory syndrome ", "name_a": "遺伝性自己炎症疾患 下位グループ NLRC4 異常症 エカルディ・グティエール症候群 ADA2 欠損症 家族性ベーチェット病様自己炎症性症候群 "} +{"id": 31433, "instruction": "alpha-D-Mannosyl-1,3-(R1)-beta-D-mannosyl-R2の別表現は?", "response": "alpha-D-Mannosyl-1,3-(R1)-beta-D-mannosyl-R2の別表現は3-(alpha-D-Mannosyl)-beta-D-mannosyl-Rです。", "task": "replace", "name_q": "alpha-D-Mannosyl-1,3-(R1)-beta-D-mannosyl-R2", "name_a": "3-(alpha-D-Mannosyl)-beta-D-mannosyl-R"} +{"id": 11546, "instruction": "Tomaralimab (USAN)をの化学式は?", "response": "Tomaralimab (USAN)をの化学式はC6452H9958N1706O2028S44です。", "task": "formula", "name_q": "Tomaralimab (USAN)", "name_a": "C6452H9958N1706O2028S44"} +{"id": 20883, "instruction": "プロパミジンをを化学構造で表すと?", "response": "プロパミジンをを化学構造で表すとC17H20N4O2です。", "task": "formula", "name_q": "プロパミジン", "name_a": "C17H20N4O2"} +{"id": 6063, "instruction": "杜松油の異なる名称は?", "response": "杜松油の異なる名称はトショウジツです。", "task": "replace", "name_q": "杜松油", "name_a": "トショウジツ"} +{"id": 13033, "instruction": "ニューロテンシンの別名は?", "response": "ニューロテンシンの別名はノイロテンシンです。", "task": "replace", "name_q": "ニューロテンシン", "name_a": "ノイロテンシン"} +{"id": 22611, "instruction": "五酸化バナジウムの異なる名称は?", "response": "五酸化バナジウムの異なる名称はVanadium pentoxideです。", "task": "replace", "name_q": "五酸化バナジウム", "name_a": "Vanadium pentoxide"} +{"id": 4661, "instruction": "UDP-3-keto-D-glucoseをは化学構造で表すと?", "response": "UDP-3-keto-D-glucoseをは化学構造で表すとC15H22N2O17P2です。", "task": "formula", "name_q": "UDP-3-keto-D-glucose", "name_a": "C15H22N2O17P2"} +{"id": 31915, "instruction": "Delta7-Avenasterolをは分子式で表すと?", "response": "Delta7-Avenasterolをは分子式で表すとC29H48Oです。", "task": "formula", "name_q": "Delta7-Avenasterol", "name_a": "C29H48O"} +{"id": 15389, "instruction": "2-Methylcholineをは分子式で表すと?", "response": "2-Methylcholineをは分子式で表すとC6H16NOです。", "task": "formula", "name_q": "2-Methylcholine", "name_a": "C6H16NO"} +{"id": 13424, "instruction": "2,2-Dimethyl-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-7-ol acetateをの分子式は?", "response": "2,2-Dimethyl-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-7-ol acetateをの分子式はC23H26O4です。", "task": "formula", "name_q": "2,2-Dimethyl-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-7-ol acetate", "name_a": "C23H26O4"} +{"id": 5808, "instruction": "キナプリルの英訳は?", "response": "キナプリルの英訳はQuinapril (INN)です。", "task": "replace ja to en", "name_q": "キナプリル", "name_a": "Quinapril (INN)"} +{"id": 15054, "instruction": "TESTOSTERONECYPIONATE(ActavisPharma)を用いた医薬品は?", "response": "TESTOSTERONECYPIONATE(ActavisPharma)を用いた医薬品はTESTOSTERONECYPIONATE(EugiaUSLLC)です。", "task": "product", "name_q": "TESTOSTERONECYPIONATE(ActavisPharma)", "name_a": "TESTOSTERONECYPIONATE(EugiaUSLLC)"} +{"id": 467, "instruction": "多脾症候群を英語で記述すると?", "response": "多脾症候群を英語で記述するとPolysplenia syndromeです。", "task": "replace ja to en", "name_q": "多脾症候群", "name_a": "Polysplenia syndrome"} +{"id": 33451, "instruction": "カラートを英語で書くと?", "response": "カラートを英語で書くとCarateです。", "task": "replace ja to en", "name_q": "カラート", "name_a": "Carate"} +{"id": 26053, "instruction": "JZTX-Iは別の呼び方では?", "response": "JZTX-Iは別の呼び方ではJingzhaotoxin Iです。", "task": "replace", "name_q": "JZTX-I", "name_a": "Jingzhaotoxin I"} +{"id": 11431, "instruction": "Heptopargilをを化学構造で記述すると?", "response": "Heptopargilをを化学構造で記述するとC13H19NOです。", "task": "formula", "name_q": "Heptopargil", "name_a": "C13H19NO"} +{"id": 25002, "instruction": "Alprazolamをの化学構造は?", "response": "Alprazolamをの化学構造はC17H13ClN4です。", "task": "formula", "name_q": "Alprazolam", "name_a": "C17H13ClN4"} +{"id": 14015, "instruction": "Porencephaly SUPERGRP Brain small vessel disease Neuronal migration disorder を日本語に訳すと?", "response": "Porencephaly SUPERGRP Brain small vessel disease Neuronal migration disorder を日本語に訳すと���脳症 上位グループ 脳小血管病 神経細胞移動異常症 です。", "task": "replace en to ja", "name_q": "Porencephaly SUPERGRP Brain small vessel disease Neuronal migration disorder ", "name_a": "孔脳症 上位グループ 脳小血管病 神経細胞移動異常症 "} +{"id": 28227, "instruction": "SIROLIMUS(AmnealPharmaceuticalsNYLLC)を利用した薬品は?", "response": "SIROLIMUS(AmnealPharmaceuticalsNYLLC)を利用した薬品はHYFTOR(NobelpharmaAmerica)です。", "task": "product", "name_q": "SIROLIMUS(AmnealPharmaceuticalsNYLLC)", "name_a": "HYFTOR(NobelpharmaAmerica)"} +{"id": 14362, "instruction": "Bacitracin (JP18/USP/INN)の異なる表現は?", "response": "Bacitracin (JP18/USP/INN)の異なる表現はバシトラシン (JP18)です。", "task": "replace", "name_q": "Bacitracin (JP18/USP/INN)", "name_a": "バシトラシン (JP18)"} +{"id": 33425, "instruction": "Nexlizet (TN)の異なる名称は?", "response": "Nexlizet (TN)の異なる名称はBempedoic acid and ezetimibeです。", "task": "replace", "name_q": "Nexlizet (TN)", "name_a": "Bempedoic acid and ezetimibe"} +{"id": 23763, "instruction": "Zealexin A1をを分子式で書くと?", "response": "Zealexin A1をを分子式で書くとC15H22O2です。", "task": "formula", "name_q": "Zealexin A1", "name_a": "C15H22O2"} +{"id": 30077, "instruction": "17beta-Hydroxy-4-oxa-5alpha-androstan-3-one acetateをを化学構造で表すと?", "response": "17beta-Hydroxy-4-oxa-5alpha-androstan-3-one acetateをを化学構造で表すとC20H30O4です。", "task": "formula", "name_q": "17beta-Hydroxy-4-oxa-5alpha-androstan-3-one acetate", "name_a": "C20H30O4"} +{"id": 25407, "instruction": "Fisetin 8-C-glucosideの異なる表記は?", "response": "Fisetin 8-C-glucosideの異なる表記はフィセチン8-C-グルコシドです。", "task": "replace", "name_q": "Fisetin 8-C-glucoside", "name_a": "フィセチン8-C-グルコシド"} +{"id": 9973, "instruction": "Phenanthrenequinoneをの化学構造は?", "response": "Phenanthrenequinoneをの化学構造はC14H8O2です。", "task": "formula", "name_q": "Phenanthrenequinone", "name_a": "C14H8O2"} +{"id": 34398, "instruction": "LXA4の異なる名称は?", "response": "LXA4の異なる名称は5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acidです。", "task": "replace", "name_q": "LXA4", "name_a": "5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid"} +{"id": 7673, "instruction": "リアテルミンを英語で書くと?", "response": "リアテルミンを英語で書くとLiatermin (USAN/INN)です。", "task": "replace ja to en", "name_q": "リアテルミン", "name_a": "Liatermin (USAN/INN)"} +{"id": 6184, "instruction": "Spectinamineをを組成式で表すと?", "response": "Spectinamineをを組成式で表すとC8H18N2O4です。", "task": "formula", "name_q": "Spectinamine", "name_a": "C8H18N2O4"} +{"id": 26300, "instruction": "Phenytoin and phenobarbitalを利用した医薬品名は?", "response": "Phenytoin and phenobarbitalを利用した医薬品名はヒダントール(藤永製薬)です。", "task": "product", "name_q": "Phenytoin and phenobarbital", "name_a": "ヒダントール(藤永製薬)"} +{"id": 26831, "instruction": "Belumosudil (USAN)の別呼称は?", "response": "Belumosudil (USAN)の別呼称はベルモスジルです。", "task": "replace", "name_q": "Belumosudil (USAN)", "name_a": "ベルモスジル"} +{"id": 15341, "instruction": "Sulfamic acidの別名称は?", "response": "Sulfamic acidの別名称はAmidosulfuric acidです。", "task": "replace", "name_q": "Sulfamic acid", "name_a": "Amidosulfuric acid"} +{"id": 25492, "instruction": "Pimitespib (JAN)を日本語で書くと?", "response": "Pimitespib (JAN)を日本語で書くとピミテスピブ (JAN)です。", "task": "replace en to ja", "name_q": "Pimitespib (JAN)", "name_a": "ピミテスピブ (JAN)"} +{"id": 1637, "instruction": "2-Acyl-sn-glycero-3-phosphoserineの異なる表現は?", "response": "2-Acyl-sn-glycero-3-phosphoserineの異なる表現は2-Acyl-1-lyso-phosphatidylserineです。", "task": "replace", "name_q": "2-Acyl-sn-glycero-3-phosphoserine", "name_a": "2-Acyl-1-lyso-phosphatidylserine"} +{"id": 1399, "instruction": "Doisynoestrolをを化学式で表すと?", "response": "Doisynoestrolをを化学式で表すとC19H22O3です。", "task": "formula", "name_q": "Doisynoestrol", "name_a": "C19H22O3"} +{"id": 6076, "instruction": "Orgalutran (TN)は別の呼び方では?", "response": "Orgalutran (TN)は別の呼び方ではGanirelix (INN)です。", "task": "replace", "name_q": "Orgalutran (TN)", "name_a": "Ganirelix (INN)"} +{"id": 30911, "instruction": "Atractyloneをを分子式で表すと?", "response": "Atractyloneをを分子式で表すとC15H20Oです。", "task": "formula", "name_q": "Atractylone", "name_a": "C15H20O"} +{"id": 25636, "instruction": "Celenid (TN)をの化学式は?", "response": "Celenid (TN)をの化学式はC26H28N2. 2HClです。", "task": "formula", "name_q": "Celenid (TN)", "name_a": "C26H28N2. 2HCl"} +{"id": 15781, "instruction": "フラボキサートの別名称は?", "response": "フラボキサートの別名称はFlavoxateです。", "task": "replace", "name_q": "フラボキサート", "name_a": "Flavoxate"} +{"id": 32517, "instruction": "Flazalone (USAN)の別表現は?", "response": "Flazalone (USAN)の別表現はフラザロンです。", "task": "replace", "name_q": "Flazalone (USAN)", "name_a": "フラザロン"} +{"id": 26059, "instruction": "Bleomycin (INN)をの組成式は?", "response": "Bleomycin (INN)をの組成式はC50H71N16O21S2Rです。", "task": "formula", "name_q": "Bleomycin (INN)", "name_a": "C50H71N16O21S2R"} +{"id": 10849, "instruction": "ノルゲストメットをは化学構造で表すと?", "response": "ノルゲストメットをは化学構造で表すとC23H32O4です。", "task": "formula", "name_q": "ノルゲストメット", "name_a": "C23H32O4"} +{"id": 11629, "instruction": "Ergocornineをは化学構造で表すと?", "response": "Ergocornineをは化学構造で表すとC31H39N5O5です。", "task": "formula", "name_q": "Ergocornine", "name_a": "C31H39N5O5"} +{"id": 11534, "instruction": "Sulfur-carrier proteinをは組成式で表すと?", "response": "Sulfur-carrier proteinをは組成式で表すとC4H7N2O3Rです。", "task": "formula", "name_q": "Sulfur-carrier protein", "name_a": "C4H7N2O3R"} +{"id": 8864, "instruction": "Peucenidinをを分子式で記述すると?", "response": "Peucenidinをを分子式で記述するとC21H22O7です。", "task": "formula", "name_q": "Peucenidin", "name_a": "C21H22O7"} +{"id": 19902, "instruction": "Fisogatinib (USAN/INN)の別の言い方は?", "response": "Fisogatinib (USAN/INN)の別の言い方はフィソガチニブです。", "task": "replace", "name_q": "Fisogatinib (USAN/INN)", "name_a": "フィソガチニブ"} +{"id": 19298, "instruction": "チモナシクを英語表記で表すと?", "response": "チモナシクを英語表記で表すとHepacom (TN)です。", "task": "replace ja to en", "name_q": "チモナシク", "name_a": "Hepacom (TN)"} +{"id": 11669, "instruction": "Retinyl-ester-(cellular-retinol-binding-protein)をは化学式で表すと?", "response": "Retinyl-ester-(cellular-retinol-binding-protein)をは化学式で表すとC21H29O2Rです。", "task": "formula", "name_q": "Retinyl-ester-(cellular-retinol-binding-protein)", "name_a": "C21H29O2R"} +{"id": 8360, "instruction": "Furylfuramideを日本語表記で表すと?", "response": "Furylfuramideを日本語表記で表すとフリルフラマイドです。", "task": "replace en to ja", "name_q": "Furylfuramide", "name_a": "フリルフラマイド"} +{"id": 18514, "instruction": "Atractyloside Hをを組成式で表すと?", "response": "Atractyloside Hをを組成式で表すとC32H54O17です。", "task": "formula", "name_q": "Atractyloside H", "name_a": "C32H54O17"} +{"id": 31461, "instruction": "Robinow syndromeの日本語訳は?", "response": "Robinow syndromeの日本語訳はロビノウ症候群です。", "task": "replace en to ja", "name_q": "Robinow syndrome", "name_a": "ロビノウ症候群"} +{"id": 27391, "instruction": "6-Sulfo-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,3-1-O-alkyl-2-O-acylglycerolをを分子式で表すと?", "response": "6-Sulfo-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,3-1-O-alkyl-2-O-acylglycerolをを分子式で表すとC22H36O22SR2です。", "task": "formula", "name_q": "6-Sulfo-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,3-1-O-alkyl-2-O-acylglycerol", "name_a": "C22H36O22SR2"} +{"id": 2447, "instruction": "3-Amino-3-(4-hydroxyphenyl)propanoateをを化学式で記述すると?", "response": "3-Amino-3-(4-hydroxyphenyl)propanoateをを化学式で記述するとC9H11NO3です。", "task": "formula", "name_q": "3-Amino-3-(4-hydroxyphenyl)propanoate", "name_a": "C9H11NO3"} +{"id": 7680, "instruction": "Apo-[methylmalonyl-CoA:pyruvate carboxytransferase]をの化学構造は?", "response": "Apo-[methylmalonyl-CoA:pyruvate carboxytransferase]をの化学構造はC7H13N3O2R2です。", "task": "formula", "name_q": "Apo-[methylmalonyl-CoA:pyruvate carboxytransferase]", "name_a": "C7H13N3O2R2"} +{"id": 494, "instruction": "ヨージパミドナトリウムI131は別の呼び方では?", "response": "ヨージパミドナトリウムI131は別の呼び方ではIodipamide sodium I 131 (USAN)です。", "task": "replace", "name_q": "ヨージパミドナトリウムI131", "name_a": "Iodipamide sodium I 131 (USAN)"} +{"id": 18272, "instruction": "オロチジン5'-リン酸の異なる表記は?", "response": "オロチジン5'-リン酸の異なる表記はOrotidine 5'-phosphateです。", "task": "replace", "name_q": "オロチジン5'-リン酸", "name_a": "Orotidine 5'-phosphate"} +{"id": 31386, "instruction": "オウショウサンの別名は?", "response": "オウショウサンの別名は芎黄散です。", "task": "replace", "name_q": "オウショウサン", "name_a": "芎黄散"} +{"id": 23180, "instruction": "ブロノポールの別の言い方は?", "response": "ブロノポールの別の言い方はBronopolです。", "task": "replace", "name_q": "ブロノポール", "name_a": "Bronopol"} +{"id": 21888, "instruction": "Gleptoferron (USAN/INN)を日本語に訳すと?", "response": "Gleptoferron (USAN/INN)を日本語に訳すとグレプトフェロンです。", "task": "replace en to ja", "name_q": "Gleptoferron (USAN/INN)", "name_a": "グレプトフェロン"} +{"id": 8604, "instruction": "Acetamipridの別名称は?", "response": "Acetamipridの別名称はアセタミプリドです。", "task": "replace", "name_q": "Acetamiprid", "name_a": "アセタミプリド"} +{"id": 30993, "instruction": "バプレオチドをは分子式で表すと?", "response": "バプレオチドをは分子式で表すとC57H70N12O9S2です。", "task": "formula", "name_q": "バプレオチド", "name_a": "C57H70N12O9S2"} +{"id": 1089, "instruction": "ブマジゾンをを組成式で記述すると?", "response": "ブマジゾンをを組成式で記述するとC19H22N2O3です。", "task": "formula", "name_q": "ブマジゾン", "name_a": "C19H22N2O3"} +{"id": 12160, "instruction": "Werner syndrome SUPERGRP Defects in RecQ helicases の日本語表記は?", "response": "Werner syndrome SUPERGRP Defects in RecQ helicases の日本語表記はウェルナー症候群 上位グループ RecQヘリカーゼ欠損症 です。", "task": "replace en to ja", "name_q": "Werner syndrome SUPERGRP Defects in RecQ helicases ", "name_a": "ウェルナー症候群 上位グループ RecQヘリカーゼ欠損症 "} +{"id": 12522, "instruction": "インダナゾリン塩酸塩の英訳は?", "response": "インダナゾリン塩酸塩の英訳はIndanazoline hydrochlorideです。", "task": "replace ja to en", "name_q": "インダナゾリン塩酸塩", "name_a": "Indanazoline hydrochloride"} +{"id": 21406, "instruction": "Tumor predisposition syndromeを日本語で記述すると?", "response": "Tumor predisposition syndromeを日本語で記述すると腫瘍感受性症候群です。", "task": "replace en to ja", "name_q": "Tumor predisposition syndrome", "name_a": "腫瘍感受性症候群"} +{"id": 24231, "instruction": "4-Methylmuconolactoneをは組成式で表すと?", "response": "4-Methylmuconolactoneをは組成式で表すとC7H8O4です。", "task": "formula", "name_q": "4-Methylmuconolactone", "name_a": "C7H8O4"} +{"id": 30595, "instruction": "ミオチンをを組成式で書くと?", "response": "ミオチンをを組成式で書くとC12H18N2O2です。", "task": "formula", "name_q": "ミオチン", "name_a": "C12H18N2O2"} +{"id": 2296, "instruction": "肩甲腓骨型筋ジストロフィー 上位グループ 先天性ミオパチー を英語表記で表すと?", "response": "肩甲腓骨型筋ジストロフィー 上位グループ 先天性ミオパチー を英語表記で表すとScapuloperoneal myopathy SUPERGRP Congenital myopathy です。", "task": "replace ja to en", "name_q": "肩甲腓骨型筋ジストロフィー 上位グループ 先天性ミオパチー ", "name_a": "Scapuloperoneal myopathy SUPERGRP Congenital myopathy "} +{"id": 17090, "instruction": "シモキサニルをを組成式で記述すると?", "response": "シモキサニルをを組成式で記述するとC7H10N4O3です。", "task": "formula", "name_q": "シモキサニル", "name_a": "C7H10N4O3"} +{"id": 19280, "instruction": "Malt extract (JAN)の英語表記は?", "response": "Malt extract (JAN)の英語表記はMalt extract (TN)です。", "task": "replace ja to en", "name_q": "Malt extract (JAN)", "name_a": "Malt extract (TN)"} +{"id": 24161, "instruction": "イノブロジブの別名は?", "response": "イノブロジブの別名はInobrodib (USAN)です。", "task": "replace", "name_q": "イノブロジブ", "name_a": "Inobrodib (USAN)"} +{"id": 18542, "instruction": "Paromomycin IIをは化学構造で表すと?", "response": "Paromomycin IIをは化学構造で表すとC23H45N5O14です。", "task": "formula", "name_q": "Paromomycin II", "name_a": "C23H45N5O14"} +{"id": 3218, "instruction": "Onasemnogene abeparvovec (USAN/INN)の異なる表現は?", "response": "Onasemnogene abeparvovec (USAN/INN)の異なる表現はOnasemnogene abeparvovec-xioiです。", "task": "replace", "name_q": "Onasemnogene abeparvovec (USAN/INN)", "name_a": "Onasemnogene abeparvovec-xioi"} +{"id": 5841, "instruction": "Cembrene Cをを化学構造で記述すると?", "response": "Cembrene Cをを化学構造で記述するとC20H32です。", "task": "formula", "name_q": "Cembrene C", "name_a": "C20H32"} +{"id": 15545, "instruction": "Smith-McCort dysplasiaの日本語表記は?", "response": "Smith-McCort dysplasiaの日本語表記はSmith-McCort 異形成症です。", "task": "replace en to ja", "name_q": "Smith-McCort dysplasia", "name_a": "Smith-McCort 異形成症"} +{"id": 11998, "instruction": "Perindopril (USAN/INN)を言い換えると?", "response": "Perindopril (USAN/INN)を言い換えるとペリンドプリルです。", "task": "replace", "name_q": "Perindopril (USAN/INN)", "name_a": "ペ���ンドプリル"} +{"id": 26755, "instruction": "(R)-2-[(R)-2-Aminopropanoyloxy]propanoic acidの別名は?", "response": "(R)-2-[(R)-2-Aminopropanoyloxy]propanoic acidの別名はD-Alanyl-(R)-lactateです。", "task": "replace", "name_q": "(R)-2-[(R)-2-Aminopropanoyloxy]propanoic acid", "name_a": "D-Alanyl-(R)-lactate"} +{"id": 11643, "instruction": "Benzhydrocodone (USAN/INN)を日本語に訳すと?", "response": "Benzhydrocodone (USAN/INN)を日本語に訳すとベンズヒドロコドンです。", "task": "replace en to ja", "name_q": "Benzhydrocodone (USAN/INN)", "name_a": "ベンズヒドロコドン"} +{"id": 3639, "instruction": "Spinaceneの別名称は?", "response": "Spinaceneの別名称はSqualeneです。", "task": "replace", "name_q": "Spinacene", "name_a": "Squalene"} +{"id": 19600, "instruction": "Seleniumをは化学構造で表すと?", "response": "Seleniumをは化学構造で表すとSeです。", "task": "formula", "name_q": "Selenium", "name_a": "Se"} +{"id": 25573, "instruction": "Candicidin (USAN/INN)を英語で記述すると?", "response": "Candicidin (USAN/INN)を英語で記述するとVanobid (TN)です。", "task": "replace ja to en", "name_q": "Candicidin (USAN/INN)", "name_a": "Vanobid (TN)"} +{"id": 24200, "instruction": "Amitriptyline (INN)の別名称は?", "response": "Amitriptyline (INN)の別名称はアミトリプチリンです。", "task": "replace", "name_q": "Amitriptyline (INN)", "name_a": "アミトリプチリン"} +{"id": 26437, "instruction": "N-Phospho-D-lombricineをを分子式で書くと?", "response": "N-Phospho-D-lombricineをを分子式で書くとC6H16N4O9P2です。", "task": "formula", "name_q": "N-Phospho-D-lombricine", "name_a": "C6H16N4O9P2"} +{"id": 17864, "instruction": "Oportuzumab monatox (USAN)をを組成式で記述すると?", "response": "Oportuzumab monatox (USAN)をを組成式で記述するとC3072H4731N877O952S12です。", "task": "formula", "name_q": "Oportuzumab monatox (USAN)", "name_a": "C3072H4731N877O952S12"} +{"id": 27969, "instruction": "Mycinamicin VIをを化学式で書くと?", "response": "Mycinamicin VIをを化学式で書くとC35H57NO11です。", "task": "formula", "name_q": "Mycinamicin VI", "name_a": "C35H57NO11"} +{"id": 31896, "instruction": "4-Nitro-1,1'-biphenylをを組成式で記述すると?", "response": "4-Nitro-1,1'-biphenylをを組成式で記述するとC12H9NO2です。", "task": "formula", "name_q": "4-Nitro-1,1'-biphenyl", "name_a": "C12H9NO2"} +{"id": 20548, "instruction": "Obaberineの別の呼び方は?", "response": "Obaberineの別の呼び方はオバベリンです。", "task": "replace", "name_q": "Obaberine", "name_a": "オバベリン"} +{"id": 19478, "instruction": "dTDP-3-amino-2,3,6-trideoxy-C-methyl-D-erythro-hexopyranos-4-uloseをは化学構造で表すと?", "response": "dTDP-3-amino-2,3,6-trideoxy-C-methyl-D-erythro-hexopyranos-4-uloseをは化学構造で表すとC17H27N3O13P2です。", "task": "formula", "name_q": "dTDP-3-amino-2,3,6-trideoxy-C-methyl-D-erythro-hexopyranos-4-ulose", "name_a": "C17H27N3O13P2"} +{"id": 30429, "instruction": "cis-Dihydroquercetinをの化学式は?", "response": "cis-Dihydroquercetinをの化学式はC15H12O7です。", "task": "formula", "name_q": "cis-Dihydroquercetin", "name_a": "C15H12O7"} +{"id": 9841, "instruction": "L-2-Amino-4-(hydroxymethylphosphinyl)butanoateの別記述は?", "response": "L-2-Amino-4-(hydroxymethylphosphinyl)butanoateの別記述はL-Glufosinateです。", "task": "replace", "name_q": "L-2-Amino-4-(hydroxymethylphosphinyl)butanoate", "name_a": "L-Glufosinate"} +{"id": 15659, "instruction": "アスパルチルグルコサミン尿症 上位グループ 糖タンパク分解反応異常症 ライソゾーム病 (リソソーム蓄積症) を英語で記述すると?", "response": "アスパルチルグルコサミン尿症 上位グループ 糖タンパク分解反応異常症 ライソゾーム病 (リソソーム蓄積症) を英語で記述するとAspartylglucosaminuria SUPERGRP Glycoproteinoses Lysosomal storage disease です。", "task": "replace ja to en", "name_q": "アスパルチルグルコサミン尿症 上位グループ 糖タンパク分解反応異常症 ライソゾーム病 (リソソーム蓄積症) ", "name_a": "Aspartylglucosaminuria SUPERGRP Glycoproteinoses Lysosomal storage disease "} +{"id": 3536, "instruction": "臭化メチルヒヨスチアミン (JAN)の英語表記は?", "response": "臭化メチルヒヨスチアミン (JAN)の英語表記はHyoscyamine methylbromide (JAN)です。", "task": "replace ja to en", "name_q": "臭化メチルヒヨスチアミン (JAN)", "name_a": "Hyoscyamine methylbromide (JAN)"} +{"id": 4126, "instruction": "Glycerophosphoric acidの異なる名称は?", "response": "Glycerophosphoric acidの異なる名称はsn-Glycerol 3-phosphateです。", "task": "replace", "name_q": "Glycerophosphoric acid", "name_a": "sn-Glycerol 3-phosphate"} +{"id": 17527, "instruction": "Sjogren syndromeの日本語表記は?", "response": "Sjogren syndromeの日本語表記はシェーグレン症候群です。", "task": "replace en to ja", "name_q": "Sjogren syndrome", "name_a": "シェーグレン症候群"} +{"id": 4663, "instruction": "4',6-Dihydroxy-5,7-dimethoxyflavanoneをの化学構造は?", "response": "4',6-Dihydroxy-5,7-dimethoxyflavanoneをの化学構造はC17H16O6です。", "task": "formula", "name_q": "4',6-Dihydroxy-5,7-dimethoxyflavanone", "name_a": "C17H16O6"} +{"id": 6248, "instruction": "N-Acyl-L-amino acidをの組成式は?", "response": "N-Acyl-L-amino acidをの組成式はC3H3NO3R2です。", "task": "formula", "name_q": "N-Acyl-L-amino acid", "name_a": "C3H3NO3R2"} +{"id": 7305, "instruction": "Nicotinic acid (JP18/INN)を英語で記述すると?", "response": "Nicotinic acid (JP18/INN)を英語で記述するとNiaspan (TN)です。", "task": "replace ja to en", "name_q": "Nicotinic acid (JP18/INN)", "name_a": "Niaspan (TN)"} +{"id": 32737, "instruction": "Xantheneをを化学構造で表すと?", "response": "Xantheneをを化学構造で表すとC13H10Oです。", "task": "formula", "name_q": "Xanthene", "name_a": "C13H10O"} +{"id": 17067, "instruction": "UDP-N-acetyl-6-deoxy-alpha-D-glucosamineの別名称は?", "response": "UDP-N-acetyl-6-deoxy-alpha-D-glucosamineの別名称はUDP-D-QuiNAcです。", "task": "replace", "name_q": "UDP-N-acetyl-6-deoxy-alpha-D-glucosamine", "name_a": "UDP-D-QuiNAc"} +{"id": 5172, "instruction": "Dipivefrinをを分子式で表すと?", "response": "Dipivefrinをを分子式で表すとC19H29NO5です。", "task": "formula", "name_q": "Dipivefrin", "name_a": "C19H29NO5"} +{"id": 27652, "instruction": "Iproplatin (USAN/INN)をを化学式で表すと?", "response": "Iproplatin (USAN/INN)をを化学式で表すと(C3H9N)2. Pt. 2Cl. 2OHです。", "task": "formula", "name_q": "Iproplatin (USAN/INN)", "name_a": "(C3H9N)2. Pt. 2Cl. 2OH"} +{"id": 24980, "instruction": "alpha-Ketopimelateをを分子式で記述すると?", "response": "alpha-Ketopimelateをを分子式で記述するとC7H10O5です。", "task": "formula", "name_q": "alpha-Ketopimelate", "name_a": "C7H10O5"} +{"id": 32648, "instruction": "Antibiotic PS 5をを組成式で書くと?", "response": "Antibiotic PS 5をを組成式で書くとC13H18N2O4Sです。", "task": "formula", "name_q": "Antibiotic PS 5", "name_a": "C13H18N2O4S"} +{"id": 2217, "instruction": "ベツリンをを化学式で書くと?", "response": "ベツリンをを化学式で書くとC30H50O2です。", "task": "formula", "name_q": "ベツリン", "name_a": "C30H50O2"} +{"id": 3012, "instruction": "Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanineをを化学構造で表すと?", "response": "Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanineをを化学構造で表すとC86H143N7O21P2です。", "task": "formula", "name_q": "Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine", "name_a": "C86H143N7O21P2"} +{"id": 7871, "instruction": "家族性複合型高脂血症 上位グループ 脂質異常症 を英語表記で表すと?", "response": "家族性複合型高脂血症 上位グループ 脂質異常症 を英語表記で表すとFamilial combined hyperlipidemia SUPERGRP Hyperlipidemia です。", "task": "replace ja to en", "name_q": "家族性複合型高脂血症 上位グループ 脂質異常症 ", "name_a": "Familial combined hyperlipidemia SUPERGRP Hyperlipidemia "} +{"id": 34466, "instruction": "Parastremmatic dysplasiaの異なる表現は?", "response": "Parastremmatic dysplasiaの異なる表現はParastremmatic dwarfismです。", "task": "replace", "name_q": "Parastremmatic dysplasia", "name_a": "Parastremmatic dwarfism"} +{"id": 12732, "instruction": "Celgosivir hydrochloride (USAN)をの化学構造は?", "response": "Celgosivir hydrochloride (USAN)をの化学構造はC12H21NO5. HClです。", "task": "formula", "name_q": "Celgosivir hydrochloride (USAN)", "name_a": "C12H21NO5. HCl"} +{"id": 21130, "instruction": "Zelicapavir (USAN/INN)をを分子式で表すと?", "response": "Zelicapavir (USAN/INN)をを分子式で表すとC27H22F3N7O3です。", "task": "formula", "name_q": "Zelicapavir (USAN/INN)", "name_a": "C27H22F3N7O3"} +{"id": 21348, "instruction": "2,3-Butanedioneをを化学構造で記述すると?", "response": "2,3-Butanedioneをを化学構造で記述するとC4H6O2です。", "task": "formula", "name_q": "2,3-Butanedione", "name_a": "C4H6O2"} +{"id": 15562, "instruction": "Coagulation factor XIIaの別の言い方は?", "response": "Coagulation factor XIIaの別の言い方は凝固第XIIa因子です。", "task": "replace", "name_q": "Coagulation factor XIIa", "name_a": "凝固第XIIa因子"} +{"id": 21864, "instruction": "Asini corii collasを英語表記で表すと?", "response": "Asini corii collasを英語表記で表すとGelatin (TN)です。", "task": "replace ja to en", "name_q": "Asini corii collas", "name_a": "Gelatin (TN)"} +{"id": 15812, "instruction": "5-Dehydro-4-deoxy-D-glucarateの別の言い方��?", "response": "5-Dehydro-4-deoxy-D-glucarateの別の言い方は(2R,3S)-2,3-Dihydroxy-5-oxohexanedioateです。", "task": "replace", "name_q": "5-Dehydro-4-deoxy-D-glucarate", "name_a": "(2R,3S)-2,3-Dihydroxy-5-oxohexanedioate"} +{"id": 28089, "instruction": "ドキソフィリンを言い換えると?", "response": "ドキソフィリンを言い換えるとDoxofylline (USAN/INN)です。", "task": "replace", "name_q": "ドキソフィリン", "name_a": "Doxofylline (USAN/INN)"} +{"id": 20490, "instruction": "Tilsotolimod sodium (USAN)をの化学式は?", "response": "Tilsotolimod sodium (USAN)をの化学式はC223H262N74O115P22S22Na22です。", "task": "formula", "name_q": "Tilsotolimod sodium (USAN)", "name_a": "C223H262N74O115P22S22Na22"} +{"id": 5925, "instruction": "Cyanidin 5-O-glucosideをを分子式で表すと?", "response": "Cyanidin 5-O-glucosideをを分子式で表すとC21H21O11です。", "task": "formula", "name_q": "Cyanidin 5-O-glucoside", "name_a": "C21H21O11"} +{"id": 25247, "instruction": "alpha-D-Glucosyl-(1,3)-D-mannoseをは組成式で表すと?", "response": "alpha-D-Glucosyl-(1,3)-D-mannoseをは組成式で表すとC12H22O11です。", "task": "formula", "name_q": "alpha-D-Glucosyl-(1,3)-D-mannose", "name_a": "C12H22O11"} +{"id": 1379, "instruction": "アメリカ先住民ミオパチーの英訳は?", "response": "アメリカ先住民ミオパチーの英訳はNative American myopathy SUPERGRP Congenital myopathy です。", "task": "replace ja to en", "name_q": "アメリカ先住民ミオパチー", "name_a": "Native American myopathy SUPERGRP Congenital myopathy "} +{"id": 14375, "instruction": "Megalencephaly-capillary malformation syndromeの異なる表現は?", "response": "Megalencephaly-capillary malformation syndromeの異なる表現はMCAP syndromeです。", "task": "replace", "name_q": "Megalencephaly-capillary malformation syndrome", "name_a": "MCAP syndrome"} +{"id": 11800, "instruction": "エンドリソンを英語で書くと?", "response": "エンドリソンを英語で書くとEndrysone (USAN/INN)です。", "task": "replace ja to en", "name_q": "エンドリソン", "name_a": "Endrysone (USAN/INN)"} +{"id": 22327, "instruction": "コバミドをは分子式で表すと?", "response": "コバミドをは分子式で表すとC53H79CoN11O14P(R1)(R2)です。", "task": "formula", "name_q": "コバミド", "name_a": "C53H79CoN11O14P(R1)(R2)"} +{"id": 18001, "instruction": "Cyfluthrin (BAN)の別記述は?", "response": "Cyfluthrin (BAN)の別記述はCylence (TN)です。", "task": "replace", "name_q": "Cyfluthrin (BAN)", "name_a": "Cylence (TN)"} +{"id": 32832, "instruction": "Hycanthone (USAN/INN)の異なる名称は?", "response": "Hycanthone (USAN/INN)の異なる名称はヒカントンです。", "task": "replace", "name_q": "Hycanthone (USAN/INN)", "name_a": "ヒカントン"} +{"id": 7958, "instruction": "Limoneneを日本語表記で表すと?", "response": "Limoneneを日本語表記で表すとd-リモネン (JAN)です。", "task": "replace en to ja", "name_q": "Limonene", "name_a": "d-リモネン (JAN)"} +{"id": 25606, "instruction": "1,6-Dimethylnaphthaleneをを組成式で記述すると?", "response": "1,6-Dimethylnaphthaleneをを組成式で記述するとC12H12です。", "task": "formula", "name_q": "1,6-Dimethylnaphthalene", "name_a": "C12H12"} +{"id": 12575, "instruction": "(5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoateの別記述は?", "response": "(5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoateの別記述は15-Keto-prostaglandin E2です。", "task": "replace", "name_q": "(5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoate", "name_a": "15-Keto-prostaglandin E2"} +{"id": 10111, "instruction": "Trachelanthamidineの別表現は?", "response": "Trachelanthamidineの別表現はトラケランタミジンです。", "task": "replace", "name_q": "Trachelanthamidine", "name_a": "トラケランタミジン"} +{"id": 30344, "instruction": "Ditekiren (USAN)をを組成式で書くと?", "response": "Ditekiren (USAN)をを組成式で書くとC50H75N9O8です。", "task": "formula", "name_q": "Ditekiren (USAN)", "name_a": "C50H75N9O8"} +{"id": 13285, "instruction": "レパリキシンをを化学構造で記述すると?", "response": "レパリキシンをを化学構造で記述するとC14H21NO3Sです。", "task": "formula", "name_q": "レパリキシン", "name_a": "C14H21NO3S"} +{"id": 32766, "instruction": "Clocapramine dihydrochlorideをを分子式で表すと?", "response": "Clocapramine dihydrochlorideをを分子式で表すとC28H37ClN4O. 2HClです。", "task": "formula", "name_q": "Clocapramine dihydrochloride", "name_a": "C28H37ClN4O. 2HCl"} +{"id": 1746, "instruction": "20-COOH-Leukotriene B4をを分子式で書くと?", "response": "20-COOH-Leukotriene B4をを分子式で書くとC20H30O6です。", "task": "formula", "name_q": "20-COOH-Leukotriene B4", "name_a": "C20H30O6"} +{"id": 14291, "instruction": "Chlorobacteneをを分子式で記述すると?", "response": "Chlorobacteneをを分子式で記述す��とC40H52です。", "task": "formula", "name_q": "Chlorobactene", "name_a": "C40H52"} +{"id": 22260, "instruction": "Bleph (TN)を材料とする薬品は?", "response": "Bleph (TN)を材料とする薬品はGENERICSODIUMSULFACETAMIDE(OceansidePharmaceuticals)です。", "task": "product", "name_q": "Bleph (TN)", "name_a": "GENERICSODIUMSULFACETAMIDE(OceansidePharmaceuticals)"} +{"id": 24097, "instruction": "(5Z,8Z,12E,14Z)-(11R)-Hydroperoxyicosa-5,8,12,14-tetraenoic acidをの分子式は?", "response": "(5Z,8Z,12E,14Z)-(11R)-Hydroperoxyicosa-5,8,12,14-tetraenoic acidをの分子式はC20H32O4です。", "task": "formula", "name_q": "(5Z,8Z,12E,14Z)-(11R)-Hydroperoxyicosa-5,8,12,14-tetraenoic acid", "name_a": "C20H32O4"} +{"id": 25448, "instruction": "[Protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serineの異なる名称は?", "response": "[Protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serineの異なる名称は3-beta-D-Glucuronosyl-3-beta-D-galactosyl-4-beta-D-galactosyl-O-beta-D-xylosylproteinです。", "task": "replace", "name_q": "[Protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine", "name_a": "3-beta-D-Glucuronosyl-3-beta-D-galactosyl-4-beta-D-galactosyl-O-beta-D-xylosylprotein"} +{"id": 19498, "instruction": "Dolicholをの分子式は?", "response": "Dolicholをの分子式はC20H36O(C5H8)nです。", "task": "formula", "name_q": "Dolichol", "name_a": "C20H36O(C5H8)n"} +{"id": 8233, "instruction": "Silomat (TN)を日本語で書くと?", "response": "Silomat (TN)を日本語で書くとClobutinol Hydrochloride (JAN)です。", "task": "replace en to ja", "name_q": "Silomat (TN)", "name_a": "Clobutinol Hydrochloride (JAN)"} +{"id": 3229, "instruction": "2-Hydroxy-6-ketononatrienedioateをを化学式で書くと?", "response": "2-Hydroxy-6-ketononatrienedioateをを化学式で書くとC9H8O6です。", "task": "formula", "name_q": "2-Hydroxy-6-ketononatrienedioate", "name_a": "C9H8O6"} +{"id": 31797, "instruction": "GENERICLEVOTHYROXINESODIUM(MAIAPharmaceuticals)を主材料とする商品は?", "response": "GENERICLEVOTHYROXINESODIUM(MAIAPharmaceuticals)を主材料とする商品はLEVOTHYROXINESODIUM(SagentPharmaceuticals)です。", "task": "product", "name_q": "GENERICLEVOTHYROXINESODIUM(MAIAPharmaceuticals)", "name_a": "LEVOTHYROXINESODIUM(SagentPharmaceuticals)"} +{"id": 29702, "instruction": "5-[1-(2-Furanyl)-2-(5-nitro-2-furanyl)ethenyl]-1,3,4-oxadiazol-2-amineの異なる表記は?", "response": "5-[1-(2-Furanyl)-2-(5-nitro-2-furanyl)ethenyl]-1,3,4-oxadiazol-2-amineの異なる表記はNF 161です。", "task": "replace", "name_q": "5-[1-(2-Furanyl)-2-(5-nitro-2-furanyl)ethenyl]-1,3,4-oxadiazol-2-amine", "name_a": "NF 161"} +{"id": 20090, "instruction": "ナバゼニルの異なる表現は?", "response": "ナバゼニルの異なる表現はNabazenil (USAN/INN)です。", "task": "replace", "name_q": "ナバゼニル", "name_a": "Nabazenil (USAN/INN)"} +{"id": 1289, "instruction": "2alpha-Methyl-5alpha-androstane-3,17-dioneをは化学式で表すと?", "response": "2alpha-Methyl-5alpha-androstane-3,17-dioneをは化学式で表すとC20H30O2です。", "task": "formula", "name_q": "2alpha-Methyl-5alpha-androstane-3,17-dione", "name_a": "C20H30O2"} +{"id": 19667, "instruction": "Aprotinin, thrombin and human fibrinogenの別表現は?", "response": "Aprotinin, thrombin and human fibrinogenの別表現はアプロチニン・トロンビン・ヒトフィブリノゲンです。", "task": "replace", "name_q": "Aprotinin, thrombin and human fibrinogen", "name_a": "アプロチニン・トロンビン・ヒトフィブリノゲン"} +{"id": 15845, "instruction": "Mefenidil fumarate (USAN)をを化学構造で書くと?", "response": "Mefenidil fumarate (USAN)をを化学構造で書くとC12H11N3. C4H4O4です。", "task": "formula", "name_q": "Mefenidil fumarate (USAN)", "name_a": "C12H11N3. C4H4O4"} +{"id": 18331, "instruction": "Treprostinil palmitil (USAN/INN)をを組成式で表すと?", "response": "Treprostinil palmitil (USAN/INN)をを組成式で表すとC39H66O5です。", "task": "formula", "name_q": "Treprostinil palmitil (USAN/INN)", "name_a": "C39H66O5"} +{"id": 24166, "instruction": "Alangicineの異なる表記は?", "response": "Alangicineの異なる表記はアランギシンです。", "task": "replace", "name_q": "Alangicine", "name_a": "アランギシン"} +{"id": 3271, "instruction": "スベリン酸の別呼称は?", "response": "スベリン酸の別呼称はSuberic acidです。", "task": "replace", "name_q": "スベリン酸", "name_a": "Suberic acid"} +{"id": 7203, "instruction": "オイルオレンジSSをの組成式は?", "response": "オイルオレンジSSをの組成式はC17H14N2Oです。", "task": "formula", "name_q": "オイルオレンジSS", "name_a": "C17H14N2O"} +{"id": 30929, "instruction": "Neltependocel (INN)は別の呼び方では?", "response": "Neltependocel (INN)は別の呼び方ではVyznova (TN)です。", "task": "replace", "name_q": "Neltependocel (INN)", "name_a": "Vyznova (TN)"} +{"id": 12148, "instruction": "VLCAD deficiencyの日本語訳は?", "response": "VLCAD deficiencyの日本語訳はVLCAD 欠損症です。", "task": "replace en to ja", "name_q": "VLCAD deficiency", "name_a": "VLCAD 欠損症"} +{"id": 32344, "instruction": "Craniotubular dysplasia, Ikegawa typeを日本語表記で表すと?", "response": "Craniotubular dysplasia, Ikegawa typeを日本語表記で表すとIkegawa 型頭蓋管状骨異形成症です。", "task": "replace en to ja", "name_q": "Craniotubular dysplasia, Ikegawa type", "name_a": "Ikegawa 型頭蓋管状骨異形成症"} +{"id": 16309, "instruction": "Rugosalをは化学式で表すと?", "response": "Rugosalをは化学式で表すとC15H22O4です。", "task": "formula", "name_q": "Rugosal", "name_a": "C15H22O4"} +{"id": 2179, "instruction": "1,2,3,4-Tetrachlorodibenzodioxinの別名称は?", "response": "1,2,3,4-Tetrachlorodibenzodioxinの別名称は1,2,3,4-Tetrachlorodibenzo-p-dioxinです。", "task": "replace", "name_q": "1,2,3,4-Tetrachlorodibenzodioxin", "name_a": "1,2,3,4-Tetrachlorodibenzo-p-dioxin"} +{"id": 15720, "instruction": "Telacebec (USAN/INN)の別の言い方は?", "response": "Telacebec (USAN/INN)の別の言い方はテラセベクです。", "task": "replace", "name_q": "Telacebec (USAN/INN)", "name_a": "テラセベク"} +{"id": 33705, "instruction": "テルラキレンをを組成式で表すと?", "response": "テルラキレンをを組成式で表すとC31H48N4O7Sです。", "task": "formula", "name_q": "テルラキレン", "name_a": "C31H48N4O7S"} +{"id": 11487, "instruction": "ロバチレリン水和物 (JAN)の異なる名称は?", "response": "ロバチレリン水和物 (JAN)の異なる名称はRovatirelin trihydrateです。", "task": "replace", "name_q": "ロバチレリン水和物 (JAN)", "name_a": "Rovatirelin trihydrate"} +{"id": 17849, "instruction": "Vulgaxanthin-IIをは組成式で表すと?", "response": "Vulgaxanthin-IIをは組成式で表すとC14H16N2O8です。", "task": "formula", "name_q": "Vulgaxanthin-II", "name_a": "C14H16N2O8"} +{"id": 17539, "instruction": "Sulfasuxidine (TN)をを化学式で記述すると?", "response": "Sulfasuxidine (TN)をを化学式で記述するとC13H13N3O5S2. H2Oです。", "task": "formula", "name_q": "Sulfasuxidine (TN)", "name_a": "C13H13N3O5S2. H2O"} +{"id": 19933, "instruction": "サンソウニン(ツムラ)を用いた医薬品は?", "response": "サンソウニン(ツムラ)を用いた医薬品はサンソウニン(ウチダ和漢薬)です。", "task": "product", "name_q": "サンソウニン(ツムラ)", "name_a": "サンソウニン(ウチダ和漢薬)"} +{"id": 23188, "instruction": "ツペチニブを言い換えると?", "response": "ツペチニブを言い換えるとTuspetinib (USAN/INN)です。", "task": "replace", "name_q": "ツペチニブ", "name_a": "Tuspetinib (USAN/INN)"} +{"id": 10554, "instruction": "Cousin 症候群の別名称は?", "response": "Cousin 症候群の別名称は肩甲骨骨盤異形成です。", "task": "replace", "name_q": "Cousin 症候群", "name_a": "肩甲骨骨盤異形成"} +{"id": 30984, "instruction": "[eIF5A-precursor]-lysineの別呼称は?", "response": "[eIF5A-precursor]-lysineの別呼称は[enzyme]-lysineです。", "task": "replace", "name_q": "[eIF5A-precursor]-lysine", "name_a": "[enzyme]-lysine"} +{"id": 2249, "instruction": "Alveolar soft part sarcoma SUPERGRP Solid tumor Soft tissue sarcomas を日本語に訳すと?", "response": "Alveolar soft part sarcoma SUPERGRP Solid tumor Soft tissue sarcomas を日本語に訳すと胞巣状軟部肉腫 上位グループ 固形腫瘍 軟部肉腫 です。", "task": "replace en to ja", "name_q": "Alveolar soft part sarcoma SUPERGRP Solid tumor Soft tissue sarcomas ", "name_a": "胞巣状軟部肉腫 上位グループ 固形腫瘍 軟部肉腫 "} +{"id": 12067, "instruction": "Quinpirole hydrochloride (USAN)をは化学式で表すと?", "response": "Quinpirole hydrochloride (USAN)をは化学式で表すとC13H21N3. HClです。", "task": "formula", "name_q": "Quinpirole hydrochloride (USAN)", "name_a": "C13H21N3. HCl"} +{"id": 23454, "instruction": "1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamideをを化学式で書くと?", "response": "1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamideをを化学式で書くとC11H16N2O5です。", "task": "formula", "name_q": "1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamide", "name_a": "C11H16N2O5"} +{"id": 28741, "instruction": "Trulicity (TN)の日本語表記は?", "response": "Trulicity (TN)の日本語表記はデュラグルチド (遺伝子組換え) (JAN)です。", "task": "replace en to ja", "name_q": "Trulicity (TN)", "name_a": "デュラグルチド (遺伝子組換え) (JAN)"} +{"id": 8322, "instruction": "Maleimideの別表現は?", "response": "Maleimideの別表現は2,5-Pyrroledioneです。", "task": "replace", "name_q": "Maleimide", "name_a": "2,5-Pyrroledione"} +{"id": 19780, "instruction": "Poly[(1->4)-beta-D-glucuronosyl-(1->4)-N-sulfo-alpha-D-glucosaminyl]をを化学構造で記述すると?", "response": "Poly[(1->4)-beta-D-glucuronosyl-(1->4)-N-sulfo-alpha-D-glucosaminyl]をを化学構造で記述するとC12H19NO14SR2です。", "task": "formula", "name_q": "Poly[(1->4)-beta-D-glucuronosyl-(1->4)-N-sulfo-alpha-D-glucosaminyl]", "name_a": "C12H19NO14SR2"} +{"id": 27780, "instruction": "エピジヒドロコレステリン (JAN)を英語で記述すると?", "response": "エピジヒドロコレステリン (JAN)を英語で記述するとEpidihydrocholesterin (JAN)です。", "task": "replace ja to en", "name_q": "エピジヒドロコレステリン (JAN)", "name_a": "Epidihydrocholesterin (JAN)"} +{"id": 1322, "instruction": "ロットレリンをは化学構造で表すと?", "response": "ロットレリンをは化学構造で表すとC30H28O8です。", "task": "formula", "name_q": "ロットレリン", "name_a": "C30H28O8"} +{"id": 12756, "instruction": "Carbetocinをの組成式は?", "response": "Carbetocinをの組成式はC45H69N11O12Sです。", "task": "formula", "name_q": "Carbetocin", "name_a": "C45H69N11O12S"} +{"id": 25052, "instruction": "Brexanolone (USAN/INN)をを分子式で表すと?", "response": "Brexanolone (USAN/INN)をを分子式で表すとC21H34O2です。", "task": "formula", "name_q": "Brexanolone (USAN/INN)", "name_a": "C21H34O2"} +{"id": 17155, "instruction": "Hydrocotarnine hydrochlorideをを化学式で書くと?", "response": "Hydrocotarnine hydrochlorideをを化学式で書くとC12H15NO3. HClです。", "task": "formula", "name_q": "Hydrocotarnine hydrochloride", "name_a": "C12H15NO3. HCl"} +{"id": 5643, "instruction": "Dimethamineをを化学構造で表すと?", "response": "Dimethamineをを化学構造で表すとC24H32N4O2です。", "task": "formula", "name_q": "Dimethamine", "name_a": "C24H32N4O2"} +{"id": 17579, "instruction": "シンバスタチン・シタグリプチンリン酸塩の英訳は?", "response": "シンバスタチン・シタグリプチンリン酸塩の英訳はSimvastatin and sitagliptin phosphateです。", "task": "replace ja to en", "name_q": "シンバスタチン・シタグリプチンリン酸塩", "name_a": "Simvastatin and sitagliptin phosphate"} +{"id": 4440, "instruction": "Cilmostim (USAN/INN)をを組成式で表すと?", "response": "Cilmostim (USAN/INN)をを組成式で表すとC2198H3424N588O704S28です。", "task": "formula", "name_q": "Cilmostim (USAN/INN)", "name_a": "C2198H3424N588O704S28"} +{"id": 1367, "instruction": "Nucleoside 3',5'-bisphosphateをを化学構造で記述すると?", "response": "Nucleoside 3',5'-bisphosphateをを化学構造で記述するとC5H11O10P2Rです。", "task": "formula", "name_q": "Nucleoside 3',5'-bisphosphate", "name_a": "C5H11O10P2R"} +{"id": 5188, "instruction": "Panic disorderを日本語に訳すと?", "response": "Panic disorderを日本語に訳すとパニック障害です。", "task": "replace en to ja", "name_q": "Panic disorder", "name_a": "パニック障害"} +{"id": 1807, "instruction": "Phenazepamの異なる表記は?", "response": "Phenazepamの異なる表記は7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-oneです。", "task": "replace", "name_q": "Phenazepam", "name_a": "7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one"} +{"id": 15129, "instruction": "Metaraminol bitartrate (JAN/USP)の異なる表記は?", "response": "Metaraminol bitartrate (JAN/USP)の異なる表記はAramine (TN)です。", "task": "replace", "name_q": "Metaraminol bitartrate (JAN/USP)", "name_a": "Aramine (TN)"} +{"id": 2292, "instruction": "レクスジェンルーセル-Tの英訳は?", "response": "レクスジェンルーセル-Tの英訳はLexgenleucel-T (USAN)です。", "task": "replace ja to en", "name_q": "レクスジェンルーセル-T", "name_a": "Lexgenleucel-T (USAN)"} +{"id": 7416, "instruction": "Fluvalinateをを分子式で表すと?", "response": "Fluvalinateをを分子式で表すとC26H22ClF3N2O3です。", "task": "formula", "name_q": "Fluvalinate", "name_a": "C26H22ClF3N2O3"} +{"id": 27911, "instruction": "Bacitracin methylenedisalicylate (USP)を日本語に訳すと?", "response": "Bacitracin methylenedisalicylate (USP)を日本語に訳すとバシトラシンメチレンジサリチル酸塩です。", "task": "replace en to ja", "name_q": "Bacitracin methylenedisalicylate (USP)", "name_a": "バシトラシンメチレンジサリチル酸塩"} +{"id": 30499, "instruction": "10beta-Hydroxy-6beta-isobutyrylfuranoeremophilaneをを分子式で記述すると?", "response": "10beta-Hydroxy-6beta-isobutyrylfuranoeremophilaneをを分子式で記述するとC19H28O4です。", "task": "formula", "name_q": "10beta-Hydroxy-6beta-isobutyrylfuranoeremophilane", "name_a": "C19H28O4"} +{"id": 1869, "instruction": "3-Isopropyl-3-butenoic acidをの分子式は?", "response": "3-Isopropyl-3-butenoic acidをの分子式はC7H12O2です。", "task": "formula", "name_q": "3-Isopropyl-3-butenoic acid", "name_a": "C7H12O2"} +{"id": 24115, "instruction": "Avelumab (USAN/INN)の日本語表記は?", "response": "Avelumab (USAN/INN)の日本語表記はAvelumab (genetical recombination) (JAN)です。", "task": "replace en to ja", "name_q": "Avelumab (USAN/INN)", "name_a": "Avelumab (genetical recombination) (JAN)"} +{"id": 29227, "instruction": "Neurotic disorderを日本語に訳すと?", "response": "Neurotic disorderを日本語に訳すとノイローゼです。", "task": "replace en to ja", "name_q": "Neurotic disorder", "name_a": "ノイローゼ"} +{"id": 1492, "instruction": "バルニジピン塩酸塩 (JAN)を使用した製品は?", "response": "バルニジピン塩酸塩 (JAN)を使用した製品はヒポカ(LTLファーマ)です。", "task": "product", "name_q": "バルニジピン塩酸塩 (JAN)", "name_a": "ヒポカ(LTLファーマ)"} +{"id": 19922, "instruction": "先天性脊椎骨端異形成 下位グループ 脊椎骨端異形成 Stanescu 型 上位グループ II 型コラーゲン異常症 脊椎骨端異形成 を英語で書くと?", "response": "先天性脊椎骨端異形成 下位グループ 脊椎骨端異形成 Stanescu 型 上位グループ II 型コラーゲン異常症 脊椎骨端異形成 を英語で書くとSpondyloepiphyseal dysplasia congenita SUBGROUP Spondyloepiphyseal dysplasia, Stanescu type SUPERGRP Type II collagenopathies Spondyloepiphyseal dysplasia です。", "task": "replace ja to en", "name_q": "先天性脊椎骨端異形成 下位グループ 脊椎骨端異形成 Stanescu 型 上位グループ II 型コラーゲン異常症 脊椎骨端異形成 ", "name_a": "Spondyloepiphyseal dysplasia congenita SUBGROUP Spondyloepiphyseal dysplasia, Stanescu type SUPERGRP Type II collagenopathies Spondyloepiphyseal dysplasia "} +{"id": 10698, "instruction": "Tulathromycin (JAN/USAN/INN)の別の呼び方は?", "response": "Tulathromycin (JAN/USAN/INN)の別の呼び方はツラスロマイシン (JAN)です。", "task": "replace", "name_q": "Tulathromycin (JAN/USAN/INN)", "name_a": "ツラスロマイシン (JAN)"} +{"id": 33281, "instruction": "Cytalux (TN)をを組成式で表すと?", "response": "Cytalux (TN)をを組成式で表すとC61H63N9O17S4. 4Naです。", "task": "formula", "name_q": "Cytalux (TN)", "name_a": "C61H63N9O17S4. 4Na"} +{"id": 29314, "instruction": "Citronellalの別の言い方は?", "response": "Citronellalの別の言い方はシトロネラールです。", "task": "replace", "name_q": "Citronellal", "name_a": "シトロネラール"} +{"id": 13915, "instruction": "Homoamino acidをを組成式で記述すると?", "response": "Homoamino acidをを組成式で記述するとC3H6NO2Rです。", "task": "formula", "name_q": "Homoamino acid", "name_a": "C3H6NO2R"} +{"id": 13931, "instruction": "Cloethocarbをは化学構造で表すと?", "response": "Cloethocarbをは化学構造で表すとC11H14ClNO4です。", "task": "formula", "name_q": "Cloethocarb", "name_a": "C11H14ClNO4"} +{"id": 17809, "instruction": "(9Z)-Tetradecenoic acidの別名は?", "response": "(9Z)-Tetradecenoic acidの別名はMyristoleic acidです。", "task": "replace", "name_q": "(9Z)-Tetradecenoic acid", "name_a": "Myristoleic acid"} +{"id": 16647, "instruction": "Pantoprazoleを言い換えると?", "response": "Pantoprazoleを言い換えるとパントプラゾールです。", "task": "replace", "name_q": "Pantoprazole", "name_a": "パントプラゾール"} +{"id": 23254, "instruction": "Methyl sulfateは別の呼び方では?", "response": "Methyl sulfateは別の呼び方ではMonomethyl sulfateです。", "task": "replace", "name_q": "Methyl sulfate", "name_a": "Monomethyl sulfate"} +{"id": 29251, "instruction": "L-2-Amino-6-oxoheptanedioateをを分子式で書くと?", "response": "L-2-Amino-6-oxoheptanedioateをを分子式で書くとC7H11NO5です。", "task": "formula", "name_q": "L-2-Amino-6-oxoheptanedioate", "name_a": "C7H11NO5"} +{"id": 22972, "instruction": "D-Glucosideをを組成式で書くと?", "response": "D-Glucosideをを組成式で書くとC6H11O6Rです。", "task": "formula", "name_q": "D-Glucoside", "name_a": "C6H11O6R"} +{"id": 21521, "instruction": "4-(Ethylamino)-2-hydroxy-6-(isopropylamino)-1,3,5-triazineをを分子式で記述すると?", "response": "4-(Ethylamino)-2-hydroxy-6-(isopropylamino)-1,3,5-triazineをを分子式で記述するとC8H15N5Oです。", "task": "formula", "name_q": "4-(Ethylamino)-2-hydroxy-6-(isopropylamino)-1,3,5-triazine", "name_a": "C8H15N5O"} +{"id": 6787, "instruction": "パナミンの別名称は?", "response": "パナミンの別名称はPanamineです。", "task": "replace", "name_q": "パナミン", "name_a": "Panamine"} +{"id": 33242, "instruction": "Methycaine hydrochloride (TN)の日本語訳は?", "response": "Methycaine hydrochloride (TN)の日本語訳はピペロカイン塩酸塩です。", "task": "replace en to ja", "name_q": "Methycaine hydrochloride (TN)", "name_a": "ピペロカイン塩酸塩"} +{"id": 2095, "instruction": "Loxapineをを分子式で書くと?", "response": "Loxapineをを分子式で書くとC18H18ClN3Oです。", "task": "formula", "name_q": "Loxapine", "name_a": "C18H18ClN3O"} +{"id": 15074, "instruction": "BUDESONIDE(TevaPharmaceuticalsUSA)を材料とする商品は?", "response": "BUDESONIDE(TevaPharmaceuticalsUSA)を材料とする商品は(GoldenStateMedicalSupply)です。", "task": "product", "name_q": "BUDESONIDE(TevaPharmaceuticalsUSA)", "name_a": "(GoldenStateMedicalSupply)"} +{"id": 18707, "instruction": "ACETYLCYSTEINE(ONESOURCESPECIALTYPHARMALIMITED)を利用した製品は?", "response": "ACETYLCYSTEINE(ONESOURCESPECIALTYPHARMALIMITED)を利用した製品はACETYLCYSTEINE(AmericanRegent)です。", "task": "product", "name_q": "ACETYLCYSTEINE(ONESOURCESPECIALTYPHARMALIMITED)", "name_a": "ACETYLCYSTEINE(AmericanRegent)"} +{"id": 2009, "instruction": "AppppAをの化学式は?", "response": "AppppAをの化学式はC20H28N10O19P4です。", "task": "formula", "name_q": "AppppA", "name_a": "C20H28N10O19P4"} +{"id": 5403, "instruction": "Ritipenem acoxil hydrate (JAN) 略語 RIPMをを分子式で書くと?", "response": "Ritipenem acoxil hydrate (JAN) 略語 RIPMをを分子式で書くとC13H16N2O8S. H2Oです。", "task": "formula", "name_q": "Ritipenem acoxil hydrate (JAN) 略語 RIPM", "name_a": "C13H16N2O8S. H2O"} +{"id": 13224, "instruction": "7,8-Dihydro-7,8-dihydroxykynurenateをの分子式は?", "response": "7,8-Dihydro-7,8-dihydroxykynurenateをの分子式はC10H9NO5です。", "task": "formula", "name_q": "7,8-Dihydro-7,8-dihydroxykynurenate", "name_a": "C10H9NO5"} +{"id": 1595, "instruction": "2,6-Dihydroxypseudooxynicotineをを化学式で書くと?", "response": "2,6-Dihydroxypseudooxynicotineをを化学式で書くとC10H14N2O3です。", "task": "formula", "name_q": "2,6-Dihydroxypseudooxynicotine", "name_a": "C10H14N2O3"} +{"id": 5583, "instruction": "Ifetroban sodium (USAN)の異なる表現は?", "response": "Ifetroban sodium (USAN)の異なる表現はイフェトロバンナトリウムです。", "task": "replace", "name_q": "Ifetroban sodium (USAN)", "name_a": "イフェトロバンナトリウム"} +{"id": 23351, "instruction": "Byakangelicolをを化学構造で表すと?", "response": "Byakangelicolをを化学構造で表すとC17H16O6です。", "task": "formula", "name_q": "Byakangelicol", "name_a": "C17H16O6"} +{"id": 27140, "instruction": "ラミオシドの別の言い方は?", "response": "ラミオシドの別の言い方はLamiosideです。", "task": "replace", "name_q": "ラミオシド", "name_a": "Lamioside"} +{"id": 27737, "instruction": "(8E,10S,12Z)-10-Hydroperoxyoctadeca-8,12-dienoateをの化学構造は?", "response": "(8E,10S,12Z)-10-Hydroperoxyoctadeca-8,12-dienoateをの化学構造はC18H32O4です。", "task": "formula", "name_q": "(8E,10S,12Z)-10-Hydroperoxyoctadeca-8,12-dienoate", "name_a": "C18H32O4"} +{"id": 34029, "instruction": "臭化メチルホマトロピンをの化学構造は?", "response": "臭化メチルホマトロピンをの化学構造はC17H24NO3. Brです。", "task": "formula", "name_q": "臭化メチルホマトロピン", "name_a": "C17H24NO3. Br"} +{"id": 3836, "instruction": "ジエタジンをを化学構造で表すと?", "response": "ジエタジンをを化学構造で表すとC18H22N2Sです。", "task": "formula", "name_q": "ジエタジン", "name_a": "C18H22N2S"} +{"id": 31997, "instruction": "Relenopride (USAN/INN)をを化学式で書くと?", "response": "Relenopride (USAN/INN)をを化学式で書くとC24H30ClFN4O4です。", "task": "formula", "name_q": "Relenopride (USAN/INN)", "name_a": "C24H30ClFN4O4"} +{"id": 11853, "instruction": "Penicillin V benzathine (USP)を日本語で記述すると?", "response": "Penicillin V benzathine (USP)を日本語で記述するとペニシリンVベンザチンです。", "task": "replace en to ja", "name_q": "Penicillin V benzathine (USP)", "name_a": "ペニシリンVベンザチン"} +{"id": 19740, "instruction": "パルマリンの別記述は?", "response": "パルマリンの別記述はPalmarinです。", "task": "replace", "name_q": "パルマリン", "name_a": "Palmarin"} +{"id": 17219, "instruction": "ジドロバルトラートをを化学式で記述すると?", "response": "ジドロバルトラートをを化学式で記述するとC22H32O8です。", "task": "formula", "name_q": "ジドロバルトラート", "name_a": "C22H32O8"} +{"id": 2244, "instruction": "7-メトキシプラジミシノンIIをは化学構造で表すと?", "response": "7-メトキシプラジミシノンIIをは化学構造で表すとC29H25NO12です。", "task": "formula", "name_q": "7-メトキシプラジミシノンII", "name_a": "C29H25NO12"} +{"id": 4496, "instruction": "Phenylhydrazineの異なる名称は?", "response": "Phenylhydrazineの異なる名称はPhenyldiazaneです。", "task": "replace", "name_q": "Phenylhydrazine", "name_a": "Phenyldiazane"} +{"id": 14681, "instruction": "後発品アメジニウムメチル硫酸塩(扶桑薬品工業)をを化学式で記述すると?", "response": "後発品アメジニウムメチル硫酸塩(扶桑薬品工業)をを化学式で記述するとC11H12N3O. CH3SO4です。", "task": "formula", "name_q": "後発品アメジニウムメチル硫酸塩(扶桑薬品工業)", "name_a": "C11H12N3O. CH3SO4"} +{"id": 2878, "instruction": "Brachyolmia SUBGROUP Autosomal dominant brachyolmia Spondyloepiphyseal dysplasia, Pakistani type の日本語表記は?", "response": "Brachyolmia SUBGROUP Autosomal dominant brachyolmia Spondyloepiphyseal dysplasia, Pakistani type の日本語表記は短体幹症 下位グループ 常染色体優性型短体幹症 Pakistani 型脊椎骨幹端異形成症 です。", "task": "replace en to ja", "name_q": "Brachyolmia SUBGROUP Autosomal dominant brachyolmia Spondyloepiphyseal dysplasia, Pakistani type ", "name_a": "短体幹症 下位グループ 常染色体優性型短体幹症 Pakistani 型脊椎骨幹端異形成症 "} +{"id": 21102, "instruction": "Hasubanonineをを分子式で記述すると?", "response": "Hasubanonineをを分子式で記述するとC21H27NO5です。", "task": "formula", "name_q": "Hasubanonine", "name_a": "C21H27NO5"} +{"id": 27353, "instruction": "アプリシンをは化学式で表すと?", "response": "アプリシンをは化学式で表すとC15H19BrOです。", "task": "formula", "name_q": "アプリシン", "name_a": "C15H19BrO"} +{"id": 18690, "instruction": "アーミッシュ小児てんかん症候群の英語表記は?", "response": "アーミッシュ小児てんかん症候群の英語表記はAmish infantile epilepsy syndromeです。", "task": "replace ja to en", "name_q": "アーミッシュ小児てんかん症候群", "name_a": "Amish infantile epilepsy syndrome"} +{"id": 3389, "instruction": "3'-デオキシジヒドロストレプトマイシン 3''-リン酸をを化学式で記述すると?", "response": "3'-デオキシジヒドロストレプトマイシン 3''-リン酸をを化学式で記述するとC21H42N7O14Pです。", "task": "formula", "name_q": "3'-デオキシジヒドロストレプトマイシン 3''-リン酸", "name_a": "C21H42N7O14P"} +{"id": 22143, "instruction": "C22H26N2O4S. HClを用いた商品名は?", "response": "C22H26N2O4S. HClを用いた商品名は後発品ジルチアゼム塩酸塩(佐藤薬品工業)です。", "task": "product", "name_q": "C22H26N2O4S. HCl", "name_a": "後発品ジルチアゼム塩酸塩(佐藤薬品工業)"} +{"id": 3176, "instruction": "5'-Nucleotideを言い換えると?", "response": "5'-Nucleotideを言い換えると5'-Phosphomononucleotideです。", "task": "replace", "name_q": "5'-Nucleotide", "name_a": "5'-Phosphomononucleotide"} +{"id": 10944, "instruction": "Onfasprodil (USAN/INN)をを化学式で書くと?", "response": "Onfasprodil (USAN/INN)をを化学式で書くとC20H23FN2O3です。", "task": "formula", "name_q": "Onfasprodil (USAN/INN)", "name_a": "C20H23FN2O3"} +{"id": 28173, "instruction": "Bemnifosbuvir (USAN)をを分子式で記述すると?", "response": "Bemnifosbuvir (USAN)をを分子式で記述するとC24H33FN7O7Pです。", "task": "formula", "name_q": "Bemnifosbuvir (USAN)", "name_a": "C24H33FN7O7P"} +{"id": 24688, "instruction": "メタクレゾールをを分子式で表すと?", "response": "メタクレゾールをを分子式で表すとC7H8Oです。", "task": "formula", "name_q": "メタクレゾール", "name_a": "C7H8O"} +{"id": 4195, "instruction": "C8-HSLの異なる名称は?", "response": "C8-HSLの異なる名称はN-Octanoyl-L-homoserine lactoneです。", "task": "replace", "name_q": "C8-HSL", "name_a": "N-Octanoyl-L-homoserine lactone"} +{"id": 8819, "instruction": "Metrizoate sodium (USAN)をを分子式で表すと?", "response": "Metrizoate sodium (USAN)をを分子式で表すとC12H10I3N2O4. Naです。", "task": "formula", "name_q": "Metrizoate sodium (USAN)", "name_a": "C12H10I3N2O4. Na"} +{"id": 23136, "instruction": "Clavam-2-carboxylateをを化学式で表すと?", "response": "Clavam-2-carboxylateをを化学式で表すとC6H7NO4です。", "task": "formula", "name_q": "Clavam-2-carboxylate", "name_a": "C6H7NO4"} +{"id": 12367, "instruction": "l-イソプレナリン塩酸塩 (JP18)をを化学構造で表すと?", "response": "l-イソプレナリン塩酸塩 (JP18)をを化学構造で表すとC11H17NO3. HClです。", "task": "formula", "name_q": "l-イソプレナリン塩酸塩 (JP18)", "name_a": "C11H17NO3. HCl"} +{"id": 9599, "instruction": "Ointment, rose water (USP)の別名称は?", "response": "Ointment, rose water (USP)の別名称はローズ水軟膏です。", "task": "replace", "name_q": "Ointment, rose water (USP)", "name_a": "ローズ水軟膏"} +{"id": 9764, "instruction": "Norathyriolの異なる表現は?", "response": "Norathyriolの異なる表現は1,3,6,7-Tetrahydroxyxanthoneです。", "task": "replace", "name_q": "Norathyriol", "name_a": "1,3,6,7-Tetrahydroxyxanthone"} +{"id": 33198, "instruction": "Astrocasineをを組成式で書くと?", "response": "Astrocasineをを組成式で書くとC20H26N2Oです。", "task": "formula", "name_q": "Astrocasine", "name_a": "C20H26N2O"} +{"id": 30316, "instruction": "Nalmefene hydrochlorideを主材��とする薬品は?", "response": "Nalmefene hydrochlorideを主材料とする薬品はNALMEFENEHYDROCHLORIDE(PurduePharmaL.P.)です。", "task": "product", "name_q": "Nalmefene hydrochloride", "name_a": "NALMEFENEHYDROCHLORIDE(PurduePharmaL.P.)"} +{"id": 32912, "instruction": "Resiniferonolをを化学式で表すと?", "response": "Resiniferonolをを化学式で表すとC20H28O6です。", "task": "formula", "name_q": "Resiniferonol", "name_a": "C20H28O6"} +{"id": 1883, "instruction": "2-(2-Oxo-1,3-dihydroindol-3-yl)acetateの別の言い方は?", "response": "2-(2-Oxo-1,3-dihydroindol-3-yl)acetateの別の言い方は2-Indolinone-3-acetateです。", "task": "replace", "name_q": "2-(2-Oxo-1,3-dihydroindol-3-yl)acetate", "name_a": "2-Indolinone-3-acetate"} +{"id": 30048, "instruction": "脳・肋骨・下顎症候群の英語表記は?", "response": "脳・肋骨・下顎症候群の英語表記はCerebrocostomandibular syndromeです。", "task": "replace ja to en", "name_q": "脳・肋骨・下顎症候群", "name_a": "Cerebrocostomandibular syndrome"} +{"id": 13271, "instruction": "アレカタンニン B2の別の呼び方は?", "response": "アレカタンニン B2の別の呼び方はArecatannin B2です。", "task": "replace", "name_q": "アレカタンニン B2", "name_a": "Arecatannin B2"} +{"id": 26312, "instruction": "Tikujyoを主とした薬品名は?", "response": "Tikujyoを主とした薬品名はチクジョ(栃本天海堂)です。", "task": "product", "name_q": "Tikujyo", "name_a": "チクジョ(栃本天海堂)"} +{"id": 16032, "instruction": "Miraxanthin-IIをを分子式で書くと?", "response": "Miraxanthin-IIをを分子式で書くとC13H14N2O8です。", "task": "formula", "name_q": "Miraxanthin-II", "name_a": "C13H14N2O8"} +{"id": 4990, "instruction": "Carmellose sodium (JP18)をを化学構造で表すと?", "response": "Carmellose sodium (JP18)をを化学構造で表すとC6H12O6. C2H3O2. Naです。", "task": "formula", "name_q": "Carmellose sodium (JP18)", "name_a": "C6H12O6. C2H3O2. Na"} +{"id": 32183, "instruction": "Dibenzepin hydrochloride (JAN/USAN)をを分子式で記述すると?", "response": "Dibenzepin hydrochloride (JAN/USAN)をを分子式で記述するとC18H21N3O. HClです。", "task": "formula", "name_q": "Dibenzepin hydrochloride (JAN/USAN)", "name_a": "C18H21N3O. HCl"} +{"id": 10068, "instruction": "Norzine (TN)をの組成式は?", "response": "Norzine (TN)をの組成式はC22H29N3S2. (C4H4O4)2です。", "task": "formula", "name_q": "Norzine (TN)", "name_a": "C22H29N3S2. (C4H4O4)2"} +{"id": 16135, "instruction": "カンタキサンチンをを組成式で記述すると?", "response": "カンタキサンチンをを組成式で記述するとC40H52O2です。", "task": "formula", "name_q": "カンタキサンチン", "name_a": "C40H52O2"} +{"id": 15617, "instruction": "Thyrotropin alfa (genetical recombination) (JAN)を主とした医薬品名は?", "response": "Thyrotropin alfa (genetical recombination) (JAN)を主とした医薬品名はTHYROGEN(GenzymeCorporation)です。", "task": "product", "name_q": "Thyrotropin alfa (genetical recombination) (JAN)", "name_a": "THYROGEN(GenzymeCorporation)"} +{"id": 31721, "instruction": "L-Mimosineの異なる名称は?", "response": "L-Mimosineの異なる名称はL-ミモシンです。", "task": "replace", "name_q": "L-Mimosine", "name_a": "L-ミモシン"} +{"id": 29731, "instruction": "Vatinoxan (USAN)を日本語で記述すると?", "response": "Vatinoxan (USAN)を日本語で記述するとバチノキサンです。", "task": "replace en to ja", "name_q": "Vatinoxan (USAN)", "name_a": "バチノキサン"} +{"id": 27364, "instruction": "epsilon-Rhodomycinoneを言い換えると?", "response": "epsilon-Rhodomycinoneを言い換えるとRhodomycinoneです。", "task": "replace", "name_q": "epsilon-Rhodomycinone", "name_a": "Rhodomycinone"} +{"id": 8154, "instruction": "Tripelennamine (INN)をを化学構造で表すと?", "response": "Tripelennamine (INN)をを化学構造で表すとC16H21N3です。", "task": "formula", "name_q": "Tripelennamine (INN)", "name_a": "C16H21N3"} +{"id": 31987, "instruction": "多中心性手根足根骨溶解症症候群の英訳は?", "response": "多中心性手根足根骨溶解症症候群の英訳はMulticentric carpotarsal osteolysis syndromeです。", "task": "replace ja to en", "name_q": "多中心性手根足根骨溶解症症候群", "name_a": "Multicentric carpotarsal osteolysis syndrome"} +{"id": 18115, "instruction": "Pheniramine (INN)をを組成式で表すと?", "response": "Pheniramine (INN)をを組成式で表すとC16H20N2です。", "task": "formula", "name_q": "Pheniramine (INN)", "name_a": "C16H20N2"} +{"id": 8110, "instruction": "Lapirium chloride (INN)をを分子式で表すと?", "response": "Lapirium chloride (INN)をを分子式で表すとC21H35N2O3. Clです。", "task": "formula", "name_q": "Lapirium chloride (INN)", "name_a": "C21H35N2O3. Cl"} +{"id": 20460, "instruction": "Cellulose, oxidized regenerated (USP)の別の言い方は?", "response": "Cellulose, oxidized regenerated (USP)の別の言い方は再生酸化セルロースです。", "task": "replace", "name_q": "Cellulose, oxidized regenerated (USP)", "name_a": "再生酸化セルロース"} +{"id": 31058, "instruction": "Reverset (TN)をは化学構造で表すと?", "response": "Reverset (TN)をは化学構造で表すとC9H10FN3O3です。", "task": "formula", "name_q": "Reverset (TN)", "name_a": "C9H10FN3O3"} +{"id": 6468, "instruction": "Polatuzumab vedotin (USAN)の別名称は?", "response": "Polatuzumab vedotin (USAN)の別名称はポラツズマブベドチン (遺伝子組換え) (JAN)です。", "task": "replace", "name_q": "Polatuzumab vedotin (USAN)", "name_a": "ポラツズマブベドチン (遺伝子組換え) (JAN)"} +{"id": 1836, "instruction": "Syringetinをは分子式で表すと?", "response": "Syringetinをは分子式で表すとC17H14O8です。", "task": "formula", "name_q": "Syringetin", "name_a": "C17H14O8"} +{"id": 29666, "instruction": "Dopar (TN)を使用した製品は?", "response": "Dopar (TN)を使用した製品はINBRIJA(MerzPharmaceuticals)です。", "task": "product", "name_q": "Dopar (TN)", "name_a": "INBRIJA(MerzPharmaceuticals)"} +{"id": 20907, "instruction": "Central precocious puberty SUPERGRP Precocious puberty を日本語表記で表すと?", "response": "Central precocious puberty SUPERGRP Precocious puberty を日本語表記で表すと中枢性思春期早発症 上位グループ 思春期早発症 です。", "task": "replace en to ja", "name_q": "Central precocious puberty SUPERGRP Precocious puberty ", "name_a": "中枢性思春期早発症 上位グループ 思春期早発症 "} +{"id": 2265, "instruction": "GPI-anchor biosynthesis intermediate 5の別記述は?", "response": "GPI-anchor biosynthesis intermediate 5の別記述はC22967です。", "task": "replace", "name_q": "GPI-anchor biosynthesis intermediate 5", "name_a": "C22967"} +{"id": 17087, "instruction": "Paerucumarinをの分子式は?", "response": "Paerucumarinをの分子式はC10H5NO4です。", "task": "formula", "name_q": "Paerucumarin", "name_a": "C10H5NO4"} +{"id": 9713, "instruction": "オウレン・センナ・ダイオウ・酸化マグネシウム・硫酸マグネシウム水和物を英語表記で表すと?", "response": "オウレン・センナ・ダイオウ・酸化マグネシウム・硫酸マグネシウム水和物を英語表記で表すとCoptis rhizome, senna leaf, rhubarb, magnesium oxide and magnesium sulfate hydrateです。", "task": "replace ja to en", "name_q": "オウレン・センナ・ダイオウ・酸化マグネシウム・硫酸マグネシウム水和物", "name_a": "Coptis rhizome, senna leaf, rhubarb, magnesium oxide and magnesium sulfate hydrate"} +{"id": 3042, "instruction": "Indocin (TN)を利用した商品名は?", "response": "Indocin (TN)を利用した商品名はINDOMETHACIN(AmericanHealthPackaging)です。", "task": "product", "name_q": "Indocin (TN)", "name_a": "INDOMETHACIN(AmericanHealthPackaging)"} +{"id": 15986, "instruction": "Trametinib (USAN)をを化学式で表すと?", "response": "Trametinib (USAN)をを化学式で表すとC26H23FIN5O4です。", "task": "formula", "name_q": "Trametinib (USAN)", "name_a": "C26H23FIN5O4"} +{"id": 30632, "instruction": "Mercury(2+)をを化学式で表すと?", "response": "Mercury(2+)をを化学式で表すとHgです。", "task": "formula", "name_q": "Mercury(2+)", "name_a": "Hg"} +{"id": 9463, "instruction": "Dehydrated ethanolを材料とする医薬品名は?", "response": "Dehydrated ethanolを材料とする医薬品名は無水エタノール(丸石製薬)です。", "task": "product", "name_q": "Dehydrated ethanol", "name_a": "無水エタノール(丸石製薬)"} +{"id": 13818, "instruction": "6-Methylpretetramideをを化学構造で書くと?", "response": "6-Methylpretetramideをを化学構造で書くとC20H15NO6です。", "task": "formula", "name_q": "6-Methylpretetramide", "name_a": "C20H15NO6"} +{"id": 20808, "instruction": "ジュベニルホルモンIIIを言い換えると?", "response": "ジュベニルホルモンIIIを言い換えると幼若ホルモンIIIです。", "task": "replace", "name_q": "ジュベニルホルモンIII", "name_a": "幼若ホルモンIII"} +{"id": 13476, "instruction": "(2E)-Hexadecenoyl-[acp]を言い換えると?", "response": "(2E)-Hexadecenoyl-[acp]を言い換えるとtrans-Hexadec-2-enoyl-[acyl-carrier protein]です。", "task": "replace", "name_q": "(2E)-Hexadecenoyl-[acp]", "name_a": "trans-Hexadec-2-enoyl-[acyl-carrier protein]"} +{"id": 11436, "instruction": "AMPICILLINANDSULBACTAM(SagentPharmaceuticals)を材料とする医薬品は?", "response": "AMPICILLINANDSULBACTAM(SagentPharmaceuticals)を材料とする医薬品はユナシン−Sキット(ファイザー)です。", "task": "product", "name_q": "AMPICILLINANDSULBACTAM(SagentPharmaceuticals)", "name_a": "ユナシン−Sキット(ファイザー)"} +{"id": 33667, "instruction": "N-[(7,8-Dihydropterin-6-yl)methyl]-4-(beta-D-ribofuranosyl)aniline 5'-phosphateを���分子式で表すと?", "response": "N-[(7,8-Dihydropterin-6-yl)methyl]-4-(beta-D-ribofuranosyl)aniline 5'-phosphateをを分子式で表すとC18H23N6O8Pです。", "task": "formula", "name_q": "N-[(7,8-Dihydropterin-6-yl)methyl]-4-(beta-D-ribofuranosyl)aniline 5'-phosphate", "name_a": "C18H23N6O8P"} +{"id": 31498, "instruction": "Guanofuracin (TN)をは化学式で表すと?", "response": "Guanofuracin (TN)をは化学式で表すとC6H7N5O3. HClです。", "task": "formula", "name_q": "Guanofuracin (TN)", "name_a": "C6H7N5O3. HCl"} +{"id": 10710, "instruction": "セラパニンをは化学構造で表すと?", "response": "セラパニンをは化学構造で表すとC30H35NO10です。", "task": "formula", "name_q": "セラパニン", "name_a": "C30H35NO10"} +{"id": 9845, "instruction": "3-Formylsalicylic acidをを化学構造で記述すると?", "response": "3-Formylsalicylic acidをを化学構造で記述するとC8H6O4です。", "task": "formula", "name_q": "3-Formylsalicylic acid", "name_a": "C8H6O4"} +{"id": 11868, "instruction": "カルパインは別の呼び方では?", "response": "カルパインは別の呼び方ではCarpaineです。", "task": "replace", "name_q": "カルパイン", "name_a": "Carpaine"} +{"id": 16115, "instruction": "7-Chloro-L-tryptophanをを組成式で表すと?", "response": "7-Chloro-L-tryptophanをを組成式で表すとC11H11ClN2O2です。", "task": "formula", "name_q": "7-Chloro-L-tryptophan", "name_a": "C11H11ClN2O2"} +{"id": 24095, "instruction": "Imusay-131 (TN)を日本語で記述すると?", "response": "Imusay-131 (TN)を日本語で記述するとインスリン (I131)です。", "task": "replace en to ja", "name_q": "Imusay-131 (TN)", "name_a": "インスリン (I131)"} +{"id": 21843, "instruction": "シンメチリンの異なる表記は?", "response": "シンメチリンの異なる表記はCinmethylinです。", "task": "replace", "name_q": "シンメチリン", "name_a": "Cinmethylin"} +{"id": 18351, "instruction": "インターフェロンベータ (JAN)を主材料とする商品名は?", "response": "インターフェロンベータ (JAN)を主材料とする商品名はフエロン(東レ)です。", "task": "product", "name_q": "インターフェロンベータ (JAN)", "name_a": "フエロン(東レ)"} +{"id": 33464, "instruction": "アタザナビルをを化学式で表すと?", "response": "アタザナビルをを化学式で表すとC38H52N6O7です。", "task": "formula", "name_q": "アタザナビル", "name_a": "C38H52N6O7"} +{"id": 16388, "instruction": "オクタデカン酸は別の呼び方では?", "response": "オクタデカン酸は別の呼び方ではステアリン酸です。", "task": "replace", "name_q": "オクタデカン酸", "name_a": "ステアリン酸"} +{"id": 1847, "instruction": "精製白糖 (JP18)を英語で書くと?", "response": "精製白糖 (JP18)を英語で書くとSucrose (JP18/NF)です。", "task": "replace ja to en", "name_q": "精製白糖 (JP18)", "name_a": "Sucrose (JP18/NF)"} +{"id": 14238, "instruction": "高メチオニン血症 下位グループ メチオニンアデノシルトランスフェラーゼ欠損症 アデノシルホモシステイン加水分解酵素欠損症 グリシン-N-メチルトランスフェラーゼ欠損症 アデノシンキナーゼ欠損症を英語で書くと?", "response": "高メチオニン血症 下位グループ メチオニンアデノシルトランスフェラーゼ欠損症 アデノシルホモシステイン加水分解酵素欠損症 グリシン-N-メチルトランスフェラーゼ欠損症 アデノシンキナーゼ欠損症を英語で書くとHypermethioninemia SUBGROUP Methionine adenosyltransferase deficiency S-adenosylhomocysteine hydrolase deficiency Glycine N-methyltransferase deficiency Adenosine kinase deficiencyです。", "task": "replace ja to en", "name_q": "高メチオニン血症 下位グループ メチオニンアデノシルトランスフェラーゼ欠損症 アデノシルホモシステイン加水分解酵素欠損症 グリシン-N-メチルトランスフェラーゼ欠損症 アデノシンキナーゼ欠損症", "name_a": "Hypermethioninemia SUBGROUP Methionine adenosyltransferase deficiency S-adenosylhomocysteine hydrolase deficiency Glycine N-methyltransferase deficiency Adenosine kinase deficiency"} +{"id": 32816, "instruction": "アスピリン・アスコルビン酸を言い換えると?", "response": "アスピリン・アスコルビン酸を言い換えるとAspirin and ascorbic acidです。", "task": "replace", "name_q": "アスピリン・アスコルビン酸", "name_a": "Aspirin and ascorbic acid"} +{"id": 15673, "instruction": "レイノー症候群 下位グループ レイノー病 レイノー現象を英語表記で表すと?", "response": "レイノー症候群 下位グループ レイノー病 レイノー現象を英語表記で表すとRaynaud syndrome SUBGROUP Raynaud disease Raynaud phenomenonです。", "task": "replace ja to en", "name_q": "レイノー症候群 下位グル��プ レイノー病 レイノー現象", "name_a": "Raynaud syndrome SUBGROUP Raynaud disease Raynaud phenomenon"} +{"id": 32037, "instruction": "DCVCをを分子式で記述すると?", "response": "DCVCをを分子式で記述するとC5H7Cl2NO2Sです。", "task": "formula", "name_q": "DCVC", "name_a": "C5H7Cl2NO2S"} +{"id": 28193, "instruction": "イルソグラジンをの化学式は?", "response": "イルソグラジンをの化学式はC9H7Cl2N5です。", "task": "formula", "name_q": "イルソグラジン", "name_a": "C9H7Cl2N5"} +{"id": 6072, "instruction": "Leu-Gly-Proをを分子式で記述すると?", "response": "Leu-Gly-Proをを分子式で記述するとC13H23N3O4です。", "task": "formula", "name_q": "Leu-Gly-Pro", "name_a": "C13H23N3O4"} +{"id": 5915, "instruction": "Nigakilactone Lの別の呼び方は?", "response": "Nigakilactone Lの別の呼び方はニガキラクトンLです。", "task": "replace", "name_q": "Nigakilactone L", "name_a": "ニガキラクトンL"} +{"id": 17951, "instruction": "メシル酸アルミトリンを英語で書くと?", "response": "メシル酸アルミトリンを英語で書くとVectarion (TN)です。", "task": "replace ja to en", "name_q": "メシル酸アルミトリン", "name_a": "Vectarion (TN)"} +{"id": 3270, "instruction": "ビククリンをを分子式で書くと?", "response": "ビククリンをを分子式で書くとC20H17NO6です。", "task": "formula", "name_q": "ビククリン", "name_a": "C20H17NO6"} +{"id": 27201, "instruction": "Birk-Landau-Perez 症候群を英語で書くと?", "response": "Birk-Landau-Perez 症候群を英語で書くとBirk-Landau-Perez syndromeです。", "task": "replace ja to en", "name_q": "Birk-Landau-Perez 症候群", "name_a": "Birk-Landau-Perez syndrome"} +{"id": 29363, "instruction": "Methylcorrinoidをの組成式は?", "response": "Methylcorrinoidをの組成式はC20H3CoN4R21です。", "task": "formula", "name_q": "Methylcorrinoid", "name_a": "C20H3CoN4R21"} +{"id": 11747, "instruction": "L-Cysteinyl-proteinの別名は?", "response": "L-Cysteinyl-proteinの別名はL-Cysteinyl-[peptidyl-carrier protein]です。", "task": "replace", "name_q": "L-Cysteinyl-protein", "name_a": "L-Cysteinyl-[peptidyl-carrier protein]"} +{"id": 12662, "instruction": "L-Lactateの別記述は?", "response": "L-Lactateの別記述は(S)-Lactateです。", "task": "replace", "name_q": "L-Lactate", "name_a": "(S)-Lactate"} +{"id": 8992, "instruction": "Axenfeld-Rieger syndrome SUPERGRP Anterior segment dysgenesis の日本語訳は?", "response": "Axenfeld-Rieger syndrome SUPERGRP Anterior segment dysgenesis の日本語訳はAxenfeld–Rieger 症候群 上位グループ 前眼部形成異常 です。", "task": "replace en to ja", "name_q": "Axenfeld-Rieger syndrome SUPERGRP Anterior segment dysgenesis ", "name_a": "Axenfeld–Rieger 症候群 上位グループ 前眼部形成異常 "} +{"id": 28554, "instruction": "AZELAICACID(GlenmarkPharmaceuticals)を材料とする薬品名は?", "response": "AZELAICACID(GlenmarkPharmaceuticals)を材料とする薬品名はAZELEX(Almirall)です。", "task": "product", "name_q": "AZELAICACID(GlenmarkPharmaceuticals)", "name_a": "AZELEX(Almirall)"} +{"id": 8364, "instruction": "7alpha,12alpha-Dihydroxy-3-oxochol-24-oyl-CoAの別の呼び方は?", "response": "7alpha,12alpha-Dihydroxy-3-oxochol-24-oyl-CoAの別の呼び方は3-Oxocholoyl-CoAです。", "task": "replace", "name_q": "7alpha,12alpha-Dihydroxy-3-oxochol-24-oyl-CoA", "name_a": "3-Oxocholoyl-CoA"} +{"id": 10416, "instruction": "Narcobarbitalをは分子式で表すと?", "response": "Narcobarbitalをは分子式で表すとC11H15BrN2O3です。", "task": "formula", "name_q": "Narcobarbital", "name_a": "C11H15BrN2O3"} +{"id": 7652, "instruction": "DNA N4-methylcytosineをは組成式で表すと?", "response": "DNA N4-methylcytosineをは組成式で表すとC10H16N3O7P(C5H8O5PR)n(C5H8O5PR)nです。", "task": "formula", "name_q": "DNA N4-methylcytosine", "name_a": "C10H16N3O7P(C5H8O5PR)n(C5H8O5PR)n"} +{"id": 13055, "instruction": "Cardiac valvular dysplasia SUBGROUP Cardiac valvular defect, developmental (CVDD)を日本語に訳すと?", "response": "Cardiac valvular dysplasia SUBGROUP Cardiac valvular defect, developmental (CVDD)を日本語に訳すと心臓弁形成異常 下位グループ 心臓弁発生異常 (CVDD)です。", "task": "replace en to ja", "name_q": "Cardiac valvular dysplasia SUBGROUP Cardiac valvular defect, developmental (CVDD)", "name_a": "心臓弁形成異常 下位グループ 心臓弁発生異常 (CVDD)"} +{"id": 8761, "instruction": "Cefmatilen hydrochloride hydrate (JAN)をを組成式で表すと?", "response": "Cefmatilen hydrochloride hydrate (JAN)をを組成式で表すとC15H14N8O5S4. HCl. H2Oです。", "task": "formula", "name_q": "Cefmatilen hydrochloride hydrate (JAN)", "name_a": "C15H14N8O5S4. HCl. H2O"} +{"id": 27961, "instruction": "Poretti-Boltshauser 症候群の英語表記は?", "response": "Poretti-Boltshauser 症候群の英語表記はPoretti-Boltshauser syndromeです。", "task": "replace ja to en", "name_q": "Poretti-Boltshauser 症候群", "name_a": "Poretti-Boltshauser syndrome"} +{"id": 27482, "instruction": "(Z)-But-1-ene-1,2,4-tricarboxylateの異なる名称は?", "response": "(Z)-But-1-ene-1,2,4-tricarboxylateの異なる名称は(Z)-1,2,4-But-1-enetricarboxylic acidです。", "task": "replace", "name_q": "(Z)-But-1-ene-1,2,4-tricarboxylate", "name_a": "(Z)-1,2,4-But-1-enetricarboxylic acid"} +{"id": 14828, "instruction": "Phenylmethanolをは組成式で表すと?", "response": "Phenylmethanolをは組成式で表すとC7H8Oです。", "task": "formula", "name_q": "Phenylmethanol", "name_a": "C7H8O"} +{"id": 6543, "instruction": "Panvitan (TN)を材料とする製品は?", "response": "Panvitan (TN)を材料とする製品はパンビタン(武田テバ薬品)です。", "task": "product", "name_q": "Panvitan (TN)", "name_a": "パンビタン(武田テバ薬品)"} +{"id": 12050, "instruction": "アカメガシワエキス (Non-JPS)の英訳は?", "response": "アカメガシワエキス (Non-JPS)の英訳はMallotus bark extract (Non-JPS)です。", "task": "replace ja to en", "name_q": "アカメガシワエキス (Non-JPS)", "name_a": "Mallotus bark extract (Non-JPS)"} +{"id": 8310, "instruction": "L-ヒスチジン (JP18)を英語で記述すると?", "response": "L-ヒスチジン (JP18)を英語で記述するとHistidine (USP/INN)です。", "task": "replace ja to en", "name_q": "L-ヒスチジン (JP18)", "name_a": "Histidine (USP/INN)"} +{"id": 31443, "instruction": "エドデキンアルファの異なる表記は?", "response": "エドデキンアルファの異なる表記はEdodekin alfa (USAN/INN)です。", "task": "replace", "name_q": "エドデキンアルファ", "name_a": "Edodekin alfa (USAN/INN)"} +{"id": 11013, "instruction": "4-Sulfobenzyl alcoholを言い換えると?", "response": "4-Sulfobenzyl alcoholを言い換えると4-(Hydroxymethyl)benzenesulfonateです。", "task": "replace", "name_q": "4-Sulfobenzyl alcohol", "name_a": "4-(Hydroxymethyl)benzenesulfonate"} +{"id": 4149, "instruction": "Tyrosinemia SUBGROUP Tyrosinemia, type I Tyrosinemia, type II Tyrosinemia, type III Hawkinsinuriaを日本語で書くと?", "response": "Tyrosinemia SUBGROUP Tyrosinemia, type I Tyrosinemia, type II Tyrosinemia, type III Hawkinsinuriaを日本語で書くとチロシン血症 下位グループ チロシン血症 I 型 チロシン血症 II 型 チロシン血症 III 型 ホーキンシン尿症です。", "task": "replace en to ja", "name_q": "Tyrosinemia SUBGROUP Tyrosinemia, type I Tyrosinemia, type II Tyrosinemia, type III Hawkinsinuria", "name_a": "チロシン血症 下位グループ チロシン血症 I 型 チロシン血症 II 型 チロシン血症 III 型 ホーキンシン尿症"} +{"id": 18950, "instruction": "ミューバラプリンの別名称は?", "response": "ミューバラプリンの別名称はMuvalaplin (USAN)です。", "task": "replace", "name_q": "ミューバラプリン", "name_a": "Muvalaplin (USAN)"} +{"id": 12738, "instruction": "beta-Nicotinate D-ribonucleotideは別の呼び方では?", "response": "beta-Nicotinate D-ribonucleotideは別の呼び方ではNicotinic acid ribonucleotideです。", "task": "replace", "name_q": "beta-Nicotinate D-ribonucleotide", "name_a": "Nicotinic acid ribonucleotide"} +{"id": 4213, "instruction": "ブルンナー症候群の別の呼び方は?", "response": "ブルンナー症候群の別の呼び方はMAOA欠損症です。", "task": "replace", "name_q": "ブルンナー症候群", "name_a": "MAOA欠損症"} +{"id": 15001, "instruction": "C25H24N6O2を材料とする医薬品は?", "response": "C25H24N6O2を材料とする医薬品はIMBRUVICA(PharmacyclicsLLC)です。", "task": "product", "name_q": "C25H24N6O2", "name_a": "IMBRUVICA(PharmacyclicsLLC)"} +{"id": 10045, "instruction": "Relacatib (USAN/INN)をの組成式は?", "response": "Relacatib (USAN/INN)をの組成式はC27H32N4O6Sです。", "task": "formula", "name_q": "Relacatib (USAN/INN)", "name_a": "C27H32N4O6S"} +{"id": 5700, "instruction": "Cintramide (INN)を日本語で書くと?", "response": "Cintramide (INN)を日本語で書くとCintriamide (USAN)です。", "task": "replace en to ja", "name_q": "Cintramide (INN)", "name_a": "Cintriamide (USAN)"} +{"id": 33860, "instruction": "Friedreich ataxia SUPERGRP Spinocerebellar degeneration の日本語訳は?", "response": "Friedreich ataxia SUPERGRP Spinocerebellar degeneration の日本語訳はフリードライヒ運動失調症 上位グループ 脊髄小脳変性症 です。", "task": "replace en to ja", "name_q": "Friedreich ataxia SUPERGRP Spinocerebellar degeneration ", "name_a": "フリードライヒ運動失調症 上位グループ 脊髄小脳変性症 "} +{"id": 31050, "instruction": "Sulphuretinをを化学式で書くと?", "response": "Sulphuretinをを化学式で書くとC15H10O5です。", "task": "formula", "name_q": "Sulphuretin", "name_a": "C15H10O5"} +{"id": 7265, "instruction": "19-Hydroxycucurbitadienolをは化学式で��すと?", "response": "19-Hydroxycucurbitadienolをは化学式で表すとC30H50O2です。", "task": "formula", "name_q": "19-Hydroxycucurbitadienol", "name_a": "C30H50O2"} +{"id": 14860, "instruction": "イブプロフェンアルギニン塩の別呼称は?", "response": "イブプロフェンアルギニン塩の別呼称はIbuprofen arginine saltです。", "task": "replace", "name_q": "イブプロフェンアルギニン塩", "name_a": "Ibuprofen arginine salt"} +{"id": 12873, "instruction": "トラピジル (JP18)を使用した医薬品は?", "response": "トラピジル (JP18)を使用した医薬品は後発品トラピジル(日医工ファーマ)です。", "task": "product", "name_q": "トラピジル (JP18)", "name_a": "後発品トラピジル(日医工ファーマ)"} +{"id": 3729, "instruction": "Laureth 9 (USAN)をを化学構造で書くと?", "response": "Laureth 9 (USAN)をを化学構造で書くとC12H26O(C2H4O)nです。", "task": "formula", "name_q": "Laureth 9 (USAN)", "name_a": "C12H26O(C2H4O)n"} +{"id": 13787, "instruction": "(-)-エピガロカテキンをを組成式で書くと?", "response": "(-)-エピガロカテキンをを組成式で書くとC15H14O7です。", "task": "formula", "name_q": "(-)-エピガロカテキン", "name_a": "C15H14O7"} +{"id": 21771, "instruction": "(+)TAN-67をは分子式で表すと?", "response": "(+)TAN-67をは分子式で表すとC23H24N2Oです。", "task": "formula", "name_q": "(+)TAN-67", "name_a": "C23H24N2O"} +{"id": 15016, "instruction": "Acantholytic blistering of the oral and laryngeal mucosaを日本語で記述すると?", "response": "Acantholytic blistering of the oral and laryngeal mucosaを日本語で記述すると口腔咽頭粘膜の棘融解性水疱です。", "task": "replace en to ja", "name_q": "Acantholytic blistering of the oral and laryngeal mucosa", "name_a": "口腔咽頭粘膜の棘融解性水疱"} +{"id": 5070, "instruction": "Fluphenazineをは組成式で表すと?", "response": "Fluphenazineをは組成式で表すとC22H26F3N3OSです。", "task": "formula", "name_q": "Fluphenazine", "name_a": "C22H26F3N3OS"} +{"id": 4627, "instruction": "Poloxamer 188の異なる名称は?", "response": "Poloxamer 188の異なる名称はPolyoxyethylene (160) polyoxypropylene (30) glycolです。", "task": "replace", "name_q": "Poloxamer 188", "name_a": "Polyoxyethylene (160) polyoxypropylene (30) glycol"} +{"id": 27453, "instruction": "Choanal atresia and lymphedemaの日本語訳は?", "response": "Choanal atresia and lymphedemaの日本語訳は後鼻孔閉鎖症 および リンパ浮腫です。", "task": "replace en to ja", "name_q": "Choanal atresia and lymphedema", "name_a": "後鼻孔閉鎖症 および リンパ浮腫"} +{"id": 21458, "instruction": "Zynyz (TN)を主材料とする商品は?", "response": "Zynyz (TN)を主材料とする商品はZYNYZ(IncyteCorporation)です。", "task": "product", "name_q": "Zynyz (TN)", "name_a": "ZYNYZ(IncyteCorporation)"} +{"id": 19674, "instruction": "Quinomycin Aをの化学構造は?", "response": "Quinomycin Aをの化学構造はC51H64N12O12S2です。", "task": "formula", "name_q": "Quinomycin A", "name_a": "C51H64N12O12S2"} +{"id": 20378, "instruction": "alpha-D-Glutamyl phosphateをの化学式は?", "response": "alpha-D-Glutamyl phosphateをの化学式はC5H10NO7Pです。", "task": "formula", "name_q": "alpha-D-Glutamyl phosphate", "name_a": "C5H10NO7P"} +{"id": 5267, "instruction": "桂枝加朮附湯を用いた商品は?", "response": "桂枝加朮附湯を用いた商品は桂枝加朮附湯(ツムラ)です。", "task": "product", "name_q": "桂枝加朮附湯", "name_a": "桂枝加朮附湯(ツムラ)"} +{"id": 18423, "instruction": "4-Bromo-3,5-cyclohexadiene-1,2-dioneをを化学式で表すと?", "response": "4-Bromo-3,5-cyclohexadiene-1,2-dioneをを化学式で表すとC6H3BrO2です。", "task": "formula", "name_q": "4-Bromo-3,5-cyclohexadiene-1,2-dione", "name_a": "C6H3BrO2"} +{"id": 10863, "instruction": "UK 63598をを分子式で表すと?", "response": "UK 63598をを分子式で表すとC53H62N10O14S2です。", "task": "formula", "name_q": "UK 63598", "name_a": "C53H62N10O14S2"} +{"id": 24305, "instruction": "Menfegol (JAN/INN)をは化学構造で表すと?", "response": "Menfegol (JAN/INN)をは化学構造で表すとC16H24O(C2H4O)nです。", "task": "formula", "name_q": "Menfegol (JAN/INN)", "name_a": "C16H24O(C2H4O)n"} +{"id": 7450, "instruction": "Isohelenolをを化学式で書くと?", "response": "Isohelenolをを化学式で書くとC15H18O5です。", "task": "formula", "name_q": "Isohelenol", "name_a": "C15H18O5"} +{"id": 9402, "instruction": "Inherited thrombophiliaの別名は?", "response": "Inherited thrombophiliaの別名はThrombophilia due to thrombin defect (THPH) SUBGROUP Antithrombin III deficiency Congenital dysfibrinogenemia です。", "task": "replace", "name_q": "Inherited thrombophilia", "name_a": "Thrombophilia due to thrombin defect (THPH) SUBGROUP Antithrombin III deficiency Congenital dysfibrinogenemia "} +{"id": 19660, "instruction": "Ethyl methanesulfonateの異なる表現は?", "response": "Ethyl methanesulfonateの異なる表現はメタンスルホン酸エチルです。", "task": "replace", "name_q": "Ethyl methanesulfonate", "name_a": "メタンスルホン酸エチル"} +{"id": 11666, "instruction": "Posterior column ataxia with retinitis pigmentosaを日本語で書くと?", "response": "Posterior column ataxia with retinitis pigmentosaを日本語で書くと網膜色素変性症を伴う後索型失調症です。", "task": "replace en to ja", "name_q": "Posterior column ataxia with retinitis pigmentosa", "name_a": "網膜色素変性症を伴う後索型失調症"} +{"id": 5674, "instruction": "[Biotin carboxyl-carrier protein]-biotin-N6-L-lysineの別記述は?", "response": "[Biotin carboxyl-carrier protein]-biotin-N6-L-lysineの別記述は[Biotin carboxyl-carrier protein]-N6-biotinyl-L-lysineです。", "task": "replace", "name_q": "[Biotin carboxyl-carrier protein]-biotin-N6-L-lysine", "name_a": "[Biotin carboxyl-carrier protein]-N6-biotinyl-L-lysine"} +{"id": 4931, "instruction": "発作性激痛症の英語表記は?", "response": "発作性激痛症の英語表記はParoxysmal extreme pain disorderです。", "task": "replace ja to en", "name_q": "発作性激痛症", "name_a": "Paroxysmal extreme pain disorder"} +{"id": 30994, "instruction": "S-Glutathionyl-L-cysteineをを化学構造で書くと?", "response": "S-Glutathionyl-L-cysteineをを化学構造で書くとC13H22N4O8S2です。", "task": "formula", "name_q": "S-Glutathionyl-L-cysteine", "name_a": "C13H22N4O8S2"} +{"id": 26333, "instruction": "Arnicaは別の呼び方では?", "response": "Arnicaは別の呼び方ではアルニカです。", "task": "replace", "name_q": "Arnica", "name_a": "アルニカ"} +{"id": 10423, "instruction": "Diglucosyl-(2,3-dihydroxybenzoylserine)3をの化学式は?", "response": "Diglucosyl-(2,3-dihydroxybenzoylserine)3をの化学式はC42H49N3O26です。", "task": "formula", "name_q": "Diglucosyl-(2,3-dihydroxybenzoylserine)3", "name_a": "C42H49N3O26"} +{"id": 13733, "instruction": "Rutacridoneをを化学式で記述すると?", "response": "Rutacridoneをを化学式で記述するとC19H17NO3です。", "task": "formula", "name_q": "Rutacridone", "name_a": "C19H17NO3"} +{"id": 11718, "instruction": "NALOXONEHYDROCHLORIDE(HFAcquisitionCoLLC)を主とした商品名は?", "response": "NALOXONEHYDROCHLORIDE(HFAcquisitionCoLLC)を主とした商品名はNALOXONEHYDROCHLORIDE(FreseniusKabiUSA)です。", "task": "product", "name_q": "NALOXONEHYDROCHLORIDE(HFAcquisitionCoLLC)", "name_a": "NALOXONEHYDROCHLORIDE(FreseniusKabiUSA)"} +{"id": 18784, "instruction": "ニコチン酸ベータ-ブトキシエチル (JAN)をの化学式は?", "response": "ニコチン酸ベータ-ブトキシエチル (JAN)をの化学式はC12H17NO3です。", "task": "formula", "name_q": "ニコチン酸ベータ-ブトキシエチル (JAN)", "name_a": "C12H17NO3"} +{"id": 3892, "instruction": "ブルガダ症候群を英語表記で表すと?", "response": "ブルガダ症候群を英語表記で表すとBrugada syndromeです。", "task": "replace ja to en", "name_q": "ブルガダ症候群", "name_a": "Brugada syndrome"} +{"id": 12771, "instruction": "Jodfenphosをの化学式は?", "response": "Jodfenphosをの化学式はC8H8Cl2IO3PSです。", "task": "formula", "name_q": "Jodfenphos", "name_a": "C8H8Cl2IO3PS"} +{"id": 6983, "instruction": "5-Methyl-3-oxo-4-hexenoyl-CoAをを化学式で表すと?", "response": "5-Methyl-3-oxo-4-hexenoyl-CoAをを化学式で表すとC28H44N7O18P3Sです。", "task": "formula", "name_q": "5-Methyl-3-oxo-4-hexenoyl-CoA", "name_a": "C28H44N7O18P3S"} +{"id": 13469, "instruction": "Autoimmune hepatitisを日本語で記述すると?", "response": "Autoimmune hepatitisを日本語で記述すると自己免疫性肝炎です。", "task": "replace en to ja", "name_q": "Autoimmune hepatitis", "name_a": "自己免疫性肝炎"} +{"id": 29258, "instruction": "5-Methylthiopentanaldoximeをを化学構造で書くと?", "response": "5-Methylthiopentanaldoximeをを化学構造で書くとC6H13NOSです。", "task": "formula", "name_q": "5-Methylthiopentanaldoxime", "name_a": "C6H13NOS"} +{"id": 41, "instruction": "ジフェナジオンをは化学構造で表すと?", "response": "ジフェナジオンをは化学構造で表すとC23H16O3です。", "task": "formula", "name_q": "ジフェナジオン", "name_a": "C23H16O3"} +{"id": 33867, "instruction": "リビドマイシンAの別名称は?", "response": "リビドマイシンAの別名称はLividomycin Aです。", "task": "replace", "name_q": "リビドマイシンA", "name_a": "Lividomycin A"} +{"id": 8153, "instruction": "脊椎骨端異形成 Maroteaux 型の別の呼び方は?", "response": "脊椎骨端異形成 Maroteaux 型の別の呼び方は偽モルキオ症候群 2型 上位グループ 脊椎骨端異形成 です。", "task": "replace", "name_q": "脊椎骨端異形成 Maroteaux 型", "name_a": "偽モルキオ症候群 2型 上位グループ 脊椎���端異形成 "} +{"id": 8317, "instruction": "ケジラミ症を英語で記述すると?", "response": "ケジラミ症を英語で記述するとPhthiriasis pubisです。", "task": "replace ja to en", "name_q": "ケジラミ症", "name_a": "Phthiriasis pubis"} +{"id": 7752, "instruction": "酸性ホスファターゼ欠損症 上位グループ ライソゾーム病 (リソソーム蓄積症) の英訳は?", "response": "酸性ホスファターゼ欠損症 上位グループ ライソゾーム病 (リソソーム蓄積症) の英訳はAcid phosphatase deficiency SUPERGRP Lysosomal storage disease です。", "task": "replace ja to en", "name_q": "酸性ホスファターゼ欠損症 上位グループ ライソゾーム病 (リソソーム蓄積症) ", "name_a": "Acid phosphatase deficiency SUPERGRP Lysosomal storage disease "} +{"id": 6500, "instruction": "3,4-Dihydrocoumarinをを化学構造で記述すると?", "response": "3,4-Dihydrocoumarinをを化学構造で記述するとC9H8O2です。", "task": "formula", "name_q": "3,4-Dihydrocoumarin", "name_a": "C9H8O2"} +{"id": 427, "instruction": "3,5-Dichloro-4-hydroxyphenylpyruvateをを化学式で書くと?", "response": "3,5-Dichloro-4-hydroxyphenylpyruvateをを化学式で書くとC9H6Cl2O4です。", "task": "formula", "name_q": "3,5-Dichloro-4-hydroxyphenylpyruvate", "name_a": "C9H6Cl2O4"} +{"id": 9247, "instruction": "Isopentenyladenosine-5'-diphosphateの異なる表記は?", "response": "Isopentenyladenosine-5'-diphosphateの異なる表記はIsopentenyl-ADPです。", "task": "replace", "name_q": "Isopentenyladenosine-5'-diphosphate", "name_a": "Isopentenyl-ADP"} +{"id": 15386, "instruction": "Tasosartan (USAN/INN)をは化学構造で表すと?", "response": "Tasosartan (USAN/INN)をは化学構造で表すとC23H21N7Oです。", "task": "formula", "name_q": "Tasosartan (USAN/INN)", "name_a": "C23H21N7O"} +{"id": 447, "instruction": "Moxifloxacin hydrochloride monohydrateの別名称は?", "response": "Moxifloxacin hydrochloride monohydrateの別名称はモキシフロキサシン塩酸塩水和物です。", "task": "replace", "name_q": "Moxifloxacin hydrochloride monohydrate", "name_a": "モキシフロキサシン塩酸塩水和物"} +{"id": 19841, "instruction": "Lolitrem Bをは組成式で表すと?", "response": "Lolitrem Bをは組成式で表すとC42H55NO7です。", "task": "formula", "name_q": "Lolitrem B", "name_a": "C42H55NO7"} +{"id": 2246, "instruction": "Naropin (TN)を日本語で書くと?", "response": "Naropin (TN)を日本語で書くとロピバカインです。", "task": "replace en to ja", "name_q": "Naropin (TN)", "name_a": "ロピバカイン"} +{"id": 4193, "instruction": "ネオイソステガンの別表現は?", "response": "ネオイソステガンの別表現はNeoisosteganeです。", "task": "replace", "name_q": "ネオイソステガン", "name_a": "Neoisostegane"} +{"id": 29709, "instruction": "Crotonaldehydeは別の呼び方では?", "response": "Crotonaldehydeは別の呼び方ではクロトンアルデヒドです。", "task": "replace", "name_q": "Crotonaldehyde", "name_a": "クロトンアルデヒド"} +{"id": 14162, "instruction": "Intradine (TN)の別の呼び方は?", "response": "Intradine (TN)の別の呼び方はSulfadimidin (TN)です。", "task": "replace", "name_q": "Intradine (TN)", "name_a": "Sulfadimidin (TN)"} +{"id": 16292, "instruction": "10-デオキシメチノリドをを分子式で記述すると?", "response": "10-デオキシメチノリドをを分子式で記述するとC17H28O4です。", "task": "formula", "name_q": "10-デオキシメチノリド", "name_a": "C17H28O4"} +{"id": 16636, "instruction": "デルカンテルを英語表記で表すと?", "response": "デルカンテルを英語表記で表すとDerquantel (USAN/INN)です。", "task": "replace ja to en", "name_q": "デルカンテル", "name_a": "Derquantel (USAN/INN)"} +{"id": 5143, "instruction": "ベタキソロール塩酸塩(東和薬品)を材料とする医薬品名は?", "response": "ベタキソロール塩酸塩(東和薬品)を材料とする医薬品名はケルロング(チェプラファーム)です。", "task": "product", "name_q": "ベタキソロール塩酸塩(東和薬品)", "name_a": "ケルロング(チェプラファーム)"} +{"id": 23259, "instruction": "Edratide (USAN/INN)をを化学構造で表すと?", "response": "Edratide (USAN/INN)をを化学構造で表すとC111H149N27O28です。", "task": "formula", "name_q": "Edratide (USAN/INN)", "name_a": "C111H149N27O28"} +{"id": 11078, "instruction": "Glisoxepide (INN)をを分子式で表すと?", "response": "Glisoxepide (INN)をを分子式で表すとC20H27N5O5Sです。", "task": "formula", "name_q": "Glisoxepide (INN)", "name_a": "C20H27N5O5S"} +{"id": 27414, "instruction": "リン酸アンモニウムをを化学式で記述すると?", "response": "リン酸アンモニウムをを化学式で記述するとHPO4. 2NH4です。", "task": "formula", "name_q": "リン酸アンモニウム", "name_a": "HPO4. 2NH4"} +{"id": 474, "instruction": "トリロボリドを言い換えると?", "response": "トリロボリドを言い換えるとTrilobolideです。", "task": "replace", "name_q": "トリロボリド", "name_a": "Trilobolide"} +{"id": 12221, "instruction": "Pinocembrin chalconeをを化学式で表すと?", "response": "Pinocembrin chalconeをを化学式で表すとC15H12O4です。", "task": "formula", "name_q": "Pinocembrin chalcone", "name_a": "C15H12O4"} +{"id": 1792, "instruction": "Tiapamil hydrochloride (USAN)を日本語で書くと?", "response": "Tiapamil hydrochloride (USAN)を日本語で書くとチアパミル塩酸塩です。", "task": "replace en to ja", "name_q": "Tiapamil hydrochloride (USAN)", "name_a": "チアパミル塩酸塩"} +{"id": 24825, "instruction": "Wax, emulsifying (NF)の別記述は?", "response": "Wax, emulsifying (NF)の別記述は乳化ワックスです。", "task": "replace", "name_q": "Wax, emulsifying (NF)", "name_a": "乳化ワックス"} +{"id": 5595, "instruction": "パムレブルマブの異なる表現は?", "response": "パムレブルマブの異なる表現はPamrevlumab (USAN/INN)です。", "task": "replace", "name_q": "パムレブルマブ", "name_a": "Pamrevlumab (USAN/INN)"} +{"id": 18714, "instruction": "(4S)-31,4-Dihydroxy-L-isoleucineをを化学式で表すと?", "response": "(4S)-31,4-Dihydroxy-L-isoleucineをを化学式で表すとC6H13NO4です。", "task": "formula", "name_q": "(4S)-31,4-Dihydroxy-L-isoleucine", "name_a": "C6H13NO4"} +{"id": 15834, "instruction": "ELLA(A-SMedicationSolutions)を利用した商品名は?", "response": "ELLA(A-SMedicationSolutions)を利用した商品名はELLA(RPKPharmaceuticals)です。", "task": "product", "name_q": "ELLA(A-SMedicationSolutions)", "name_a": "ELLA(RPKPharmaceuticals)"} +{"id": 1491, "instruction": "Dihydrocodeine thiocyanateの異なる表記は?", "response": "Dihydrocodeine thiocyanateの異なる表記はParacodin (TN)です。", "task": "replace", "name_q": "Dihydrocodeine thiocyanate", "name_a": "Paracodin (TN)"} +{"id": 28208, "instruction": "7-Chlorodehydrotryptophanをを分子式で記述すると?", "response": "7-Chlorodehydrotryptophanをを分子式で記述するとC11H9ClN2O2です。", "task": "formula", "name_q": "7-Chlorodehydrotryptophan", "name_a": "C11H9ClN2O2"} +{"id": 4978, "instruction": "Flutroline (USAN/INN)をの化学構造は?", "response": "Flutroline (USAN/INN)をの化学構造はC27H25F3N2Oです。", "task": "formula", "name_q": "Flutroline (USAN/INN)", "name_a": "C27H25F3N2O"} +{"id": 33733, "instruction": "2-Hydroxy-3-chloropenta-2,4-dienoateをは化学構造で表すと?", "response": "2-Hydroxy-3-chloropenta-2,4-dienoateをは化学構造で表すとC5H5ClO3です。", "task": "formula", "name_q": "2-Hydroxy-3-chloropenta-2,4-dienoate", "name_a": "C5H5ClO3"} +{"id": 2792, "instruction": "Mosnodenvir (USAN/INN)をを組成式で表すと?", "response": "Mosnodenvir (USAN/INN)をを組成式で表すとC26H22ClF3N2O6Sです。", "task": "formula", "name_q": "Mosnodenvir (USAN/INN)", "name_a": "C26H22ClF3N2O6S"} +{"id": 25642, "instruction": "Camptothecinをの分子式は?", "response": "Camptothecinをの分子式はC20H16N2O4です。", "task": "formula", "name_q": "Camptothecin", "name_a": "C20H16N2O4"} +{"id": 10283, "instruction": "S-Octanoyl-L-cysteinyl-proteinをを分子式で表すと?", "response": "S-Octanoyl-L-cysteinyl-proteinをを分子式で表すとC11H20NO2SRです。", "task": "formula", "name_q": "S-Octanoyl-L-cysteinyl-protein", "name_a": "C11H20NO2SR"} +{"id": 14749, "instruction": "Sodium phenylacetate (JAN/USAN)をの分子式は?", "response": "Sodium phenylacetate (JAN/USAN)をの分子式はC8H7O2. Naです。", "task": "formula", "name_q": "Sodium phenylacetate (JAN/USAN)", "name_a": "C8H7O2. Na"} +{"id": 6950, "instruction": "17beta-Hydroxy-2-methyl-5alpha-androst-1-en-3-oneを言い換えると?", "response": "17beta-Hydroxy-2-methyl-5alpha-androst-1-en-3-oneを言い換えるとStenboloneです。", "task": "replace", "name_q": "17beta-Hydroxy-2-methyl-5alpha-androst-1-en-3-one", "name_a": "Stenbolone"} +{"id": 9886, "instruction": "MOPD IIを英語表記で表すと?", "response": "MOPD IIを英語表記で表すとMicrocephalic osteodysplastic primordial dwarfism, type II (MOPD II)です。", "task": "replace ja to en", "name_q": "MOPD II", "name_a": "Microcephalic osteodysplastic primordial dwarfism, type II (MOPD II)"} +{"id": 24839, "instruction": "Gibberellin 19の別記述は?", "response": "Gibberellin 19の別記述はGibberellin A19です。", "task": "replace", "name_q": "Gibberellin 19", "name_a": "Gibberellin A19"} +{"id": 15324, "instruction": "Tabalumab (genetical recombination) (JAN)の別の呼び方は?", "response": "Tabalumab (genetical recombination) (JAN)の別の呼び方はタバルマブ (遺伝子組換え) (JAN)です。", "task": "replace", "name_q": "Tabalumab (genetical recombination) (JAN)", "name_a": "タバルマブ (遺伝子組換え) (JAN)"} +{"id": 14866, "instruction": "Crovalimab-akkzを主とした商品は?", "response": "Crovalimab-akkzを主とした商品はピアスカイ(中外製薬)です。", "task": "product", "name_q": "Crovalimab-akkz", "name_a": "ピアスカイ(中外製薬)"} +{"id": 2061, "instruction": "Gamifant (TN)を使用した商品は?", "response": "Gamifant (TN)を使用した商品は)です。", "task": "product", "name_q": "Gamifant (TN)", "name_a": ")"} +{"id": 30727, "instruction": "Urispas (TN)を主材料とする製品は?", "response": "Urispas (TN)を主材料とする製品はDICYCLOMINEHYDROCHLORIDE(NuCarePharmaceuticals)です。", "task": "product", "name_q": "Urispas (TN)", "name_a": "DICYCLOMINEHYDROCHLORIDE(NuCarePharmaceuticals)"} +{"id": 9911, "instruction": "Schaaf-Yang 症候群 上位グループ プラダー・ウィリー症候群 男子性腺機能不全症 の英語表記は?", "response": "Schaaf-Yang 症候群 上位グループ プラダー・ウィリー症候群 男子性腺機能不全症 の英語表記はSchaaf-Yang syndrome SUPERGRP Prader-Willi syndrome Male hypogonadism です。", "task": "replace ja to en", "name_q": "Schaaf-Yang 症候群 上位グループ プラダー・ウィリー症候群 男子性腺機能不全症 ", "name_a": "Schaaf-Yang syndrome SUPERGRP Prader-Willi syndrome Male hypogonadism "} +{"id": 28816, "instruction": "2'-Deoxy-beta-L-cytidineの異なる表記は?", "response": "2'-Deoxy-beta-L-cytidineの異なる表記はL-dCです。", "task": "replace", "name_q": "2'-Deoxy-beta-L-cytidine", "name_a": "L-dC"} +{"id": 25510, "instruction": "パルテニンの別表現は?", "response": "パルテニンの別表現はPartheninです。", "task": "replace", "name_q": "パルテニン", "name_a": "Parthenin"} +{"id": 12366, "instruction": "Caffeoyl-CoAをを化学式で書くと?", "response": "Caffeoyl-CoAをを化学式で書くとC30H42N7O19P3Sです。", "task": "formula", "name_q": "Caffeoyl-CoA", "name_a": "C30H42N7O19P3S"} +{"id": 15557, "instruction": "Pinaverium bromide (INN)を日本語で書くと?", "response": "Pinaverium bromide (INN)を日本語で書くとピナベリウムブロミドです。", "task": "replace en to ja", "name_q": "Pinaverium bromide (INN)", "name_a": "ピナベリウムブロミド"} +{"id": 8133, "instruction": "11Z,14Z,17Z,20Z-Hexacosatetraenoic acidの別の呼び方は?", "response": "11Z,14Z,17Z,20Z-Hexacosatetraenoic acidの別の呼び方は(11Z,14Z,17Z,20Z)-Hexacosa-11,14,17,20-tetraenoic acidです。", "task": "replace", "name_q": "11Z,14Z,17Z,20Z-Hexacosatetraenoic acid", "name_a": "(11Z,14Z,17Z,20Z)-Hexacosa-11,14,17,20-tetraenoic acid"} +{"id": 9318, "instruction": "ゼラレノンは別の呼び方では?", "response": "ゼラレノンは別の呼び方ではZearalenoneです。", "task": "replace", "name_q": "ゼラレノン", "name_a": "Zearalenone"} +{"id": 32640, "instruction": "ラサロシドの別の呼び方は?", "response": "ラサロシドの別の呼び方はLasalocid (USAN/INN)です。", "task": "replace", "name_q": "ラサロシド", "name_a": "Lasalocid (USAN/INN)"} +{"id": 8924, "instruction": "1-Keto-D-chiro-inositolをの化学構造は?", "response": "1-Keto-D-chiro-inositolをの化学構造はC6H10O6です。", "task": "formula", "name_q": "1-Keto-D-chiro-inositol", "name_a": "C6H10O6"} +{"id": 3641, "instruction": "Eosinophilic esophagitisの日本語表記は?", "response": "Eosinophilic esophagitisの日本語表記は好酸球性食道炎です。", "task": "replace en to ja", "name_q": "Eosinophilic esophagitis", "name_a": "好酸球性食道炎"} +{"id": 21881, "instruction": "シプロキサン(バイエル薬品)をを化学式で表すと?", "response": "シプロキサン(バイエル薬品)をを化学式で表すとC17H18FN3O3です。", "task": "formula", "name_q": "シプロキサン(バイエル薬品)", "name_a": "C17H18FN3O3"} +{"id": 19748, "instruction": "TENIVAC(A-SMedicationSolutions)を利用した医薬品名は?", "response": "TENIVAC(A-SMedicationSolutions)を利用した医薬品名はDIPHTHERIAANDTETANUSTOXOIDSADSORBED(SanofiPasteur)です。", "task": "product", "name_q": "TENIVAC(A-SMedicationSolutions)", "name_a": "DIPHTHERIAANDTETANUSTOXOIDSADSORBED(SanofiPasteur)"} +{"id": 23793, "instruction": "シムロセルチブをを組成式で書くと?", "response": "シムロセルチブをを組成式で書くとC17H19N5OSです。", "task": "formula", "name_q": "シムロセルチブ", "name_a": "C17H19N5OS"} +{"id": 29379, "instruction": "3alpha,21-Dihydroxy-D-homo-5beta-pregn-17a(20)-en-11-oneをを分子式で表すと?", "response": "3alpha,21-Dihydroxy-D-homo-5beta-pregn-17a(20)-en-11-oneをを分子式で表すとC22H34O3です。", "task": "formula", "name_q": "3alpha,21-Dihydroxy-D-homo-5beta-pregn-17a(20)-en-11-one", "name_a": "C22H34O3"} +{"id": 14014, "instruction": "Achromobacter xylosoxidans infectionを日本語で記述すると?", "response": "Achromobacter xylosoxidans infectionを日本語で記述するとAchromobacter xylosoxidans 感染です。", "task": "replace en to ja", "name_q": "Achromobacter xylosoxidans infection", "name_a": "Achromobacter xylosoxidans 感染"} +{"id": 14250, "instruction": "Plutoniumをを組成式で表すと?", "response": "Plutoniumをを組成式で表すとPuです。", "task": "formula", "name_q": "Plutonium", "name_a": "Pu"} +{"id": 20783, "instruction": "Yunis-Varon 症候群を英語で記述すると?", "response": "Yunis-Varon 症候群を英語で記述するとYunis-Varon syndromeです。", "task": "replace ja to en", "name_q": "Yunis-Varon 症候群", "name_a": "Yunis-Varon syndrome"} +{"id": 25866, "instruction": "19-Norpregn-4-ene-3,20-dioneの別の呼び方は?", "response": "19-Norpregn-4-ene-3,20-dioneの別の呼び方は19-Norprogesteroneです。", "task": "replace", "name_q": "19-Norpregn-4-ene-3,20-dione", "name_a": "19-Norprogesterone"} +{"id": 26802, "instruction": "Glyoxylateの別の呼び方は?", "response": "Glyoxylateの別の呼び方はGlyoxalateです。", "task": "replace", "name_q": "Glyoxylate", "name_a": "Glyoxalate"} +{"id": 11377, "instruction": "Loxitane (TN)を日本語で書くと?", "response": "Loxitane (TN)を日本語で書くとLoxapine succinate (USP)です。", "task": "replace en to ja", "name_q": "Loxitane (TN)", "name_a": "Loxapine succinate (USP)"} +{"id": 17693, "instruction": "ロソミドナルをを化学式で表すと?", "response": "ロソミドナルをを化学式で表すとC227H291N88O141P23です。", "task": "formula", "name_q": "ロソミドナル", "name_a": "C227H291N88O141P23"} +{"id": 26988, "instruction": "Iodine I 124 girentuximab (USAN/INN)を日本語表記で表すと?", "response": "Iodine I 124 girentuximab (USAN/INN)を日本語表記で表すとヨウ素(124I)ギレンツキシマブです。", "task": "replace en to ja", "name_q": "Iodine I 124 girentuximab (USAN/INN)", "name_a": "ヨウ素(124I)ギレンツキシマブ"} +{"id": 20887, "instruction": "ペピネマブの別名称は?", "response": "ペピネマブの別名称はPepinemab (USAN)です。", "task": "replace", "name_q": "ペピネマブ", "name_a": "Pepinemab (USAN)"} +{"id": 491, "instruction": "Florbetaben (18F) (JAN/USAN/INN)をを組成式で記述すると?", "response": "Florbetaben (18F) (JAN/USAN/INN)をを組成式で記述するとC21H26FNO3です。", "task": "formula", "name_q": "Florbetaben (18F) (JAN/USAN/INN)", "name_a": "C21H26FNO3"} +{"id": 14781, "instruction": "スロクリンの別表現は?", "response": "スロクリンの別表現はSulochrinです。", "task": "replace", "name_q": "スロクリン", "name_a": "Sulochrin"} +{"id": 12046, "instruction": "9-Demethylmunduseroneをは組成式で表すと?", "response": "9-Demethylmunduseroneをは組成式で表すとC18H16O6です。", "task": "formula", "name_q": "9-Demethylmunduserone", "name_a": "C18H16O6"} +{"id": 31504, "instruction": "Melagatran (INN)をは組成式で表すと?", "response": "Melagatran (INN)をは組成式で表すとC22H31N5O4です。", "task": "formula", "name_q": "Melagatran (INN)", "name_a": "C22H31N5O4"} +{"id": 6799, "instruction": "ペニメピサイクリンをは化学式で表すと?", "response": "ペニメピサイクリンをは化学式で表すとC29H38N4O9. C16H18N2O5Sです。", "task": "formula", "name_q": "ペニメピサイクリン", "name_a": "C29H38N4O9. C16H18N2O5S"} +{"id": 20079, "instruction": "Diphenhydramine laurylsulfate (JAN)をの組成式は?", "response": "Diphenhydramine laurylsulfate (JAN)をの組成式はC12H26O4S. C17H21NOです。", "task": "formula", "name_q": "Diphenhydramine laurylsulfate (JAN)", "name_a": "C12H26O4S. C17H21NO"} +{"id": 1679, "instruction": "Clofazimineをを化学式で表すと?", "response": "Clofazimineをを化学式で表すとC27H22Cl2N4です。", "task": "formula", "name_q": "Clofazimine", "name_a": "C27H22Cl2N4"} +{"id": 16386, "instruction": "7,12-Decaketide intermediate 1をを組成式で表すと?", "response": "7,12-Decaketide intermediate 1をを組成式で表すとC20H19O9SRです。", "task": "formula", "name_q": "7,12-Decaketide intermediate 1", "name_a": "C20H19O9SR"} +{"id": 13795, "instruction": "Banti syndromeを日本語で記述すると?", "response": "Banti syndromeを日本語で記述するとバンチ症候群です。", "task": "replace en to ja", "name_q": "Banti syndrome", "name_a": "バンチ症候群"} +{"id": 7912, "instruction": "6'-Hydroxy-O-desmethylangolensinをを組成式で表すと?", "response": "6'-Hydroxy-O-desmethylangolensinをを組成式で表すとC15H14O5です。", "task": "formula", "name_q": "6'-Hydroxy-O-desmethylangolensin", "name_a": "C15H14O5"} +{"id": 31227, "instruction": "ERTAPENEM(GlandPharmaLimited)を用いた商品名は?", "response": "ERTAPENEM(GlandPharmaLimited)を用いた商品名はERTAPENEM(SaviorLifetecCorporation)です。", "task": "product", "name_q": "ERTAPENEM(GlandPharmaLimited)", "name_a": "ERTAPENEM(SaviorLifetecCorporation)"} +{"id": 1759, "instruction": "3',4'-アンヒドロビンブラスチンは別の呼び方では?", "response": "3',4'-アンヒドロビンブラスチンは別の呼び方では3',4'-Anhydrovinblastineで��。", "task": "replace", "name_q": "3',4'-アンヒドロビンブラスチン", "name_a": "3',4'-Anhydrovinblastine"} +{"id": 27533, "instruction": "グラミシジン (JAN)の別名称は?", "response": "グラミシジン (JAN)の別名称はGramicidin (JAN/USP/INN)です。", "task": "replace", "name_q": "グラミシジン (JAN)", "name_a": "Gramicidin (JAN/USP/INN)"} +{"id": 34015, "instruction": "Zederoneの別呼称は?", "response": "Zederoneの別呼称はゼデロンです。", "task": "replace", "name_q": "Zederone", "name_a": "ゼデロン"} +{"id": 16749, "instruction": "PDX1 欠損による乳酸血症 上位グループ ピルビン酸脱水素酵素複合体欠損症 の英語表記は?", "response": "PDX1 欠損による乳酸血症 上位グループ ピルビン酸脱水素酵素複合体欠損症 の英語表記はPyruvate dehydrogenase E3-binding protein deficiencyです。", "task": "replace ja to en", "name_q": "PDX1 欠損による乳酸血症 上位グループ ピルビン酸脱水素酵素複合体欠損症 ", "name_a": "Pyruvate dehydrogenase E3-binding protein deficiency"} +{"id": 5895, "instruction": "Hyperchlorhidrosis isolatedを英語で書くと?", "response": "Hyperchlorhidrosis isolatedを英語で書くとHyperchlorhidrosis isolated (HCHLH)です。", "task": "replace ja to en", "name_q": "Hyperchlorhidrosis isolated", "name_a": "Hyperchlorhidrosis isolated (HCHLH)"} +{"id": 7654, "instruction": "肝吸虫症 上位グループ 食物媒介吸虫類感染症 を英語表記で表すと?", "response": "肝吸虫症 上位グループ 食物媒介吸虫類感染症 を英語表記で表すとClonorchiasis SUPERGRP Foodborne trematodiasis です。", "task": "replace ja to en", "name_q": "肝吸虫症 上位グループ 食物媒介吸虫類感染症 ", "name_a": "Clonorchiasis SUPERGRP Foodborne trematodiasis "} +{"id": 13325, "instruction": "Isomaltuloseの異なる表現は?", "response": "Isomaltuloseの異なる表現はPalatinoseです。", "task": "replace", "name_q": "Isomaltulose", "name_a": "Palatinose"} +{"id": 16423, "instruction": "Multidrug-resistant Pseudomonas aeruginosa infectionを日本語に訳すと?", "response": "Multidrug-resistant Pseudomonas aeruginosa infectionを日本語に訳すと多剤耐性緑膿菌感染症です。", "task": "replace en to ja", "name_q": "Multidrug-resistant Pseudomonas aeruginosa infection", "name_a": "多剤耐性緑膿菌感染症"} +{"id": 10933, "instruction": "Serentil (TN)の日本語表記は?", "response": "Serentil (TN)の日本語表記はメソリダジンベシレートです。", "task": "replace en to ja", "name_q": "Serentil (TN)", "name_a": "メソリダジンベシレート"} +{"id": 30053, "instruction": "Naloxone hydrochloride and pentazocine hydrochlorideの別の呼び方は?", "response": "Naloxone hydrochloride and pentazocine hydrochlorideの別の呼び方はナロキソン塩酸塩・ペンタゾシン塩酸塩です。", "task": "replace", "name_q": "Naloxone hydrochloride and pentazocine hydrochloride", "name_a": "ナロキソン塩酸塩・ペンタゾシン塩酸塩"} +{"id": 20, "instruction": "N-Methyl-L-amino acidをを組成式で書くと?", "response": "N-Methyl-L-amino acidをを組成式で書くとC3H6NO2Rです。", "task": "formula", "name_q": "N-Methyl-L-amino acid", "name_a": "C3H6NO2R"} +{"id": 737, "instruction": "SULFASALAZINE(REMEDYREPACK)を材料とする医薬品は?", "response": "SULFASALAZINE(REMEDYREPACK)を材料とする医薬品はアザルフィジン(あゆみ製薬)です。", "task": "product", "name_q": "SULFASALAZINE(REMEDYREPACK)", "name_a": "アザルフィジン(あゆみ製薬)"} +{"id": 30965, "instruction": "メトホルミン塩酸塩・レパグリニドを英語表記で表すと?", "response": "メトホルミン塩酸塩・レパグリニドを英語表記で表すとPrandimet (TN)です。", "task": "replace ja to en", "name_q": "メトホルミン塩酸塩・レパグリニド", "name_a": "Prandimet (TN)"} +{"id": 16600, "instruction": "Frunevetmab (USAN/INN)を日本語で書くと?", "response": "Frunevetmab (USAN/INN)を日本語で書くとフルネベトマブです。", "task": "replace en to ja", "name_q": "Frunevetmab (USAN/INN)", "name_a": "フルネベトマブ"} +{"id": 27349, "instruction": "寒冷誘発性発汗症候群 下位グループ Crisponi 症候群の英語表記は?", "response": "寒冷誘発性発汗症候群 下位グループ Crisponi 症候群の英語表記はCold-induced sweating syndrome SUBGROUP Crisponi syndromeです。", "task": "replace ja to en", "name_q": "寒冷誘発性発汗症候群 下位グループ Crisponi 症候群", "name_a": "Cold-induced sweating syndrome SUBGROUP Crisponi syndrome"} +{"id": 19192, "instruction": "Microphthalmia, syndromicを日本語で書くと?", "response": "Microphthalmia, syndromicを日本語で書くと小眼球症 (症候群性)です。", "task": "replace en to ja", "name_q": "Microphthalmia, syndromic", "name_a": "小眼球症 (症候群性)"} +{"id": 13007, "instruction": "Glaucineの別呼称は?", "response": "Glaucineの別呼称はグラウシンです。", "task": "replace", "name_q": "Glaucine", "name_a": "グラウシン"} +{"id": 20447, "instruction": "Brunet-Wagner 神経発達症候群を英語で記述すると?", "response": "Brunet-Wagner 神経発達症候群を英語で記述するとBrunet-Wagner neurodevelopmental syndromeです。", "task": "replace ja to en", "name_q": "Brunet-Wagner 神経発達症候群", "name_a": "Brunet-Wagner neurodevelopmental syndrome"} +{"id": 23575, "instruction": "キノボースをを分子式で書くと?", "response": "キノボースをを分子式で書くとC6H12O5です。", "task": "formula", "name_q": "キノボース", "name_a": "C6H12O5"} +{"id": 6397, "instruction": "フルカルバゾンナトリウムをの化学式は?", "response": "フルカルバゾンナトリウムをの化学式はC12H10F3N4O6S. Naです。", "task": "formula", "name_q": "フルカルバゾンナトリウム", "name_a": "C12H10F3N4O6S. Na"} +{"id": 11779, "instruction": "Avridine (USAN)をを分子式で記述すると?", "response": "Avridine (USAN)をを分子式で記述するとC43H90N2O2です。", "task": "formula", "name_q": "Avridine (USAN)", "name_a": "C43H90N2O2"} +{"id": 31546, "instruction": "メシル酸カリポリドの別の言い方は?", "response": "メシル酸カリポリドの別の言い方はCariporide mesylate (USAN)です。", "task": "replace", "name_q": "メシル酸カリポリド", "name_a": "Cariporide mesylate (USAN)"} +{"id": 8080, "instruction": "Sertaconazole nitrateをを化学構造で書くと?", "response": "Sertaconazole nitrateをを化学構造で書くとC20H15Cl3N2OS. HNO3です。", "task": "formula", "name_q": "Sertaconazole nitrate", "name_a": "C20H15Cl3N2OS. HNO3"} +{"id": 23675, "instruction": "Mucopolysaccharidosis type VIを日本語で記述すると?", "response": "Mucopolysaccharidosis type VIを日本語で記述するとマロトー・ラミー症候群 上位グループ ムコ多糖症 ライソゾーム病 (リソソーム蓄積症) です。", "task": "replace en to ja", "name_q": "Mucopolysaccharidosis type VI", "name_a": "マロトー・ラミー症候群 上位グループ ムコ多糖症 ライソゾーム病 (リソソーム蓄積症) "} +{"id": 14246, "instruction": "Silapo (TN)の別の言い方は?", "response": "Silapo (TN)の別の言い方はRetacrit (TN)です。", "task": "replace", "name_q": "Silapo (TN)", "name_a": "Retacrit (TN)"} +{"id": 4693, "instruction": "Collodion (USP)の別表現は?", "response": "Collodion (USP)の別表現はコロジオンです。", "task": "replace", "name_q": "Collodion (USP)", "name_a": "コロジオン"} +{"id": 24967, "instruction": "Crocetin dialdehydeの別の呼び方は?", "response": "Crocetin dialdehydeの別の呼び方は8,8'-Diapocarotene-8,8'-dialです。", "task": "replace", "name_q": "Crocetin dialdehyde", "name_a": "8,8'-Diapocarotene-8,8'-dial"} +{"id": 25450, "instruction": "Fallopian tube cancerの日本語表記は?", "response": "Fallopian tube cancerの日本語表記は卵管癌です。", "task": "replace en to ja", "name_q": "Fallopian tube cancer", "name_a": "卵管癌"} +{"id": 15150, "instruction": "甲状腺内分泌不全症を英語表記で表すと?", "response": "甲状腺内分泌不全症を英語表記で表すとThyroid dyshormonogenesisです。", "task": "replace ja to en", "name_q": "甲状腺内分泌不全症", "name_a": "Thyroid dyshormonogenesis"} +{"id": 32544, "instruction": "ZOLMITRIPTAN(AlembicPharmaceuticalsLimited)をを分子式で表すと?", "response": "ZOLMITRIPTAN(AlembicPharmaceuticalsLimited)をを分子式で表すとC16H21N3O2です。", "task": "formula", "name_q": "ZOLMITRIPTAN(AlembicPharmaceuticalsLimited)", "name_a": "C16H21N3O2"} +{"id": 7474, "instruction": "ジムロビセルチブをを化学式で書くと?", "response": "ジムロビセルチブをを化学式で書くとC18H20FN3O4です。", "task": "formula", "name_q": "ジムロビセルチブ", "name_a": "C18H20FN3O4"} +{"id": 4284, "instruction": "マレイン酸イコペジルをは組成式で表すと?", "response": "マレイン酸イコペジルをは組成式で表すとC23H25N3O2. C4H4O4です。", "task": "formula", "name_q": "マレイン酸イコペジル", "name_a": "C23H25N3O2. C4H4O4"} +{"id": 19587, "instruction": "Amobamの別の呼び方は?", "response": "Amobamの別の呼び方はアンバムです。", "task": "replace", "name_q": "Amobam", "name_a": "アンバム"} +{"id": 29704, "instruction": "Alsactide (INN)をを化学式で記述すると?", "response": "Alsactide (INN)をを化学式で記述するとC99H155N29O21Sです。", "task": "formula", "name_q": "Alsactide (INN)", "name_a": "C99H155N29O21S"} +{"id": 14254, "instruction": "Precocious puberty SUBGROUP Central precocious puberty Familial male-limited precocious puberty を日本語表記で表すと?", "response": "Precocious puberty SUBGROUP Central precocious puberty Familial male-limited precocious puberty を日本語表記で表すと思春期早発症 下位グループ 中枢性思春期早発症 家族性男性思春期早発症 です。", "task": "replace en to ja", "name_q": "Precocious puberty SUBGROUP Central precocious puberty Familial male-limited precocious puberty ", "name_a": "思春期早発症 下位グループ 中枢性思春期早発症 家族性男性思春期早発症 "} +{"id": 33123, "instruction": "(R)-2-Aza-3-chloro-beta-tyrosyl-[pcp]をの組成式は?", "response": "(R)-2-Aza-3-chloro-beta-tyrosyl-[pcp]をの組成式はC8H8ClN2O2SRです。", "task": "formula", "name_q": "(R)-2-Aza-3-chloro-beta-tyrosyl-[pcp]", "name_a": "C8H8ClN2O2SR"} +{"id": 23129, "instruction": "Carpenter syndrome SUPERGRP Syndromic craniosynostoses を日本語で記述すると?", "response": "Carpenter syndrome SUPERGRP Syndromic craniosynostoses を日本語で記述するとカーペンター症候群 上位グループ 症候性頭蓋縫合早期癒合症 です。", "task": "replace en to ja", "name_q": "Carpenter syndrome SUPERGRP Syndromic craniosynostoses ", "name_a": "カーペンター症候群 上位グループ 症候性頭蓋縫合早期癒合症 "} +{"id": 29233, "instruction": "パントテニールエチルエーテル (JAN)をを分子式で記述すると?", "response": "パントテニールエチルエーテル (JAN)をを分子式で記述するとC11H23NO4です。", "task": "formula", "name_q": "パントテニールエチルエーテル (JAN)", "name_a": "C11H23NO4"} +{"id": 15073, "instruction": "19-Chloro-17beta-hydroxyandrost-4-en-3-oneをを化学構造で表すと?", "response": "19-Chloro-17beta-hydroxyandrost-4-en-3-oneをを化学構造で表すとC19H27ClO2です。", "task": "formula", "name_q": "19-Chloro-17beta-hydroxyandrost-4-en-3-one", "name_a": "C19H27ClO2"} +{"id": 13309, "instruction": "地榆の別名称は?", "response": "地榆の別名称は地楡です。", "task": "replace", "name_q": "地榆", "name_a": "地楡"} +{"id": 13406, "instruction": "マレイン酸ブラソフェンシンの別名称は?", "response": "マレイン酸ブラソフェンシンの別名称はBrasofensine maleate (USAN)です。", "task": "replace", "name_q": "マレイン酸ブラソフェンシン", "name_a": "Brasofensine maleate (USAN)"} +{"id": 24226, "instruction": "Truvada (TN)を主材料とする薬品は?", "response": "Truvada (TN)を主材料とする薬品はEMTRICITABINEANDTENOFOVIRDISOPROXILFUMARATE(LaurusLabsLimited)です。", "task": "product", "name_q": "Truvada (TN)", "name_a": "EMTRICITABINEANDTENOFOVIRDISOPROXILFUMARATE(LaurusLabsLimited)"} +{"id": 34072, "instruction": "Amidineの別名称は?", "response": "Amidineの別名称はアミジンです。", "task": "replace", "name_q": "Amidine", "name_a": "アミジン"} +{"id": 33252, "instruction": "xì xīnを言い換えると?", "response": "xì xīnを言い換えると细辛です。", "task": "replace", "name_q": "xì xīn", "name_a": "细辛"} +{"id": 21863, "instruction": "(5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoyl-CoAをの組成式は?", "response": "(5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoyl-CoAをの組成式はC41H64N7O17P3Sです。", "task": "formula", "name_q": "(5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoyl-CoA", "name_a": "C41H64N7O17P3S"} +{"id": 26457, "instruction": "カノコシドBをを化学式で記述すると?", "response": "カノコシドBをを化学式で記述するとC21H34O12です。", "task": "formula", "name_q": "カノコシドB", "name_a": "C21H34O12"} +{"id": 7064, "instruction": "14,15-DHETをは組成式で表すと?", "response": "14,15-DHETをは組成式で表すとC20H34O4です。", "task": "formula", "name_q": "14,15-DHET", "name_a": "C20H34O4"} +{"id": 27092, "instruction": "カロウガイハクトウは別の呼び方では?", "response": "カロウガイハクトウは別の呼び方では栝楼薤白湯です。", "task": "replace", "name_q": "カロウガイハクトウ", "name_a": "栝楼薤白湯"} +{"id": 27260, "instruction": "Desogestrelをの化学式は?", "response": "Desogestrelをの化学式はC22H30Oです。", "task": "formula", "name_q": "Desogestrel", "name_a": "C22H30O"} +{"id": 23472, "instruction": "Quinidine sulfate (USP)を主とした商品名は?", "response": "Quinidine sulfate (USP)を主とした商品名はキニジン硫酸塩(ヴィアトリス・ヘルスケア)です。", "task": "product", "name_q": "Quinidine sulfate (USP)", "name_a": "キニジン硫酸塩(ヴィアトリス・ヘルスケア)"} +{"id": 2459, "instruction": "Clazosentan sodium (JAN/USAN)をを分子式で書くと?", "response": "Clazosentan sodium (JAN/USAN)をを分子式で書くとC25H21N9Na2O6Sです。", "task": "formula", "name_q": "Clazosentan sodium (JAN/USAN)", "name_a": "C25H21N9Na2O6S"} +{"id": 13718, "instruction": "Palytoxinをを化学構造で書くと?", "response": "Palytoxinをを化学構造で書くとC129H223N3O54です。", "task": "formula", "name_q": "Palytoxin", "name_a": "C129H223N3O54"} +{"id": 30452, "instruction": "���盤性ラクトゲンの別の言い方は?", "response": "胎盤性ラクトゲンの別の言い方は絨毛性乳腺刺激ホルモンです。", "task": "replace", "name_q": "胎盤性ラクトゲン", "name_a": "絨毛性乳腺刺激ホルモン"} +{"id": 10479, "instruction": "オキセドリンを言い換えると?", "response": "オキセドリンを言い換えると(+/-)-Synephrineです。", "task": "replace", "name_q": "オキセドリン", "name_a": "(+/-)-Synephrine"} +{"id": 20131, "instruction": "亜麻仁の別の言い方は?", "response": "亜麻仁の別の言い方は亚麻仁です。", "task": "replace", "name_q": "亜麻仁", "name_a": "亚麻仁"} +{"id": 4901, "instruction": "Benetazon (TN)を日本語表記で表すと?", "response": "Benetazon (TN)を日本語表記で表すとトリブゾンです。", "task": "replace en to ja", "name_q": "Benetazon (TN)", "name_a": "トリブゾン"} +{"id": 10868, "instruction": "クエン酸プロキサゾール (JAN)の別表現は?", "response": "クエン酸プロキサゾール (JAN)の別表現はProxazole citrate (JAN/USAN)です。", "task": "replace", "name_q": "クエン酸プロキサゾール (JAN)", "name_a": "Proxazole citrate (JAN/USAN)"} +{"id": 23945, "instruction": "KAO 264は別の呼び方では?", "response": "KAO 264は別の呼び方ではMazaticol hydrochlorideです。", "task": "replace", "name_q": "KAO 264", "name_a": "Mazaticol hydrochloride"} +{"id": 14521, "instruction": "Sennidin Dをは組成式で表すと?", "response": "Sennidin Dをは組成式で表すとC30H20O9です。", "task": "formula", "name_q": "Sennidin D", "name_a": "C30H20O9"} +{"id": 23785, "instruction": "短指‐合指症候群の英語表記は?", "response": "短指‐合指症候群の英語表記はBrachydactyly-syndactyly syndromeです。", "task": "replace ja to en", "name_q": "短指‐合指症候群", "name_a": "Brachydactyly-syndactyly syndrome"} +{"id": 21609, "instruction": "Polyneuridine aldehydeをは化学構造で表すと?", "response": "Polyneuridine aldehydeをは化学構造で表すとC21H22N2O3です。", "task": "formula", "name_q": "Polyneuridine aldehyde", "name_a": "C21H22N2O3"} +{"id": 16015, "instruction": "Aluminum sesquichlorohydrex propylene glycol (USP)を日本語表記で表すと?", "response": "Aluminum sesquichlorohydrex propylene glycol (USP)を日本語表記で表すとアルミニウムセスキクロロハイドレックスプロピレングリコールです。", "task": "replace en to ja", "name_q": "Aluminum sesquichlorohydrex propylene glycol (USP)", "name_a": "アルミニウムセスキクロロハイドレックスプロピレングリコール"} +{"id": 9156, "instruction": "14'-apo-beta-Carotenalをは化学構造で表すと?", "response": "14'-apo-beta-Carotenalをは化学構造で表すとC22H30Oです。", "task": "formula", "name_q": "14'-apo-beta-Carotenal", "name_a": "C22H30O"} +{"id": 6676, "instruction": "(R)-Indenestrol Aをを化学式で書くと?", "response": "(R)-Indenestrol Aをを化学式で書くとC18H18O2です。", "task": "formula", "name_q": "(R)-Indenestrol A", "name_a": "C18H18O2"} +{"id": 5904, "instruction": "Zeteletinib adipate (USAN)をを化学構造で記述すると?", "response": "Zeteletinib adipate (USAN)をを化学構造で記述すると(C25H23F3N4O4)2. C6H10O4です。", "task": "formula", "name_q": "Zeteletinib adipate (USAN)", "name_a": "(C25H23F3N4O4)2. C6H10O4"} +{"id": 19216, "instruction": "2alpha-Hydroxytestosterone dipropionateをを組成式で書くと?", "response": "2alpha-Hydroxytestosterone dipropionateをを組成式で書くとC25H36O5です。", "task": "formula", "name_q": "2alpha-Hydroxytestosterone dipropionate", "name_a": "C25H36O5"} +{"id": 12057, "instruction": "(+)-Limoneneの異なる表現は?", "response": "(+)-Limoneneの異なる表現は(R)-Limoneneです。", "task": "replace", "name_q": "(+)-Limonene", "name_a": "(R)-Limonene"} +{"id": 7015, "instruction": "Echothiophate iodide (USP)をを組成式で記述すると?", "response": "Echothiophate iodide (USP)をを組成式で記述するとC9H23NO3PS. Iです。", "task": "formula", "name_q": "Echothiophate iodide (USP)", "name_a": "C9H23NO3PS. I"} +{"id": 4025, "instruction": "3,3-Difluoro-17-methyl-5alpha-androstan-17beta-olをを化学式で記述すると?", "response": "3,3-Difluoro-17-methyl-5alpha-androstan-17beta-olをを化学式で記述するとC20H32F2Oです。", "task": "formula", "name_q": "3,3-Difluoro-17-methyl-5alpha-androstan-17beta-ol", "name_a": "C20H32F2O"} +{"id": 8711, "instruction": "9,10-Epoxyoctadecanoic acidの別名称は?", "response": "9,10-Epoxyoctadecanoic acidの別名称は9,10-Epoxystearateです。", "task": "replace", "name_q": "9,10-Epoxyoctadecanoic acid", "name_a": "9,10-Epoxystearate"} +{"id": 28119, "instruction": "クロフルカルバンの別の呼び方は?", "response": "クロフルカルバンの別の呼び方はCloflucarban (USAN)です。", "task": "replace", "name_q": "クロフルカルバン", "name_a": "Cloflucarban (USAN)"} +{"id": 721, "instruction": "Ethacridine (INN)の別表現は?", "response": "Ethacridine (INN)の別表現はOphosept (TN)です。", "task": "replace", "name_q": "Ethacridine (INN)", "name_a": "Ophosept (TN)"} +{"id": 28417, "instruction": "Girentuximab (USAN/INN)を日本語で書くと?", "response": "Girentuximab (USAN/INN)を日本語で書くとギレンツキシマブです。", "task": "replace en to ja", "name_q": "Girentuximab (USAN/INN)", "name_a": "ギレンツキシマブ"} +{"id": 2877, "instruction": "Ipradol (TN)を日本語で記述すると?", "response": "Ipradol (TN)を日本語で記述するとHexoprenaline (INN)です。", "task": "replace en to ja", "name_q": "Ipradol (TN)", "name_a": "Hexoprenaline (INN)"} +{"id": 22059, "instruction": "アトロピン硫酸塩･ジフェノキシラート塩酸塩を利用した薬品名は?", "response": "アトロピン硫酸塩･ジフェノキシラート塩酸塩を利用した薬品名はDIPHENOXYLATEHYDROCHLORIDEANDATROPINESULFATE(RedpharmDrug)です。", "task": "product", "name_q": "アトロピン硫酸塩･ジフェノキシラート塩酸塩", "name_a": "DIPHENOXYLATEHYDROCHLORIDEANDATROPINESULFATE(RedpharmDrug)"} +{"id": 12143, "instruction": "Fungimycin (USAN)を日本語で書くと?", "response": "Fungimycin (USAN)を日本語で書くとフンギマイシンです。", "task": "replace en to ja", "name_q": "Fungimycin (USAN)", "name_a": "フンギマイシン"} +{"id": 23688, "instruction": "Imagabalin hydrochloride (USAN)を日本語で記述すると?", "response": "Imagabalin hydrochloride (USAN)を日本語で記述するとイマガバリン塩酸塩です。", "task": "replace en to ja", "name_q": "Imagabalin hydrochloride (USAN)", "name_a": "イマガバリン塩酸塩"} +{"id": 18696, "instruction": "Buprofezinをの組成式は?", "response": "Buprofezinをの組成式はC16H23N3OSです。", "task": "formula", "name_q": "Buprofezin", "name_a": "C16H23N3OS"} +{"id": 6570, "instruction": "5beta-Pregnane-3alpha,17alpha,20alpha-triolをを分子式で表すと?", "response": "5beta-Pregnane-3alpha,17alpha,20alpha-triolをを分子式で表すとC21H36O3です。", "task": "formula", "name_q": "5beta-Pregnane-3alpha,17alpha,20alpha-triol", "name_a": "C21H36O3"} +{"id": 4960, "instruction": "Etiprednol dicloacetate (USAN/INN)をを化学式で記述すると?", "response": "Etiprednol dicloacetate (USAN/INN)をを化学式で記述するとC24H30Cl2O6です。", "task": "formula", "name_q": "Etiprednol dicloacetate (USAN/INN)", "name_a": "C24H30Cl2O6"} +{"id": 1038, "instruction": "gamma-Hydroxy-L-arginineをの組成式は?", "response": "gamma-Hydroxy-L-arginineをの組成式はC6H14N4O3です。", "task": "formula", "name_q": "gamma-Hydroxy-L-arginine", "name_a": "C6H14N4O3"} +{"id": 3811, "instruction": "ビオタミン(第一三共)をを組成式で表すと?", "response": "ビオタミン(第一三共)をを組成式で表すとC19H23N4O6PSです。", "task": "formula", "name_q": "ビオタミン(第一三共)", "name_a": "C19H23N4O6PS"} +{"id": 26946, "instruction": "Corynantheineの別の言い方は?", "response": "Corynantheineの別の言い方はコリナンテインです。", "task": "replace", "name_q": "Corynantheine", "name_a": "コリナンテイン"} +{"id": 29868, "instruction": "大茴香の異なる名称は?", "response": "大茴香の異なる名称はStar aniseです。", "task": "replace", "name_q": "大茴香", "name_a": "Star anise"} +{"id": 6236, "instruction": "アムサクリンを言い換えると?", "response": "アムサクリンを言い換えるとAmsacrineです。", "task": "replace", "name_q": "アムサクリン", "name_a": "Amsacrine"} +{"id": 29957, "instruction": "Sodium glucuronateをは組成式で表すと?", "response": "Sodium glucuronateをは組成式で表すとC6H9O7. Naです。", "task": "formula", "name_q": "Sodium glucuronate", "name_a": "C6H9O7. Na"} +{"id": 20933, "instruction": "(-)-Chimonanthineの別名は?", "response": "(-)-Chimonanthineの別名は(-)-キモナンチンです。", "task": "replace", "name_q": "(-)-Chimonanthine", "name_a": "(-)-キモナンチン"} +{"id": 8999, "instruction": "Cibarianの異なる表現は?", "response": "Cibarianの異なる表現はbeta-D-Glucopyranose, 1,6-bis(3-nitropropanoate)です。", "task": "replace", "name_q": "Cibarian", "name_a": "beta-D-Glucopyranose, 1,6-bis(3-nitropropanoate)"} +{"id": 16263, "instruction": "Puromycin dihydrochlorideを日本語で書くと?", "response": "Puromycin dihydrochlorideを日本語で書くとPuromycin hydrochloride (USAN)です。", "task": "replace en to ja", "name_q": "Puromycin dihydrochloride", "name_a": "Puromycin hydrochloride (USAN)"} +{"id": 29120, "instruction": "シクロホスファミドの別記述は?", "response": "シクロホスファミドの別記述はCyclophosphamide (INN)です。", "task": "replace", "name_q": "シクロホスファミド", "name_a": "Cyclophosphamide (INN)"} +{"id": 32610, "instruction": "Aromolineをを化学構造で書くと?", "response": "Aromolineを��化学構造で書くとC36H38N2O6です。", "task": "formula", "name_q": "Aromoline", "name_a": "C36H38N2O6"} +{"id": 25019, "instruction": "MRD Aをは化学式で表すと?", "response": "MRD Aをは化学式で表すとC38H48N8O12Sです。", "task": "formula", "name_q": "MRD A", "name_a": "C38H48N8O12S"} +{"id": 16118, "instruction": "Liberfarb syndromeの日本語訳は?", "response": "Liberfarb syndromeの日本語訳はLiberfarb 症候群です。", "task": "replace en to ja", "name_q": "Liberfarb syndrome", "name_a": "Liberfarb 症候群"} +{"id": 18858, "instruction": "(R)-3-Ureidoisobutyrateをを分子式で表すと?", "response": "(R)-3-Ureidoisobutyrateをを分子式で表すとC5H10N2O3です。", "task": "formula", "name_q": "(R)-3-Ureidoisobutyrate", "name_a": "C5H10N2O3"} +{"id": 4420, "instruction": "7-Methylthioheptyl-desulfoglucosinolateをの組成式は?", "response": "7-Methylthioheptyl-desulfoglucosinolateをの組成式はC15H29NO6S2です。", "task": "formula", "name_q": "7-Methylthioheptyl-desulfoglucosinolate", "name_a": "C15H29NO6S2"} +{"id": 16275, "instruction": "テブフェノジドをは分子式で表すと?", "response": "テブフェノジドをは分子式で表すとC22H28N2O2です。", "task": "formula", "name_q": "テブフェノジド", "name_a": "C22H28N2O2"} +{"id": 26462, "instruction": "デカノヒドロキサム酸 (JAN)をは化学構造で表すと?", "response": "デカノヒドロキサム酸 (JAN)をは化学構造で表すとC10H21NO2です。", "task": "formula", "name_q": "デカノヒドロキサム酸 (JAN)", "name_a": "C10H21NO2"} +{"id": 27719, "instruction": "Epileptic encephalopathy, childhood-onsetの日本語訳は?", "response": "Epileptic encephalopathy, childhood-onsetの日本語訳は小児発症てんかん性脳症です。", "task": "replace en to ja", "name_q": "Epileptic encephalopathy, childhood-onset", "name_a": "小児発症てんかん性脳症"} +{"id": 23567, "instruction": "Deethylatrazineをを分子式で表すと?", "response": "Deethylatrazineをを分子式で表すとC6H10ClN5です。", "task": "formula", "name_q": "Deethylatrazine", "name_a": "C6H10ClN5"} +{"id": 4689, "instruction": "2,2',3',4,4',5,5'-Heptachloro-3-biphenylolをを分子式で表すと?", "response": "2,2',3',4,4',5,5'-Heptachloro-3-biphenylolをを分子式で表すとC12H3Cl7Oです。", "task": "formula", "name_q": "2,2',3',4,4',5,5'-Heptachloro-3-biphenylol", "name_a": "C12H3Cl7O"} +{"id": 10854, "instruction": "Dry distillation tar of defatting soybeanを英語表記で表すと?", "response": "Dry distillation tar of defatting soybeanを英語表記で表すとGlyteer (TN)です。", "task": "replace ja to en", "name_q": "Dry distillation tar of defatting soybean", "name_a": "Glyteer (TN)"} +{"id": 32370, "instruction": "カスドゾキツグをを化学構造で表すと?", "response": "カスドゾキツグをを化学構造で表すとC6536H10104N1756O2046S42です。", "task": "formula", "name_q": "カスドゾキツグ", "name_a": "C6536H10104N1756O2046S42"} +{"id": 16897, "instruction": "Fawcettidineをを化学式で表すと?", "response": "Fawcettidineをを化学式で表すとC16H23NOです。", "task": "formula", "name_q": "Fawcettidine", "name_a": "C16H23NO"} +{"id": 1059, "instruction": "Mitotane (JAN/USP/INN)を主材料とする製品は?", "response": "Mitotane (JAN/USP/INN)を主材料とする製品はLYSODREN(HRAPharmaRareDiseases)です。", "task": "product", "name_q": "Mitotane (JAN/USP/INN)", "name_a": "LYSODREN(HRAPharmaRareDiseases)"} +{"id": 13821, "instruction": "Quinine (TN)をを化学構造で表すと?", "response": "Quinine (TN)をを化学構造で表すとC20H24N2O2. 2HClです。", "task": "formula", "name_q": "Quinine (TN)", "name_a": "C20H24N2O2. 2HCl"} +{"id": 16418, "instruction": "Oropharyngeal cancer SUPERGRP Head and neck cancer Solid tumor を日本語に訳すと?", "response": "Oropharyngeal cancer SUPERGRP Head and neck cancer Solid tumor を日本語に訳すと中咽頭癌 上位グループ 頭頸部癌 固形腫瘍 です。", "task": "replace en to ja", "name_q": "Oropharyngeal cancer SUPERGRP Head and neck cancer Solid tumor ", "name_a": "中咽頭癌 上位グループ 頭頸部癌 固形腫瘍 "} +{"id": 26090, "instruction": "乳酸亜鉛をを組成式で記述すると?", "response": "乳酸亜鉛をを組成式で記述するとC6H10O6Znです。", "task": "formula", "name_q": "乳酸亜鉛", "name_a": "C6H10O6Zn"} +{"id": 2272, "instruction": "Famciclovir (JAN/USP/INN)を主材料とする医薬品は?", "response": "Famciclovir (JAN/USP/INN)を主材料とする医薬品は後発品ファムシクロビル(コーアバイオテックベイ)です。", "task": "product", "name_q": "Famciclovir (JAN/USP/INN)", "name_a": "後発品ファムシクロビル(コーアバイオテックベイ)"} +{"id": 31071, "instruction": "2-Iodophenol methyl etherをを化学式で書くと?", "response": "2-Iodophenol methyl etherをを化学式で書くとC7H7IOです。", "task": "formula", "name_q": "2-Iodophenol methyl ether", "name_a": "C7H7IO"} +{"id": 3733, "instruction": "カミシモツトウの別名は?", "response": "カミシモツトウの別名は加味四物湯です。", "task": "replace", "name_q": "カミシモツトウ", "name_a": "加味四物湯"} +{"id": 2188, "instruction": "Extrinsic allergic alveolitisの別名は?", "response": "Extrinsic allergic alveolitisの別名はHypersensitivity pneumonitisです。", "task": "replace", "name_q": "Extrinsic allergic alveolitis", "name_a": "Hypersensitivity pneumonitis"} +{"id": 3626, "instruction": "Niclocide (TN)を日本語に訳すと?", "response": "Niclocide (TN)を日本語に訳すとNiclosamide (USAN/INN)です。", "task": "replace en to ja", "name_q": "Niclocide (TN)", "name_a": "Niclosamide (USAN/INN)"} +{"id": 29142, "instruction": "S-(2-Methylpropanoyl)-dihydrolipoamideをを化学式で書くと?", "response": "S-(2-Methylpropanoyl)-dihydrolipoamideをを化学式で書くとC12H23NO2S2です。", "task": "formula", "name_q": "S-(2-Methylpropanoyl)-dihydrolipoamide", "name_a": "C12H23NO2S2"} +{"id": 31960, "instruction": "ベイナグルチドの異なる表記は?", "response": "ベイナグルチドの異なる表記はBeinaglutide (INN)です。", "task": "replace", "name_q": "ベイナグルチド", "name_a": "Beinaglutide (INN)"} +{"id": 17135, "instruction": "Apronalを日本語表記で表すと?", "response": "Apronalを日本語表記で表すとアプロナリドです。", "task": "replace en to ja", "name_q": "Apronal", "name_a": "アプロナリド"} +{"id": 23727, "instruction": "Prochlorperazine edisylate (USP)をを化学構造で表すと?", "response": "Prochlorperazine edisylate (USP)をを化学構造で表すとC20H24ClN3S. C2H6O6S2です。", "task": "formula", "name_q": "Prochlorperazine edisylate (USP)", "name_a": "C20H24ClN3S. C2H6O6S2"} +{"id": 24689, "instruction": "ent-Copalyl diphosphateをを組成式で書くと?", "response": "ent-Copalyl diphosphateをを組成式で書くとC20H36O7P2です。", "task": "formula", "name_q": "ent-Copalyl diphosphate", "name_a": "C20H36O7P2"} +{"id": 20704, "instruction": "Rhodojaponin Iをは化学構造で表すと?", "response": "Rhodojaponin Iをは化学構造で表すとC24H36O8です。", "task": "formula", "name_q": "Rhodojaponin I", "name_a": "C24H36O8"} +{"id": 9119, "instruction": "Lanraplenib succinate (USAN)をを化学構造で記述すると?", "response": "Lanraplenib succinate (USAN)をを化学構造で記述すると(C23H25N9O)2. (C4H6O4)3です。", "task": "formula", "name_q": "Lanraplenib succinate (USAN)", "name_a": "(C23H25N9O)2. (C4H6O4)3"} +{"id": 21280, "instruction": "Sennoside A&Bの別の呼び方は?", "response": "Sennoside A&Bの別の呼び方はSennosideです。", "task": "replace", "name_q": "Sennoside A&B", "name_a": "Sennoside"} +{"id": 21245, "instruction": "Barnetil (TN)を日本語表記で表すと?", "response": "Barnetil (TN)を日本語表記で表すとSultopride hydrochloride (JAN)です。", "task": "replace en to ja", "name_q": "Barnetil (TN)", "name_a": "Sultopride hydrochloride (JAN)"} +{"id": 1314, "instruction": "チアメニジンをを組成式で表すと?", "response": "チアメニジンをを組成式で表すとC8H10ClN3Sです。", "task": "formula", "name_q": "チアメニジン", "name_a": "C8H10ClN3S"} +{"id": 2250, "instruction": "Trodusquemine (USAN/INN)をを化学式で記述すると?", "response": "Trodusquemine (USAN/INN)をを化学式で記述するとC37H72N4O5Sです。", "task": "formula", "name_q": "Trodusquemine (USAN/INN)", "name_a": "C37H72N4O5S"} +{"id": 13930, "instruction": "Anthracene-cis-1,2-dihydrodiolをの化学式は?", "response": "Anthracene-cis-1,2-dihydrodiolをの化学式はC14H12O2です。", "task": "formula", "name_q": "Anthracene-cis-1,2-dihydrodiol", "name_a": "C14H12O2"} +{"id": 27544, "instruction": "Cefazaflur sodium (USAN)をを化学式で表すと?", "response": "Cefazaflur sodium (USAN)をを化学式で表すとC13H12F3N6O4S3. Naです。", "task": "formula", "name_q": "Cefazaflur sodium (USAN)", "name_a": "C13H12F3N6O4S3. Na"} +{"id": 24899, "instruction": "Ginger (TN)の日本語訳は?", "response": "Ginger (TN)の日本語訳はGinger (JP18)です。", "task": "replace en to ja", "name_q": "Ginger (TN)", "name_a": "Ginger (JP18)"} +{"id": 4783, "instruction": "Isomangiferinをを化学式で表すと?", "response": "Isomangiferinをを化学式で表すとC19H18O11です。", "task": "formula", "name_q": "Isomangiferin", "name_a": "C19H18O11"} +{"id": 18315, "instruction": "Celiac diseaseを日本語で記述すると?", "response": "Celiac diseaseを日本語で記述するとセリアック病です。", "task": "replace en to ja", "name_q": "Celiac disease", "name_a": "セリアック病"} +{"id": 8321, "instruction": "Ecromeximab (USAN/INN)の別の言い方は?", "response": "Ecromeximab (USAN/INN)の別の言い方はエクロメキシマブです。", "task": "replace", "name_q": "Ecromeximab (USAN/INN)", "name_a": "エクロメキシマブ"} +{"id": 2372, "instruction": "Liothyronine (INN)の英語表記は?", "response": "Liothyronine (INN)の英語表記はThyrolar (TN)です。", "task": "replace ja to en", "name_q": "Liothyronine (INN)", "name_a": "Thyrolar (TN)"} +{"id": 13947, "instruction": "Becocalcidiol (USAN/INN)をを化学構造で記述すると?", "response": "Becocalcidiol (USAN/INN)をを化学構造で記述するとC23H36O2です。", "task": "formula", "name_q": "Becocalcidiol (USAN/INN)", "name_a": "C23H36O2"} +{"id": 15084, "instruction": "クロラムブシルをの組成式は?", "response": "クロラムブシルをの組成式はC14H19Cl2NO2です。", "task": "formula", "name_q": "クロラムブシル", "name_a": "C14H19Cl2NO2"} +{"id": 12185, "instruction": "Parbendazole (USAN/INN)をを組成式で記述すると?", "response": "Parbendazole (USAN/INN)をを組成式で記述するとC13H17N3O2です。", "task": "formula", "name_q": "Parbendazole (USAN/INN)", "name_a": "C13H17N3O2"} +{"id": 16875, "instruction": "カルバノレートは別の呼び方では?", "response": "カルバノレートは別の呼び方ではCarbanolateです。", "task": "replace", "name_q": "カルバノレート", "name_a": "Carbanolate"} +{"id": 32535, "instruction": "Wernicke-Korsakoff syndromeを日本語表記で表すと?", "response": "Wernicke-Korsakoff syndromeを日本語表記で表すとウェルニッケ・コルサコフ症候群です。", "task": "replace en to ja", "name_q": "Wernicke-Korsakoff syndrome", "name_a": "ウェルニッケ・コルサコフ症候群"} +{"id": 23947, "instruction": "GENERICFEBUXOSTAT(AlembicPharmaceuticalsLimited)を材料とする医薬品名は?", "response": "GENERICFEBUXOSTAT(AlembicPharmaceuticalsLimited)を材料とする医薬品名はFEBUXOSTAT(ZydusLifesciencesLimited)です。", "task": "product", "name_q": "GENERICFEBUXOSTAT(AlembicPharmaceuticalsLimited)", "name_a": "FEBUXOSTAT(ZydusLifesciencesLimited)"} +{"id": 11753, "instruction": "Trezix (TN)の異なる名称は?", "response": "Trezix (TN)の異なる名称はAcetaminophen, caffeine and dihydrocodeine bitartrateです。", "task": "replace", "name_q": "Trezix (TN)", "name_a": "Acetaminophen, caffeine and dihydrocodeine bitartrate"} +{"id": 7585, "instruction": "テトラカイン塩酸塩 (JP18)を英語で書くと?", "response": "テトラカイン塩酸塩 (JP18)を英語で書くとTetracaine hydrochloride (JP18/USP)です。", "task": "replace ja to en", "name_q": "テトラカイン塩酸塩 (JP18)", "name_a": "Tetracaine hydrochloride (JP18/USP)"} +{"id": 25488, "instruction": "Proxicromil (USAN/INN)をを化学構造で書くと?", "response": "Proxicromil (USAN/INN)をを化学構造で書くとC17H18O5です。", "task": "formula", "name_q": "Proxicromil (USAN/INN)", "name_a": "C17H18O5"} +{"id": 26748, "instruction": "ダネガプチドの英訳は?", "response": "ダネガプチドの英訳はDanegaptide (USAN/INN)です。", "task": "replace ja to en", "name_q": "ダネガプチド", "name_a": "Danegaptide (USAN/INN)"} +{"id": 32380, "instruction": "(+)-Muconolactoneの別呼称は?", "response": "(+)-Muconolactoneの別呼称は(S)-5-Oxo-2,5-dihydrofuran-2-acetateです。", "task": "replace", "name_q": "(+)-Muconolactone", "name_a": "(S)-5-Oxo-2,5-dihydrofuran-2-acetate"} +{"id": 12220, "instruction": "精巣形成不全を伴う乳児突然死症候群の英語表記は?", "response": "精巣形成不全を伴う乳児突然死症候群の英語表記はSudden infant death with dysgenesis of the testes syndromeです。", "task": "replace ja to en", "name_q": "精巣形成不全を伴う乳児突然死症候群", "name_a": "Sudden infant death with dysgenesis of the testes syndrome"} +{"id": 6438, "instruction": "1-Phosphatidyl-1D-myo-inositol 4-phosphateの異なる名称は?", "response": "1-Phosphatidyl-1D-myo-inositol 4-phosphateの異なる名称は1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate)です。", "task": "replace", "name_q": "1-Phosphatidyl-1D-myo-inositol 4-phosphate", "name_a": "1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate)"} +{"id": 18194, "instruction": "4alpha-(Hydroxymethyl)ergosta-7,24(24(1))-dien-3beta-olをを化学式で表すと?", "response": "4alpha-(Hydroxymethyl)ergosta-7,24(24(1))-dien-3beta-olをを化学式で表すとC29H48O2です。", "task": "formula", "name_q": "4alpha-(Hydroxymethyl)ergosta-7,24(24(1))-dien-3beta-ol", "name_a": "C29H48O2"} +{"id": 13069, "instruction": "Fenuronをを化学構造で書くと?", "response": "Fenuronをを化学構造で書くとC9H12N2Oです。", "task": "formula", "name_q": "Fenuron", "name_a": "C9H12N2O"} +{"id": 26614, "instruction": "家族性低βリポタンパク血症を英語に訳すと?", "response": "家族性低βリポタンパク血症を英語に訳すとFamilial hypobetalipoproteinemiaです。", "task": "replace ja to en", "name_q": "家族性低βリポタンパク血症", "name_a": "Familial hypobetalipoproteinemia"} +{"id": 870, "instruction": "アルベカシンを言い換えると?", "response": "アルベカシン��言い換えるとArbekacin (INN)です。", "task": "replace", "name_q": "アルベカシン", "name_a": "Arbekacin (INN)"} +{"id": 14632, "instruction": "Fenspiride hydrochloride (USAN)をを化学式で書くと?", "response": "Fenspiride hydrochloride (USAN)をを化学式で書くとC15H20N2O2. HClです。", "task": "formula", "name_q": "Fenspiride hydrochloride (USAN)", "name_a": "C15H20N2O2. HCl"} +{"id": 33076, "instruction": "Xenleta (TN)を利用した医薬品名は?", "response": "Xenleta (TN)を利用した医薬品名はANHYDROUSCITRICACID(NabrivaTherapeuticsUS)です。", "task": "product", "name_q": "Xenleta (TN)", "name_a": "ANHYDROUSCITRICACID(NabrivaTherapeuticsUS)"} +{"id": 21036, "instruction": "脳梁、心臓、目および生殖器形成不全症候群を英語で記述すると?", "response": "脳梁、心臓、目および生殖器形成不全症候群を英語で記述するとAgenesis of corpus callosum, cardiac, ocular, and genital syndromeです。", "task": "replace ja to en", "name_q": "脳梁、心臓、目および生殖器形成不全症候群", "name_a": "Agenesis of corpus callosum, cardiac, ocular, and genital syndrome"} +{"id": 34011, "instruction": "Physostigmine sulfate (USP)をの組成式は?", "response": "Physostigmine sulfate (USP)をの組成式は(C15H21N3O2)2. H2SO4です。", "task": "formula", "name_q": "Physostigmine sulfate (USP)", "name_a": "(C15H21N3O2)2. H2SO4"} +{"id": 3202, "instruction": "アセチル-CoA カルボキシラーゼ α 欠損症を英語で書くと?", "response": "アセチル-CoA カルボキシラーゼ α 欠損症を英語で書くとAcetyl-CoA carboxylase-alpha deficiencyです。", "task": "replace ja to en", "name_q": "アセチル-CoA カルボキシラーゼ α 欠損症", "name_a": "Acetyl-CoA carboxylase-alpha deficiency"} +{"id": 22723, "instruction": "2-Phosphinomethylmalateをの化学式は?", "response": "2-Phosphinomethylmalateをの化学式はC5H9O7Pです。", "task": "formula", "name_q": "2-Phosphinomethylmalate", "name_a": "C5H9O7P"} +{"id": 34134, "instruction": "Dystrophinopathies SUBGROUP Duchenne muscular dystrophy (DMD) Becker muscular dystrophy (BMD) X-linked dilated cardiomyopathy (XLCM) を日本語で記述すると?", "response": "Dystrophinopathies SUBGROUP Duchenne muscular dystrophy (DMD) Becker muscular dystrophy (BMD) X-linked dilated cardiomyopathy (XLCM) を日本語で記述するとジストロフィン異常症 下位グループ デュシェンヌ型筋ジストロフィー ベッカー型筋ジストロフィー X連鎖拡張型心筋症 です。", "task": "replace en to ja", "name_q": "Dystrophinopathies SUBGROUP Duchenne muscular dystrophy (DMD) Becker muscular dystrophy (BMD) X-linked dilated cardiomyopathy (XLCM) ", "name_a": "ジストロフィン異常症 下位グループ デュシェンヌ型筋ジストロフィー ベッカー型筋ジストロフィー X連鎖拡張型心筋症 "} +{"id": 29593, "instruction": "ケンペリドをは組成式で表すと?", "response": "ケンペリドをは組成式で表すとC16H12O6です。", "task": "formula", "name_q": "ケンペリド", "name_a": "C16H12O6"} +{"id": 24485, "instruction": "色素性乾皮症 上位グループ ヌクレオチド除去修復機構異常疾患 を英語表記で表すと?", "response": "色素性乾皮症 上位グループ ヌクレオチド除去修復機構異常疾患 を英語表記で表すとXeroderma pigmentosum SUPERGRP Disorders of nucleotide excision repair です。", "task": "replace ja to en", "name_q": "色素性乾皮症 上位グループ ヌクレオチド除去修復機構異常疾患 ", "name_a": "Xeroderma pigmentosum SUPERGRP Disorders of nucleotide excision repair "} +{"id": 26656, "instruction": "Flumioxazinをを分子式で書くと?", "response": "Flumioxazinをを分子式で書くとC19H15FN2O4です。", "task": "formula", "name_q": "Flumioxazin", "name_a": "C19H15FN2O4"} +{"id": 258, "instruction": "dTDP-D-galacturonateをを組成式で記述すると?", "response": "dTDP-D-galacturonateをを組成式で記述するとC16H24N2O17P2です。", "task": "formula", "name_q": "dTDP-D-galacturonate", "name_a": "C16H24N2O17P2"} +{"id": 4722, "instruction": "ジョウガンイッポウを英語で書くと?", "response": "ジョウガンイッポウを英語で書くとJogan'ippoです。", "task": "replace ja to en", "name_q": "ジョウガンイッポウ", "name_a": "Jogan'ippo"} +{"id": 33604, "instruction": "dl-メチルエフェドリン塩酸塩・ジヒドロコデインリン酸塩・ジプロフィリン・ジフェンヒドラミンサリチル酸塩・アセトアミノフェン・ブロモバレリル尿素を用いた医薬品名は?", "response": "dl-メチルエフェドリン塩酸塩・ジヒドロコデインリン酸塩・ジプロフィリン・ジフェンヒドラミンサリチル酸塩・アセトアミノフェン・ブロモバレリル尿素を用いた医薬品名はカフコデ(ヴィアトリス・ヘルスケア)です。", "task": "product", "name_q": "dl-メチルエフェドリン塩酸塩・ジヒドロコデインリン酸塩・ジプロフィリン・ジフェンヒドラミンサリチル酸塩・アセトアミノフェン・ブロモバレリル尿素", "name_a": "カフコデ(ヴィアトリス・ヘルスケア)"} +{"id": 32155, "instruction": "Imazosulfuronをを組成式で表すと?", "response": "Imazosulfuronをを組成式で表すとC14H13ClN6O5Sです。", "task": "formula", "name_q": "Imazosulfuron", "name_a": "C14H13ClN6O5S"} +{"id": 15291, "instruction": "Allyl chlorideをの分子式は?", "response": "Allyl chlorideをの分子式はC3H5Clです。", "task": "formula", "name_q": "Allyl chloride", "name_a": "C3H5Cl"} +{"id": 16288, "instruction": "Coly-Mycin S (TN)の別呼称は?", "response": "Coly-Mycin S (TN)の別呼称はHydrocortisone acetate, neomycin sulfate, colistin sulfate and thonzonium bromideです。", "task": "replace", "name_q": "Coly-Mycin S (TN)", "name_a": "Hydrocortisone acetate, neomycin sulfate, colistin sulfate and thonzonium bromide"} +{"id": 18381, "instruction": "塩酸プロカテロールをの分子式は?", "response": "塩酸プロカテロールをの分子式はC16H22N2O3. HClです。", "task": "formula", "name_q": "塩酸プロカテロール", "name_a": "C16H22N2O3. HCl"} +{"id": 6167, "instruction": "カテコールアミン誘発性多形性心室頻拍の英訳は?", "response": "カテコールアミン誘発性多形性心室頻拍の英訳はCatecholaminergic polymorphic ventricular tachycardiaです。", "task": "replace ja to en", "name_q": "カテコールアミン誘発性多形性心室頻拍", "name_a": "Catecholaminergic polymorphic ventricular tachycardia"} +{"id": 22422, "instruction": "シチコリンナトリウムの別名は?", "response": "シチコリンナトリウムの別名はCiticoline sodium (USAN)です。", "task": "replace", "name_q": "シチコリンナトリウム", "name_a": "Citicoline sodium (USAN)"} +{"id": 14808, "instruction": "Pentazocineをを分子式で表すと?", "response": "Pentazocineをを分子式で表すとC19H27NOです。", "task": "formula", "name_q": "Pentazocine", "name_a": "C19H27NO"} +{"id": 27044, "instruction": "o-Phthalaldehydeを使用した医薬品は?", "response": "o-Phthalaldehydeを使用した医薬品はフタラール(中北薬品)です。", "task": "product", "name_q": "o-Phthalaldehyde", "name_a": "フタラール(中北薬品)"} +{"id": 10031, "instruction": "6-alpha-Maltosylglucoseをを分子式で書くと?", "response": "6-alpha-Maltosylglucoseをを分子式で書くとC18H32O16です。", "task": "formula", "name_q": "6-alpha-Maltosylglucose", "name_a": "C18H32O16"} +{"id": 7233, "instruction": "2-ニトロプロパンをの分子式は?", "response": "2-ニトロプロパンをの分子式はC3H7NO2です。", "task": "formula", "name_q": "2-ニトロプロパン", "name_a": "C3H7NO2"} +{"id": 19113, "instruction": "T+B+Severe combined immunodeficiencies (SCIDs) SUPERGRP Disorders of adaptive immunity Primary immunodeficiency disease を日本語で書くと?", "response": "T+B+Severe combined immunodeficiencies (SCIDs) SUPERGRP Disorders of adaptive immunity Primary immunodeficiency disease を日本語で書くとT+B+ 重症複合免疫不全症 上位グループ 獲得免疫の障害 原発性免疫不全症 です。", "task": "replace en to ja", "name_q": "T+B+Severe combined immunodeficiencies (SCIDs) SUPERGRP Disorders of adaptive immunity Primary immunodeficiency disease ", "name_a": "T+B+ 重症複合免疫不全症 上位グループ 獲得免疫の障害 原発性免疫不全症 "} +{"id": 4501, "instruction": "クロルプロマジンの別の呼び方は?", "response": "クロルプロマジンの別の呼び方はChlorpromazineです。", "task": "replace", "name_q": "クロルプロマジン", "name_a": "Chlorpromazine"} +{"id": 29618, "instruction": "Benzoxonium chloride (INN)をを化学構造で表すと?", "response": "Benzoxonium chloride (INN)をを化学構造で表すとC23H42NO2. Clです。", "task": "formula", "name_q": "Benzoxonium chloride (INN)", "name_a": "C23H42NO2. Cl"} +{"id": 3542, "instruction": "2-(4-Methoxyphenethyl)chromoneを言い換えると?", "response": "2-(4-Methoxyphenethyl)chromoneを言い換えると2-(4-メトキシフェネチル)クロモンです。", "task": "replace", "name_q": "2-(4-Methoxyphenethyl)chromone", "name_a": "2-(4-メトキシフェネチル)クロモン"} +{"id": 30749, "instruction": "N-acetylglutamate synthase deficiency SUPERGRP Primary hyperammonemia (Urea cycle disorders) を日本語に訳すと?", "response": "N-acetylglutamate synthase deficiency SUPERGRP Primary hyperammonemia (Urea cycle disorders) を日本語に訳すとNAGS欠損症 上位グループ 尿素サイクル異常症 です。", "task": "replace en to ja", "name_q": "N-acetylglutamate synthase deficiency SUPERGRP Primary hyperammonemia (Urea cycle disorders) ", "name_a": "NAGS欠損症 上位グループ 尿素サイクル異常症 "} +{"id": 1071, "instruction": "クロルテトラサイクリンの別名は?", "response": "クロルテトラサイクリンの別名はChlortetracycline (INN)です。", "task": "replace", "name_q": "クロルテトラサイクリン", "name_a": "Chlortetracycline (INN)"} +{"id": 2395, "instruction": "オベスタチンは別の呼び方では?", "response": "オベスタチンは別の呼び方ではObestatinです。", "task": "replace", "name_q": "オベスタチン", "name_a": "Obestatin"} +{"id": 4715, "instruction": "Micheliolideをは組成式で表すと?", "response": "Micheliolideをは組成式で表すとC15H20O3です。", "task": "formula", "name_q": "Micheliolide", "name_a": "C15H20O3"} +{"id": 11726, "instruction": "O-D-Mannosylproteinをを化学式で書くと?", "response": "O-D-Mannosylproteinをを化学式で書くとC10H16N2O8R2です。", "task": "formula", "name_q": "O-D-Mannosylprotein", "name_a": "C10H16N2O8R2"} +{"id": 34208, "instruction": "Guinea green Bをを化学構造で記述すると?", "response": "Guinea green Bをを化学構造で記述するとC37H35N2O6S2. 2Naです。", "task": "formula", "name_q": "Guinea green B", "name_a": "C37H35N2O6S2. 2Na"} +{"id": 33722, "instruction": "UDP-2-deoxyglucoseをを化学式で表すと?", "response": "UDP-2-deoxyglucoseをを化学式で表すとC15H24N2O16P2です。", "task": "formula", "name_q": "UDP-2-deoxyglucose", "name_a": "C15H24N2O16P2"} +{"id": 27252, "instruction": "3-(m-Aminophenyl)-2-(p-methoxyphenyl)acrylonitrileをを組成式で書くと?", "response": "3-(m-Aminophenyl)-2-(p-methoxyphenyl)acrylonitrileをを組成式で書くとC16H14N2Oです。", "task": "formula", "name_q": "3-(m-Aminophenyl)-2-(p-methoxyphenyl)acrylonitrile", "name_a": "C16H14N2O"} +{"id": 10811, "instruction": "Plasminogen activator inhibitor type 1 deficiencyの日本語訳は?", "response": "Plasminogen activator inhibitor type 1 deficiencyの日本語訳はプラスミノーゲン活性化因子インヒビター1欠損症です。", "task": "replace en to ja", "name_q": "Plasminogen activator inhibitor type 1 deficiency", "name_a": "プラスミノーゲン活性化因子インヒビター1欠損症"} +{"id": 3232, "instruction": "Biocidan (TN)をは分子式で表すと?", "response": "Biocidan (TN)をは分子式で表すとC24H50NO. Brです。", "task": "formula", "name_q": "Biocidan (TN)", "name_a": "C24H50NO. Br"} +{"id": 28456, "instruction": "ヒアルロン酸Na(科研製薬)を用いた製品は?", "response": "ヒアルロン酸Na(科研製薬)を用いた製品は後発品ヒアルロン酸Na(MeijiSeikaファルマ)です。", "task": "product", "name_q": "ヒアルロン酸Na(科研製薬)", "name_a": "後発品ヒアルロン酸Na(MeijiSeikaファルマ)"} +{"id": 30991, "instruction": "Ruzotolimod (USAN/INN)をの分子式は?", "response": "Ruzotolimod (USAN/INN)をの分子式はC14H18N4O5Sです。", "task": "formula", "name_q": "Ruzotolimod (USAN/INN)", "name_a": "C14H18N4O5S"} +{"id": 13240, "instruction": "N-Acetyl-D-mannosamine 6-phosphateをの分子式は?", "response": "N-Acetyl-D-mannosamine 6-phosphateをの分子式はC8H16NO9Pです。", "task": "formula", "name_q": "N-Acetyl-D-mannosamine 6-phosphate", "name_a": "C8H16NO9P"} +{"id": 27554, "instruction": "Oleyl oleate (NF)を日本語で書くと?", "response": "Oleyl oleate (NF)を日本語で書くとオレイン酸オレイルです。", "task": "replace en to ja", "name_q": "Oleyl oleate (NF)", "name_a": "オレイン酸オレイル"} +{"id": 2317, "instruction": "Chinese angelica rootの別呼称は?", "response": "Chinese angelica rootの別呼称は唐当帰です。", "task": "replace", "name_q": "Chinese angelica root", "name_a": "唐当帰"} +{"id": 3654, "instruction": "シクロプロパンをは組成式で表すと?", "response": "シクロプロパンをは組成式で表すとC3H6です。", "task": "formula", "name_q": "シクロプロパン", "name_a": "C3H6"} +{"id": 24861, "instruction": "Argi-U (TN)の日本語訳は?", "response": "Argi-U (TN)の日本語訳はL-アルギニン・L-アルギニン塩酸塩です。", "task": "replace en to ja", "name_q": "Argi-U (TN)", "name_a": "L-アルギニン・L-アルギニン塩酸塩"} +{"id": 31849, "instruction": "1,3,7-Trimethyluric acidの別名称は?", "response": "1,3,7-Trimethyluric acidの別名称は1,3,7-Trimethylurateです。", "task": "replace", "name_q": "1,3,7-Trimethyluric acid", "name_a": "1,3,7-Trimethylurate"} +{"id": 3431, "instruction": "Boric acid and Inorganic saltの異なる表記は?", "response": "Boric acid and Inorganic saltの異なる表記はホウ酸・無機塩類です。", "task": "replace", "name_q": "Boric acid and Inorganic salt", "name_a": "ホウ酸・無機塩類"} +{"id": 33761, "instruction": "2-Hydroxy-1,3-benzenedicarboxylic acidをの化学式は?", "response": "2-Hydroxy-1,3-benzenedicarboxylic acidをの化学式はC8H6O5です。", "task": "formula", "name_q": "2-Hydroxy-1,3-benzenedicarboxylic acid", "name_a": "C8H6O5"} +{"id": 8883, "instruction": "Phosphijet (TN)をを組��式で書くと?", "response": "Phosphijet (TN)をを組成式で書くとC9H14NO2Pです。", "task": "formula", "name_q": "Phosphijet (TN)", "name_a": "C9H14NO2P"} +{"id": 1126, "instruction": "Lymecycline (INN)をを化学構造で表すと?", "response": "Lymecycline (INN)をを化学構造で表すとC29H38N4O10です。", "task": "formula", "name_q": "Lymecycline (INN)", "name_a": "C29H38N4O10"} +{"id": 2424, "instruction": "IPRATROPIUMBROMIDEANDALBUTEROLSULFATE(PreferredPharmaceuticals)を利用した薬品は?", "response": "IPRATROPIUMBROMIDEANDALBUTEROLSULFATE(PreferredPharmaceuticals)を利用した薬品はIPRATROPIUMBROMIDEANDALBUTEROLSULFATE(GoldenStateMedicalSupply)です。", "task": "product", "name_q": "IPRATROPIUMBROMIDEANDALBUTEROLSULFATE(PreferredPharmaceuticals)", "name_a": "IPRATROPIUMBROMIDEANDALBUTEROLSULFATE(GoldenStateMedicalSupply)"} +{"id": 14079, "instruction": "L-アスパラギナーゼ (JAN)を英語表記で表すと?", "response": "L-アスパラギナーゼ (JAN)を英語表記で表すとAsparaginase erwinia chrysanthemi (recombinant)-rywnです。", "task": "replace ja to en", "name_q": "L-アスパラギナーゼ (JAN)", "name_a": "Asparaginase erwinia chrysanthemi (recombinant)-rywn"} +{"id": 10561, "instruction": "2,3,5,6-Tetrachlorophenolをは分子式で表すと?", "response": "2,3,5,6-Tetrachlorophenolをは分子式で表すとC6H2Cl4Oです。", "task": "formula", "name_q": "2,3,5,6-Tetrachlorophenol", "name_a": "C6H2Cl4O"} +{"id": 12020, "instruction": "Fradiomycin Bを言い換えると?", "response": "Fradiomycin Bを言い換えるとネオマイシンBです。", "task": "replace", "name_q": "Fradiomycin B", "name_a": "ネオマイシンB"} +{"id": 21209, "instruction": "Palmitoyl-CoAを言い換えると?", "response": "Palmitoyl-CoAを言い換えるとHexadecanoyl-CoAです。", "task": "replace", "name_q": "Palmitoyl-CoA", "name_a": "Hexadecanoyl-CoA"} +{"id": 15677, "instruction": "Nocturnal frontal lobe epilepsy SUBGROUP Autosomal dominant nocturnal frontal lobe epilepsyを日本語表記で表すと?", "response": "Nocturnal frontal lobe epilepsy SUBGROUP Autosomal dominant nocturnal frontal lobe epilepsyを日本語表記で表すと夜間前頭葉てんかん 下位グループ 常染色体優性夜間前頭葉てんかんです。", "task": "replace en to ja", "name_q": "Nocturnal frontal lobe epilepsy SUBGROUP Autosomal dominant nocturnal frontal lobe epilepsy", "name_a": "夜間前頭葉てんかん 下位グループ 常染色体優性夜間前頭葉てんかん"} +{"id": 33467, "instruction": "シスタチオニン尿症を英語で書くと?", "response": "シスタチオニン尿症を英語で書くとCystathioninuriaです。", "task": "replace ja to en", "name_q": "シスタチオニン尿症", "name_a": "Cystathioninuria"} +{"id": 27579, "instruction": "p-Cresyl acetateの別記述は?", "response": "p-Cresyl acetateの別記述はTolylacetateです。", "task": "replace", "name_q": "p-Cresyl acetate", "name_a": "Tolylacetate"} +{"id": 18007, "instruction": "Ombitasvir (USAN/INN)をを化学構造で書くと?", "response": "Ombitasvir (USAN/INN)をを化学構造で書くとC50H67N7O8です。", "task": "formula", "name_q": "Ombitasvir (USAN/INN)", "name_a": "C50H67N7O8"} +{"id": 24212, "instruction": "Forasartan (USAN/INN)をは組成式で表すと?", "response": "Forasartan (USAN/INN)をは組成式で表すとC23H28N8です。", "task": "formula", "name_q": "Forasartan (USAN/INN)", "name_a": "C23H28N8"} +{"id": 4755, "instruction": "11H-Benz[bc]aceanthryleneをは化学構造で表すと?", "response": "11H-Benz[bc]aceanthryleneをは化学構造で表すとC19H12です。", "task": "formula", "name_q": "11H-Benz[bc]aceanthrylene", "name_a": "C19H12"} +{"id": 15899, "instruction": "Asperlicin Cをを化学式で書くと?", "response": "Asperlicin Cをを化学式で書くとC25H18N4O2です。", "task": "formula", "name_q": "Asperlicin C", "name_a": "C25H18N4O2"} +{"id": 14528, "instruction": "Aminoguanidine hydrochlorideをを化学式で書くと?", "response": "Aminoguanidine hydrochlorideをを化学式で書くとCH6N4. HClです。", "task": "formula", "name_q": "Aminoguanidine hydrochloride", "name_a": "CH6N4. HCl"} +{"id": 14869, "instruction": "オキシラセタムを英語表記で表すと?", "response": "オキシラセタムを英語表記で表すとOxiracetam (INN)です。", "task": "replace ja to en", "name_q": "オキシラセタム", "name_a": "Oxiracetam (INN)"} +{"id": 25460, "instruction": "1-Nitroso-L-prolineをを化学式で記述すると?", "response": "1-Nitroso-L-prolineをを化学式で記述するとC5H8N2O3です。", "task": "formula", "name_q": "1-Nitroso-L-proline", "name_a": "C5H8N2O3"} +{"id": 22904, "instruction": "Penile cancerを日本語に訳すと?", "response": "Penile cancerを日本語に訳すと陰茎癌です。", "task": "replace en to ja", "name_q": "Penile cancer", "name_a": "陰茎癌"} +{"id": 6811, "instruction": "Bromperidol (JAN/USAN/INN)をは化学構造で表すと?", "response": "Bromperidol (JAN/USAN/INN)をは化学構造で表すとC21H23BrFNO2です。", "task": "formula", "name_q": "Bromperidol (JAN/USAN/INN)", "name_a": "C21H23BrFNO2"} +{"id": 11654, "instruction": "3,5,3'-Triiodothyropyruvateの異なる名称は?", "response": "3,5,3'-Triiodothyropyruvateの異なる名称は3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-2-oxopropanoateです。", "task": "replace", "name_q": "3,5,3'-Triiodothyropyruvate", "name_a": "3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-2-oxopropanoate"} +{"id": 3045, "instruction": "遺伝性痙性対麻痺 下位グループ MASA 症候群 を英語に訳すと?", "response": "遺伝性痙性対麻痺 下位グループ MASA 症候群 を英語に訳すとHereditary spastic paraplegia SUBGROUP MASA syndrome です。", "task": "replace ja to en", "name_q": "遺伝性痙性対麻痺 下位グループ MASA 症候群 ", "name_a": "Hereditary spastic paraplegia SUBGROUP MASA syndrome "} +{"id": 27371, "instruction": "イミダプリルをを組成式で表すと?", "response": "イミダプリルをを組成式で表すとC20H27N3O6です。", "task": "formula", "name_q": "イミダプリル", "name_a": "C20H27N3O6"} +{"id": 16704, "instruction": "Zolmitriptanの異なる表記は?", "response": "Zolmitriptanの異なる表記はゾルミトリプタンです。", "task": "replace", "name_q": "Zolmitriptan", "name_a": "ゾルミトリプタン"} +{"id": 11030, "instruction": "Darunavir hydrateをを組成式で表すと?", "response": "Darunavir hydrateをを組成式で表すとC27H37N3O7S. xH2Oです。", "task": "formula", "name_q": "Darunavir hydrate", "name_a": "C27H37N3O7S. xH2O"} +{"id": 21248, "instruction": "2-Glycolylamido-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranoseの別名称は?", "response": "2-Glycolylamido-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranoseの別名称はN-Glycolylmuramic acidです。", "task": "replace", "name_q": "2-Glycolylamido-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose", "name_a": "N-Glycolylmuramic acid"} +{"id": 399, "instruction": "ダカルバジンクエン酸塩をを化学式で書くと?", "response": "ダカルバジンクエン酸塩をを化学式で書くとC6H8O7. C6H10N6Oです。", "task": "formula", "name_q": "ダカルバジンクエン酸塩", "name_a": "C6H8O7. C6H10N6O"} +{"id": 10319, "instruction": "Benexate hydrochloride betadex (JAN)の英訳は?", "response": "Benexate hydrochloride betadex (JAN)の英訳はUlgut (TN)です。", "task": "replace ja to en", "name_q": "Benexate hydrochloride betadex (JAN)", "name_a": "Ulgut (TN)"} +{"id": 32076, "instruction": "シュクシャ(栃本天海堂)を利用した製品名は?", "response": "シュクシャ(栃本天海堂)を利用した製品名は縮砂(小島漢方)です。", "task": "product", "name_q": "シュクシャ(栃本天海堂)", "name_a": "縮砂(小島漢方)"} +{"id": 6283, "instruction": "メストラノール・リネストレノールの別名称は?", "response": "メストラノール・リネストレノールの別名称はMestranol and lynestrenolです。", "task": "replace", "name_q": "メストラノール・リネストレノール", "name_a": "Mestranol and lynestrenol"} +{"id": 26749, "instruction": "Etofenproxをを化学構造で記述すると?", "response": "Etofenproxをを化学構造で記述するとC25H28O3です。", "task": "formula", "name_q": "Etofenprox", "name_a": "C25H28O3"} +{"id": 3909, "instruction": "Merestinib (USAN/INN)をを組成式で記述すると?", "response": "Merestinib (USAN/INN)をを組成式で記述するとC30H22F2N6O3です。", "task": "formula", "name_q": "Merestinib (USAN/INN)", "name_a": "C30H22F2N6O3"} +{"id": 11286, "instruction": "C40H59NO11. CH4SO3を使用した製品は?", "response": "C40H59NO11. CH4SO3を使用した製品はERIBULINMESYLATE(GlandPharmaLimited)です。", "task": "product", "name_q": "C40H59NO11. CH4SO3", "name_a": "ERIBULINMESYLATE(GlandPharmaLimited)"} +{"id": 2912, "instruction": "Pemfexy (TN)をは化学構造で表すと?", "response": "Pemfexy (TN)をは化学構造で表すとC20H21N5O6です。", "task": "formula", "name_q": "Pemfexy (TN)", "name_a": "C20H21N5O6"} +{"id": 30119, "instruction": "Zaki syndromeの日本語表記は?", "response": "Zaki syndromeの日本語表記はZaki 症候群です。", "task": "replace en to ja", "name_q": "Zaki syndrome", "name_a": "Zaki 症候群"} +{"id": 1325, "instruction": "Elm (USP)の異なる名称は?", "response": "Elm (USP)の異なる名称はニレです。", "task": "replace", "name_q": "Elm (USP)", "name_a": "ニレ"} +{"id": 23202, "instruction": "Dexylosylpradimicin Cをを組成式で記述すると?", "response": "Dexylosylpradimicin Cをを組成式で記述するとC34H34N2O14です。", "task": "formula", "name_q": "Dexylosylpradimicin C", "name_a": "C34H34N2O14"} +{"id": 16572, "instruction": "アルミニウムジルコニウムテトラクロロ水和物の異なる表記は?", "response": "アルミニウムジルコニウムテトラクロロ水和物の異なる表��はAluminum zirconium tetrachlorohydrate (USP)です。", "task": "replace", "name_q": "アルミニウムジルコニウムテトラクロロ水和物", "name_a": "Aluminum zirconium tetrachlorohydrate (USP)"} +{"id": 31015, "instruction": "Sabatolimab (genetical recombination) (JAN)の別の呼び方は?", "response": "Sabatolimab (genetical recombination) (JAN)の別の呼び方はサバトリマブ (遺伝子組換え) (JAN)です。", "task": "replace", "name_q": "Sabatolimab (genetical recombination) (JAN)", "name_a": "サバトリマブ (遺伝子組換え) (JAN)"} +{"id": 21909, "instruction": "Mucocutaneous lymph node syndromeの日本語訳は?", "response": "Mucocutaneous lymph node syndromeの日本語訳は川崎病です。", "task": "replace en to ja", "name_q": "Mucocutaneous lymph node syndrome", "name_a": "川崎病"} +{"id": 29972, "instruction": "PROPYLTHIOURACIL(AmericanHealthPackaging)をは化学構造で表すと?", "response": "PROPYLTHIOURACIL(AmericanHealthPackaging)をは化学構造で表すとC7H10N2OSです。", "task": "formula", "name_q": "PROPYLTHIOURACIL(AmericanHealthPackaging)", "name_a": "C7H10N2OS"} +{"id": 28083, "instruction": "Retosiban (USAN)をを化学構造で記述すると?", "response": "Retosiban (USAN)をを化学構造で記述するとC27H34N4O5です。", "task": "formula", "name_q": "Retosiban (USAN)", "name_a": "C27H34N4O5"} +{"id": 2037, "instruction": "Hereditary congenital facial paresisを日本語表記で表すと?", "response": "Hereditary congenital facial paresisを日本語表記で表すと先天性顔面神経麻痺です。", "task": "replace en to ja", "name_q": "Hereditary congenital facial paresis", "name_a": "先天性顔面神経麻痺"} +{"id": 26880, "instruction": "SODIUMPHENYLACETATEANDSODIUMBENZOATE(ZydusPharmaceuticalsUSA)を材料とする商品は?", "response": "SODIUMPHENYLACETATEANDSODIUMBENZOATE(ZydusPharmaceuticalsUSA)を材料とする商品はSODIUMPHENYLACETATEANDSODIUMBENZOATE(MAIAPHARMACEUTICALS)です。", "task": "product", "name_q": "SODIUMPHENYLACETATEANDSODIUMBENZOATE(ZydusPharmaceuticalsUSA)", "name_a": "SODIUMPHENYLACETATEANDSODIUMBENZOATE(MAIAPHARMACEUTICALS)"} +{"id": 9141, "instruction": "ゴニオタレノールの別記述は?", "response": "ゴニオタレノールの別記述はGoniothalenolです。", "task": "replace", "name_q": "ゴニオタレノール", "name_a": "Goniothalenol"} +{"id": 21800, "instruction": "明細胞肉腫 上位グループ 固形腫瘍 軟部肉腫 の英訳は?", "response": "明細胞肉腫 上位グループ 固形腫瘍 軟部肉腫 の英訳はClear cell sarcoma of soft tissue SUPERGRP Solid tumor Soft tissue sarcomas です。", "task": "replace ja to en", "name_q": "明細胞肉腫 上位グループ 固形腫瘍 軟部肉腫 ", "name_a": "Clear cell sarcoma of soft tissue SUPERGRP Solid tumor Soft tissue sarcomas "} +{"id": 16596, "instruction": "歌舞伎症候群を英語に訳すと?", "response": "歌舞伎症候群を英語に訳すとKabuki syndromeです。", "task": "replace ja to en", "name_q": "歌舞伎症候群", "name_a": "Kabuki syndrome"} +{"id": 10538, "instruction": "Protelos (TN)をを化学構造で記述すると?", "response": "Protelos (TN)をを化学構造で記述するとC12H10N2O8S. 2Srです。", "task": "formula", "name_q": "Protelos (TN)", "name_a": "C12H10N2O8S. 2Sr"} +{"id": 859, "instruction": "Benzal chlorideの別記述は?", "response": "Benzal chlorideの別記述はベンザルクロリドです。", "task": "replace", "name_q": "Benzal chloride", "name_a": "ベンザルクロリド"} +{"id": 14992, "instruction": "Imazalil nitrateをの化学構造は?", "response": "Imazalil nitrateをの化学構造はC14H14Cl2N2O. HNO3です。", "task": "formula", "name_q": "Imazalil nitrate", "name_a": "C14H14Cl2N2O. HNO3"} +{"id": 6932, "instruction": "N-Benzyloxycarbonylglycineをを化学式で書くと?", "response": "N-Benzyloxycarbonylglycineをを化学式で書くとC10H11NO4です。", "task": "formula", "name_q": "N-Benzyloxycarbonylglycine", "name_a": "C10H11NO4"} +{"id": 17276, "instruction": "Teplizumab (USAN/INN)をの化学構造は?", "response": "Teplizumab (USAN/INN)をの化学構造はC6462H9938N1738O2022S46です。", "task": "formula", "name_q": "Teplizumab (USAN/INN)", "name_a": "C6462H9938N1738O2022S46"} +{"id": 14907, "instruction": "サルコシン血症を英語で記述すると?", "response": "サルコシン血症を英語で記述するとSarcosinemiaです。", "task": "replace ja to en", "name_q": "サルコシン血症", "name_a": "Sarcosinemia"} +{"id": 8524, "instruction": "Estradiol dipropionate (JAN)をの組成式は?", "response": "Estradiol dipropionate (JAN)をの組成式はC24H32O4です。", "task": "formula", "name_q": "Estradiol dipropionate (JAN)", "name_a": "C24H32O4"} +{"id": 16830, "instruction": "高良姜の別名は?", "response": "高良姜の別名はコウリョウキョウです。", "task": "replace", "name_q": "高良姜", "name_a": "コウリョウキョウ"} +{"id": 672, "instruction": "ミトスペルを英語で記述すると?", "response": "ミトスペルを英語で記述するとMitosper (USAN/INN)です。", "task": "replace ja to en", "name_q": "ミトスペル", "name_a": "Mitosper (USAN/INN)"} +{"id": 32450, "instruction": "N-Methylanthranilic acidの別の呼び方は?", "response": "N-Methylanthranilic acidの別の呼び方はN-Methylanthranilateです。", "task": "replace", "name_q": "N-Methylanthranilic acid", "name_a": "N-Methylanthranilate"} +{"id": 18787, "instruction": "SB 200646をを分子式で記述すると?", "response": "SB 200646をを分子式で記述するとC15H14N4Oです。", "task": "formula", "name_q": "SB 200646", "name_a": "C15H14N4O"} +{"id": 4471, "instruction": "Adaprolol maleate (USAN)をを分子式で書くと?", "response": "Adaprolol maleate (USAN)をを分子式で書くとC26H39NO4. C4H4O4です。", "task": "formula", "name_q": "Adaprolol maleate (USAN)", "name_a": "C26H39NO4. C4H4O4"} +{"id": 7537, "instruction": "Elemental mercuryの異なる表現は?", "response": "Elemental mercuryの異なる表現はMercuryです。", "task": "replace", "name_q": "Elemental mercury", "name_a": "Mercury"} +{"id": 8727, "instruction": "ペキサスチモジンデバシレプベクの英訳は?", "response": "ペキサスチモジンデバシレプベクの英訳はPexastimogene devacirepvec (USAN/INN)です。", "task": "replace ja to en", "name_q": "ペキサスチモジンデバシレプベク", "name_a": "Pexastimogene devacirepvec (USAN/INN)"} +{"id": 33802, "instruction": "4-Hydroxycinnamoylmethaneの異なる表記は?", "response": "4-Hydroxycinnamoylmethaneの異なる表記は4-Hydroxybenzalacetoneです。", "task": "replace", "name_q": "4-Hydroxycinnamoylmethane", "name_a": "4-Hydroxybenzalacetone"} +{"id": 1623, "instruction": "Bensulfuron-methylをの分子式は?", "response": "Bensulfuron-methylをの分子式はC16H18N4O7Sです。", "task": "formula", "name_q": "Bensulfuron-methyl", "name_a": "C16H18N4O7S"} +{"id": 31738, "instruction": "ホスホセリンホスファターゼ欠損症の英語表記は?", "response": "ホスホセリンホスファターゼ欠損症の英語表記はPhosphoserine phosphatase deficiencyです。", "task": "replace ja to en", "name_q": "ホスホセリンホスファターゼ欠損症", "name_a": "Phosphoserine phosphatase deficiency"} +{"id": 34445, "instruction": "塩化アルミニウム水和物の英訳は?", "response": "塩化アルミニウム水和物の英訳はAluminum chloride (USP)です。", "task": "replace ja to en", "name_q": "塩化アルミニウム水和物", "name_a": "Aluminum chloride (USP)"} +{"id": 28848, "instruction": "Cannabisin Fをを分子式で表すと?", "response": "Cannabisin Fをを分子式で表すとC36H36N2O8です。", "task": "formula", "name_q": "Cannabisin F", "name_a": "C36H36N2O8"} +{"id": 5501, "instruction": "フロニカミドを言い換えると?", "response": "フロニカミドを言い換えるとFlonicamidです。", "task": "replace", "name_q": "フロニカミド", "name_a": "Flonicamid"} +{"id": 8633, "instruction": "Milnacipran (INN)をは化学式で表すと?", "response": "Milnacipran (INN)をは化学式で表すとC15H22N2Oです。", "task": "formula", "name_q": "Milnacipran (INN)", "name_a": "C15H22N2O"} +{"id": 34362, "instruction": "Alkeneをを化学式で記述すると?", "response": "Alkeneをを化学式で記述するとC2H2R2です。", "task": "formula", "name_q": "Alkene", "name_a": "C2H2R2"} +{"id": 31064, "instruction": "(-)-Tylocrebrineの異なる名称は?", "response": "(-)-Tylocrebrineの異なる名称は(-)-チロクレブリンです。", "task": "replace", "name_q": "(-)-Tylocrebrine", "name_a": "(-)-チロクレブリン"} +{"id": 21958, "instruction": "9,10alpha-Dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonateの異なる表記は?", "response": "9,10alpha-Dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonateの異なる表記はDihydro-alpha-ergocryptine mesylateです。", "task": "replace", "name_q": "9,10alpha-Dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate", "name_a": "Dihydro-alpha-ergocryptine mesylate"} +{"id": 22606, "instruction": "Djenkolic acidの別の言い方は?", "response": "Djenkolic acidの別の言い方はL-Djenkolic acidです。", "task": "replace", "name_q": "Djenkolic acid", "name_a": "L-Djenkolic acid"} +{"id": 31832, "instruction": "Oracaine (TN)の別の言い方は?", "response": "Oracaine (TN)の別の言い方はMeprylcaine hydrochloride (JAN)です。", "task": "replace", "name_q": "Oracaine (TN)", "name_a": "Meprylcaine hydrochloride (JAN)"} +{"id": 20207, "instruction": "(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoAをは分子式で表すと?", "response": "(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoAをは分子式で表すとC26H44N7O18P3Sです。", "task": "formula", "name_q": "(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA", "name_a": "C26H44N7O18P3S"} +{"id": 6194, "instruction": "Guanoclor sulfate (USAN)の英訳は?", "response": "Guanoclor sulfate (USAN)の英訳はVatensol (TN)です。", "task": "replace ja to en", "name_q": "Guanoclor sulfate (USAN)", "name_a": "Vatensol (TN)"} +{"id": 28649, "instruction": "2,3-Dihydroxybenzoyl-[aryl-carrier protein]をの分子式は?", "response": "2,3-Dihydroxybenzoyl-[aryl-carrier protein]をの分子式はC7H5O3SRです。", "task": "formula", "name_q": "2,3-Dihydroxybenzoyl-[aryl-carrier protein]", "name_a": "C7H5O3SR"} +{"id": 11746, "instruction": "Demethylmenaquinoneをを化学式で表すと?", "response": "Demethylmenaquinoneをを化学式で表すとC15H14O2(C5H8)nです。", "task": "formula", "name_q": "Demethylmenaquinone", "name_a": "C15H14O2(C5H8)n"} +{"id": 33718, "instruction": "Bent bone dysplasia syndromeを日本語で書くと?", "response": "Bent bone dysplasia syndromeを日本語で書くと湾曲骨異形成症候群です。", "task": "replace en to ja", "name_q": "Bent bone dysplasia syndrome", "name_a": "湾曲骨異形成症候群"} +{"id": 20317, "instruction": "Urofacial syndromeの日本語表記は?", "response": "Urofacial syndromeの日本語表記はUrofacial 症候群です。", "task": "replace en to ja", "name_q": "Urofacial syndrome", "name_a": "Urofacial 症候群"} +{"id": 4536, "instruction": "Vertebral, cardiac, renal, and limb defects syndromeの異なる名称は?", "response": "Vertebral, cardiac, renal, and limb defects syndromeの異なる名称はCongenital NAD deficiency disorderです。", "task": "replace", "name_q": "Vertebral, cardiac, renal, and limb defects syndrome", "name_a": "Congenital NAD deficiency disorder"} +{"id": 8807, "instruction": "エピネフリルボラートをは化学構造で表すと?", "response": "エピネフリルボラートをは化学構造で表すとC9H12BNO4です。", "task": "formula", "name_q": "エピネフリルボラート", "name_a": "C9H12BNO4"} +{"id": 3995, "instruction": "Terra flava ustaの異なる表記は?", "response": "Terra flava ustaの異なる表記はLoessです。", "task": "replace", "name_q": "Terra flava usta", "name_a": "Loess"} +{"id": 30528, "instruction": "Urateの別の言い方は?", "response": "Urateの別の言い方はUric acidです。", "task": "replace", "name_q": "Urate", "name_a": "Uric acid"} +{"id": 29137, "instruction": "3-Oxohexanoyl-CoAをの化学式は?", "response": "3-Oxohexanoyl-CoAをの化学式はC27H44N7O18P3Sです。", "task": "formula", "name_q": "3-Oxohexanoyl-CoA", "name_a": "C27H44N7O18P3S"} +{"id": 17069, "instruction": "[Protein] with 3-methyllanthionine crosslinkをは化学構造で表すと?", "response": "[Protein] with 3-methyllanthionine crosslinkをは化学構造で表すとC7H10N2O2SR4です。", "task": "formula", "name_q": "[Protein] with 3-methyllanthionine crosslink", "name_a": "C7H10N2O2SR4"} +{"id": 8333, "instruction": "Endothelin-3の別呼称は?", "response": "Endothelin-3の別呼称はエンドセリン-3です。", "task": "replace", "name_q": "Endothelin-3", "name_a": "エンドセリン-3"} +{"id": 29514, "instruction": "dTDP-N-hydroxy-beta-L-evernosamineをは化学式で表すと?", "response": "dTDP-N-hydroxy-beta-L-evernosamineをは化学式で表すとC18H31N3O14P2です。", "task": "formula", "name_q": "dTDP-N-hydroxy-beta-L-evernosamine", "name_a": "C18H31N3O14P2"} +{"id": 9979, "instruction": "心臓および脳の奇形症候群を英語表記で表すと?", "response": "心臓および脳の奇形症候群を英語表記で表すとHeart and brain malformation syndromeです。", "task": "replace ja to en", "name_q": "心臓および脳の奇形症候群", "name_a": "Heart and brain malformation syndrome"} +{"id": 30871, "instruction": "Aflatoxin B1 diolをを組成式で記述すると?", "response": "Aflatoxin B1 diolをを組成式で記述するとC17H14O8です。", "task": "formula", "name_q": "Aflatoxin B1 diol", "name_a": "C17H14O8"} +{"id": 24139, "instruction": "(R)-3-(Tetradecanoyloxy)hexadecanoic acidをを分子式で記述すると?", "response": "(R)-3-(Tetradecanoyloxy)hexadecanoic acidをを分子式で記述するとC30H58O4です。", "task": "formula", "name_q": "(R)-3-(Tetradecanoyloxy)hexadecanoic acid", "name_a": "C30H58O4"} +{"id": 6117, "instruction": "Pocepullan (JAN)を日本語で書くと?", "response": "Pocepullan (JAN)を日本語で書くとポセプラン (JAN)です。", "task": "replace en to ja", "name_q": "Pocepullan (JAN)", "name_a": "ポセプラン (JAN)"} +{"id": 21737, "instruction": "Raubasine (DCF)を英語表記で表すと?", "response": "Raubasine (DCF)を英語表記で表すとLamuran (TN)です。", "task": "replace ja to en", "name_q": "Raubasine (DCF)", "name_a": "Lamuran (TN)"} +{"id": 11705, "instruction": "ナフシリンナトリウムの異なる表記は?", "response": "ナフシリンナトリウムの異なる表記はNafcillin sodiumです。", "task": "replace", "name_q": "ナフシリンナトリウム", "name_a": "Nafcillin sodium"} +{"id": 33666, "instruction": "Macular dystrophy SUBGROUP Retinal macular dystrophy (MCDR) Macular dystrophy with central cone involvement (CCMD) Macular dystrophy with or without cone dysfunction (MDCD) Stargardt disease Cone-rod dystrophy Vitelliform macular dystrophy X-linked juvenile retinoschisis Occult macular dystrophy Central areolar choroidal dystrophy Pattern dystrophies of the retinal pigment epithelium を日本語で記述すると?", "response": "Macular dystrophy SUBGROUP Retinal macular dystrophy (MCDR) Macular dystrophy with central cone involvement (CCMD) Macular dystrophy with or without cone dysfunction (MDCD) Stargardt disease Cone-rod dystrophy Vitelliform macular dystrophy X-linked juvenile retinoschisis Occult macular dystrophy Central areolar choroidal dystrophy Pattern dystrophies of the retinal pigment epithelium を日本語で記述すると黄斑ジストロフィー 下位グループ 網膜黄斑ジストロフィー (MCDR) 中心錐体病変を伴う黄斑ジストロフィー (CCMD) 錐体機能不全を伴う(伴わない)黄斑ジストロフィー (MDCD) シュタルガルト病 錐体杆体ジストロフィー 卵黄状黄斑ジストロフィー X連鎖性若年網膜分離症 オカルト黄斑ジストロフィー 中心性輪紋状脈絡膜ジストロフィー 模様黄斑ジストロフィー です。", "task": "replace en to ja", "name_q": "Macular dystrophy SUBGROUP Retinal macular dystrophy (MCDR) Macular dystrophy with central cone involvement (CCMD) Macular dystrophy with or without cone dysfunction (MDCD) Stargardt disease Cone-rod dystrophy Vitelliform macular dystrophy X-linked juvenile retinoschisis Occult macular dystrophy Central areolar choroidal dystrophy Pattern dystrophies of the retinal pigment epithelium ", "name_a": "黄斑ジストロフィー 下位グループ 網膜黄斑ジストロフィー (MCDR) 中心錐体病変を伴う黄斑ジストロフィー (CCMD) 錐体機能不全を伴う(伴わない)黄斑ジストロフィー (MDCD) シュタルガルト病 錐体杆体ジストロフィー 卵黄状黄斑ジストロフィー X連鎖性若年網膜分離症 オカルト黄斑ジストロフィー 中心性輪紋状脈絡膜ジストロフィー 模様黄斑ジストロフィー "} +{"id": 1159, "instruction": "4p 欠失症候群を英語に訳すと?", "response": "4p 欠失症候群を英語に訳すとWolf-Hirschhorn syndromeです。", "task": "replace ja to en", "name_q": "4p 欠失症候群", "name_a": "Wolf-Hirschhorn syndrome"} +{"id": 5535, "instruction": "Phenethyl caffeateをを化学式で記述すると?", "response": "Phenethyl caffeateをを化学式で記述するとC17H16O4です。", "task": "formula", "name_q": "Phenethyl caffeate", "name_a": "C17H16O4"} +{"id": 26471, "instruction": "(+)-Sophorolをを化学構造で表すと?", "response": "(+)-Sophorolをを化学構造で表すとC16H12O6です。", "task": "formula", "name_q": "(+)-Sophorol", "name_a": "C16H12O6"} +{"id": 28094, "instruction": "蛤蚧尾の別表現は?", "response": "蛤蚧尾の別表現はhá jiè wěiです。", "task": "replace", "name_q": "蛤蚧尾", "name_a": "há jiè wěi"} +{"id": 14009, "instruction": "ベルガプテンをを組成式で書くと?", "response": "ベルガプテンをを組成式で書くとC12H8O4です。", "task": "formula", "name_q": "ベルガプテン", "name_a": "C12H8O4"} +{"id": 33165, "instruction": "Methacrifosをを分子式で記述すると?", "response": "Methacrifosをを分子式で記述するとC7H13O5PSです。", "task": "formula", "name_q": "Methacrifos", "name_a": "C7H13O5PS"} +{"id": 19071, "instruction": "Rocatinlimab (USAN/INN)を言い換えると?", "response": "Rocatinlimab (USAN/INN)を言い換えるとロカチンリマブです。", "task": "replace", "name_q": "Rocatinlimab (USAN/INN)", "name_a": "ロカチンリマブ"} +{"id": 25313, "instruction": "Behyd (TN)の日本語訳は?", "response": "Behyd (TN)の日本語訳はBenzylhydrochlorothiazide (JAN)です。", "task": "replace en to ja", "name_q": "Behyd (TN)", "name_a": "Benzylhydrochlorothiazide (JAN)"} +{"id": 14652, "instruction": "ICOSAPENTETHYL(BryantRanchPrepack)を用いた医薬品名は?", "response": "ICOSAPENTETHYL(BryantRanchPrepack)を用いた医薬品名はイコサペント酸エチル(原沢製薬工業)です。", "task": "product", "name_q": "ICOSAPENTETHYL(BryantRanchPrepack)", "name_a": "イコサペント酸エチル(原沢製薬工業)"} +{"id": 30315, "instruction": "trans-1,3-Dichloropropeneの別記述は?", "response": "trans-1,3-Dichloropropeneの別記述はtrans-3-Chloroallyl chlorideです。", "task": "replace", "name_q": "trans-1,3-Dichloropropene", "name_a": "trans-3-Chloroallyl chloride"} +{"id": 13268, "instruction": "(3Z)-Hex-3-en-1-olの異なる表記は?", "response": "(3Z)-Hex-3-en-1-olの異なる表記は(3Z)-3-Hexen-1-olです。", "task": "replace", "name_q": "(3Z)-Hex-3-en-1-ol", "name_a": "(3Z)-3-Hexen-1-ol"} +{"id": 16270, "instruction": "カベルゴリンの別記述は?", "response": "カベルゴリンの別記述はCabergolineです。", "task": "replace", "name_q": "カベルゴリン", "name_a": "Cabergoline"} +{"id": 24969, "instruction": "亜ヒ酸の別の呼び方は?", "response": "亜ヒ酸の別の呼び方はArsenous oxideです。", "task": "replace", "name_q": "亜ヒ酸", "name_a": "Arsenous oxide"} +{"id": 3775, "instruction": "3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanateをを組成式で表すと?", "response": "3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanateをを組成式で表すとC24H38O5です。", "task": "formula", "name_q": "3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanate", "name_a": "C24H38O5"} +{"id": 7751, "instruction": "Oncaspar (TN)の別名は?", "response": "Oncaspar (TN)の別名はPegaspargase (JAN/USAN/INN)です。", "task": "replace", "name_q": "Oncaspar (TN)", "name_a": "Pegaspargase (JAN/USAN/INN)"} +{"id": 27805, "instruction": "Sulfadoxine (JAN/USP/INN)をを化学式で記述すると?", "response": "Sulfadoxine (JAN/USP/INN)をを化学式で記述するとC12H14N4O4Sです。", "task": "formula", "name_q": "Sulfadoxine (JAN/USP/INN)", "name_a": "C12H14N4O4S"} +{"id": 22988, "instruction": "Bendamustine hydrochloride hydrate (JAN)を利用した製品名は?", "response": "Bendamustine hydrochloride hydrate (JAN)を利用した製品名はベンダムスチン塩酸塩(ファイザー)です。", "task": "product", "name_q": "Bendamustine hydrochloride hydrate (JAN)", "name_a": "ベンダムスチン塩酸塩(ファイザー)"} +{"id": 14493, "instruction": "オキシモナムナトリウムを英語に訳すと?", "response": "オキシモナムナトリウムを英語に訳すとOximonam sodium (USAN)です。", "task": "replace ja to en", "name_q": "オキシモナムナトリウム", "name_a": "Oximonam sodium (USAN)"} +{"id": 3244, "instruction": "Etranacogene dezaparvovec-drlbを日本語で記述すると?", "response": "Etranacogene dezaparvovec-drlbを日本語で記述するとエトラナコゲンデザパルボベクです。", "task": "replace en to ja", "name_q": "Etranacogene dezaparvovec-drlb", "name_a": "エトラナコゲンデザパルボベク"} +{"id": 6664, "instruction": "Adenosylcobalamin 5'-phosphateをを組成式で書くと?", "response": "Adenosylcobalamin 5'-phosphateをを組成式で書くとC72H101CoN18O20P2です。", "task": "formula", "name_q": "Adenosylcobalamin 5'-phosphate", "name_a": "C72H101CoN18O20P2"} +{"id": 25359, "instruction": "alpha,alpha'-Diethyl-4,4'-bis(2-propynyloxy)stilbeneをを組成式で記述すると?", "response": "alpha,alpha'-Diethyl-4,4'-bis(2-propynyloxy)stilbeneをを組成式で記述するとC24H24O2です。", "task": "formula", "name_q": "alpha,alpha'-Diethyl-4,4'-bis(2-propynyloxy)stilbene", "name_a": "C24H24O2"} +{"id": 3921, "instruction": "脈絡叢乳頭腫の英訳は?", "response": "脈絡叢乳頭腫の英訳はChoroid plexus papillomaです。", "task": "replace ja to en", "name_q": "脈絡叢乳頭腫", "name_a": "Choroid plexus papilloma"} +{"id": 4520, "instruction": "OXYCODONEHYDROCHLORIDE(BryantRanchPrepack)を用いた医薬品名は?", "response": "OXYCODONEHYDROCHLORIDE(BryantRanchPrepack)を用いた医薬品名はOXYCODONEHYDROCHLORIDE(CamberPharmaceuticals)です。", "task": "product", "name_q": "OXYCODONEHYDROCHLORIDE(BryantRanchPrepack)", "name_a": "OXYCODONEHYDROCHLORIDE(CamberPharmaceuticals)"} +{"id": 14234, "instruction": "Peptideglycan(N-acetyl-D-glucosamine)の別名は?", "response": "Peptideglycan(N-acetyl-D-glucosamine)の別名はPeptidoglycan(N-acetyl-D-glucosamine)です。", "task": "replace", "name_q": "Peptideglycan(N-acetyl-D-glucosamine)", "name_a": "Peptidoglycan(N-acetyl-D-glucosamine)"} +{"id": 11765, "instruction": "LLC.)を主材料とする医薬品は?", "response": "LLC.)を主材料とする医薬品はSUNITINIBMALATE(NorthStarRxLLC)です。", "task": "product", "name_q": "LLC.)", "name_a": "SUNITINIBMALATE(NorthStarRxLLC)"} +{"id": 20439, "instruction": "カルフログリタザルの別記述は?", "response": "カルフログリタザルの別記述はCarfloglitazar (INN)です。", "task": "replace", "name_q": "カルフログリタザル", "name_a": "Carfloglitazar (INN)"} +{"id": 22054, "instruction": "Valaciclovir hydrochloride (JP18)を用いた医薬品名は?", "response": "Valaciclovir hydrochloride (JP18)を用いた医薬品名はVALACYCLOVIRHYDROCHLORIDE(AmericanHealthPackaging)です。", "task": "product", "name_q": "Valaciclovir hydrochloride (JP18)", "name_a": "VALACYCLOVIRHYDROCHLORIDE(AmericanHealthPackaging)"} +{"id": 21862, "instruction": "2-Arachidonoylglycerolをの化学式は?", "response": "2-Arachidonoylglycerolをの化学式はC23H38O4です。", "task": "formula", "name_q": "2-Arachidonoylglycerol", "name_a": "C23H38O4"} +{"id": 26261, "instruction": "α-アミリンの別の言い方は?", "response": "α-アミリンの別の言い方はalpha-Amyrinです。", "task": "replace", "name_q": "α-アミリン", "name_a": "alpha-Amyrin"} +{"id": 11268, "instruction": "3,4-Dimethylphenyl methylcarbamateの別名称は?", "response": "3,4-Dimethylphenyl methylcarbamateの別名称はMeobalです。", "task": "replace", "name_q": "3,4-Dimethylphenyl methylcarbamate", "name_a": "Meobal"} +{"id": 19971, "instruction": "Diphosphoryl hexaacyl lipid Aをを分子式で書くと?", "response": "Diphosphoryl hexaacyl lipid Aをを分子式で書くとC94H178N2O25P2です。", "task": "formula", "name_q": "Diphosphoryl hexaacyl lipid A", "name_a": "C94H178N2O25P2"} +{"id": 25620, "instruction": "ガラクトース血症 II 型 上位グループ ガラクトース血症 の別表現は?", "response": "ガラクトース血症 II 型 上位グループ ガラクトース血症 の別表現はガラクトキナーゼ欠損症です。", "task": "replace", "name_q": "ガラクトース血症 II 型 上位グループ ガラクトース血症 ", "name_a": "ガラクトキナーゼ欠損症"} +{"id": 10420, "instruction": "Pyochelinをは化学式で表すと?", "response": "Pyochelinをは化学式で表すとC14H16N2O3S2です。", "task": "formula", "name_q": "Pyochelin", "name_a": "C14H16N2O3S2"} +{"id": 3700, "instruction": "Sveinsson chorioretinal atrophy (SCRA)を日本語で書くと?", "response": "Sveinsson chorioretinal atrophy (SCRA)を日本語で書くとSveinsson 網脈絡膜萎縮です。", "task": "replace en to ja", "name_q": "Sveinsson chorioretinal atrophy (SCRA)", "name_a": "Sveinsson 網脈絡膜萎縮"} +{"id": 29348, "instruction": "Mocravimod hydrochloride (USAN)を日本語で書くと?", "response": "Mocravimod hydrochloride (USAN)を日本語で書くとモクラビモド塩酸塩です。", "task": "replace en to ja", "name_q": "Mocravimod hydrochloride (USAN)", "name_a": "モクラビモド塩酸塩"} +{"id": 10372, "instruction": "Penillic acidをは組成式で表すと?", "response": "Penillic acidをは組成式で表すとC9H11N2O4SRです。", "task": "formula", "name_q": "Penillic acid", "name_a": "C9H11N2O4SR"} +{"id": 31329, "instruction": "1,2,4-Trichloro-5-(2,4-dichlorophenoxy)benzeneは別の呼び方では?", "response": "1,2,4-Trichloro-5-(2,4-dichlorophenoxy)benzeneは別の呼び方では2,2',4,4',5-Pentachlorodiphenyl etherです。", "task": "replace", "name_q": "1,2,4-Trichloro-5-(2,4-dichlorophenoxy)benzene", "name_a": "2,2',4,4',5-Pentachlorodiphenyl ether"} +{"id": 31845, "instruction": "Benzyl thiocyanateをを化学式で書くと?", "response": "Benzyl thiocyanateをを化学式で書くとC8H7NSです。", "task": "formula", "name_q": "Benzyl thiocyanate", "name_a": "C8H7NS"} +{"id": 19772, "instruction": "Hydrazineをを化学構造で表すと?", "response": "Hydrazineをを化学構造で表すとN2H4です。", "task": "formula", "name_q": "Hydrazine", "name_a": "N2H4"} +{"id": 5853, "instruction": "Hexacosan-1-olをは組成式で表すと?", "response": "Hexacosan-1-olをは組成式で表すとC26H54Oです。", "task": "formula", "name_q": "Hexacosan-1-ol", "name_a": "C26H54O"} +{"id": 2441, "instruction": "ツブリシンBをを分子式で書くと?", "response": "ツブリシンBをを分子式で書くとC42H63N5O10Sです。", "task": "formula", "name_q": "ツブリシンB", "name_a": "C42H63N5O10S"} +{"id": 28533, "instruction": "Propicillin (BAN)を日本語表記で表すと?", "response": "Propicillin (BAN)を日本語表記で表すとプロピシリンです。", "task": "replace en to ja", "name_q": "Propicillin (BAN)", "name_a": "プロピシリン"} +{"id": 31264, "instruction": "Danirixin (USAN/INN)をを組成式で記述すると?", "response": "Danirixin (USAN/INN)をを組成式で記述するとC19H21ClFN3O4Sです。", "task": "formula", "name_q": "Danirixin (USAN/INN)", "name_a": "C19H21ClFN3O4S"} +{"id": 7747, "instruction": "Hyoscyamine methylbromideの別表現は?", "response": "Hyoscyamine methylbromideの別表現はアトロピンメトブロミドです。", "task": "replace", "name_q": "Hyoscyamine methylbromide", "name_a": "アトロピンメトブロミド"} +{"id": 32165, "instruction": "ピパンペロン塩酸塩 (JAN)を主材料とする製品名は?", "response": "ピパンペロン塩酸塩 (JAN)を主材料とする製品名はプロピタン(アルフレッサファーマ)です。", "task": "product", "name_q": "ピパンペロン塩酸塩 (JAN)", "name_a": "プロピタン(アルフレッサファーマ)"} +{"id": 20711, "instruction": "Leu-leu-tyrをを組成式で記述すると?", "response": "Leu-leu-tyrをを組成式で記述するとC21H33N3O5です。", "task": "formula", "name_q": "Leu-leu-tyr", "name_a": "C21H33N3O5"} +{"id": 14592, "instruction": "ゼフィラミンをを分子式で書くと?", "response": "ゼフィラミンをを分子式で書くとC17H21NO3です。", "task": "formula", "name_q": "ゼフィラミン", "name_a": "C17H21NO3"} +{"id": 16308, "instruction": "17beta-Hydroxy-3-methoxyestra-1,3,5(10)-triene-17-carbonitrileをを組成式で記述すると?", "response": "17beta-Hydroxy-3-methoxyestra-1,3,5(10)-triene-17-carbonitrileをを組成式で記述するとC20H25NO2です。", "task": "formula", "name_q": "17beta-Hydroxy-3-methoxyestra-1,3,5(10)-triene-17-carbonitrile", "name_a": "C20H25NO2"} +{"id": 6280, "instruction": "Inositol 1,2,3,5,6-pentakisphosphateの別呼称は?", "response": "Inositol 1,2,3,5,6-pentakisphosphateの別呼称は1L-myo-Inositol 1,2,3,4,5-pentakisphosphateです。", "task": "replace", "name_q": "Inositol 1,2,3,5,6-pentakisphosphate", "name_a": "1L-myo-Inositol 1,2,3,4,5-pentakisphosphate"} +{"id": 4460, "instruction": "Foodborne trematode infection SUBGROUP Clonorchiasis Fascioliasis Opisthorchiasis Paragonimiasis を日本語で書くと?", "response": "Foodborne trematode infection SUBGROUP Clonorchiasis Fascioliasis Opisthorchiasis Paragonimiasis を日本語で書くと食物媒介吸虫類感染症 下位グループ 肝吸虫症 肝蛭症 オピストルキス症 肺吸虫症 です。", "task": "replace en to ja", "name_q": "Foodborne trematode infection SUBGROUP Clonorchiasis Fascioliasis Opisthorchiasis Paragonimiasis ", "name_a": "食物媒介吸虫類感染症 下位グループ 肝吸虫症 肝蛭症 オピストルキス症 肺吸虫症 "} +{"id": 19888, "instruction": "風疹 下位グループ 先天性風疹症候群の英訳は?", "response": "風疹 下位グループ 先天性風疹症候群の英訳はRubella SUBGROUP Congenital rubella syndromeです。", "task": "replace ja to en", "name_q": "風疹 下位グループ 先天性風疹症候群", "name_a": "Rubella SUBGROUP Congenital rubella syndrome"} +{"id": 22550, "instruction": "網膜ジストロフィーおよび微絨毛封入体病を英語に訳すと?", "response": "網膜ジストロフィーおよび微絨毛封入体病を英語に訳すとRetinal dystrophy and microvillus inclusion diseaseです。", "task": "replace ja to en", "name_q": "網膜ジストロフィーおよび微絨毛封入体病", "name_a": "Retinal dystrophy and microvillus inclusion disease"} +{"id": 32631, "instruction": "Xanthoxinをを組成式で表すと?", "response": "Xanthoxinをを組成式で表すとC15H22O3です。", "task": "formula", "name_q": "Xanthoxin", "name_a": "C15H22O3"} +{"id": 17213, "instruction": "L-Glycolをを化学構造で書くと?", "response": "L-Glycolをを化学構造で書くとC2H5O2Rです。", "task": "formula", "name_q": "L-Glycol", "name_a": "C2H5O2R"} +{"id": 16559, "instruction": "Neurodevelopmental disorder with histone modification defect SUBGROUP Shashi-Pena syndrome (SHAPNS) O'Donnell-Luria-Rodan syndrome (ODLURO) NED with central hypotonia and dysmorphic facies (NEDCHF) NED with dysmorphic facies and thin corpus callosum (NEDDFAC) NED with speech impairment and dysmorphic facies (NEDSID) NED-craniofacial syndrome with variable renal and cardiac abnormalities (NECRC) NED with dysmorphic facies, sleep disturbance, and brain abnormalities (NEDFASB) Stolerman neurodevelopmental syndrome (NEDSST) El Hayek-Chahrour neurodevelopmental disorder (NEDEHC) NED with dysmorphic facies and distal limb anomalies (NEDDFL) SUPERGRP Neurodevelopmental disorder with dysmorphic facies Syndromic neurodevelopmental disorder の日本語表記は?", "response": "Neurodevelopmental disorder with histone modification defect SUBGROUP Shashi-Pena syndrome (SHAPNS) O'Donnell-Luria-Rodan syndrome (ODLURO) NED with central hypotonia and dysmorphic facies (NEDCHF) NED with dysmorphic facies and thin corpus callosum (NEDDFAC) NED with speech impairment and dysmorphic facies (NEDSID) NED-craniofacial syndrome with variable renal and cardiac abnormalities (NECRC) NED with dysmorphic facies, sleep disturbance, and brain abnormalities (NEDFASB) Stolerman neurodevelopmental syndrome (NEDSST) El Hayek-Chahrour neurodevelopmental disorder (NEDEHC) NED with dysmorphic facies and distal limb anomalies (NEDDFL) SUPERGRP Neurodevelopmental disorder with dysmorphic facies Syndromic neurodevelopmental disorder の日本語表記はヒストン修飾異常を伴う神経発達障害 下位グループ Shashi-Pena 症候群 (SHAPNS) O'Donnell-Luria-Rodan 症候群 (ODLURO) 中枢性筋緊張低下および顔異形を伴う神経発達障害 (NEDCHF) 顔異形と脳梁の菲薄化を伴う神経発達障害 (NEDDFAC) 発話障害と顔異形を伴う神経発達障害 (NEDSID) 様々な腎臓および心臓の異常を伴う神経発達・頭蓋顔面症候群 (NECRC) 顔異形と睡眠障害および脳の異常を伴う神経発達障害 (NEDFASB) Stolerman 神経発達症候群 (NEDSST) El Hayek-Chahrour 神経発達症候群 (NEDEHC) 顔異形および四肢遠位部の異常を伴う神経発達障害 (NEDDFL) 上位グループ 顔異形を伴う神経発達障害 症候群性神経発達障害 です。", "task": "replace en to ja", "name_q": "Neurodevelopmental disorder with histone modification defect SUBGROUP Shashi-Pena syndrome (SHAPNS) O'Donnell-Luria-Rodan syndrome (ODLURO) NED with central hypotonia and dysmorphic facies (NEDCHF) NED with dysmorphic facies and thin corpus callosum (NEDDFAC) NED with speech impairment and dysmorphic facies (NEDSID) NED-craniofacial syndrome with variable renal and cardiac abnormalities (NECRC) NED with dysmorphic facies, sleep disturbance, and brain abnormalities (NEDFASB) Stolerman neurodevelopmental syndrome (NEDSST) El Hayek-Chahrour neurodevelopmental disorder (NEDEHC) NED with dysmorphic facies and distal limb anomalies (NEDDFL) SUPERGRP Neurodevelopmental disorder with dysmorphic facies Syndromic neurodevelopmental disorder ", "name_a": "ヒストン修飾異常を伴う神経発達障害 下位グループ Shashi-Pena 症候群 (SHAPNS) O'Donnell-Luria-Rodan 症候群 (ODLURO) 中枢性筋緊張低下および顔異形を伴う神経発達障害 (NEDCHF) 顔異形と脳梁の菲薄化を伴う神経発達障害 (NEDDFAC) 発話障害と顔異形を伴う神経発達障害 (NEDSID) 様々な腎臓および心臓の異常を伴う神経発達・頭蓋顔面症候群 (NECRC) 顔異形と睡眠障害および脳の異常を伴う神経発達障害 (NEDFASB) Stolerman 神経発達症候群 (NEDSST) El Hayek-Chahrour 神経発達症候群 (NEDEHC) 顔異形および四肢遠位部の異常を伴う神経発達障害 (NEDDFL) 上位グループ 顔異形を伴う神経発達障害 症候群性神経発達障害 "} +{"id": 14332, "instruction": "Dihydrolipoyl-AMPをは分子式で表すと?", "response": "Dihydrolipoyl-AMPをは分子式で表すとC18H28N5O8PS2です。", "task": "formula", "name_q": "Dihydrolipoyl-AMP", "name_a": "C18H28N5O8PS2"} +{"id": 20298, "instruction": "2-Acetylphloroglucinolの別の言い方は?", "response": "2-Acetylphloroglucinolの別の言い方はMonoacetylphloroglucinolです。", "task": "replace", "name_q": "2-Acetylphloroglucinol", "name_a": "Monoacetylphloroglucinol"} +{"id": 696, "instruction": "NS 1619をを分子式で記述すると?", "response": "NS 1619をを分子式で記述するとC15H8F6N2O2です。", "task": "formula", "name_q": "NS 1619", "name_a": "C15H8F6N2O2"} +{"id": 1187, "instruction": "Rose fruit (JP18)の別名は?", "response": "Rose fruit (JP18)の別名はエイジツ末 (JP18)です。", "task": "replace", "name_q": "Rose fruit (JP18)", "name_a": "エイジツ末 (JP18)"} +{"id": 24704, "instruction": "6-Hydroxycyanidinの別の呼び方は?", "response": "6-Hydroxycyanidinの別の呼び方は6-ヒドロキシシアニジンです。", "task": "replace", "name_q": "6-Hydroxycyanidin", "name_a": "6-ヒドロキシシアニジン"} +{"id": 12339, "instruction": "ダンマランをの化学構造は?", "response": "ダンマランをの化学構造はC30H54です。", "task": "formula", "name_q": "ダンマラン", "name_a": "C30H54"} +{"id": 23653, "instruction": "8-Oxoguanineをを分子式で表すと?", "response": "8-Oxoguanineをを分子式で表すとC5H5N5O2です。", "task": "formula", "name_q": "8-Oxoguanine", "name_a": "C5H5N5O2"} +{"id": 33788, "instruction": "Miridesap (USAN/INN)をを組成式で表すと?", "response": "Miridesap (USAN/INN)をを組成式で表すとC16H24N2O6です。", "task": "formula", "name_q": "Miridesap (USAN/INN)", "name_a": "C16H24N2O6"} +{"id": 9432, "instruction": "(+)-6-endo-Hydroxycamphorをは分子式で表すと?", "response": "(+)-6-endo-Hydroxycamphorをは分子式で表すとC10H16O2です。", "task": "formula", "name_q": "(+)-6-endo-Hydroxycamphor", "name_a": "C10H16O2"} +{"id": 25949, "instruction": "Sepiapterinをの組成式は?", "response": "Sepiapterinをの組成式はC9H11N5O3です。", "task": "formula", "name_q": "Sepiapterin", "name_a": "C9H11N5O3"} +{"id": 27138, "instruction": "クロルゾキサゾンをの組成式は?", "response": "クロルゾキサゾンをの組成式はC7H4ClNO2です。", "task": "formula", "name_q": "クロルゾキサゾン", "name_a": "C7H4ClNO2"} +{"id": 1193, "instruction": "Reduced 2,6-dichlorophenolindophenolをの組成式は?", "response": "Reduced 2,6-dichlorophenolindophenolをの組成式はC12H9Cl2NO2です。", "task": "formula", "name_q": "Reduced 2,6-dichlorophenolindophenol", "name_a": "C12H9Cl2NO2"} +{"id": 8296, "instruction": "Levocetirizine (USAN/INN)をは化学構造で表すと?", "response": "Levocetirizine (USAN/INN)をは化学構造で表すとC21H25ClN2O3です。", "task": "formula", "name_q": "Levocetirizine (USAN/INN)", "name_a": "C21H25ClN2O3"} +{"id": 7965, "instruction": "Leumorphinの異なる表記は?", "response": "Leumorphinの異なる表記はロイモルフィンです。", "task": "replace", "name_q": "Leumorphin", "name_a": "ロイモルフィン"} +{"id": 33151, "instruction": "Ascaridoleの別記述は?", "response": "Ascaridoleの別記述はアスカリドールです。", "task": "replace", "name_q": "Ascaridole", "name_a": "アスカリドール"} +{"id": 7714, "instruction": "(S)-6-ヒドロキシニコチンをを組成式で表すと?", "response": "(S)-6-ヒドロキシニコチンをを組成式で表すとC10H14N2Oです。", "task": "formula", "name_q": "(S)-6-ヒドロキシニコチン", "name_a": "C10H14N2O"} +{"id": 24884, "instruction": "インターフェロンアルファ-n3の英訳は?", "response": "インターフェロンアルファ-n3の英訳はAlferon N (TN)です。", "task": "replace ja to en", "name_q": "インターフェロンアルファ-n3", "name_a": "Alferon N (TN)"} +{"id": 11529, "instruction": "Anemia due to disorders of glycolytic enzymesを日本語表記で表すと?", "response": "Anemia due to disorders of glycolytic enzymesを日本語表記で表すと解糖系酵素障害による貧血です。", "task": "replace en to ja", "name_q": "Anemia due to disorders of glycolytic enzymes", "name_a": "解糖系酵素障害による貧血"} +{"id": 11847, "instruction": "ビンゾリジンスルファートをを化学式で書くと?", "response": "ビンゾリジンスルファートをを化学式で書くとC48H58ClN5O9. H2SO4です。", "task": "formula", "name_q": "ビンゾリジンスルファート", "name_a": "C48H58ClN5O9. H2SO4"} +{"id": 12605, "instruction": "beta-D-Fructose 2-phosphateをを分子式で書くと?", "response": "beta-D-Fructose 2-phosphateをを分子式で書くとC6H13O9Pです。", "task": "formula", "name_q": "beta-D-Fructose 2-phosphate", "name_a": "C6H13O9P"} +{"id": 30726, "instruction": "Cerebellar atrophy, visual impairment, and psychomotor retardationを日本語で書くと?", "response": "Cerebellar atrophy, visual impairment, and psychomotor retardationを日本語で書くと小脳萎縮、視力障害および精神運動発達遅滞です。", "task": "replace en to ja", "name_q": "Cerebellar atrophy, visual impairment, and psychomotor retardation", "name_a": "小脳萎縮、視力障害および精神運動発達遅滞"} +{"id": 18208, "instruction": "OA-6129 Cをの組成式は?", "response": "OA-6129 Cをの組成式はC20H31N3O11S2です。", "task": "formula", "name_q": "OA-6129 C", "name_a": "C20H31N3O11S2"} +{"id": 16747, "instruction": "Domvanalimab (USAN/INN)の日本語訳は?", "response": "Domvanalimab (USAN/INN)の日本語訳はドムバナリマブです。", "task": "replace en to ja", "name_q": "Domvanalimab (USAN/INN)", "name_a": "ドムバナリマブ"} +{"id": 20247, "instruction": "alpha-D-Lyxosideをを組成式で表すと?", "response": "alpha-D-Lyxosideをを組成式で表すとC5H9O5Rです。", "task": "formula", "name_q": "alpha-D-Lyxoside", "name_a": "C5H9O5R"} +{"id": 18883, "instruction": "烏梅の異なる表記は?", "response": "烏梅の異なる表記はウバイ (Non-JPS)です。", "task": "replace", "name_q": "烏梅", "name_a": "ウバイ (Non-JPS)"} +{"id": 28054, "instruction": "バダスツキシマブタリリンの別呼称は?", "response": "バダスツキシマブタリリンの別呼称はVadastuximab talirine (USAN)です。", "task": "replace", "name_q": "バダスツキシマブタリリン", "name_a": "Vadastuximab talirine (USAN)"} +{"id": 27712, "instruction": "Lithospermosideの異なる名称は?", "response": "Lithospermosideの異なる名称はGriffoninです。", "task": "replace", "name_q": "Lithospermoside", "name_a": "Griffonin"} +{"id": 2915, "instruction": "Bictegravir, emtricitabine and tenofovir alafenamideを使用した商品名は?", "response": "Bictegravir, emtricitabine and tenofovir alafenamideを使用した商品名はBIKTARVY(GileadSciences)です。", "task": "product", "name_q": "Bictegravir, emtricitabine and tenofovir alafenamide", "name_a": "BIKTARVY(GileadSciences)"} +{"id": 31019, "instruction": "常染色体劣性遺伝性脊髄小脳失調症 下位グループ 常染色体劣性遺伝性脊髄小脳失調症および軸索性ニューロパチー (SCAN)を英語に訳すと?", "response": "常染色体劣性遺伝性脊髄小脳失調症 下位グループ 常染色体劣性遺伝性脊髄小脳失調症および軸索性ニューロパチー (SCAN)を英語に訳すとAutosomal recessive spinocerebellar ataxias SUBGROUP Autosomal recessive spinocerebellar ataxias with axonal neuropathy (SCAN)です。", "task": "replace ja to en", "name_q": "常染色体劣性遺伝性脊髄小脳失調症 下位グループ 常染色体劣性遺伝性脊髄小脳失調症および軸索性ニューロパチー (SCAN)", "name_a": "Autosomal recessive spinocerebellar ataxias SUBGROUP Autosomal recessive spinocerebellar ataxias with axonal neuropathy (SCAN)"} +{"id": 26739, "instruction": "4-Hydroxy-2,2',4',6'-tetrachlorobiphenylをを化学構造で表すと?", "response": "4-Hydroxy-2,2',4',6'-tetrachlorobiphenylをを化学構造で表すとC12H6Cl4Oです。", "task": "formula", "name_q": "4-Hydroxy-2,2',4',6'-tetrachlorobiphenyl", "name_a": "C12H6Cl4O"} +{"id": 27434, "instruction": "アルビルセプトスドトックスの別記述は?", "response": "アルビルセプトスドトックスの別記述はAlvircept sudotox (USAN/INN)です。", "task": "replace", "name_q": "アルビルセプトスドトックス", "name_a": "Alvircept sudotox (USAN/INN)"} +{"id": 5493, "instruction": "ベンズフェタミン塩酸塩の別名称は?", "response": "ベンズフェタミン塩酸塩の別名称はBenzphetamine hydrochlorideです。", "task": "replace", "name_q": "ベンズフェタミン塩酸塩", "name_a": "Benzphetamine hydrochloride"} +{"id": 4231, "instruction": "オマセタキシンメペスクシナートをの化学構造は?", "response": "オマセタキシンメペスクシナートをの化学構造はC29H39NO9です。", "task": "formula", "name_q": "オマセタキシンメペスクシナート", "name_a": "C29H39NO9"} +{"id": 33922, "instruction": "2,3,5-Trichloro-cis,cis-muconic acidの異なる名称は?", "response": "2,3,5-Trichloro-cis,cis-muconic acidの異なる名称は2,3,5-Trichloro-cis,cis-muconateです。", "task": "replace", "name_q": "2,3,5-Trichloro-cis,cis-muconic acid", "name_a": "2,3,5-Trichloro-cis,cis-muconate"} +{"id": 10066, "instruction": "Risankizumab (USAN/INN)の日本語訳は?", "response": "Risankizumab (USAN/INN)の日本語訳はリサンキズマブ (遺伝子組換え) (JAN)です。", "task": "replace en to ja", "name_q": "Risankizumab (USAN/INN)", "name_a": "リサンキズマブ (遺伝子組換え) (JAN)"} +{"id": 10352, "instruction": "アルハムラ出血熱 上位グループ 節足動物媒介ウイルス熱 を英語で記述すると?", "response": "アルハムラ出血熱 上位グループ 節足動物媒介ウイルス熱 を英語で記述するとAlkhumra hemorrhagic fever SUPERGRP Arthropod-borne viral fever です。", "task": "replace ja to en", "name_q": "アルハムラ出血熱 上位グループ 節足動物媒介ウイルス熱 ", "name_a": "Alkhumra hemorrhagic fever SUPERGRP Arthropod-borne viral fever "} +{"id": 24941, "instruction": "Neo Heliopan (TN)の異なる表記は?", "response": "Neo Heliopan (TN)の異なる表記はAmiloxate (USP/INN)です。", "task": "replace", "name_q": "Neo Heliopan (TN)", "name_a": "Amiloxate (USP/INN)"} +{"id": 9613, "instruction": "Dextrose excipient (NF)を日本語に訳すと?", "response": "Dextrose excipient (NF)を日本語に訳すとデキトロース賦形剤です。", "task": "replace en to ja", "name_q": "Dextrose excipient (NF)", "name_a": "デキトロース賦形剤"} +{"id": 32206, "instruction": "パンテチンの別記述は?", "response": "パンテチンの別記述はPantethineです。", "task": "replace", "name_q": "パンテチン", "name_a": "Pantethine"} +{"id": 4137, "instruction": "ツツガムシ病を英語で書くと?", "response": "ツツガムシ病を英語で書くとScrub typhusです。", "task": "replace ja to en", "name_q": "ツツガムシ病", "name_a": "Scrub typhus"} +{"id": 16936, "instruction": "Leptodactyloneをの組成式は?", "response": "Leptodactyloneをの組成式はC11H10O5です。", "task": "formula", "name_q": "Leptodactylone", "name_a": "C11H10O5"} +{"id": 18812, "instruction": "セルトラリン(サンド)を利用した医薬品名は?", "response": "セルトラリン(サンド)を利用した医薬品名はセルトラリン(第一三共エスファ)です。", "task": "product", "name_q": "セルトラリン(サンド)", "name_a": "セルトラリン(第一三共エスファ)"} +{"id": 2404, "instruction": "Oxymorphone hydrochloride (USP)の日本語訳は?", "response": "Oxymorphone hydrochloride (USP)の日本語訳はオキシモルホン塩酸塩です。", "task": "replace en to ja", "name_q": "Oxymorphone hydrochloride (USP)", "name_a": "オキシモルホン塩酸塩"} +{"id": 29825, "instruction": "テルペンドールKをを化学構造で表すと?", "response": "テルペンドールKをを化学構造で表すとC32H39NO5です。", "task": "formula", "name_q": "テルペンドールK", "name_a": "C32H39NO5"} +{"id": 27182, "instruction": "ギトホルマートをを組成式で記述すると?", "response": "ギトホルマートをを組成式で記述するとC46H64O19です。", "task": "formula", "name_q": "ギトホルマート", "name_a": "C46H64O19"} +{"id": 13497, "instruction": "シュワルツ・ヤンペル症候群 上位グループ ヘパラン硫酸プロテオグリカン異常 の英語表記は?", "response": "シュワルツ・ヤンペル症候群 上位グループ ヘパラン硫酸プロテオグリカン異常 の英語表記はSchwartz-Jampel syndrome SUPERGRP Heparan sulfate proteoglycan gene defects です。", "task": "replace ja to en", "name_q": "シュワルツ・ヤンペル症候群 上位グループ ヘパラン硫酸プロテオグリカン異常 ", "name_a": "Schwartz-Jampel syndrome SUPERGRP Heparan sulfate proteoglycan gene defects "} +{"id": 13590, "instruction": "7alpha,12alpha-Dihydroxy-5alpha-cholestan-3-oneをを分子式で書くと?", "response": "7alpha,12alpha-Dihydroxy-5alpha-cholestan-3-oneをを分子式で書くとC27H46O3です。", "task": "formula", "name_q": "7alpha,12alpha-Dihydroxy-5alpha-cholestan-3-one", "name_a": "C27H46O3"} +{"id": 13786, "instruction": "メチルプレドニゾロンコハク酸エステル (JP18)の別呼称は?", "response": "メチルプレドニゾロンコハク酸エステル (JP18)の別呼称はMethylprednisolone succinate (JP18)です。", "task": "replace", "name_q": "メチルプレドニゾロンコハク酸エステル (JP18)", "name_a": "Methylprednisolone succinate (JP18)"} +{"id": 15214, "instruction": "Burn-McKeown 症候群を英語表記で表すと?", "response": "Burn-McKeown 症候群を英語表記で表すとBurn-McKeown syndromeです。", "task": "replace ja to en", "name_q": "Burn-McKeown 症候群", "name_a": "Burn-McKeown syndrome"} +{"id": 28917, "instruction": "ベラフェルミンをを組成式で表すと?", "response": "ベラフェルミンをを組成式で表すとC1047H1632N306O302S5です。", "task": "formula", "name_q": "ベラフェルミン", "name_a": "C1047H1632N306O302S5"} +{"id": 32247, "instruction": "塩酸アンシタビンをは組成式で表すと?", "response": "塩酸アンシタビンをは組成式で表すとC9H11N3O4. HClです。", "task": "formula", "name_q": "塩酸アンシタビン", "name_a": "C9H11N3O4. HCl"} +{"id": 33709, "instruction": "Nicergoline tartrateをを化学式で記述すると?", "response": "Nicergoline tartrateをを化学式で記述するとC24H26BrN3O3. (C4H6O6)xです。", "task": "formula", "name_q": "Nicergoline tartrate", "name_a": "C24H26BrN3O3. (C4H6O6)x"} +{"id": 33776, "instruction": "CALCIUMCHLORIDE(Hospira)を使用した薬品名は?", "response": "CALCIUMCHLORIDE(Hospira)を使用した薬品名はCALCIUMCHLORIDE(HFAcquisitionCoLLC)です。", "task": "product", "name_q": "CALCIUMCHLORIDE(Hospira)", "name_a": "CALCIUMCHLORIDE(HFAcquisitionCoLLC)"} +{"id": 22921, "instruction": "3'-Hydroxyflavoneをを化学構造で記述すると?", "response": "3'-Hydroxyflavoneをを化学構造で記述するとC15H10O3です。", "task": "formula", "name_q": "3'-Hydroxyflavone", "name_a": "C15H10O3"} +{"id": 27095, "instruction": "4,6-Dichloro-3-methyl-cis-1,2-dihydroxycyclohexa-3,5-dieneをを組成式で記述すると?", "response": "4,6-Dichloro-3-methyl-cis-1,2-dihydroxycyclohexa-3,5-dieneをを組成式で記述するとC7H8Cl2O2です。", "task": "formula", "name_q": "4,6-Dichloro-3-methyl-cis-1,2-dihydroxycyclohexa-3,5-diene", "name_a": "C7H8Cl2O2"} +{"id": 5586, "instruction": "17alpha-Caproyloxypregn-4-ene-3,20-dioneの異なる名称は?", "response": "17alpha-Caproyloxypregn-4-ene-3,20-dioneの異なる名称はPrimolut depotです。", "task": "replace", "name_q": "17alpha-Caproyloxypregn-4-ene-3,20-dione", "name_a": "Primolut depot"} +{"id": 10179, "instruction": "Paliperidoneの別名は?", "response": "Paliperidoneの別名は9-ヒドロキシリスペリドンです。", "task": "replace", "name_q": "Paliperidone", "name_a": "9-ヒドロキシリスペリドン"} +{"id": 24717, "instruction": "4-Hydroxy-4-(4-hydroxyphenyl)-butan-2-oneをを分子式で表すと?", "response": "4-Hydroxy-4-(4-hydroxyphenyl)-butan-2-oneをを分子式で表すとC10H12O3です。", "task": "formula", "name_q": "4-Hydroxy-4-(4-hydroxyphenyl)-butan-2-one", "name_a": "C10H12O3"} +{"id": 21221, "instruction": "ギトキシンをを分子式で書くと?", "response": "ギトキシンをを分子式で書くとC41H64O14です。", "task": "formula", "name_q": "ギトキシン", "name_a": "C41H64O14"} +{"id": 12464, "instruction": "酒石酸ピランテルをを化学構造で記述すると?", "response": "酒石酸ピランテルをを化学構造で記述するとC11H14N2S. C4H6O6です。", "task": "formula", "name_q": "酒石酸ピランテル", "name_a": "C11H14N2S. C4H6O6"} +{"id": 33350, "instruction": "2-Methoxyestrone 3-glucuronideをを分子式で書くと?", "response": "2-Methoxyestrone 3-glucuronideをを分子式で書くとC25H32O9です。", "task": "formula", "name_q": "2-Methoxyestrone 3-glucuronide", "name_a": "C25H32O9"} +{"id": 2829, "instruction": "Hexobarbitoneは別の呼び方では?", "response": "Hexobarbitoneは別の呼び方ではヘキソバルビトンです。", "task": "replace", "name_q": "Hexobarbitone", "name_a": "ヘキソバルビトン"} +{"id": 12348, "instruction": "2-Amino-4-nitrophenolの異なる表現は?", "response": "2-Amino-4-nitrophenolの異なる表現は2-アミノ-4-ニトロフェノールです。", "task": "replace", "name_q": "2-Amino-4-nitrophenol", "name_a": "2-アミノ-4-ニトロフェノール"} +{"id": 2632, "instruction": "Panobinostat (USAN/INN)を英語で書くと?", "response": "Panobinostat (USAN/INN)を英語で書くとFarydak (TN)です。", "task": "replace ja to en", "name_q": "Panobinostat (USAN/INN)", "name_a": "Farydak (TN)"} +{"id": 24155, "instruction": "フルクロラリンの別表現は?", "response": "フルクロラリンの別表現はFluchloralinです。", "task": "replace", "name_q": "フルクロラリン", "name_a": "Fluchloralin"} +{"id": 6157, "instruction": "Floxuridine (USP/INN)をを分子式で記述すると?", "response": "Floxuridine (USP/INN)をを分子式で記述するとC9H11FN2O5です。", "task": "formula", "name_q": "Floxuridine (USP/INN)", "name_a": "C9H11FN2O5"} +{"id": 22779, "instruction": "Riley-Day syndromeの異なる表記は?", "response": "Riley-Day syndromeの異なる表記はFamilial dysautonomiaです。", "task": "replace", "name_q": "Riley-Day syndrome", "name_a": "Familial dysautonomia"} +{"id": 4340, "instruction": "Jeffries-Lakhani 神経発達症候群を英語表記で表すと?", "response": "Jeffries-Lakhani 神経発達症候群を英語表記で表すとJeffries-Lakhani neurodevelopmental syndromeです。", "task": "replace ja to en", "name_q": "Jeffries-Lakhani 神経発達症候群", "name_a": "Jeffries-Lakhani neurodevelopmental syndrome"} +{"id": 20910, "instruction": "Macrogol ester (INN)の別名は?", "response": "Macrogol ester (INN)の別名はPolyoxyl 40 stearate (JP18/NF)です。", "task": "replace", "name_q": "Macrogol ester (INN)", "name_a": "Polyoxyl 40 stearate (JP18/NF)"} +{"id": 1749, "instruction": "5-Deoxy-D-glucuronic acidを言い換えると?", "response": "5-Deoxy-D-glucuronic acidを言い換えると5-Deoxy-D-xylo-hexuronic acidです。", "task": "replace", "name_q": "5-Deoxy-D-glucuronic acid", "name_a": "5-Deoxy-D-xylo-hexuronic acid"} +{"id": 11618, "instruction": "N-Acetylgalactosamine 4-sulfateをを化学構造で記述すると?", "response": "N-Acetylgalactosamine 4-sulfateをを化学構造で記述するとC8H15NO9Sです。", "task": "formula", "name_q": "N-Acetylgalactosamine 4-sulfate", "name_a": "C8H15NO9S"} +{"id": 14407, "instruction": "Arthropod-borne viral fever SUBGROUP Mosquito-borne viral fevers Omsk hemorrhagic fever Kyasanur Forest disease Alkhumra hemorrhagic fever Sandfly fever Severe fever with thrombocytopenia syndrome Crimean-Congo hemorrhagic fever Colorado tick fever Oropouche feverを日本語に訳すと?", "response": "Arthropod-borne viral fever SUBGROUP Mosquito-borne viral fevers Omsk hemorrhagic fever Kyasanur Forest disease Alkhumra hemorrhagic fever Sandfly fever Severe fever with thrombocytopenia syndrome Crimean-Congo hemorrhagic fever Colorado tick fever Oropouche feverを日本語に訳すと節足動物媒介ウイルス熱 下位グループ 蚊媒介ウイルス熱 オムスク出血熱 キャサヌル森林病 アルハムラ出血熱 サシチョウバエ熱 重症熱性血小板減少症候群 クリミア・コンゴ出血熱 コロラドダニ熱 オロプーシェ熱です。", "task": "replace en to ja", "name_q": "Arthropod-borne viral fever SUBGROUP Mosquito-borne viral fevers Omsk hemorrhagic fever Kyasanur Forest disease Alkhumra hemorrhagic fever Sandfly fever Severe fever with thrombocytopenia syndrome Crimean-Congo hemorrhagic fever Colorado tick fever Oropouche fever", "name_a": "節足動物媒介ウイルス熱 下位グループ 蚊媒介ウイルス熱 オムスク出血熱 キャサヌル森林病 アルハムラ出血熱 サシチョウバエ熱 重症熱性血小板減少症候群 クリミア・コンゴ出血熱 コロラドダニ熱 オロプーシェ熱"} +{"id": 13510, "instruction": "Empasiprubart (USAN/INN)をは分子式で表すと?", "response": "Empasiprubart (USAN/INN)をは分子式で表すとC6454H9980N1720O2042S44です。", "task": "formula", "name_q": "Empasiprubart (USAN/INN)", "name_a": "C6454H9980N1720O2042S44"} +{"id": 4087, "instruction": "播種性表在性光線性汗孔角化症を英語で書くと?", "response": "播種性表在性光線性汗孔角化症を英語で書くとDisseminated superficial actinic porokeratosis (DSAP)です。", "task": "replace ja to en", "name_q": "播種性表在性光線性汗孔角化症", "name_a": "Disseminated superficial actinic porokeratosis (DSAP)"} +{"id": 14610, "instruction": "ブルセインBの別の呼び方は?", "response": "ブルセインBの別の呼び方はBruceine Bです。", "task": "replace", "name_q": "ブルセインB", "name_a": "Bruceine B"} +{"id": 2783, "instruction": "Ferrioxamineをを化学構造で表すと?", "response": "Ferrioxamineをを化学構造で表すとC25H45FeN6O8です。", "task": "formula", "name_q": "Ferrioxamine", "name_a": "C25H45FeN6O8"} +{"id": 11221, "instruction": "Nasodigitoacoustic syndromeの日本語表記は?", "response": "Nasodigitoacoustic syndromeの日本語表記はKeipert 症候群です。", "task": "replace en to ja", "name_q": "Nasodigitoacoustic syndrome", "name_a": "Keipert 症候群"} +{"id": 3627, "instruction": "クロモグリク酸Na(共和薬品工業)を使用した商品は?", "response": "クロモグリク酸Na(共和薬品工業)を使用した商品はCROMOLYNSODIUM(WoodwardPharmaServicesLLC)です。", "task": "product", "name_q": "クロモグリク酸Na(共和薬品工業)", "name_a": "CROMOLYNSODIUM(WoodwardPharmaServicesLLC)"} +{"id": 13552, "instruction": "Prodiamineをは化学構造で表すと?", "response": "Prodiamineをは化学構造で表すとC13H17F3N4O4です。", "task": "formula", "name_q": "Prodiamine", "name_a": "C13H17F3N4O4"} +{"id": 15075, "instruction": "Everninomicinをを分子式で表すと?", "response": "Everninomicinをを分子式で表すとC70H97Cl2NO38です。", "task": "formula", "name_q": "Everninomicin", "name_a": "C70H97Cl2NO38"} +{"id": 19565, "instruction": "Leukotriene F4をは化学構造で表すと?", "response": "Leukotriene F4をは化学構造で表すとC28H44N2O8Sです。", "task": "formula", "name_q": "Leukotriene F4", "name_a": "C28H44N2O8S"} +{"id": 29615, "instruction": "Piroheptine (INN)をを化学構造で書くと?", "response": "Piroheptine (INN)をを化学構造で書くとC22H25Nです。", "task": "formula", "name_q": "Piroheptine (INN)", "name_a": "C22H25N"} +{"id": 32442, "instruction": "Artemisinic acidの別名は?", "response": "Artemisinic acidの別名はArtemisinateです。", "task": "replace", "name_q": "Artemisinic acid", "name_a": "Artemisinate"} +{"id": 23958, "instruction": "O-Isovaleryl-L-carnitineの別名は?", "response": "O-Isovaleryl-L-carnitineの別名はIsovalerylcarnitineです。", "task": "replace", "name_q": "O-Isovaleryl-L-carnitine", "name_a": "Isovalerylcarnitine"} +{"id": 1901, "instruction": "5,6-Dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-oneをを化学式で書くと?", "response": "5,6-Dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-oneをを化学式で書くとC9H8Cl2N2Oです。", "task": "formula", "name_q": "5,6-Dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one", "name_a": "C9H8Cl2N2O"} +{"id": 17528, "instruction": "2,6-Dioxo-5-diazopyrimidineをの化学式は?", "response": "2,6-Dioxo-5-diazopyrimidineをの化学式はC4H2N4O2です。", "task": "formula", "name_q": "2,6-Dioxo-5-diazopyrimidine", "name_a": "C4H2N4O2"} +{"id": 4584, "instruction": "Fenitropanをの化学式は?", "response": "Fenitropanをの化学式はC13H15NO6です。", "task": "formula", "name_q": "Fenitropan", "name_a": "C13H15NO6"} +{"id": 7674, "instruction": "Phenyltoloxamine citrate (USP)を日本語で記述すると?", "response": "Phenyltoloxamine citrate (USP)を日本語で記述するとフェニルトロキサミンクエン酸塩です。", "task": "replace en to ja", "name_q": "Phenyltoloxamine citrate (USP)", "name_a": "フェニルトロキサミンクエン酸塩"} +{"id": 16414, "instruction": "オリザビンをを化学構造で記述すると?", "response": "オリザビンをを化学構造で記述するとC19H26O7です。", "task": "formula", "name_q": "オリザビン", "name_a": "C19H26O7"} +{"id": 1488, "instruction": "3-(O-Geranylgeranyl)-sn-glycerol 1-phosphateをを分子式で表すと?", "response": "3-(O-Geranylgeranyl)-sn-glycerol 1-phosphateをを分子式で表すとC23H41O6Pです。", "task": "formula", "name_q": "3-(O-Geranylgeranyl)-sn-glycerol 1-phosphate", "name_a": "C23H41O6P"} +{"id": 15952, "instruction": "(5S)-6-Hydroxy-5-isopropenyl-2-methylhexanoateをを分子式で表すと?", "response": "(5S)-6-Hydroxy-5-isopropenyl-2-methylhexanoateをを分子式で表すとC10H18O3です。", "task": "formula", "name_q": "(5S)-6-Hydroxy-5-isopropenyl-2-methylhexanoate", "name_a": "C10H18O3"} +{"id": 5167, "instruction": "Traumatinをは化学構造で表すと?", "response": "Traumatinをは化学構造で表すとC12H20O3です。", "task": "formula", "name_q": "Traumatin", "name_a": "C12H20O3"} +{"id": 11123, "instruction": "Efegatran sulfate (USAN)をを化学式で表すと?", "response": "Efegatran sulfate (USAN)をを化学式で表すとC21H32N6O3. H2SO4です。", "task": "formula", "name_q": "Efegatran sulfate (USAN)", "name_a": "C21H32N6O3. H2SO4"} +{"id": 22340, "instruction": "Piperocaineをは組成式で表すと?", "response": "Piperocaineをは組成式で表すとC16H23NO2です。", "task": "formula", "name_q": "Piperocaine", "name_a": "C16H23NO2"} +{"id": 33011, "instruction": "n-ヘキサンをを化学構造で記述すると?", "response": "n-ヘキサンをを化学構造で記述するとC6H14です。", "task": "formula", "name_q": "n-ヘキサン", "name_a": "C6H14"} +{"id": 15804, "instruction": "バダスツキシマブの異なる表現は?", "response": "バダスツキシマブの異なる表現はVadastuximab (USAN/INN)です。", "task": "replace", "name_q": "バダスツキシマブ", "name_a": "Vadastuximab (USAN/INN)"} +{"id": 13884, "instruction": "プロトロンビン欠乏症を英語で書くと?", "response": "プロトロンビン欠乏症を英語で書くとCongenital prothrombin deficiencyです。", "task": "replace ja to en", "name_q": "プロトロンビン欠乏症", "name_a": "Congenital prothrombin deficiency"} +{"id": 5327, "instruction": "Serlopitant (USAN)をは分子式で表すと?", "response": "Serlopitant (USAN)をは分子式で表すとC29H28F7NO2です。", "task": "formula", "name_q": "Serlopitant (USAN)", "name_a": "C29H28F7NO2"} +{"id": 33037, "instruction": "[Ribulose-bisphosphate carboxylase large chain]-N6,N6,N6-trimethyl-L-lysineは別の呼び方では?", "response": "[Ribulose-bisphosphate carboxylase large chain]-N6,N6,N6-trimethyl-L-lysineは別の呼び方では[Ribulose-1,5-bisphosphate carboxylase]-N6,N6,N6-trimethyl-L-lysineです。", "task": "replace", "name_q": "[Ribulose-bisphosphate carboxylase large chain]-N6,N6,N6-trimethyl-L-lysine", "name_a": "[Ribulose-1,5-bisphosphate carboxylase]-N6,N6,N6-trimethyl-L-lysine"} +{"id": 22816, "instruction": "CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerolをは組成式で表すと?", "response": "CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerolをは組成式で表すとC52H85N3O13P2です。", "task": "formula", "name_q": "CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerol", "name_a": "C52H85N3O13P2"} +{"id": 953, "instruction": "ジベレリン A4を言い換えると?", "response": "ジベレリン A4を言い換えるとGibberellin A4です。", "task": "replace", "name_q": "ジベレリン A4", "name_a": "Gibberellin A4"} +{"id": 18665, "instruction": "19(S)-HETEの別表現は?", "response": "19(S)-HETEの別表現は(19S)-Hydroxyicosatetraenoic acidです。", "task": "replace", "name_q": "19(S)-HETE", "name_a": "(19S)-Hydroxyicosatetraenoic acid"} +{"id": 4351, "instruction": "Parkinsonian syndromeを日本語表記で表すと?", "response": "Parkinsonian syndromeを日本語表記で表すとパーキンソン症候群です。", "task": "replace en to ja", "name_q": "Parkinsonian syndrome", "name_a": "パーキンソン症候群"} +{"id": 17969, "instruction": "Alcolo (TN)を日本語で記述すると?", "response": "Alcolo (TN)を日本語で記述すると消毒用アルコールです。", "task": "replace en to ja", "name_q": "Alcolo (TN)", "name_a": "消毒用アルコール"} +{"id": 30748, "instruction": "Neomycin Cをを化学式で表すと?", "response": "Neomycin Cをを化学式で表すとC23H46N6O13です。", "task": "formula", "name_q": "Neomycin C", "name_a": "C23H46N6O13"} +{"id": 34469, "instruction": "ミリンカマイシン塩酸塩の異なる表記は?", "response": "ミリンカマイシン塩酸塩の異なる表記はMirincamycin hydrochloride (USAN)です。", "task": "replace", "name_q": "ミリンカマイシン塩酸塩", "name_a": "Mirincamycin hydrochloride (USAN)"} +{"id": 17261, "instruction": "複合下垂体ホルモン欠損症 上位グループ 成長ホルモン分泌不全症 下垂体前葉機能低下症 の英訳は?", "response": "複合下垂体ホルモン欠損症 上位グループ 成長ホルモン分泌不全症 下垂体前葉機能低下症 の英訳はCombined pituitary hormone deficiency SUPERGRP Growth hormone deficiency Hypopituitarism です。", "task": "replace ja to en", "name_q": "複合下垂体ホルモン欠損症 上位グループ 成長ホルモン分泌不全症 下垂体前葉機能低下症 ", "name_a": "Combined pituitary hormone deficiency SUPERGRP Growth hormone deficiency Hypopituitarism "} +{"id": 28306, "instruction": "乾燥細胞培養痘そうワクチン (JP18)の別名は?", "response": "乾燥細胞培養痘そうワクチン (JP18)の別名はFreeze-dried smallpox vaccine prepared in cell culture (JP18)です。", "task": "replace", "name_q": "乾燥細胞培養痘そうワクチン (JP18)", "name_a": "Freeze-dried smallpox vaccine prepared in cell culture (JP18)"} +{"id": 6488, "instruction": "2-O-(alpha-D-Mannosyl)-1-phosphatidyl-1D-myo-inositolをは組成式で表すと?", "response": "2-O-(alpha-D-Mannosyl)-1-phosphatidyl-1D-myo-inositolをは組成式で表すとC17H27O18PR2です。", "task": "formula", "name_q": "2-O-(alpha-D-Mannosyl)-1-phosphatidyl-1D-myo-inositol", "name_a": "C17H27O18PR2"} +{"id": 1418, "instruction": "Racephedrineをを化学式で表すと?", "response": "Racephedrineをを化学式で表すとC10H15NOです。", "task": "formula", "name_q": "Racephedrine", "name_a": "C10H15NO"} +{"id": 29591, "instruction": "アダグロキサドシモレニンを英語表記で表すと?", "response": "アダグロキサドシモレニンを英語表記で表すとAdagloxad simolenin (USAN)です。", "task": "replace ja to en", "name_q": "アダグロキサドシモレニン", "name_a": "Adagloxad simolenin (USAN)"} +{"id": 31633, "instruction": "4-Vinylcyclohexene diepoxideをを組成式で書くと?", "response": "4-Vinylcyclohexene diepoxideをを組成式で書くとC8H12O2です。", "task": "formula", "name_q": "4-Vinylcyclohexene diepoxide", "name_a": "C8H12O2"} +{"id": 14657, "instruction": "2-Dehydro-D-xylonateをを化学式で書くと?", "response": "2-Dehydro-D-xylonateをを化学式で書くとC5H8O6です。", "task": "formula", "name_q": "2-Dehydro-D-xylonate", "name_a": "C5H8O6"} +{"id": 23024, "instruction": "デルイソマルトース第二鉄 (JAN)の別名は?", "response": "デルイソマルトース第二鉄 (JAN)の別名はFerric derisomaltose (JAN/USAN)です。", "task": "replace", "name_q": "デルイソマルトース第二鉄 (JAN)", "name_a": "Ferric derisomaltose (JAN/USAN)"} +{"id": 12172, "instruction": "(Z)-3,5-Hexadienyl butyrateをを分子式で表すと?", "response": "(Z)-3,5-Hexadienyl butyrateをを分子式で表すとC10H16O2です。", "task": "formula", "name_q": "(Z)-3,5-Hexadienyl butyrate", "name_a": "C10H16O2"} +{"id": 22385, "instruction": "CLADRIBINE(HikmaPharmaceuticalsUSA)をは組成式で表すと?", "response": "CLADRIBINE(HikmaPharmaceuticalsUSA)をは組成式で表すとC10H12ClN5O3です。", "task": "formula", "name_q": "CLADRIBINE(HikmaPharmaceuticalsUSA)", "name_a": "C10H12ClN5O3"} +{"id": 32943, "instruction": "D-Tagatopyranose 1-phosphateの異なる表記は?", "response": "D-Tagatopyranose 1-phosphateの異なる表記はD-Tagatose 1-phosphateです。", "task": "replace", "name_q": "D-Tagatopyranose 1-phosphate", "name_a": "D-Tagatose 1-phosphate"} +{"id": 23085, "instruction": "Methyl salicylate (JP18/NF)の英訳は?", "response": "Methyl salicylate (JP18/NF)の英訳はMethyl salicylate (TN)です。", "task": "replace ja to en", "name_q": "Methyl salicylate (JP18/NF)", "name_a": "Methyl salicylate (TN)"} +{"id": 7946, "instruction": "Sulfaperin (INN)をの分子式は?", "response": "Sulfaperin (INN)をの分子式はC11H12N4O2Sです。", "task": "formula", "name_q": "Sulfaperin (INN)", "name_a": "C11H12N4O2S"} +{"id": 30274, "instruction": "アルジカルブをの組成式は?", "response": "アルジカルブをの組成式はC7H14N2O2Sです。", "task": "formula", "name_q": "アルジカルブ", "name_a": "C7H14N2O2S"} +{"id": 986, "instruction": "Motilinの異なる表現は?", "response": "Motilinの異なる表現はモチリンです。", "task": "replace", "name_q": "Motilin", "name_a": "モチリン"} +{"id": 1231, "instruction": "Belatacept (USAN/INN)を利用した医薬品は?", "response": "Belatacept (USAN/INN)を利用した医薬品はNULOJIX(E.R.Squibb&Sons)です。", "task": "product", "name_q": "Belatacept (USAN/INN)", "name_a": "NULOJIX(E.R.Squibb&Sons)"} +{"id": 22341, "instruction": "7,8-ジヒドロキシキヌレン酸をの化学式は?", "response": "7,8-ジヒドロキシキヌレン酸をの化学式はC10H7NO5です。", "task": "formula", "name_q": "7,8-ジヒドロキシキヌレン酸", "name_a": "C10H7NO5"} +{"id": 10751, "instruction": "Terbinafine (USAN/INN)をは化学式で表すと?", "response": "Terbinafine (USAN/INN)をは化学式で表すとC21H25Nです。", "task": "formula", "name_q": "Terbinafine (USAN/INN)", "name_a": "C21H25N"} +{"id": 17875, "instruction": "ウミフェノビルの異なる表現は?", "response": "ウミフェノビルの異なる表現はUmifenovir (INN)です。", "task": "replace", "name_q": "ウミフェノビル", "name_a": "Umifenovir (INN)"} +{"id": 9763, "instruction": "S-Allyl-L-cysteineをを化学構造で記述すると?", "response": "S-Allyl-L-cysteineをを化学構造で記述するとC6H11NO2Sです。", "task": "formula", "name_q": "S-Allyl-L-cysteine", "name_a": "C6H11NO2S"} +{"id": 17140, "instruction": "myo-Inositol 5-phosphateの別名は?", "response": "myo-Inositol 5-phosphateの別名はmyo-イノシトール5-リン酸です。", "task": "replace", "name_q": "myo-Inositol 5-phosphate", "name_a": "myo-イノシトール5-リン酸"} +{"id": 6586, "instruction": "Yttrium Y 90 clivatuzumab tetraxetan (USAN)の日本語表記は?", "response": "Yttrium Y 90 clivatuzumab tetraxetan (USAN)の日本語表記はイットリウム(Y90)クリバツズマブテトラキセタンです。", "task": "replace en to ja", "name_q": "Yttrium Y 90 clivatuzumab tetraxetan (USAN)", "name_a": "イットリウム(Y90)クリバツズマブテトラキセタン"} +{"id": 15187, "instruction": "(-)-スパルチカルピンをを化学式で書くと?", "response": "(-)-スパルチカルピンをを化学式で書くとC17H16O5です。", "task": "formula", "name_q": "(-)-スパルチカルピン", "name_a": "C17H16O5"} +{"id": 25282, "instruction": "Lancerinをの組成式は?", "response": "Lancerinをの組成式はC19H18O10です。", "task": "formula", "name_q": "Lancerin", "name_a": "C19H18O10"} +{"id": 17294, "instruction": "Neural tube defects, folate-sensitive SUBGROUP Spina bifida, folate-sensitive SUPERGRP Neural tube defects を日本語に訳すと?", "response": "Neural tube defects, folate-sensitive SUBGROUP Spina bifida, folate-sensitive SUPERGRP Neural tube defects を日本語に訳すと葉酸感受性神経管欠損症 下位グループ 葉酸感受性二分脊椎症 上位グループ 神経管欠損症 です。", "task": "replace en to ja", "name_q": "Neural tube defects, folate-sensitive SUBGROUP Spina bifida, folate-sensitive SUPERGRP Neural tube defects ", "name_a": "葉酸感受性神経管欠損症 下位グループ 葉酸感受性二分脊椎症 上位グループ 神経管欠損症 "} +{"id": 17009, "instruction": "Bromobenzene-3,4-oxideの別名は?", "response": "Bromobenzene-3,4-oxideの別名はBromobenzene-3,4-epoxideです。", "task": "replace", "name_q": "Bromobenzene-3,4-oxide", "name_a": "Bromobenzene-3,4-epoxide"} +{"id": 5395, "instruction": "グリパラミドの別名は?", "response": "グリパラミドの別名はGlyparamide (USAN)です。", "task": "replace", "name_q": "グリパラミド", "name_a": "Glyparamide (USAN)"} +{"id": 2809, "instruction": "Gonaneの異なる表記は?", "response": "Gonaneの異なる表記は18-Norestraneです。", "task": "replace", "name_q": "Gonane", "name_a": "18-Norestrane"} +{"id": 17489, "instruction": "シナシグアト (JAN)の異なる名称は?", "response": "シナシグアト (JAN)の異なる名称はCinaciguat (JAN/INN)です。", "task": "replace", "name_q": "シナシグアト (JAN)", "name_a": "Cinaciguat (JAN/INN)"} +{"id": 9562, "instruction": "ホップ (Non-JPS)を英語に訳すと?", "response": "ホップ (Non-JPS)を英語に訳すとLuppuli strobilusです。", "task": "replace ja to en", "name_q": "ホップ (Non-JPS)", "name_a": "Luppuli strobilus"} +{"id": 1199, "instruction": "プミリオトキシンAをは組成式で表すと?", "response": "プミリオトキシンAをは組成式で表すとC19H33NO2です。", "task": "formula", "name_q": "プミリオトキシンA", "name_a": "C19H33NO2"} +{"id": 11245, "instruction": "若年性欠神てんかん 上位グループ 特発性全般てんかん の英語表記は?", "response": "若年性欠神てんかん 上位グループ 特発性全般てんかん の英語表記はJuvenile absence epilepsy SUPERGRP Idiopathic generalized epilepsies です。", "task": "replace ja to en", "name_q": "若年性欠神てんかん 上位グループ 特発性全般てんかん ", "name_a": "Juvenile absence epilepsy SUPERGRP Idiopathic generalized epilepsies "} +{"id": 10404, "instruction": "セルペンチンの別表現は?", "response": "セルペンチンの別表現はSerpentineです。", "task": "replace", "name_q": "セルペンチン", "name_a": "Serpentine"} +{"id": 23517, "instruction": "Durlobactam sodium (USAN)をは化学構造で表すと?", "response": "Durlobactam sodium (USAN)をは化学構造で表すとC8H10N3O6S. Naです。", "task": "formula", "name_q": "Durlobactam sodium (USAN)", "name_a": "C8H10N3O6S. Na"} +{"id": 5949, "instruction": "4‐クロロフェノキシ酢酸をは化学式で表すと?", "response": "4‐クロロフェノキシ酢酸をは化学式で表すとC8H7ClO3です。", "task": "formula", "name_q": "4‐クロロフェノキシ酢酸", "name_a": "C8H7ClO3"} +{"id": 25971, "instruction": "Erythromycin Cをの分子式は?", "response": "Erythromycin Cをの分子式はC36H65NO13です。", "task": "formula", "name_q": "Erythromycin C", "name_a": "C36H65NO13"} +{"id": 3332, "instruction": "Familial multinodular goiter SUBGROUP Multinodular goiter-1 with or without Sertoli-Leydig cell tumors (MNG1)を日本語に訳すと?", "response": "Familial multinodular goiter SUBGROUP Multinodular goiter-1 with or without Sertoli-Leydig cell tumors (MNG1)を日本語に訳すと家族性多結節性甲状腺腫 下位グループ セルトリ・ライディッヒ細胞腫を伴う(伴わない)多結節性甲状腺腫 (MNG1)です。", "task": "replace en to ja", "name_q": "Familial multinodular goiter SUBGROUP Multinodular goiter-1 with or without Sertoli-Leydig cell tumors (MNG1)", "name_a": "家族性多結節性甲状腺腫 下位グループ セルトリ・ライディッヒ細胞腫を伴う(伴わない)多結節性甲状腺腫 (MNG1)"} +{"id": 19004, "instruction": "Urushiol IIIをを化学式で記述すると?", "response": "Urushiol IIIをを化学式で記述するとC21H32O2です。", "task": "formula", "name_q": "Urushiol III", "name_a": "C21H32O2"} +{"id": 29168, "instruction": "沈降精製百日せきワクチン (JP18)を英語で記述すると?", "response": "沈降精製百日せきワクチン (JP18)を英語で記述するとAdsorbed purified pertussis vaccine (JP18)です。", "task": "replace ja to en", "name_q": "沈降精製百日せきワクチン (JP18)", "name_a": "Adsorbed purified pertussis vaccine (JP18)"} +{"id": 11923, "instruction": "Saikokeishikankyotoは別の呼び方では?", "response": "Saikokeishikankyotoは別の呼び方ではサイコケイシカンキョウトウです。", "task": "replace", "name_q": "Saikokeishikankyoto", "name_a": "サイコケイシカンキョウトウ"} +{"id": 3327, "instruction": "Santonin (TN)をを分子式で記述すると?", "response": "Santonin (TN)をを分子式で記述するとC15H18O3です。", "task": "formula", "name_q": "Santonin (TN)", "name_a": "C15H18O3"} +{"id": 7127, "instruction": "エトドラク (JP18)を主とした薬品は?", "response": "エトドラク (JP18)を主とした薬品はハイペン(日本新薬)です。", "task": "product", "name_q": "エトドラク (JP18)", "name_a": "ハイペン(日本新薬)"} +{"id": 15017, "instruction": "2,2-Dimethyl-3-(4-methoxyphenyl)-4-ethyl-6-(1-pyrrolidinylmethyl)-2H-1-benzopyran-7-olをを化学式で表すと?", "response": "2,2-Dimethyl-3-(4-methoxyphenyl)-4-ethyl-6-(1-pyrrolidinylmethyl)-2H-1-benzopyran-7-olをを化学式で表すとC25H31NO3です。", "task": "formula", "name_q": "2,2-Dimethyl-3-(4-methoxyphenyl)-4-ethyl-6-(1-pyrrolidinylmethyl)-2H-1-benzopyran-7-ol", "name_a": "C25H31NO3"} +{"id": 31748, "instruction": "Nicomol (JP18/INN)をを分子式で記述すると?", "response": "Nicomol (JP18/INN)をを分子式で記述するとC34H32N4O9です。", "task": "formula", "name_q": "Nicomol (JP18/INN)", "name_a": "C34H32N4O9"} +{"id": 27457, "instruction": "ヨウ化カリウム(小堺製薬)を主材料とする商品は?", "response": "ヨウ化カリウム(小堺製薬)を主材料とする商品はヨウ���カリウム(山善製薬)です。", "task": "product", "name_q": "ヨウ化カリウム(小堺製薬)", "name_a": "ヨウ化カリウム(山善製薬)"} +{"id": 7683, "instruction": "AquaTar (TN)の異なる表記は?", "response": "AquaTar (TN)の異なる表記はCoal tar (USP)です。", "task": "replace", "name_q": "AquaTar (TN)", "name_a": "Coal tar (USP)"} +{"id": 15821, "instruction": "Duteplase (genetical recombination) (JAN)をを化学式で書くと?", "response": "Duteplase (genetical recombination) (JAN)をを化学式で書くとC2736H4174N914O824S46です。", "task": "formula", "name_q": "Duteplase (genetical recombination) (JAN)", "name_a": "C2736H4174N914O824S46"} +{"id": 1355, "instruction": "5beta-Cyprinolsulfateをを化学構造で記述すると?", "response": "5beta-Cyprinolsulfateをを化学構造で記述するとC27H48O8Sです。", "task": "formula", "name_q": "5beta-Cyprinolsulfate", "name_a": "C27H48O8S"} +{"id": 25787, "instruction": "脊髄空洞症を英語で記述すると?", "response": "脊髄空洞症を英語で記述するとSyringomyeliaです。", "task": "replace ja to en", "name_q": "脊髄空洞症", "name_a": "Syringomyelia"} +{"id": 30594, "instruction": "2-Ethylphenolの別表現は?", "response": "2-Ethylphenolの別表現は2-エチルフェノールです。", "task": "replace", "name_q": "2-Ethylphenol", "name_a": "2-エチルフェノール"} +{"id": 17667, "instruction": "Prolergic (TN)をを分子式で表すと?", "response": "Prolergic (TN)をを分子式で表すとC18H19ClN2. C4H4O4です。", "task": "formula", "name_q": "Prolergic (TN)", "name_a": "C18H19ClN2. C4H4O4"} +{"id": 32606, "instruction": "原発性硬化性胆管炎を英語で記述すると?", "response": "原発性硬化性胆管炎を英語で記述するとPrimary sclerosing cholangitisです。", "task": "replace ja to en", "name_q": "原発性硬化性胆管炎", "name_a": "Primary sclerosing cholangitis"} +{"id": 27784, "instruction": "Penicillenic acidの異なる表現は?", "response": "Penicillenic acidの異なる表現はペニシレン酸です。", "task": "replace", "name_q": "Penicillenic acid", "name_a": "ペニシレン酸"} +{"id": 23333, "instruction": "エスクレントシドBは別の呼び方では?", "response": "エスクレントシドBは別の呼び方ではPhytolaccoside Bです。", "task": "replace", "name_q": "エスクレントシドB", "name_a": "Phytolaccoside B"} +{"id": 15788, "instruction": "B.V.)を主材料とする商品名は?", "response": "B.V.)を主材料とする商品名はTISSUEBLUE(D.O.R.C.DutchOphthalmicResearchCenter(International)です。", "task": "product", "name_q": "B.V.)", "name_a": "TISSUEBLUE(D.O.R.C.DutchOphthalmicResearchCenter(International)"} +{"id": 9168, "instruction": "4-(N-Maleimido)phenyltrimethylammonium iodideをは化学構造で表すと?", "response": "4-(N-Maleimido)phenyltrimethylammonium iodideをは化学構造で表すとC13H15N2O2. Iです。", "task": "formula", "name_q": "4-(N-Maleimido)phenyltrimethylammonium iodide", "name_a": "C13H15N2O2. I"} +{"id": 9104, "instruction": "Osthenol-7-O-beta-D-gentiobiosideの別の呼び方は?", "response": "Osthenol-7-O-beta-D-gentiobiosideの別の呼び方はオステノール-7-O-ベータ-D-ゲンチオビオシドです。", "task": "replace", "name_q": "Osthenol-7-O-beta-D-gentiobioside", "name_a": "オステノール-7-O-ベータ-D-ゲンチオビオシド"} +{"id": 29962, "instruction": "ピモジビルの英語表記は?", "response": "ピモジビルの英語表記はPimodivir (USAN/INN)です。", "task": "replace ja to en", "name_q": "ピモジビル", "name_a": "Pimodivir (USAN/INN)"} +{"id": 20915, "instruction": "Pseudoephedrine polistirex (USAN)の異なる表記は?", "response": "Pseudoephedrine polistirex (USAN)の異なる表記はプソイドエフェドリンポリスチレクスです。", "task": "replace", "name_q": "Pseudoephedrine polistirex (USAN)", "name_a": "プソイドエフェドリンポリスチレクス"} +{"id": 23122, "instruction": "(2S,3S)-Flavan-3-olをの化学構造は?", "response": "(2S,3S)-Flavan-3-olをの化学構造はC15H14O2です。", "task": "formula", "name_q": "(2S,3S)-Flavan-3-ol", "name_a": "C15H14O2"} +{"id": 4475, "instruction": "Ufrenmeran (JAN/INN)を英語で記述すると?", "response": "Ufrenmeran (JAN/INN)を英語で記述するとMAFB-7256aです。", "task": "replace ja to en", "name_q": "Ufrenmeran (JAN/INN)", "name_a": "MAFB-7256a"} +{"id": 6391, "instruction": "セミカルバジド塩酸塩をを組成式で書くと?", "response": "セミカルバジド塩酸塩をを組成式で書くとCH5N3O. HClです。", "task": "formula", "name_q": "セミカルバジド塩酸塩", "name_a": "CH5N3O. HCl"} +{"id": 26667, "instruction": "Nitro blue tetrazoliumをは分子式で表すと?", "response": "Nitro blue tetrazoliumをは分子式で表すとC40H30N10O6. 2Clです。", "task": "formula", "name_q": "Nitro blue tetrazolium", "name_a": "C40H30N10O6. 2Cl"} +{"id": 17615, "instruction": "Demethylluteothinをの組成式は?", "response": "Demethylluteothinをの組成式はC21H23NO5です。", "task": "formula", "name_q": "Demethylluteothin", "name_a": "C21H23NO5"} +{"id": 2463, "instruction": "BEPOTASTINEBESILATE(Bausch&LombIncorporated)を利用した製品名は?", "response": "BEPOTASTINEBESILATE(Bausch&LombIncorporated)を利用した製品名はBEPOTASTINEBESILATEOPHTHALMICSOLUTION1.5%(AlembicPharmaceuticals)です。", "task": "product", "name_q": "BEPOTASTINEBESILATE(Bausch&LombIncorporated)", "name_a": "BEPOTASTINEBESILATEOPHTHALMICSOLUTION1.5%(AlembicPharmaceuticals)"} +{"id": 25851, "instruction": "n-Propyl alcoholをの化学式は?", "response": "n-Propyl alcoholをの化学式はC3H8Oです。", "task": "formula", "name_q": "n-Propyl alcohol", "name_a": "C3H8O"} +{"id": 31967, "instruction": "フルボキサミンの別の言い方は?", "response": "フルボキサミンの別の言い方はFluvoxamine (INN)です。", "task": "replace", "name_q": "フルボキサミン", "name_a": "Fluvoxamine (INN)"} +{"id": 9914, "instruction": "1-Hydroxyhexane-1,2,6-tricarboxylateの異なる名称は?", "response": "1-Hydroxyhexane-1,2,6-tricarboxylateの異なる名称は(-)-threo-1-Hydroxy-1,2,6-hexanetricarboxylic acidです。", "task": "replace", "name_q": "1-Hydroxyhexane-1,2,6-tricarboxylate", "name_a": "(-)-threo-1-Hydroxy-1,2,6-hexanetricarboxylic acid"} +{"id": 5410, "instruction": "Casimiroedineの別名称は?", "response": "Casimiroedineの別名称はカシミレジンです。", "task": "replace", "name_q": "Casimiroedine", "name_a": "カシミレジン"} +{"id": 2503, "instruction": "Dextran sulfate sodium sulfur 18 (JP18)の日本語表記は?", "response": "Dextran sulfate sodium sulfur 18 (JP18)の日本語表記はDextran sulfate sodium sulfur 5 (JP18)です。", "task": "replace en to ja", "name_q": "Dextran sulfate sodium sulfur 18 (JP18)", "name_a": "Dextran sulfate sodium sulfur 5 (JP18)"} +{"id": 21277, "instruction": "Sevelamer (INN)をを化学構造で表すと?", "response": "Sevelamer (INN)をを化学構造で表すと((C3H7N)mon. (C3H5ClO)mon)coです。", "task": "formula", "name_q": "Sevelamer (INN)", "name_a": "((C3H7N)mon. (C3H5ClO)mon)co"} +{"id": 27685, "instruction": "裂毛症 上位グループ ヌクレオチド除去修復機構異常疾患 を英語表記で表すと?", "response": "裂毛症 上位グループ ヌクレオチド除去修復機構異常疾患 を英語表記で表すとTrichothiodystrophy SUPERGRP Disorders of nucleotide excision repair です。", "task": "replace ja to en", "name_q": "裂毛症 上位グループ ヌクレオチド除去修復機構異常疾患 ", "name_a": "Trichothiodystrophy SUPERGRP Disorders of nucleotide excision repair "} +{"id": 11271, "instruction": "Flucetosulfuronをの分子式は?", "response": "Flucetosulfuronをの分子式はC18H22FN5O8Sです。", "task": "formula", "name_q": "Flucetosulfuron", "name_a": "C18H22FN5O8S"} +{"id": 28628, "instruction": "2-Methylfumaryl-CoAの異なる表記は?", "response": "2-Methylfumaryl-CoAの異なる表記はMesaconyl-CoAです。", "task": "replace", "name_q": "2-Methylfumaryl-CoA", "name_a": "Mesaconyl-CoA"} +{"id": 8684, "instruction": "Pancreatic neuroendocrine tumorの日本語表記は?", "response": "Pancreatic neuroendocrine tumorの日本語表記は膵神経内分泌腫瘍です。", "task": "replace en to ja", "name_q": "Pancreatic neuroendocrine tumor", "name_a": "膵神経内分泌腫瘍"} +{"id": 4216, "instruction": "マレイン酸ブロマドリンをの化学構造は?", "response": "マレイン酸ブロマドリンをの化学構造はC15H21BrN2O. C4H4O4です。", "task": "formula", "name_q": "マレイン酸ブロマドリン", "name_a": "C15H21BrN2O. C4H4O4"} +{"id": 17250, "instruction": "マントル細胞リンパ腫 上位グループ 非ホジキンリンパ腫 の英訳は?", "response": "マントル細胞リンパ腫 上位グループ 非ホジキンリンパ腫 の英訳はMantle cell lymphoma SUPERGRP Non-Hodgkin lymphoma です。", "task": "replace ja to en", "name_q": "マントル細胞リンパ腫 上位グループ 非ホジキンリンパ腫 ", "name_a": "Mantle cell lymphoma SUPERGRP Non-Hodgkin lymphoma "} +{"id": 13652, "instruction": "セホニシドの別表現は?", "response": "セホニシドの別表現はCefonicidです。", "task": "replace", "name_q": "セホニシド", "name_a": "Cefonicid"} +{"id": 10505, "instruction": "Pyridoxal phosphate, fursultiamine hydrochloride, riboflavin and hydroxocobalamin acetateを日本語表記で表すと?", "response": "Pyridoxal phosphate, fursultiamine hydrochloride, riboflavin and hydroxocobalamin acetateを日本語表記で表すとリン酸ピリドキサール・フルスルチアミン塩酸塩・リボフラビン・ヒドロキソコバラミン酢酸塩です。", "task": "replace en to ja", "name_q": "Pyridoxal phosphate, fursultiamine hydrochloride, riboflavin and hydroxocobalamin acetate", "name_a": "リン酸ピリドキサール・フルスルチアミン塩酸塩・リボフラビン・ヒドロキソコバラミン酢酸塩"} +{"id": 11413, "instruction": "beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcpの別の言い方は?", "response": "beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcpの別の言い方はbeta-D-Glc-(1->4)-alpha-L-Rha-(1->3)-D-Glcです。", "task": "replace", "name_q": "beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp", "name_a": "beta-D-Glc-(1->4)-alpha-L-Rha-(1->3)-D-Glc"} +{"id": 27992, "instruction": "CARDIOGEN-82(BraccoDiagnostics)を材料とする製品名は?", "response": "CARDIOGEN-82(BraccoDiagnostics)を材料とする製品名はRUBY-FILL(JubilantDraxImage)です。", "task": "product", "name_q": "CARDIOGEN-82(BraccoDiagnostics)", "name_a": "RUBY-FILL(JubilantDraxImage)"} +{"id": 2520, "instruction": "2-Hydroxy-4-(2-oxo-1,3-dihydro-2H-inden-1-ylidene)but-2-enoic acidをの分子式は?", "response": "2-Hydroxy-4-(2-oxo-1,3-dihydro-2H-inden-1-ylidene)but-2-enoic acidをの分子式はC13H10O4です。", "task": "formula", "name_q": "2-Hydroxy-4-(2-oxo-1,3-dihydro-2H-inden-1-ylidene)but-2-enoic acid", "name_a": "C13H10O4"} +{"id": 7620, "instruction": "Pentylenetetrazoleの別名は?", "response": "Pentylenetetrazoleの別名はペンテトラゾールです。", "task": "replace", "name_q": "Pentylenetetrazole", "name_a": "ペンテトラゾール"} +{"id": 17714, "instruction": "関節弛緩・低身長および近視 上位グループ ラーセン症候群 を英語に訳すと?", "response": "関節弛緩・低身長および近視 上位グループ ラーセン症候群 を英語に訳すとJoint laxity, short stature, and myopia SUPERGRP Larsen syndrome です。", "task": "replace ja to en", "name_q": "関節弛緩・低身長および近視 上位グループ ラーセン症候群 ", "name_a": "Joint laxity, short stature, and myopia SUPERGRP Larsen syndrome "} +{"id": 28329, "instruction": "トウキシャクヤクサンカニンジンを言い換えると?", "response": "トウキシャクヤクサンカニンジンを言い換えるとTokishakuyakusankaninjinです。", "task": "replace", "name_q": "トウキシャクヤクサンカニンジン", "name_a": "Tokishakuyakusankaninjin"} +{"id": 24613, "instruction": "Transcobalamin II deficiencyを日本語に訳すと?", "response": "Transcobalamin II deficiencyを日本語に訳すとトランスコバラミン II 欠乏症です。", "task": "replace en to ja", "name_q": "Transcobalamin II deficiency", "name_a": "トランスコバラミン II 欠乏症"} +{"id": 17499, "instruction": "レカナクロチドを英語表記で表すと?", "response": "レカナクロチドを英語表記で表すとRecanaclotide (USAN/INN)です。", "task": "replace ja to en", "name_q": "レカナクロチド", "name_a": "Recanaclotide (USAN/INN)"} +{"id": 17037, "instruction": "1-O-(2-Amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositolをを分子式で表すと?", "response": "1-O-(2-Amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositolをを分子式で表すとC12H23NO10です。", "task": "formula", "name_q": "1-O-(2-Amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol", "name_a": "C12H23NO10"} +{"id": 20508, "instruction": "ベルメキマブを英語に訳すと?", "response": "ベルメキマブを英語に訳すとBermekimab (USAN)です。", "task": "replace ja to en", "name_q": "ベルメキマブ", "name_a": "Bermekimab (USAN)"} +{"id": 28210, "instruction": "Petosemtamab (USAN/INN)をの分子式は?", "response": "Petosemtamab (USAN/INN)をの分子式はC6479H9972N1714O2040S46です。", "task": "formula", "name_q": "Petosemtamab (USAN/INN)", "name_a": "C6479H9972N1714O2040S46"} +{"id": 20735, "instruction": "ビャッコトウの別名称は?", "response": "ビャッコトウの別名称はByakkotoです。", "task": "replace", "name_q": "ビャッコトウ", "name_a": "Byakkoto"} +{"id": 14626, "instruction": "(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoAをを化学式で書くと?", "response": "(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoAをを化学式で書くとC49H78N7O17P3Sです。", "task": "formula", "name_q": "(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA", "name_a": "C49H78N7O17P3S"} +{"id": 21075, "instruction": "GPI-anchor biosynthesis intermediate 6を言い換えると?", "response": "GPI-anchor biosynthesis intermediate 6を言い換えるとC22968です。", "task": "replace", "name_q": "GPI-anchor biosynthesis intermediate 6", "name_a": "C22968"} +{"id": 27642, "instruction": "Ojemda (TN)を用いた薬品は?", "response": "Ojemda (TN)を用いた薬品はOJEMDA(DayOneBiopharmaceuticals)です。", "task": "product", "name_q": "Ojemda (TN)", "name_a": "OJEMDA(DayOneBiopharmaceuticals)"} +{"id": 23246, "instruction": "オゾリノンを英語で記述すると?", "response": "オゾリノンを英語で記述するとOzolinone (USAN)です。", "task": "replace ja to en", "name_q": "オゾリノン", "name_a": "Ozolinone (USAN)"} +{"id": 32611, "instruction": "Avenacoside Aをを組成式で表すと?", "response": "Avenacoside Aをを組成式で表すとC51H82O23です。", "task": "formula", "name_q": "Avenacoside A", "name_a": "C51H82O23"} +{"id": 14522, "instruction": "Deltibant (USAN/INN)の日本語表記は?", "response": "Deltibant (USAN/INN)の日本語表記はデルチバントです。", "task": "replace en to ja", "name_q": "Deltibant (USAN/INN)", "name_a": "デルチバント"} +{"id": 1074, "instruction": "カプレオマイシンをは組成式で表すと?", "response": "カプレオマイシンをは組成式で表すとC19H30N12O6(R1)(R2)です。", "task": "formula", "name_q": "カプレオマイシン", "name_a": "C19H30N12O6(R1)(R2)"} +{"id": 27062, "instruction": "Beckwith-Wiedemann syndromeの日本語訳は?", "response": "Beckwith-Wiedemann syndromeの日本語訳はベックウィズ・ウイーデマン症候群です。", "task": "replace en to ja", "name_q": "Beckwith-Wiedemann syndrome", "name_a": "ベックウィズ・ウイーデマン症候群"} +{"id": 20006, "instruction": "ニフルメロンをの組成式は?", "response": "ニフルメロンをの組成式はC6H4ClNO4です。", "task": "formula", "name_q": "ニフルメロン", "name_a": "C6H4ClNO4"} +{"id": 21851, "instruction": "橋小脳低形成の英訳は?", "response": "橋小脳低形成の英訳はPontocerebellar hypoplasiaです。", "task": "replace ja to en", "name_q": "橋小脳低形成", "name_a": "Pontocerebellar hypoplasia"} +{"id": 31703, "instruction": "Atypical chronic myeloid leukemia SUPERGRP Myelodysplastic/myeloproliferative neoplasms の日本語訳は?", "response": "Atypical chronic myeloid leukemia SUPERGRP Myelodysplastic/myeloproliferative neoplasms の日本語訳は非定型慢性骨髄性白血病 上位グループ 骨髄異形成/骨髄増殖性腫瘍 です。", "task": "replace en to ja", "name_q": "Atypical chronic myeloid leukemia SUPERGRP Myelodysplastic/myeloproliferative neoplasms ", "name_a": "非定型慢性骨髄性白血病 上位グループ 骨髄異形成/骨髄増殖性腫瘍 "} +{"id": 13121, "instruction": "イズラリマブをを化学式で書くと?", "response": "イズラリマブをを化学式で書くとC5622H8636N1502O1738S38です。", "task": "formula", "name_q": "イズラリマブ", "name_a": "C5622H8636N1502O1738S38"} +{"id": 33048, "instruction": "4-Oxocyclohexanecarboxylateをを化学構造で表すと?", "response": "4-Oxocyclohexanecarboxylateをを化学構造で表すとC7H10O3です。", "task": "formula", "name_q": "4-Oxocyclohexanecarboxylate", "name_a": "C7H10O3"} +{"id": 10294, "instruction": "Biclodil hydrochloride (USAN)をを化学式で記述すると?", "response": "Biclodil hydrochloride (USAN)をを化学式で記述するとC8H8Cl2N4O. HClです。", "task": "formula", "name_q": "Biclodil hydrochloride (USAN)", "name_a": "C8H8Cl2N4O. HCl"} +{"id": 14172, "instruction": "5-L-Glutamyl-Se-methylselenocysteineをを化学式で表すと?", "response": "5-L-Glutamyl-Se-methylselenocysteineをを化学式で表すとC9H16N2O5Seです。", "task": "formula", "name_q": "5-L-Glutamyl-Se-methylselenocysteine", "name_a": "C9H16N2O5Se"} +{"id": 29435, "instruction": "4-Benzyloxy-2'-hydroxy-3',4',5',6'-tetramethoxychalconeをを化学構造で書くと?", "response": "4-Benzyloxy-2'-hydroxy-3',4',5',6'-tetramethoxychalconeをを化学構造で書くとC26H26O7です。", "task": "formula", "name_q": "4-Benzyloxy-2'-hydroxy-3',4',5',6'-tetramethoxychalcone", "name_a": "C26H26O7"} +{"id": 9526, "instruction": "Aggressive periodontitisの日本語表記は?", "response": "Aggressive periodontitisの日本語表記は侵襲性歯周炎です。", "task": "replace en to ja", "name_q": "Aggressive periodontitis", "name_a": "侵襲性歯周炎"} +{"id": 8231, "instruction": "Cytidine 3'-phospho-5'-diphosphoramidateは別の呼び方では?", "response": "Cytidine 3'-phospho-5'-diphosphoramidateは別の呼び方では3'-Phospho-cytidine-5'-diphosphoramidateです。", "task": "replace", "name_q": "Cytidine 3'-phospho-5'-diphosphoramidate", "name_a": "3'-Phospho-cytidine-5'-diphosphoramidate"} +{"id": 32586, "instruction": "12(S)-HHTをを化学式で書くと?", "response": "12(S)-HHTをを化学式で書くとC17H28O3です。", "task": "formula", "name_q": "12(S)-HHT", "name_a": "C17H28O3"} +{"id": 19384, "instruction": "Dehydrotrametenolic acidをを分子式で記述すると?", "response": "Dehydrotrametenolic acidをを分子式で記述するとC31H48O3です。", "task": "formula", "name_q": "Dehydrotrametenolic acid", "name_a": "C31H48O3"} +{"id": 34434, "instruction": "インドール-3-エタノールは別の呼び方では?", "response": "インドール-3-エタノールは別の呼び方ではトリプトホールです。", "task": "replace", "name_q": "インドール-3-エタノール", "name_a": "トリプトホール"} +{"id": 18247, "instruction": "Lithium citrate (USP)をの化学構造は?", "response": "Lithium citrate (USP)をの化学構造はC6H5O7. 4H2O. 3Liです。", "task": "formula", "name_q": "Lithium citrate (USP)", "name_a": "C6H5O7. 4H2O. 3Li"} +{"id": 14809, "instruction": "イス���トラビルの異なる表現は?", "response": "イスラトラビルの異なる表現はIslatravir (USAN)です。", "task": "replace", "name_q": "イスラトラビル", "name_a": "Islatravir (USAN)"} +{"id": 6526, "instruction": "Tedizolid phosphate (JAN/USAN)を主とした医薬品は?", "response": "Tedizolid phosphate (JAN/USAN)を主とした医薬品はSIVEXTRO(MerckSharp&DohmeLLC)です。", "task": "product", "name_q": "Tedizolid phosphate (JAN/USAN)", "name_a": "SIVEXTRO(MerckSharp&DohmeLLC)"} +{"id": 27684, "instruction": "Combined deficiency of factors V and VIIIを日本語に訳すと?", "response": "Combined deficiency of factors V and VIIIを日本語に訳すと第Vおよび第VIII因子合併欠乏症です。", "task": "replace en to ja", "name_q": "Combined deficiency of factors V and VIII", "name_a": "第Vおよび第VIII因子合併欠乏症"} +{"id": 33610, "instruction": "3,6,8-Trimethylallantoinをを分子式で記述すると?", "response": "3,6,8-Trimethylallantoinをを分子式で記述するとC7H12N4O3です。", "task": "formula", "name_q": "3,6,8-Trimethylallantoin", "name_a": "C7H12N4O3"} +{"id": 31352, "instruction": "1,2-ジヒドロキシミントラクトンをは化学構造で表すと?", "response": "1,2-ジヒドロキシミントラクトンをは化学構造で表すとC10H14O4です。", "task": "formula", "name_q": "1,2-ジヒドロキシミントラクトン", "name_a": "C10H14O4"} +{"id": 1449, "instruction": "Compound oxycodone (JP18)の異なる表現は?", "response": "Compound oxycodone (JP18)の異なる表現は複方オキシコドン (JP18)です。", "task": "replace", "name_q": "Compound oxycodone (JP18)", "name_a": "複方オキシコドン (JP18)"} +{"id": 4402, "instruction": "L-(-)-1-Butyl-2',6'-pipecoloxylidideをは化学式で表すと?", "response": "L-(-)-1-Butyl-2',6'-pipecoloxylidideをは化学式で表すとC18H28N2Oです。", "task": "formula", "name_q": "L-(-)-1-Butyl-2',6'-pipecoloxylidide", "name_a": "C18H28N2O"} +{"id": 16739, "instruction": "C13H17Nを材料とする医薬品名は?", "response": "C13H17Nを材料とする医薬品名はEMSAM(MylanSpecialtyL.P.)です。", "task": "product", "name_q": "C13H17N", "name_a": "EMSAM(MylanSpecialtyL.P.)"} +{"id": 9955, "instruction": "Sandalwoodの異なる表現は?", "response": "Sandalwoodの異なる表現はダンコウです。", "task": "replace", "name_q": "Sandalwood", "name_a": "ダンコウ"} +{"id": 29173, "instruction": "alpha-D-Glucosylglycogeninをを化学構造で記述すると?", "response": "alpha-D-Glucosylglycogeninをを化学構造で記述するとC16H20N2O8R2です。", "task": "formula", "name_q": "alpha-D-Glucosylglycogenin", "name_a": "C16H20N2O8R2"} +{"id": 8205, "instruction": "C12H19N2O2. Brを主材料とする薬品は?", "response": "C12H19N2O2. Brを主材料とする薬品はワゴスチグミン(共和薬品工業)です。", "task": "product", "name_q": "C12H19N2O2. Br", "name_a": "ワゴスチグミン(共和薬品工業)"} +{"id": 5470, "instruction": "Furmecycloxの別の言い方は?", "response": "Furmecycloxの別の言い方はフルメシクロックスです。", "task": "replace", "name_q": "Furmecyclox", "name_a": "フルメシクロックス"} +{"id": 26951, "instruction": "Ferrous sulfate Fe 59 (USAN)の異なる表記は?", "response": "Ferrous sulfate Fe 59 (USAN)の異なる表記は硫酸第一鉄 (Fe59)です。", "task": "replace", "name_q": "Ferrous sulfate Fe 59 (USAN)", "name_a": "硫酸第一鉄 (Fe59)"} +{"id": 2467, "instruction": "Xemilofiban hydrochloride (USAN)をは分子式で表すと?", "response": "Xemilofiban hydrochloride (USAN)をは分子式で表すとC18H22N4O4. HClです。", "task": "formula", "name_q": "Xemilofiban hydrochloride (USAN)", "name_a": "C18H22N4O4. HCl"} +{"id": 16825, "instruction": "Rhexifolineをを組成式で表すと?", "response": "Rhexifolineをを組成式で表すとC11H13NO3です。", "task": "formula", "name_q": "Rhexifoline", "name_a": "C11H13NO3"} +{"id": 11423, "instruction": "吉草酸エストラジオールの別名は?", "response": "吉草酸エストラジオールの別名はEstradiol valerateです。", "task": "replace", "name_q": "吉草酸エストラジオール", "name_a": "Estradiol valerate"} +{"id": 649, "instruction": "HMOQをを化学式で書くと?", "response": "HMOQをを化学式で書くとC17H23NO2です。", "task": "formula", "name_q": "HMOQ", "name_a": "C17H23NO2"} +{"id": 34401, "instruction": "Gal-alpha1->2Glc-alpha1->3acyl2Groの異なる表記は?", "response": "Gal-alpha1->2Glc-alpha1->3acyl2Groの異なる表記は1,2-Diacyl-3-O-[alpha-D-galactopyranosyl-(1->2)-O-alpha-D-glucopyranosyl]-sn-glycerolです。", "task": "replace", "name_q": "Gal-alpha1->2Glc-alpha1->3acyl2Gro", "name_a": "1,2-Diacyl-3-O-[alpha-D-galactopyranosyl-(1->2)-O-alpha-D-glucopyranosyl]-sn-glycerol"} +{"id": 4497, "instruction": "白色軟膏 (JP18)を用いた医薬品名は?", "response": "白色軟膏 (JP18)を用いた医薬品名は白色軟膏(吉田製薬)です。", "task": "product", "name_q": "白色軟膏 (JP18)", "name_a": "白色軟膏(吉田製薬)"} +{"id": 21530, "instruction": "Medrogestone (USAN/INN)の別名は?", "response": "Medrogestone (USAN/INN)の別名はメドロゲストンです。", "task": "replace", "name_q": "Medrogestone (USAN/INN)", "name_a": "メドロゲストン"} +{"id": 18235, "instruction": "Craniodiaphyseal dysplasiaを日本語で記述すると?", "response": "Craniodiaphyseal dysplasiaを日本語で記述すると頭蓋骨幹異形成です。", "task": "replace en to ja", "name_q": "Craniodiaphyseal dysplasia", "name_a": "頭蓋骨幹異形成"} +{"id": 30076, "instruction": "デヒドロコール酸の別記述は?", "response": "デヒドロコール酸の別記述はDehydrocholic acidです。", "task": "replace", "name_q": "デヒドロコール酸", "name_a": "Dehydrocholic acid"} +{"id": 18289, "instruction": "3D-3,5/4-Trihydroxycyclohexane-1,2-dioneをを組成式で表すと?", "response": "3D-3,5/4-Trihydroxycyclohexane-1,2-dioneをを組成式で表すとC6H8O5です。", "task": "formula", "name_q": "3D-3,5/4-Trihydroxycyclohexane-1,2-dione", "name_a": "C6H8O5"} +{"id": 28389, "instruction": "Matrine N-oxideをを分子式で表すと?", "response": "Matrine N-oxideをを分子式で表すとC15H24N2O2です。", "task": "formula", "name_q": "Matrine N-oxide", "name_a": "C15H24N2O2"} +{"id": 12563, "instruction": "タプシガルギンをを分子式で記述すると?", "response": "タプシガルギンをを分子式で記述するとC34H50O12です。", "task": "formula", "name_q": "タプシガルギン", "name_a": "C34H50O12"} +{"id": 25334, "instruction": "3-Phenylphenolの別の言い方は?", "response": "3-Phenylphenolの別の言い方は3-Hydroxybiphenylです。", "task": "replace", "name_q": "3-Phenylphenol", "name_a": "3-Hydroxybiphenyl"} +{"id": 11647, "instruction": "ソウジュツ(東洋漢方製薬)を利用した商品は?", "response": "ソウジュツ(東洋漢方製薬)を利用した商品はソウジュツ(ツムラ)です。", "task": "product", "name_q": "ソウジュツ(東洋漢方製薬)", "name_a": "ソウジュツ(ツムラ)"} +{"id": 1754, "instruction": "2-Napthyloxyacetic acidをは化学式で表すと?", "response": "2-Napthyloxyacetic acidをは化学式で表すとC12H10O3です。", "task": "formula", "name_q": "2-Napthyloxyacetic acid", "name_a": "C12H10O3"} +{"id": 3642, "instruction": "Pancreatic lipase deficiencyを日本語に訳すと?", "response": "Pancreatic lipase deficiencyを日本語に訳すと膵リパーゼ欠損症です。", "task": "replace en to ja", "name_q": "Pancreatic lipase deficiency", "name_a": "膵リパーゼ欠損症"} +{"id": 33141, "instruction": "2'-Hydroxygenisteinをを化学式で表すと?", "response": "2'-Hydroxygenisteinをを化学式で表すとC15H10O6です。", "task": "formula", "name_q": "2'-Hydroxygenistein", "name_a": "C15H10O6"} +{"id": 16501, "instruction": "肺サーファクタント代謝異常症 上位グループ 肺胞蛋白症 を英語で記述すると?", "response": "肺サーファクタント代謝異常症 上位グループ 肺胞蛋白症 を英語で記述するとCongenital pulmonary alveolar proteinosisです。", "task": "replace ja to en", "name_q": "肺サーファクタント代謝異常症 上位グループ 肺胞蛋白症 ", "name_a": "Congenital pulmonary alveolar proteinosis"} +{"id": 1080, "instruction": "alpha-Cadineneをは化学構造で表すと?", "response": "alpha-Cadineneをは化学構造で表すとC15H24です。", "task": "formula", "name_q": "alpha-Cadinene", "name_a": "C15H24"} +{"id": 10088, "instruction": "Chloramphenicol pantothenate complex (USAN/INN)は別の呼び方では?", "response": "Chloramphenicol pantothenate complex (USAN/INN)は別の呼び方ではパントテン酸クロラムフェニコール複合体です。", "task": "replace", "name_q": "Chloramphenicol pantothenate complex (USAN/INN)", "name_a": "パントテン酸クロラムフェニコール複合体"} +{"id": 26579, "instruction": "ゲルダナマイシンをを分子式で表すと?", "response": "ゲルダナマイシンをを分子式で表すとC29H40N2O9です。", "task": "formula", "name_q": "ゲルダナマイシン", "name_a": "C29H40N2O9"} +{"id": 4375, "instruction": "Organidin (TN)をを化学構造で記述すると?", "response": "Organidin (TN)をを化学構造で記述するとC7H13IO2です。", "task": "formula", "name_q": "Organidin (TN)", "name_a": "C7H13IO2"} +{"id": 16385, "instruction": "限局性常染色体劣性遺伝性貧毛症 上位グループ 乏毛症 を英語で記述すると?", "response": "限局性常染色体劣性遺伝性貧毛症 上位グループ 乏毛症 を英語で記述するとLocalized autosomal recessive hypotrichosis SUPERGRP Hypotrichosis です。", "task": "replace ja to en", "name_q": "限局性常染色体劣性遺伝性貧毛症 上位グループ 乏毛症 ", "name_a": "Localized autosomal recessive hypotrichosis SUPERGRP Hypotrichosis "} +{"id": 19511, "instruction": "Iodocholesterol (131I) (INN)をは組成式で表すと?", "response": "Iodocholesterol (131I) (INN)をは組成式で表すとC27H45IOです。", "task": "formula", "name_q": "Iodocholesterol (131I) (INN)", "name_a": "C27H45IO"} +{"id": 1996, "instruction": "汗孔角化症を英語に訳すと?", "response": "汗孔角化症を英語に訳すとPorokeratosisです。", "task": "replace ja to en", "name_q": "汗孔角化症", "name_a": "Porokeratosis"} +{"id": 33243, "instruction": "Lodoxamide ethyl (USAN)をを組成式で表すと?", "response": "Lodoxamide ethyl (USAN)をを組成式で表すとC15H14ClN3O6です。", "task": "formula", "name_q": "Lodoxamide ethyl (USAN)", "name_a": "C15H14ClN3O6"} +{"id": 10427, "instruction": "エスアテノロール (JAN)の別の呼び方は?", "response": "エスアテノロール (JAN)の別の呼び方はEsatenolol (JAN/INN)です。", "task": "replace", "name_q": "エスアテノロール (JAN)", "name_a": "Esatenolol (JAN/INN)"} +{"id": 10185, "instruction": "Talnetant hydrochloride (USAN)を日本語で記述すると?", "response": "Talnetant hydrochloride (USAN)を日本語で記述するとタルネタント塩酸塩です。", "task": "replace en to ja", "name_q": "Talnetant hydrochloride (USAN)", "name_a": "タルネタント塩酸塩"} +{"id": 15824, "instruction": "バンチクツマブをを分子式で記述すると?", "response": "バンチクツマブをを分子式で記述するとC6322H9722N1674O1988S46です。", "task": "formula", "name_q": "バンチクツマブ", "name_a": "C6322H9722N1674O1988S46"} +{"id": 5051, "instruction": "Rabefine (TN)を言い換えると?", "response": "Rabefine (TN)を言い換えるとRabeprazole, amoxicillin and metronidazoleです。", "task": "replace", "name_q": "Rabefine (TN)", "name_a": "Rabeprazole, amoxicillin and metronidazole"} +{"id": 25578, "instruction": "リキリチゲニン-4'-β-グルコシドの別の呼び方は?", "response": "リキリチゲニン-4'-β-グルコシドの別の呼び方はLiquiritinです。", "task": "replace", "name_q": "リキリチゲニン-4'-β-グルコシド", "name_a": "Liquiritin"} +{"id": 10578, "instruction": "烏苓通気散の異なる表現は?", "response": "烏苓通気散の異なる表現はUreitsukisanです。", "task": "replace", "name_q": "烏苓通気散", "name_a": "Ureitsukisan"} +{"id": 1986, "instruction": "ピレトリンIの英語表記は?", "response": "ピレトリンIの英語表記はBubil (TN)です。", "task": "replace ja to en", "name_q": "ピレトリンI", "name_a": "Bubil (TN)"} +{"id": 28485, "instruction": "Vantas (TN)をを分子式で書くと?", "response": "Vantas (TN)をを分子式で書くとC66H86N18O12です。", "task": "formula", "name_q": "Vantas (TN)", "name_a": "C66H86N18O12"} +{"id": 1268, "instruction": "N-ベンジルフタルイミドの別名称は?", "response": "N-ベンジルフタルイミドの別名称はN-Benzylphthalimideです。", "task": "replace", "name_q": "N-ベンジルフタルイミド", "name_a": "N-Benzylphthalimide"} +{"id": 15440, "instruction": "4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritolをを分子式で表すと?", "response": "4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritolをを分子式で表すとC14H25N3O14P2です。", "task": "formula", "name_q": "4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol", "name_a": "C14H25N3O14P2"} +{"id": 33738, "instruction": "(1R,2S)-Naphthalene 1,2-oxideをを組成式で表すと?", "response": "(1R,2S)-Naphthalene 1,2-oxideをを組成式で表すとC10H8Oです。", "task": "formula", "name_q": "(1R,2S)-Naphthalene 1,2-oxide", "name_a": "C10H8O"} +{"id": 14485, "instruction": "Efrotomycin (USAN/INN)をを組成式で表すと?", "response": "Efrotomycin (USAN/INN)をを組成式で表すとC59H88N2O20です。", "task": "formula", "name_q": "Efrotomycin (USAN/INN)", "name_a": "C59H88N2O20"} +{"id": 19515, "instruction": "SPIRONOLACTONE(OxfordPharmaceuticals)を利用した商品は?", "response": "SPIRONOLACTONE(OxfordPharmaceuticals)を利用した商品はSPIRONOLACTONE(CardinalHealth107)です。", "task": "product", "name_q": "SPIRONOLACTONE(OxfordPharmaceuticals)", "name_a": "SPIRONOLACTONE(CardinalHealth107)"} +{"id": 26314, "instruction": "UDP-L-arabinofuranoseの別記述は?", "response": "UDP-L-arabinofuranoseの別記述はUDP-beta-L-arabinofuranoseです。", "task": "replace", "name_q": "UDP-L-arabinofuranose", "name_a": "UDP-beta-L-arabinofuranose"} +{"id": 21915, "instruction": "Trietazineをの分子式は?", "response": "Trietazineをの分子式はC9H16ClN5です。", "task": "formula", "name_q": "Trietazine", "name_a": "C9H16ClN5"} +{"id": 1493, "instruction": "ジランテルをを組成式で表すと?", "response": "ジランテルをを組成式で表すとC26H38N2O6P2S4です。", "task": "formula", "name_q": "ジランテル", "name_a": "C26H38N2O6P2S4"} +{"id": 10133, "instruction": "エルソフェルミンをを分子式で書くと?", "response": "エルソフェルミンをを分子式で書くとC775H1220N220O223S7です。", "task": "formula", "name_q": "エルソフェルミン", "name_a": "C775H1220N220O223S7"} +{"id": 33823, "instruction": "2-Hydroxyethyl-CoMをを分子式で記述すると?", "response": "2-Hydroxyethyl-CoMをを分子式で記述するとC4H10O4S2です。", "task": "formula", "name_q": "2-Hydroxyethyl-CoM", "name_a": "C4H10O4S2"} +{"id": 20017, "instruction": "KISQALI(NovartisPharmaceuticalsCorporation)をを化学式で表すと?", "response": "KISQALI(NovartisPharmaceuticalsCorporation)をを化学式で表すとC23H30N8O. C4H6O4です。", "task": "formula", "name_q": "KISQALI(NovartisPharmaceuticalsCorporation)", "name_a": "C23H30N8O. C4H6O4"} +{"id": 8119, "instruction": "Proxibarbal (INN)の別の言い方は?", "response": "Proxibarbal (INN)の別の言い方はCentralgol (TN)です。", "task": "replace", "name_q": "Proxibarbal (INN)", "name_a": "Centralgol (TN)"} +{"id": 26116, "instruction": "Human amniotic membrane matrix used human (autologous) oral mucosa-derived epithelium cell sheetを主とした製品名は?", "response": "Human amniotic membrane matrix used human (autologous) oral mucosa-derived epithelium cell sheetを主とした製品名はサクラシー(ひろさきLI)です。", "task": "product", "name_q": "Human amniotic membrane matrix used human (autologous) oral mucosa-derived epithelium cell sheet", "name_a": "サクラシー(ひろさきLI)"} +{"id": 29929, "instruction": "3-[(2,6-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-oneをを化学構造で表すと?", "response": "3-[(2,6-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-oneをを化学構造で表すとC20H11Cl2NO2です。", "task": "formula", "name_q": "3-[(2,6-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one", "name_a": "C20H11Cl2NO2"} +{"id": 22253, "instruction": "beta-D-Sedoheptulopyranoseの異なる表現は?", "response": "beta-D-Sedoheptulopyranoseの異なる表現はbeta-D-Sedoheptuloseです。", "task": "replace", "name_q": "beta-D-Sedoheptulopyranose", "name_a": "beta-D-Sedoheptulose"} +{"id": 18726, "instruction": "BMS-268770をは分子式で表すと?", "response": "BMS-268770をは分子式で表すとC23H30N4O4S2です。", "task": "formula", "name_q": "BMS-268770", "name_a": "C23H30N4O4S2"} +{"id": 21803, "instruction": "S-セブンの別の呼び方は?", "response": "S-セブンの別の呼び方はS-Sevenです。", "task": "replace", "name_q": "S-セブン", "name_a": "S-Seven"} +{"id": 6057, "instruction": "Brazilinの別名称は?", "response": "Brazilinの別名称はブラジリンです。", "task": "replace", "name_q": "Brazilin", "name_a": "ブラジリン"} +{"id": 22698, "instruction": "3-aci-Nitropropanoateの別名称は?", "response": "3-aci-Nitropropanoateの別名称は3-aci-Nitropropionic acidです。", "task": "replace", "name_q": "3-aci-Nitropropanoate", "name_a": "3-aci-Nitropropionic acid"} +{"id": 9589, "instruction": "Dihydro-4,4-dimethyl-2,3-furandioneの異なる名称は?", "response": "Dihydro-4,4-dimethyl-2,3-furandioneの異なる名称は2-Dehydropantolactoneです。", "task": "replace", "name_q": "Dihydro-4,4-dimethyl-2,3-furandione", "name_a": "2-Dehydropantolactone"} +{"id": 14421, "instruction": "クエン酸トリを英語に訳すと?", "response": "クエン酸トリを英語に訳すとTricitrates (USP)です。", "task": "replace ja to en", "name_q": "クエン酸トリ", "name_a": "Tricitrates (USP)"} +{"id": 13026, "instruction": "Pretomanid (USAN/INN)をを化学構造で表すと?", "response": "Pretomanid (USAN/INN)をを化学構造で表すとC14H12F3N3O5です。", "task": "formula", "name_q": "Pretomanid (USAN/INN)", "name_a": "C14H12F3N3O5"} +{"id": 34235, "instruction": "Ulixertinib (INN)をは組成式で表すと?", "response": "Ulixertinib (INN)をは組成式で表すとC21H22Cl2N4O2です。", "task": "formula", "name_q": "Ulixertinib (INN)", "name_a": "C21H22Cl2N4O2"} +{"id": 4464, "instruction": "Gastrointestinal defects and immunodeficiency syndromeを日本語で書くと?", "response": "Gastrointestinal defects and immunodeficiency syndromeを日本語で書くと多発性小腸閉鎖症を伴う複合免疫不全症です。", "task": "replace en to ja", "name_q": "Gastrointestinal defects and immunodeficiency syndrome", "name_a": "多発性小腸閉鎖症を伴う複合免疫不全症"} +{"id": 23751, "instruction": "5-Oxoprolyl-tRNAをは組成式で表すと?", "response": "5-Oxoprolyl-tRNAをは組成式で表すとC15H22NO12PR2(C5H8O6PR)nです。", "task": "formula", "name_q": "5-Oxoprolyl-tRNA", "name_a": "C15H22NO12PR2(C5H8O6PR)n"} +{"id": 9395, "instruction": "tRNA containing s2Uをは組成式で表すと?", "response": "tRNA containing s2Uをは組成式で表すとC9H13N2O8PS(C5H8O6PR)n(C5H8O6PR)nです。", "task": "formula", "name_q": "tRNA containing s2U", "name_a": "C9H13N2O8PS(C5H8O6PR)n(C5H8O6PR)n"} +{"id": 30809, "instruction": "Dexamethasone beloxil (USAN)をを化学構造で書くと?", "response": "Dexamethasone beloxil (USAN)をを化学構造で書くとC29H35FO5です。", "task": "formula", "name_q": "Dexamethasone beloxil (USAN)", "name_a": "C29H35FO5"} +{"id": 32768, "instruction": "ent-Kaureneは別の呼び方では?", "response": "ent-Kaureneは別の呼び方ではent-Kaur-16-eneです。", "task": "replace", "name_q": "ent-Kaurene", "name_a": "ent-Kaur-16-ene"} +{"id": 22332, "instruction": "Nocardicin Fの別の呼び方は?", "response": "Nocardicin Fの別の呼び方はノカルジシンFです。", "task": "replace", "name_q": "Nocardicin F", "name_a": "ノカルジシンF"} +{"id": 13467, "instruction": "2'-Acetylerythromycinは別の呼び方では?", "response": "2'-Acetylerythromycinは別の呼び方ではErythromycin 2'-acetateです。", "task": "replace", "name_q": "2'-Acetylerythromycin", "name_a": "Erythromycin 2'-acetate"} +{"id": 29577, "instruction": "Foscenvivint (JAN/INN)をは化学式で表すと?", "response": "Foscenvivint (JAN/INN)をは化学式で表すとC33H35N6O7Pです。", "task": "formula", "name_q": "Foscenvivint (JAN/INN)", "name_a": "C33H35N6O7P"} +{"id": 18702, "instruction": "Epicatechin-(4beta->8)-ent-epicatechinをの化学式は?", "response": "Epicatechin-(4beta->8)-ent-epicatechinをの化学式はC30H26O12です。", "task": "formula", "name_q": "Epicatechin-(4beta->8)-ent-epicatechin", "name_a": "C30H26O12"} +{"id": 13742, "instruction": "カスポファンギンをを組成式で記述すると?", "response": "カスポファンギンをを組成式で記述するとC52H88N10O15です。", "task": "formula", "name_q": "カスポファンギン", "name_a": "C52H88N10O15"} +{"id": 1957, "instruction": "Perchloroethyleneをを化学式で書くと?", "response": "Perchloroethyleneをを化学式で書くとC2Cl4です。", "task": "formula", "name_q": "Perchloroethylene", "name_a": "C2Cl4"} +{"id": 2973, "instruction": "Mazaticol hydrochloride hydrate (JAN)を英語表記で表すと?", "response": "Mazaticol hydrochloride hydrate (JAN)を英語表記で表すとMazaticol hydrochlorideです。", "task": "replace ja to en", "name_q": "Mazaticol hydrochloride hydrate (JAN)", "name_a": "Mazaticol hydrochloride"} +{"id": 12317, "instruction": "Tirapazamine (USAN/INN)をを化学式で記述すると?", "response": "Tirapazamine (USAN/INN)をを化学式で記述するとC7H6N4O2です。", "task": "formula", "name_q": "Tirapazamine (USAN/INN)", "name_a": "C7H6N4O2"} +{"id": 24661, "instruction": "Bextra (TN)をは化学式で表すと?", "response": "Bextra (TN)をは化学式で表すとC16H14N2O3Sです。", "task": "formula", "name_q": "Bextra (TN)", "name_a": "C16H14N2O3S"} +{"id": 34389, "instruction": "グリーンバーグ骨異形成症の英語表記は?", "response": "グリーンバーグ骨異形成症の英語表記はHEM skeletal dysplasiaです。", "task": "replace ja to en", "name_q": "グリーンバーグ骨異形成症", "name_a": "HEM skeletal dysplasia"} +{"id": 941, "instruction": "経口生ポリオワクチン (JAN)を英語で書くと?", "response": "経口生ポリオワクチン (JAN)を英語で書くとOrimune (TN)です。", "task": "replace ja to en", "name_q": "経口生ポリオワクチン (JAN)", "name_a": "Orimune (TN)"} +{"id": 32209, "instruction": "Fuchs corneal dystrophyの別の呼び方は?", "response": "Fuchs corneal dystrophyの別の呼び方はFuchs endothelial corneal dystrophyです。", "task": "replace", "name_q": "Fuchs corneal dystrophy", "name_a": "Fuchs endothelial corneal dystrophy"} +{"id": 9020, "instruction": "Esaxerenone (JAN/INN)をは化学式で表すと?", "response": "Esaxerenone (JAN/INN)をは化学式で表すとC22H21F3N2O4Sです。", "task": "formula", "name_q": "Esaxerenone (JAN/INN)", "name_a": "C22H21F3N2O4S"} +{"id": 22375, "instruction": "メガホンの別表現は?", "response": "メガホンの別表現はMegaphoneです。", "task": "replace", "name_q": "メガホン", "name_a": "Megaphone"} +{"id": 1889, "instruction": "エテプリルセンを言い換えると?", "response": "エテプリルセンを言い換えるとEteplirsen (USAN/INN)です。", "task": "replace", "name_q": "エテプリルセン", "name_a": "Eteplirsen (USAN/INN)"} +{"id": 12024, "instruction": "ビンカミンをを化学構造で記述すると?", "response": "ビンカミンをを化学構造で記述するとC21H26N2O3です。", "task": "formula", "name_q": "ビンカミン", "name_a": "C21H26N2O3"} +{"id": 33368, "instruction": "Citenamide (USAN/INN)をは化学構造で表すと?", "response": "Citenamide (USAN/INN)をは化学構造で表すとC16H13NOです。", "task": "formula", "name_q": "Citenamide (USAN/INN)", "name_a": "C16H13NO"} +{"id": 5103, "instruction": "4-O-β-D-グルコピラノシル-D-マンノースの異なる表現は?", "response": "4-O-β-D-グルコピラノシル-D-マンノースの異なる表現は4-O-beta-D-Glucopyranosyl-D-mannoseです。", "task": "replace", "name_q": "4-O-β-D-グルコピラノシル-D-マンノース", "name_a": "4-O-beta-D-Glucopyranosyl-D-mannose"} +{"id": 31475, "instruction": "アルテコナゾールの異なる表現は?", "response": "アルテコ��ゾールの異なる表現はAlteconazole (INN)です。", "task": "replace", "name_q": "アルテコナゾール", "name_a": "Alteconazole (INN)"} +{"id": 9069, "instruction": "Vonlerolizumab (USAN/INN)の英訳は?", "response": "Vonlerolizumab (USAN/INN)の英訳はPogalizumabです。", "task": "replace ja to en", "name_q": "Vonlerolizumab (USAN/INN)", "name_a": "Pogalizumab"} +{"id": 31088, "instruction": "Naldemedine tosilateを主材料とする製品は?", "response": "Naldemedine tosilateを主材料とする製品はSYMPROIC(BioDeliverySciencesInternational)です。", "task": "product", "name_q": "Naldemedine tosilate", "name_a": "SYMPROIC(BioDeliverySciencesInternational)"} +{"id": 21064, "instruction": "Behenic acidの別呼称は?", "response": "Behenic acidの別呼称はDocosanoateです。", "task": "replace", "name_q": "Behenic acid", "name_a": "Docosanoate"} +{"id": 15814, "instruction": "Bis(1-aziridinyl)morpholinophosphine sulfideをは化学式で表すと?", "response": "Bis(1-aziridinyl)morpholinophosphine sulfideをは化学式で表すとC8H16N3OPSです。", "task": "formula", "name_q": "Bis(1-aziridinyl)morpholinophosphine sulfide", "name_a": "C8H16N3OPS"} +{"id": 19946, "instruction": "カリベノリドIをの分子式は?", "response": "カリベノリドIをの分子式はC33H52O11です。", "task": "formula", "name_q": "カリベノリドI", "name_a": "C33H52O11"} +{"id": 7014, "instruction": "Dextran 40 and glucoseを日本語表記で表すと?", "response": "Dextran 40 and glucoseを日本語表記で表すとデキストラン40・ブドウ糖です。", "task": "replace en to ja", "name_q": "Dextran 40 and glucose", "name_a": "デキストラン40・ブドウ糖"} +{"id": 19784, "instruction": "(3S)-3-Isopropenyl-6-oxoheptanoyl-CoAをを化学構造で表すと?", "response": "(3S)-3-Isopropenyl-6-oxoheptanoyl-CoAをを化学構造で表すとC31H50N7O18P3Sです。", "task": "formula", "name_q": "(3S)-3-Isopropenyl-6-oxoheptanoyl-CoA", "name_a": "C31H50N7O18P3S"} +{"id": 24273, "instruction": "ゴミシ(大晃生薬)を利用した商品は?", "response": "ゴミシ(大晃生薬)を利用した商品はゴミシ(ウチダ和漢薬)です。", "task": "product", "name_q": "ゴミシ(大晃生薬)", "name_a": "ゴミシ(ウチダ和漢薬)"} +{"id": 32402, "instruction": "Erythromycin estorateの別名称は?", "response": "Erythromycin estorateの別名称はErythromycin estolateです。", "task": "replace", "name_q": "Erythromycin estorate", "name_a": "Erythromycin estolate"} +{"id": 19428, "instruction": "クレイスタンチン Aをは化学構造で表すと?", "response": "クレイスタンチン Aをは化学構造で表すとC28H28O11です。", "task": "formula", "name_q": "クレイスタンチン A", "name_a": "C28H28O11"} +{"id": 28582, "instruction": "[Protein]-(3S)-3-hydroxy-L-lysineをの化学構造は?", "response": "[Protein]-(3S)-3-hydroxy-L-lysineをの化学構造はC7H13N3O3R2です。", "task": "formula", "name_q": "[Protein]-(3S)-3-hydroxy-L-lysine", "name_a": "C7H13N3O3R2"} +{"id": 28412, "instruction": "Catechin 7-O-beta-D-xylosideをの組成式は?", "response": "Catechin 7-O-beta-D-xylosideをの組成式はC20H22O10です。", "task": "formula", "name_q": "Catechin 7-O-beta-D-xyloside", "name_a": "C20H22O10"} +{"id": 9131, "instruction": "3-Octaprenyl-4-hydroxybenzoateをの組成式は?", "response": "3-Octaprenyl-4-hydroxybenzoateをの組成式はC47H70O3です。", "task": "formula", "name_q": "3-Octaprenyl-4-hydroxybenzoate", "name_a": "C47H70O3"} +{"id": 3637, "instruction": "Omodysplasia SUPERGRP Heparan sulfate proteoglycan gene defects の日本語表記は?", "response": "Omodysplasia SUPERGRP Heparan sulfate proteoglycan gene defects の日本語表記は上腕骨異形成症 上位グループ ヘパラン硫酸プロテオグリカン異常 です。", "task": "replace en to ja", "name_q": "Omodysplasia SUPERGRP Heparan sulfate proteoglycan gene defects ", "name_a": "上腕骨異形成症 上位グループ ヘパラン硫酸プロテオグリカン異常 "} +{"id": 15843, "instruction": "胃癌を英語で記述すると?", "response": "胃癌を英語で記述するとGastric cancerです。", "task": "replace ja to en", "name_q": "胃癌", "name_a": "Gastric cancer"} +{"id": 26843, "instruction": "Irdabisant hydrochloride (USAN)をを組成式で書くと?", "response": "Irdabisant hydrochloride (USAN)をを組成式で書くとC18H23N3O2. HClです。", "task": "formula", "name_q": "Irdabisant hydrochloride (USAN)", "name_a": "C18H23N3O2. HCl"} +{"id": 18773, "instruction": "Gelatineの別名は?", "response": "Gelatineの別名はゼラチンです。", "task": "replace", "name_q": "Gelatine", "name_a": "ゼラチン"} +{"id": 34383, "instruction": "Benazeprilをの分子式は?", "response": "Benazeprilをの分子式はC24H28N2O5です。", "task": "formula", "name_q": "Benazepril", "name_a": "C24H28N2O5"} +{"id": 28536, "instruction": "5alpha-Dihydroprogesteroneは別の呼び方では?", "response": "5alpha-Dihydroprogesteroneは別の呼び方では5alpha-Pregnane-3,20-dioneです。", "task": "replace", "name_q": "5alpha-Dihydroprogesterone", "name_a": "5alpha-Pregnane-3,20-dione"} +{"id": 12153, "instruction": "Gadoteric acid (INN)をの化学式は?", "response": "Gadoteric acid (INN)をの化学式はC16H25N4O8. Gdです。", "task": "formula", "name_q": "Gadoteric acid (INN)", "name_a": "C16H25N4O8. Gd"} +{"id": 14793, "instruction": "(R)-4-Hydroxymandelonitrile beta-D-glucosideの別呼称は?", "response": "(R)-4-Hydroxymandelonitrile beta-D-glucosideの別呼称はTaxiphyllinです。", "task": "replace", "name_q": "(R)-4-Hydroxymandelonitrile beta-D-glucoside", "name_a": "Taxiphyllin"} +{"id": 15529, "instruction": "塩酸レプロテロールをを化学式で書くと?", "response": "塩酸レプロテロールをを化学式で書くとC18H23N5O5. HClです。", "task": "formula", "name_q": "塩酸レプロテロール", "name_a": "C18H23N5O5. HCl"} +{"id": 6148, "instruction": "beta-Santaleneをを化学構造で記述すると?", "response": "beta-Santaleneをを化学構造で記述するとC15H24です。", "task": "formula", "name_q": "beta-Santalene", "name_a": "C15H24"} +{"id": 33433, "instruction": "フルオコルチンの別表現は?", "response": "フルオコルチンの別表現はFluocortinです。", "task": "replace", "name_q": "フルオコルチン", "name_a": "Fluocortin"} +{"id": 17586, "instruction": "MESALAMINE(BryantRanchPrepack)を利用した商品は?", "response": "MESALAMINE(BryantRanchPrepack)を利用した商品はMESALAMINE(TevaPharmaceuticals)です。", "task": "product", "name_q": "MESALAMINE(BryantRanchPrepack)", "name_a": "MESALAMINE(TevaPharmaceuticals)"} +{"id": 21491, "instruction": "2,3',4,4',5,5'-Hexachlorobiphenylの別記述は?", "response": "2,3',4,4',5,5'-Hexachlorobiphenylの別記述は2,3',4,4',5,5'-ヘキサクロロビフェニルです。", "task": "replace", "name_q": "2,3',4,4',5,5'-Hexachlorobiphenyl", "name_a": "2,3',4,4',5,5'-ヘキサクロロビフェニル"} +{"id": 705, "instruction": "Atiprimod dimaleate (USAN)をを化学式で表すと?", "response": "Atiprimod dimaleate (USAN)をを化学式で表すとC22H44N2. (C4H4O4)2です。", "task": "formula", "name_q": "Atiprimod dimaleate (USAN)", "name_a": "C22H44N2. (C4H4O4)2"} +{"id": 7459, "instruction": "(3Z,6S)-3-Benzylidene-6-(2-methylpropyl)piperazine-2,5-dioneをは組成式で表すと?", "response": "(3Z,6S)-3-Benzylidene-6-(2-methylpropyl)piperazine-2,5-dioneをは組成式で表すとC15H18N2O2です。", "task": "formula", "name_q": "(3Z,6S)-3-Benzylidene-6-(2-methylpropyl)piperazine-2,5-dione", "name_a": "C15H18N2O2"} +{"id": 15293, "instruction": "後発品FLUORESCEINSODIUMANDBENOXINATEHYDROCHLORIDE(Bausch&LombAmericas)を使用した薬品は?", "response": "後発品FLUORESCEINSODIUMANDBENOXINATEHYDROCHLORIDE(Bausch&LombAmericas)を使用した薬品はFLUORESCEINSODIUMANDBENOXINATEHYDROCHLORIDE(OceansidePharmaceuticals)です。", "task": "product", "name_q": "後発品FLUORESCEINSODIUMANDBENOXINATEHYDROCHLORIDE(Bausch&LombAmericas)", "name_a": "FLUORESCEINSODIUMANDBENOXINATEHYDROCHLORIDE(OceansidePharmaceuticals)"} +{"id": 21640, "instruction": "Atizoram (USAN/INN)の別の呼び方は?", "response": "Atizoram (USAN/INN)の別の呼び方はアチゾラムです。", "task": "replace", "name_q": "Atizoram (USAN/INN)", "name_a": "アチゾラム"} +{"id": 5030, "instruction": "Solriamfetol (USAN)をを分子式で記述すると?", "response": "Solriamfetol (USAN)をを分子式で記述するとC10H14N2O2です。", "task": "formula", "name_q": "Solriamfetol (USAN)", "name_a": "C10H14N2O2"} +{"id": 28648, "instruction": "アネキセート(サンドファーマ)を用いた商品名は?", "response": "アネキセート(サンドファーマ)を用いた商品名はフルマゼニル(富士製薬工業)です。", "task": "product", "name_q": "アネキセート(サンドファーマ)", "name_a": "フルマゼニル(富士製薬工業)"} +{"id": 33023, "instruction": "カンピロバクター感染症を英語で書くと?", "response": "カンピロバクター感染症を英語で書くとCampylobacteriosisです。", "task": "replace ja to en", "name_q": "カンピロバクター感染症", "name_a": "Campylobacteriosis"} +{"id": 1636, "instruction": "第 4-5 中手骨癒合症の英語表記は?", "response": "第 4-5 中手骨癒合症の英語表記はMetacarpal 4-5 fusionです。", "task": "replace ja to en", "name_q": "第 4-5 中手骨癒合症", "name_a": "Metacarpal 4-5 fusion"} +{"id": 19331, "instruction": "下肢静止不能症候群の異なる表現は?", "response": "下肢静止不能症候群の異なる表現はむずむず脚症候群です。", "task": "replace", "name_q": "下肢静止不能症候群", "name_a": "むずむず脚症候群"} +{"id": 11214, "instruction": "Dilmapimod tosylate (USAN)をの分子式は?", "response": "Dilmapimod tosylate (USAN)をの分子式はC23H19F3N4O3. C7H8O3Sです。", "task": "formula", "name_q": "Dilmapimod tosylate (USAN)", "name_a": "C23H19F3N4O3. C7H8O3S"} +{"id": 19755, "instruction": "Heparamineをを組成式で表すと?", "response": "Heparamineをを組成式で表すと(C12H19NO17S2)nです。", "task": "formula", "name_q": "Heparamine", "name_a": "(C12H19NO17S2)n"} +{"id": 13181, "instruction": "Halopemide (USAN/INN)の日本語表記は?", "response": "Halopemide (USAN/INN)の日本語表記はハロペミドです。", "task": "replace en to ja", "name_q": "Halopemide (USAN/INN)", "name_a": "ハロペミド"} +{"id": 12648, "instruction": "Remestemcel-L (USAN)の別名称は?", "response": "Remestemcel-L (USAN)の別名称はレメステムセルLです。", "task": "replace", "name_q": "Remestemcel-L (USAN)", "name_a": "レメステムセルL"} +{"id": 13778, "instruction": "Orteronel (JAN/USAN)を日本語表記で表すと?", "response": "Orteronel (JAN/USAN)を日本語表記で表すとオルテロネル (JAN)です。", "task": "replace en to ja", "name_q": "Orteronel (JAN/USAN)", "name_a": "オルテロネル (JAN)"} +{"id": 22917, "instruction": "Tercian (TN)の日本語訳は?", "response": "Tercian (TN)の日本語訳はシアメマジンです。", "task": "replace en to ja", "name_q": "Tercian (TN)", "name_a": "シアメマジン"} +{"id": 28215, "instruction": "Technetium Tc 99m albumin colloid (USP)の日本語訳は?", "response": "Technetium Tc 99m albumin colloid (USP)の日本語訳はテクネチウムアルブミンコロイド (99mTc)です。", "task": "replace en to ja", "name_q": "Technetium Tc 99m albumin colloid (USP)", "name_a": "テクネチウムアルブミンコロイド (99mTc)"} +{"id": 28383, "instruction": "3-[(2,4-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-oneをは組成式で表すと?", "response": "3-[(2,4-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-oneをは組成式で表すとC20H11Cl2NO2です。", "task": "formula", "name_q": "3-[(2,4-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one", "name_a": "C20H11Cl2NO2"} +{"id": 5239, "instruction": "MOXIFLOXACIN(RedPharmDrug)を主材料とする商品は?", "response": "MOXIFLOXACIN(RedPharmDrug)を主材料とする商品は後発品モキシフロキサシン(サンド)です。", "task": "product", "name_q": "MOXIFLOXACIN(RedPharmDrug)", "name_a": "後発品モキシフロキサシン(サンド)"} +{"id": 15785, "instruction": "イアナルマブをを組成式で表すと?", "response": "イアナルマブをを組成式で表すとC6606H10224N1740O2098S40です。", "task": "formula", "name_q": "イアナルマブ", "name_a": "C6606H10224N1740O2098S40"} +{"id": 3589, "instruction": "エトキサゾールの別名は?", "response": "エトキサゾールの別名はEtoxazoleです。", "task": "replace", "name_q": "エトキサゾール", "name_a": "Etoxazole"} +{"id": 15619, "instruction": "SODIUMCITRATE4%W/VANTICOAGULANT(TerumoBCT)を使用した製品名は?", "response": "SODIUMCITRATE4%W/VANTICOAGULANT(TerumoBCT)を使用した製品名はANTICOAGULANTSODIUMCITRATE(BaxterHealthcareCorporation)です。", "task": "product", "name_q": "SODIUMCITRATE4%W/VANTICOAGULANT(TerumoBCT)", "name_a": "ANTICOAGULANTSODIUMCITRATE(BaxterHealthcareCorporation)"} +{"id": 116, "instruction": "1-(2-Hydroxy-3,4,5,6-tetramethoxyphenyl)-3-(2,3,4,6-tetramethoxyphenyl)-2-propen-1-oneをを化学式で記述すると?", "response": "1-(2-Hydroxy-3,4,5,6-tetramethoxyphenyl)-3-(2,3,4,6-tetramethoxyphenyl)-2-propen-1-oneをを化学式で記述するとC23H28O10です。", "task": "formula", "name_q": "1-(2-Hydroxy-3,4,5,6-tetramethoxyphenyl)-3-(2,3,4,6-tetramethoxyphenyl)-2-propen-1-one", "name_a": "C23H28O10"} +{"id": 32067, "instruction": "QDOLO(AthenaBioscience)を利用した製品は?", "response": "QDOLO(AthenaBioscience)を利用した製品はTRAMADOLHYDROCHLORIDE(RedpharmDrug)です。", "task": "product", "name_q": "QDOLO(AthenaBioscience)", "name_a": "TRAMADOLHYDROCHLORIDE(RedpharmDrug)"} +{"id": 32784, "instruction": "Enilconazole (USAN/INN)の別呼称は?", "response": "Enilconazole (USAN/INN)の別呼称はエニルコナゾールです。", "task": "replace", "name_q": "Enilconazole (USAN/INN)", "name_a": "エニルコナゾール"} +{"id": 3404, "instruction": "Bunitrolol hydrochloride (JAN)をの組成式は?", "response": "Bunitrolol hydrochloride (JAN)をの組成式はC14H20N2O2. HClです。", "task": "formula", "name_q": "Bunitrolol hydrochloride (JAN)", "name_a": "C14H20N2O2. HCl"} +{"id": 28503, "instruction": "Carbasalate calcium (INN)をの組成式は?", "response": "Carbasalate calcium (INN)をの組成式は(C9H7O4)2. CH4N2O. Caです。", "task": "formula", "name_q": "Carbasalate calcium (INN)", "name_a": "(C9H7O4)2. CH4N2O. Ca"} +{"id": 32502, "instruction": "Congenital disorder of deglycosylationを日本語で書くと?", "response": "Congenital disorder of deglycosylationを日本語で書くと先天性脱グリコシル化異常症です。", "task": "replace en to ja", "name_q": "Congenital disorder of deglycosylation", "name_a": "先天性脱グリコシル化異常症"} +{"id": 27727, "instruction": "Albumin human, recombinant (NF)をを化学構造で書くと?", "response": "Albumin human, recombinant (NF)をを化学構造で書くとC2936H4624N786O889S41です。", "task": "formula", "name_q": "Albumin human, recombinant (NF)", "name_a": "C2936H4624N786O889S41"} +{"id": 25128, "instruction": "Amylinの異なる名称は?", "response": "Amylinの異なる名称はIslet amyloid polypeptideです。", "task": "replace", "name_q": "Amylin", "name_a": "Islet amyloid polypeptide"} +{"id": 22940, "instruction": "黄色腫 下位グループ 脳腱黄色腫症 の英語表記は?", "response": "黄色腫 下位グループ 脳腱黄色腫症 の英語表記はXanthomatosis SUBGROUP Cerebrotendinous xanthomatosis です。", "task": "replace ja to en", "name_q": "黄色腫 下位グループ 脳腱黄色腫症 ", "name_a": "Xanthomatosis SUBGROUP Cerebrotendinous xanthomatosis "} +{"id": 26402, "instruction": "CYCLOBENZAPRINEHCLER(Direct_Rx)を用いた薬品は?", "response": "CYCLOBENZAPRINEHCLER(Direct_Rx)を用いた薬品はCYCLOBENZAPRINEHYDROCHLORIDE(NuCarePharmaceutuicals)です。", "task": "product", "name_q": "CYCLOBENZAPRINEHCLER(Direct_Rx)", "name_a": "CYCLOBENZAPRINEHYDROCHLORIDE(NuCarePharmaceutuicals)"} +{"id": 10800, "instruction": "ラベンダー油の異なる表記は?", "response": "ラベンダー油の異なる表記はLavender oil (NF)です。", "task": "replace", "name_q": "ラベンダー油", "name_a": "Lavender oil (NF)"} +{"id": 5362, "instruction": "肺静脈の連結不良を伴う肺胞毛細管形成異常を英語に訳すと?", "response": "肺静脈の連結不良を伴う肺胞毛細管形成異常を英語に訳すとAlveolar capillary dysplasia with misalignment of pulmonary veinsです。", "task": "replace ja to en", "name_q": "肺静脈の連結不良を伴う肺胞毛細管形成異常", "name_a": "Alveolar capillary dysplasia with misalignment of pulmonary veins"} +{"id": 10971, "instruction": "3, 4, 3'-トリ-O-メチルエラグ酸の異なる表現は?", "response": "3, 4, 3'-トリ-O-メチルエラグ酸の異なる表現は3,4,3'-Tri-O-methylellagic acidです。", "task": "replace", "name_q": "3, 4, 3'-トリ-O-メチルエラグ酸", "name_a": "3,4,3'-Tri-O-methylellagic acid"} +{"id": 3061, "instruction": "4-Methylburimamideをは分子式で表すと?", "response": "4-Methylburimamideをは分子式で表すとC10H18N4Sです。", "task": "formula", "name_q": "4-Methylburimamide", "name_a": "C10H18N4S"} +{"id": 6849, "instruction": "D-アラビノースを言い換えると?", "response": "D-アラビノースを言い換えるとD-アラビノピラノースです。", "task": "replace", "name_q": "D-アラビノース", "name_a": "D-アラビノピラノース"} +{"id": 17899, "instruction": "先天性甲状腺機能亢進症 下位グループ 家族性妊娠甲状腺機能亢進症 非自己免疫性甲状腺機能亢進症を英語で記述すると?", "response": "先天性甲状腺機能亢進症 下位グループ 家族性妊娠甲状腺機能亢進症 非自己免疫性甲状腺機能亢進症を英語で記述するとCongenital hyperthyroidism SUBGROUP Familial gestational hyperthyroidism (HTFG) Hyperthyroidism non-autoimmune (HTNA)です。", "task": "replace ja to en", "name_q": "先天性甲状腺機能亢進症 下位グループ 家族性妊娠甲状腺機能亢進症 非自己免疫性甲状腺機能亢進症", "name_a": "Congenital hyperthyroidism SUBGROUP Familial gestational hyperthyroidism (HTFG) Hyperthyroidism non-autoimmune (HTNA)"} +{"id": 4867, "instruction": "Thiosulfateをの化学式は?", "response": "Thiosulfateをの化学式はHS2O3です。", "task": "formula", "name_q": "Thiosulfate", "name_a": "HS2O3"} +{"id": 25685, "instruction": "Donohue syndromeを日本語に訳すと?", "response": "Donohue syndromeを日本語に訳すと妖精症です。", "task": "replace en to ja", "name_q": "Donohue syndrome", "name_a": "妖精症"} +{"id": 1814, "instruction": "シゾネペトシド Aをは化学構造で表すと?", "response": "シゾネペトシド Aをは化学構造で表すとC16H26O7です。", "task": "formula", "name_q": "シゾネペトシド A", "name_a": "C16H26O7"} +{"id": 11493, "instruction": "Paracetamol (INN)を利用した製品は?", "response": "Paracetamol (INN)を利用した製品はACETAMINOPHEN(REMEDYREPACK)です。", "task": "product", "name_q": "Paracetamol (INN)", "name_a": "ACETAMINOPHEN(REMEDYREPACK)"} +{"id": 32675, "instruction": "後発品ZILEUTON(CamberPharmaceuticals)を主とした薬品は?", "response": "後発品ZILEUTON(CamberPharmaceuticals)を主とした薬品はZILEUTON(RisingPharmaHoldings)です。", "task": "product", "name_q": "後発品ZILEUTON(CamberPharmaceuticals)", "name_a": "ZILEUTON(RisingPharmaHoldings)"} +{"id": 12433, "instruction": "Olprinone hydrochloride hydrate (JAN)の別の呼び方は?", "response": "Olprinone hydrochloride hydrate (JAN)の別の呼び方はCoretec (TN)です。", "task": "replace", "name_q": "Olprinone hydrochloride hydrate (JAN)", "name_a": "Coretec (TN)"} +{"id": 5591, "instruction": "Ethidimuronをを組成式で書くと?", "response": "Ethidimuronをを組成式で書くとC7H12N4O3S2です。", "task": "formula", "name_q": "Ethidimuron", "name_a": "C7H12N4O3S2"} +{"id": 30751, "instruction": "xiān yě báiの別表現は?", "response": "xiān yě báiの別表現はセンヤハクです。", "task": "replace", "name_q": "xiān yě bái", "name_a": "センヤハク"} +{"id": 33422, "instruction": "Kaempferol-3-O-rutinosideの別名称は?", "response": "Kaempferol-3-O-rutinosideの別名称はNictoflorinです。", "task": "replace", "name_q": "Kaempferol-3-O-rutinoside", "name_a": "Nictoflorin"} +{"id": 31411, "instruction": "Protein L-isoaspartate alpha-methyl esterをは組成式で表すと?", "response": "Protein L-isoaspartate alpha-methyl esterをは組成式で表すとC6H8N2O4R2です。", "task": "formula", "name_q": "Protein L-isoaspartate alpha-methyl ester", "name_a": "C6H8N2O4R2"} +{"id": 28418, "instruction": "GP 47779をは化学構造で表すと?", "response": "GP 47779をは化学構造で表すとC15H14N2O2です。", "task": "formula", "name_q": "GP 47779", "name_a": "C15H14N2O2"} +{"id": 22435, "instruction": "ポリオキシン Bの別名称は?", "response": "ポリオキシン Bの別名称はPolyoxin Bです。", "task": "replace", "name_q": "ポリオキシン B", "name_a": "Polyoxin B"} +{"id": 29647, "instruction": "Tricho-dento-osseous syndromeの日本語表記は?", "response": "Tricho-dento-osseous syndromeの日本語表記は毛髪・歯・骨症候群です。", "task": "replace en to ja", "name_q": "Tricho-dento-osseous syndrome", "name_a": "毛髪・歯・骨症候群"} +{"id": 6070, "instruction": "DETROL(PHARMACIA&UPJOHNCOMPANYLLC)を主とした商品名は?", "response": "DETROL(PHARMACIA&UPJOHNCOMPANYLLC)を主とした商品名はTOLTERODINETARTRATE(AjantaPharmaUSA)です。", "task": "product", "name_q": "DETROL(PHARMACIA&UPJOHNCOMPANYLLC)", "name_a": "TOLTERODINETARTRATE(AjantaPharmaUSA)"} +{"id": 18239, "instruction": "響声破笛丸を英語に訳すと?", "response": "響声破笛丸を英語に訳すとKyoseihatekiganです。", "task": "replace ja to en", "name_q": "響声破笛丸", "name_a": "Kyoseihatekigan"} +{"id": 21553, "instruction": "Potassium sulfateをを組成式で記述すると?", "response": "Potassium sulfateをを組成式で記述するとK2SO4です。", "task": "formula", "name_q": "Potassium sulfate", "name_a": "K2SO4"} +{"id": 28168, "instruction": "Emavusertib mesylate (USAN)をを化学式で記述すると?", "response": "Emavusertib mesylate (USAN)をを化学式で記述するとC24H25N7O5. CH4SO3です。", "task": "formula", "name_q": "Emavusertib mesylate (USAN)", "name_a": "C24H25N7O5. CH4SO3"} +{"id": 3440, "instruction": "ヒビスコキノンAをを組成式で表すと?", "response": "ヒビスコキノンAをを組成式で表すとC15H14O4です。", "task": "formula", "name_q": "ヒビスコキノンA", "name_a": "C15H14O4"} +{"id": 4474, "instruction": "Flucloxacillin (INN)をを組成式で記述すると?", "response": "Flucloxacillin (INN)をを組成式で記述するとC19H17ClFN3O5Sです。", "task": "formula", "name_q": "Flucloxacillin (INN)", "name_a": "C19H17ClFN3O5S"} +{"id": 13242, "instruction": "アクツミジンの別名称は?", "response": "アクツミジンの別名称はAcutumidineです。", "task": "replace", "name_q": "アクツミジン", "name_a": "Acutumidine"} +{"id": 595, "instruction": "2-メチル-5-ヒドロキシトリプタミンの異なる表現は?", "response": "2-メチル-5-ヒドロキシトリプタミンの異なる表現は2-Methyl-5-hydroxytryptamineです。", "task": "replace", "name_q": "2-メチル-5-ヒドロキシトリプタミン", "name_a": "2-Methyl-5-hydroxytryptamine"} +{"id": 26658, "instruction": "Jujuboside Bをを組成式で記述すると?", "response": "Jujuboside Bをを組成式で記述するとC52H84O21です。", "task": "formula", "name_q": "Jujuboside B", "name_a": "C52H84O21"} +{"id": 15770, "instruction": "ダロツズマブを言い換えると?", "response": "ダロツズマブを言い換えるとDalotuzumab (USAN)です。", "task": "replace", "name_q": "ダロツズマブ", "name_a": "Dalotuzumab (USAN)"} +{"id": 1168, "instruction": "トロパコカインをを組成式で書くと?", "response": "トロパコカインをを組成式で書くとC15H19NO2です。", "task": "formula", "name_q": "トロパコカイン", "name_a": "C15H19NO2"} +{"id": 30244, "instruction": "Empirin compound (TN)の日本語表記は?", "response": "Empirin compound (TN)の日本語表記はコデイン・アスピリンです。", "task": "replace en to ja", "name_q": "Empirin compound (TN)", "name_a": "コデイン・アスピリン"} +{"id": 14344, "instruction": "Tetrangomycinをは組成式で表すと?", "response": "Tetrangomycinをは組成式で表すとC19H14O5です。", "task": "formula", "name_q": "Tetrangomycin", "name_a": "C19H14O5"} +{"id": 8182, "instruction": "LUPRONDEPOT(AbbVie)を使用した商品は?", "response": "LUPRONDEPOT(AbbVie)を使用した商品はLEUPROLIDEACETATE(VGYAANPharmaceuticalsLLC)です。", "task": "product", "name_q": "LUPRONDEPOT(AbbVie)", "name_a": "LEUPROLIDEACETATE(VGYAANPharmaceuticalsLLC)"} +{"id": 17686, "instruction": "Curatoderm (TN)の別の呼び方は?", "response": "Curatoderm (TN)の別の呼び方はTacalcitol hydrate (JP18)です。", "task": "replace", "name_q": "Curatoderm (TN)", "name_a": "Tacalcitol hydrate (JP18)"} +{"id": 26464, "instruction": "CAVERJECT(Pharmacia&UpjohnCompanyLLC)を使用した製品名は?", "response": "CAVERJECT(Pharmacia&UpjohnCompanyLLC)を使用した製品名はEDEX(ENDOUSA)です。", "task": "product", "name_q": "CAVERJECT(Pharmacia&UpjohnCompanyLLC)", "name_a": "EDEX(ENDOUSA)"} +{"id": 29845, "instruction": "クエン酸ラニチジンビスマスは別の呼び方では?", "response": "クエン酸ラニチジンビスマスは別の呼び方ではRanitidine bismuth citrate (USAN)です。", "task": "replace", "name_q": "クエン酸ラニチジンビスマス", "name_a": "Ranitidine bismuth citrate (USAN)"} +{"id": 33947, "instruction": "AMP 3'-phosphateの別名は?", "response": "AMP 3'-phosphateの別名はAdenosine-3'-monophosphateです。", "task": "replace", "name_q": "AMP 3'-phosphate", "name_a": "Adenosine-3'-monophosphate"} +{"id": 22468, "instruction": "Trimetoquinol hydrochloride hydrate (JP18)をは化学式で表すと?", "response": "Trimetoquinol hydrochloride hydrate (JP18)をは化学式で表すとC19H23NO5. HCl. H2Oです。", "task": "formula", "name_q": "Trimetoquinol hydrochloride hydrate (JP18)", "name_a": "C19H23NO5. HCl. H2O"} +{"id": 7414, "instruction": "レンサ球菌感染症 下位グループ A群溶血性レンサ球菌咽頭炎 劇症型溶血性レンサ球菌感染症 壊死性筋膜炎 猩紅熱 丹毒 の英語表記は?", "response": "レンサ球菌感染症 下位グループ A群溶血性レンサ球菌咽頭炎 劇症型溶血性レンサ球菌感染症 壊死性筋膜炎 猩紅熱 丹毒 の英語表記はStreptococcal infection SUBGROUP Group A streptococcal pharyngitis Invasive streptococcal disease Necrotizing fasciitis Scarlet fever Erysipelas です。", "task": "replace ja to en", "name_q": "レンサ球菌感染症 下位グループ A群溶血性レンサ球菌咽頭炎 劇症型溶血性レンサ球菌感染症 壊死性筋膜炎 猩紅熱 丹毒 ", "name_a": "Streptococcal infection SUBGROUP Group A streptococcal pharyngitis Invasive streptococcal disease Necrotizing fasciitis Scarlet fever Erysipelas "} +{"id": 10716, "instruction": "Thiamine monophosphate chlorideの別の言い方は?", "response": "Thiamine monophosphate chlorideの別の言い方はチアミンリン酸クロリドです。", "task": "replace", "name_q": "Thiamine monophosphate chloride", "name_a": "チアミンリン酸クロリド"} +{"id": 9003, "instruction": "KETAMINEHYDROCHLORIDE(MedicalPurchasingSolutions)を主とした医薬品は?", "response": "KETAMINEHYDROCHLORIDE(MedicalPurchasingSolutions)を主とした医薬品はKETAMINEHYDROCHLORIDE(Hospira)です。", "task": "product", "name_q": "KETAMINEHYDROCHLORIDE(MedicalPurchasingSolutions)", "name_a": "KETAMINEHYDROCHLORIDE(Hospira)"} +{"id": 4636, "instruction": "ビシファジン塩酸塩をを化学式で記述すると?", "response": "ビシファジン塩酸塩をを化学式で記述するとC12H15N. HClです。", "task": "formula", "name_q": "ビシファジン塩酸塩", "name_a": "C12H15N. HCl"} +{"id": 25097, "instruction": "UDP-2-acetamido-4-(D-alanylamino)-2,4,6-trideoxy-alpha-D-mannopyranoseをを組成式で書くと?", "response": "UDP-2-acetamido-4-(D-alanylamino)-2,4,6-trideoxy-alpha-D-mannopyranoseをを組成式で書くとC20H33N5O16P2です。", "task": "formula", "name_q": "UDP-2-acetamido-4-(D-alanylamino)-2,4,6-trideoxy-alpha-D-mannopyranose", "name_a": "C20H33N5O16P2"} +{"id": 2306, "instruction": "Berberine sulfate hydrate (JAN)をを化学構造で書くと?", "response": "Berberine sulfate hydrate (JAN)をを化学構造で書くと(C20H18NO4)2. SO4. xH2Oです。", "task": "formula", "name_q": "Berberine sulfate hydrate (JAN)", "name_a": "(C20H18NO4)2. SO4. xH2O"} +{"id": 33052, "instruction": "Ciramadol (USAN/INN)をを組成式で表すと?", "response": "Ciramadol (USAN/INN)をを組成式で表すとC15H23NO2です。", "task": "formula", "name_q": "Ciramadol (USAN/INN)", "name_a": "C15H23NO2"} +{"id": 10297, "instruction": "プロピレンをを分子式で書くと?", "response": "プロピレンをを分子式で書くとC3H6です。", "task": "formula", "name_q": "プロピレン", "name_a": "C3H6"} +{"id": 21440, "instruction": "N-Methylpavineをの分子式は?", "response": "N-Methylpavineをの分子式はC21H25NO4です。", "task": "formula", "name_q": "N-Methylpavine", "name_a": "C21H25NO4"} +{"id": 6791, "instruction": "Octreotide acetate (JAN)を使用した商品は?", "response": "Octreotide acetate (JAN)を使用した商品はオクトレオチド(サンファーマ)です。", "task": "product", "name_q": "Octreotide acetate (JAN)", "name_a": "オクトレオチド(サンファーマ)"} +{"id": 4135, "instruction": "Vebicorvir (USAN/INN)をは組成式で表すと?", "response": "Vebicorvir (USAN/INN)をは組成式で表すとC19H12F3N3O4S2です。", "task": "formula", "name_q": "Vebicorvir (USAN/INN)", "name_a": "C19H12F3N3O4S2"} +{"id": 29674, "instruction": "Rimiducid (USAN/INN)をは組成式で表すと?", "response": "Rimiducid (USAN/INN)をは組成式で表すとC78H98N4O20です。", "task": "formula", "name_q": "Rimiducid (USAN/INN)", "name_a": "C78H98N4O20"} +{"id": 21037, "instruction": "2-Hydroxy-2,27-secorifampicinをを分子式で書くと?", "response": "2-Hydroxy-2,27-secorifampicinをを分子式で書くとC43H58N4O13です。", "task": "formula", "name_q": "2-Hydroxy-2,27-secorifampicin", "name_a": "C43H58N4O13"} +{"id": 14763, "instruction": "trans,octacis-Decaprenylphospho-beta-D-arabinofuranoseをを組成式で表すと?", "response": "trans,octacis-Decaprenylphospho-beta-D-arabinofuranoseをを組成式で表すとC55H91O8Pです。", "task": "formula", "name_q": "trans,octacis-Decaprenylphospho-beta-D-arabinofuranose", "name_a": "C55H91O8P"} +{"id": 10327, "instruction": "(S)-beta-Tyrosyl-[pcp]をを化学式で記述すると?", "response": "(S)-beta-Tyrosyl-[pcp]をを化学式で記述するとC9H10NO2SRです。", "task": "formula", "name_q": "(S)-beta-Tyrosyl-[pcp]", "name_a": "C9H10NO2SR"} +{"id": 28017, "instruction": "心房細動を英語で書くと?", "response": "心房細動を英語で書くとAtrial fibrillationです。", "task": "replace ja to en", "name_q": "心房細動", "name_a": "Atrial fibrillation"} +{"id": 29207, "instruction": "停留精巣を英語で書くと?", "response": "停留精巣を英語で書くとCryptorchidismです。", "task": "replace ja to en", "name_q": "停留精巣", "name_a": "Cryptorchidism"} +{"id": 4103, "instruction": "4-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehydeをは組成式で表すと?", "response": "4-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehydeをは組成式で表すとC9H11NO6です。", "task": "formula", "name_q": "4-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde", "name_a": "C9H11NO6"} +{"id": 7126, "instruction": "3-Butyn-1-alをを分子式で表すと?", "response": "3-Butyn-1-alをを分子式で表すとC4H4Oです。", "task": "formula", "name_q": "3-Butyn-1-al", "name_a": "C4H4O"} +{"id": 30291, "instruction": "Soliqua (TN)の別名称は?", "response": "Soliqua (TN)の別名称はInsulin glargine (genetical recombination) and lixisenatideです。", "task": "replace", "name_q": "Soliqua (TN)", "name_a": "Insulin glargine (genetical recombination) and lixisenatide"} +{"id": 23628, "instruction": "Osteochondrodysplasia, brachydactyly, and overlapping malformed digitsを日本語で書くと?", "response": "Osteochondrodysplasia, brachydactyly, and overlapping malformed digitsを日本語で書くと骨軟骨異形成・短指症および重複奇形指趾です。", "task": "replace en to ja", "name_q": "Osteochondrodysplasia, brachydactyly, and overlapping malformed digits", "name_a": "骨軟骨異形成・短指症および重複奇形指趾"} +{"id": 18087, "instruction": "Elestat (TN)を使用した薬品は?", "response": "Elestat (TN)を使用した薬品はアレジオン(日本ベーリンガーインゲルハイム)です。", "task": "product", "name_q": "Elestat (TN)", "name_a": "アレジオン(日本ベーリンガーインゲルハイム)"} +{"id": 20351, "instruction": "6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-olをの組成式は?", "response": "6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-olをの組成式はC21H30O2です。", "task": "formula", "name_q": "6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol", "name_a": "C21H30O2"} +{"id": 29461, "instruction": "Dilmapimod (USAN/INN)をは組成式で表すと?", "response": "Dilmapimod (USAN/INN)をは組成式で表すとC23H19F3N4O3です。", "task": "formula", "name_q": "Dilmapimod (USAN/INN)", "name_a": "C23H19F3N4O3"} +{"id": 19076, "instruction": "Quercetin 3,3'-bissulfateの別名は?", "response": "Quercetin 3,3'-bissulfateの別名はケルセチン 3,3'-ビススルファートです。", "task": "replace", "name_q": "Quercetin 3,3'-bissulfate", "name_a": "ケルセチン 3,3'-ビススルファート"} +{"id": 302, "instruction": "Cefpodoxime (INN)の別名は?", "response": "Cefpodoxime (INN)の別名はセフポドキシムです。", "task": "replace", "name_q": "Cefpodoxime (INN)", "name_a": "セフポドキシム"} +{"id": 24793, "instruction": "dù zhòngを主とした薬品名は?", "response": "dù zhòngを主とした薬品名はトチュウ(高砂薬業)です。", "task": "product", "name_q": "dù zhòng", "name_a": "トチュウ(高砂薬業)"} +{"id": 14337, "instruction": "GENERICKITFORTHEPREPARATIONOFTECHNETIUMTC99MSESTAMIBI(CardinalHealth414)を主材料とする製品名は?", "response": "GENERICKITFORTHEPREPARATIONOFTECHNETIUMTC99MSESTAMIBI(CardinalHealth414)を主材料とする製品名はKITFORTHEPREPARATIONOFTECHNETIUMTC99MSESTAMIBI(LantheusMedicalImaging)です。", "task": "product", "name_q": "GENERICKITFORTHEPREPARATIONOFTECHNETIUMTC99MSESTAMIBI(CardinalHealth414)", "name_a": "KITFORTHEPREPARATIONOFTECHNETIUMTC99MSESTAMIBI(LantheusMedicalImaging)"} +{"id": 9071, "instruction": "ペパーミント水の英語表記は?", "response": "ペパーミント水の英語表記はPeppermint water (NF)です。", "task": "replace ja to en", "name_q": "ペパーミント水", "name_a": "Peppermint water (NF)"} +{"id": 18324, "instruction": "遺伝性感覚性自律神経性ニューロパチー 下位グループ 家族性自律神経失調症 先天性無痛無汗症 遺伝性感覚性ニューロパチー (HSN) 痙性対麻痺を伴う遺伝性感覚性ニューロパチー を英語で書くと?", "response": "遺伝性感覚性自律神経性ニューロパチー 下位グループ 家族性自律神経失調症 先天性無痛無汗症 遺伝性感覚性ニューロパチー (HSN) 痙性対麻痺を伴う遺伝性感覚性ニューロパチー を英語で書くとHereditary sensory and autonomic neuropathy SUBGROUP Familial dysautonomia Congenital pain insensitivity with anhidrosis Hereditary sensory neuropathy (HSN) Hereditary sensory neuropathy with spastic paraplegia です。", "task": "replace ja to en", "name_q": "遺伝性感覚性自律神経性ニューロパチー 下位グループ 家族性自律神経失調症 先天性無痛無汗症 遺伝性感覚性ニューロパチー (HSN) 痙性対麻痺を伴う遺伝性感覚性ニューロパチー ", "name_a": "Hereditary sensory and autonomic neuropathy SUBGROUP Familial dysautonomia Congenital pain insensitivity with anhidrosis Hereditary sensory neuropathy (HSN) Hereditary sensory neuropathy with spastic paraplegia "} +{"id": 16286, "instruction": "横紋筋肉腫 下位グループ 胞巣状横紋筋肉腫 胎児型横紋筋肉腫 上位グループ 固形腫瘍 軟部肉腫 を英語で書くと?", "response": "横紋筋肉腫 下位グループ 胞巣状横紋筋肉腫 胎児型横紋筋肉腫 上位グループ 固形腫瘍 軟部肉腫 を英語で書くとRhabdomyosarcoma SUBGROUP Alveolar rhabdomyosarcoma Embryonal rhabdomyosarcoma SUPERGRP Solid tumor Soft tissue sarcomas です。", "task": "replace ja to en", "name_q": "横紋筋肉腫 下位グループ 胞巣状横紋筋肉腫 胎児型横紋筋肉腫 上位グループ 固形腫瘍 軟部肉腫 ", "name_a": "Rhabdomyosarcoma SUBGROUP Alveolar rhabdomyosarcoma Embryonal rhabdomyosarcoma SUPERGRP Solid tumor Soft tissue sarcomas "} +{"id": 28415, "instruction": "Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasiaを日本語で記述すると?", "response": "Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasiaを日本語で記述すると白内障・成長ホルモン分泌不全症・感覚ニューロパチー・感音性難聴および骨異形成症です。", "task": "replace en to ja", "name_q": "Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia", "name_a": "白内障・成長ホルモン分泌不全症・感覚ニューロパチー・感音性難聴および骨異形成症"} +{"id": 16527, "instruction": "2-Hexanoyl-1,3,6,8-tetrahydroxy-9,10-anthraquinoneの別の言い方は?", "response": "2-Hexanoyl-1,3,6,8-tetrahydroxy-9,10-anthraquinoneの別の言い方はNorsolorinateです。", "task": "replace", "name_q": "2-Hexanoyl-1,3,6,8-tetrahydroxy-9,10-anthraquinone", "name_a": "Norsolorinate"} +{"id": 29943, "instruction": "Delphinidolの別の言い方は?", "response": "Delphinidolの別の言い方はIdB 1056です。", "task": "replace", "name_q": "Delphinidol", "name_a": "IdB 1056"} +{"id": 22378, "instruction": "Sodium ascorbate (USP/INN)をは組成式で表すと?", "response": "Sodium ascorbate (USP/INN)をは組成式で表すとC6H7O6. Naです。", "task": "formula", "name_q": "Sodium ascorbate (USP/INN)", "name_a": "C6H7O6. Na"} +{"id": 23341, "instruction": "Methyl [4,5-dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetateの異なる表記は?", "response": "Methyl [4,5-dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetateの異なる表記はMethyl nogalonateです。", "task": "replace", "name_q": "Methyl [4,5-dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetate", "name_a": "Methyl nogalonate"} +{"id": 27346, "instruction": "DIAZEPAM(QualityCareProductsLLC)をは化学構造で表すと?", "response": "DIAZEPAM(QualityCareProductsLLC)をは化学構造で表すとC16H13ClN2Oです。", "task": "formula", "name_q": "DIAZEPAM(QualityCareProductsLLC)", "name_a": "C16H13ClN2O"} +{"id": 17310, "instruction": "グリコペリンの異なる名称は?", "response": "グリコペリンの異なる���称はGlycoperineです。", "task": "replace", "name_q": "グリコペリン", "name_a": "Glycoperine"} +{"id": 24912, "instruction": "重症先天性肝疾患の英訳は?", "response": "重症先天性肝疾患の英訳はSevere congenital liver diseaseです。", "task": "replace ja to en", "name_q": "重症先天性肝疾患", "name_a": "Severe congenital liver disease"} +{"id": 3822, "instruction": "Buthiobateの異なる表記は?", "response": "Buthiobateの異なる表記はブチオベートです。", "task": "replace", "name_q": "Buthiobate", "name_a": "ブチオベート"} +{"id": 7397, "instruction": "1-(5-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazoleをを分子式で書くと?", "response": "1-(5-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazoleをを分子式で書くとC12H20N5O9Pです。", "task": "formula", "name_q": "1-(5-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole", "name_a": "C12H20N5O9P"} +{"id": 7512, "instruction": "Mirtazapine hydrate (JAN)の別記述は?", "response": "Mirtazapine hydrate (JAN)の別記述はミルタザピン水和物 (JAN)です。", "task": "replace", "name_q": "Mirtazapine hydrate (JAN)", "name_a": "ミルタザピン水和物 (JAN)"} +{"id": 30522, "instruction": "dl-Camphor, l-menthol and methyl salicylateを日本語で書くと?", "response": "dl-Camphor, l-menthol and methyl salicylateを日本語で書くとdl-カンフル・l-メントール・サリチル酸メチルです。", "task": "replace en to ja", "name_q": "dl-Camphor, l-menthol and methyl salicylate", "name_a": "dl-カンフル・l-メントール・サリチル酸メチル"} +{"id": 10364, "instruction": "Sarmazenil (INN)をは化学構造で表すと?", "response": "Sarmazenil (INN)をは化学構造で表すとC15H14ClN3O3です。", "task": "formula", "name_q": "Sarmazenil (INN)", "name_a": "C15H14ClN3O3"} +{"id": 31976, "instruction": "炙甘草湯の別名は?", "response": "炙甘草湯の別名はシャカンゾウトウです。", "task": "replace", "name_q": "炙甘草湯", "name_a": "シャカンゾウトウ"} +{"id": 15210, "instruction": "2-Deoxy-2-dimethylamino-alpha-D-Glucoseをを化学式で書くと?", "response": "2-Deoxy-2-dimethylamino-alpha-D-Glucoseをを化学式で書くとC8H17NO5です。", "task": "formula", "name_q": "2-Deoxy-2-dimethylamino-alpha-D-Glucose", "name_a": "C8H17NO5"} +{"id": 30498, "instruction": "Leucyl-leucineをを組成式で表すと?", "response": "Leucyl-leucineをを組成式で表すとC12H24N2O3です。", "task": "formula", "name_q": "Leucyl-leucine", "name_a": "C12H24N2O3"} +{"id": 24170, "instruction": "Aztreonam and avibactamの異なる表記は?", "response": "Aztreonam and avibactamの異なる表記はアズトレオナム・アビバクタムです。", "task": "replace", "name_q": "Aztreonam and avibactam", "name_a": "アズトレオナム・アビバクタム"} +{"id": 26596, "instruction": "(-)-Sedamineをを化学式で表すと?", "response": "(-)-Sedamineをを化学式で表すとC14H21NOです。", "task": "formula", "name_q": "(-)-Sedamine", "name_a": "C14H21NO"} +{"id": 27461, "instruction": "5-(D-Galactosyloxy)-L-lysine-procollagenをの分子式は?", "response": "5-(D-Galactosyloxy)-L-lysine-procollagenをの分子式はC13H23N3O8R2です。", "task": "formula", "name_q": "5-(D-Galactosyloxy)-L-lysine-procollagen", "name_a": "C13H23N3O8R2"} +{"id": 2221, "instruction": "Macrophyllineの別呼称は?", "response": "Macrophyllineの別呼称はマクロフィリンです。", "task": "replace", "name_q": "Macrophylline", "name_a": "マクロフィリン"} +{"id": 27629, "instruction": "9-O-Demethyl-2alpha-hydroxyhomolycorineをは化学式で表すと?", "response": "9-O-Demethyl-2alpha-hydroxyhomolycorineをは化学式で表すとC17H19NO5です。", "task": "formula", "name_q": "9-O-Demethyl-2alpha-hydroxyhomolycorine", "name_a": "C17H19NO5"} +{"id": 10235, "instruction": "ケイシエッピトウを英語表記で表すと?", "response": "ケイシエッピトウを英語表記で表すとKeishieppitoです。", "task": "replace ja to en", "name_q": "ケイシエッピトウ", "name_a": "Keishieppito"} +{"id": 4896, "instruction": "12-デメチル−11,12-デヒドロパスパリンをを組成式で記述すると?", "response": "12-デメチル−11,12-デヒドロパスパリンをを組成式で記述するとC27H35NO2です。", "task": "formula", "name_q": "12-デメチル−11,12-デヒドロパスパリン", "name_a": "C27H35NO2"} +{"id": 8472, "instruction": "N1-Acetyl-tabtoxinine-beta-lactamをを分子式で書くと?", "response": "N1-Acetyl-tabtoxinine-beta-lactamをを分子式で書くとC9H14N2O5です。", "task": "formula", "name_q": "N1-Acetyl-tabtoxinine-beta-lactam", "name_a": "C9H14N2O5"} +{"id": 20363, "instruction": "Clonixin (USAN/INN)をを化学式で記述すると?", "response": "Clonixin (USAN/INN)をを化学式で記述するとC13H11ClN2O2です。", "task": "formula", "name_q": "Clonixin (USAN/INN)", "name_a": "C13H11ClN2O2"} +{"id": 13421, "instruction": "Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC)を日本語で書くと?", "response": "Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC)を日本語で書くとHANAC 症候群です。", "task": "replace en to ja", "name_q": "Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC)", "name_a": "HANAC 症候群"} +{"id": 12534, "instruction": "Cinoxacin (JP18/USP/INN) 略語 CINXをは化学式で表すと?", "response": "Cinoxacin (JP18/USP/INN) 略語 CINXをは化学式で表すとC12H10N2O5です。", "task": "formula", "name_q": "Cinoxacin (JP18/USP/INN) 略語 CINX", "name_a": "C12H10N2O5"} +{"id": 954, "instruction": "ワイスタール(ニプロ)を主とした医薬品名は?", "response": "ワイスタール(ニプロ)を主とした医薬品名はセフォセフ(沢井製薬)です。", "task": "product", "name_q": "ワイスタール(ニプロ)", "name_a": "セフォセフ(沢井製薬)"} +{"id": 9273, "instruction": "2-(2'-メチルチオ)エチルマリックアシッドをの分子式は?", "response": "2-(2'-メチルチオ)エチルマリックアシッドをの分子式はC7H12O5Sです。", "task": "formula", "name_q": "2-(2'-メチルチオ)エチルマリックアシッド", "name_a": "C7H12O5S"} +{"id": 12490, "instruction": "Baycaron (TN)をを化学式で表すと?", "response": "Baycaron (TN)をを化学式で表すとC13H19ClN2O5S2です。", "task": "formula", "name_q": "Baycaron (TN)", "name_a": "C13H19ClN2O5S2"} +{"id": 154, "instruction": "Etamiphylline (INN)をを化学式で表すと?", "response": "Etamiphylline (INN)をを化学式で表すとC13H21N5O2です。", "task": "formula", "name_q": "Etamiphylline (INN)", "name_a": "C13H21N5O2"} +{"id": 1202, "instruction": "1-Amino-2,4-dinitrobenzeneをを分子式で書くと?", "response": "1-Amino-2,4-dinitrobenzeneをを分子式で書くとC6H5N3O4です。", "task": "formula", "name_q": "1-Amino-2,4-dinitrobenzene", "name_a": "C6H5N3O4"} +{"id": 17554, "instruction": "Cyclohexyl acetateをを化学式で書くと?", "response": "Cyclohexyl acetateをを化学式で書くとC8H14O2です。", "task": "formula", "name_q": "Cyclohexyl acetate", "name_a": "C8H14O2"} +{"id": 27758, "instruction": "チンラレバントを言い換えると?", "response": "チンラレバントを言い換えるとTinlarebant (USAN)です。", "task": "replace", "name_q": "チンラレバント", "name_a": "Tinlarebant (USAN)"} +{"id": 3638, "instruction": "ビダラビン水和物をは分子式で表すと?", "response": "ビダラビン水和物をは分子式で表すとC10H13N5O4. H2Oです。", "task": "formula", "name_q": "ビダラビン水和物", "name_a": "C10H13N5O4. H2O"} +{"id": 34155, "instruction": "Berotralstat (USAN/INN)をを分子式で書くと?", "response": "Berotralstat (USAN/INN)をを分子式で書くとC30H26F4N6Oです。", "task": "formula", "name_q": "Berotralstat (USAN/INN)", "name_a": "C30H26F4N6O"} +{"id": 18743, "instruction": "ブロメライン (JAN)の異なる表記は?", "response": "ブロメライン (JAN)の異なる表記はBromelain (JAN)です。", "task": "replace", "name_q": "ブロメライン (JAN)", "name_a": "Bromelain (JAN)"} +{"id": 19550, "instruction": "デシタビン・セダズリジンを使用した製品は?", "response": "デシタビン・セダズリジンを使用した製品はINQOVI(TaihoPharmaceutical)です。", "task": "product", "name_q": "デシタビン・セダズリジン", "name_a": "INQOVI(TaihoPharmaceutical)"} +{"id": 17459, "instruction": "疥癬の英訳は?", "response": "疥癬の英訳はScabiesです。", "task": "replace ja to en", "name_q": "疥癬", "name_a": "Scabies"} +{"id": 14017, "instruction": "CARBOPROSTTROMETHAMINE(AlembicPharmaceuticals)を主とした製品名は?", "response": "CARBOPROSTTROMETHAMINE(AlembicPharmaceuticals)を主とした製品名はCARBOPROSTTROMETHAMINE(ONESOURCESPECIALTYPHARMALIMITED)です。", "task": "product", "name_q": "CARBOPROSTTROMETHAMINE(AlembicPharmaceuticals)", "name_a": "CARBOPROSTTROMETHAMINE(ONESOURCESPECIALTYPHARMALIMITED)"} +{"id": 10850, "instruction": "Cyclic Gp(2'-5')Ap(3'-5')をは分子式で表すと?", "response": "Cyclic Gp(2'-5')Ap(3'-5')をは分子式で表すとC20H24N10O13P2です。", "task": "formula", "name_q": "Cyclic Gp(2'-5')Ap(3'-5')", "name_a": "C20H24N10O13P2"} +{"id": 30458, "instruction": "カルバペネム耐性菌感染症 下位グループ カルバペネム耐性腸内細菌科細菌感染症 カルバペネム耐性緑膿菌感染症 カルバペネム耐性アシネトバクター感染症の英訳は?", "response": "カルバペネム耐性菌感染症 下位グループ カルバペネム耐性腸内細菌科細菌感染症 カルバペネム耐性緑膿菌感染症 カルバペネム耐性アシネトバクター感染症の英訳はCarbapenem-resistant bacterial infection SUBGROUP Carbapenem-resistant Enterobacteriaceae (CRE) infection Carbapenem-resistant Pseudomonas aeruginosa infection Carbapenem-resistant Acinetobacter baumannii infectionです。", "task": "replace ja to en", "name_q": "カルバペネム耐性菌感染症 下位グループ カルバペネム耐性腸内細菌科細菌感染症 カルバペネム耐性緑膿菌感染症 カルバペネム耐性アシネトバクター感染症", "name_a": "Carbapenem-resistant bacterial infection SUBGROUP Carbapenem-resistant Enterobacteriaceae (CRE) infection Carbapenem-resistant Pseudomonas aeruginosa infection Carbapenem-resistant Acinetobacter baumannii infection"} +{"id": 30944, "instruction": "チザニジンをを組成式で書くと?", "response": "チザニジンをを組成式で書くとC9H8ClN5Sです。", "task": "formula", "name_q": "チザニジン", "name_a": "C9H8ClN5S"} +{"id": 10255, "instruction": "Zeatinの別名は?", "response": "Zeatinの別名は(E)-2-Methyl-4-(1H-purin-6-ylamino)but-2-en-1-olです。", "task": "replace", "name_q": "Zeatin", "name_a": "(E)-2-Methyl-4-(1H-purin-6-ylamino)but-2-en-1-ol"} +{"id": 29841, "instruction": "Tromethamol, sodium chloride and potassium chlorideを英語に訳すと?", "response": "Tromethamol, sodium chloride and potassium chlorideを英語に訳すとTham Set (TN)です。", "task": "replace ja to en", "name_q": "Tromethamol, sodium chloride and potassium chloride", "name_a": "Tham Set (TN)"} +{"id": 2609, "instruction": "Tiludronate disodium (USAN)の異なる表記は?", "response": "Tiludronate disodium (USAN)の異なる表記はSkelid (TN)です。", "task": "replace", "name_q": "Tiludronate disodium (USAN)", "name_a": "Skelid (TN)"} +{"id": 19276, "instruction": "アゾマイシンの別名は?", "response": "アゾマイシンの別名はAzomycinです。", "task": "replace", "name_q": "アゾマイシン", "name_a": "Azomycin"} +{"id": 18921, "instruction": "トリパンブルーを英語で記述すると?", "response": "トリパンブルーを英語で記述するとVisionblue (TN)です。", "task": "replace ja to en", "name_q": "トリパンブルー", "name_a": "Visionblue (TN)"} +{"id": 28127, "instruction": "L-Glutamic acid, pipethanate hydrochloride and aluminum hydroxide-sodium bicarbonate co-precipitateの日本語表記は?", "response": "L-Glutamic acid, pipethanate hydrochloride and aluminum hydroxide-sodium bicarbonate co-precipitateの日本語表記はL-グルタミン・ピペタナート塩酸塩・水酸化アルミニウム・炭酸水素ナトリウム共沈物です。", "task": "replace en to ja", "name_q": "L-Glutamic acid, pipethanate hydrochloride and aluminum hydroxide-sodium bicarbonate co-precipitate", "name_a": "L-グルタミン・ピペタナート塩酸塩・水酸化アルミニウム・炭酸水素ナトリウム共沈物"} +{"id": 6587, "instruction": "Tobicillin (JAN/INN)をの分子式は?", "response": "Tobicillin (JAN/INN)をの分子式はC27H30N2O6Sです。", "task": "formula", "name_q": "Tobicillin (JAN/INN)", "name_a": "C27H30N2O6S"} +{"id": 12573, "instruction": "Puregon (TN)を材料とする商品は?", "response": "Puregon (TN)を材料とする商品はフォリスチム(オルガノン)です。", "task": "product", "name_q": "Puregon (TN)", "name_a": "フォリスチム(オルガノン)"} +{"id": 8826, "instruction": "ギャバクリンをを化学式で記述すると?", "response": "ギャバクリンをを化学式で記述するとC7H9NO2です。", "task": "formula", "name_q": "ギャバクリン", "name_a": "C7H9NO2"} +{"id": 16178, "instruction": "Bukuryoinを利用した商品は?", "response": "Bukuryoinを利用した商品は茯苓飲(ツムラ)です。", "task": "product", "name_q": "Bukuryoin", "name_a": "茯苓飲(ツムラ)"} +{"id": 23932, "instruction": "XYREM(JazzPharmaceuticals)を主材料とする商品は?", "response": "XYREM(JazzPharmaceuticals)を主材料とする商品はGENERICSODIUMOXYBATE(AmnealPharmaceuticalsNYLLC)です。", "task": "product", "name_q": "XYREM(JazzPharmaceuticals)", "name_a": "GENERICSODIUMOXYBATE(AmnealPharmaceuticalsNYLLC)"} +{"id": 7439, "instruction": "NITROUSOXIDE(LindeGas&Equipment)を主材料とする医薬品名は?", "response": "NITROUSOXIDE(LindeGas&Equipment)を主材料とする医薬品名はNITROUSOXIDE(GeneralWeldingSupplyCorp.)です。", "task": "product", "name_q": "NITROUSOXIDE(LindeGas&Equipment)", "name_a": "NITROUSOXIDE(GeneralWeldingSupplyCorp.)"} +{"id": 280, "instruction": "Voxilaprevir (USAN/INN)をを化学構造で記述すると?", "response": "Voxilaprevir (USAN/INN)をを化学構造で記述するとC40H52F4N6O9Sです。", "task": "formula", "name_q": "Voxilaprevir (USAN/INN)", "name_a": "C40H52F4N6O9S"} +{"id": 9852, "instruction": "Arsthinol (INN)の別呼称は?", "response": "Arsthinol (INN)の別呼称はArsthinenolです。", "task": "replace", "name_q": "Arsthinol (INN)", "name_a": "Arsthinenol"} +{"id": 1853, "instruction": "Lonicerinを言い換えると?", "response": "Lonicerinを言い換えるとロニセリンです。", "task": "replace", "name_q": "Lonicerin", "name_a": "ロニセリン"} +{"id": 10536, "instruction": "Congenital hypotrichosis with juvenile macular dystrophyを日本語で記述すると?", "response": "Congenital hypotrichosis with juvenile macular dystrophyを日本語で記述すると若年性黄斑変性を伴う先天性貧毛症です。", "task": "replace en to ja", "name_q": "Congenital hypotrichosis with juvenile macular dystrophy", "name_a": "若年性黄斑変性を伴う先天性貧毛症"} +{"id": 2843, "instruction": "感染性胃腸炎を英語で書くと?", "response": "感染性胃腸炎を英語で書くとViral gastroenteritisです。", "task": "replace ja to en", "name_q": "感染性胃腸炎", "name_a": "Viral gastroenteritis"} +{"id": 21886, "instruction": "Formyl phosphateをを組成式で表すと?", "response": "Formyl phosphateをを組成式で表すとCH3O5Pです。", "task": "formula", "name_q": "Formyl phosphate", "name_a": "CH3O5P"} +{"id": 25276, "instruction": "Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) SUPERGRP Other well-defined immunodeficiency syndromes Primary immunodeficiency disease を日本語に訳すと?", "response": "Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) SUPERGRP Other well-defined immunodeficiency syndromes Primary immunodeficiency disease を日本語に訳すと多腺性自己免疫症候群 1型です。", "task": "replace en to ja", "name_q": "Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) SUPERGRP Other well-defined immunodeficiency syndromes Primary immunodeficiency disease ", "name_a": "多腺性自己免疫症候群 1型"} +{"id": 9357, "instruction": "Cobicistat (JAN/USAN/INN)を用いた商品名は?", "response": "Cobicistat (JAN/USAN/INN)を用いた商品名はTYBOST(GileadSciences)です。", "task": "product", "name_q": "Cobicistat (JAN/USAN/INN)", "name_a": "TYBOST(GileadSciences)"} +{"id": 31234, "instruction": "alfa-Interferonを言い換えると?", "response": "alfa-Interferonを言い換えるとInterferon alfa-n1 (USAN)です。", "task": "replace", "name_q": "alfa-Interferon", "name_a": "Interferon alfa-n1 (USAN)"} +{"id": 21756, "instruction": "N-Acylmuramateをは化学構造で表すと?", "response": "N-Acylmuramateをは化学構造で表すとC10H16NO8Rです。", "task": "formula", "name_q": "N-Acylmuramate", "name_a": "C10H16NO8R"} +{"id": 23177, "instruction": "Lessel-Kreienkamp 症候群を英語で記述すると?", "response": "Lessel-Kreienkamp 症候群を英語で記述するとLessel-Kreienkamp syndromeです。", "task": "replace ja to en", "name_q": "Lessel-Kreienkamp 症候群", "name_a": "Lessel-Kreienkamp syndrome"} +{"id": 24737, "instruction": "高カリウム血性周期性四肢麻痺 上位グループ 遺伝性周期性四肢麻痺 を英語で記述すると?", "response": "高カリウム血性周期性四肢麻痺 上位グループ 遺伝性周期性四肢麻痺 を英語で記述するとHyperkalemic periodic paralysis SUPERGRP Periodic paralysis です。", "task": "replace ja to en", "name_q": "高カリウム血性周期性四肢麻痺 上位グループ 遺伝性周期性四肢麻痺 ", "name_a": "Hyperkalemic periodic paralysis SUPERGRP Periodic paralysis "} +{"id": 25867, "instruction": "クァゾジンをは組成式で表すと?", "response": "クァゾジンをは組成式で表すとC12H14N2O2です。", "task": "formula", "name_q": "クァゾジン", "name_a": "C12H14N2O2"} +{"id": 18971, "instruction": "beta-Selineneをは化学式で表すと?", "response": "beta-Selineneをは化学式で表すとC15H24です。", "task": "formula", "name_q": "beta-Selinene", "name_a": "C15H24"} +{"id": 6611, "instruction": "先天性赤血球異形成貧血を英語で記述すると?", "response": "先天性赤血球異形成貧血を英語で記述するとCongenital dyserythropoietic anemiaです。", "task": "replace ja to en", "name_q": "先天性赤血球異形成貧血", "name_a": "Congenital dyserythropoietic anemia"} +{"id": 6909, "instruction": "イソ吉草酸血症 上位グループ 二次性高アンモニア血症 を英語で記述すると?", "response": "イソ吉草酸血症 上位グループ 二次性高アンモニア血症 を英語で記述するとIsovaleric acidemia SUPERGRP Secondary hyperammonemia です。", "task": "replace ja to en", "name_q": "イソ吉草酸血症 上位グループ 二次性高アンモニア血症 ", "name_a": "Isovaleric acidemia SUPERGRP Secondary hyperammonemia "} +{"id": 14153, "instruction": "Florilenalinをを分子式で表すと?", "response": "Florilenalinをを分子式で表すとC15H20O4です。", "task": "formula", "name_q": "Florilenalin", "name_a": "C15H20O4"} +{"id": 14088, "instruction": "Potassium dichromateを言い換えると?", "response": "Potassium dichromateを言い換えると二クロム酸カリウムです。", "task": "replace", "name_q": "Potassium dichromate", "name_a": "二クロム酸カリウム"} +{"id": 12114, "instruction": "2-Hydroxyadipic acidをを化学式で書くと?", "response": "2-Hydroxyadipic acidをを化学式で書くとC6H10O5です。", "task": "formula", "name_q": "2-Hydroxyadipic acid", "name_a": "C6H10O5"} +{"id": 2266, "instruction": "オムスク出血熱 上位グループ 節足動物媒介ウイルス熱 を英語表記で表すと?", "response": "オムスク出血熱 上位グループ 節足動物媒介ウイルス熱 を英語表記で表すとOmsk hemorrhagic fever SUPERGRP Arthropod-borne viral fever です。", "task": "replace ja to en", "name_q": "オムスク出血熱 上位グループ 節足動物媒介ウイルス熱 ", "name_a": "Omsk hemorrhagic fever SUPERGRP Arthropod-borne viral fever "} +{"id": 10635, "instruction": "生姜瀉心湯の別表現は?", "response": "生姜瀉心湯の別表現はShokyoshashintoです。", "task": "replace", "name_q": "生姜瀉心湯", "name_a": "Shokyoshashinto"} +{"id": 27321, "instruction": "Vitamin B1を言い換えると?", "response": "Vitamin B1を言い換えるとThiamineです。", "task": "replace", "name_q": "Vitamin B1", "name_a": "Thiamine"} +{"id": 14516, "instruction": "メシル酸ビフェプルノクスを英語表記で表すと?", "response": "メシル酸ビフェプルノクスを英語表記で表すとBifeprunox mesylate (USAN)です。", "task": "replace ja to en", "name_q": "メシル酸ビフェプルノクス", "name_a": "Bifeprunox mesylate (USAN)"} +{"id": 6498, "instruction": "Indometacin sodiumを言い換えると?", "response": "Indometacin sodiumを言い換えるとIndomethacin sodium trihydrateです。", "task": "replace", "name_q": "Indometacin sodium", "name_a": "Indomethacin sodium trihydrate"} +{"id": 8425, "instruction": "3-Hydroxy-5-methyl-L-tyrosineをを化学構造で表すと?", "response": "3-Hydroxy-5-methyl-L-tyrosineをを化学構造で表すとC10H13NO4です。", "task": "formula", "name_q": "3-Hydroxy-5-methyl-L-tyrosine", "name_a": "C10H13NO4"} +{"id": 13940, "instruction": "Osteosclerotic metaphyseal dysplasiaを日本語表記で表すと?", "response": "Osteosclerotic metaphyseal dysplasiaを日本語表記で表すと骨硬化性骨幹端異形成症です。", "task": "replace en to ja", "name_q": "Osteosclerotic metaphyseal dysplasia", "name_a": "骨硬化性骨幹端異形成症"} +{"id": 23814, "instruction": "Bellsan (TN)の別名は?", "response": "Bellsan (TN)の別名はl-Menthol, gentian, scopolia extract powder and sodium bicarbonateです。", "task": "replace", "name_q": "Bellsan (TN)", "name_a": "l-Menthol, gentian, scopolia extract powder and sodium bicarbonate"} +{"id": 550, "instruction": "ブトカルボキシムの別の呼び方は?", "response": "ブトカルボキシムの別の呼び方はButocarboximです。", "task": "replace", "name_q": "ブトカルボキシム", "name_a": "Butocarboxim"} +{"id": 26391, "instruction": "2,4-Dihydroxy-1,4-benzoxazin-3-one glucosideをは化学構造で表すと?", "response": "2,4-Dihydroxy-1,4-benzoxazin-3-one glucosideをは化学構造で表すとC14H17NO9です。", "task": "formula", "name_q": "2,4-Dihydroxy-1,4-benzoxazin-3-one glucoside", "name_a": "C14H17NO9"} +{"id": 7963, "instruction": "Marmesinの別の呼び方は?", "response": "Marmesinの別の呼び方は(S)-2-(2-Hydroxypropan-2-yl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-oneです。", "task": "replace", "name_q": "Marmesin", "name_a": "(S)-2-(2-Hydroxypropan-2-yl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one"} +{"id": 18961, "instruction": "Tyrindoxyl sulfateをは化学構造で表すと?", "response": "Tyrindoxyl sulfateをは化学構造で表すとC9H8BrNO4S2です。", "task": "formula", "name_q": "Tyrindoxyl sulfate", "name_a": "C9H8BrNO4S2"} +{"id": 5747, "instruction": "7,8-Dihydroneopterin 2',3'-cyclic phosphateをは化学式で表すと?", "response": "7,8-Dihydroneopterin 2',3'-cyclic phosphateをは化学式で表すとC9H12N5O6Pです。", "task": "formula", "name_q": "7,8-Dihydroneopterin 2',3'-cyclic phosphate", "name_a": "C9H12N5O6P"} +{"id": 8601, "instruction": "ヌクレオチド除去修復機構異常疾患 下位グループ 色素性乾皮症 コケイン症候群 紫外線高感受性症候群 裂毛症 White-Kernohan 症候群 脳・眼・顔・骨格症候群 XFE 早老症候群を英語表記で表すと?", "response": "ヌクレオチド除去修復機構異常疾患 下位グループ 色素性乾皮症 コケイン症候群 紫外線高感受性症候群 裂毛症 White-Kernohan 症候群 脳・眼・顔・骨格症候群 XFE 早老症候群を英語表記で表すとDisorders of nucleotide excision repair SUBGROUP Xeroderma pigmentosum Cockayne syndrome UV-sensitive syndrome Trichothiodystrophy White-Kernohan syndrome Cerebro-oculo-facio-skeletal syndrome XFE progeroid syndromeです。", "task": "replace ja to en", "name_q": "ヌクレオチド除去修復機構異常疾患 下位グループ 色素性乾皮症 コケイン症候群 紫外線高感受性症候群 裂毛症 White-Kernohan 症候群 脳・眼・顔・骨格症候群 XFE 早老症候群", "name_a": "Disorders of nucleotide excision repair SUBGROUP Xeroderma pigmentosum Cockayne syndrome UV-sensitive syndrome Trichothiodystrophy White-Kernohan syndrome Cerebro-oculo-facio-skeletal syndrome XFE progeroid syndrome"} +{"id": 18403, "instruction": "ピペルジアールをを化学構造で記述すると?", "response": "ピペルジアールをを化学構造で記述するとC15H22O3です。", "task": "formula", "name_q": "ピペルジアール", "name_a": "C15H22O3"} +{"id": 23513, "instruction": "1,2-Campholideをは分子式で表すと?", "response": "1,2-Campholideをは分子式で表すとC10H16O2です。", "task": "formula", "name_q": "1,2-Campholide", "name_a": "C10H16O2"} +{"id": 14574, "instruction": "(+)-メントンをを化学式で記述すると?", "response": "(+)-メントンをを化学式で記述するとC10H18Oです。", "task": "formula", "name_q": "(+)-メントン", "name_a": "C10H18O"} +{"id": 33005, "instruction": "デルモルフィンをを分子式で書くと?", "response": "デルモルフィンをを分子式で書くとC40H50N8O10です。", "task": "formula", "name_q": "デルモルフィン", "name_a": "C40H50N8O10"} +{"id": 5233, "instruction": "メトホルミン塩酸塩・ロシグリタゾンマレイン酸塩の異なる名称は?", "response": "メトホルミン塩酸塩・ロシグリタゾンマレイン酸塩の異なる名称はMetformin hydrochloride and rosiglitazone maleateです。", "task": "replace", "name_q": "メトホルミン塩酸塩・ロシグリタゾンマレイン酸塩", "name_a": "Metformin hydrochloride and rosiglitazone maleate"} +{"id": 6642, "instruction": "Rukobia (TN) ABBR FTRの異なる表現は?", "response": "Rukobia (TN) ABBR FTRの異なる表現はFostemsavir tromethamine (USAN)です。", "task": "replace", "name_q": "Rukobia (TN) ABBR FTR", "name_a": "Fostemsavir tromethamine (USAN)"} +{"id": 5719, "instruction": "N-Succinyl-L-citrullineをを化学構造で書くと?", "response": "N-Succinyl-L-citrullineをを化学構造で書くとC10H17N3O6です。", "task": "formula", "name_q": "N-Succinyl-L-citrulline", "name_a": "C10H17N3O6"} +{"id": 13923, "instruction": "Parafluorofentanylの別表現は?", "response": "Parafluorofentanylの別表現はp-Fluorofentanylです。", "task": "replace", "name_q": "Parafluorofentanyl", "name_a": "p-Fluorofentanyl"} +{"id": 17826, "instruction": "L-β-リジンの別の呼び方は?", "response": "L-β-リジンの別の呼び方は(3S)-3,6-Diaminohexanoateです。", "task": "replace", "name_q": "L-β-リジン", "name_a": "(3S)-3,6-Diaminohexanoate"} +{"id": 10858, "instruction": "Ensitrelvir fumaric acid (JAN)を使用した商品は?", "response": "Ensitrelvir fumaric acid (JAN)を使用した商品はゾコーバ(塩野義製薬)です。", "task": "product", "name_q": "Ensitrelvir fumaric acid (JAN)", "name_a": "ゾコーバ(塩野義製薬)"} +{"id": 4331, "instruction": "Ochrobactrum anthropi infectionを日本語で書くと?", "response": "Ochrobactrum anthropi infectionを日本語で書くとOchrobactrum anthropi 感染です。", "task": "replace en to ja", "name_q": "Ochrobactrum anthropi infection", "name_a": "Ochrobactrum anthropi 感染"} +{"id": 19630, "instruction": "ユベラN(エーザイ)を主材料とする医薬品名は?", "response": "ユベラN(エーザイ)を主材料とする医薬品名は後発品トコフェロールニコチン酸エステル(堀井薬品工業)です。", "task": "product", "name_q": "ユベラN(エーザイ)", "name_a": "後発品トコフェロールニコチン酸エステル(堀井薬品工業)"} +{"id": 25863, "instruction": "Efungumab (USAN/INN)を日本語表記で表すと?", "response": "Efungumab (USAN/INN)を日本語表記で表すとエファングマブです。", "task": "replace en to ja", "name_q": "Efungumab (USAN/INN)", "name_a": "エファングマブ"} +{"id": 19982, "instruction": "Deleobuvir sodium (JAN/USAN)をは分子式で表すと?", "response": "Deleobuvir sodium (JAN/USAN)をは分子式で表すとC34H32BrN6O3. Naです。", "task": "formula", "name_q": "Deleobuvir sodium (JAN/USAN)", "name_a": "C34H32BrN6O3. Na"} +{"id": 12833, "instruction": "テマフロキサシン塩酸塩 (JAN)をの分子式は?", "response": "テマフロキサシン塩酸塩 (JAN)をの分子式はC21H18F3N3O3. HClです。", "task": "formula", "name_q": "テマフロキサシン塩酸塩 (JAN)", "name_a": "C21H18F3N3O3. HCl"} +{"id": 2153, "instruction": "Myotonia congenita SUBGROUP Autosomal dominant myotonia congenita (Thomsen disease) Autosomal recessive myotonia congenita (Becker disease) SUPERGRP Non-dystrophic myotonia の日本語訳は?", "response": "Myotonia congenita SUBGROUP Autosomal dominant myotonia congenita (Thomsen disease) Autosomal recessive myotonia congenita (Becker disease) SUPERGRP Non-dystrophic myotonia の日本語訳は先天性ミオトニー 下位グループ 常染色体優性遺伝性ミオトニー（トムゼン病) 常染色体劣性遺伝性ミオトニー（ベッカー病) 上位グループ 非ジストロフィー性ミオトニー症候群 です。", "task": "replace en to ja", "name_q": "Myotonia congenita SUBGROUP Autosomal dominant myotonia congenita (Thomsen disease) Autosomal recessive myotonia congenita (Becker disease) SUPERGRP Non-dystrophic myotonia ", "name_a": "先天性ミオトニー 下位グループ 常染色体優性遺伝性ミオトニー（トムゼン病) 常染色体劣性遺伝性ミオトニー（ベッカー病) 上位グループ 非ジストロフィー性ミオトニー症候群 "} +{"id": 31355, "instruction": "Setoperone (USAN/INN)の日本語訳は?", "response": "Setoperone (USAN/INN)の日本語訳はセトペロンです。", "task": "replace en to ja", "name_q": "Setoperone (USAN/INN)", "name_a": "セトペロン"} +{"id": 20065, "instruction": "Lufotrelvir (USAN)を日本語表記で表すと?", "response": "Lufotrelvir (USAN)を日本語表記で表すとルフォトレルビルです。", "task": "replace en to ja", "name_q": "Lufotrelvir (USAN)", "name_a": "ルフォトレルビル"} +{"id": 11876, "instruction": "Median facial cleft syndromeの異なる名称は?", "response": "Median facial cleft syndromeの異なる名称はFrontonasal dysplasia 1 SUPERGRP Frontonasal dysplasia です。", "task": "replace", "name_q": "Median facial cleft syndrome", "name_a": "Frontonasal dysplasia 1 SUPERGRP Frontonasal dysplasia "} +{"id": 23699, "instruction": "Coenzyme F420-1をを化学構造で記述すると?", "response": "Coenzyme F420-1をを化学構造で記述するとC24H29N4O15Pです。", "task": "formula", "name_q": "Coenzyme F420-1", "name_a": "C24H29N4O15P"} +{"id": 5275, "instruction": "Dona (TN)をを分子式で書くと?", "response": "Dona (TN)をを分子式で書くと(C6H13NO5)2. H2SO4です。", "task": "formula", "name_q": "Dona (TN)", "name_a": "(C6H13NO5)2. H2SO4"} +{"id": 9465, "instruction": "チャクシンの別呼称は?", "response": "チャクシンの別呼称はChaksineです。", "task": "replace", "name_q": "チャクシン", "name_a": "Chaksine"} +{"id": 21390, "instruction": "Zolunicant (USAN)をを組成式で記述すると?", "response": "Zolunicant (USAN)をを組成式で記述するとC22H28N2O3です。", "task": "formula", "name_q": "Zolunicant (USAN)", "name_a": "C22H28N2O3"} +{"id": 3322, "instruction": "5-Chloro-2-hydroxy-p-benzoquinoneをを組成式で書くと?", "response": "5-Chloro-2-hydroxy-p-benzoquinoneをを組成式で書くとC6H3ClO3です。", "task": "formula", "name_q": "5-Chloro-2-hydroxy-p-benzoquinone", "name_a": "C6H3ClO3"} +{"id": 2347, "instruction": "APD-D-mannoseの異なる表現は?", "response": "APD-D-mannoseの異なる表現はADP-mannoseです。", "task": "replace", "name_q": "APD-D-mannose", "name_a": "ADP-mannose"} +{"id": 4176, "instruction": "プラジミシノンIをの分子式は?", "response": "プラジミシノンIをの分子式はC28H23NO11です。", "task": "formula", "name_q": "プラジミシノンI", "name_a": "C28H23NO11"} +{"id": 18394, "instruction": "リナマリンの別呼称は?", "response": "リナマリンの別呼称はLinamarinです。", "task": "replace", "name_q": "リナマリン", "name_a": "Linamarin"} +{"id": 20558, "instruction": "アミノ安息香酸カリウムの英訳は?", "response": "アミノ安息香酸カリウムの英訳はAminobenzoate potassium (USP)です。", "task": "replace ja to en", "name_q": "アミノ安息香酸カリウム", "name_a": "Aminobenzoate potassium (USP)"} +{"id": 23676, "instruction": "プロカインアミドをの組成式は?", "response": "プロカインアミドをの組成式はC13H21N3Oです。", "task": "formula", "name_q": "プロカインアミド", "name_a": "C13H21N3O"} +{"id": 32190, "instruction": "フェナジンメトサルフェートの異なる名称は?", "response": "フェナジンメトサルフェートの異なる名称はN-メチルフェナジニウムメトサルフェートです。", "task": "replace", "name_q": "フェナジンメトサルフェート", "name_a": "N-メチルフェナジニウムメトサルフェート"} +{"id": 2565, "instruction": "若年性ポリポーシス症候群を英語に訳すと?", "response": "若年性ポリポーシス症候群を英語に訳すとJuvenile polyposis syndromeです。", "task": "replace ja to en", "name_q": "若年性ポリポーシス症候群", "name_a": "Juvenile polyposis syndrome"} +{"id": 16781, "instruction": "Dichlormidをを化学式で書くと?", "response": "Dichlormidをを化学式で書くとC8H11Cl2NOです。", "task": "formula", "name_q": "Dichlormid", "name_a": "C8H11Cl2NO"} +{"id": 21195, "instruction": "Otocephalyの英訳は?", "response": "Otocephalyの英訳はAgnathia-otocephaly complexです。", "task": "replace ja to en", "name_q": "Otocephaly", "name_a": "Agnathia-otocephaly complex"} +{"id": 23185, "instruction": "Bluensomycinをは分子式で表すと?", "response": "Bluensomycinをは分子式で表すとC21H39N5O14です。", "task": "formula", "name_q": "Bluensomycin", "name_a": "C21H39N5O14"} +{"id": 24774, "instruction": "Oxidronic acid (USAN)の別呼称は?", "response": "Oxidronic acid (USAN)の別呼称はオキシドロン酸です。", "task": "replace", "name_q": "Oxidronic acid (USAN)", "name_a": "オキシドロン酸"} +{"id": 29826, "instruction": "塩酸モキシフロキサシンをを化学式で記述すると?", "response": "塩酸モキシフロキサシンをを化学式で記述するとC21H24FN3O4. HClです。", "task": "formula", "name_q": "塩酸モキシフロキサシン", "name_a": "C21H24FN3O4. HCl"} +{"id": 14230, "instruction": "alpha-Isomaltosyl-1,3-isomaltoseをの分子式は?", "response": "alpha-Isomaltosyl-1,3-isomaltoseをの分子式はC24H42O21です。", "task": "formula", "name_q": "alpha-Isomaltosyl-1,3-isomaltose", "name_a": "C24H42O21"} +{"id": 19495, "instruction": "Egualen sodium hydrate (JAN)をを組成式で表すと?", "response": "Egualen sodium hydrate (JAN)をを組成式で表すと(C15H17O3S. Na)3. H2Oです。", "task": "formula", "name_q": "Egualen sodium hydrate (JAN)", "name_a": "(C15H17O3S. Na)3. H2O"} +{"id": 17973, "instruction": "Apiforolをは組成式で表すと?", "response": "Apiforolをは組成式で表すとC15H14O5です。", "task": "formula", "name_q": "Apiforol", "name_a": "C15H14O5"} +{"id": 15725, "instruction": "8-Hydroxyadenineをは組成式で表すと?", "response": "8-Hydroxyadenineをは組成式で表すとC5H5N5Oです。", "task": "formula", "name_q": "8-Hydroxyadenine", "name_a": "C5H5N5O"} +{"id": 18979, "instruction": "1-Methyluric acidをは化学構造で表すと?", "response": "1-Methyluric acidをは化学構造で表すとC6H6N4O3です。", "task": "formula", "name_q": "1-Methyluric acid", "name_a": "C6H6N4O3"} +{"id": 30827, "instruction": "Bart-Pumphrey syndromeを日本語で記述すると?", "response": "Bart-Pumphrey syndromeを日本語で記述するとBart-Pumphrey 症候群です。", "task": "replace en to ja", "name_q": "Bart-Pumphrey syndrome", "name_a": "Bart-Pumphrey 症候群"} +{"id": 17781, "instruction": "Evogliptin (INN)を日本語で記述すると?", "response": "Evogliptin (INN)を日本語で記述するとエボグリプチンです。", "task": "replace en to ja", "name_q": "Evogliptin (INN)", "name_a": "エボグリプチン"} +{"id": 4170, "instruction": "ビマトプロストグレノドは別の呼び方では?", "response": "ビマトプロストグレノドは別の呼び方ではBimatoprost grenod (USAN)です。", "task": "replace", "name_q": "ビマトプロストグレノド", "name_a": "Bimatoprost grenod (USAN)"} +{"id": 17153, "instruction": "Triamcinolone hexacetonide (USP/INN)を英語で記述すると?", "response": "Triamcinolone hexacetonide (USP/INN)を英語で記述するとAristospan (TN)です。", "task": "replace ja to en", "name_q": "Triamcinolone hexacetonide (USP/INN)", "name_a": "Aristospan (TN)"} +{"id": 31459, "instruction": "Treosulfan (USAN/INN)の異なる表現は?", "response": "Treosulfan (USAN/INN)の異なる表現はOvastat (TN)です。", "task": "replace", "name_q": "Treosulfan (USAN/INN)", "name_a": "Ovastat (TN)"} +{"id": 13080, "instruction": "Dimethachlorをは組成式で表すと?", "response": "Dimethachlorをは組成式で表すとC13H18ClNO2です。", "task": "formula", "name_q": "Dimethachlor", "name_a": "C13H18ClNO2"} +{"id": 25246, "instruction": "Flurocitabine (USAN/INN)をは組成式で表すと?", "response": "Flurocitabine (USAN/INN)をは組成式で表すとC9H10FN3O4です。", "task": "formula", "name_q": "Flurocitabine (USAN/INN)", "name_a": "C9H10FN3O4"} +{"id": 2570, "instruction": "Ultra-long-chain di-unsaturated (3R)-3-hydroxyacyl-[acyl-carrier protein]の異なる表記は?", "response": "Ultra-long-chain di-unsaturated (3R)-3-hydroxyacyl-[acyl-carrier protein]の異なる表記はUltra-long-chain di-unsaturated (3R)-3-hydroxyacyl-[acp]です。", "task": "replace", "name_q": "Ultra-long-chain di-unsaturated (3R)-3-hydroxyacyl-[acyl-carrier protein]", "name_a": "Ultra-long-chain di-unsaturated (3R)-3-hydroxyacyl-[acp]"} +{"id": 27567, "instruction": "alpha-D-Galactosyl-N-acetyllactosamineをを組成式で記述すると?", "response": "alpha-D-Galactosyl-N-acetyllactosamineをを組成式で記述するとC20H35NO16です。", "task": "formula", "name_q": "alpha-D-Galactosyl-N-acetyllactosamine", "name_a": "C20H35NO16"} +{"id": 9932, "instruction": "3alpha-Hydroxy-2alpha-methyl-5alpha-androstan-17-oneの別の言い方は?", "response": "3alpha-Hydroxy-2alpha-methyl-5alpha-androstan-17-oneの別の言い方は2alpha-Methylandrosteroneです。", "task": "replace", "name_q": "3alpha-Hydroxy-2alpha-methyl-5alpha-androstan-17-one", "name_a": "2alpha-Methylandrosterone"} +{"id": 10930, "instruction": "硫酸スパルテイン (JAN)をは組成式で表すと?", "response": "硫酸スパルテイン (JAN)をは組成式で表すとC15H26N2. H2SO4. 5H2Oです。", "task": "formula", "name_q": "硫酸スパルテイン (JAN)", "name_a": "C15H26N2. H2SO4. 5H2O"} +{"id": 31455, "instruction": "シクロパミンをを化学式で記述すると?", "response": "シクロパミン���を化学式で記述するとC27H41NO2です。", "task": "formula", "name_q": "シクロパミン", "name_a": "C27H41NO2"} +{"id": 31343, "instruction": "Erythromycin Bの別呼称は?", "response": "Erythromycin Bの別呼称はBerythromycinです。", "task": "replace", "name_q": "Erythromycin B", "name_a": "Berythromycin"} +{"id": 4077, "instruction": "4,21-Dehydrogeissoschizineをの化学構造は?", "response": "4,21-Dehydrogeissoschizineをの化学構造はC21H23N2O3です。", "task": "formula", "name_q": "4,21-Dehydrogeissoschizine", "name_a": "C21H23N2O3"} +{"id": 28748, "instruction": "D-アピイトールの異なる表記は?", "response": "D-アピイトールの異なる表記はD-Apiitolです。", "task": "replace", "name_q": "D-アピイトール", "name_a": "D-Apiitol"} +{"id": 16072, "instruction": "杆体１色覚を英語で書くと?", "response": "杆体１色覚を英語で書くとAchromatopsiaです。", "task": "replace ja to en", "name_q": "杆体１色覚", "name_a": "Achromatopsia"} +{"id": 14297, "instruction": "Disperse Blue 1の別表現は?", "response": "Disperse Blue 1の別表現はジスパースブルー1です。", "task": "replace", "name_q": "Disperse Blue 1", "name_a": "ジスパースブルー1"} +{"id": 3331, "instruction": "Palivizumab (genetical recombination) (JAN)を利用した製品名は?", "response": "Palivizumab (genetical recombination) (JAN)を利用した製品名はシナジス(アストラゼネカ)です。", "task": "product", "name_q": "Palivizumab (genetical recombination) (JAN)", "name_a": "シナジス(アストラゼネカ)"} +{"id": 9871, "instruction": "Oxedrine hydrochlorideの別記述は?", "response": "Oxedrine hydrochlorideの別記述はOcuton (TN)です。", "task": "replace", "name_q": "Oxedrine hydrochloride", "name_a": "Ocuton (TN)"} +{"id": 23284, "instruction": "N-Methyl-N'-phenylurea compoundをの分子式は?", "response": "N-Methyl-N'-phenylurea compoundをの分子式はC8H8N2OR2です。", "task": "formula", "name_q": "N-Methyl-N'-phenylurea compound", "name_a": "C8H8N2OR2"} +{"id": 4245, "instruction": "Oremepermin alfa (genetical recombination) (JAN)をは分子式で表すと?", "response": "Oremepermin alfa (genetical recombination) (JAN)をは分子式で表すとC3460H5320N996O1029S56です。", "task": "formula", "name_q": "Oremepermin alfa (genetical recombination) (JAN)", "name_a": "C3460H5320N996O1029S56"} +{"id": 8258, "instruction": "Propentofylline (JAN/INN)の日本語表記は?", "response": "Propentofylline (JAN/INN)の日本語表記はプロペントフィリン (JAN)です。", "task": "replace en to ja", "name_q": "Propentofylline (JAN/INN)", "name_a": "プロペントフィリン (JAN)"} +{"id": 30389, "instruction": "Ethyl (S)-3-hydroxyhexanoateをは化学式で表すと?", "response": "Ethyl (S)-3-hydroxyhexanoateをは化学式で表すとC8H16O3です。", "task": "formula", "name_q": "Ethyl (S)-3-hydroxyhexanoate", "name_a": "C8H16O3"} +{"id": 16098, "instruction": "Moutan bark (JP18)を主材料とする商品名は?", "response": "Moutan bark (JP18)を主材料とする商品名はボタンピ(東洋漢方製薬)です。", "task": "product", "name_q": "Moutan bark (JP18)", "name_a": "ボタンピ(東洋漢方製薬)"} +{"id": 1448, "instruction": "クピエニン1aの異なる名称は?", "response": "クピエニン1aの異なる名称はCupiennin 1aです。", "task": "replace", "name_q": "クピエニン1a", "name_a": "Cupiennin 1a"} +{"id": 3910, "instruction": "Aptazapine maleate (USAN)を日本語で記述すると?", "response": "Aptazapine maleate (USAN)を日本語で記述するとマレイン酸アプタザピンです。", "task": "replace en to ja", "name_q": "Aptazapine maleate (USAN)", "name_a": "マレイン酸アプタザピン"} +{"id": 32338, "instruction": "Ankorineをを分子式で書くと?", "response": "Ankorineをを分子式で書くとC19H29NO4です。", "task": "formula", "name_q": "Ankorine", "name_a": "C19H29NO4"} +{"id": 23681, "instruction": "遺伝性周期性四肢麻痺 下位グループ 高カリウム血性周期性四肢麻痺 低カリウム血性周期性四肢麻痺 Andersen-Tawil 症候群 の英訳は?", "response": "遺伝性周期性四肢麻痺 下位グループ 高カリウム血性周期性四肢麻痺 低カリウム血性周期性四肢麻痺 Andersen-Tawil 症候群 の英訳はPeriodic paralysis SUBGROUP Hyperkalemic periodic paralysis (HyperPP) Hypokalemic periodic paralysis (HypoPP) Andersen-Tawil syndrome (ATS) です。", "task": "replace ja to en", "name_q": "遺伝性周期性四肢麻痺 下位グループ 高カリウム血性周期性四肢麻痺 低カリウム血性周期性四肢麻痺 Andersen-Tawil 症候群 ", "name_a": "Periodic paralysis SUBGROUP Hyperkalemic periodic paralysis (HyperPP) Hypokalemic periodic paralysis (HypoPP) Andersen-Tawil syndrome (ATS) "} +{"id": 21797, "instruction": "ナラトリプタンの異なる表記は?", "response": "ナラトリプタンの異なる表記はNaratriptan (INN)です。", "task": "replace", "name_q": "ナラトリプタン", "name_a": "Naratriptan (INN)"} +{"id": 30061, "instruction": "Anisotineをを化学構造で記述すると?", "response": "Anisotineをを化学構造で記述するとC20H19N3O3です。", "task": "formula", "name_q": "Anisotine", "name_a": "C20H19N3O3"} +{"id": 3801, "instruction": "カリソプロドール・アスピリン・コデインリン酸塩の別記述は?", "response": "カリソプロドール・アスピリン・コデインリン酸塩の別記述はCarisoprodol, aspirin and codeine phosphateです。", "task": "replace", "name_q": "カリソプロドール・アスピリン・コデインリン酸塩", "name_a": "Carisoprodol, aspirin and codeine phosphate"} +{"id": 7622, "instruction": "Dexketoprofen (INN)の異なる名称は?", "response": "Dexketoprofen (INN)の異なる名称はデクスケトプロフェンです。", "task": "replace", "name_q": "Dexketoprofen (INN)", "name_a": "デクスケトプロフェン"} +{"id": 4243, "instruction": "Craniofacial microsomia SUBGROUP Hemifacial microsomia Goldenhar syndrome Oculo-auricular-vertebral spectrumの日本語表記は?", "response": "Craniofacial microsomia SUBGROUP Hemifacial microsomia Goldenhar syndrome Oculo-auricular-vertebral spectrumの日本語表記は頭蓋顔面低形成 下位グループ 顔面片側低形成 Goldenhar 症候群 眼・耳・脊椎スペクトラムです。", "task": "replace en to ja", "name_q": "Craniofacial microsomia SUBGROUP Hemifacial microsomia Goldenhar syndrome Oculo-auricular-vertebral spectrum", "name_a": "頭蓋顔面低形成 下位グループ 顔面片側低形成 Goldenhar 症候群 眼・耳・脊椎スペクトラム"} +{"id": 25379, "instruction": "RAMELTEON(GoldenStateMedicalSupply)を主とした薬品は?", "response": "RAMELTEON(GoldenStateMedicalSupply)を主とした薬品はラメルテオン(日本ジェネリック)です。", "task": "product", "name_q": "RAMELTEON(GoldenStateMedicalSupply)", "name_a": "ラメルテオン(日本ジェネリック)"} +{"id": 11470, "instruction": "ハマボウフウ(ヤマダ薬研)を主とした医薬品は?", "response": "ハマボウフウ(ヤマダ薬研)を主とした医薬品は浜防風(小島漢方)です。", "task": "product", "name_q": "ハマボウフウ(ヤマダ薬研)", "name_a": "浜防風(小島漢方)"} +{"id": 22328, "instruction": "Anagyrineをを化学式で書くと?", "response": "Anagyrineをを化学式で書くとC15H20N2Oです。", "task": "formula", "name_q": "Anagyrine", "name_a": "C15H20N2O"} +{"id": 17022, "instruction": "trans-beta-D-Glucosyl-2-hydroxycinnamateをを化学式で書くと?", "response": "trans-beta-D-Glucosyl-2-hydroxycinnamateをを化学式で書くとC15H18O8です。", "task": "formula", "name_q": "trans-beta-D-Glucosyl-2-hydroxycinnamate", "name_a": "C15H18O8"} +{"id": 9412, "instruction": "Streptase (TN)の日本語表記は?", "response": "Streptase (TN)の日本語表記はStreptokinase (INN)です。", "task": "replace en to ja", "name_q": "Streptase (TN)", "name_a": "Streptokinase (INN)"} +{"id": 1376, "instruction": "Roluperidone hydrochloride dihydrateは別の呼び方では?", "response": "Roluperidone hydrochloride dihydrateは別の呼び方ではRoluperidone hydrochloride (USAN)です。", "task": "replace", "name_q": "Roluperidone hydrochloride dihydrate", "name_a": "Roluperidone hydrochloride (USAN)"} +{"id": 19245, "instruction": "(gamma-Glutamylcysteine)n-glycineの別名称は?", "response": "(gamma-Glutamylcysteine)n-glycineの別名称は[Glu(-Cys)]n-Glyです。", "task": "replace", "name_q": "(gamma-Glutamylcysteine)n-glycine", "name_a": "[Glu(-Cys)]n-Gly"} +{"id": 15314, "instruction": "Kaempferitrinの異なる表現は?", "response": "Kaempferitrinの異なる表現はLespenefrilです。", "task": "replace", "name_q": "Kaempferitrin", "name_a": "Lespenefril"} +{"id": 14546, "instruction": "アミノバクト(日医工)を用いた製品は?", "response": "アミノバクト(日医工)を用いた製品はリックル(沢井製薬)です。", "task": "product", "name_q": "アミノバクト(日医工)", "name_a": "リックル(沢井製薬)"} +{"id": 18602, "instruction": "バルフロジニウムを言い換えると?", "response": "バルフロジニウムを言い換えるとBalfourodiniumです。", "task": "replace", "name_q": "バルフロジニウム", "name_a": "Balfourodinium"} +{"id": 33764, "instruction": "ペグロチカーゼをを化学式で書くと?", "response": "ペグロチカーゼをを化学式で書くとC1549H2430N408O448S8です。", "task": "formula", "name_q": "ペグロチカーゼ", "name_a": "C1549H2430N408O448S8"} +{"id": 20242, "instruction": "Deep vein thrombosisを日本語で書くと?", "response": "Deep vein thrombosisを日本語で書くと深部静脈血栓症です。", "task": "replace en to ja", "name_q": "Deep vein thrombosis", "name_a": "深部静脈血栓症"} +{"id": 28120, "instruction": "Lidaprim (TN)を日本語で書くと?", "response": "Lidaprim (TN)を日本���で書くとSulfametrole (INN)です。", "task": "replace en to ja", "name_q": "Lidaprim (TN)", "name_a": "Sulfametrole (INN)"} +{"id": 3044, "instruction": "Zinc sulfate, iodine, sodium iodine and glycerinを材料とする医薬品名は?", "response": "Zinc sulfate, iodine, sodium iodine and glycerinを材料とする医薬品名はネオグリセロール(ネオ製薬工業)です。", "task": "product", "name_q": "Zinc sulfate, iodine, sodium iodine and glycerin", "name_a": "ネオグリセロール(ネオ製薬工業)"} +{"id": 9461, "instruction": "リコリコンをを分子式で表すと?", "response": "リコリコンをを分子式で表すとC22H22O6です。", "task": "formula", "name_q": "リコリコン", "name_a": "C22H22O6"} +{"id": 29050, "instruction": "2-Amino-5-chloromuconate 6-semialdehydeをを化学構造で表すと?", "response": "2-Amino-5-chloromuconate 6-semialdehydeをを化学構造で表すとC6H6ClNO3です。", "task": "formula", "name_q": "2-Amino-5-chloromuconate 6-semialdehyde", "name_a": "C6H6ClNO3"} +{"id": 7536, "instruction": "L-Tryptophanyl-tRNA(Trp)をは分子式で表すと?", "response": "L-Tryptophanyl-tRNA(Trp)をは分子式で表すとC26H31N7O11PR(C5H8O6PR)nです。", "task": "formula", "name_q": "L-Tryptophanyl-tRNA(Trp)", "name_a": "C26H31N7O11PR(C5H8O6PR)n"} +{"id": 23714, "instruction": "プルカロプリドコハク酸塩をの組成式は?", "response": "プルカロプリドコハク酸塩をの組成式はC18H26ClN3O3. C4H6O4です。", "task": "formula", "name_q": "プルカロプリドコハク酸塩", "name_a": "C18H26ClN3O3. C4H6O4"} +{"id": 16044, "instruction": "Capnocytophaga ochracea infectionを日本語で記述すると?", "response": "Capnocytophaga ochracea infectionを日本語で記述するとCapnocytophaga ochracea 感染です。", "task": "replace en to ja", "name_q": "Capnocytophaga ochracea infection", "name_a": "Capnocytophaga ochracea 感染"} +{"id": 15967, "instruction": "Telisotuzumab vedotin (USAN)を日本語で書くと?", "response": "Telisotuzumab vedotin (USAN)を日本語で書くとTelisotuzumab vedotin (genetical recombination) (JAN)です。", "task": "replace en to ja", "name_q": "Telisotuzumab vedotin (USAN)", "name_a": "Telisotuzumab vedotin (genetical recombination) (JAN)"} +{"id": 28182, "instruction": "UDP-3-keto-GlcNAcAの異なる名称は?", "response": "UDP-3-keto-GlcNAcAの異なる名称はUDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronateです。", "task": "replace", "name_q": "UDP-3-keto-GlcNAcA", "name_a": "UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate"} +{"id": 22702, "instruction": "Lattice corneal dystrophies SUBGROUP Amyloidosis, Finnish type の日本語訳は?", "response": "Lattice corneal dystrophies SUBGROUP Amyloidosis, Finnish type の日本語訳は格子状角膜ジストロフィー 下位グループ アミロイド症フィンランド型 です。", "task": "replace en to ja", "name_q": "Lattice corneal dystrophies SUBGROUP Amyloidosis, Finnish type ", "name_a": "格子状角膜ジストロフィー 下位グループ アミロイド症フィンランド型 "} +{"id": 21612, "instruction": "成人T細胞性白血病の英語表記は?", "response": "成人T細胞性白血病の英語表記はAdult T-cell leukemiaです。", "task": "replace ja to en", "name_q": "成人T細胞性白血病", "name_a": "Adult T-cell leukemia"} +{"id": 10356, "instruction": "L-Iduronate 2-sulfateをは化学構造で表すと?", "response": "L-Iduronate 2-sulfateをは化学構造で表すとC6H10O10Sです。", "task": "formula", "name_q": "L-Iduronate 2-sulfate", "name_a": "C6H10O10S"} +{"id": 30040, "instruction": "側頭動脈炎 上位グループ 大型血管炎 の英語表記は?", "response": "側頭動脈炎 上位グループ 大型血管炎 の英語表記はTemporal arteritis SUPERGRP Large-vessel vasculitis です。", "task": "replace ja to en", "name_q": "側頭動脈炎 上位グループ 大型血管炎 ", "name_a": "Temporal arteritis SUPERGRP Large-vessel vasculitis "} +{"id": 25667, "instruction": "Tetrachlorohydroquinoneの別の言い方は?", "response": "Tetrachlorohydroquinoneの別の言い方は2,3,5,6-Tetrachlorohydroquinoneです。", "task": "replace", "name_q": "Tetrachlorohydroquinone", "name_a": "2,3,5,6-Tetrachlorohydroquinone"} +{"id": 19539, "instruction": "LOTEPREDNOLETABONATE(Bausch&LombAmericas)を用いた薬品名は?", "response": "LOTEPREDNOLETABONATE(Bausch&LombAmericas)を用いた薬品名はLOTEPREDNOLETABONATE(ARMASPHARMACEUTICALS)です。", "task": "product", "name_q": "LOTEPREDNOLETABONATE(Bausch&LombAmericas)", "name_a": "LOTEPREDNOLETABONATE(ARMASPHARMACEUTICALS)"} +{"id": 6754, "instruction": "ラセカドトリルの別の呼び方は?", "response": "ラセカドトリルの別の呼び方はRacecadotril (INN)です。", "task": "replace", "name_q": "ラセカドトリル", "name_a": "Racecadotril (INN)"} +{"id": 8023, "instruction": "酢酸アマジノンの異なる表記は?", "response": "酢酸アマジノンの異なる表��はAmadinone acetate (USAN)です。", "task": "replace", "name_q": "酢酸アマジノン", "name_a": "Amadinone acetate (USAN)"} +{"id": 5541, "instruction": "クロロピラミンをを化学構造で表すと?", "response": "クロロピラミンをを化学構造で表すとC16H20ClN3です。", "task": "formula", "name_q": "クロロピラミン", "name_a": "C16H20ClN3"} +{"id": 6367, "instruction": "3-Nitroacrylateをは分子式で表すと?", "response": "3-Nitroacrylateをは分子式で表すとC3H3NO4です。", "task": "formula", "name_q": "3-Nitroacrylate", "name_a": "C3H3NO4"} +{"id": 18516, "instruction": "7,9,12-Octaketide intermediate 1をの化学構造は?", "response": "7,9,12-Octaketide intermediate 1をの化学構造はC16H17O8SRです。", "task": "formula", "name_q": "7,9,12-Octaketide intermediate 1", "name_a": "C16H17O8SR"} +{"id": 25682, "instruction": "(Glycerophosphate)nをは化学構造で表すと?", "response": "(Glycerophosphate)nをは化学構造で表すとC3H9O6P(C3H7O5P)nです。", "task": "formula", "name_q": "(Glycerophosphate)n", "name_a": "C3H9O6P(C3H7O5P)n"} +{"id": 30253, "instruction": "Amikacin (USP/INN)の別呼称は?", "response": "Amikacin (USP/INN)の別呼称はアミカシンです。", "task": "replace", "name_q": "Amikacin (USP/INN)", "name_a": "アミカシン"} +{"id": 9808, "instruction": "二酸化塩素の別の呼び方は?", "response": "二酸化塩素の別の呼び方はChlorine dioxideです。", "task": "replace", "name_q": "二酸化塩素", "name_a": "Chlorine dioxide"} +{"id": 11712, "instruction": "扁平苔癬の英訳は?", "response": "扁平苔癬の英訳はLichen planusです。", "task": "replace ja to en", "name_q": "扁平苔癬", "name_a": "Lichen planus"} +{"id": 9007, "instruction": "カハラリド Fをを化学式で書くと?", "response": "カハラリド Fをを化学式で書くとC75H124N14O16です。", "task": "formula", "name_q": "カハラリド F", "name_a": "C75H124N14O16"} +{"id": 4366, "instruction": "2',3',4',5'-Tetrachloro-3-hydroxybiphenylをを分子式で書くと?", "response": "2',3',4',5'-Tetrachloro-3-hydroxybiphenylをを分子式で書くとC12H6Cl4Oです。", "task": "formula", "name_q": "2',3',4',5'-Tetrachloro-3-hydroxybiphenyl", "name_a": "C12H6Cl4O"} +{"id": 4834, "instruction": "Vericiguat (JAN/USAN/INN)の別名称は?", "response": "Vericiguat (JAN/USAN/INN)の別名称はVerquvo (TN)です。", "task": "replace", "name_q": "Vericiguat (JAN/USAN/INN)", "name_a": "Verquvo (TN)"} +{"id": 15745, "instruction": "2,5-Furandicarboxaldehydeをを組成式で記述すると?", "response": "2,5-Furandicarboxaldehydeをを組成式で記述するとC6H4O3です。", "task": "formula", "name_q": "2,5-Furandicarboxaldehyde", "name_a": "C6H4O3"} +{"id": 16375, "instruction": "DIGOXIN(AmericanHealthPackaging)を利用した商品は?", "response": "DIGOXIN(AmericanHealthPackaging)を利用した商品はDIGOXIN(MarlexPharmaceuticals)です。", "task": "product", "name_q": "DIGOXIN(AmericanHealthPackaging)", "name_a": "DIGOXIN(MarlexPharmaceuticals)"} +{"id": 32902, "instruction": "(S)-3-Hydroxy-3-methylglutaryl-CoAの別名は?", "response": "(S)-3-Hydroxy-3-methylglutaryl-CoAの別名は3-Hydroxy-3-methylglutaryl-CoAです。", "task": "replace", "name_q": "(S)-3-Hydroxy-3-methylglutaryl-CoA", "name_a": "3-Hydroxy-3-methylglutaryl-CoA"} +{"id": 16081, "instruction": "Polycythemia veraを日本語で書くと?", "response": "Polycythemia veraを日本語で書くと真性赤血球増加症です。", "task": "replace en to ja", "name_q": "Polycythemia vera", "name_a": "真性赤血球増加症"} +{"id": 7150, "instruction": "ギメラシル (JAN)をを組成式で書くと?", "response": "ギメラシル (JAN)をを組成式で書くとC5H4ClNO2です。", "task": "formula", "name_q": "ギメラシル (JAN)", "name_a": "C5H4ClNO2"} +{"id": 15577, "instruction": "ジベカシン硫酸塩 (JP18)をを組成式で書くと?", "response": "ジベカシン硫酸塩 (JP18)をを組成式で書くとC18H37N5O8. xH2SO4です。", "task": "formula", "name_q": "ジベカシン硫酸塩 (JP18)", "name_a": "C18H37N5O8. xH2SO4"} +{"id": 4712, "instruction": "bì bōの別名は?", "response": "bì bōの別名はIndian long pepper fruitです。", "task": "replace", "name_q": "bì bō", "name_a": "Indian long pepper fruit"} +{"id": 12124, "instruction": "Nibrozetone (USAN)をを分子式で書くと?", "response": "Nibrozetone (USAN)をを分子式で書くとC5H6BrN3O5です。", "task": "formula", "name_q": "Nibrozetone (USAN)", "name_a": "C5H6BrN3O5"} +{"id": 32681, "instruction": "2alpha-(Hydroxymethyl)-17-methyl-5alpha-androstane-3beta,17beta-diolをを化学式で書くと?", "response": "2alpha-(Hydroxymethyl)-17-methyl-5alpha-androstane-3beta,17beta-diolをを化学式で書くとC21H36O3です。", "task": "formula", "name_q": "2alpha-(Hydroxymethyl)-17-methyl-5alpha-androstane-3beta,17beta-diol", "name_a": "C21H36O3"} +{"id": 10777, "instruction": "Extraskeletal myxoid chondrosarcoma SUPERGRP Solid tumor Soft tissue sarcomas の日本語表記は?", "response": "Extraskeletal myxoid chondrosarcoma SUPERGRP Solid tumor Soft tissue sarcomas の日本語表記は粘液様軟骨肉腫 上位グループ 固形腫瘍 軟部肉腫 です。", "task": "replace en to ja", "name_q": "Extraskeletal myxoid chondrosarcoma SUPERGRP Solid tumor Soft tissue sarcomas ", "name_a": "粘液様軟骨肉腫 上位グループ 固形腫瘍 軟部肉腫 "} +{"id": 32725, "instruction": "Amprolium hydrochlorideの別名称は?", "response": "Amprolium hydrochlorideの別名称はAmprolium (TN)です。", "task": "replace", "name_q": "Amprolium hydrochloride", "name_a": "Amprolium (TN)"} +{"id": 19065, "instruction": "Mycolactone Cをを化学構造で書くと?", "response": "Mycolactone Cをを化学構造で書くとC44H70O8です。", "task": "formula", "name_q": "Mycolactone C", "name_a": "C44H70O8"} +{"id": 4603, "instruction": "Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 上位グループ 骨形成不全症 エーラス・ダンロス症候群 を英語に訳すと?", "response": "Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 上位グループ 骨形成不全症 エーラス・ダンロス症候群 を英語に訳すとCombined osteogenesis imperfecta and Ehlers-Danlos syndrome SUPERGRP Osteogenesis imperfecta Ehlers-Danlos syndrome です。", "task": "replace ja to en", "name_q": "Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 上位グループ 骨形成不全症 エーラス・ダンロス症候群 ", "name_a": "Combined osteogenesis imperfecta and Ehlers-Danlos syndrome SUPERGRP Osteogenesis imperfecta Ehlers-Danlos syndrome "} +{"id": 33721, "instruction": "A180 (TN)は別の呼び方では?", "response": "A180 (TN)は別の呼び方ではDanofloxacin (INN)です。", "task": "replace", "name_q": "A180 (TN)", "name_a": "Danofloxacin (INN)"} +{"id": 34216, "instruction": "Subacute thyroiditisの別の呼び方は?", "response": "Subacute thyroiditisの別の呼び方はDe Quervain thyroiditisです。", "task": "replace", "name_q": "Subacute thyroiditis", "name_a": "De Quervain thyroiditis"} +{"id": 17790, "instruction": "Atorvastatin calcium anhydorousをの化学式は?", "response": "Atorvastatin calcium anhydorousをの化学式は(C33H34FN2O5)2. Caです。", "task": "formula", "name_q": "Atorvastatin calcium anhydorous", "name_a": "(C33H34FN2O5)2. Ca"} +{"id": 22427, "instruction": "10-epi-Cubebolをを化学式で記述すると?", "response": "10-epi-Cubebolをを化学式で記述するとC15H26Oです。", "task": "formula", "name_q": "10-epi-Cubebol", "name_a": "C15H26O"} +{"id": 33110, "instruction": "Cartazolate (USAN/INN)をを分子式で書くと?", "response": "Cartazolate (USAN/INN)をを分子式で書くとC15H22N4O2です。", "task": "formula", "name_q": "Cartazolate (USAN/INN)", "name_a": "C15H22N4O2"} +{"id": 29760, "instruction": "Androsta-5,16-dieno[17,16-b]quinolin-3beta-olをを分子式で記述すると?", "response": "Androsta-5,16-dieno[17,16-b]quinolin-3beta-olをを分子式で記述するとC26H31NOです。", "task": "formula", "name_q": "Androsta-5,16-dieno[17,16-b]quinolin-3beta-ol", "name_a": "C26H31NO"} +{"id": 27620, "instruction": "8-Br-cGMPの異なる表現は?", "response": "8-Br-cGMPの異なる表現は8-Bromocyclic GMPです。", "task": "replace", "name_q": "8-Br-cGMP", "name_a": "8-Bromocyclic GMP"} +{"id": 2397, "instruction": "1,3-Dichloro-2-propanolをの化学構造は?", "response": "1,3-Dichloro-2-propanolをの化学構造はC3H6Cl2Oです。", "task": "formula", "name_q": "1,3-Dichloro-2-propanol", "name_a": "C3H6Cl2O"} +{"id": 21115, "instruction": "1,2,3,4,5,6-Hexachlorocyclohexaneは別の呼び方では?", "response": "1,2,3,4,5,6-Hexachlorocyclohexaneは別の呼び方ではBHCです。", "task": "replace", "name_q": "1,2,3,4,5,6-Hexachlorocyclohexane", "name_a": "BHC"} +{"id": 16912, "instruction": "フェナセミドをを化学式で記述すると?", "response": "フェナセミドをを化学式で記述するとC9H10N2O2です。", "task": "formula", "name_q": "フェナセミド", "name_a": "C9H10N2O2"} +{"id": 423, "instruction": "O-Phosphoseryl-tRNA(Sec)をは化学式で表すと?", "response": "O-Phosphoseryl-tRNA(Sec)をは化学式で表すとC13H23NO15P2R2(C5H8O6PR)nです。", "task": "formula", "name_q": "O-Phosphoseryl-tRNA(Sec)", "name_a": "C13H23NO15P2R2(C5H8O6PR)n"} +{"id": 28410, "instruction": "Calpurnineをを分子式で記述すると?", "response": "Calpurnineをを分子式で記述するとC20H27N3O3です。", "task": "formula", "name_q": "Calpurnine", "name_a": "C20H27N3O3"} +{"id": 25742, "instruction": "Leucomycin A8の異なる表記は?", "response": "Leucomycin A8の異なる表記はロイコマイシンA8です。", "task": "replace", "name_q": "Leucomycin A8", "name_a": "ロイコマイシンA8"} +{"id": 31532, "instruction": "アンギオテンシン(1-5)の別名称は?", "response": "アンギオテンシン(1-5)の別名称はAngiotensin (1-5)です。", "task": "replace", "name_q": "アンギオテンシン(1-5)", "name_a": "Angiotensin (1-5)"} +{"id": 26356, "instruction": "Tick-borne lymphadenopathyの別名称は?", "response": "Tick-borne lymphadenopathyの別名称はTick-borne lymphadenitisです。", "task": "replace", "name_q": "Tick-borne lymphadenopathy", "name_a": "Tick-borne lymphadenitis"} +{"id": 12607, "instruction": "Crystodigin (TN)の日本語表記は?", "response": "Crystodigin (TN)の日本語表記はDigitoxin (JAN/USP/INN)です。", "task": "replace en to ja", "name_q": "Crystodigin (TN)", "name_a": "Digitoxin (JAN/USP/INN)"} +{"id": 18999, "instruction": "モテキサフィンルテチウムの別名は?", "response": "モテキサフィンルテチウムの別名はMotexafin lutetium (USAN)です。", "task": "replace", "name_q": "モテキサフィンルテチウム", "name_a": "Motexafin lutetium (USAN)"} +{"id": 30873, "instruction": "Sul-Spansion (TN)の異なる表記は?", "response": "Sul-Spansion (TN)の異なる表記はSulfaethidole (INN)です。", "task": "replace", "name_q": "Sul-Spansion (TN)", "name_a": "Sulfaethidole (INN)"} +{"id": 26303, "instruction": "ピノキセピン塩酸塩をの化学式は?", "response": "ピノキセピン塩酸塩をの化学式はC23H27ClN2O2. 2HClです。", "task": "formula", "name_q": "ピノキセピン塩酸塩", "name_a": "C23H27ClN2O2. 2HCl"} +{"id": 9078, "instruction": "カンチウミンをは化学式で表すと?", "response": "カンチウミンをは化学式で表すとC33H36N4O4です。", "task": "formula", "name_q": "カンチウミン", "name_a": "C33H36N4O4"} +{"id": 28139, "instruction": "Dichlorotetrafluoroethane (NF)の別表現は?", "response": "Dichlorotetrafluoroethane (NF)の別表現はクリオフルオランです。", "task": "replace", "name_q": "Dichlorotetrafluoroethane (NF)", "name_a": "クリオフルオラン"} +{"id": 29648, "instruction": "[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-A2pm-D-Ala-D-Ala)]n-diphosphoundecaprenolの別名称は?", "response": "[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-A2pm-D-Ala-D-Ala)]n-diphosphoundecaprenolの別名称は[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-A2pm-D-Ala-D-Ala)]n+1-diphosphoundecaprenolです。", "task": "replace", "name_q": "[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-A2pm-D-Ala-D-Ala)]n-diphosphoundecaprenol", "name_a": "[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-A2pm-D-Ala-D-Ala)]n+1-diphosphoundecaprenol"} +{"id": 3220, "instruction": "Albendazole-gamma-hydroxysulphoneをは組成式で表すと?", "response": "Albendazole-gamma-hydroxysulphoneをは組成式で表すとC12H15N3O5Sです。", "task": "formula", "name_q": "Albendazole-gamma-hydroxysulphone", "name_a": "C12H15N3O5S"} +{"id": 25099, "instruction": "dTDP-6-deoxy-alpha-D-alloseの別記述は?", "response": "dTDP-6-deoxy-alpha-D-alloseの別記述はdTDP-6-deoxy-D-alloseです。", "task": "replace", "name_q": "dTDP-6-deoxy-alpha-D-allose", "name_a": "dTDP-6-deoxy-D-allose"} +{"id": 18251, "instruction": "13-Deoxycarminomycinをを組成式で表すと?", "response": "13-Deoxycarminomycinをを組成式で表すとC26H29NO9です。", "task": "formula", "name_q": "13-Deoxycarminomycin", "name_a": "C26H29NO9"} +{"id": 24418, "instruction": "9,10-Dihydroxy-12,13-epoxyoctadecanoateをを組成式で書くと?", "response": "9,10-Dihydroxy-12,13-epoxyoctadecanoateをを組成式で書くとC18H34O5です。", "task": "formula", "name_q": "9,10-Dihydroxy-12,13-epoxyoctadecanoate", "name_a": "C18H34O5"} +{"id": 25465, "instruction": "2-Deoxy-D-gluconateをを化学式で表すと?", "response": "2-Deoxy-D-gluconateをを化学式で表すとC6H12O6です。", "task": "formula", "name_q": "2-Deoxy-D-gluconate", "name_a": "C6H12O6"} +{"id": 6829, "instruction": "Thio-molybdenum cofactorをを組成式で表すと?", "response": "Thio-molybdenum cofactorをを組成式で表すとC10H12MoN5O7PS3です。", "task": "formula", "name_q": "Thio-molybdenum cofactor", "name_a": "C10H12MoN5O7PS3"} +{"id": 19926, "instruction": "2-Methylchryseneをを組成式で書くと?", "response": "2-Methylchryseneをを組成式で書くとC19H14です。", "task": "formula", "name_q": "2-Methylchrysene", "name_a": "C19H14"} +{"id": 25106, "instruction": "大承気湯を主とした商品は?", "response": "大承気湯を主とした商品は大承気湯(ツムラ)です。", "task": "product", "name_q": "大承気湯", "name_a": "大承気湯(ツムラ)"} +{"id": 34081, "instruction": "Casopitant mesylate (USAN)をの分子式は?", "response": "Casopitant mesylate (USAN)をの分子式はC30H35F7N4O2. CH4SO3です。", "task": "formula", "name_q": "Casopitant mesylate (USAN)", "name_a": "C30H35F7N4O2. CH4SO3"} +{"id": 2682, "instruction": "Etiguanfacine (USAN/INN)をを化学式で表すと?", "response": "Etiguanfacine (USAN/INN)をを化学式で表すとC12H13Cl2N3O3です。", "task": "formula", "name_q": "Etiguanfacine (USAN/INN)", "name_a": "C12H13Cl2N3O3"} +{"id": 9495, "instruction": "2-Methylideneglutaric acidをを化学構造で書くと?", "response": "2-Methylideneglutaric acidをを化学構��で書くとC6H8O4です。", "task": "formula", "name_q": "2-Methylideneglutaric acid", "name_a": "C6H8O4"} +{"id": 17630, "instruction": "イソブタンベンをを組成式で表すと?", "response": "イソブタンベンをを組成式で表すとC11H15NO2です。", "task": "formula", "name_q": "イソブタンベン", "name_a": "C11H15NO2"} +{"id": 16229, "instruction": "ACGP-3は別の呼び方では?", "response": "ACGP-3は別の呼び方では4''-O-Carbamoyl ansamitocinoside P-3です。", "task": "replace", "name_q": "ACGP-3", "name_a": "4''-O-Carbamoyl ansamitocinoside P-3"} +{"id": 6213, "instruction": "Darzalex faspro (TN)の別の呼び方は?", "response": "Darzalex faspro (TN)の別の呼び方はDaratumumab and hyaluronidaseです。", "task": "replace", "name_q": "Darzalex faspro (TN)", "name_a": "Daratumumab and hyaluronidase"} +{"id": 23789, "instruction": "11beta,17beta-Dihydroxyandrost-4-en-3-one 17-propionateをの化学構造は?", "response": "11beta,17beta-Dihydroxyandrost-4-en-3-one 17-propionateをの化学構造はC22H32O4です。", "task": "formula", "name_q": "11beta,17beta-Dihydroxyandrost-4-en-3-one 17-propionate", "name_a": "C22H32O4"} +{"id": 25914, "instruction": "Nicotinamide adenine dinucleotideを日本語で書くと?", "response": "Nicotinamide adenine dinucleotideを日本語で書くとNadide (JAN/USAN/INN)です。", "task": "replace en to ja", "name_q": "Nicotinamide adenine dinucleotide", "name_a": "Nadide (JAN/USAN/INN)"} +{"id": 30837, "instruction": "cis-p-Coumarateをの分子式は?", "response": "cis-p-Coumarateをの分子式はC9H8O3です。", "task": "formula", "name_q": "cis-p-Coumarate", "name_a": "C9H8O3"} +{"id": 14134, "instruction": "Basal cell carcinomaを日本語で記述すると?", "response": "Basal cell carcinomaを日本語で記述すると基底細胞癌です。", "task": "replace en to ja", "name_q": "Basal cell carcinoma", "name_a": "基底細胞癌"} +{"id": 21235, "instruction": "DTIC-Dome (TN)は別の呼び方では?", "response": "DTIC-Dome (TN)は別の呼び方ではDacarbazine (JAN/USP/INN)です。", "task": "replace", "name_q": "DTIC-Dome (TN)", "name_a": "Dacarbazine (JAN/USP/INN)"} +{"id": 16050, "instruction": "Plamotamab (USAN/INN)をを化学構造で書くと?", "response": "Plamotamab (USAN/INN)をを化学構造で書くとC5571H8576N1490O1722S37です。", "task": "formula", "name_q": "Plamotamab (USAN/INN)", "name_a": "C5571H8576N1490O1722S37"} +{"id": 11901, "instruction": "Muromonab-CD3 (JAN/USAN/INN)の別名称は?", "response": "Muromonab-CD3 (JAN/USAN/INN)の別名称はムロモナブ-CD3 (JAN)です。", "task": "replace", "name_q": "Muromonab-CD3 (JAN/USAN/INN)", "name_a": "ムロモナブ-CD3 (JAN)"} +{"id": 9960, "instruction": "ホキシムの別名称は?", "response": "ホキシムの別名称はPhoximです。", "task": "replace", "name_q": "ホキシム", "name_a": "Phoxim"} +{"id": 9640, "instruction": "Diclofopの別名称は?", "response": "Diclofopの別名称はジクロホップです。", "task": "replace", "name_q": "Diclofop", "name_a": "ジクロホップ"} +{"id": 34237, "instruction": "Neuvenge (TN)を日本語に訳すと?", "response": "Neuvenge (TN)を日本語に訳すとAPC 8024です。", "task": "replace en to ja", "name_q": "Neuvenge (TN)", "name_a": "APC 8024"} +{"id": 1138, "instruction": "チアマゾール (JP18)を材料とする医薬品は?", "response": "チアマゾール (JP18)を材料とする医薬品はメルカゾール(あすか製薬)です。", "task": "product", "name_q": "チアマゾール (JP18)", "name_a": "メルカゾール(あすか製薬)"} +{"id": 19146, "instruction": "ポラプレジンク (JP18)を英語に訳すと?", "response": "ポラプレジンク (JP18)を英語に訳すとPromac (TN)です。", "task": "replace ja to en", "name_q": "ポラプレジンク (JP18)", "name_a": "Promac (TN)"} +{"id": 5193, "instruction": "Ethynodiolをの分子式は?", "response": "Ethynodiolをの分子式はC20H28O2です。", "task": "formula", "name_q": "Ethynodiol", "name_a": "C20H28O2"} +{"id": 28597, "instruction": "尋常性白斑 下位グループ 多発性自己免疫疾患を伴う白斑 (VAMAS)を英語表記で表すと?", "response": "尋常性白斑 下位グループ 多発性自己免疫疾患を伴う白斑 (VAMAS)を英語表記で表すとVitiligo SUBGROUP Vitiligo-associated multiple autoimmune disease (VAMAS)です。", "task": "replace ja to en", "name_q": "尋常性白斑 下位グループ 多発性自己免疫疾患を伴う白斑 (VAMAS)", "name_a": "Vitiligo SUBGROUP Vitiligo-associated multiple autoimmune disease (VAMAS)"} +{"id": 32647, "instruction": "4-Methylamino-4-de(dimethylamino)anhydrotetracyclineをは分子式で表すと?", "response": "4-Methylamino-4-de(dimethylamino)anhydrotetracyclineをは分子式で表すとC21H20N2O7です。", "task": "formula", "name_q": "4-Methylamino-4-de(dimethylamino)anhydrotetracycline", "name_a": "C21H20N2O7"} +{"id": 33366, "instruction": "Danaparoid sodium (JAN/USAN)を主材料とする���品は?", "response": "Danaparoid sodium (JAN/USAN)を主材料とする商品はオルガラン(ネオクリティケア製薬)です。", "task": "product", "name_q": "Danaparoid sodium (JAN/USAN)", "name_a": "オルガラン(ネオクリティケア製薬)"} +{"id": 22373, "instruction": "Familial breast-ovarian cancer SUBGROUP Hereditary breast ovarian cancer syndrome (HBOC)を日本語で記述すると?", "response": "Familial breast-ovarian cancer SUBGROUP Hereditary breast ovarian cancer syndrome (HBOC)を日本語で記述すると家族性乳がん卵巣がん 下位グループ 遺伝性乳癌卵巣癌症候群 (HBOC)です。", "task": "replace en to ja", "name_q": "Familial breast-ovarian cancer SUBGROUP Hereditary breast ovarian cancer syndrome (HBOC)", "name_a": "家族性乳がん卵巣がん 下位グループ 遺伝性乳癌卵巣癌症候群 (HBOC)"} +{"id": 487, "instruction": "Xanthopterin-B2をは化学構造で表すと?", "response": "Xanthopterin-B2をは化学構造で表すとC9H10N4O4です。", "task": "formula", "name_q": "Xanthopterin-B2", "name_a": "C9H10N4O4"} +{"id": 21774, "instruction": "ent-Cassa-12,15-dien-2-oneをを組成式で書くと?", "response": "ent-Cassa-12,15-dien-2-oneをを組成式で書くとC20H30Oです。", "task": "formula", "name_q": "ent-Cassa-12,15-dien-2-one", "name_a": "C20H30O"} +{"id": 14613, "instruction": "Dikegulacの別記述は?", "response": "Dikegulacの別記述はDiprogulic acidです。", "task": "replace", "name_q": "Dikegulac", "name_a": "Diprogulic acid"} +{"id": 23565, "instruction": "4-Imidazolone-5-acetateの異なる表記は?", "response": "4-Imidazolone-5-acetateの異なる表記はImidazolone acetateです。", "task": "replace", "name_q": "4-Imidazolone-5-acetate", "name_a": "Imidazolone acetate"} +{"id": 14020, "instruction": "Cetrimonium tosilateをの分子式は?", "response": "Cetrimonium tosilateをの分子式はC19H42N. C7H7O3Sです。", "task": "formula", "name_q": "Cetrimonium tosilate", "name_a": "C19H42N. C7H7O3S"} +{"id": 29638, "instruction": "Tagraxofusp-erzsを日本語で記述すると?", "response": "Tagraxofusp-erzsを日本語で記述するとTagraxofusp (genetical recombination) (JAN)です。", "task": "replace en to ja", "name_q": "Tagraxofusp-erzs", "name_a": "Tagraxofusp (genetical recombination) (JAN)"} +{"id": 20536, "instruction": "Alvocidib hydrochloride (USAN)の別名称は?", "response": "Alvocidib hydrochloride (USAN)の別名称はアルボシジブ塩酸塩です。", "task": "replace", "name_q": "Alvocidib hydrochloride (USAN)", "name_a": "アルボシジブ塩酸塩"} +{"id": 20705, "instruction": "Bifenazateの異なる表記は?", "response": "Bifenazateの異なる表記はビフェナゼートです。", "task": "replace", "name_q": "Bifenazate", "name_a": "ビフェナゼート"} +{"id": 10792, "instruction": "スルホブロモフタレインナトリウム (JP18)を英語に訳すと?", "response": "スルホブロモフタレインナトリウム (JP18)を英語に訳すとSulfobromophthalein sodium (JP18)です。", "task": "replace ja to en", "name_q": "スルホブロモフタレインナトリウム (JP18)", "name_a": "Sulfobromophthalein sodium (JP18)"} +{"id": 8433, "instruction": "21-(3-Carboxy-1-oxopropoxy)-17-hydroxypregn-4-ene-3,11,20-trioneは別の呼び方では?", "response": "21-(3-Carboxy-1-oxopropoxy)-17-hydroxypregn-4-ene-3,11,20-trioneは別の呼び方では17,21-Dihydroxypregn-4-ene-3,11,20-trione 21-(hydrogensuccinate)です。", "task": "replace", "name_q": "21-(3-Carboxy-1-oxopropoxy)-17-hydroxypregn-4-ene-3,11,20-trione", "name_a": "17,21-Dihydroxypregn-4-ene-3,11,20-trione 21-(hydrogensuccinate)"} +{"id": 31410, "instruction": "Uridine 5'-diphosphateを言い換えると?", "response": "Uridine 5'-diphosphateを言い換えるとUDPです。", "task": "replace", "name_q": "Uridine 5'-diphosphate", "name_a": "UDP"} +{"id": 26201, "instruction": "ビタミン K 欠乏による凝固因子欠乏の英語表記は?", "response": "ビタミン K 欠乏による凝固因子欠乏の英語表記はCombined deficiency of vitamin K-dependent clotting factorsです。", "task": "replace ja to en", "name_q": "ビタミン K 欠乏による凝固因子欠乏", "name_a": "Combined deficiency of vitamin K-dependent clotting factors"} +{"id": 15470, "instruction": "Pamaquineをを組成式で記述すると?", "response": "Pamaquineをを組成式で記述するとC19H29N3Oです。", "task": "formula", "name_q": "Pamaquine", "name_a": "C19H29N3O"} +{"id": 3038, "instruction": "6-Hydroxy-3,4-dichlorodibenzofuranをを化学式で記述すると?", "response": "6-Hydroxy-3,4-dichlorodibenzofuranをを化学式で記述するとC12H6Cl2O2です。", "task": "formula", "name_q": "6-Hydroxy-3,4-dichlorodibenzofuran", "name_a": "C12H6Cl2O2"} +{"id": 4710, "instruction": "ファンコニ貧血を英語で記述すると?", "response": "ファンコニ貧血を英語で記述するとFanconi anemiaです。", "task": "replace ja to en", "name_q": "ファンコニ貧血", "name_a": "Fanconi anemia"} +{"id": 24135, "instruction": "Deaminohydroxyblasticidin Sの別呼称は?", "response": "Deaminohydroxyblasticidin Sの別呼称はデアミノヒドロキシブラスチシジンSです。", "task": "replace", "name_q": "Deaminohydroxyblasticidin S", "name_a": "デアミノヒドロキシブラスチシジンS"} +{"id": 22242, "instruction": "Phenolphthalein, yellowの別名は?", "response": "Phenolphthalein, yellowの別名は淡黄色フェノールフタレインです。", "task": "replace", "name_q": "Phenolphthalein, yellow", "name_a": "淡黄色フェノールフタレイン"} +{"id": 11558, "instruction": "Cerebellar hypoplasia, epilepsy, and global developmental delayを日本語に訳すと?", "response": "Cerebellar hypoplasia, epilepsy, and global developmental delayを日本語に訳すと小脳低形成、てんかん、および全般的発達遅滞です。", "task": "replace en to ja", "name_q": "Cerebellar hypoplasia, epilepsy, and global developmental delay", "name_a": "小脳低形成、てんかん、および全般的発達遅滞"} +{"id": 19094, "instruction": "Pelrinone hydrochloride (USAN)の別の言い方は?", "response": "Pelrinone hydrochloride (USAN)の別の言い方はペルリノン塩酸塩です。", "task": "replace", "name_q": "Pelrinone hydrochloride (USAN)", "name_a": "ペルリノン塩酸塩"} +{"id": 1572, "instruction": "Bunshotoを日本語表記で表すと?", "response": "Bunshotoを日本語表記で表すとJippiinです。", "task": "replace en to ja", "name_q": "Bunshoto", "name_a": "Jippiin"} +{"id": 9116, "instruction": "Glucocorticoid-induced osteonecrosisの日本語表記は?", "response": "Glucocorticoid-induced osteonecrosisの日本語表記は特発性ステロイド性骨壊死症です。", "task": "replace en to ja", "name_q": "Glucocorticoid-induced osteonecrosis", "name_a": "特発性ステロイド性骨壊死症"} +{"id": 29322, "instruction": "Co-methyl-5-hydroxybenzimidazolylcobamideをを組成式で書くと?", "response": "Co-methyl-5-hydroxybenzimidazolylcobamideをを組成式で書くとC61H87CoN13O15Pです。", "task": "formula", "name_q": "Co-methyl-5-hydroxybenzimidazolylcobamide", "name_a": "C61H87CoN13O15P"} +{"id": 29606, "instruction": "乙字湯を使用した製品名は?", "response": "乙字湯を使用した製品名は乙字湯(三和生薬)です。", "task": "product", "name_q": "乙字湯", "name_a": "乙字湯(三和生薬)"} +{"id": 31544, "instruction": "4-Hydroxy-2,2',3',4',6'-pentachlorobiphenylを言い換えると?", "response": "4-Hydroxy-2,2',3',4',6'-pentachlorobiphenylを言い換えると2,2',3',4',6'-Pentachloro-4-biphenylolです。", "task": "replace", "name_q": "4-Hydroxy-2,2',3',4',6'-pentachlorobiphenyl", "name_a": "2,2',3',4',6'-Pentachloro-4-biphenylol"} +{"id": 15045, "instruction": "ミドドリンを英語表記で表すと?", "response": "ミドドリンを英語表記で表すとMidodrine (INN)です。", "task": "replace ja to en", "name_q": "ミドドリン", "name_a": "Midodrine (INN)"} +{"id": 11671, "instruction": "エリスロマイシンラクトビオン酸塩・コリスチンメタンスルホン酸ナトリウムの別名称は?", "response": "エリスロマイシンラクトビオン酸塩・コリスチンメタンスルホン酸ナトリウムの別名称はErythromycin lactobionate and colistin sodium methanesulfonateです。", "task": "replace", "name_q": "エリスロマイシンラクトビオン酸塩・コリスチンメタンスルホン酸ナトリウム", "name_a": "Erythromycin lactobionate and colistin sodium methanesulfonate"} +{"id": 34178, "instruction": "糖原病 XIII 型 上位グループ 糖原病 筋型糖原病 の英語表記は?", "response": "糖原病 XIII 型 上位グループ 糖原病 筋型糖原病 の英語表記はGlycogen storage disease type XIII SUPERGRP Glycogen storage disease Muscle glycogen storage disease です。", "task": "replace ja to en", "name_q": "糖原病 XIII 型 上位グループ 糖原病 筋型糖原病 ", "name_a": "Glycogen storage disease type XIII SUPERGRP Glycogen storage disease Muscle glycogen storage disease "} +{"id": 16456, "instruction": "新生児永続型糖尿病を英語に訳すと?", "response": "新生児永続型糖尿病を英語に訳すとPermanent neonatal diabetes mellitusです。", "task": "replace ja to en", "name_q": "新生児永続型糖尿病", "name_a": "Permanent neonatal diabetes mellitus"} +{"id": 8085, "instruction": "アベキシチド酢酸塩をを化学構造で表すと?", "response": "アベキシチド酢酸塩をを化学構造で表すとC149H234N40O47S. (C2H4O2)3です。", "task": "formula", "name_q": "アベキシチド酢酸塩", "name_a": "C149H234N40O47S. (C2H4O2)3"} +{"id": 7492, "instruction": "4-Hydroxy-2,2'-bipyrrole-5-methanolをの組成式は?", "response": "4-Hydroxy-2,2'-bipyrrole-5-methanolをの組成式はC9H10N2O2です。", "task": "formula", "name_q": "4-Hydroxy-2,2'-bipyrrole-5-methanol", "name_a": "C9H10N2O2"} +{"id": 19974, "instruction": "Cornelia de Lange syndromeの日本語表記は?", "response": "Cornelia de Lange syndromeの日本語表記はコルネリア・デランゲ症候群です。", "task": "replace en to ja", "name_q": "Cornelia de Lange syndrome", "name_a": "コルネリア・デランゲ症候群"} +{"id": 17137, "instruction": "サルビアノール酸Aの別名は?", "response": "サルビアノール酸Aの別名はSalvianolic acid Aです。", "task": "replace", "name_q": "サルビアノール酸A", "name_a": "Salvianolic acid A"} +{"id": 5175, "instruction": "Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndromeの別の呼び方は?", "response": "Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndromeの別の呼び方はCEDNIK syndromeです。", "task": "replace", "name_q": "Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome", "name_a": "CEDNIK syndrome"} +{"id": 19031, "instruction": "Mal de Meledaの別表現は?", "response": "Mal de Meledaの別表現はMeleda disease SUPERGRP Non-epidermolytic palmoplantar keratoderma Palmoplantar keratoderma です。", "task": "replace", "name_q": "Mal de Meleda", "name_a": "Meleda disease SUPERGRP Non-epidermolytic palmoplantar keratoderma Palmoplantar keratoderma "} +{"id": 28275, "instruction": "N6-(Δ2-イソペンテニル)アデニンをの化学構造は?", "response": "N6-(Δ2-イソペンテニル)アデニンをの化学構造はC10H13N5です。", "task": "formula", "name_q": "N6-(Δ2-イソペンテニル)アデニン", "name_a": "C10H13N5"} +{"id": 28766, "instruction": "アレタミン塩酸塩の別記述は?", "response": "アレタミン塩酸塩の別記述はAletamine hydrochloride (USAN)です。", "task": "replace", "name_q": "アレタミン塩酸塩", "name_a": "Aletamine hydrochloride (USAN)"} +{"id": 32509, "instruction": "2,6-Dichlorobenzamideをを組成式で書くと?", "response": "2,6-Dichlorobenzamideをを組成式で書くとC7H5Cl2NOです。", "task": "formula", "name_q": "2,6-Dichlorobenzamide", "name_a": "C7H5Cl2NO"} +{"id": 12529, "instruction": "シスチン尿症の英訳は?", "response": "シスチン尿症の英訳はCystinuriaです。", "task": "replace ja to en", "name_q": "シスチン尿症", "name_a": "Cystinuria"} +{"id": 20941, "instruction": "アミスルブロムをは組成式で表すと?", "response": "アミスルブロムをは組成式で表すとC13H13BrFN5O4S2です。", "task": "formula", "name_q": "アミスルブロム", "name_a": "C13H13BrFN5O4S2"} +{"id": 24246, "instruction": "Wolcott-Rallison syndromeを日本語で書くと?", "response": "Wolcott-Rallison syndromeを日本語で書くとWolcott-Rallison 症候群です。", "task": "replace en to ja", "name_q": "Wolcott-Rallison syndrome", "name_a": "Wolcott-Rallison 症候群"} +{"id": 13331, "instruction": "Leonurus herb (JP18)の別の呼び方は?", "response": "Leonurus herb (JP18)の別の呼び方はLeonuri herbaです。", "task": "replace", "name_q": "Leonurus herb (JP18)", "name_a": "Leonuri herba"} +{"id": 17454, "instruction": "Tipentosin hydrochloride (USAN)の日本語訳は?", "response": "Tipentosin hydrochloride (USAN)の日本語訳はチペントシン塩酸塩です。", "task": "replace en to ja", "name_q": "Tipentosin hydrochloride (USAN)", "name_a": "チペントシン塩酸塩"} +{"id": 25254, "instruction": "3-Isochromanoneをの化学式は?", "response": "3-Isochromanoneをの化学式はC9H8O2です。", "task": "formula", "name_q": "3-Isochromanone", "name_a": "C9H8O2"} +{"id": 3837, "instruction": "Hinokitiolをを分子式で記述すると?", "response": "Hinokitiolをを分子式で記述するとC10H12O2です。", "task": "formula", "name_q": "Hinokitiol", "name_a": "C10H12O2"} +{"id": 12118, "instruction": "Letrozoleをの化学構造は?", "response": "Letrozoleをの化学構造はC17H11N5です。", "task": "formula", "name_q": "Letrozole", "name_a": "C17H11N5"} +{"id": 4729, "instruction": "C26-CoAをを化学式で表すと?", "response": "C26-CoAをを化学式で表すとC22H35N7O17P3SRです。", "task": "formula", "name_q": "C26-CoA", "name_a": "C22H35N7O17P3SR"} +{"id": 2893, "instruction": "Emepronium bromide (INN)をは組成式で表すと?", "response": "Emepronium bromide (INN)をは組成式で表すとC20H28N. Brです。", "task": "formula", "name_q": "Emepronium bromide (INN)", "name_a": "C20H28N. Br"} +{"id": 27599, "instruction": "ダウノルビシン・シタラビンを利用した薬品は?", "response": "ダウノルビシン・シタラビンを利用した薬品はVYXEOS(JazzPharmaceuticals)です。", "task": "product", "name_q": "ダウノルビシン・シタラビン", "name_a": "VYXEOS(JazzPharmaceuticals)"} +{"id": 367, "instruction": "フルナリジンを英語に訳すと?", "response": "フルナリジンを英語に訳すとSibelium (TN)です。", "task": "replace ja to en", "name_q": "フルナリジン", "name_a": "Sibelium (TN)"} +{"id": 31177, "instruction": "Cofetuzumab pelidotin (USAN)をを��子式で表すと?", "response": "Cofetuzumab pelidotin (USAN)をを分子式で表すとC6774H10418N1778O2096S46です。", "task": "formula", "name_q": "Cofetuzumab pelidotin (USAN)", "name_a": "C6774H10418N1778O2096S46"} +{"id": 33065, "instruction": "TARP 症候群の英語表記は?", "response": "TARP 症候群の英語表記はTARP syndromeです。", "task": "replace ja to en", "name_q": "TARP 症候群", "name_a": "TARP syndrome"} +{"id": 8806, "instruction": "カルビシン塩酸塩をの分子式は?", "response": "カルビシン塩酸塩をの分子式はC26H27NO10. HClです。", "task": "formula", "name_q": "カルビシン塩酸塩", "name_a": "C26H27NO10. HCl"} +{"id": 26564, "instruction": "Rose oil (NF)の別名は?", "response": "Rose oil (NF)の別名はRose oil (TN)です。", "task": "replace", "name_q": "Rose oil (NF)", "name_a": "Rose oil (TN)"} +{"id": 12240, "instruction": "ミラキサンチン-IIIをの組成式は?", "response": "ミラキサンチン-IIIをの組成式はC17H18N2O5です。", "task": "formula", "name_q": "ミラキサンチン-III", "name_a": "C17H18N2O5"} +{"id": 22948, "instruction": "リファブチンをの分子式は?", "response": "リファブチンをの分子式はC46H62N4O11です。", "task": "formula", "name_q": "リファブチン", "name_a": "C46H62N4O11"} +{"id": 25332, "instruction": "Sannamycin Bをを化学式で表すと?", "response": "Sannamycin Bをを化学式で表すとC15H32N4O4です。", "task": "formula", "name_q": "Sannamycin B", "name_a": "C15H32N4O4"} +{"id": 4801, "instruction": "Asparlas (TN)の別名は?", "response": "Asparlas (TN)の別名はCalaspargase pegol-mknlです。", "task": "replace", "name_q": "Asparlas (TN)", "name_a": "Calaspargase pegol-mknl"} +{"id": 14577, "instruction": "Resacetophenoneの異なる表記は?", "response": "Resacetophenoneの異なる表記は2',4'-Dihydroxyacetophenoneです。", "task": "replace", "name_q": "Resacetophenone", "name_a": "2',4'-Dihydroxyacetophenone"} +{"id": 8398, "instruction": "Didemnin Bをは化学構造で表すと?", "response": "Didemnin Bをは化学構造で表すとC57H89N7O15です。", "task": "formula", "name_q": "Didemnin B", "name_a": "C57H89N7O15"} +{"id": 4343, "instruction": "Bimagrumab (JAN/USAN/INN)を日本語で書くと?", "response": "Bimagrumab (JAN/USAN/INN)を日本語で書くとビマグルマブ (遺伝子組換え) (JAN)です。", "task": "replace en to ja", "name_q": "Bimagrumab (JAN/USAN/INN)", "name_a": "ビマグルマブ (遺伝子組換え) (JAN)"} +{"id": 16703, "instruction": "Rovelizumab (USAN/INN)の別名は?", "response": "Rovelizumab (USAN/INN)の別名はロベリズマブです。", "task": "replace", "name_q": "Rovelizumab (USAN/INN)", "name_a": "ロベリズマブ"} +{"id": 14241, "instruction": "他の体液性免疫不全症 上位グループ 獲得免疫の障害 原発性免疫不全症 を英語表記で表すと?", "response": "他の体液性免疫不全症 上位グループ 獲得免疫の障害 原発性免疫不全症 を英語表記で表すとOther humoral immunodeficiencies SUPERGRP Disorders of adaptive immunity Primary immunodeficiency disease です。", "task": "replace ja to en", "name_q": "他の体液性免疫不全症 上位グループ 獲得免疫の障害 原発性免疫不全症 ", "name_a": "Other humoral immunodeficiencies SUPERGRP Disorders of adaptive immunity Primary immunodeficiency disease "} +{"id": 34266, "instruction": "新型コロナウイルス感染症を英語表記で表すと?", "response": "新型コロナウイルス感染症を英語表記で表すとCOVID-19です。", "task": "replace ja to en", "name_q": "新型コロナウイルス感染症", "name_a": "COVID-19"} +{"id": 9215, "instruction": "3-O-alpha-D-Mannopyranosyl-alpha-D-mannopyranoseをを化学式で記述すると?", "response": "3-O-alpha-D-Mannopyranosyl-alpha-D-mannopyranoseをを化学式で記述するとC12H22O11です。", "task": "formula", "name_q": "3-O-alpha-D-Mannopyranosyl-alpha-D-mannopyranose", "name_a": "C12H22O11"} +{"id": 12990, "instruction": "UDP-6-sulfoquinovoseをを化学式で書くと?", "response": "UDP-6-sulfoquinovoseをを化学式で書くとC15H24N2O19P2Sです。", "task": "formula", "name_q": "UDP-6-sulfoquinovose", "name_a": "C15H24N2O19P2S"} +{"id": 16312, "instruction": "Nutropin (TN)を使用した医薬品は?", "response": "Nutropin (TN)を使用した医薬品はヒューマトロープ(日本イーライリリー)です。", "task": "product", "name_q": "Nutropin (TN)", "name_a": "ヒューマトロープ(日本イーライリリー)"} +{"id": 4904, "instruction": "7a-Hydroxy-O-carbamoyl-deacetylcephalosporin Cをを化学構造で書くと?", "response": "7a-Hydroxy-O-carbamoyl-deacetylcephalosporin Cをを化学構造で書くとC15H20N4O9Sです。", "task": "formula", "name_q": "7a-Hydroxy-O-carbamoyl-deacetylcephalosporin C", "name_a": "C15H20N4O9S"} +{"id": 22227, "instruction": "シャルルヴォア・サグエ型痙性失調症 上位グループ 家族性痙性失調症 脊髄小脳変性症 を英語で書くと?", "response": "シャルルヴォア・サグエ型痙性失調症 上位グループ 家族性痙性失調症 脊髄小脳変性症 を英語で書くとAutosomal recessive spastic ataxia of Charlevoix-Saguenay SUPERGRP Spastic ataxia Spinocerebellar degeneration です。", "task": "replace ja to en", "name_q": "シャルルヴォア・サグエ型痙性失調症 上位グループ 家族性痙性失調症 脊髄小脳変性症 ", "name_a": "Autosomal recessive spastic ataxia of Charlevoix-Saguenay SUPERGRP Spastic ataxia Spinocerebellar degeneration "} +{"id": 28986, "instruction": "(13S,14R)-13-O-Acetyl-1,8-dihydroxy-cis-N-methylcanadineをを分子式で記述すると?", "response": "(13S,14R)-13-O-Acetyl-1,8-dihydroxy-cis-N-methylcanadineをを分子式で記述するとC23H26NO8です。", "task": "formula", "name_q": "(13S,14R)-13-O-Acetyl-1,8-dihydroxy-cis-N-methylcanadine", "name_a": "C23H26NO8"} +{"id": 22028, "instruction": "カロコン(大晃生薬)を主材料とする製品は?", "response": "カロコン(大晃生薬)を主材料とする製品はか楼根(小島漢方)です。", "task": "product", "name_q": "カロコン(大晃生薬)", "name_a": "か楼根(小島漢方)"} +{"id": 7451, "instruction": "Diphenylene carbinolをを化学構造で表すと?", "response": "Diphenylene carbinolをを化学構造で表すとC13H10Oです。", "task": "formula", "name_q": "Diphenylene carbinol", "name_a": "C13H10O"} +{"id": 13586, "instruction": "6-(Hydroxymethyl)-7,8-dihydropterinをは化学式で表すと?", "response": "6-(Hydroxymethyl)-7,8-dihydropterinをは化学式で表すとC7H9N5O2です。", "task": "formula", "name_q": "6-(Hydroxymethyl)-7,8-dihydropterin", "name_a": "C7H9N5O2"} +{"id": 26608, "instruction": "フルレトフェンの英語表記は?", "response": "フルレトフェンの英語表記はFluretofen (USAN)です。", "task": "replace ja to en", "name_q": "フルレトフェン", "name_a": "Fluretofen (USAN)"} +{"id": 13516, "instruction": "2-Hydroxy fatty acidをを組成式で表すと?", "response": "2-Hydroxy fatty acidをを組成式で表すとC2H3O3R(CH2)nです。", "task": "formula", "name_q": "2-Hydroxy fatty acid", "name_a": "C2H3O3R(CH2)n"} +{"id": 31346, "instruction": "Methyl-CoMをを分子式で表すと?", "response": "Methyl-CoMをを分子式で表すとC3H8O3S2です。", "task": "formula", "name_q": "Methyl-CoM", "name_a": "C3H8O3S2"} +{"id": 13616, "instruction": "Dihydrocodeine phosphate (JP18)をは化学式で表すと?", "response": "Dihydrocodeine phosphate (JP18)をは化学式で表すとC18H23NO3. H3PO4です。", "task": "formula", "name_q": "Dihydrocodeine phosphate (JP18)", "name_a": "C18H23NO3. H3PO4"} +{"id": 31536, "instruction": "Fluazifop butylをを組成式で書くと?", "response": "Fluazifop butylをを組成式で書くとC19H20F3NO4です。", "task": "formula", "name_q": "Fluazifop butyl", "name_a": "C19H20F3NO4"} +{"id": 26171, "instruction": "Sparteineをを組成式で記述すると?", "response": "Sparteineをを組成式で記述するとC15H26N2です。", "task": "formula", "name_q": "Sparteine", "name_a": "C15H26N2"} +{"id": 11559, "instruction": "(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoateは別の呼び方では?", "response": "(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoateは別の呼び方では2,3-Diketo-L-gulonic acidです。", "task": "replace", "name_q": "(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate", "name_a": "2,3-Diketo-L-gulonic acid"} +{"id": 12022, "instruction": "Methotrimeprazine (USP)の別記述は?", "response": "Methotrimeprazine (USP)の別記述はレボメプロマジンです。", "task": "replace", "name_q": "Methotrimeprazine (USP)", "name_a": "レボメプロマジン"} +{"id": 32895, "instruction": "Angeliq (TN)の異なる表記は?", "response": "Angeliq (TN)の異なる表記はDrospirenone and estradiolです。", "task": "replace", "name_q": "Angeliq (TN)", "name_a": "Drospirenone and estradiol"} +{"id": 19132, "instruction": "複合性リパーゼ欠損症の英語表記は?", "response": "複合性リパーゼ欠損症の英語表記はCombined lipase deficiencyです。", "task": "replace ja to en", "name_q": "複合性リパーゼ欠損症", "name_a": "Combined lipase deficiency"} +{"id": 18453, "instruction": "Oxycodegol phosphate (USAN)をは組成式で表すと?", "response": "Oxycodegol phosphate (USAN)をは組成式で表すとC31H49NO10. H3PO4です。", "task": "formula", "name_q": "Oxycodegol phosphate (USAN)", "name_a": "C31H49NO10. H3PO4"} +{"id": 31675, "instruction": "Cotinine fumarate (USAN)をを組成式で書くと?", "response": "Cotinine fumarate (USAN)をを組成式で書くと(C10H12N2O)2. C4H4O4です。", "task": "formula", "name_q": "Cotinine fumarate (USAN)", "name_a": "(C10H12N2O)2. C4H4O4"} +{"id": 19965, "instruction": "抗狂犬病血清を英語に訳すと?", "response": "抗狂犬病血清を英語に訳すとAntirabies serumです。", "task": "replace ja to en", "name_q": "抗狂犬病血清", "name_a": "Antirabies serum"} +{"id": 27314, "instruction": "Brodalumab (USAN)を主材料とする医薬品は?", "response": "Brodalumab (USAN)を主材料とする医薬品はSILIQ(BauschHealthUSLLC)です。", "task": "product", "name_q": "Brodalumab (USAN)", "name_a": "SILIQ(BauschHealthUSLLC)"} +{"id": 615, "instruction": "6-(1,2,3,4-Tetrahydro-6-hydroxy-2-naphthyl)-2(1H)-pyridoneをは分子式で表すと?", "response": "6-(1,2,3,4-Tetrahydro-6-hydroxy-2-naphthyl)-2(1H)-pyridoneをは分子式で表すとC15H15NO2です。", "task": "formula", "name_q": "6-(1,2,3,4-Tetrahydro-6-hydroxy-2-naphthyl)-2(1H)-pyridone", "name_a": "C15H15NO2"} +{"id": 11101, "instruction": "HISTAMINEPOSITIVE(ALK-Abello)をは分子式で表すと?", "response": "HISTAMINEPOSITIVE(ALK-Abello)をは分子式で表すと2H3PO4. C5H9N3です。", "task": "formula", "name_q": "HISTAMINEPOSITIVE(ALK-Abello)", "name_a": "2H3PO4. C5H9N3"} +{"id": 16502, "instruction": "beta-Santalolをを化学構造で書くと?", "response": "beta-Santalolをを化学構造で書くとC15H24Oです。", "task": "formula", "name_q": "beta-Santalol", "name_a": "C15H24O"} +{"id": 27488, "instruction": "Cyanocobalamin (60Co) (INN)を言い換えると?", "response": "Cyanocobalamin (60Co) (INN)を言い換えるとCyanocobalamin Co 60 (USP)です。", "task": "replace", "name_q": "Cyanocobalamin (60Co) (INN)", "name_a": "Cyanocobalamin Co 60 (USP)"} +{"id": 197, "instruction": "[Protein]-S-[5-carboxy-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridin-1-ium-3-carbonyl]-L-cysteineをは化学式で表すと?", "response": "[Protein]-S-[5-carboxy-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridin-1-ium-3-carbonyl]-L-cysteineをは化学式で表すとC16H19N3O12PSR2です。", "task": "formula", "name_q": "[Protein]-S-[5-carboxy-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridin-1-ium-3-carbonyl]-L-cysteine", "name_a": "C16H19N3O12PSR2"} +{"id": 30335, "instruction": "2,2-ビス (4-ヒドロキシフェニル) ブタンの別表現は?", "response": "2,2-ビス (4-ヒドロキシフェニル) ブタンの別表現はBisphenol Bです。", "task": "replace", "name_q": "2,2-ビス (4-ヒドロキシフェニル) ブタン", "name_a": "Bisphenol B"} +{"id": 9323, "instruction": "レテプラーゼの別の呼び方は?", "response": "レテプラーゼの別の呼び方はReteplase (USAN/INN)です。", "task": "replace", "name_q": "レテプラーゼ", "name_a": "Reteplase (USAN/INN)"} +{"id": 8062, "instruction": "D-Taluronic acidをを組成式で表すと?", "response": "D-Taluronic acidをを組成式で表すとC6H10O7です。", "task": "formula", "name_q": "D-Taluronic acid", "name_a": "C6H10O7"} +{"id": 5520, "instruction": "ミホバートをの組成式は?", "response": "ミホバートをの組成式はC11H17ClO7P2です。", "task": "formula", "name_q": "ミホバート", "name_a": "C11H17ClO7P2"} +{"id": 20814, "instruction": "N-(Aminomethyl)ureaの異なる表現は?", "response": "N-(Aminomethyl)ureaの異なる表現はN- (アミノメチル) 尿素です。", "task": "replace", "name_q": "N-(Aminomethyl)urea", "name_a": "N- (アミノメチル) 尿素"} +{"id": 19145, "instruction": "フシジン酸をを分子式で記述すると?", "response": "フシジン酸をを分子式で記述するとC31H48O6です。", "task": "formula", "name_q": "フシジン酸", "name_a": "C31H48O6"} +{"id": 25601, "instruction": "Navane (TN)を日本語に訳すと?", "response": "Navane (TN)を日本語に訳すとTiotixene (JAN)です。", "task": "replace en to ja", "name_q": "Navane (TN)", "name_a": "Tiotixene (JAN)"} +{"id": 29794, "instruction": "2-Hydroxy-3-methyl-fatty-acyl-CoAをは組成式で表すと?", "response": "2-Hydroxy-3-methyl-fatty-acyl-CoAをは組成式で表すとC25H41N7O18P3SRです。", "task": "formula", "name_q": "2-Hydroxy-3-methyl-fatty-acyl-CoA", "name_a": "C25H41N7O18P3SR"} +{"id": 25205, "instruction": "4-Methylphenolの別名称は?", "response": "4-Methylphenolの別名称は4-Hydroxytolueneです。", "task": "replace", "name_q": "4-Methylphenol", "name_a": "4-Hydroxytoluene"} +{"id": 27079, "instruction": "Cyclopenta[cd]pyreneを言い換えると?", "response": "Cyclopenta[cd]pyreneを言い換えるとシクロペンタ[cd]ピレンです。", "task": "replace", "name_q": "Cyclopenta[cd]pyrene", "name_a": "シクロペンタ[cd]ピレン"} +{"id": 27940, "instruction": "塩酸ジメフリンの別名称は?", "response": "塩酸ジメフリンの別名称はDimefline hydrochlorideです。", "task": "replace", "name_q": "塩酸ジメフリン", "name_a": "Dimefline hydrochloride"} +{"id": 22729, "instruction": "Anhydrous monobasic sodium phosphateをを化学構造で表すと?", "response": "Anhydrous monobasic sodium phosphateをを化学構造で表すとH2PO4. Naです。", "task": "formula", "name_q": "Anhydrous monobasic sodium phosphate", "name_a": "H2PO4. Na"} +{"id": 13541, "instruction": "Helicobacter heilmannii infectionを日本語で書くと?", "response": "Helicobacter heilmannii infectionを日本語で書くとHelicobacter heilmannii 感染です。", "task": "replace en to ja", "name_q": "Helicobacter heilmannii infection", "name_a": "Helicobacter heilmannii 感染"} +{"id": 12120, "instruction": "ポリカプラムを英語で書くと?", "response": "ポリカプラムを英語で書くとPolicapram (USAN/INN)です。", "task": "replace ja to en", "name_q": "ポリカプラム", "name_a": "Policapram (USAN/INN)"} +{"id": 11978, "instruction": "l−メントール(ヴィアトリス・ヘルスケア)を材料とする薬品名は?", "response": "l−メントール(ヴィアトリス・ヘルスケア)を材料とする薬品名はミンクリア(富士製薬工業)です。", "task": "product", "name_q": "l−メントール(ヴィアトリス・ヘルスケア)", "name_a": "ミンクリア(富士製薬工業)"} +{"id": 29337, "instruction": "Urocortin IIの別名は?", "response": "Urocortin IIの別名はウロコルチン IIです。", "task": "replace", "name_q": "Urocortin II", "name_a": "ウロコルチン II"} +{"id": 25066, "instruction": "Phenylobacterium 感染を英語で記述すると?", "response": "Phenylobacterium 感染を英語で記述するとPhenylobacterium infectionです。", "task": "replace ja to en", "name_q": "Phenylobacterium 感染", "name_a": "Phenylobacterium infection"} +{"id": 19610, "instruction": "R-gene (TN)の日本語表記は?", "response": "R-gene (TN)の日本語表記はアルギニン塩酸塩です。", "task": "replace en to ja", "name_q": "R-gene (TN)", "name_a": "アルギニン塩酸塩"} +{"id": 28311, "instruction": "Evorpacept (USAN)をは組成式で表すと?", "response": "Evorpacept (USAN)をは組成式で表すとC3414H5304N920O1038S24です。", "task": "formula", "name_q": "Evorpacept (USAN)", "name_a": "C3414H5304N920O1038S24"} +{"id": 22738, "instruction": "n-7 Unsaturated acyl-[acyl-carrier protein]の別の呼び方は?", "response": "n-7 Unsaturated acyl-[acyl-carrier protein]の別の呼び方はomega-7 Fatty acyl-[acyl-carrier protein]です。", "task": "replace", "name_q": "n-7 Unsaturated acyl-[acyl-carrier protein]", "name_a": "omega-7 Fatty acyl-[acyl-carrier protein]"} +{"id": 32551, "instruction": "ブラジル出血熱 上位グループ 南米出血熱 アレナウイルス性出血熱 を英語で書くと?", "response": "ブラジル出血熱 上位グループ 南米出血熱 アレナウイルス性出血熱 を英語で書くとBrazilian hemorrhagic fever SUPERGRP South American hemorrhagic fever Arenaviral hemorrhagic fever です。", "task": "replace ja to en", "name_q": "ブラジル出血熱 上位グループ 南米出血熱 アレナウイルス性出血熱 ", "name_a": "Brazilian hemorrhagic fever SUPERGRP South American hemorrhagic fever Arenaviral hemorrhagic fever "} +{"id": 18585, "instruction": "Weiss-Kruszka 症候群を英語表記で表すと?", "response": "Weiss-Kruszka 症候群を英語表記で表すとWeiss-Kruszka syndromeです。", "task": "replace ja to en", "name_q": "Weiss-Kruszka 症候群", "name_a": "Weiss-Kruszka syndrome"} +{"id": 22358, "instruction": "ゾナンパネルを英語に訳すと?", "response": "ゾナンパネルを英語に訳すとZonampanel (INN/USAN)です。", "task": "replace ja to en", "name_q": "ゾナンパネル", "name_a": "Zonampanel (INN/USAN)"} +{"id": 30374, "instruction": "ジメチルツボクラリンを英語に訳すと?", "response": "ジメチルツボクラリンを英語に訳すとDimethyltubocurarine (BAN)です。", "task": "replace ja to en", "name_q": "ジメチルツボクラリン", "name_a": "Dimethyltubocurarine (BAN)"} +{"id": 21727, "instruction": "Cortisoneは別の呼び方では?", "response": "Cortisoneは別の呼び方ではReichstein's substance Faです。", "task": "replace", "name_q": "Cortisone", "name_a": "Reichstein's substance Fa"} +{"id": 16815, "instruction": "13-Hydroxy-2-(hydroxymethylene)-3-oxo-13,17-seco-5alpha-androstan-17-oic acid, delta-lactoneをは組成式で表すと?", "response": "13-Hydroxy-2-(hydroxymethylene)-3-oxo-13,17-seco-5alpha-androstan-17-oic acid, delta-lactoneをは組成式で表すとC20H28O4です。", "task": "formula", "name_q": "13-Hydroxy-2-(hydroxymethylene)-3-oxo-13,17-seco-5alpha-androstan-17-oic acid, delta-lactone", "name_a": "C20H28O4"} +{"id": 10886, "instruction": "Defects in lysosomal trafficking SUBGROUP Niemann-Pick disease type C Mucolipidosis II Mucolipidosis III Mucolipidosis IV Hermansky-Pudlak syndrome Chediak-Higashi syndrome SUPERGRP Lysosomal storage disease を日本語表記で表すと?", "response": "Defects in lysosomal trafficking SUBGROUP Niemann-Pick disease type C Mucolipidosis II Mucolipidosis III Mucolipidosis IV Hermansky-Pudlak syndrome Chediak-Higashi syndrome SUPERGRP Lysosomal storage disease を日本語表記で表すとリソソーム輸送障害 下位グループ ニーマン・ピック病 C 型 ムコリピドーシス II 型 ムコリピドーシス III 型 ムコリピドーシス IV 型 ヘルマンスキー・パドラック症候群 チェディアック���東症候群 上位グループ ライソゾーム病 (リソソーム蓄積症) です。", "task": "replace en to ja", "name_q": "Defects in lysosomal trafficking SUBGROUP Niemann-Pick disease type C Mucolipidosis II Mucolipidosis III Mucolipidosis IV Hermansky-Pudlak syndrome Chediak-Higashi syndrome SUPERGRP Lysosomal storage disease ", "name_a": "リソソーム輸送障害 下位グループ ニーマン・ピック病 C 型 ムコリピドーシス II 型 ムコリピドーシス III 型 ムコリピドーシス IV 型 ヘルマンスキー・パドラック症候群 チェディアック・東症候群 上位グループ ライソゾーム病 (リソソーム蓄積症) "} +{"id": 17920, "instruction": "Tetanus toxoid adsorbed (USP)を日本語で書くと?", "response": "Tetanus toxoid adsorbed (USP)を日本語で書くとAdsorbed tetanus toxoid (JP18)です。", "task": "replace en to ja", "name_q": "Tetanus toxoid adsorbed (USP)", "name_a": "Adsorbed tetanus toxoid (JP18)"} +{"id": 12606, "instruction": "Amorolfine (USAN/INN)は別の呼び方では?", "response": "Amorolfine (USAN/INN)は別の呼び方ではアモロルフィンです。", "task": "replace", "name_q": "Amorolfine (USAN/INN)", "name_a": "アモロルフィン"} +{"id": 33917, "instruction": "Yokukansan extract (JP18)を言い換えると?", "response": "Yokukansan extract (JP18)を言い換えると抑肝散です。", "task": "replace", "name_q": "Yokukansan extract (JP18)", "name_a": "抑肝散"} +{"id": 14504, "instruction": "Neptazane (TN)を日本語で記述すると?", "response": "Neptazane (TN)を日本語で記述するとメタゾラミド (JAN)です。", "task": "replace en to ja", "name_q": "Neptazane (TN)", "name_a": "メタゾラミド (JAN)"} +{"id": 27676, "instruction": "Ilacirnon sodium (USAN)をの分子式は?", "response": "Ilacirnon sodium (USAN)をの分子式はC20H12ClF3N5O3S. Naです。", "task": "formula", "name_q": "Ilacirnon sodium (USAN)", "name_a": "C20H12ClF3N5O3S. Na"} +{"id": 34078, "instruction": "ジフェンヒドラミン塩酸塩 (JP18)を主材料とする製品は?", "response": "ジフェンヒドラミン塩酸塩 (JP18)を主材料とする製品はジフェンヒドラミン塩酸塩(日新製薬－山形)です。", "task": "product", "name_q": "ジフェンヒドラミン塩酸塩 (JP18)", "name_a": "ジフェンヒドラミン塩酸塩(日新製薬－山形)"} +{"id": 31093, "instruction": "Acetone (NF)の異なる表記は?", "response": "Acetone (NF)の異なる表記は2-Propanoneです。", "task": "replace", "name_q": "Acetone (NF)", "name_a": "2-Propanone"} +{"id": 28357, "instruction": "Glucofrangulin Bをを化学構造で表すと?", "response": "Glucofrangulin Bをを化学構造で表すとC26H28O14です。", "task": "formula", "name_q": "Glucofrangulin B", "name_a": "C26H28O14"} +{"id": 21538, "instruction": "5,10-Methylene-THFの別の呼び方は?", "response": "5,10-Methylene-THFの別の呼び方は5,10-Methylenetetrahydrofolateです。", "task": "replace", "name_q": "5,10-Methylene-THF", "name_a": "5,10-Methylenetetrahydrofolate"} +{"id": 5073, "instruction": "Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside)をは化学構造で表すと?", "response": "Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside)をは化学構造で表すとC36H37O18です。", "task": "formula", "name_q": "Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside)", "name_a": "C36H37O18"} +{"id": 10281, "instruction": "Iosarcolの異なる名称は?", "response": "Iosarcolの異なる名称はMelitrast (TN)です。", "task": "replace", "name_q": "Iosarcol", "name_a": "Melitrast (TN)"} +{"id": 27162, "instruction": "17-Methyl-18-norandrosta-4,13(17)-dien-3-oneをを化学式で書くと?", "response": "17-Methyl-18-norandrosta-4,13(17)-dien-3-oneをを化学式で書くとC19H26Oです。", "task": "formula", "name_q": "17-Methyl-18-norandrosta-4,13(17)-dien-3-one", "name_a": "C19H26O"} +{"id": 32459, "instruction": "Phoslo (TN)を日本語表記で表すと?", "response": "Phoslo (TN)を日本語表記で表すと酢酸カルシウムです。", "task": "replace en to ja", "name_q": "Phoslo (TN)", "name_a": "酢酸カルシウム"} +{"id": 18419, "instruction": "Chloraminophenamideは別の呼び方では?", "response": "Chloraminophenamideは別の呼び方ではクロロアミノフェナミドです。", "task": "replace", "name_q": "Chloraminophenamide", "name_a": "クロロアミノフェナミド"} +{"id": 23086, "instruction": "活性化 PI3K-delta 症候群 上位グループ 獲得免疫の障害 原発性免疫不全症 を英語表記で表すと?", "response": "活性化 PI3K-delta 症候群 上位グループ 獲得免疫の障害 原発性免疫不全症 を英語表記で表すとActivated PI3K-delta syndrome SUPERGRP Disorders of adaptive immunity Primary immunodeficiency disease です。", "task": "replace ja to en", "name_q": "活性化 PI3K-delta 症候群 上位グループ 獲得免疫の障害 原発性���疫不全症 ", "name_a": "Activated PI3K-delta syndrome SUPERGRP Disorders of adaptive immunity Primary immunodeficiency disease "} +{"id": 22076, "instruction": "Cytochrome c N6-methyl-L-lysineをの化学構造は?", "response": "Cytochrome c N6-methyl-L-lysineをの化学構造はC8H15N3O2R2です。", "task": "formula", "name_q": "Cytochrome c N6-methyl-L-lysine", "name_a": "C8H15N3O2R2"} +{"id": 18994, "instruction": "ネドクロミルカルシウムをの分子式は?", "response": "ネドクロミルカルシウムをの分子式はC19H15NO7. Caです。", "task": "formula", "name_q": "ネドクロミルカルシウム", "name_a": "C19H15NO7. Ca"} +{"id": 19882, "instruction": "DPPDの異なる名称は?", "response": "DPPDの異なる名称はN,N'-Diphenyl-p-phenylenediamineです。", "task": "replace", "name_q": "DPPD", "name_a": "N,N'-Diphenyl-p-phenylenediamine"} +{"id": 22699, "instruction": "beta-D-Galactosyl-(1->4)-L-rhamnoseをの分子式は?", "response": "beta-D-Galactosyl-(1->4)-L-rhamnoseをの分子式はC12H22O10です。", "task": "formula", "name_q": "beta-D-Galactosyl-(1->4)-L-rhamnose", "name_a": "C12H22O10"} +{"id": 19864, "instruction": "X-linked lymphoproliferative syndromeを日本語で書くと?", "response": "X-linked lymphoproliferative syndromeを日本語で書くとDuncan 病 上位グループ リンパ球増殖症候群 他のよく定義された免疫不全症候群 原発性免疫不全症 です。", "task": "replace en to ja", "name_q": "X-linked lymphoproliferative syndrome", "name_a": "Duncan 病 上位グループ リンパ球増殖症候群 他のよく定義された免疫不全症候群 原発性免疫不全症 "} +{"id": 4350, "instruction": "Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucosideの別表現は?", "response": "Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucosideの別表現はシソニンです。", "task": "replace", "name_q": "Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucoside", "name_a": "シソニン"} +{"id": 18900, "instruction": "D-Tagatose 1,6-bisphosphateをを化学式で記述すると?", "response": "D-Tagatose 1,6-bisphosphateをを化学式で記述するとC6H14O12P2です。", "task": "formula", "name_q": "D-Tagatose 1,6-bisphosphate", "name_a": "C6H14O12P2"} +{"id": 25874, "instruction": "L-ヒスチジンの別の言い方は?", "response": "L-ヒスチジンの別の言い方はL-Histidineです。", "task": "replace", "name_q": "L-ヒスチジン", "name_a": "L-Histidine"} +{"id": 4283, "instruction": "Myxochromide S1をを分子式で表すと?", "response": "Myxochromide S1をを分子式で表すとC38H54N6O8です。", "task": "formula", "name_q": "Myxochromide S1", "name_a": "C38H54N6O8"} +{"id": 31919, "instruction": "ケイシニンジントウを利用した商品は?", "response": "ケイシニンジントウを利用した商品は桂枝人参湯(ツムラ)です。", "task": "product", "name_q": "ケイシニンジントウ", "name_a": "桂枝人参湯(ツムラ)"} +{"id": 27063, "instruction": "N-Benzoyl-D-arginine-4-nitroanilideをを化学式で記述すると?", "response": "N-Benzoyl-D-arginine-4-nitroanilideをを化学式で記述するとC19H22N6O4です。", "task": "formula", "name_q": "N-Benzoyl-D-arginine-4-nitroanilide", "name_a": "C19H22N6O4"} +{"id": 12376, "instruction": "Angiotensin Aをを化学構造で書くと?", "response": "Angiotensin Aをを化学構造で書くとC49H71N13O10です。", "task": "formula", "name_q": "Angiotensin A", "name_a": "C49H71N13O10"} +{"id": 1591, "instruction": "ペンテトラゾールの別名は?", "response": "ペンテトラゾールの別名はPentetrazol (INN)です。", "task": "replace", "name_q": "ペンテトラゾール", "name_a": "Pentetrazol (INN)"} +{"id": 10452, "instruction": "3-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)amino]benzenesulfonateをは化学構造で表すと?", "response": "3-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)amino]benzenesulfonateをは化学構造で表すとC9H8ClN5O3Sです。", "task": "formula", "name_q": "3-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)amino]benzenesulfonate", "name_a": "C9H8ClN5O3S"} +{"id": 11740, "instruction": "EP Hormone (TN)の日本語表記は?", "response": "EP Hormone (TN)の日本語表記はヒドロキシプロゲステロンカプロン酸エステル・エストラジオールプロピオン酸エステルです。", "task": "replace en to ja", "name_q": "EP Hormone (TN)", "name_a": "ヒドロキシプロゲステロンカプロン酸エステル・エストラジオールプロピオン酸エステル"} +{"id": 10735, "instruction": "シクロプロトブキシンCの別名は?", "response": "シクロプロトブキシンCの別名はCycloprotobuxine Cです。", "task": "replace", "name_q": "シクロプロトブキシンC", "name_a": "Cycloprotobuxine C"} +{"id": 21979, "instruction": "3-Amino-4,7-dihydroxy-8-chlorocoumarinをを分子式で書くと?", "response": "3-Amino-4,7-dihydroxy-8-chlorocoumarinをを分子式で書くとC9H6ClNO4です。", "task": "formula", "name_q": "3-Amino-4,7-dihydroxy-8-chlorocoumarin", "name_a": "C9H6ClNO4"} +{"id": 27000, "instruction": "シチジン5'リン酸は別の呼び方では?", "response": "シチジン5'リン酸は別の呼び方ではシチジル酸です。", "task": "replace", "name_q": "シチジン5'リン酸", "name_a": "シチジル酸"} +{"id": 22080, "instruction": "Asparaginyl-tRNA(Asn)の別表現は?", "response": "Asparaginyl-tRNA(Asn)の別表現はL-Asparaginyl-tRNA(Asn)です。", "task": "replace", "name_q": "Asparaginyl-tRNA(Asn)", "name_a": "L-Asparaginyl-tRNA(Asn)"} +{"id": 20691, "instruction": "Protomycinolide IVをは分子式で表すと?", "response": "Protomycinolide IVをは分子式で表すとC21H32O4です。", "task": "formula", "name_q": "Protomycinolide IV", "name_a": "C21H32O4"} +{"id": 32383, "instruction": "Aceclofenac (JAN/INN)をを化学構造で書くと?", "response": "Aceclofenac (JAN/INN)をを化学構造で書くとC16H13Cl2NO4です。", "task": "formula", "name_q": "Aceclofenac (JAN/INN)", "name_a": "C16H13Cl2NO4"} +{"id": 20663, "instruction": "アプリシアトキシンをの組成式は?", "response": "アプリシアトキシンをの組成式はC32H47BrO10です。", "task": "formula", "name_q": "アプリシアトキシン", "name_a": "C32H47BrO10"} +{"id": 7574, "instruction": "Decaprenol phosphateをを分子式で記述すると?", "response": "Decaprenol phosphateをを分子式で記述するとC50H83O4Pです。", "task": "formula", "name_q": "Decaprenol phosphate", "name_a": "C50H83O4P"} +{"id": 26364, "instruction": "Leukotriene D4をは組成式で表すと?", "response": "Leukotriene D4をは組成式で表すとC25H40N2O6Sです。", "task": "formula", "name_q": "Leukotriene D4", "name_a": "C25H40N2O6S"} +{"id": 15654, "instruction": "ニソルジピンの異なる名称は?", "response": "ニソルジピンの異なる名称はNisoldipineです。", "task": "replace", "name_q": "ニソルジピン", "name_a": "Nisoldipine"} +{"id": 27862, "instruction": "コパリフェロールBをの化学構造は?", "response": "コパリフェロールBをの化学構造はC42H32O9です。", "task": "formula", "name_q": "コパリフェロールB", "name_a": "C42H32O9"} +{"id": 28039, "instruction": "Amurensineをの化学構造は?", "response": "Amurensineをの化学構造はC19H19NO4です。", "task": "formula", "name_q": "Amurensine", "name_a": "C19H19NO4"} +{"id": 25819, "instruction": "早期卵巣機能不全の英語表記は?", "response": "早期卵巣機能不全の英語表記はPremature ovarian failureです。", "task": "replace ja to en", "name_q": "早期卵巣機能不全", "name_a": "Premature ovarian failure"} +{"id": 31540, "instruction": "Gildeuretinol acetate (USAN)の別記述は?", "response": "Gildeuretinol acetate (USAN)の別記述はギルデューレチノール酢酸エステルです。", "task": "replace", "name_q": "Gildeuretinol acetate (USAN)", "name_a": "ギルデューレチノール酢酸エステル"} +{"id": 20446, "instruction": "Olmesartan medoxomil and azelnidipineの別の呼び方は?", "response": "Olmesartan medoxomil and azelnidipineの別の呼び方はRezaltas (TN)です。", "task": "replace", "name_q": "Olmesartan medoxomil and azelnidipine", "name_a": "Rezaltas (TN)"} +{"id": 24188, "instruction": "Odevixibat (USAN)を主とした商品は?", "response": "Odevixibat (USAN)を主とした商品はBYLVAY(IpsenBiopharmaceuticals)です。", "task": "product", "name_q": "Odevixibat (USAN)", "name_a": "BYLVAY(IpsenBiopharmaceuticals)"} +{"id": 19769, "instruction": "緑内障 3 型を英語で記述すると?", "response": "緑内障 3 型を英語で記述するとGlaucoma 3です。", "task": "replace ja to en", "name_q": "緑内障 3 型", "name_a": "Glaucoma 3"} +{"id": 14760, "instruction": "(-)-Kolavenyl diphosphateをを化学構造で記述すると?", "response": "(-)-Kolavenyl diphosphateをを化学構造で記述するとC20H36O7P2です。", "task": "formula", "name_q": "(-)-Kolavenyl diphosphate", "name_a": "C20H36O7P2"} +{"id": 8222, "instruction": "クラミジア肺炎を英語で書くと?", "response": "クラミジア肺炎を英語で書くとChlamydial pneumoniaです。", "task": "replace ja to en", "name_q": "クラミジア肺炎", "name_a": "Chlamydial pneumonia"} +{"id": 11885, "instruction": "Fistularin 2をの化学式は?", "response": "Fistularin 2をの化学式はC22H21Br4N3O8です。", "task": "formula", "name_q": "Fistularin 2", "name_a": "C22H21Br4N3O8"} +{"id": 16426, "instruction": "Eosinophil peroxidase deficiencyを日本語表記で表すと?", "response": "Eosinophil peroxidase deficiencyを日本語表記で表すと好酸球ペルオキシダーゼ欠損です。", "task": "replace en to ja", "name_q": "Eosinophil peroxidase deficiency", "name_a": "好酸球ペルオキシダーゼ欠損"} +{"id": 3594, "instruction": "無トランスフェリン血症を英語で書くと?", "response": "無トランスフェリン血症を英語で書くとAtransferrinemiaです。", "task": "replace ja to en", "name_q": "無トランスフェリン血症", "name_a": "Atransferrinemia"} +{"id": 16034, "instruction": "Pamiteplase (genetical recombination) (JAN)の異なる名称は?", "response": "Pamiteplase (genetical recombination) (JAN)の異なる名称はPamiteplase (INN)です。", "task": "replace", "name_q": "Pamiteplase (genetical recombination) (JAN)", "name_a": "Pamiteplase (INN)"} +{"id": 9568, "instruction": "(C27H23N5O4)2. H2Oを主材料とする医薬品は?", "response": "(C27H23N5O4)2. H2Oを主材料とする医薬品はプランルカスト(日本ジェネリック)です。", "task": "product", "name_q": "(C27H23N5O4)2. H2O", "name_a": "プランルカスト(日本ジェネリック)"} +{"id": 5637, "instruction": "メトプレンの別の言い方は?", "response": "メトプレンの別の言い方はMethopreneです。", "task": "replace", "name_q": "メトプレン", "name_a": "Methoprene"} +{"id": 2026, "instruction": "DECITABINE(GlandPharmaLimited)を使用した製品名は?", "response": "DECITABINE(GlandPharmaLimited)を使用した製品名はDECITABINE(QiluPharmaceutical)です。", "task": "product", "name_q": "DECITABINE(GlandPharmaLimited)", "name_a": "DECITABINE(QiluPharmaceutical)"} +{"id": 26983, "instruction": "Gardenin Bをを化学式で表すと?", "response": "Gardenin Bをを化学式で表すとC19H18O7です。", "task": "formula", "name_q": "Gardenin B", "name_a": "C19H18O7"} +{"id": 22436, "instruction": "N-Formylderivativesをを化学式で書くと?", "response": "N-Formylderivativesをを化学式で書くとCH2NORです。", "task": "formula", "name_q": "N-Formylderivatives", "name_a": "CH2NOR"} +{"id": 22858, "instruction": "セプテントリオニンの異なる表現は?", "response": "セプテントリオニンの異なる表現はSeptentrionineです。", "task": "replace", "name_q": "セプテントリオニン", "name_a": "Septentrionine"} +{"id": 421, "instruction": "Dulcinの別の呼び方は?", "response": "Dulcinの別の呼び方はズルチンです。", "task": "replace", "name_q": "Dulcin", "name_a": "ズルチン"} +{"id": 12026, "instruction": "Guanosineをを化学構造で書くと?", "response": "Guanosineをを化学構造で書くとC10H13N5O5です。", "task": "formula", "name_q": "Guanosine", "name_a": "C10H13N5O5"} +{"id": 28160, "instruction": "Dicodid (TN)を使用した製品は?", "response": "Dicodid (TN)を使用した製品はHYSINGLAER(PurduePharmaLP)です。", "task": "product", "name_q": "Dicodid (TN)", "name_a": "HYSINGLAER(PurduePharmaLP)"} +{"id": 19900, "instruction": "Fumonisin B1を言い換えると?", "response": "Fumonisin B1を言い換えるとフモニシンB1です。", "task": "replace", "name_q": "Fumonisin B1", "name_a": "フモニシンB1"} +{"id": 26559, "instruction": "Endosteal hyperostosisの別名は?", "response": "Endosteal hyperostosisの別名はWorth type autosomal dominant osteosclerosisです。", "task": "replace", "name_q": "Endosteal hyperostosis", "name_a": "Worth type autosomal dominant osteosclerosis"} +{"id": 9158, "instruction": "Hydranencephaly with renal aplasia-dysplasiaの別名称は?", "response": "Hydranencephaly with renal aplasia-dysplasiaの別名称はMultinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephalyです。", "task": "replace", "name_q": "Hydranencephaly with renal aplasia-dysplasia", "name_a": "Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly"} +{"id": 19734, "instruction": "Bucrilate (INN)をの分子式は?", "response": "Bucrilate (INN)をの分子式はC8H11NO2です。", "task": "formula", "name_q": "Bucrilate (INN)", "name_a": "C8H11NO2"} +{"id": 4321, "instruction": "2-Acetamido-6H-dibenzo[b,d]pyran-6-oneをを化学式で書くと?", "response": "2-Acetamido-6H-dibenzo[b,d]pyran-6-oneをを化学式で書くとC15H11NO3です。", "task": "formula", "name_q": "2-Acetamido-6H-dibenzo[b,d]pyran-6-one", "name_a": "C15H11NO3"} +{"id": 26481, "instruction": "Histamine (DCF)をの組成式は?", "response": "Histamine (DCF)をの組成式はC5H9N3です。", "task": "formula", "name_q": "Histamine (DCF)", "name_a": "C5H9N3"} +{"id": 7656, "instruction": "マイカラミド Bは別の呼び方では?", "response": "マイカラミド Bは別の呼び方ではMycalamide Bです。", "task": "replace", "name_q": "マイカラミド B", "name_a": "Mycalamide B"} +{"id": 188, "instruction": "Medetomidine (INN)を日本語表記で表すと?", "response": "Medetomidine (INN)を日本語表記で表すとメデトミジンです。", "task": "replace en to ja", "name_q": "Medetomidine (INN)", "name_a": "メデトミジン"} +{"id": 33126, "instruction": "Congo redをを分子式で記述すると?", "response": "Congo redをを分子式で記述するとC32H22N6O6S2. 2Naです。", "task": "formula", "name_q": "Congo red", "name_a": "C32H22N6O6S2. 2Na"} +{"id": 21793, "instruction": "3-O-(3,6-Anhydro-alpha-D-galactopyranosyl)-D-galactose 4-O-sulfateをを化学構造で書くと?", "response": "3-O-(3,6-Anhydro-alpha-D-galactopyranosyl)-D-galactose 4-O-sulfateをを化学構造で書くとC12H20O13Sです。", "task": "formula", "name_q": "3-O-(3,6-Anhydro-alpha-D-galactopyranosyl)-D-galactose 4-O-sulfate", "name_a": "C12H20O13S"} +{"id": 11336, "instruction": "仙茅を英語で記述すると?", "response": "仙茅を英語で記述するとCurculigo rhizomeです。", "task": "replace ja to en", "name_q": "仙茅", "name_a": "Curculigo rhizome"} +{"id": 32901, "instruction": "Long-chain acid anionをを組成式で表すと?", "response": "Long-chain acid anionをを組成式で表すとC3H4O2R(C2H4)nです。", "task": "formula", "name_q": "Long-chain acid anion", "name_a": "C3H4O2R(C2H4)n"} +{"id": 26867, "instruction": "Dicymine (TN)の異なる表記は?", "response": "Dicymine (TN)の異なる表記はDicycloverine (INN)です。", "task": "replace", "name_q": "Dicymine (TN)", "name_a": "Dicycloverine (INN)"} +{"id": 17396, "instruction": "原発性繊毛ジスキネジア 下位グループ カータジェナー症候群を英語に訳すと?", "response": "原発性繊毛ジスキネジア 下位グループ カータジェナー症候群を英語に訳すとPrimary ciliary dyskinesia SUBGROUP Kartagener syndromeです。", "task": "replace ja to en", "name_q": "原発性繊毛ジスキネジア 下位グループ カータジェナー症候群", "name_a": "Primary ciliary dyskinesia SUBGROUP Kartagener syndrome"} +{"id": 9523, "instruction": "関節弛緩と骨年齢亢進を伴う骨異形成症の英語表記は?", "response": "関節弛緩と骨年齢亢進を伴う骨異形成症の英語表記はSkeletal dysplasia with joint laxity and advanced bone ageです。", "task": "replace ja to en", "name_q": "関節弛緩と骨年齢亢進を伴う骨異形成症", "name_a": "Skeletal dysplasia with joint laxity and advanced bone age"} +{"id": 12352, "instruction": "Isopropyl unoprostone (JAN)の日本語訳は?", "response": "Isopropyl unoprostone (JAN)の日本語訳はUnoprostone isopropylです。", "task": "replace en to ja", "name_q": "Isopropyl unoprostone (JAN)", "name_a": "Unoprostone isopropyl"} +{"id": 22473, "instruction": "2-Methylbutyl glucosinolateをを分子式で記述すると?", "response": "2-Methylbutyl glucosinolateをを分子式で記述するとC12H23NO9S2です。", "task": "formula", "name_q": "2-Methylbutyl glucosinolate", "name_a": "C12H23NO9S2"} +{"id": 1194, "instruction": "ルシタニブをを分子式で書くと?", "response": "ルシタニブをを分子式で書くとC26H25N3O4です。", "task": "formula", "name_q": "ルシタニブ", "name_a": "C26H25N3O4"} +{"id": 4009, "instruction": "Lolitriolの異なる表現は?", "response": "Lolitriolの異なる表現はロリトリオールです。", "task": "replace", "name_q": "Lolitriol", "name_a": "ロリトリオール"} +{"id": 34408, "instruction": "エチリノテカンペゴルをの分子式は?", "response": "エチリノテカンペゴルをの分子式はC153H176N20O36(C2H4O)n(C2H4O)n(C2H4O)n(C2H4O)nです。", "task": "formula", "name_q": "エチリノテカンペゴル", "name_a": "C153H176N20O36(C2H4O)n(C2H4O)n(C2H4O)n(C2H4O)n"} +{"id": 20267, "instruction": "17beta-Estradiol-2,3-quinoneの別名は?", "response": "17beta-Estradiol-2,3-quinoneの別名はEstradiol-2,3-quinoneです。", "task": "replace", "name_q": "17beta-Estradiol-2,3-quinone", "name_a": "Estradiol-2,3-quinone"} +{"id": 29164, "instruction": "Lambert-Eaton myasthenic syndromeの日本語表記は?", "response": "Lambert-Eaton myasthenic syndromeの日本語表記はイートン・ランバート症候群です。", "task": "replace en to ja", "name_q": "Lambert-Eaton myasthenic syndrome", "name_a": "イートン・ランバート症候群"} +{"id": 26434, "instruction": "2,3,5,6-Tetrachlorobiphenylをを化学式で表すと?", "response": "2,3,5,6-Tetrachlorobiphenylをを化学式で表すとC12H6Cl4です。", "task": "formula", "name_q": "2,3,5,6-Tetrachlorobiphenyl", "name_a": "C12H6Cl4"} +{"id": 22744, "instruction": "p-Coumaroylputrescineの別呼称は?", "response": "p-Coumaroylputrescineの別呼称はp-クマロイルプトレスシンです。", "task": "replace", "name_q": "p-Coumaroylputrescine", "name_a": "p-クマロイルプトレスシン"} +{"id": 13398, "instruction": "2'-Phosphoadenylylsulfateをを化学構造で書くと?", "response": "2'-Phosphoadenylylsulfateをを化学構造で書くとC10H15N5O13P2Sです。", "task": "formula", "name_q": "2'-Phosphoadenylylsulfate", "name_a": "C10H15N5O13P2S"} +{"id": 10089, "instruction": "3,4-Diphenyltetrahydrofuranをを化学構造で記述すると?", "response": "3,4-Diphenyltetrahydrofuranをを化学構造で記述するとC16H16Oです。", "task": "formula", "name_q": "3,4-Diphenyltetrahydrofuran", "name_a": "C16H16O"} +{"id": 2976, "instruction": "Iodineの異なる表現は?", "response": "Iodineの異なる表現はI2です。", "task": "replace", "name_q": "Iodine", "name_a": "I2"} +{"id": 34328, "instruction": "(11R)-Dihydroartemisinic aldehydeをを化学構造で表すと?", "response": "(11R)-Dihydroartemisinic aldehydeをを化学構造で表すとC15H24Oです。", "task": "formula", "name_q": "(11R)-Dihydroartemisinic aldehyde", "name_a": "C15H24O"} +{"id": 211, "instruction": "Glycidolをを組成式で記述すると?", "response": "Glycidolをを組成式で記述するとC3H6O2です。", "task": "formula", "name_q": "Glycidol", "name_a": "C3H6O2"} +{"id": 25910, "instruction": "アイミクス(住友ファーマ)を利用した医薬品名は?", "response": "アイミクス(住友ファーマ)を利用した医薬品名はイルアミクス(東和薬品)です。", "task": "product", "name_q": "アイミクス(住友ファーマ)", "name_a": "イルアミクス(東和薬品)"} +{"id": 346, "instruction": "Acylcholineをを組成式で記述すると?", "response": "Acylcholineをを組成式で記述するとC6H13NO2Rです。", "task": "formula", "name_q": "Acylcholine", "name_a": "C6H13NO2R"} +{"id": 31353, "instruction": "Glyprothiazol (INN)をを分子式で書くと?", "response": "Glyprothiazol (INN)をを分子式で書くとC11H14N4O2S2です。", "task": "formula", "name_q": "Glyprothiazol (INN)", "name_a": "C11H14N4O2S2"} +{"id": 22408, "instruction": "2,3-Dihydroxypropanalの異なる表記は?", "response": "2,3-Dihydroxypropanalの異なる表記はGlyceroseです。", "task": "replace", "name_q": "2,3-Dihydroxypropanal", "name_a": "Glycerose"} +{"id": 21293, "instruction": "4-Hydroxy-3-methylbenzaldehydeをを組成式で書くと?", "response": "4-Hydroxy-3-methylbenzaldehydeをを組成式で書くとC8H8O2です。", "task": "formula", "name_q": "4-Hydroxy-3-methylbenzaldehyde", "name_a": "C8H8O2"} +{"id": 22415, "instruction": "Postaxial polydactylyを日本語で書くと?", "response": "Postaxial polydactylyを日本語で書くと軸後性多指症です。", "task": "replace en to ja", "name_q": "Postaxial polydactyly", "name_a": "軸後性多指症"} +{"id": 31350, "instruction": "テクネチウム(Tc99m)ニトリドケイドの英語表記は?", "response": "テクネチウム(Tc99m)ニトリドケイドの英語表記はTechnetium Tc 99m nitridocade (USAN)です。", "task": "replace ja to en", "name_q": "テクネチウム(Tc99m)ニトリドケイド", "name_a": "Technetium Tc 99m nitridocade (USAN)"} +{"id": 22649, "instruction": "Buphenine (INN)をを化学式で書くと?", "response": "Buphenine (INN)をを化学式で書くとC19H25NO2です。", "task": "formula", "name_q": "Buphenine (INN)", "name_a": "C19H25NO2"} +{"id": 23369, "instruction": "エラロフィバンをは組成式で表すと?", "response": "エラロフィバンをは組成式で表すとC22H32N4O4. H2Oです。", "task": "formula", "name_q": "エラロフィバン", "name_a": "C22H32N4O4. H2O"} +{"id": 921, "instruction": "2',4',6'-Trihydroxy-3'-formyldihydrochalconeをを化学構造で記述すると?", "response": "2',4',6'-Trihydroxy-3'-formyldihydrochalconeをを化学構造で記述するとC16H14O5です。", "task": "formula", "name_q": "2',4',6'-Trihydroxy-3'-formyldihydrochalcone", "name_a": "C16H14O5"} +{"id": 20765, "instruction": "Ompekimig (USAN)を日本語表記で表すと?", "response": "Ompekimig (USAN)を日本語表記で表すとオムペキミグです。", "task": "replace en to ja", "name_q": "Ompekimig (USAN)", "name_a": "オムペキミグ"} +{"id": 8245, "instruction": "アモバルビタール (JP18)をは分子式で表すと?", "response": "アモバルビタール (JP18)をは分子式で表すとC11H18N2O3です。", "task": "formula", "name_q": "アモバルビタール (JP18)", "name_a": "C11H18N2O3"} +{"id": 10973, "instruction": "オデシビマブを言い換えると?", "response": "オデシビマブを言い換えるとOdesivimab-ebgnです。", "task": "replace", "name_q": "オデシビマブ", "name_a": "Odesivimab-ebgn"} +{"id": 4751, "instruction": "GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GlcNAc-beta1->3LacCerをを組成式で表すと?", "response": "GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GlcNAc-beta1->3LacCerをを組成式で表すとC59H102N3O32Rです。", "task": "formula", "name_q": "GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GlcNAc-beta1->3LacCer", "name_a": "C59H102N3O32R"} +{"id": 23629, "instruction": "Exelon (TN)を主とした薬品は?", "response": "Exelon (TN)を主とした薬品はリバスチグミン(祐徳薬品工業)です。", "task": "product", "name_q": "Exelon (TN)", "name_a": "リバスチグミン(祐徳薬品工業)"} +{"id": 5862, "instruction": "Wybutosine in tRNA(Phe)をは分子式で表すと?", "response": "Wybutosine in tRNA(Phe)をは分子式で表すとC21H29N6O12P(C5H8O6PR)n(C5H8O6PR)nです。", "task": "formula", "name_q": "Wybutosine in tRNA(Phe)", "name_a": "C21H29N6O12P(C5H8O6PR)n(C5H8O6PR)n"} +{"id": 11792, "instruction": "trans-L-3-Hydroxyprolineの別名称は?", "response": "trans-L-3-Hydroxyprolineの別名称はtrans-3-Hydroxy-L-prolineです。", "task": "replace", "name_q": "trans-L-3-Hydroxyproline", "name_a": "trans-3-Hydroxy-L-proline"} +{"id": 10341, "instruction": "Migalastat (USAN/INN)を日本語で書くと?", "response": "Migalastat (USAN/INN)を日本語で書くとミガーラスタットです。", "task": "replace en to ja", "name_q": "Migalastat (USAN/INN)", "name_a": "ミガーラスタット"} +{"id": 3142, "instruction": "パリシンBの別表現は?", "response": "パリシンBの別表現はParishin Bです。", "task": "replace", "name_q": "パリシンB", "name_a": "Parishin B"} +{"id": 12804, "instruction": "7-Carboxy-7-carbaguanineの別表現は?", "response": "7-Carboxy-7-carbaguanineの別表現は7-Carboxy-7-deazaguanineです。", "task": "replace", "name_q": "7-Carboxy-7-carbaguanine", "name_a": "7-Carboxy-7-deazaguanine"} +{"id": 1356, "instruction": "タイクロベン(山善製薬)を利用した商品は?", "response": "タイクロベン(山善製薬)を利用した商品はラスノン(日本歯科薬品)です。", "task": "product", "name_q": "タイクロベン(山善製薬)", "name_a": "ラスノン(日本歯科薬品)"} +{"id": 7010, "instruction": "Oxychlorosene (USAN)を日本語で書くと?", "response": "Oxychlorosene (USAN)を日本語で書くとオキシクロロセンです。", "task": "replace en to ja", "name_q": "Oxychlorosene (USAN)", "name_a": "オキシクロロセン"} +{"id": 2651, "instruction": "帰耆建中湯を英語で記述すると?", "response": "帰耆建中湯を英語で記述するとKigikenchutoです。", "task": "replace ja to en", "name_q": "帰耆建中湯", "name_a": "Kigikenchuto"} +{"id": 32756, "instruction": "Muscular dystrophy-dystroglycanopathy SUBGROUP Muscular dystrophy-dystroglycanopathy type A Muscular dystrophy-dystroglycanopathy type B Muscular dystrophy-dystroglycanopathy type C を日本語で記述すると?", "response": "Muscular dystrophy-dystroglycanopathy SUBGROUP Muscular dystrophy-dystroglycanopathy type A Muscular dystrophy-dystroglycanopathy type B Muscular dystrophy-dystroglycanopathy type C を日本語で記述すると筋ジストロフィー・ジストログリカノパチー 下位グループ 筋ジストロフィー・ジストログリカノパチー A 型 筋ジストロフィー・ジストログリカノパチー B 型 筋ジストロフィー・ジストログリカノパチー C 型 です。", "task": "replace en to ja", "name_q": "Muscular dystrophy-dystroglycanopathy SUBGROUP Muscular dystrophy-dystroglycanopathy type A Muscular dystrophy-dystroglycanopathy type B Muscular dystrophy-dystroglycanopathy type C ", "name_a": "筋ジストロフィー・ジストログリカノパチー 下位グループ 筋ジストロフィー・ジストログリカノパチー A 型 筋ジストロフィー・ジストログリカノパチー B 型 筋ジストロフィー・ジストログリカノパチー C 型 "} +{"id": 8635, "instruction": "3-Amino-2,3-dideoxy-scyllo-inososeをは化学式で表すと?", "response": "3-Amino-2,3-dideoxy-scyllo-inososeをは化学式で表すとC6H11NO4です。", "task": "formula", "name_q": "3-Amino-2,3-dideoxy-scyllo-inosose", "name_a": "C6H11NO4"} +{"id": 21120, "instruction": "NSC4928をを化学式で書くと?", "response": "NSC4928をを化学式で書くとC9H13N5です。", "task": "formula", "name_q": "NSC4928", "name_a": "C9H13N5"} +{"id": 6464, "instruction": "ビオンジニン Cをを分子式で記述すると?", "response": "ビオンジニン Cをを分子式で記述するとC19H24O3です。", "task": "formula", "name_q": "ビオンジニン C", "name_a": "C19H24O3"} +{"id": 1031, "instruction": "Chlorsulfuronをを組成式で記述すると?", "response": "Chlorsulfuronをを組成式で記述するとC12H12ClN5O4Sです。", "task": "formula", "name_q": "Chlorsulfuron", "name_a": "C12H12ClN5O4S"} +{"id": 7096, "instruction": "(1,4-beta-D-Glucosyl)n-1の異なる表現は?", "response": "(1,4-beta-D-Glucosyl)n-1の異なる表現はMicrocrystalline celluloseです。", "task": "replace", "name_q": "(1,4-beta-D-Glucosyl)n-1", "name_a": "Microcrystalline cellulose"} +{"id": 24033, "instruction": "(3beta,5beta,22R)-3,14,22,25-Tetrahydroxycholest-7-en-6-oneをは組成式で表すと?", "response": "(3beta,5beta,22R)-3,14,22,25-Tetrahydroxycholest-7-en-6-oneをは組成式で表すとC27H44O5です。", "task": "formula", "name_q": "(3beta,5beta,22R)-3,14,22,25-Tetrahydroxycholest-7-en-6-one", "name_a": "C27H44O5"} +{"id": 27141, "instruction": "Meester-Loeys syndrome SUPERGRP Familial thoracic aortic aneurysm and dissection を日本語表記で表すと?", "response": "Meester-Loeys syndrome SUPERGRP Familial thoracic aortic aneurysm and dissection を日本語表記で表すとMeester-Loeys 症候群 上位グループ 家族性胸部大動脈瘤及び解離 です。", "task": "replace en to ja", "name_q": "Meester-Loeys syndrome SUPERGRP Familial thoracic aortic aneurysm and dissection ", "name_a": "Meester-Loeys 症候群 上位グループ 家族性胸部大動脈瘤及び解離 "} +{"id": 572, "instruction": "1-(4-Hydroxy-3-methoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diolをを化学式で記述すると?", "response": "1-(4-Hydroxy-3-methoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diolをを化学式で記述するとC17H20O6です。", "task": "formula", "name_q": "1-(4-Hydroxy-3-methoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol", "name_a": "C17H20O6"} +{"id": 26477, "instruction": "1a,7a-Dihydro-1a-methyl-7a-(3,7,11,15-tetramethyl-2-hexadecenyl)-naphth[2,3-b]oxirene-2,7-dioneの異なる表記は?", "response": "1a,7a-Dihydro-1a-methyl-7a-(3,7,11,15-tetramethyl-2-hexadecenyl)-naphth[2,3-b]oxirene-2,7-dioneの異なる表記はPhylloquinone oxideです。", "task": "replace", "name_q": "1a,7a-Dihydro-1a-methyl-7a-(3,7,11,15-tetramethyl-2-hexadecenyl)-naphth[2,3-b]oxirene-2,7-dione", "name_a": "Phylloquinone oxide"} +{"id": 3544, "instruction": "CLARAVIS(TevaPharmaceuticalsUSA)を使用した薬品名は?", "response": "CLARAVIS(TevaPharmaceuticalsUSA)を使用した薬品名はISOTRETINOIN(SunPharmaceuticalIndustries)です。", "task": "product", "name_q": "CLARAVIS(TevaPharmaceuticalsUSA)", "name_a": "ISOTRETINOIN(SunPharmaceuticalIndustries)"} +{"id": 2468, "instruction": "2-Coumarinateをの組成式は?", "response": "2-Coumarinateをの組成式はC9H8O3です。", "task": "formula", "name_q": "2-Coumarinate", "name_a": "C9H8O3"} +{"id": 17722, "instruction": "様々な知的障害と顔異形を伴う発達遅滞を英語で書くと?", "response": "様々な知的障害と顔異形を伴う発達遅滞を英語で書くとDevelopmental delay with variable intellectual disability and dysmorphic faciesです。", "task": "replace ja to en", "name_q": "様々な知的障害と顔異形を伴う発達遅滞", "name_a": "Developmental delay with variable intellectual disability and dysmorphic facies"} +{"id": 2705, "instruction": "ロイコボリンの別の言い方は?", "response": "ロイコボリンの別の言い方はホリニン酸です。", "task": "replace", "name_q": "ロイコボリン", "name_a": "ホリニン酸"} +{"id": 15326, "instruction": "Benzobicyclonをを化学式で書くと?", "response": "Benzobicyclonをを化学式で書くとC22H19ClO4S2です。", "task": "formula", "name_q": "Benzobicyclon", "name_a": "C22H19ClO4S2"} +{"id": 24513, "instruction": "Ixmyelocel-T (USAN)の異なる表記は?", "response": "Ixmyelocel-T (USAN)の異なる表記はイクスミエロセル-Tです。", "task": "replace", "name_q": "Ixmyelocel-T (USAN)", "name_a": "イクスミエロセル-T"} +{"id": 23597, "instruction": "PEBELの別名は?", "response": "PEBELの別名は脳浮腫と白質脳症を伴う早期発症進行性脳症です。", "task": "replace", "name_q": "PEBEL", "name_a": "脳浮腫と白質脳症を伴う早期発症進行性脳症"} +{"id": 5869, "instruction": "Calafatimineをを組成式で書くと?", "response": "Calafatimineをを組成式で書くとC38H40N2O7です。", "task": "formula", "name_q": "Calafatimine", "name_a": "C38H40N2O7"} +{"id": 23475, "instruction": "Mecasermin rinfabate (USAN/INN)をは分子式で表すと?", "response": "Mecasermin rinfabate (USAN/INN)をは分子式で表すとC1231H1967N371O384S20です。", "task": "formula", "name_q": "Mecasermin rinfabate (USAN/INN)", "name_a": "C1231H1967N371O384S20"} +{"id": 16176, "instruction": "4-Hydroxybenzoyl-adenylateをを組成式で表すと?", "response": "4-Hydroxybenzoyl-adenylateをを組成式で表すとC17H18N5O9Pです。", "task": "formula", "name_q": "4-Hydroxybenzoyl-adenylate", "name_a": "C17H18N5O9P"} +{"id": 20177, "instruction": "ブルガキサンチン-Iの異なる表現は?", "response": "ブルガキサンチン-Iの異なる表現はVulgaxanthin-Iです。", "task": "replace", "name_q": "ブルガキサンチン-I", "name_a": "Vulgaxanthin-I"} +{"id": 2872, "instruction": "イソアラントラクトンの別呼称は?", "response": "イソアラントラクトンの別呼称はIsoalantolactoneです。", "task": "replace", "name_q": "イソアラントラクトン", "name_a": "Isoalantolactone"} +{"id": 20114, "instruction": "Cyomin (TN)を材料とする製品は?", "response": "Cyomin (TN)を材料とする製品はCYANOCOBALAMIN(HenrySchein)です。", "task": "product", "name_q": "Cyomin (TN)", "name_a": "CYANOCOBALAMIN(HenrySchein)"} +{"id": 18343, "instruction": "ルクセプチニブを英語表記で表すと?", "response": "ルクセプチニブを英語表記で表すとLuxeptinib (USAN)です。", "task": "replace ja to en", "name_q": "ルクセプチニブ", "name_a": "Luxeptinib (USAN)"} +{"id": 19054, "instruction": "Dihydroalbocyclineをを分子式で記述すると?", "response": "Dihydroalbocyclineをを分子式で記述するとC18H30O4です。", "task": "formula", "name_q": "Dihydroalbocycline", "name_a": "C18H30O4"} +{"id": 18437, "instruction": "D-Galactosideをを分子式で表すと?", "response": "D-Galactosideをを分子式で表すとC6H11O6Rです。", "task": "formula", "name_q": "D-Galactoside", "name_a": "C6H11O6R"} +{"id": 29472, "instruction": "Deamido-NAD+の別記述は?", "response": "Deamido-NAD+の別記述はNicotinic acid adenine dinucleotide��す。", "task": "replace", "name_q": "Deamido-NAD+", "name_a": "Nicotinic acid adenine dinucleotide"} +{"id": 15070, "instruction": "8-Ethyl-12-methyl-3-vinylbacteriochlorophyllide dをを組成式で書くと?", "response": "8-Ethyl-12-methyl-3-vinylbacteriochlorophyllide dをを組成式で書くとC33H32MgN4O3です。", "task": "formula", "name_q": "8-Ethyl-12-methyl-3-vinylbacteriochlorophyllide d", "name_a": "C33H32MgN4O3"} +{"id": 13286, "instruction": "7-Methyl-2-hydroxy-6-oxoocta-2,4-dienoateをは化学式で表すと?", "response": "7-Methyl-2-hydroxy-6-oxoocta-2,4-dienoateをは化学式で表すとC9H12O4です。", "task": "formula", "name_q": "7-Methyl-2-hydroxy-6-oxoocta-2,4-dienoate", "name_a": "C9H12O4"} +{"id": 6298, "instruction": "チオサランをは化学式で表すと?", "response": "チオサランをは化学式で表すとC13H8Br3NOSです。", "task": "formula", "name_q": "チオサラン", "name_a": "C13H8Br3NOS"} +{"id": 23321, "instruction": "5-Chloro-1H-pyrrole-2-carbonyl-[peptidyl-carrier protein]をを化学式で表すと?", "response": "5-Chloro-1H-pyrrole-2-carbonyl-[peptidyl-carrier protein]をを化学式で表すとC5H3ClNOSRです。", "task": "formula", "name_q": "5-Chloro-1H-pyrrole-2-carbonyl-[peptidyl-carrier protein]", "name_a": "C5H3ClNOSR"} +{"id": 4596, "instruction": "Argentine hemorrhagic fever SUPERGRP South American hemorrhagic fever Arenaviral hemorrhagic fever を日本語表記で表すと?", "response": "Argentine hemorrhagic fever SUPERGRP South American hemorrhagic fever Arenaviral hemorrhagic fever を日本語表記で表すとアルゼンチン出血熱 上位グループ 南米出血熱 アレナウイルス性出血熱 です。", "task": "replace en to ja", "name_q": "Argentine hemorrhagic fever SUPERGRP South American hemorrhagic fever Arenaviral hemorrhagic fever ", "name_a": "アルゼンチン出血熱 上位グループ 南米出血熱 アレナウイルス性出血熱 "} +{"id": 21343, "instruction": "Fibronectin (human plasma) (JAN)を日本語で書くと?", "response": "Fibronectin (human plasma) (JAN)を日本語で書くとフィブロネクチン (ヒト血漿) (JAN)です。", "task": "replace en to ja", "name_q": "Fibronectin (human plasma) (JAN)", "name_a": "フィブロネクチン (ヒト血漿) (JAN)"} +{"id": 18698, "instruction": "Ecoza (TN)をを組成式で記述すると?", "response": "Ecoza (TN)をを組成式で記述するとC18H15Cl3N2O. HNO3です。", "task": "formula", "name_q": "Ecoza (TN)", "name_a": "C18H15Cl3N2O. HNO3"} +{"id": 6860, "instruction": "Dordaviprone (USAN/INN)をは化学構造で表すと?", "response": "Dordaviprone (USAN/INN)をは化学構造で表すとC24H26N4Oです。", "task": "formula", "name_q": "Dordaviprone (USAN/INN)", "name_a": "C24H26N4O"} +{"id": 21239, "instruction": "Nephrotic syndromeの日本語表記は?", "response": "Nephrotic syndromeの日本語表記はネフローゼ症候群です。", "task": "replace en to ja", "name_q": "Nephrotic syndrome", "name_a": "ネフローゼ症候群"} +{"id": 10582, "instruction": "Athabascan brainstem dysgenesis syndromeの別の言い方は?", "response": "Athabascan brainstem dysgenesis syndromeの別の言い方はBosley-Salih-Alorainy syndromeです。", "task": "replace", "name_q": "Athabascan brainstem dysgenesis syndrome", "name_a": "Bosley-Salih-Alorainy syndrome"} +{"id": 29612, "instruction": "リトラミンの異なる表現は?", "response": "リトラミンの異なる表現はLythramineです。", "task": "replace", "name_q": "リトラミン", "name_a": "Lythramine"} +{"id": 8057, "instruction": "Mg-2,4-divinyl-phaeoporphyrin a5-monomethylesterをを組成式で書くと?", "response": "Mg-2,4-divinyl-phaeoporphyrin a5-monomethylesterをを組成式で書くとC35H30MgN4O5です。", "task": "formula", "name_q": "Mg-2,4-divinyl-phaeoporphyrin a5-monomethylester", "name_a": "C35H30MgN4O5"} +{"id": 15408, "instruction": "Stizolobinateの別表現は?", "response": "Stizolobinateの別表現はスチゾロビニン酸です。", "task": "replace", "name_q": "Stizolobinate", "name_a": "スチゾロビニン酸"} +{"id": 11009, "instruction": "N-Acetyl-beta-muramate 6-phosphateをは分子式で表すと?", "response": "N-Acetyl-beta-muramate 6-phosphateをは分子式で表すとC11H20NO11Pです。", "task": "formula", "name_q": "N-Acetyl-beta-muramate 6-phosphate", "name_a": "C11H20NO11P"} +{"id": 16216, "instruction": "SUCCINYLCHOLINECHLORIDE(EugiaUSLLC)を主材料とする商品名は?", "response": "SUCCINYLCHOLINECHLORIDE(EugiaUSLLC)を主材料とする商品名はQUELICIN(MedicalPurchasingSolutions)です。", "task": "product", "name_q": "SUCCINYLCHOLINECHLORIDE(EugiaUSLLC)", "name_a": "QUELICIN(MedicalPurchasingSolutions)"} +{"id": 30840, "instruction": "タドシズマブをは分子式で表すと?", "response": "タドシズマブをは分子式で表すとC2107H3252N562O673S12です。", "task": "formula", "name_q": "タドシズマブ", "name_a": "C2107H3252N562O673S12"} +{"id": 3955, "instruction": "Frovatriptan (INN)の英訳は?", "response": "Frovatriptan (INN)の英訳はAllergo filmtabletten (TN)です。", "task": "replace ja to en", "name_q": "Frovatriptan (INN)", "name_a": "Allergo filmtabletten (TN)"} +{"id": 19992, "instruction": "[SoxY protein]-S-disulfanyl-L-cysteineをを化学式で書くと?", "response": "[SoxY protein]-S-disulfanyl-L-cysteineをを化学式で書くとC3H5NOS3R2です。", "task": "formula", "name_q": "[SoxY protein]-S-disulfanyl-L-cysteine", "name_a": "C3H5NOS3R2"} +{"id": 25944, "instruction": "Witschel dystrophyを日本語表記で表すと?", "response": "Witschel dystrophyを日本語表記で表すと先天性角膜実質変性症です。", "task": "replace en to ja", "name_q": "Witschel dystrophy", "name_a": "先天性角膜実質変性症"} +{"id": 23716, "instruction": "C42H53NO15. HClを使用した商品名は?", "response": "C42H53NO15. HClを使用した商品名はアクラシノン(日本マイクロバイオファーマ)です。", "task": "product", "name_q": "C42H53NO15. HCl", "name_a": "アクラシノン(日本マイクロバイオファーマ)"} +{"id": 16366, "instruction": "Gloximonam (USAN/INN)をは化学構造で表すと?", "response": "Gloximonam (USAN/INN)をは化学構造で表すとC18H25N5O8Sです。", "task": "formula", "name_q": "Gloximonam (USAN/INN)", "name_a": "C18H25N5O8S"} +{"id": 23978, "instruction": "クエン酸水和物(日興製薬)をを組成式で書くと?", "response": "クエン酸水和物(日興製薬)をを組成式で書くとC6H8O7. H2Oです。", "task": "formula", "name_q": "クエン酸水和物(日興製薬)", "name_a": "C6H8O7. H2O"} +{"id": 17427, "instruction": "ボコデプシンベシル酸塩をを組成式で表すと?", "response": "ボコデプシンベシル酸塩をを組成式で表すとC26H39N5O6S2. C6H6O3Sです。", "task": "formula", "name_q": "ボコデプシンベシル酸塩", "name_a": "C26H39N5O6S2. C6H6O3S"} +{"id": 31599, "instruction": "子宮頸癌を英語表記で表すと?", "response": "子宮頸癌を英語表記で表すとCervical cancerです。", "task": "replace ja to en", "name_q": "子宮頸癌", "name_a": "Cervical cancer"} +{"id": 11909, "instruction": "ベルメロンをの化学式は?", "response": "ベルメロンをの化学式はC10H10O3です。", "task": "formula", "name_q": "ベルメロン", "name_a": "C10H10O3"} +{"id": 25385, "instruction": "Difelikefalin acetate (JAN)を用いた医薬品は?", "response": "Difelikefalin acetate (JAN)を用いた医薬品は)です。", "task": "product", "name_q": "Difelikefalin acetate (JAN)", "name_a": ")"} +{"id": 20056, "instruction": "2,3,4,6,7,8-Hexachlorodibenzofuranの別の呼び方は?", "response": "2,3,4,6,7,8-Hexachlorodibenzofuranの別の呼び方は2,3,4,6,7,8-ヘキサクロロジベンゾフランです。", "task": "replace", "name_q": "2,3,4,6,7,8-Hexachlorodibenzofuran", "name_a": "2,3,4,6,7,8-ヘキサクロロジベンゾフラン"} +{"id": 6954, "instruction": "Keishikakakkontoを材料とする医薬品名は?", "response": "Keishikakakkontoを材料とする医薬品名は桂枝加葛根湯(東洋薬行)です。", "task": "product", "name_q": "Keishikakakkonto", "name_a": "桂枝加葛根湯(東洋薬行)"} +{"id": 8692, "instruction": "Vonjo (TN)を主材料とする医薬品名は?", "response": "Vonjo (TN)を主材料とする医薬品名はVONJO(CTIBioPharmaCorp.)です。", "task": "product", "name_q": "Vonjo (TN)", "name_a": "VONJO(CTIBioPharmaCorp.)"} +{"id": 21791, "instruction": "Reduced coenzyme F420の異なる名称は?", "response": "Reduced coenzyme F420の異なる名称は還元型補酵素F420です。", "task": "replace", "name_q": "Reduced coenzyme F420", "name_a": "還元型補酵素F420"} +{"id": 4414, "instruction": "Olumiant (TN)を日本語で記述すると?", "response": "Olumiant (TN)を日本語で記述するとBaricitinib (JAN/USAN/INN)です。", "task": "replace en to ja", "name_q": "Olumiant (TN)", "name_a": "Baricitinib (JAN/USAN/INN)"} +{"id": 8019, "instruction": "Pyoverdine Iは別の呼び方では?", "response": "Pyoverdine Iは別の呼び方ではピオベルジンIです。", "task": "replace", "name_q": "Pyoverdine I", "name_a": "ピオベルジンI"} +{"id": 28055, "instruction": "Pediapred (TN)を利用した医薬品は?", "response": "Pediapred (TN)を利用した医薬品はPREDNISOLONESODIUMPHOSPHATE(EdenbridgePharmaceuticalsLLC.)です。", "task": "product", "name_q": "Pediapred (TN)", "name_a": "PREDNISOLONESODIUMPHOSPHATE(EdenbridgePharmaceuticalsLLC.)"} +{"id": 817, "instruction": "9(10H)-Acridoneの異なる名称は?", "response": "9(10H)-Acridoneの異なる名称はAcridoneです。", "task": "replace", "name_q": "9(10H)-Acridone", "name_a": "Acridone"} +{"id": 25527, "instruction": "Tretoquinol (INN)の別の呼び方は?", "response": "Tretoquinol (INN)の別の呼び方はトレトキノールです。", "task": "replace", "name_q": "Tretoquinol (INN)", "name_a": "トレトキノール"} +{"id": 22356, "instruction": "Nitrogen regulatory protein P-IIの別名は?", "response": "Nitrogen regulatory protein P-IIの別名は[Protein-PII]です。", "task": "replace", "name_q": "Nitrogen regulatory protein P-II", "name_a": "[Protein-PII]"} +{"id": 14207, "instruction": "Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoateの別の言い方は?", "response": "Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoateの別の言い方は5F-MDMB-PICAです。", "task": "replace", "name_q": "Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate", "name_a": "5F-MDMB-PICA"} +{"id": 33674, "instruction": "Mazindol (JAN/USP/INN)をは分子式で表すと?", "response": "Mazindol (JAN/USP/INN)をは分子式で表すとC16H13ClN2Oです。", "task": "formula", "name_q": "Mazindol (JAN/USP/INN)", "name_a": "C16H13ClN2O"} +{"id": 4365, "instruction": "Cetyl esters wax (NF)の日本語表記は?", "response": "Cetyl esters wax (NF)の日本語表記はセチルエステルワックスです。", "task": "replace en to ja", "name_q": "Cetyl esters wax (NF)", "name_a": "セチルエステルワックス"} +{"id": 4696, "instruction": "Cinerin Iは別の呼び方では?", "response": "Cinerin Iは別の呼び方ではシネリンIです。", "task": "replace", "name_q": "Cinerin I", "name_a": "シネリンI"} +{"id": 3834, "instruction": "イリノテカン塩酸塩(沢井製薬)を主材料とする医薬品は?", "response": "イリノテカン塩酸塩(沢井製薬)を主材料とする医薬品はIRINOTECANHYDROCHLORIDE(HikmaPharmaceuticalsUSA)です。", "task": "product", "name_q": "イリノテカン塩酸塩(沢井製薬)", "name_a": "IRINOTECANHYDROCHLORIDE(HikmaPharmaceuticalsUSA)"} +{"id": 29057, "instruction": "Sanggenon Aの別記述は?", "response": "Sanggenon Aの別記述はサンゲノン Aです。", "task": "replace", "name_q": "Sanggenon A", "name_a": "サンゲノン A"} +{"id": 21528, "instruction": "Vedotin (USAN)は別の呼び方では?", "response": "Vedotin (USAN)は別の呼び方ではMMAEです。", "task": "replace", "name_q": "Vedotin (USAN)", "name_a": "MMAE"} +{"id": 6520, "instruction": "Elisabethatrieneをの組成式は?", "response": "Elisabethatrieneをの組成式はC20H32です。", "task": "formula", "name_q": "Elisabethatriene", "name_a": "C20H32"} +{"id": 32057, "instruction": "Pronethalolをを組成式で表すと?", "response": "Pronethalolをを組成式で表すとC15H19NOです。", "task": "formula", "name_q": "Pronethalol", "name_a": "C15H19NO"} +{"id": 15848, "instruction": "Bergenin (JAN)をの化学構造は?", "response": "Bergenin (JAN)をの化学構造はC14H16O9です。", "task": "formula", "name_q": "Bergenin (JAN)", "name_a": "C14H16O9"} +{"id": 8427, "instruction": "Croscarmellose sodium (JP18/NF)の日本語訳は?", "response": "Croscarmellose sodium (JP18/NF)の日本語訳はクロスカルメロースナトリウム (JP18)です。", "task": "replace en to ja", "name_q": "Croscarmellose sodium (JP18/NF)", "name_a": "クロスカルメロースナトリウム (JP18)"} +{"id": 5988, "instruction": "Poziotinib (USAN/INN)をの化学式は?", "response": "Poziotinib (USAN/INN)をの化学式はC23H21Cl2FN4O3です。", "task": "formula", "name_q": "Poziotinib (USAN/INN)", "name_a": "C23H21Cl2FN4O3"} +{"id": 8712, "instruction": "HMR1556をを組成式で表すと?", "response": "HMR1556をを組成式で表すとC15H20N2O4Sです。", "task": "formula", "name_q": "HMR1556", "name_a": "C15H20N2O4S"} +{"id": 16, "instruction": "5-epi-Valiolone 7-phosphateをは化学式で表すと?", "response": "5-epi-Valiolone 7-phosphateをは化学式で表すとC7H13O9Pです。", "task": "formula", "name_q": "5-epi-Valiolone 7-phosphate", "name_a": "C7H13O9P"} +{"id": 30635, "instruction": "Fenofibrate and simvastatinを日本語で記述すると?", "response": "Fenofibrate and simvastatinを日本語で記述するとフェノフィブラート・シンバスタチンです。", "task": "replace en to ja", "name_q": "Fenofibrate and simvastatin", "name_a": "フェノフィブラート・シンバスタチン"} +{"id": 30088, "instruction": "Morbid obesity and spermatogenic failureを日本語で書くと?", "response": "Morbid obesity and spermatogenic failureを日本語で書くと病的肥満および精子形成不全です。", "task": "replace en to ja", "name_q": "Morbid obesity and spermatogenic failure", "name_a": "病的肥満および精子形成不全"} +{"id": 22072, "instruction": "ミオパシーを伴う中性脂質蓄積症の英語表記は?", "response": "ミオパシーを伴う中性脂質蓄積症の英語表記はNeutral lipid storage disease with myopathyです。", "task": "replace ja to en", "name_q": "ミオパシーを伴う中性脂質蓄積症", "name_a": "Neutral lipid storage disease with myopathy"} +{"id": 26956, "instruction": "Ginsenoside Rdをを組成式で表すと?", "response": "Ginsenoside Rdをを組成式で表すとC48H82O18です。", "task": "formula", "name_q": "Ginsenoside Rd", "name_a": "C48H82O18"} +{"id": 31944, "instruction": "Alisertib (USAN)の日本語訳は?", "response": "Alisertib (USAN)の日本語訳はアリセルチブです。", "task": "replace en to ja", "name_q": "Alisertib (USAN)", "name_a": "アリセルチブ"} +{"id": 2673, "instruction": "先天性中枢性低換気症候群を英語で記述すると?", "response": "先天性中枢性低換気症候群を英語で記述するとCongenital central hypoventilation syndromeです。", "task": "replace ja to en", "name_q": "先天性中枢性低換気症候群", "name_a": "Congenital central hypoventilation syndrome"} +{"id": 32354, "instruction": "Tocilizumab-baviを材料とする医薬品名は?", "response": "Tocilizumab-baviを材料とする医薬品名はTOFIDENCE(BiogenMA)です。", "task": "product", "name_q": "Tocilizumab-bavi", "name_a": "TOFIDENCE(BiogenMA)"} +{"id": 20470, "instruction": "ボセプレビルを英語で記述すると?", "response": "ボセプレビルを英語で記述するとBoceprevir (INN/USAN)です。", "task": "replace ja to en", "name_q": "ボセプレビル", "name_a": "Boceprevir (INN/USAN)"} +{"id": 541, "instruction": "Oleic acid I 131 (USAN)の異なる表現は?", "response": "Oleic acid I 131 (USAN)の異なる表現はオレイン酸 (I131)です。", "task": "replace", "name_q": "Oleic acid I 131 (USAN)", "name_a": "オレイン酸 (I131)"} +{"id": 30967, "instruction": "Yellow beewax, almond oil and salicylic acidの別の呼び方は?", "response": "Yellow beewax, almond oil and salicylic acidの別の呼び方はミツロウ・アーモンド油・サリチル酸です。", "task": "replace", "name_q": "Yellow beewax, almond oil and salicylic acid", "name_a": "ミツロウ・アーモンド油・サリチル酸"} +{"id": 31646, "instruction": "Liothyronine I 131 (USAN)の別の呼び方は?", "response": "Liothyronine I 131 (USAN)の別の呼び方はTriomet-131 (TN)です。", "task": "replace", "name_q": "Liothyronine I 131 (USAN)", "name_a": "Triomet-131 (TN)"} +{"id": 9962, "instruction": "(1H-Indol-3-ylmethyl)dimethylamineの異なる表現は?", "response": "(1H-Indol-3-ylmethyl)dimethylamineの異なる表現はGramineです。", "task": "replace", "name_q": "(1H-Indol-3-ylmethyl)dimethylamine", "name_a": "Gramine"} +{"id": 11171, "instruction": "アルテニモールをを組成式で表すと?", "response": "アルテニモールをを組成式で表すとC15H24O5です。", "task": "formula", "name_q": "アルテニモール", "name_a": "C15H24O5"} +{"id": 23796, "instruction": "Butacarbをの化学構造は?", "response": "Butacarbをの化学構造はC16H25NO2です。", "task": "formula", "name_q": "Butacarb", "name_a": "C16H25NO2"} +{"id": 22495, "instruction": "beta-D-Glucosamineをを組成式で表すと?", "response": "beta-D-Glucosamineをを組成式で表すとC6H13NO5です。", "task": "formula", "name_q": "beta-D-Glucosamine", "name_a": "C6H13NO5"} +{"id": 24585, "instruction": "Leukotriene E4をを組成式で表すと?", "response": "Leukotriene E4をを組成式で表すとC23H37NO5Sです。", "task": "formula", "name_q": "Leukotriene E4", "name_a": "C23H37NO5S"} +{"id": 1556, "instruction": "(13E)-9-Hydroxy-8alpha-labda-13-en-15-yl diphosphateの別名称は?", "response": "(13E)-9-Hydroxy-8alpha-labda-13-en-15-yl diphosphateの別名称はPeregrinol diphosphateです。", "task": "replace", "name_q": "(13E)-9-Hydroxy-8alpha-labda-13-en-15-yl diphosphate", "name_a": "Peregrinol diphosphate"} +{"id": 5417, "instruction": "Asthpyllin (TN)を言い換えると?", "response": "Asthpyllin (TN)を言い換えるとDiprophylline, ephedrine hydrochloride, papaverine hydrochloride, noscapine and diphenhydramine hydrochlorideです。", "task": "replace", "name_q": "Asthpyllin (TN)", "name_a": "Diprophylline, ephedrine hydrochloride, papaverine hydrochloride, noscapine and diphenhydramine hydrochloride"} +{"id": 19753, "instruction": "VTAMA(DermavantSciences)をを化学式で表すと?", "response": "VTAMA(DermavantSciences)をを化学式で表すとC17H18O2です。", "task": "formula", "name_q": "VTAMA(DermavantSciences)", "name_a": "C17H18O2"} +{"id": 11649, "instruction": "(4aR,10bS)-Noroxomaritidineをは化学構造で表すと?", "response": "(4aR,10bS)-Noroxomaritidineをは化学構造で表すとC16H17NO3です。", "task": "formula", "name_q": "(4aR,10bS)-Noroxomaritidine", "name_a": "C16H17NO3"} +{"id": 11864, "instruction": "(4S)-4,6-Dihydroxy-2,5-dioxohexanoateをを組成式で書くと?", "response": "(4S)-4,6-Dihydroxy-2,5-dioxohexanoateをを組成式で書くとC6H8O6です。", "task": "formula", "name_q": "(4S)-4,6-Dihydroxy-2,5-dioxohexanoate", "name_a": "C6H8O6"} +{"id": 20936, "instruction": "アリスキレンフマル酸塩・ヒドロクロロチアジドの異なる表現は?", "response": "アリスキレンフマル酸塩・ヒドロクロロチアジドの異なる表現はAliskiren hemifumarate and hydrochlorothiazideです。", "task": "replace", "name_q": "アリスキレンフマル酸塩・ヒドロクロロチアジド", "name_a": "Aliskiren hemifumarate and hydrochlorothiazide"} +{"id": 27614, "instruction": "Hemorrhagic destruction of the brain, subependymal calcification, and cataractsを日本語で書くと?", "response": "Hemorrhagic destruction of the brain, subependymal calcification, and cataractsを日本語で書くと出血性脳疾患・上衣下石灰化および白内障です。", "task": "replace en to ja", "name_q": "Hemorrhagic destruction of the brain, subependymal calcification, and cataracts", "name_a": "出血性脳疾患・上衣下石灰化および白内障"} +{"id": 2939, "instruction": "好酸球性筋膜炎の異なる表現は?", "response": "好酸球性筋膜炎の異なる表現はびまん性筋膜炎です。", "task": "replace", "name_q": "好酸球性筋膜炎", "name_a": "びまん性筋膜炎"} +{"id": 23316, "instruction": "シゾネペトシド Eの別記述は?", "response": "シゾネペトシド Eの別記述はSchizonepetoside Eです。", "task": "replace", "name_q": "シゾネペトシド E", "name_a": "Schizonepetoside E"} +{"id": 12323, "instruction": "4-Carboxy-4-hydroxy-2-oxoadipateの異なる表記は?", "response": "4-Carboxy-4-hydroxy-2-oxoadipateの異なる表記は2-Hydroxy-4-oxobutane-1,2,4-tricarboxylateです。", "task": "replace", "name_q": "4-Carboxy-4-hydroxy-2-oxoadipate", "name_a": "2-Hydroxy-4-oxobutane-1,2,4-tricarboxylate"} +{"id": 33273, "instruction": "Stri-Dex cleansing bar (TN)をは分子式で表すと?", "response": "Stri-Dex cleansing bar (TN)をは分子式で表すとC12H7Cl3O2です。", "task": "formula", "name_q": "Stri-Dex cleansing bar (TN)", "name_a": "C12H7Cl3O2"} +{"id": 24483, "instruction": "硫酸第二鉄を英語表記で表すと?", "response": "硫酸第二鉄を英語表記で表すとFerric sulfate (USP)です。", "task": "replace ja to en", "name_q": "硫酸第二鉄", "name_a": "Ferric sulfate (USP)"} +{"id": 3897, "instruction": "7,9,12-Octaketide intermediate 3をを化学構造で記述すると?", "response": "7,9,12-Octaketide intermediate 3をを化学構造で記述するとC16H15O6SRです。", "task": "formula", "name_q": "7,9,12-Octaketide intermediate 3", "name_a": "C16H15O6SR"} +{"id": 33455, "instruction": "自己炎症性疾患・脂肪織炎および皮膚疾患症候群の英語表記は?", "response": "自己炎症性疾患・脂肪織炎および皮膚疾患症候群の英語表記はAutoinflammation, panniculitis, and dermatosis syndromeです。", "task": "replace ja to en", "name_q": "自己炎症性疾患・脂肪織炎および皮膚疾患症候群", "name_a": "Autoinflammation, panniculitis, and dermatosis syndrome"} +{"id": 24836, "instruction": "Quemliclustat (USAN/INN)の別名は?", "response": "Quemliclustat (USAN/INN)の別名はクエムリクルスタットです。", "task": "replace", "name_q": "Quemliclustat (USAN/INN)", "name_a": "クエムリクルスタット"} +{"id": 13334, "instruction": "イオタラム酸メグルミン (JP18)を英語に訳すと?", "response": "イオタラム酸メグルミン (JP18)を英語に訳すとIothalamate meglumine (USP)です。", "task": "replace ja to en", "name_q": "イオタラム酸メグルミン (JP18)", "name_a": "Iothalamate meglumine (USP)"} +{"id": 7821, "instruction": "トロキサトンを英語に訳すと?", "response": "トロキサトンを英語に訳すとToloxatone (INN)です。", "task": "replace ja to en", "name_q": "トロキサトン", "name_a": "Toloxatone (INN)"} +{"id": 13678, "instruction": "タキソジオンをを組成式で表すと?", "response": "タキソジオンをを組成式で表すとC20H26O3です。", "task": "formula", "name_q": "タキソジオン", "name_a": "C20H26O3"} +{"id": 1594, "instruction": "Reltecimod sodium (USAN)を日本語で記述すると?", "response": "Reltecimod sodium (USAN)を日本語で記述するとレルテシモドナトリウムです。", "task": "replace en to ja", "name_q": "Reltecimod sodium (USAN)", "name_a": "レルテシモドナトリウム"} +{"id": 4226, "instruction": "Proteasome-associated autoinflammatory syndrome SUBGROUP Autoinflammation lipodystrophy and dermatosis syndrome を日本語で記述すると?", "response": "Proteasome-associated autoinflammatory syndrome SUBGROUP Autoinflammation lipodystrophy and dermatosis syndrome を日本語で記述するとプロテアソーム関連自己炎症性症候群 下位グループ 中條-西村症候群 です。", "task": "replace en to ja", "name_q": "Proteasome-associated autoinflammatory syndrome SUBGROUP Autoinflammation lipodystrophy and dermatosis syndrome ", "name_a": "プロテアソーム関連自己炎症性症候群 下位グループ 中條-西村症候群 "} +{"id": 4893, "instruction": "Sulfamethoxazole sodiumをを分子式で書くと?", "response": "Sulfamethoxazole sodiumをを分子式で書くとC10H11N3O3S. Naです。", "task": "formula", "name_q": "Sulfamethoxazole sodium", "name_a": "C10H11N3O3S. Na"} +{"id": 32929, "instruction": "イクラプリムをの組成式は?", "response": "イクラプリムをの組成式はC19H22N4O3です。", "task": "formula", "name_q": "イクラプリム", "name_a": "C19H22N4O3"} +{"id": 21460, "instruction": "Eril-S (TN)を日本語で記述すると?", "response": "Eril-S (TN)を日本語で記述するとFasudil hydrochloride hydrate (JAN)です。", "task": "replace en to ja", "name_q": "Eril-S (TN)", "name_a": "Fasudil hydrochloride hydrate (JAN)"} +{"id": 20889, "instruction": "プロタミン塩酸塩の英語表記は?", "response": "プロタミン塩酸塩の英語表記はProtamine hydrochloride (BAN)です。", "task": "replace ja to en", "name_q": "プロタミン塩酸塩", "name_a": "Protamine hydrochloride (BAN)"} +{"id": 33503, "instruction": "Imneskibart (USAN)をを組成式で表すと?", "response": "Imneskibart (USAN)をを組成式で表すとC6494H10070N1730O2050S42です。", "task": "formula", "name_q": "Imneskibart (USAN)", "name_a": "C6494H10070N1730O2050S42"} +{"id": 21100, "instruction": "TYPHIMVI(SanofiPasteur)を利用した医薬品は?", "response": "TYPHIMVI(SanofiPasteur)を利用した医薬品はタイフィムブイアイ(サノフィ)です。", "task": "product", "name_q": "TYPHIMVI(SanofiPasteur)", "name_a": "タイフィムブイアイ(サノフィ)"} +{"id": 958, "instruction": "アムドキソビルを英語に訳すと?", "response": "アムドキソビルを英語に訳すとAmdoxovir (USAN/INN)です。", "task": "replace ja to en", "name_q": "アムドキソビル", "name_a": "Amdoxovir (USAN/INN)"} +{"id": 15041, "instruction": "ナファゾリン塩酸塩 (JP18)の英語表記は?", "response": "ナファゾリン塩酸塩 (JP18)の英語表記はVasocon (TN)です。", "task": "replace ja to en", "name_q": "ナファゾリン塩酸塩 (JP18)", "name_a": "Vasocon (TN)"} +{"id": 29830, "instruction": "(24R)-5alpha-Ergostan-3-oneの異なる表現は?", "response": "(24R)-5alpha-Ergostan-3-oneの異なる表現は5alpha-Campestan-3-oneです。", "task": "replace", "name_q": "(24R)-5alpha-Ergostan-3-one", "name_a": "5alpha-Campestan-3-one"} +{"id": 31917, "instruction": "ペムビデュチドをを化学式で書くと?", "response": "ペムビデュチドをを化学式で書くとC182H275N39O54です。", "task": "formula", "name_q": "ペムビデュチド", "name_a": "C182H275N39O54"} +{"id": 11815, "instruction": "(+)-8-Hydroxycalameneneをは化学式で表すと?", "response": "(+)-8-Hydroxycalameneneをは化学式で表すとC15H22Oです。", "task": "formula", "name_q": "(+)-8-Hydroxycalamenene", "name_a": "C15H22O"} +{"id": 11714, "instruction": "Ampreloxetine (USAN/INN)をの組成式は?", "response": "Ampreloxetine (USAN/INN)をの組成式はC18H18F3NOです。", "task": "formula", "name_q": "Ampreloxetine (USAN/INN)", "name_a": "C18H18F3NO"} +{"id": 19501, "instruction": "(ADP-D-ribosyl)n+1-acceptorの異なる表記は?", "response": "(ADP-D-ribosyl)n+1-acceptorの異なる表記は(ADP-D-ribosyl)n-acceptorです。", "task": "replace", "name_q": "(ADP-D-ribosyl)n+1-acceptor", "name_a": "(ADP-D-ribosyl)n-acceptor"} +{"id": 2358, "instruction": "Bismuth hydroxide nitrate oxideの別の呼び方は?", "response": "Bismuth hydroxide nitrate oxideの別の呼び方はBismuth subnitrateです。", "task": "replace", "name_q": "Bismuth hydroxide nitrate oxide", "name_a": "Bismuth subnitrate"} +{"id": 16489, "instruction": "Epothilone Bの別呼称は?", "response": "Epothilone Bの別呼称はPatupiloneです。", "task": "replace", "name_q": "Epothilone B", "name_a": "Patupilone"} +{"id": 33987, "instruction": "硬化植物油を英語で記述すると?", "response": "硬化植物油を英語で記述するとHydrogenated vegetable oilです。", "task": "replace ja to en", "name_q": "硬化植物油", "name_a": "Hydrogenated vegetable oil"} +{"id": 5961, "instruction": "Portulacaxanthin IIをを分子式で書くと?", "response": "Portulacaxanthin IIをを分子式で書くとC18H18N2O7です。", "task": "formula", "name_q": "Portulacaxanthin II", "name_a": "C18H18N2O7"} +{"id": 15970, "instruction": "艾叶の別名は?", "response": "艾叶の別名はガイヨウ (JP18)です。", "task": "replace", "name_q": "艾叶", "name_a": "ガイヨウ (JP18)"} +{"id": 1801, "instruction": "Heteratisineの別記述は?", "response": "Heteratisineの別記述はヘテラチシンです。", "task": "replace", "name_q": "Heteratisine", "name_a": "ヘテラチシン"} +{"id": 978, "instruction": "Citrateをを組成式で表すと?", "response": "Citrateをを組成式で表すとC6H8O7です。", "task": "formula", "name_q": "Citrate", "name_a": "C6H8O7"} +{"id": 18458, "instruction": "D-Glucarateの別の言い方は?", "response": "D-Glucarateの別の言い方はD-グルカル酸です。", "task": "replace", "name_q": "D-Glucarate", "name_a": "D-グルカル酸"} +{"id": 11924, "instruction": "Poriferasterolの異なる名称は?", "response": "Poriferasterolの異なる名称は(3beta,22E,24R)-Stigmasta-5,22-dien-3-olです。", "task": "replace", "name_q": "Poriferasterol", "name_a": "(3beta,22E,24R)-Stigmasta-5,22-dien-3-ol"} +{"id": 18354, "instruction": "Light liquid paraffin (JP18)の別の呼び方は?", "response": "Light liquid paraffin (JP18)の別の呼び方はMineral oil, light (NF)です。", "task": "replace", "name_q": "Light liquid paraffin (JP18)", "name_a": "Mineral oil, light (NF)"} +{"id": 26280, "instruction": "Iptacopan (USAN/INN)をの化学式は?", "response": "Iptacopan (USAN/INN)をの化学式はC25H30N2O4です。", "task": "formula", "name_q": "Iptacopan (USAN/INN)", "name_a": "C25H30N2O4"} +{"id": 2818, "instruction": "6beta,19-Epoxypregn-4-ene-3,20-dioneをの組成式は?", "response": "6beta,19-Epoxypregn-4-ene-3,20-dioneをの組成式はC21H28O3です。", "task": "formula", "name_q": "6beta,19-Epoxypregn-4-ene-3,20-dione", "name_a": "C21H28O3"} +{"id": 3949, "instruction": "パンテノール (JAN)をの化学構造は?", "response": "パンテノール (JAN)をの化学構造はC9H19NO4です。", "task": "formula", "name_q": "パンテノール (JAN)", "name_a": "C9H19NO4"} +{"id": 9558, "instruction": "Beaulieu-Boycott-Innes syndromeの日本語表記は?", "response": "Beaulieu-Boycott-Innes syndromeの日本語表記はBeaulieu-Boycott-Innes 症候群です。", "task": "replace en to ja", "name_q": "Beaulieu-Boycott-Innes syndrome", "name_a": "Beaulieu-Boycott-Innes 症候群"} +{"id": 15504, "instruction": "Ethyl acetateをを組成式で記述すると?", "response": "Ethyl acetateをを組成式で記述するとC4H8O2です。", "task": "formula", "name_q": "Ethyl acetate", "name_a": "C4H8O2"} +{"id": 22294, "instruction": "CLAPO 症候群を英語表記で表すと?", "response": "CLAPO 症候群を英語表記で表すとCLAPO syndromeです。", "task": "replace ja to en", "name_q": "CLAPO 症候群", "name_a": "CLAPO syndrome"} +{"id": 16119, "instruction": "ブナフチンの異なる表記は?", "response": "ブナフチンの異なる表記はBunaftine (INN)です。", "task": "replace", "name_q": "ブナフチン", "name_a": "Bunaftine (INN)"} +{"id": 4529, "instruction": "GA1をを化学構造で表すと?", "response": "GA1をを化学構造で表すとC45H79N2O23Rです。", "task": "formula", "name_q": "GA1", "name_a": "C45H79N2O23R"} +{"id": 19296, "instruction": "シポトリンを言い換えると?", "response": "シポトリンを言い換えるとCypothrin (USAN)です。", "task": "replace", "name_q": "シポトリン", "name_a": "Cypothrin (USAN)"} +{"id": 5138, "instruction": "Nasaruplase (cell culture) (JAN)を日本語表記で表すと?", "response": "Nasaruplase (cell culture) (JAN)を日本語表記で表すとナサルプラーゼ (細胞培養) (JAN)です。", "task": "replace en to ja", "name_q": "Nasaruplase (cell culture) (JAN)", "name_a": "ナサルプラーゼ (細胞培養) (JAN)"} +{"id": 29153, "instruction": "トリトンX-100をは化学式で表すと?", "response": "トリトンX-100をは化学式で表すとC14H22O(C2H4O)nです。", "task": "formula", "name_q": "トリトンX-100", "name_a": "C14H22O(C2H4O)n"} +{"id": 21265, "instruction": "リフィルーセルを利用した薬品名は?", "response": "リフィルーセルを利用した薬品名はAMTAGVI(IovanceBiotherapeutics)です。", "task": "product", "name_q": "リフィルーセル", "name_a": "AMTAGVI(IovanceBiotherapeutics)"} +{"id": 32006, "instruction": "KDN 9-phosphateをを化学構造で書くと?", "response": "KDN 9-phosphateをを化学構造で書くとC9H17O12Pです。", "task": "formula", "name_q": "KDN 9-phosphate", "name_a": "C9H17O12P"} +{"id": 13173, "instruction": "11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-5alpha-androstan-3-oneをを化学構造で表すと?", "response": "11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-5alpha-androstan-3-oneをを化学構造で表すとC20H31FO3です。", "task": "formula", "name_q": "11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-5alpha-androstan-3-one", "name_a": "C20H31FO3"} +{"id": 11060, "instruction": "2-Amino-1,5-anhydro-2-deoxyglucitolをは組成式で表すと?", "response": "2-Amino-1,5-anhydro-2-deoxyglucitolをは組成式で表すとC6H14NO7Pです。", "task": "formula", "name_q": "2-Amino-1,5-anhydro-2-deoxyglucitol", "name_a": "C6H14NO7P"} +{"id": 25003, "instruction": "ジメチコン350を英語で書くと?", "response": "ジメチコン350を英語で書くとDimethicone 350 (USAN)です。", "task": "replace ja to en", "name_q": "ジメチコン350", "name_a": "Dimethicone 350 (USAN)"} +{"id": 1023, "instruction": "セイネツホケツトウの英語表記は?", "response": "セイネツホケツトウの英語表記はSeinetsuhoketsutoです。", "task": "replace ja to en", "name_q": "セイネツホケツトウ", "name_a": "Seinetsuhoketsuto"} +{"id": 11096, "instruction": "Styrene-butadiene copolymerをを組成式で書くと?", "response": "Styrene-butadiene copolymerをを組成式で書くと(C8H8)n. (C4H6)nです。", "task": "formula", "name_q": "Styrene-butadiene copolymer", "name_a": "(C8H8)n. (C4H6)n"} +{"id": 33004, "instruction": "Infantile cortical hyperostosisの別名は?", "response": "Infantile cortical hyperostosisの別名はCaffey diseaseです。", "task": "replace", "name_q": "Infantile cortical hyperostosis", "name_a": "Caffey disease"} +{"id": 31615, "instruction": "セボフルラン (JP18)を利用した医薬品は?", "response": "セボフルラン (JP18)を利用した医薬品はSEVOFLURANE(Sandoz)です。", "task": "product", "name_q": "セボフルラン (JP18)", "name_a": "SEVOFLURANE(Sandoz)"} +{"id": 29852, "instruction": "Osteopetrosis SUBGROUP Osteopetrosis, autosomal dominant (OPTA) Osteopetrosis, autosomal recessive (OPTB)を日本語で記述すると?", "response": "Osteopetrosis SUBGROUP Osteopetrosis, autosomal dominant (OPTA) Osteopetrosis, autosomal recessive (OPTB)を日本語で記述すると大理石骨病 下位グループ 常染色体優性大理石骨病 (OPTA) 常染色体劣性大理石骨病 (OPTB)です。", "task": "replace en to ja", "name_q": "Osteopetrosis SUBGROUP Osteopetrosis, autosomal dominant (OPTA) Osteopetrosis, autosomal recessive (OPTB)", "name_a": "大理石骨病 下位グループ 常染色体優性大理石骨病 (OPTA) 常染色体劣性大理石骨病 (OPTB)"} +{"id": 6075, "instruction": "(3R)-3-Hydroxy-2,3-dihydrotabersonineをを化学式で記述すると?", "response": "(3R)-3-Hydroxy-2,3-dihydrotabersonineをを化学式で記述するとC21H26N2O3です。", "task": "formula", "name_q": "(3R)-3-Hydroxy-2,3-dihydrotabersonine", "name_a": "C21H26N2O3"} +{"id": 13162, "instruction": "N-Ethylglycocyamineをは化学式で表すと?", "response": "N-Ethylglycocyamineをは化学式で表すとC8H17NO5です。", "task": "formula", "name_q": "N-Ethylglycocyamine", "name_a": "C8H17NO5"} +{"id": 28272, "instruction": "MCHを言い換えると?", "response": "MCHを言い換えるとMelanin-concentrating hormoneです。", "task": "replace", "name_q": "MCH", "name_a": "Melanin-concentrating hormone"} +{"id": 24666, "instruction": "Landomycin Iの別呼称は?", "response": "Landomycin Iの別呼称は8-D-Olivosyl-landomycinです。", "task": "replace", "name_q": "Landomycin I", "name_a": "8-D-Olivosyl-landomycin"} +{"id": 1905, "instruction": "ACADM deficiency SUPERGRP Disorders of mitochondrial fatty-acid oxidation Secondary hyperammonemia Mitochondrial disease を日本語に訳すと?", "response": "ACADM deficiency SUPERGRP Disorders of mitochondrial fatty-acid oxidation Secondary hyperammonemia Mitochondrial disease を日本語に訳すとACADM 欠損症 上位グループ ミトコンドリアの脂肪酸酸化異常症 二次性高アンモニア血症 ミトコンドリア病 です。", "task": "replace en to ja", "name_q": "ACADM deficiency SUPERGRP Disorders of mitochondrial fatty-acid oxidation Secondary hyperammonemia Mitochondrial disease ", "name_a": "ACADM 欠損症 上位グループ ミトコンドリアの脂肪酸酸化異常症 二次性高アンモニア血症 ミトコンドリア病 "} +{"id": 19599, "instruction": "6-(2-Chloroallylthio)purineをは化学式で表すと?", "response": "6-(2-Chloroallylthio)purineをは化学式で表すとC8H7ClN4Sです。", "task": "formula", "name_q": "6-(2-Chloroallylthio)purine", "name_a": "C8H7ClN4S"} +{"id": 23792, "instruction": "セトメラノチド塩酸塩の別名は?", "response": "セトメラノチド塩酸塩の別名はSetmelanotide hydrochloride (USAN)です。", "task": "replace", "name_q": "セトメラノチド塩酸塩", "name_a": "Setmelanotide hydrochloride (USAN)"} +{"id": 9415, "instruction": "先天性鏡像運動症を英語表記で表すと?", "response": "先天性鏡像運動症を英語表記で表すとCongenital mirror movementsです。", "task": "replace ja to en", "name_q": "先天性鏡像運動症", "name_a": "Congenital mirror movements"} +{"id": 29064, "instruction": "ENOXAPARINSODIUM(ZydusPharmaceuticalsUSA)を材料とする製品名は?", "response": "ENOXAPARINSODIUM(ZydusPharmaceuticalsUSA)を材料とする製品名はENOXAPARINSODIUM(MeithealPharmaceuticals)です。", "task": "product", "name_q": "ENOXAPARINSODIUM(ZydusPharmaceuticalsUSA)", "name_a": "ENOXAPARINSODIUM(MeithealPharmaceuticals)"} +{"id": 29375, "instruction": "Alfadhel syndromeを日本語で記述すると?", "response": "Alfadhel syndromeを日本語で記述するとAlfadhel 症候群です。", "task": "replace en to ja", "name_q": "Alfadhel syndrome", "name_a": "Alfadhel 症候群"} +{"id": 15032, "instruction": "cis-シトラールをを化学構造で表すと?", "response": "cis-シトラールをを化学構造で表すとC10H16Oです。", "task": "formula", "name_q": "cis-シトラール", "name_a": "C10H16O"} +{"id": 3497, "instruction": "2,3-Diaminopropionic acidをの化学構造は?", "response": "2,3-Diaminopropionic acidをの化学構造はC3H8N2O2です。", "task": "formula", "name_q": "2,3-Diaminopropionic acid", "name_a": "C3H8N2O2"} +{"id": 1073, "instruction": "Lenapenem hydrochloride hydrate (JAN)の異なる表記は?", "response": "Lenapenem hydrochloride hydrate (JAN)の異なる表記はBO 2727です。", "task": "replace", "name_q": "Lenapenem hydrochloride hydrate (JAN)", "name_a": "BO 2727"} +{"id": 30213, "instruction": "ポリグルコサン小体ミオパチー 下位グループ HOIL-1 欠損症を英語で書くと?", "response": "ポリグルコサン小体ミオパチー 下位グループ HOIL-1 欠損症を英語で書くとPolyglucosan body myopathy SUBGROUP Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis HOIL-1 deficiencyです。", "task": "replace ja to en", "name_q": "ポリグルコサン小体ミオパチー 下位グループ HOIL-1 欠損症", "name_a": "Polyglucosan body myopathy SUBGROUP Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis HOIL-1 deficiency"} +{"id": 29623, "instruction": "26-Deglucoprotodioscinをを化学式で記述すると?", "response": "26-Deglucoprotodioscinをを化学式で記述するとC45H74O17です。", "task": "formula", "name_q": "26-Deglucoprotodioscin", "name_a": "C45H74O17"} +{"id": 25803, "instruction": "Orthophosphoric monoesterをは化学構造で表すと?", "response": "Orthophosphoric monoesterをは化学構造で表すとH2PO4Rです。", "task": "formula", "name_q": "Orthophosphoric monoester", "name_a": "H2PO4R"} +{"id": 5860, "instruction": "2-(4-Hydroxybenzyl)isoindole-1,3-dioneをを分子式で表すと?", "response": "2-(4-Hydroxybenzyl)isoindole-1,3-dioneをを分子式で表すとC15H11NO3です。", "task": "formula", "name_q": "2-(4-Hydroxybenzyl)isoindole-1,3-dione", "name_a": "C15H11NO3"} +{"id": 2259, "instruction": "beta-Lipotropinは別の呼び方では?", "response": "beta-Lipotropinは別の呼び方ではβ-リポトロピンです。", "task": "replace", "name_q": "beta-Lipotropin", "name_a": "β-リポトロピン"} +{"id": 10830, "instruction": "ツバキ油 (JP18)の異なる表記は?", "response": "ツバキ油 (JP18)の異なる表記はCamellia oil (JP18)です。", "task": "replace", "name_q": "ツバキ油 (JP18)", "name_a": "Camellia oil (JP18)"} +{"id": 2029, "instruction": "Monoammonium glycyrrhizinate, glycine and DL-methionineを主材料とする製品は?", "response": "Monoammonium glycyrrhizinate, glycine and DL-methionineを主材料とする製品はニチファーゲン(日新製薬－山形)です。", "task": "product", "name_q": "Monoammonium glycyrrhizinate, glycine and DL-methionine", "name_a": "ニチファーゲン(日新製薬－山形)"} +{"id": 544, "instruction": "Spirolucidineの別表現は?", "response": "Spirolucidineの別表現はスピロルシジンです。", "task": "replace", "name_q": "Spirolucidine", "name_a": "スピロルシジン"} +{"id": 4134, "instruction": "クロニキセリルをの組成式は?", "response": "クロニキセリルをの組成式はC16H17ClN2O4です。", "task": "formula", "name_q": "クロニキセリル", "name_a": "C16H17ClN2O4"} +{"id": 21865, "instruction": "グルタル酸の別名称は?", "response": "グルタル酸の別名称はGlutarateです。", "task": "replace", "name_q": "グルタル酸", "name_a": "Glutarate"} +{"id": 6775, "instruction": "Pentrinitrol (USAN)を英語で書くと?", "response": "Pentrinitrol (USAN)を英語で書くとPetrin (TN)です。", "task": "replace ja to en", "name_q": "Pentrinitrol (USAN)", "name_a": "Petrin (TN)"} +{"id": 10839, "instruction": "Polyferose (USAN)を言い換えると?", "response": "Polyferose (USAN)を言い換えるとポリフェロースです。", "task": "replace", "name_q": "Polyferose (USAN)", "name_a": "ポリフェロース"} +{"id": 12179, "instruction": "Shishishitoは別の呼び方では?", "response": "Shishishitoは別の呼び方では梔子豉湯です。", "task": "replace", "name_q": "Shishishito", "name_a": "梔子豉湯"} +{"id": 9773, "instruction": "poly-cis-Polyprenyl diphosphateをを化学構造で表すと?", "response": "poly-cis-Polyprenyl diphosphateをを化学構造で表すとC5H12O7P2(C5H8)nです。", "task": "formula", "name_q": "poly-cis-Polyprenyl diphosphate", "name_a": "C5H12O7P2(C5H8)n"} +{"id": 33296, "instruction": "チトクロームCの別名称は?", "response": "チトクロームCの別名称はチトクロムC(JAN)です。", "task": "replace", "name_q": "チトクロームC", "name_a": "チトクロムC(JAN)"} +{"id": 30629, "instruction": "椎間板症 下位グループ 腰部椎間板症を英語に訳すと?", "response": "椎間板症 下位グループ 腰部椎間板症を英語に訳すとIntervertebral disc disease SUBGROUP Lumbar disc diseaseです。", "task": "replace ja to en", "name_q": "椎間板症 下位グループ 腰部椎間板症", "name_a": "Intervertebral disc disease SUBGROUP Lumbar disc disease"} +{"id": 2587, "instruction": "Gefanil (TN)の別表現は?", "response": "Gefanil (TN)の別表現はGefarnate (JP18/INN)です。", "task": "replace", "name_q": "Gefanil (TN)", "name_a": "Gefarnate (JP18/INN)"} +{"id": 24041, "instruction": "Bezafibrate (JP18/USAN/INN)を材料とする薬品は?", "response": "Bezafibrate (JP18/USAN/INN)を材料とする薬品はベザフィブラート(日医工岐阜工場)です。", "task": "product", "name_q": "Bezafibrate (JP18/USAN/INN)", "name_a": "ベザフィブラート(日医工岐阜工場)"} +{"id": 24975, "instruction": "Patuletinをの分子式は?", "response": "Patuletinをの分子式はC16H12O8です。", "task": "formula", "name_q": "Patuletin", "name_a": "C16H12O8"} +{"id": 20435, "instruction": "Dopa-responsive dystonia SUBGROUP Segawa syndrome (DYT5) Sepiapterin reductase deficiency SUPERGRP Primary dystonia を日本語に訳すと?", "response": "Dopa-responsive dystonia SUBGROUP Segawa syndrome (DYT5) Sepiapterin reductase deficiency SUPERGRP Primary dystonia を日本語に訳すとドーパ反応性ジストニア 下位グループ 瀬川病 (DYT5) セピアプテリン還元酵素欠損症 上位グループ 遺伝性ジストニア です。", "task": "replace en to ja", "name_q": "Dopa-responsive dystonia SUBGROUP Segawa syndrome (DYT5) Sepiapterin reductase deficiency SUPERGRP Primary dystonia ", "name_a": "ドーパ反応性ジストニア 下位グループ 瀬川病 (DYT5) セピアプテリン還元酵素欠損症 上位グループ 遺伝性ジストニア "} +{"id": 29447, "instruction": "Tirofibanをを分子式で記述すると?", "response": "Tirofibanをを分子式で記述するとC22H36N2O5Sです。", "task": "formula", "name_q": "Tirofiban", "name_a": "C22H36N2O5S"} +{"id": 30927, "instruction": "Oligoribonucleotideをを分子式で記述すると?", "response": "Oligoribonucleotideをを分子式で記述するとC10H17O10PR2(C5H8O6PR)nです。", "task": "formula", "name_q": "Oligoribonucleotide", "name_a": "C10H17O10PR2(C5H8O6PR)n"} +{"id": 4409, "instruction": "ペグイネサチドを英語に訳すと?", "response": "ペグイネサチドを英語に訳すとPeginesatide (USAN/INN)です。", "task": "replace ja to en", "name_q": "ペグイネサチド", "name_a": "Peginesatide (USAN/INN)"} +{"id": 32304, "instruction": "trans-4-Hydroxy-D-prolineをを化学式で表すと?", "response": "trans-4-Hydroxy-D-prolineをを化学式で表すとC5H9NO3です。", "task": "formula", "name_q": "trans-4-Hydroxy-D-proline", "name_a": "C5H9NO3"} +{"id": 30975, "instruction": "SOTALOL(BayshorePharmaceuticalsLLC)を使用した商品名は?", "response": "SOTALOL(BayshorePharmaceuticalsLLC)を使用した商品名はSOTALOLHYDROCHLORIDE(EpicPharma)です。", "task": "product", "name_q": "SOTALOL(BayshorePharmaceuticalsLLC)", "name_a": "SOTALOLHYDROCHLORIDE(EpicPharma)"} +{"id": 24299, "instruction": "Pamidronic acidの異なる表現は?", "response": "Pamidronic acidの異なる表現はPamidronateです。", "task": "replace", "name_q": "Pamidronic acid", "name_a": "Pamidronate"} +{"id": 11554, "instruction": "1,2-beta-Oligomannanをを分子式で書くと?", "response": "1,2-beta-Oligomannanをを分子式で書くとH2O(C6H10O5)nです。", "task": "formula", "name_q": "1,2-beta-Oligomannan", "name_a": "H2O(C6H10O5)n"} +{"id": 25171, "instruction": "進行性関節症を伴う遅延性脊椎骨端異形成 上位グループ 脊椎骨端異形成 の英訳は?", "response": "進行性関節症を伴う遅延性脊椎骨端異形成 上位グループ 脊椎骨端異形成 の英訳はProgressive pseudorheumatoid dysplasiaです。", "task": "replace ja to en", "name_q": "進行性関節症を伴う遅延性脊椎骨端異形成 上位グループ 脊椎骨端異形成 ", "name_a": "Progressive pseudorheumatoid dysplasia"} +{"id": 17292, "instruction": "C24H32O5を使用した製品は?", "response": "C24H32O5を使用した製品はエクラー(久光製薬)です。", "task": "product", "name_q": "C24H32O5", "name_a": "エクラー(久光製薬)"} +{"id": 24350, "instruction": "(5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyicosa-5,7,11,14-tetraenoic acidの別記述は?", "response": "(5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyicosa-5,7,11,14-tetraenoic acidの別記述は(5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyeicosa-5,7,11,14-tetraenoic acidです。", "task": "replace", "name_q": "(5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyicosa-5,7,11,14-tetraenoic acid", "name_a": "(5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyeicosa-5,7,11,14-tetraenoic acid"} +{"id": 31144, "instruction": "Dermatan 4-sulfateをを分子式で書くと?", "response": "Dermatan 4-sulfateをを分子式で書くと(C14H21NO14S)nです。", "task": "formula", "name_q": "Dermatan 4-sulfate", "name_a": "(C14H21NO14S)n"} +{"id": 19367, "instruction": "ラッカセイ油 (JP18)の別呼称は?", "response": "ラッカセイ油 (JP18)の別呼称はPeanut oil (JP18/NF)です。", "task": "replace", "name_q": "ラッカセイ油 (JP18)", "name_a": "Peanut oil (JP18/NF)"} +{"id": 24443, "instruction": "LG 100268をを化学式で記述すると?", "response": "LG 100268をを化学式で記述するとC24H29NO2です。", "task": "formula", "name_q": "LG 100268", "name_a": "C24H29NO2"} +{"id": 24081, "instruction": "高リポ蛋白血症 I 型 上位グループ 原発性高カイロミクロン血症 脂質異常症 の英訳は?", "response": "高リポ蛋白血症 I 型 上位���ループ 原発性高カイロミクロン血症 脂質異常症 の英訳はHyperlipoproteinemia, type I SUPERGRP Primary hyperchylomicronemia Hyperlipidemia です。", "task": "replace ja to en", "name_q": "高リポ蛋白血症 I 型 上位グループ 原発性高カイロミクロン血症 脂質異常症 ", "name_a": "Hyperlipoproteinemia, type I SUPERGRP Primary hyperchylomicronemia Hyperlipidemia "} +{"id": 20384, "instruction": "Carbomer 934 (NF)を英語で記述すると?", "response": "Carbomer 934 (NF)を英語で記述するとCarbopol 934 (TN)です。", "task": "replace ja to en", "name_q": "Carbomer 934 (NF)", "name_a": "Carbopol 934 (TN)"} +{"id": 23314, "instruction": "3,4,3',4'-Tetrahydroxy-alpha,alpha'-diethylstilbeneの別記述は?", "response": "3,4,3',4'-Tetrahydroxy-alpha,alpha'-diethylstilbeneの別記述はalpha,alpha'-Diethyl-3,4,3',4'-stilbenetetraolです。", "task": "replace", "name_q": "3,4,3',4'-Tetrahydroxy-alpha,alpha'-diethylstilbene", "name_a": "alpha,alpha'-Diethyl-3,4,3',4'-stilbenetetraol"} +{"id": 27375, "instruction": "3TCをは化学式で表すと?", "response": "3TCをは化学式で表すとC8H11N3O3Sです。", "task": "formula", "name_q": "3TC", "name_a": "C8H11N3O3S"} +{"id": 29422, "instruction": ")を用いた薬品名は?", "response": ")を用いた薬品名はGUANFACINE(TWiPharmaceuticals)です。", "task": "product", "name_q": ")", "name_a": "GUANFACINE(TWiPharmaceuticals)"} +{"id": 22879, "instruction": "beta-L-Fucoseをを化学構造で書くと?", "response": "beta-L-Fucoseをを化学構造で書くとC6H12O5です。", "task": "formula", "name_q": "beta-L-Fucose", "name_a": "C6H12O5"} +{"id": 22660, "instruction": "2-Dechloroethylifosfamideをを化学構造で表すと?", "response": "2-Dechloroethylifosfamideをを化学構造で表すとC5H12ClN2O2Pです。", "task": "formula", "name_q": "2-Dechloroethylifosfamide", "name_a": "C5H12ClN2O2P"} +{"id": 23222, "instruction": "(N)1-Acetylisoniazidの異なる表記は?", "response": "(N)1-Acetylisoniazidの異なる表記はN-Acetylisoniazidです。", "task": "replace", "name_q": "(N)1-Acetylisoniazid", "name_a": "N-Acetylisoniazid"} +{"id": 14175, "instruction": "3-Oxooctanoyl-[acp]をを分子式で表すと?", "response": "3-Oxooctanoyl-[acp]をを分子式で表すとC8H13O2SRです。", "task": "formula", "name_q": "3-Oxooctanoyl-[acp]", "name_a": "C8H13O2SR"} +{"id": 3770, "instruction": "クロラゼプ酸二カリウム (JP18)をを化学構造で表すと?", "response": "クロラゼプ酸二カリウム (JP18)をを化学構造で表すとC16H10ClN2O3. KOH. Kです。", "task": "formula", "name_q": "クロラゼプ酸二カリウム (JP18)", "name_a": "C16H10ClN2O3. KOH. K"} +{"id": 1032, "instruction": "Gnathodiaphyseal dysplasiaを日本語表記で表すと?", "response": "Gnathodiaphyseal dysplasiaを日本語表記で表すと顎骨骨幹異形成症です。", "task": "replace en to ja", "name_q": "Gnathodiaphyseal dysplasia", "name_a": "顎骨骨幹異形成症"} +{"id": 11665, "instruction": "ルマカフトル・イバカフトルの異なる表現は?", "response": "ルマカフトル・イバカフトルの異なる表現はLumacaftor and ivacaftorです。", "task": "replace", "name_q": "ルマカフトル・イバカフトル", "name_a": "Lumacaftor and ivacaftor"} +{"id": 28436, "instruction": "Mental retardation-stereotypic movements-epilepsy and/or cerebral malformationsを日本語表記で表すと?", "response": "Mental retardation-stereotypic movements-epilepsy and/or cerebral malformationsを日本語表記で表すと5q14.3 欠失症候群です。", "task": "replace en to ja", "name_q": "Mental retardation-stereotypic movements-epilepsy and/or cerebral malformations", "name_a": "5q14.3 欠失症候群"} +{"id": 5509, "instruction": "S-Formylmycothiolをを化学構造で書くと?", "response": "S-Formylmycothiolをを化学構造で書くとC18H30N2O13Sです。", "task": "formula", "name_q": "S-Formylmycothiol", "name_a": "C18H30N2O13S"} +{"id": 21452, "instruction": "CARBAMAZEPINE(TorrentPharmaceuticalsLimited)を主とした製品は?", "response": "CARBAMAZEPINE(TorrentPharmaceuticalsLimited)を主とした製品はカルバマゼピン(共和薬品工業)です。", "task": "product", "name_q": "CARBAMAZEPINE(TorrentPharmaceuticalsLimited)", "name_a": "カルバマゼピン(共和薬品工業)"} +{"id": 21857, "instruction": "Avermectin B1bの別名称は?", "response": "Avermectin B1bの別名称はアルベメクチン B1bです。", "task": "replace", "name_q": "Avermectin B1b", "name_a": "アルベメクチン B1b"} +{"id": 19525, "instruction": "C9H22NO7P2. Na. H2Oを主とした製品名は?", "response": "C9H22NO7P2. Na. H2Oを主とした製品名はボンビバ(大正製薬)です。", "task": "product", "name_q": "C9H22NO7P2. Na. H2O", "name_a": "ボンビバ(大正製薬)"} +{"id": 31983, "instruction": "Uracilをを化学構造で記述すると?", "response": "Uracilをを化学構造で記述するとC4H4N2O2です。", "task": "formula", "name_q": "Uracil", "name_a": "C4H4N2O2"} +{"id": 27158, "instruction": "1,4-Naphthoquinoneをを化学構造で書くと?", "response": "1,4-Naphthoquinoneをを化学構造で書くとC10H6O2です。", "task": "formula", "name_q": "1,4-Naphthoquinone", "name_a": "C10H6O2"} +{"id": 7089, "instruction": "Adatanserin hydrochloride (USAN)の異なる名称は?", "response": "Adatanserin hydrochloride (USAN)の異なる名称はアダタンセリン塩酸塩です。", "task": "replace", "name_q": "Adatanserin hydrochloride (USAN)", "name_a": "アダタンセリン塩酸塩"} +{"id": 22991, "instruction": "Estradiol enanthate (USAN)をの組成式は?", "response": "Estradiol enanthate (USAN)をの組成式はC25H36O3です。", "task": "formula", "name_q": "Estradiol enanthate (USAN)", "name_a": "C25H36O3"} +{"id": 27799, "instruction": "ミラカイニド酒石酸塩 (JAN)の英語表記は?", "response": "ミラカイニド酒石酸塩 (JAN)の英語表記はMilacainide tartrate (JAN)です。", "task": "replace ja to en", "name_q": "ミラカイニド酒石酸塩 (JAN)", "name_a": "Milacainide tartrate (JAN)"} +{"id": 20293, "instruction": "Sertindole (USAN/INN)を日本語で記述すると?", "response": "Sertindole (USAN/INN)を日本語で記述するとセルチンドールです。", "task": "replace en to ja", "name_q": "Sertindole (USAN/INN)", "name_a": "セルチンドール"} +{"id": 30509, "instruction": "5alpha-Cholesta-8,24-dien-3-oneの異なる名称は?", "response": "5alpha-Cholesta-8,24-dien-3-oneの異なる名称はZymosteroneです。", "task": "replace", "name_q": "5alpha-Cholesta-8,24-dien-3-one", "name_a": "Zymosterone"} +{"id": 30189, "instruction": "Amicycline (USAN/INN)をは組成式で表すと?", "response": "Amicycline (USAN/INN)をは組成式で表すとC21H23N3O7です。", "task": "formula", "name_q": "Amicycline (USAN/INN)", "name_a": "C21H23N3O7"} +{"id": 18814, "instruction": "GEMFIBROZIL(A-SMedicationSolutions)を材料とする製品名は?", "response": "GEMFIBROZIL(A-SMedicationSolutions)を材料とする製品名はGEMFIBROZIL(AmericanHealthPackaging)です。", "task": "product", "name_q": "GEMFIBROZIL(A-SMedicationSolutions)", "name_a": "GEMFIBROZIL(AmericanHealthPackaging)"} +{"id": 18892, "instruction": "H. pylori KDO-lipid Aをの化学式は?", "response": "H. pylori KDO-lipid Aをの化学式はC92H174N3O26Pです。", "task": "formula", "name_q": "H. pylori KDO-lipid A", "name_a": "C92H174N3O26P"} +{"id": 30855, "instruction": "tRNA adenineの別表現は?", "response": "tRNA adenineの別表現はAdenosine in tRNAです。", "task": "replace", "name_q": "tRNA adenine", "name_a": "Adenosine in tRNA"} +{"id": 5418, "instruction": "(-)-Cyatha-3,12-dieneの異なる名称は?", "response": "(-)-Cyatha-3,12-dieneの異なる名称は(3aS,5aS,10aS)-3a,5a,8-Trimethyl-1-(propan-2-yl)-2,3,4,5,6,9,10,10a-octahydrocyclohepta[e]indeneです。", "task": "replace", "name_q": "(-)-Cyatha-3,12-diene", "name_a": "(3aS,5aS,10aS)-3a,5a,8-Trimethyl-1-(propan-2-yl)-2,3,4,5,6,9,10,10a-octahydrocyclohepta[e]indene"} +{"id": 23662, "instruction": "1,4-ジオキサンの異なる表記は?", "response": "1,4-ジオキサンの異なる表記は1,4-Dioxaneです。", "task": "replace", "name_q": "1,4-ジオキサン", "name_a": "1,4-Dioxane"} +{"id": 22745, "instruction": "4'-O-beta-D-Glucosyl-cis-p-coumarateをを分子式で表すと?", "response": "4'-O-beta-D-Glucosyl-cis-p-coumarateをを分子式で表すとC15H18O8です。", "task": "formula", "name_q": "4'-O-beta-D-Glucosyl-cis-p-coumarate", "name_a": "C15H18O8"} +{"id": 506, "instruction": "セムペルビリンの別名は?", "response": "セムペルビリンの別名はSempervirineです。", "task": "replace", "name_q": "セムペルビリン", "name_a": "Sempervirine"} +{"id": 12838, "instruction": "Vobasineをを組成式で書くと?", "response": "Vobasineをを組成式で書くとC21H24N2O3です。", "task": "formula", "name_q": "Vobasine", "name_a": "C21H24N2O3"} +{"id": 20251, "instruction": "DP-TAT-59をを化学式で記述すると?", "response": "DP-TAT-59をを化学式で記述するとC29H35NO2です。", "task": "formula", "name_q": "DP-TAT-59", "name_a": "C29H35NO2"} +{"id": 20905, "instruction": "124-1をの組成式は?", "response": "124-1をの組成式はC37H44O14です。", "task": "formula", "name_q": "124-1", "name_a": "C37H44O14"} +{"id": 13122, "instruction": "Stenbolone acetate (USAN)をを組成式で書くと?", "response": "Stenbolone acetate (USAN)をを組成式で書くとC22H32O3です。", "task": "formula", "name_q": "Stenbolone acetate (USAN)", "name_a": "C22H32O3"} +{"id": 34428, "instruction": "Aphidicolan-16beta-olをを分子式で記述すると?", "response": "Aphidicolan-16beta-olをを分子式で記述するとC20H34Oです。", "task": "formula", "name_q": "Aphidicolan-16beta-ol", "name_a": "C20H34O"} +{"id": 32107, "instruction": "Chlorprothixeneをを化学式で書くと?", "response": "Chlorprothixeneをを化学式で書くとC18H18ClNSです。", "task": "formula", "name_q": "Chlorprothixene", "name_a": "C18H18ClNS"} +{"id": 8035, "instruction": "N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acidをの化学構造は?", "response": "N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acidをの化学構造はC24H25NO6です。", "task": "formula", "name_q": "N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acid", "name_a": "C24H25NO6"} +{"id": 11058, "instruction": "デキサメタゾンシペシル酸エステル (JAN)をを分子式で書くと?", "response": "デキサメタゾンシペシル酸エステル (JAN)をを分子式で書くとC33H43FO7です。", "task": "formula", "name_q": "デキサメタゾンシペシル酸エステル (JAN)", "name_a": "C33H43FO7"} +{"id": 2351, "instruction": "薬用石ケン (JP18)の別呼称は?", "response": "薬用石ケン (JP18)の別呼称はMedicinal soap (JP18)です。", "task": "replace", "name_q": "薬用石ケン (JP18)", "name_a": "Medicinal soap (JP18)"} +{"id": 4953, "instruction": "Ipexidine mesylate (USAN)の異なる名称は?", "response": "Ipexidine mesylate (USAN)の異なる名称はメシル酸イペキシジンです。", "task": "replace", "name_q": "Ipexidine mesylate (USAN)", "name_a": "メシル酸イペキシジン"} +{"id": 17896, "instruction": "Bamboo sap (Non-JPS)を英語で書くと?", "response": "Bamboo sap (Non-JPS)を英語で書くとPhyllostachydis succusです。", "task": "replace ja to en", "name_q": "Bamboo sap (Non-JPS)", "name_a": "Phyllostachydis succus"} +{"id": 23452, "instruction": "Loviride (USAN/INN)は別の呼び方では?", "response": "Loviride (USAN/INN)は別の呼び方ではロビリドです。", "task": "replace", "name_q": "Loviride (USAN/INN)", "name_a": "ロビリド"} +{"id": 6135, "instruction": "1,2,3,7,8-Pentachlorodibenzo-p-dioxinの異なる名称は?", "response": "1,2,3,7,8-Pentachlorodibenzo-p-dioxinの異なる名称は1,2,3,7,8-PeCDDです。", "task": "replace", "name_q": "1,2,3,7,8-Pentachlorodibenzo-p-dioxin", "name_a": "1,2,3,7,8-PeCDD"} +{"id": 9453, "instruction": "Bicuspid aortic valveの日本語訳は?", "response": "Bicuspid aortic valveの日本語訳は大動脈弁疾患です。", "task": "replace en to ja", "name_q": "Bicuspid aortic valve", "name_a": "大動脈弁疾患"} +{"id": 20784, "instruction": "Lifastuzumab (USAN)の異なる表記は?", "response": "Lifastuzumab (USAN)の異なる表記はリファスツズマブです。", "task": "replace", "name_q": "Lifastuzumab (USAN)", "name_a": "リファスツズマブ"} +{"id": 20014, "instruction": "パトリノシドをを化学構造で記述すると?", "response": "パトリノシドをを化学構造で記述するとC21H34O11です。", "task": "formula", "name_q": "パトリノシド", "name_a": "C21H34O11"} +{"id": 21898, "instruction": "ATROPENAUTO-INJECTOR(MeridianMedicalTechnologiesLLC)を主材料とする製品は?", "response": "ATROPENAUTO-INJECTOR(MeridianMedicalTechnologiesLLC)を主材料とする製品はリュウアト(参天製薬)です。", "task": "product", "name_q": "ATROPENAUTO-INJECTOR(MeridianMedicalTechnologiesLLC)", "name_a": "リュウアト(参天製薬)"} +{"id": 25746, "instruction": "Gentianadineの別呼称は?", "response": "Gentianadineの別呼称はゲンチアナジンです。", "task": "replace", "name_q": "Gentianadine", "name_a": "ゲンチアナジン"} +{"id": 3553, "instruction": "ポリゲリンを言い換えると?", "response": "ポリゲリンを言い換えるとPolygeline (BAN)です。", "task": "replace", "name_q": "ポリゲリン", "name_a": "Polygeline (BAN)"} +{"id": 17620, "instruction": "Demoxepam (USAN/INN)をを化学構造で表すと?", "response": "Demoxepam (USAN/INN)をを化学構造で表すとC15H11ClN2O2です。", "task": "formula", "name_q": "Demoxepam (USAN/INN)", "name_a": "C15H11ClN2O2"} +{"id": 7715, "instruction": "Jumihaidokutoを日本語表記で表すと?", "response": "Jumihaidokutoを日本語表記で表すと十味敗毒湯です。", "task": "replace en to ja", "name_q": "Jumihaidokuto", "name_a": "十味敗毒湯"} +{"id": 26050, "instruction": "Retrorsineをは化学構造で表すと?", "response": "Retrorsineをは化学構造で表すとC18H25NO6です。", "task": "formula", "name_q": "Retrorsine", "name_a": "C18H25NO6"} +{"id": 33434, "instruction": "Equimate (TN)をは組成式で表すと?", "response": "Equimate (TN)をは組成式で表すとC23H28F3O6. Naです。", "task": "formula", "name_q": "Equimate (TN)", "name_a": "C23H28F3O6. Na"} +{"id": 9869, "instruction": "Olsalazine (INN)の日本語表記は?", "response": "Olsalazine (INN)の日本語表記はオルサラジンです。", "task": "replace en to ja", "name_q": "Olsalazine (INN)", "name_a": "オルサラジン"} +{"id": 20912, "instruction": "ガスえそウマ抗毒素 (JAN)の別表現は?", "response": "ガスえそウマ抗毒素 (JAN)の別表現はGas gangrene antitoxin, equine (JAN)です。", "task": "replace", "name_q": "ガスえそウマ抗毒素 (JAN)", "name_a": "Gas gangrene antitoxin, equine (JAN)"} +{"id": 8900, "instruction": "ブファノリドをを組成式で書くと?", "response": "ブファノリドをを組成式で書くとC24H38O2です。", "task": "formula", "name_q": "ブファノリド", "name_a": "C24H38O2"} +{"id": 27804, "instruction": "Tivumecirnon (USAN/INN)を日本語表記で表すと?", "response": "Tivumecirnon (USAN/INN)を日本語表記で表すとチベメシルノンです。", "task": "replace en to ja", "name_q": "Tivumecirnon (USAN/INN)", "name_a": "チベメシルノン"} +{"id": 3620, "instruction": "エメダスチンをの組成式は?", "response": "エメダスチンをの組成式はC17H26N4Oです。", "task": "formula", "name_q": "エメダスチン", "name_a": "C17H26N4O"} +{"id": 8770, "instruction": "Paeonilactone Bの別表現は?", "response": "Paeonilactone Bの別表現はペオニラクトンBです。", "task": "replace", "name_q": "Paeonilactone B", "name_a": "ペオニラクトンB"} +{"id": 7803, "instruction": "11beta,17beta-Dihydroxy-6alpha,17-dimethylandrost-4-en-3-oneをを化学構造で表すと?", "response": "11beta,17beta-Dihydroxy-6alpha,17-dimethylandrost-4-en-3-oneをを化学構造で表すとC21H32O3です。", "task": "formula", "name_q": "11beta,17beta-Dihydroxy-6alpha,17-dimethylandrost-4-en-3-one", "name_a": "C21H32O3"} +{"id": 18206, "instruction": "l-Menthol and glycol salicylateを日本語で記述すると?", "response": "l-Menthol and glycol salicylateを日本語で記述するとl-メントール・サリチル酸グリコールです。", "task": "replace en to ja", "name_q": "l-Menthol and glycol salicylate", "name_a": "l-メントール・サリチル酸グリコール"} +{"id": 28223, "instruction": "Esprocarbの別呼称は?", "response": "Esprocarbの別呼称はエスプロカルブです。", "task": "replace", "name_q": "Esprocarb", "name_a": "エスプロカルブ"} +{"id": 26469, "instruction": "Biofermin (TN)を日本語に訳すと?", "response": "Biofermin (TN)を日本語に訳すとLactomin and amylolytic bacillusです。", "task": "replace en to ja", "name_q": "Biofermin (TN)", "name_a": "Lactomin and amylolytic bacillus"} +{"id": 14511, "instruction": "プラミラセタム塩酸塩をを化学式で表すと?", "response": "プラミラセタム塩酸塩をを化学式で表すとC14H27N3O2. HClです。", "task": "formula", "name_q": "プラミラセタム塩酸塩", "name_a": "C14H27N3O2. HCl"} +{"id": 27083, "instruction": "CSは別の呼び方では?", "response": "CSは別の呼び方ではCilastatin sodium (JP18/USP)です。", "task": "replace", "name_q": "CS", "name_a": "Cilastatin sodium (JP18/USP)"} +{"id": 26150, "instruction": "前立腺癌 下位グループ 遺伝性前立腺癌 を英語で記述すると?", "response": "前立腺癌 下位グループ 遺伝性前立腺癌 を英語で記述するとProstate cancer SUBGROUP Hereditary prostate cancer です。", "task": "replace ja to en", "name_q": "前立腺癌 下位グループ 遺伝性前立腺癌 ", "name_a": "Prostate cancer SUBGROUP Hereditary prostate cancer "} +{"id": 26352, "instruction": "Nicotinic acid adenine dinucleotide phosphateの異なる表記は?", "response": "Nicotinic acid adenine dinucleotide phosphateの異なる表記はNicotinate-adenine dinucleotide phosphateです。", "task": "replace", "name_q": "Nicotinic acid adenine dinucleotide phosphate", "name_a": "Nicotinate-adenine dinucleotide phosphate"} +{"id": 3161, "instruction": "9beta-Pimara-7,15-dien-19-olをを組成式で表すと?", "response": "9beta-Pimara-7,15-dien-19-olをを組成式で表すとC20H32Oです。", "task": "formula", "name_q": "9beta-Pimara-7,15-dien-19-ol", "name_a": "C20H32O"} +{"id": 6943, "instruction": "Brooke-Spiegler syndromeを日本語で記述すると?", "response": "Brooke-Spiegler syndromeを日本語で記述するとBrooke-Spiegler 症候群です。", "task": "replace en to ja", "name_q": "Brooke-Spiegler syndrome", "name_a": "Brooke-Spiegler 症候群"} +{"id": 20931, "instruction": "Behcet diseaseの別の呼び方は?", "response": "Behcet diseaseの別の呼び方はBehcet syndromeです。", "task": "replace", "name_q": "Behcet disease", "name_a": "Behcet syndrome"} +{"id": 20166, "instruction": "ベロテカン塩酸塩の別表現は?", "response": "ベロテカン塩酸塩の別表現はBelotecan hydrochloride (USAN)です。", "task": "replace", "name_q": "ベロテカン塩酸塩", "name_a": "Belotecan hydrochloride (USAN)"} +{"id": 24104, "instruction": "Ingenol 3,20-dibenzoateの別表現は?", "response": "Ingenol 3,20-dibenzoateの別表現はインゲノール 3,20-ジベンゾアートです。", "task": "replace", "name_q": "Ingenol 3,20-dibenzoate", "name_a": "インゲノール 3,20-ジベンゾアート"} +{"id": 27211, "instruction": "N,N'-Diacetyl-alpha-D-bacillosaminyldiphospho-tritrans,heptacis-undecaprenolをは化学構造で表すと?", "response": "N,N'-Diacetyl-alpha-D-bacillosaminyldiphospho-tritrans,heptacis-undecaprenolをは化学構造で表すとC65H108N2O11P2です。", "task": "formula", "name_q": "N,N'-Diacetyl-alpha-D-bacillosaminyldiphospho-tritrans,heptacis-undecaprenol", "name_a": "C65H108N2O11P2"} +{"id": 10406, "instruction": "Valnemulin (INN)の別名称は?", "response": "Valnemulin (INN)の別名称はバルネムリンです。", "task": "replace", "name_q": "Valnemulin (INN)", "name_a": "バルネムリン"} +{"id": 1301, "instruction": "Sclerocitrinをを化学構造で表すと?", "response": "Sclerocitrinをを化学構造で表すとC36H22O17です。", "task": "formula", "name_q": "Sclerocitrin", "name_a": "C36H22O17"} +{"id": 12603, "instruction": "3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucoseの異なる名称は?", "response": "3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucoseの異なる名称は3-(4-Deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D-glucosamineです。", "task": "replace", "name_q": "3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucose", "name_a": "3-(4-Deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D-glucosamine"} +{"id": 2299, "instruction": "バロキサビルをは化学構造で表すと?", "response": "バロキサビルをは化学構造で表すとC24H19F2N3O4Sです。", "task": "formula", "name_q": "バロキサビル", "name_a": "C24H19F2N3O4S"} +{"id": 7980, "instruction": "タクシャ(中嶋生薬)を材料とする商品は?", "response": "タクシャ(中嶋生薬)を材料とする商品は沢瀉(小島漢方)です。", "task": "product", "name_q": "タクシャ(中嶋生薬)", "name_a": "沢瀉(小島漢方)"} +{"id": 27277, "instruction": "Tributyltin oxideをを組成式で書くと?", "response": "Tributyltin oxideをを組成式で書くとC24H54OSn2です。", "task": "formula", "name_q": "Tributyltin oxide", "name_a": "C24H54OSn2"} +{"id": 33318, "instruction": "alpha-NADHをを分子式で書くと?", "response": "alpha-NADHをを分子式で書くとC21H29N7O14P2です。", "task": "formula", "name_q": "alpha-NADH", "name_a": "C21H29N7O14P2"} +{"id": 27542, "instruction": "Daphnetoxinの別表現は?", "response": "Daphnetoxinの別表現はダフネトキシンです。", "task": "replace", "name_q": "Daphnetoxin", "name_a": "ダフネトキシン"} +{"id": 4848, "instruction": "グリチルリチン酸一アンモニウムをを組成式で書くと?", "response": "グリチルリチン酸一アンモニウムをを組成式で書くとC42H62O16. NH3です。", "task": "formula", "name_q": "グリチルリチン酸一アンモニウム", "name_a": "C42H62O16. NH3"} +{"id": 9780, "instruction": "Flavonolをを化学式で記述すると?", "response": "Flavonolをを化学式で記述するとC15H10O3です。", "task": "formula", "name_q": "Flavonol", "name_a": "C15H10O3"} +{"id": 24978, "instruction": "Inapsine (TN)を日本語で記述すると?", "response": "Inapsine (TN)を日本語で記述するとDroperidol (JP18/USP/INN)です。", "task": "replace en to ja", "name_q": "Inapsine (TN)", "name_a": "Droperidol (JP18/USP/INN)"} +{"id": 26054, "instruction": "(S)-beta-Bisaboleneの異なる表記は?", "response": "(S)-beta-Bisaboleneの異なる表記はbeta-Bisaboleneです。", "task": "replace", "name_q": "(S)-beta-Bisabolene", "name_a": "beta-Bisabolene"} +{"id": 29563, "instruction": "Alexander diseaseを日本語表記で表すと?", "response": "Alexander diseaseを日本語表記で表すとアレキサンダー病です。", "task": "replace en to ja", "name_q": "Alexander disease", "name_a": "アレキサンダー病"} +{"id": 7539, "instruction": "DAPTACEL(SanofiPasteur)を主材料とする製品名は?", "response": "DAPTACEL(SanofiPasteur)を主材料とする製品名はトリビック(阪大微生物病研究会)です。", "task": "product", "name_q": "DAPTACEL(SanofiPasteur)", "name_a": "トリビック(阪大微生物病研究会)"} +{"id": 18198, "instruction": "Aplasia cutis congenitaを日本語に訳すと?", "response": "Aplasia cutis congenitaを日本語に訳すと先天性皮膚欠損です。", "task": "replace en to ja", "name_q": "Aplasia cutis congenita", "name_a": "先天性皮膚欠損"} +{"id": 12142, "instruction": "alpha-D-Ribose 1-methylphosphonate 5-phosphateをを分子式で書くと?", "response": "alpha-D-Ribose 1-methylphosphonate 5-phosphateをを分子式で書くとC6H14O10P2です。", "task": "formula", "name_q": "alpha-D-Ribose 1-methylphosphonate 5-phosphate", "name_a": "C6H14O10P2"} +{"id": 5899, "instruction": "NAc-DNP-Cysの別名称は?", "response": "NAc-DNP-Cysの別名称はN-Acetyl 2,4-dinitrophenyl cysteineです。", "task": "replace", "name_q": "NAc-DNP-Cys", "name_a": "N-Acetyl 2,4-dinitrophenyl cysteine"} +{"id": 143, "instruction": "Prequist powder (TN)の別表現は?", "response": "Prequist powder (TN)の別表現はCalcium lactate (USP)です。", "task": "replace", "name_q": "Prequist powder (TN)", "name_a": "Calcium lactate (USP)"} +{"id": 13744, "instruction": "Sodium iodide I 125 (USAN)の別の呼び方は?", "response": "Sodium iodide I 125 (USAN)の別の呼び方はIodotope I-125 (TN)です。", "task": "replace", "name_q": "Sodium iodide I 125 (USAN)", "name_a": "Iodotope I-125 (TN)"} +{"id": 28433, "instruction": "Deinoxanthinをは分子式で表すと?", "response": "Deinoxanthinをは分子式で表すとC40H54O3です。", "task": "formula", "name_q": "Deinoxanthin", "name_a": "C40H54O3"} +{"id": 6005, "instruction": "D-グルコースの別呼称は?", "response": "D-グルコースの別呼称はグルコースです。", "task": "replace", "name_q": "D-グルコース", "name_a": "グルコース"} +{"id": 17895, "instruction": "Molsidomine (JAN/USAN/INN)の日本語表記は?", "response": "Molsidomine (JAN/USAN/INN)の日本語表記はモルシドミン (JAN)です。", "task": "replace en to ja", "name_q": "Molsidomine (JAN/USAN/INN)", "name_a": "モルシドミン (JAN)"} +{"id": 32504, "instruction": "グラチオゲニンをを化学構造で表すと?", "response": "グラチオゲニンをを化学構造で表すとC30H48O4です。", "task": "formula", "name_q": "グラチオゲニン", "name_a": "C30H48O4"} +{"id": 8572, "instruction": "BISMUTHSUBCITRATEPOTASSIUM,METRONIDAZOLE,ANDTETRACYCLINEHYDROCHLORIDE(H2-Pharma)を材料とする商品名は?", "response": "BISMUTHSUBCITRATEPOTASSIUM,METRONIDAZOLE,ANDTETRACYCLINEHYDROCHLORIDE(H2-Pharma)を材料とする商品名はPYLERA(H2-Pharma)です。", "task": "product", "name_q": "BISMUTHSUBCITRATEPOTASSIUM,METRONIDAZOLE,ANDTETRACYCLINEHYDROCHLORIDE(H2-Pharma)", "name_a": "PYLERA(H2-Pharma)"} +{"id": 28874, "instruction": "(R)-Piperazine-2-carboxamideをを化学構造で記述すると?", "response": "(R)-Piperazine-2-carboxamideをを化学構造で記述するとC5H11N3Oです。", "task": "formula", "name_q": "(R)-Piperazine-2-carboxamide", "name_a": "C5H11N3O"} +{"id": 25244, "instruction": "NTBをは分子式で表すと?", "response": "NTBをは分子式で表すとC26H25NO4です。", "task": "formula", "name_q": "NTB", "name_a": "C26H25NO4"} +{"id": 16084, "instruction": "心房静止 下位グループ Atrial cardiomyopathy with heart block Cardiomyopathy, familial, with conduction disturbanceの別名称は?", "response": "心房静止 下位グループ Atrial cardiomyopathy with heart block Cardiomyopathy, familial, with conduction disturbanceの別名称は心房停止です。", "task": "replace", "name_q": "心房静止 下位グループ Atrial cardiomyopathy with heart block Cardiomyopathy, familial, with conduction disturbance", "name_a": "心房停止"} +{"id": 31369, "instruction": "Lisocabtagene maraleucel (USAN/INN)を日本語表記で表すと?", "response": "Lisocabtagene maraleucel (USAN/INN)を日本語表記で表すとリソカブタゲンマラルユーセルです。", "task": "replace en to ja", "name_q": "Lisocabtagene maraleucel (USAN/INN)", "name_a": "リソカブタゲンマラルユーセル"} +{"id": 16021, "instruction": "Diclofenac etalhyaluronate sodium (JAN)を日本語に訳すと?", "response": "Diclofenac etalhyaluronate sodium (JAN)を日本語に訳すとジクロフェナクエタルヒアルロン酸ナトリウム (JAN)です。", "task": "replace en to ja", "name_q": "Diclofenac etalhyaluronate sodium (JAN)", "name_a": "ジクロフェナクエタルヒアルロン酸ナトリウム (JAN)"} +{"id": 17494, "instruction": "15,15'-Dihydroxy-beta-caroteneをを化学式で記述すると?", "response": "15,15'-Dihydroxy-beta-caroteneをを化学式で記述するとC40H58O2です。", "task": "formula", "name_q": "15,15'-Dihydroxy-beta-carotene", "name_a": "C40H58O2"} +{"id": 18838, "instruction": "過酸化マグネシウムの別表現は?", "response": "過酸化マグネシウムの別表現はMagnesium peroxideです。", "task": "replace", "name_q": "過酸化マグネシウム", "name_a": "Magnesium peroxide"} +{"id": 30321, "instruction": "Felbinac ethyl (JAN)をを組成式で表すと?", "response": "Felbinac ethyl (JAN)をを組成式で表すとC16H16O2です。", "task": "formula", "name_q": "Felbinac ethyl (JAN)", "name_a": "C16H16O2"} +{"id": 21174, "instruction": "Carbenoxolone (INN)をを分子式で書くと?", "response": "Carbenoxolone (INN)をを分子式で書くとC34H50O7です。", "task": "formula", "name_q": "Carbenoxolone (INN)", "name_a": "C34H50O7"} +{"id": 19038, "instruction": "Opelconazole (USAN/INN)をの化学式は?", "response": "Opelconazole (USAN/INN)をの化学式はC38H37F3N6O3です。", "task": "formula", "name_q": "Opelconazole (USAN/INN)", "name_a": "C38H37F3N6O3"} +{"id": 7447, "instruction": "ミオシンストレージミオパチー 上位グループ 先天性ミオパチー を英語で書くと?", "response": "ミオシンストレージミオパチー 上位グループ 先天性ミオパチー を英語で書くとHyaline body myopathy SUPERGRP Congenital myopathy です。", "task": "replace ja to en", "name_q": "ミオシンストレージミオパチー 上位グループ 先天性ミオパチー ", "name_a": "Hyaline body myopathy SUPERGRP Congenital myopathy "} +{"id": 18919, "instruction": "Perilla herb (JP18)を主材料とする医薬品は?", "response": "Perilla herb (JP18)を主材料とする医薬品はソヨウ(ツムラ)です。", "task": "product", "name_q": "Perilla herb (JP18)", "name_a": "ソヨウ(ツムラ)"} +{"id": 31079, "instruction": "トルエンジイソシアネートの別名称は?", "response": "トルエンジイソシアネートの別名称はToluene diisocyanatesです。", "task": "replace", "name_q": "トルエンジイソシアネート", "name_a": "Toluene diisocyanates"} +{"id": 19445, "instruction": "バレット食道を英語表記で表すと?", "response": "バレット食道を英語表記で表すとBarrett esophagusです。", "task": "replace ja to en", "name_q": "バレット食道", "name_a": "Barrett esophagus"} +{"id": 11752, "instruction": "モルフィンの異なる表記は?", "response": "モルフィンの異なる表記はMorphineです。", "task": "replace", "name_q": "モルフィン", "name_a": "Morphine"} +{"id": 22246, "instruction": "Fidanacogene elaparvovec-dzktの異なる表記は?", "response": "Fidanacogene elaparvovec-dzktの異なる表記はBeqvez (TN)です。", "task": "replace", "name_q": "Fidanacogene elaparvovec-dzkt", "name_a": "Beqvez (TN)"} +{"id": 25807, "instruction": "イプロシノジン塩酸塩をを化学式で書くと?", "response": "イプロシノジン塩酸塩をを化学式で書くとC40H65N13O13. xHClです。", "task": "formula", "name_q": "イプロシノジン塩酸塩", "name_a": "C40H65N13O13. xHCl"} +{"id": 9346, "instruction": "1,3-Dimethylureaは別の呼び方では?", "response": "1,3-Dimethylureaは別の呼び方ではN,N'-Dimethylureaです。", "task": "replace", "name_q": "1,3-Dimethylurea", "name_a": "N,N'-Dimethylurea"} +{"id": 4361, "instruction": "Vernakalant hydrochloride (USAN)をを組成式で書くと?", "response": "Vernakalant hydrochloride (USAN)をを組成式で書くとC20H31NO4. HClです。", "task": "formula", "name_q": "Vernakalant hydrochloride (USAN)", "name_a": "C20H31NO4. HCl"} +{"id": 10389, "instruction": "Hydroxypropylmethylcelluloseの日本語訳は?", "response": "Hydroxypropylmethylcelluloseの日本語訳はヒプロメロース (JP18)です。", "task": "replace en to ja", "name_q": "Hydroxypropylmethylcellulose", "name_a": "ヒプロメロース (JP18)"} +{"id": 19149, "instruction": "tRNA containing N2-methylguanineをは化学構造で表すと?", "response": "tRNA containing N2-methylguanineをは化学構造で表すとC11H16N5O8P(C5H8O6PR)n(C5H8O6PR)nです。", "task": "formula", "name_q": "tRNA containing N2-methylguanine", "name_a": "C11H16N5O8P(C5H8O6PR)n(C5H8O6PR)n"} +{"id": 23884, "instruction": "Sermion (TN)を日本語で書くと?", "response": "Sermion (TN)を日本語で書くとニセルゴリン (JP18)です。", "task": "replace en to ja", "name_q": "Sermion (TN)", "name_a": "ニセルゴリン (JP18)"} +{"id": 14853, "instruction": "クラズリルをの化学式は?", "response": "クラズリルをの化学式はC17H10Cl2N4O2です。", "task": "formula", "name_q": "クラズリル", "name_a": "C17H10Cl2N4O2"} +{"id": 13321, "instruction": "Al-Raqad syndromeの日本語表記は?", "response": "Al-Raqad syndromeの日本語表記はAl-Raqad 症候群です。", "task": "replace en to ja", "name_q": "Al-Raqad syndrome", "name_a": "Al-Raqad 症候群"} +{"id": 1758, "instruction": "マンノース結合レクチン経路の構成要素の障害の異なる表現は?", "response": "マンノース結合レクチン経路の構成要素の障害の異なる表現は補体レクチン経路の障害 (LCAPD) 下位グループ マンノース結合レクチン欠損症 MASP-2 欠損症 Ficolin 3 欠損症 上位グループ 自然免疫の障害 原発性免疫不全症 です。", "task": "replace", "name_q": "マンノース結合レクチン経路の構成要素の障害", "name_a": "補体レクチン経路の障害 (LCAPD) 下位グループ マンノース結合レクチン欠損症 MASP-2 欠損症 Ficolin 3 欠損症 上位グループ 自然免疫の障害 原発性免疫不全症 "} +{"id": 24257, "instruction": "(17Z)-Hexacosenoyl-CoAの別の呼び方は?", "response": "(17Z)-Hexacosenoyl-CoAの別の呼び方はXimenoyl-CoAです。", "task": "replace", "name_q": "(17Z)-Hexacosenoyl-CoA", "name_a": "Ximenoyl-CoA"} +{"id": 29819, "instruction": "プリリキシマブを英語で記述すると?", "response": "プリリキシマブを英語で記述するとPriliximab (USAN/INN)です。", "task": "replace ja to en", "name_q": "プリリキシマブ", "name_a": "Priliximab (USAN/INN)"} +{"id": 8467, "instruction": "プロスタレンを英語に訳すと?", "response": "プロスタレンを英語に訳すとProstalene (USAN)です。", "task": "replace ja to en", "name_q": "プロスタレン", "name_a": "Prostalene (USAN)"} +{"id": 24654, "instruction": "Slentrol [veterinary] (TN)の日本語訳は?", "response": "Slentrol [veterinary] (TN)の日本語訳はジルロタピドです。", "task": "replace en to ja", "name_q": "Slentrol [veterinary] (TN)", "name_a": "ジルロタピド"} +{"id": 8933, "instruction": "Secrepan (TN)を使用した医薬品名は?", "response": "Secrepan (TN)を使用した医薬品名はHUMANSECRETIN(ChiRhoClin)です。", "task": "product", "name_q": "Secrepan (TN)", "name_a": "HUMANSECRETIN(ChiRhoClin)"} +{"id": 28326, "instruction": "Benzo[a]pyrene-9,10-oxideをを化学構造で表すと?", "response": "Benzo[a]pyrene-9,10-oxideをを化学構造で表すとC20H12Oです。", "task": "formula", "name_q": "Benzo[a]pyrene-9,10-oxide", "name_a": "C20H12O"} +{"id": 29018, "instruction": "Polyprenylphosphate-glucoseをは化学構造で表すと?", "response": "Polyprenylphosphate-glucoseをは化学構造で表すとC11H21O9P(C5H8)nです。", "task": "formula", "name_q": "Polyprenylphosphate-glucose", "name_a": "C11H21O9P(C5H8)n"} +{"id": 31438, "instruction": "3C 症候群を英語で記述すると?", "response": "3C 症候群を英語で記述すると3C syndromeです。", "task": "replace ja to en", "name_q": "3C 症候群", "name_a": "3C syndrome"} +{"id": 25901, "instruction": "Adopronをは組成式で表すと?", "response": "Adopronをは組成式で表すとC18H22Oです。", "task": "formula", "name_q": "Adopron", "name_a": "C18H22O"} +{"id": 9785, "instruction": "Barth syndrome SUPERGRP Dilated cardiomyopathy Dystrophinopathies 3-Methylglutaconic aciduria を日本語で記述すると?", "response": "Barth syndrome SUPERGRP Dilated cardiomyopathy Dystrophinopathies 3-Methylglutaconic aciduria を日本語で記述するとバース症候群 上位グループ 拡張型心筋症 ジストロフィン異常症 メチルグルタコン酸尿症 です。", "task": "replace en to ja", "name_q": "Barth syndrome SUPERGRP Dilated cardiomyopathy Dystrophinopathies 3-Methylglutaconic aciduria ", "name_a": "バース症候群 上位グループ 拡張型心筋症 ジストロフィン異常症 メチルグルタコン酸尿症 "} +{"id": 20850, "instruction": "4-Oxoprolineをを分子式で表すと?", "response": "4-Oxoprolineをを分子式で表すとC5H7NO3です。", "task": "formula", "name_q": "4-Oxoproline", "name_a": "C5H7NO3"} +{"id": 2041, "instruction": "2-ニトロフランをを化学式で記述すると?", "response": "2-ニトロフランをを化学式で記述するとC4H3NO3です。", "task": "formula", "name_q": "2-ニトロフラン", "name_a": "C4H3NO3"} +{"id": 5121, "instruction": "Metaraminol (INN)は別の呼び方では?", "response": "Metaraminol (INN)は別の呼び方ではメタラミノールです。", "task": "replace", "name_q": "Metaraminol (INN)", "name_a": "メタラミノール"} +{"id": 13607, "instruction": "(5R)-5-Hydroxy-L-lysineをを化学構造で表すと?", "response": "(5R)-5-Hydroxy-L-lysineをを化学構造で表すとC6H14N2O3です。", "task": "formula", "name_q": "(5R)-5-Hydroxy-L-lysine", "name_a": "C6H14N2O3"} +{"id": 15156, "instruction": "ALPRAZOLAM(BreckenridgePharmaceutical)を使用した薬品は?", "response": "ALPRAZOLAM(BreckenridgePharmaceutical)を使用した薬品はALPRAZOLAM(HikmaPharmaceuticalsUSA)です。", "task": "product", "name_q": "ALPRAZOLAM(BreckenridgePharmaceutical)", "name_a": "ALPRAZOLAM(HikmaPharmaceuticalsUSA)"} +{"id": 32104, "instruction": "Amfetaminil (INN)をを組成式で書くと?", "response": "Amfetaminil (INN)をを組成式で書くとC17H18N2です。", "task": "formula", "name_q": "Amfetaminil (INN)", "name_a": "C17H18N2"} +{"id": 15976, "instruction": "Phosphatidyl esterをを化学式で表すと?", "response": "Phosphatidyl esterをを化学式で表すとC5H6O8PR3です。", "task": "formula", "name_q": "Phosphatidyl ester", "name_a": "C5H6O8PR3"} +{"id": 57, "instruction": "Cellulose, microcrystalline (NF)の異なる表記は?", "response": "Cellulose, microcrystalline (NF)の異なる表記はMicrocrystalline cellulose (JP18)です。", "task": "replace", "name_q": "Cellulose, microcrystalline (NF)", "name_a": "Microcrystalline cellulose (JP18)"} +{"id": 27475, "instruction": "5'-Acetylphosphoadenosineをを分子式で記述すると?", "response": "5'-Acetylphosphoadenosineをを分子式で記述するとC12H16N5O8Pです。", "task": "formula", "name_q": "5'-Acetylphosphoadenosine", "name_a": "C12H16N5O8P"} +{"id": 12482, "instruction": "コケモモヨウを英語で記述すると?", "response": "コケモモヨウを英語で記述するとCowberry leafです。", "task": "replace ja to en", "name_q": "コケモモヨウ", "name_a": "Cowberry leaf"} +{"id": 20064, "instruction": "Adalin (TN)をを化学構造で記述すると?", "response": "Adalin (TN)をを化学構造で記述するとC7H13BrN2O2です。", "task": "formula", "name_q": "Adalin (TN)", "name_a": "C7H13BrN2O2"} +{"id": 12891, "instruction": "Noscapine (JP18/USP/INN)をの分子式は?", "response": "Noscapine (JP18/USP/INN)をの分子式はC22H23NO7です。", "task": "formula", "name_q": "Noscapine (JP18/USP/INN)", "name_a": "C22H23NO7"} +{"id": 19558, "instruction": "METHOCARBAMOL(BryantRanchPrepack)を利用した薬品は?", "response": "METHOCARBAMOL(BryantRanchPrepack)を利用した薬品はMETHOCARBAMOL(KeyTherapeutics)です。", "task": "product", "name_q": "METHOCARBAMOL(BryantRanchPrepack)", "name_a": "METHOCARBAMOL(KeyTherapeutics)"} +{"id": 34210, "instruction": "Optic nerve hypoplasia SUPERGRP Septo-optic dysplasia Ocular coloboma を日本語で記述すると?", "response": "Optic nerve hypoplasia SUPERGRP Septo-optic dysplasia Ocular coloboma を日本語で記述すると視神経形成不全 上位グループ 中隔視神経形成異常症 眼組織欠損症 です。", "task": "replace en to ja", "name_q": "Optic nerve hypoplasia SUPERGRP Septo-optic dysplasia Ocular coloboma ", "name_a": "視神経形成不全 上位グループ 中隔視神経形成異常症 眼組織欠損症 "} +{"id": 27966, "instruction": "SELEXIPAG(ActelionPharmaceuticalsUS)を利用した薬品名は?", "response": "SELEXIPAG(ActelionPharmaceuticalsUS)を利用した薬品名はウプトラビ(日本新薬)です。", "task": "product", "name_q": "SELEXIPAG(ActelionPharmaceuticalsUS)", "name_a": "ウプトラビ(日本新薬)"} +{"id": 15558, "instruction": "Bakankosideの別表現は?", "response": "Bakankosideの別表現はバカンコシドです。", "task": "replace", "name_q": "Bakankoside", "name_a": "バカンコシド"} +{"id": 34259, "instruction": "酢酸テリパラチド水和物をを分子式で表すと?", "response": "酢酸テリパラチド水和物をを分子式で表すとC181H291N55O51S2. (C2H4O2)x. yH2Oです。", "task": "formula", "name_q": "酢酸テリパラチド水和物", "name_a": "C181H291N55O51S2. (C2H4O2)x. yH2O"} +{"id": 22363, "instruction": "Erythema multiformeの日本語表記は?", "response": "Erythema multiformeの日本語表記は多型紅斑です。", "task": "replace en to ja", "name_q": "Erythema multiforme", "name_a": "多型紅斑"} +{"id": 32562, "instruction": "Junci herbaを日本語で書くと?", "response": "Junci herbaを日本語で書くと灯心草です。", "task": "replace en to ja", "name_q": "Junci herba", "name_a": "灯心草"} +{"id": 31207, "instruction": "ライエル症候群を英語に訳すと?", "response": "ライエル症候群を英語に訳すとToxic epidermal necrolysisです。", "task": "replace ja to en", "name_q": "ライエル症候群", "name_a": "Toxic epidermal necrolysis"} +{"id": 15998, "instruction": "ビジソミドは別の呼び方では?", "response": "ビジソミドは別の呼び方ではBidisomide (USAN/INN)です。", "task": "replace", "name_q": "ビジソミド", "name_a": "Bidisomide (USAN/INN)"} +{"id": 2312, "instruction": "Corioseをを分子式で記述すると?", "response": "Corioseをを分子式で記述するとC7H14O7です。", "task": "formula", "name_q": "Coriose", "name_a": "C7H14O7"} +{"id": 21357, "instruction": "Sarafotoxin S6bの別の言い方は?", "response": "Sarafotoxin S6bの別の言い方はサラフォトキシンS6bです。", "task": "replace", "name_q": "Sarafotoxin S6b", "name_a": "サラフォトキシンS6b"} +{"id": 24832, "instruction": "4',7-Dihydroxyflavanoneの別の言い方は?", "response": "4',7-Dihydroxyflavanoneの別の言い方はLiquiritigeninです。", "task": "replace", "name_q": "4',7-Dihydroxyflavanone", "name_a": "Liquiritigenin"} +{"id": 24045, "instruction": "Chebulagic acidの異なる表現は?", "response": "Chebulagic acidの異なる表現はケブラグ酸です。", "task": "replace", "name_q": "Chebulagic acid", "name_a": "ケブラグ酸"} +{"id": 27121, "instruction": "Toreforant (USAN/INN)をの組成式は?", "response": "Toreforant (USAN/INN)をの組成式はC23H32N6です。", "task": "formula", "name_q": "Toreforant (USAN/INN)", "name_a": "C23H32N6"} +{"id": 26485, "instruction": "Weissenbacher-Zweymuller syndromeを日本語に訳すと?", "response": "Weissenbacher-Zweymuller syndromeを日本語に訳すとWeissenbacher-Zweymuller 症候群です。", "task": "replace en to ja", "name_q": "Weissenbacher-Zweymuller syndrome", "name_a": "Weissenbacher-Zweymuller 症候群"} +{"id": 6250, "instruction": "Chediak-Higashi syndrome SUPERGRP Other phagocyte defects Disorders of innate immunity Primary immunodeficiency disease Defects in lysosomal trafficking Lysosomal storage disease を日本語で書くと?", "response": "Chediak-Higashi syndrome SUPERGRP Other phagocyte defects Disorders of innate immunity Primary immunodeficiency disease Defects in lysosomal trafficking Lysosomal storage disease を日本語で書くとチェディアック・東症候群 上位グループ 他の食細胞の障害 自然免疫の障害 原発性免疫不全症 リソソーム輸送障害 ライソゾーム病 (リソソーム蓄積症) です。", "task": "replace en to ja", "name_q": "Chediak-Higashi syndrome SUPERGRP Other phagocyte defects Disorders of innate immunity Primary immunodeficiency disease Defects in lysosomal trafficking Lysosomal storage disease ", "name_a": "チェディアック・東症候群 上位グループ 他の食細胞の障害 自然免疫の障害 原発性免疫不全症 リソソーム輸送障害 ライソゾーム病 (リソソーム蓄積症) "} +{"id": 10380, "instruction": "Carbomer 934P (NF)の異なる名称は?", "response": "Carbomer 934P (NF)の異なる名称はCarbopol 934P (TN)です。", "task": "replace", "name_q": "Carbomer 934P (NF)", "name_a": "Carbopol 934P (TN)"} +{"id": 24565, "instruction": "Arsanilic acid (USP/INN)を言い換えると?", "response": "Arsanilic acid (USP/INN)を言い換えるとアルサニル酸です。", "task": "replace", "name_q": "Arsanilic acid (USP/INN)", "name_a": "アルサニル酸"} +{"id": 20762, "instruction": "Arginine aspartateの英語表記は?", "response": "Arginine aspartateの英語表記はSargenor (TN)です。", "task": "replace ja to en", "name_q": "Arginine aspartate", "name_a": "Sargenor (TN)"} +{"id": 19837, "instruction": "Calcium oxideの別の呼び方は?", "response": "Calcium oxideの別の呼び方はLimeです。", "task": "replace", "name_q": "Calcium oxide", "name_a": "Lime"} +{"id": 29155, "instruction": "Hereditary motor and sensory neuropathy SUBGROUP Peroneal muscular atrophy Dejerine-Sottas disease Cowchock syndrome の異なる表記は?", "response": "Hereditary motor and sensory neuropathy SUBGROUP Peroneal muscular atrophy Dejerine-Sottas disease Cowchock syndrome の異なる表記はCharcot-Marie-Tooth diseaseです。", "task": "replace", "name_q": "Hereditary motor and sensory neuropathy SUBGROUP Peroneal muscular atrophy Dejerine-Sottas disease Cowchock syndrome ", "name_a": "Charcot-Marie-Tooth disease"} +{"id": 5823, "instruction": "Diimineをを組成式で書くと?", "response": "Diimineをを組成式で書くとN2H2です。", "task": "formula", "name_q": "Diimine", "name_a": "N2H2"} +{"id": 339, "instruction": "S-Hydroprene (JAN)をは化学構造で表すと?", "response": "S-Hydroprene (JAN)をは化学構造で表すとC17H30O2です。", "task": "formula", "name_q": "S-Hydroprene (JAN)", "name_a": "C17H30O2"} +{"id": 20415, "instruction": "Bacterioruberinをは分子式で表すと?", "response": "Bacterioruberinをは分子式で表すとC50H76O4です。", "task": "formula", "name_q": "Bacterioruberin", "name_a": "C50H76O4"} +{"id": 5441, "instruction": "Oxacillin sodium hydrateを主材料とする商品名は?", "response": "Oxacillin sodium hydrateを主材料とする商品名はOXACILLIN(BaxterHealthcareCorporation)です。", "task": "product", "name_q": "Oxacillin sodium hydrate", "name_a": "OXACILLIN(BaxterHealthcareCorporation)"} +{"id": 17590, "instruction": "Rifapentineの別呼称は?", "response": "Rifapentineの別呼称はリファペンチンです。", "task": "replace", "name_q": "Rifapentine", "name_a": "リファペンチン"} +{"id": 14513, "instruction": "dTDP-4-amino-4,6-dideoxy-alpha-D-glucoseの異なる表記は?", "response": "dTDP-4-amino-4,6-dideoxy-alpha-D-glucoseの異なる表記はdTDP-4-amino-4,6-dideoxy-D-glucoseです。", "task": "replace", "name_q": "dTDP-4-amino-4,6-dideoxy-alpha-D-glucose", "name_a": "dTDP-4-amino-4,6-dideoxy-D-glucose"} +{"id": 12419, "instruction": "Secoisolariciresinolをは組成式で表すと?", "response": "Secoisolariciresinolをは組成式で表すとC20H26O6です。", "task": "formula", "name_q": "Secoisolariciresinol", "name_a": "C20H26O6"} +{"id": 29811, "instruction": "サリチル酸ナトリウムの別名は?", "response": "サリチル酸ナトリウムの別名はSodium salicylateです。", "task": "replace", "name_q": "サリチル酸ナトリウム", "name_a": "Sodium salicylate"} +{"id": 25618, "instruction": "21-Fluoro-11beta-hydroxypregn-4-ene-3,20-dioneをを分子式で表すと?", "response": "21-Fluoro-11beta-hydroxypregn-4-ene-3,20-dioneをを分子式で表すとC21H29FO3です。", "task": "formula", "name_q": "21-Fluoro-11beta-hydroxypregn-4-ene-3,20-dione", "name_a": "C21H29FO3"} +{"id": 19691, "instruction": "アファメラノチド酢酸塩を英語で記述すると?", "response": "アファメラノチド酢酸塩を英語で記述するとAfamelanotide acetate (USAN)です。", "task": "replace ja to en", "name_q": "アファメラノチド酢酸塩", "name_a": "Afamelanotide acetate (USAN)"} +{"id": 15571, "instruction": "Trogopterus fecesを日本語で記述すると?", "response": "Trogopterus fecesを日本語で記述すると五霊脂です。", "task": "replace en to ja", "name_q": "Trogopterus feces", "name_a": "五霊脂"} +{"id": 14313, "instruction": "ピリドキサールリン酸エステル水和物 (JP18)の英訳は?", "response": "ピリドキサールリン酸エステル水和物 (JP18)の英訳はHipyridoxin (TN)です。", "task": "replace ja to en", "name_q": "ピリドキサールリン酸エステル水和物 (JP18)", "name_a": "Hipyridoxin (TN)"} +{"id": 3976, "instruction": "(-)-ソレノプシン Aの別記述は?", "response": "(-)-ソレノプシン Aの別記述は(-)-Solenopsin Aです。", "task": "replace", "name_q": "(-)-ソレノプシン A", "name_a": "(-)-Solenopsin A"} +{"id": 12442, "instruction": "Ecalcidene (USAN/INN)をを分子式で記述すると?", "response": "Ecalcidene (USAN/INN)をを分子式で記述するとC29H45NO3です。", "task": "formula", "name_q": "Ecalcidene (USAN/INN)", "name_a": "C29H45NO3"} +{"id": 1745, "instruction": "Cevan-6-one, 3,20-dihydroxy-, (3-beta,5-alpha,17-beta)-の別名称は?", "response": "Cevan-6-one, 3,20-dihydroxy-, (3-beta,5-alpha,17-beta)-の別名称はImperialineです。", "task": "replace", "name_q": "Cevan-6-one, 3,20-dihydroxy-, (3-beta,5-alpha,17-beta)-", "name_a": "Imperialine"} +{"id": 5285, "instruction": "Trusopt (TN)の日本語表記は?", "response": "Trusopt (TN)の日本語表記はドルゾラミドです。", "task": "replace en to ja", "name_q": "Trusopt (TN)", "name_a": "ドルゾラミド"} +{"id": 28371, "instruction": "Efmarodocokin alfa (USAN/INN)をは化学式で表すと?", "response": "Efmarodocokin alfa (USAN/INN)をは化学式で表すとC3802H5934N1022O1142S36です。", "task": "formula", "name_q": "Efmarodocokin alfa (USAN/INN)", "name_a": "C3802H5934N1022O1142S36"} +{"id": 16133, "instruction": "17-Methyl-3-(2,4-cyclopentadien-1-ylidene)-5alpha-androstane-17beta-olをの化学式は?", "response": "17-Methyl-3-(2,4-cyclopentadien-1-ylidene)-5alpha-androstane-17beta-olをの化学式はC25H36Oです。", "task": "formula", "name_q": "17-Methyl-3-(2,4-cyclopentadien-1-ylidene)-5alpha-androstane-17beta-ol", "name_a": "C25H36O"} +{"id": 8791, "instruction": "FLUOROURACIL(EugiaUSLLC)を主材料とする商品名は?", "response": "FLUOROURACIL(EugiaUSLLC)を主材料とする商品名はCARAC(BauschHealthUS)です。", "task": "product", "name_q": "FLUOROURACIL(EugiaUSLLC)", "name_a": "CARAC(BauschHealthUS)"} +{"id": 25105, "instruction": "Tcelna (TN)の別記述は?", "response": "Tcelna (TN)の別記述はImilecleucel-T (USAN)です。", "task": "replace", "name_q": "Tcelna (TN)", "name_a": "Imilecleucel-T (USAN)"} +{"id": 10634, "instruction": "Minovincinineの別の呼び方は?", "response": "Minovincinineの別の呼び方はミノビンシニンです。", "task": "replace", "name_q": "Minovincinine", "name_a": "ミノビンシニン"} +{"id": 27418, "instruction": "rRNA containing N1-methylguanineをを組成式で表すと?", "response": "rRNA containing N1-methylguanineをを組成式で表すとC11H16N5O8P(C5H8O6PR)n(C5H8O6PR)nです。", "task": "formula", "name_q": "rRNA containing N1-methylguanine", "name_a": "C11H16N5O8P(C5H8O6PR)n(C5H8O6PR)n"} +{"id": 10468, "instruction": "Hartnup disorderの日本語表記は?", "response": "Hartnup disorderの日本語表記はハートナップ病です。", "task": "replace en to ja", "name_q": "Hartnup disorder", "name_a": "ハートナップ病"} +{"id": 22532, "instruction": "Spondyloocular syndromeを日本語に訳すと?", "response": "Spondyloocular syndromeを日本語に訳すと椎体眼症候群です。", "task": "replace en to ja", "name_q": "Spondyloocular syndrome", "name_a": "椎体眼症候群"} +{"id": 33831, "instruction": "Nalbuphine hydrochloride (USAN)をを化学式で記述すると?", "response": "Nalbuphine hydrochloride (USAN)をを化学式で記述するとC21H27NO4. HClです。", "task": "formula", "name_q": "Nalbuphine hydrochloride (USAN)", "name_a": "C21H27NO4. HCl"}